data_1zza_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1zza _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.514 ' O ' HG23 ' A' ' 17' ' ' VAL . 54.2 t . . . . . 0 N--CA 1.5 2.046 0 N-CA-C 109.02 -0.734 . . . . 2.52 109.02 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.7 t -69.89 -42.84 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.202 -0.937 . . . . 2.26 109.036 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 49.6 m -58.98 -51.36 70.39 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.771 -0.581 . . . . 2.17 109.985 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 14' ' ' VAL . 29.1 m -66.95 -33.17 61.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.387 -0.821 . . . . 2.33 110.271 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.504 HD11 HG23 ' A' ' 18' ' ' ILE . 6.9 mm -69.64 -41.13 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 120.925 -1.109 . . . . 2.31 109.091 178.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.3 t -64.76 -45.07 96.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 108.291 -1.003 . . . . 2.15 108.291 177.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.461 HG21 HD13 ' A' ' 24' ' ' ILE . 23.6 mm -62.06 -46.79 95.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.85 -0.796 . . . . 2.11 108.85 178.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 13.1 mt -59.75 -49.67 76.81 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.849 -0.797 . . . . 2.26 108.849 178.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.445 HD12 HG21 ' A' ' 18' ' ' ILE . 30.0 mt -56.44 -43.1 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.575 -0.703 . . . . 2.36 109.293 178.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.68 -46.84 83.69 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.588 -0.695 . . . . 1.9 109.536 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.461 HD13 HG21 ' A' ' 20' ' ' ILE . 66.1 mt -58.64 -48.29 86.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.446 -0.783 . . . . 2.13 108.978 178.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.61 -45.37 94.27 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.62 -0.675 . . . . 2.03 109.937 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.4 -45.37 93.83 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 109.071 -0.714 . . . . 1.76 109.071 178.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.27 -47.1 87.55 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.014 -0.735 . . . . 2.14 109.014 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.15 -44.26 94.91 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 108.88 -1.688 . . . . 1.36 108.88 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.14 -45.73 92.14 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.409 -1.053 . . . . 1.8 109.414 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.4 mt -57.58 -41.8 81.85 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.297 -0.631 . . . . 2.07 109.297 178.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 45.6 mt -71.36 -36.04 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.302 -0.874 . . . . 1.83 110.09 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.6 tt -68.06 -45.19 74.54 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.234 -0.916 . . . . 2.12 109.825 178.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.812 0 O-C-N 121.169 -0.957 . . . . 1.29 111.469 -179.546 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 . . . . . 0 N--CA 1.495 1.79 0 N-CA-C 109.086 -0.709 . . . . 1.78 109.086 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.541 ' HA ' ' HG2' ' A' ' 70' ' ' LYS . 4.6 t80 -72.7 -35.61 67.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.781 -0.574 . . . . 1.57 109.48 178.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.0 t -61.71 -31.15 71.28 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.644 -0.66 . . . . 2.79 109.744 178.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.533 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -93.78 -50.29 5.43 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.253 -0.904 . . . . 2.54 110.868 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.541 ' HG2' ' HA ' ' A' ' 67' ' ' TYR . 5.0 pttt -70.68 -36.22 73.21 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.267 -0.896 . . . . 1.9 111.225 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.437 ' N ' ' HD2' ' A' ' 72' ' ' PRO . . . -46.6 -61.67 4.08 Favored Glycine 0 N--CA 1.498 2.83 0 N-CA-C 109.277 -1.529 . . . . 1.58 109.277 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.492 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 41.5 Cg_endo -67.23 -42.48 7.64 Favored 'Trans proline' 0 C--N 1.314 -1.242 0 O-C-N 124.039 1.547 . . . . 2.47 110.102 178.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -56.71 -44.54 81.66 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.959 -1.088 . . . . 3.05 109.815 178.876 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.0 t -71.05 -49.07 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.479 -0.763 . . . . 2.17 109.387 178.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 0.6 OUTLIER -55.26 -39.04 69.33 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.746 -0.596 . . . . 2.18 110.078 179.31 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.492 ' HD2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -68.37 -55.04 13.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.482 -0.761 . . . . 3.25 109.434 178.774 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.616 ' HG3' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -59.91 -31.27 69.67 Favored 'General case' 0 N--CA 1.505 2.282 0 C-N-CA 119.446 -0.902 . . . . 3.72 110.281 179.592 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.616 ' N ' ' HG3' ' A' ' 77' ' ' LYS . . . -71.13 -41.9 69.91 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.559 -0.713 . . . . 2.23 109.601 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 32.5 mttp -73.74 -34.58 64.82 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.441 -0.577 . . . . 2.74 109.441 178.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 71.6 mt . . . . . 0 N--CA 1.496 1.844 0 O-C-N 120.987 -1.071 . . . . 4.1 110.131 179.379 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 36.5 t . . . . . 0 N--CA 1.5 2.044 0 N-CA-C 109.347 -0.612 . . . . 1.73 109.347 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.7 t -62.81 -46.0 97.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.567 -0.708 . . . . 1.78 109.159 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.454 HG23 HD11 ' A' ' 20' ' ' ILE . 65.6 m -56.64 -46.66 80.9 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 121.206 0.527 . . . . 1.56 109.692 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.6 t -65.25 -40.71 89.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 C-N-CA 119.695 -0.802 . . . . 1.57 109.175 178.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.4 mm -60.98 -40.13 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.122 -0.986 . . . . 1.73 109.039 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 49.7 t -65.58 -45.58 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.181 -1.044 . . . . 1.49 108.181 177.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.454 HD11 HG23 ' A' ' 16' ' ' THR . 85.8 mt -61.28 -49.53 84.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.915 -0.772 . . . . 1.49 108.915 178.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 11.2 mt -57.71 -48.7 78.84 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.987 -0.746 . . . . 1.63 108.987 178.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.3 mt -56.95 -44.01 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 C-N-CA 119.845 -0.742 . . . . 1.62 109.195 178.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.36 -45.99 88.6 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.599 -0.688 . . . . 1.45 109.752 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.5 mt -59.2 -47.26 90.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.327 -0.858 . . . . 1.47 108.984 178.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.0 -44.95 95.64 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.591 -0.693 . . . . 1.41 109.849 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.97 -44.71 96.93 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.54 -0.725 . . . . 1.59 109.237 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.501 HD22 HD13 ' A' ' 31' ' ' ILE . 0.7 OUTLIER -62.56 -45.92 90.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.44 -0.788 . . . . 1.81 108.924 178.301 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.47 -43.98 95.6 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 108.69 -1.764 . . . . 1.01 108.69 178.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.68 -45.13 84.03 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.611 -0.935 . . . . 1.51 109.748 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.0 mt -58.52 -41.43 85.44 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.758 -0.589 . . . . 2.0 109.426 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.501 HD13 HD22 ' A' ' 27' ' ' LEU . 40.8 mt -69.32 -48.08 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.54 -0.725 . . . . 1.81 109.478 178.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.83 -49.8 75.45 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.585 -0.697 . . . . 2.33 110.189 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.747 0 N-CA-C 110.452 -1.059 . . . . 1.26 110.452 -179.948 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.445 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 2.0 tt0 . . . . . 0 N--CA 1.499 1.979 0 N-CA-C 109.35 -0.611 . . . . 1.61 109.35 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.499 ' HA ' ' HG2' ' A' ' 70' ' ' LYS . 0.5 OUTLIER -68.84 -41.77 78.08 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.885 -0.783 . . . . 3.45 108.885 178.201 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 68.4 m -60.33 -37.89 82.03 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 116.19 -0.459 . . . . 1.84 110.375 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.62 -41.58 16.23 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.278 -0.889 . . . . 1.9 110.726 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.559 ' HA ' ' HB3' ' A' ' 73' ' ' CYS . 0.2 OUTLIER -65.82 -35.08 79.67 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.38 -0.825 . . . . 1.21 111.5 -179.59 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.425 ' N ' ' HD2' ' A' ' 72' ' ' PRO . . . -48.97 -61.36 5.37 Favored Glycine 0 N--CA 1.505 3.259 0 N-CA-C 109.715 -1.354 . . . . 1.34 109.715 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 71' ' ' GLY . 40.9 Cg_endo -66.97 -39.54 13.78 Favored 'Trans proline' 0 C--N 1.315 -1.225 0 O-C-N 123.755 1.397 . . . . 1.69 109.864 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.559 ' HB3' ' HA ' ' A' ' 70' ' ' LYS . 2.6 t -62.17 -48.5 79.78 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.878 -1.139 . . . . 1.7 109.609 178.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.696 ' HA ' ' HE3' ' A' ' 77' ' ' LYS . 25.4 t -57.98 -49.93 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.286 -1.005 . . . . 1.53 108.286 178.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -57.47 -40.05 77.7 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.763 -0.775 . . . . 1.58 109.318 177.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.9 ttm180 -63.78 -54.88 28.21 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.694 -0.629 . . . . 1.81 111.187 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.696 ' HE3' ' HA ' ' A' ' 74' ' ' VAL . 1.6 pttt -70.62 -33.12 70.68 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.02 -1.05 . . . . 2.32 110.605 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.07 -47.77 67.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.327 -0.858 . . . . 1.58 109.636 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 16.4 mmtm -67.23 -44.53 79.26 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.377 -0.827 . . . . 1.79 109.805 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 tp . . . . . 0 N--CA 1.495 1.785 0 O-C-N 121.628 -0.67 . . . . 2.91 111.155 179.868 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.575 ' O ' HG23 ' A' ' 17' ' ' VAL . 37.9 t . . . . . 0 N--CA 1.498 1.964 0 N-CA-C 109.289 -0.634 . . . . 2.12 109.289 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.585 ' HA ' HG12 ' A' ' 18' ' ' ILE . 25.0 t -67.09 -37.73 79.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.326 -0.859 . . . . 2.0 109.468 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 98.4 m -64.61 -44.07 91.74 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.377 -0.827 . . . . 2.46 110.29 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 14' ' ' VAL . 0.5 OUTLIER -71.48 -37.39 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 C-N-CA 119.133 -1.027 . . . . 2.48 110.908 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.585 HG12 ' HA ' ' A' ' 15' ' ' VAL . 8.7 pt -69.19 -33.74 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 120.299 -1.501 . . . . 2.38 109.52 178.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.492 ' N ' HG13 ' A' ' 18' ' ' ILE . 38.6 t -69.63 -44.3 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.287 -1.005 . . . . 1.97 108.287 177.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.433 HD12 HG21 ' A' ' 20' ' ' ILE . 2.6 mm -63.52 -46.78 94.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.401 -0.812 . . . . 2.16 109.027 178.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.577 ' HA ' HG12 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -63.28 -43.47 97.82 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.515 -0.74 . . . . 2.1 109.031 178.811 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.551 ' N ' ' HG ' ' A' ' 21' ' ' LEU . 7.5 mm -62.14 -39.07 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.029 -1.044 . . . . 2.21 109.0 178.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.29 -51.0 61.74 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.549 -0.719 . . . . 1.79 110.715 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.577 HG12 ' HA ' ' A' ' 21' ' ' LEU . 40.8 pt -62.36 -37.12 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.807 -1.183 . . . . 2.15 109.266 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.495 ' N ' HG13 ' A' ' 24' ' ' ILE . . . -65.15 -46.59 80.27 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.418 -0.801 . . . . 1.97 109.192 178.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 22' ' ' ILE . . . -61.6 -43.08 99.53 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.697 -0.853 . . . . 1.94 108.697 178.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.3 tt -60.38 -48.17 82.91 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.953 -0.758 . . . . 2.12 108.953 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.72 -46.58 92.07 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 108.839 -1.705 . . . . 1.4 108.839 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.69 -42.98 99.66 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.456 -1.026 . . . . 1.97 109.558 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.4 mt -61.2 -41.3 96.58 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 109.085 -0.709 . . . . 2.29 109.085 178.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 23.5 mm -65.35 -46.14 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.519 -0.738 . . . . 1.81 109.142 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.18 -48.61 80.77 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.543 -0.723 . . . . 2.52 109.63 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.605 0 N-CA-C 110.017 -1.233 . . . . 1.53 110.017 179.221 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.427 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 6.0 tt0 . . . . . 0 N--CA 1.496 1.863 0 N-CA-C 108.758 -0.83 . . . . 2.64 108.758 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.407 ' HA ' ' HG2' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -74.44 -45.8 44.0 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 109.259 -0.645 . . . . 4.3 109.259 178.106 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 69.9 m -59.21 -37.09 76.6 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.748 -0.595 . . . . 2.42 110.488 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.432 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -84.68 -46.48 11.43 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.054 -1.028 . . . . 1.73 111.243 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.427 ' HB3' ' O ' ' A' ' 66' ' ' GLN . 12.3 ptpt -65.17 -35.66 81.78 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.338 -0.851 . . . . 2.75 111.213 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -49.07 -64.22 3.44 Favored Glycine 0 N--CA 1.502 3.068 0 N-CA-C 109.795 -1.322 . . . . 1.66 109.795 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.11 -37.15 26.5 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.734 1.386 . . . . 1.66 110.245 179.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 2.5 t -62.41 -46.04 90.39 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.039 -1.038 . . . . 1.76 109.593 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.5 t -68.66 -47.41 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.561 -0.712 . . . . 1.82 109.311 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -57.41 -40.59 78.61 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 119.799 -0.76 . . . . 1.5 109.405 178.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.8 ttm180 -65.11 -44.22 89.47 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.53 -0.731 . . . . 2.9 109.473 178.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.83 -38.7 89.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -0.871 . . . . 3.29 109.786 178.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.04 -50.71 53.59 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.377 0.608 . . . . 1.54 110.087 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.64 -30.8 71.56 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.693 -0.63 . . . . 1.99 110.109 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.8 0 O-C-N 121.245 -0.909 . . . . 2.72 109.881 178.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.431 ' O ' HG22 ' A' ' 17' ' ' VAL . 72.1 t . . . . . 0 N--CA 1.502 2.153 0 CA-C-O 121.417 0.627 . . . . 2.86 110.16 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.2 m -71.89 -42.42 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.2 -0.938 . . . . 3.86 109.847 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 56.7 m -58.22 -50.65 72.82 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.554 -0.717 . . . . 3.42 110.175 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.431 HG22 ' O ' ' A' ' 14' ' ' VAL . 27.4 m -66.03 -39.63 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.45 -0.781 . . . . 2.59 110.104 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.559 ' O ' HG12 ' A' ' 22' ' ' ILE . 10.9 mm -64.98 -43.52 96.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 O-C-N 120.994 -1.066 . . . . 2.65 109.445 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.496 ' HA ' HG12 ' A' ' 22' ' ' ILE . 32.2 t -61.78 -40.43 86.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 119.743 -0.783 . . . . 3.25 108.955 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.407 HD13 ' HA ' ' A' ' 20' ' ' ILE . 27.4 mm -69.43 -41.24 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.26 -0.9 . . . . 2.91 108.746 178.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 39.6 mt -61.99 -50.62 71.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.712 -0.617 . . . . 1.73 109.491 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.559 HG12 ' O ' ' A' ' 18' ' ' ILE . 43.5 pt -61.99 -41.16 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 120.815 -1.178 . . . . 2.87 109.409 178.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.533 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -60.27 -45.86 91.85 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.04 -0.726 . . . . 2.38 109.04 178.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 39.0 mt -59.27 -48.26 87.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.689 -0.856 . . . . 1.92 108.689 178.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.98 -42.5 94.32 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.697 -0.627 . . . . 1.8 109.878 178.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.84 -45.53 92.17 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.922 -0.769 . . . . 2.13 108.922 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.68 -45.55 93.51 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.806 -0.813 . . . . 2.01 108.806 178.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.84 -45.54 94.84 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 108.54 -1.824 . . . . 1.13 108.54 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.5 -44.73 95.67 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.507 -0.996 . . . . 1.97 109.36 178.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.3 mt -56.78 -42.87 80.19 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.088 -0.708 . . . . 2.37 109.088 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.8 mt -68.83 -49.18 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 109.07 -0.715 . . . . 1.81 109.07 178.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.83 -46.05 71.07 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.496 -0.753 . . . . 3.49 109.527 178.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.65 0 N-CA-C 109.925 -1.27 . . . . 1.97 109.925 179.066 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.446 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 6.5 tp-100 . . . . . 0 N--CA 1.495 1.776 0 N-CA-C 108.918 -0.771 . . . . 2.64 108.918 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -62.71 -42.45 99.66 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.518 -0.738 . . . . 2.79 109.459 178.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.2 m -56.72 -35.48 68.6 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-O 120.928 0.394 . . . . 2.94 110.703 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -91.69 -41.66 10.59 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.22 -0.925 . . . . 2.84 110.601 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' A' ' 66' ' ' GLN . 1.6 mmtp -65.23 -44.3 88.69 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.528 -0.733 . . . . 2.85 110.392 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -45.58 -63.68 2.67 Favored Glycine 0 N--CA 1.503 3.109 0 N-CA-C 110.22 -1.152 . . . . 1.93 110.22 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -66.65 -39.08 16.56 Favored 'Trans proline' 0 C--N 1.316 -1.18 0 O-C-N 123.783 1.412 . . . . 2.64 110.419 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 36.7 t -60.64 -43.9 97.02 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.997 -1.064 . . . . 3.08 109.679 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.8 t -70.46 -49.42 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.682 -0.636 . . . . 2.25 109.424 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.21 -31.21 68.83 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.536 0.684 . . . . 2.39 110.3 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.42 ' CZ ' HD13 ' A' ' 80' ' ' LEU . 2.2 tpt180 -75.28 -49.02 20.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.356 -0.84 . . . . 4.52 109.542 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.535 ' HG3' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -69.25 -26.95 65.04 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.364 -0.835 . . . . 3.83 109.662 179.237 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.535 ' N ' ' HG3' ' A' ' 77' ' ' LYS . . . -71.91 -52.28 18.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.451 -0.781 . . . . 2.19 108.946 178.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -68.45 -24.74 64.76 Favored 'General case' 0 N--CA 1.5 2.067 0 C-N-CA 120.48 -0.488 . . . . 2.58 110.312 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.42 HD13 ' CZ ' ' A' ' 76' ' ' ARG . 2.5 tp . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.23 -0.918 . . . . 4.04 109.53 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.546 ' O ' HG12 ' A' ' 18' ' ' ILE . 28.1 t . . . . . 0 N--CA 1.497 1.883 0 N-CA-C 109.222 -0.658 . . . . 1.91 109.222 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.558 ' HA ' HG12 ' A' ' 18' ' ' ILE . 49.8 t -68.25 -41.38 83.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.261 -0.899 . . . . 1.83 109.528 178.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 52.9 m -60.51 -47.5 85.9 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.403 -0.81 . . . . 2.29 109.785 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.466 HG21 ' O ' ' A' ' 14' ' ' VAL . 32.6 m -67.54 -41.65 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.465 -0.772 . . . . 2.2 111.272 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.558 HG12 ' HA ' ' A' ' 15' ' ' VAL . 4.0 pt -68.57 -33.56 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 120.292 -1.505 . . . . 1.82 109.925 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.482 ' N ' HG13 ' A' ' 18' ' ' ILE . 17.7 t -68.44 -44.39 83.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.24 -1.022 . . . . 1.84 108.24 177.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.452 HG22 HD13 ' A' ' 24' ' ' ILE . 69.5 mt -63.69 -49.23 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 108.843 -0.799 . . . . 2.37 108.843 178.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.546 ' HG ' ' N ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -60.71 -42.66 97.7 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 119.926 -0.71 . . . . 2.1 109.106 178.698 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.546 ' N ' ' HG ' ' A' ' 21' ' ' LEU . 14.9 mt -61.24 -44.13 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.226 -0.921 . . . . 1.65 109.131 178.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.9 -45.74 87.94 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.514 -0.741 . . . . 1.7 109.593 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.452 HD13 HG22 ' A' ' 20' ' ' ILE . 54.6 mt -58.79 -47.77 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.437 -0.789 . . . . 2.4 108.993 178.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.95 -44.83 95.94 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.561 -0.712 . . . . 1.72 109.935 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.57 -45.64 93.17 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 109.149 -0.685 . . . . 1.47 109.149 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.35 -45.96 92.2 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.488 -0.758 . . . . 2.38 108.978 178.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.22 -45.35 94.2 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 108.617 -1.793 . . . . 1.57 108.617 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.25 -44.94 93.77 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.639 -0.918 . . . . 1.72 109.888 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.7 mt -58.82 -41.28 86.49 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.618 -0.676 . . . . 2.0 109.516 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 53.2 mt -68.22 -47.0 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.272 -0.893 . . . . 2.11 109.305 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.71 -39.37 93.81 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.358 -0.839 . . . . 2.72 110.42 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.781 0 O-C-N 120.948 -1.095 . . . . 1.42 111.142 -179.658 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.468 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.812 0 N-CA-C 108.475 -0.935 . . . . 1.39 108.475 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -62.77 -41.45 99.23 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.586 -0.696 . . . . 3.01 109.473 178.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 63.7 m -60.39 -37.56 81.2 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 122.035 -0.416 . . . . 1.53 110.308 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -81.58 -39.82 23.98 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.163 -0.961 . . . . 1.58 110.221 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 66' ' ' GLN . 2.6 mmpp? -61.57 -42.63 99.12 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.577 -0.702 . . . . 1.26 110.54 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -43.09 -66.23 1.23 Allowed Glycine 0 N--CA 1.505 3.244 0 N-CA-C 110.526 -1.03 . . . . 0.95 110.526 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.406 ' HA ' ' HB3' ' A' ' 75' ' ' GLU . 40.5 Cg_endo -66.32 -38.73 19.54 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.753 1.396 . . . . 1.13 110.235 179.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.497 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -58.38 -44.82 89.07 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.039 -1.038 . . . . 1.98 109.487 178.495 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 69.6 t -74.39 -41.76 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.55 -0.718 . . . . 1.33 109.233 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.406 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 1.0 OUTLIER -54.75 -46.12 74.27 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 121.529 0.681 . . . . 1.06 109.474 178.532 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -69.09 -46.35 67.99 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.719 -0.613 . . . . 1.17 110.124 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.13 -36.29 79.36 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.531 -0.73 . . . . 2.37 110.099 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.25 -46.65 73.11 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.972 -0.751 . . . . 1.37 108.972 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 35.0 mtpt -62.48 -37.37 85.69 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.206 0.527 . . . . 1.54 110.559 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.2 tp . . . . . 0 N--CA 1.496 1.862 0 O-C-N 121.607 -0.683 . . . . 2.32 112.11 -178.683 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.557 ' O ' HG23 ' A' ' 17' ' ' VAL . 33.4 t . . . . . 0 N--CA 1.496 1.871 0 N-CA-C 109.265 -0.643 . . . . 2.46 109.265 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.458 ' HA ' HG12 ' A' ' 18' ' ' ILE . 33.9 t -68.21 -47.4 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.175 -0.953 . . . . 2.86 110.123 179.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.3 p -60.1 -37.98 81.58 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.522 -0.736 . . . . 2.77 110.987 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 14' ' ' VAL . 33.0 m -76.11 -37.71 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 120.946 -1.096 . . . . 2.21 111.095 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.525 HG12 ' O ' ' A' ' 14' ' ' VAL . 45.1 pt -70.54 -38.89 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.465 -1.397 . . . . 2.81 110.234 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.445 ' N ' HG13 ' A' ' 18' ' ' ILE . 33.7 m -68.95 -39.98 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 120.887 -1.133 . . . . 2.83 108.755 178.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.462 HD11 HG23 ' A' ' 20' ' ' ILE . 14.6 mm -65.99 -47.32 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.037 -1.039 . . . . 2.64 108.669 177.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.7 mt -59.09 -48.69 80.7 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.841 -0.8 . . . . 2.44 108.841 178.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.1 mt -56.65 -43.79 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.578 -0.702 . . . . 3.15 109.273 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.57 -46.0 87.88 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.621 -0.674 . . . . 2.53 109.779 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.462 HD12 HG21 ' A' ' 20' ' ' ILE . 71.0 mt -59.62 -46.67 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.356 -0.84 . . . . 2.37 108.893 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.65 -43.81 97.86 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.543 -0.723 . . . . 2.47 109.869 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.67 -44.29 96.62 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.532 -0.73 . . . . 2.7 109.141 178.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.2 tt -62.23 -45.94 91.1 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.839 -0.8 . . . . 2.67 108.839 178.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.45 -46.03 93.64 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 108.694 -1.762 . . . . 2.12 108.694 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.41 -43.6 97.06 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.504 -0.998 . . . . 2.77 109.915 179.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.6 mt -59.46 -41.08 88.87 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.595 -0.691 . . . . 3.2 109.613 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 17.7 mt -70.1 -45.73 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.303 -0.873 . . . . 2.58 109.546 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -50.25 74.22 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.668 -0.645 . . . . 3.17 110.01 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.753 0 N-CA-C 109.817 -1.313 . . . . 2.66 109.817 179.522 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.471 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 5.3 tt0 . . . . . 0 N--CA 1.495 1.793 0 N-CA-C 108.834 -0.802 . . . . 3.71 108.834 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.66 ' HA ' ' HG2' ' A' ' 70' ' ' LYS . 6.9 m-85 -69.12 -40.91 78.03 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.712 -0.617 . . . . 4.16 109.877 178.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.93 -37.88 86.34 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.626 -0.671 . . . . 3.49 110.194 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.529 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -83.02 -41.99 18.03 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.289 -0.882 . . . . 2.5 109.836 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.66 ' HG2' ' HA ' ' A' ' 67' ' ' TYR . 8.1 ptpt -65.78 -35.48 80.82 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.538 -0.726 . . . . 2.95 110.652 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 70' ' ' LYS . . . -43.52 -64.21 1.9 Allowed Glycine 0 N--CA 1.501 2.996 0 N-CA-C 109.384 -1.486 . . . . 2.29 109.384 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.613 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 43.2 Cg_endo -69.44 -45.54 1.72 Allowed 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.963 1.507 . . . . 2.68 110.054 178.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.529 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -55.29 -42.58 73.82 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 120.942 -1.098 . . . . 2.64 110.11 179.281 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.482 ' HA ' ' HG2' ' A' ' 77' ' ' LYS . 56.0 t -73.59 -45.21 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.831 -0.803 . . . . 2.25 108.831 178.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.57 ' HG2' ' HD2' ' A' ' 79' ' ' LYS . 1.6 tt0 -51.34 -45.19 62.24 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.872 0.844 . . . . 3.28 108.902 177.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.613 ' HD2' ' O ' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -73.55 -49.32 27.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.847 -0.533 . . . . 4.04 110.868 179.447 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.482 ' HG2' ' HA ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -66.82 -19.24 65.7 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.803 -1.185 . . . . 3.33 110.89 179.757 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -86.58 -39.96 15.66 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.775 -0.824 . . . . 2.37 108.775 179.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.57 ' HD2' ' HG2' ' A' ' 75' ' ' GLU . 13.3 mttt -68.29 -37.79 81.02 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.222 -1.029 . . . . 3.98 108.222 177.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.9 tp . . . . . 0 N--CA 1.487 1.419 0 O-C-N 121.924 -0.485 . . . . 4.14 110.494 179.384 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.57 ' O ' HG12 ' A' ' 18' ' ' ILE . 26.0 t . . . . . 0 N--CA 1.496 1.843 0 N-CA-C 109.265 -0.643 . . . . 3.07 109.265 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.62 ' HA ' HG12 ' A' ' 18' ' ' ILE . 16.5 t -70.45 -41.97 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.231 -0.918 . . . . 2.48 109.116 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.484 ' O ' HG12 ' A' ' 20' ' ' ILE . 40.7 m -57.16 -49.68 75.19 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.439 -0.788 . . . . 3.38 109.642 178.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.576 ' HA ' HG12 ' A' ' 20' ' ' ILE . 35.8 m -66.82 -44.04 89.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 C-N-CA 119.814 -0.754 . . . . 3.22 111.424 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.62 HG12 ' HA ' ' A' ' 15' ' ' VAL . 5.1 pt -66.14 -30.01 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 120.236 -1.54 . . . . 2.23 109.679 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.45 ' N ' HG13 ' A' ' 18' ' ' ILE . 8.3 t -70.59 -51.82 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.233 -0.917 . . . . 2.64 108.829 178.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.576 HG12 ' HA ' ' A' ' 17' ' ' VAL . 30.1 pt -64.46 -36.27 76.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.028 -1.045 . . . . 3.13 109.173 178.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.472 ' N ' HG13 ' A' ' 20' ' ' ILE . 13.0 mt -66.32 -47.22 74.25 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.378 -0.826 . . . . 2.4 108.831 177.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.4 HD11 ' HA ' ' A' ' 22' ' ' ILE . 7.3 mm -60.8 -41.35 88.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 108.724 -0.843 . . . . 2.38 108.724 178.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.53 -46.08 84.38 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.749 -0.595 . . . . 2.94 109.454 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 43.5 mt -61.14 -45.12 99.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.344 -0.848 . . . . 2.71 108.81 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.82 -44.87 91.95 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.519 -0.738 . . . . 2.24 109.671 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.28 -41.55 98.58 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.722 -0.844 . . . . 2.84 108.722 178.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.408 ' CD1' ' C ' ' A' ' 27' ' ' LEU . 3.2 tm? -61.91 -52.52 63.74 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.478 -0.934 . . . . 3.42 108.478 177.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.14 -43.96 83.71 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.166 -1.574 . . . . 2.34 109.166 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.29 -41.06 90.32 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.396 -1.061 . . . . 2.94 109.808 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.3 mt -62.38 -40.07 95.27 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.981 -0.748 . . . . 4.04 108.981 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.415 HD13 HG21 ' A' ' 31' ' ' ILE . 27.7 mm -71.05 -49.27 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.641 -0.662 . . . . 3.39 109.292 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.75 -46.09 84.98 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.542 -0.724 . . . . 3.45 109.616 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.666 0 N-CA-C 109.58 -1.408 . . . . 3.5 109.58 179.221 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.578 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 9.4 mm-40 . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 108.674 -0.862 . . . . 3.08 108.674 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -63.04 -41.36 99.48 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.404 -0.961 . . . . 2.43 108.404 178.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.508 ' O ' ' HD2' ' A' ' 72' ' ' PRO . 29.0 t -53.5 -42.63 67.53 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.496 -0.927 . . . . 1.93 108.496 178.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.05 -38.63 69.46 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 119.581 -0.848 . . . . 2.22 109.246 177.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.578 ' HG2' ' O ' ' A' ' 66' ' ' GLN . 4.6 mmtm -58.18 -52.34 65.97 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.425 -0.797 . . . . 2.79 110.245 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 70' ' ' LYS . . . -34.68 -68.38 0.23 Allowed Glycine 0 N--CA 1.51 3.602 0 N-CA-C 110.911 -0.876 . . . . 1.75 110.911 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.508 ' HD2' ' O ' ' A' ' 68' ' ' SER . 39.4 Cg_endo -66.51 -38.28 19.88 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.831 1.438 . . . . 2.86 110.219 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 34.3 t -61.99 -40.98 97.49 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.995 -1.065 . . . . 3.97 109.386 178.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 55.8 t -75.53 -48.22 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.655 -0.653 . . . . 3.09 109.511 178.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -57.44 -41.26 80.15 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.575 -0.898 . . . . 3.24 108.575 178.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.447 ' HB3' ' O ' ' A' ' 72' ' ' PRO . 0.3 OUTLIER -65.53 -46.72 78.49 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.675 -0.64 . . . . 5.8 109.736 178.465 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.0 -39.52 94.29 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.134 -0.978 . . . . 5.85 109.703 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.83 -46.74 64.97 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.947 -0.471 . . . . 4.18 110.278 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 76' ' ' ARG . 0.1 OUTLIER -69.53 -38.88 77.7 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.608 -0.683 . . . . 4.81 109.48 179.353 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.495 1.789 0 O-C-N 121.441 -0.787 . . . . 6.21 109.256 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.476 ' O ' HG21 ' A' ' 17' ' ' VAL . 51.1 t . . . . . 0 N--CA 1.499 1.989 0 N-CA-C 109.569 -0.53 . . . . 2.72 109.569 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.5 t -70.59 -43.15 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.073 -1.017 . . . . 2.38 109.394 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 87.7 m -59.32 -50.81 72.55 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.735 -0.603 . . . . 1.73 110.009 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.476 HG21 ' O ' ' A' ' 14' ' ' VAL . 33.1 m -66.78 -34.9 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.489 -0.757 . . . . 2.08 110.156 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.412 HD11 ' HA ' ' A' ' 18' ' ' ILE . 6.7 mm -68.08 -41.21 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 120.907 -1.121 . . . . 2.61 109.632 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.4 t -64.89 -44.74 96.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 108.289 -1.004 . . . . 2.14 108.289 177.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.608 HG23 HD12 ' A' ' 24' ' ' ILE . 23.2 mm -61.82 -46.92 95.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.519 -0.738 . . . . 1.83 109.056 178.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 11.3 mt -60.6 -49.18 78.55 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.868 -0.79 . . . . 2.32 108.868 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.2 mt -56.62 -43.83 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 C-N-CA 119.837 -0.745 . . . . 2.56 109.387 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.27 -46.08 85.28 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.615 -0.678 . . . . 1.9 110.176 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.608 HD12 HG23 ' A' ' 20' ' ' ILE . 40.6 mt -59.22 -48.15 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 108.852 -0.795 . . . . 1.89 108.852 178.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.59 -45.18 95.21 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.747 -0.595 . . . . 2.14 110.159 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.63 -49.78 76.16 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 109.086 -0.709 . . . . 2.07 109.086 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.19 -46.12 86.36 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.016 -0.735 . . . . 1.86 109.016 178.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.87 -46.18 92.72 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.073 -1.611 . . . . 1.46 109.073 178.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.13 -42.6 96.77 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.59 -0.947 . . . . 2.2 109.963 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.8 mt -61.3 -41.2 96.58 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.16 -0.682 . . . . 2.19 109.16 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 95.3 mt -67.32 -51.84 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.467 -0.771 . . . . 2.29 109.154 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.94 -45.5 78.8 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.597 -0.689 . . . . 2.58 109.921 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.671 0 N-CA-C 109.813 -1.315 . . . . 1.82 109.813 179.547 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 . . . . . 0 N--CA 1.497 1.909 0 CA-C-O 121.499 0.666 . . . . 2.16 109.231 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -67.31 -40.14 85.99 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.751 -0.593 . . . . 2.37 109.868 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 71.1 m -60.47 -32.37 71.35 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.872 -0.517 . . . . 1.78 110.686 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -94.07 -51.05 5.02 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.264 -0.897 . . . . 1.98 110.528 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -56.42 -43.93 79.88 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.44 -0.787 . . . . 1.73 110.93 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -46.64 -64.76 2.47 Favored Glycine 0 N--CA 1.503 3.108 0 N-CA-C 110.507 -1.037 . . . . 1.3 110.507 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -66.46 -40.35 14.36 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.844 1.444 . . . . 1.39 110.303 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 34.3 t -59.31 -45.3 91.68 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.058 -1.026 . . . . 2.06 109.816 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.9 t -70.61 -46.17 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.545 -0.722 . . . . 2.08 109.182 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -55.77 -40.81 73.15 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 121.637 0.732 . . . . 2.17 109.751 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.53 -47.7 59.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.85 -0.531 . . . . 1.91 110.622 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.602 ' HG3' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -67.11 -31.3 71.68 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.997 -1.064 . . . . 2.98 110.057 179.573 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.602 ' N ' ' HG3' ' A' ' 77' ' ' LYS . . . -70.61 -47.84 58.09 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.173 -0.954 . . . . 2.26 109.351 179.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.9 ptpt -71.15 -34.75 71.28 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.827 -0.749 . . . . 2.55 109.764 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.497 1.897 0 O-C-N 120.986 -1.071 . . . . 2.46 109.948 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.5 m . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 120.724 0.297 . . . . 2.87 110.273 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.4 t -71.44 -48.32 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 120.945 -1.097 . . . . 4.51 110.075 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 16.6 p -60.04 -49.29 78.23 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.365 -0.834 . . . . 5.14 109.94 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.6 m -63.79 -36.97 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 C-N-CA 119.384 -0.926 . . . . 3.95 109.855 178.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.417 HD11 ' HA ' ' A' ' 18' ' ' ILE . 6.0 mm -67.93 -38.64 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 120.792 -1.192 . . . . 2.85 109.012 178.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 51.0 t -65.84 -43.07 93.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.382 -0.969 . . . . 4.96 108.382 177.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 57.7 mt -63.87 -47.3 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 108.728 -0.842 . . . . 4.76 108.728 178.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 11.6 mt -59.37 -48.8 80.26 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.987 -0.745 . . . . 2.46 108.987 178.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.0 mt -56.33 -43.05 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 121.549 -0.719 . . . . 4.03 109.39 178.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.67 -45.47 78.79 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.461 -0.775 . . . . 4.24 110.072 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 33.0 mt -60.65 -45.7 97.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.226 -0.921 . . . . 3.41 109.264 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.95 -42.95 97.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.401 -0.812 . . . . 2.23 109.528 178.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.87 -42.58 97.49 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.368 -0.832 . . . . 3.93 109.176 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.439 ' HA ' ' CD2' ' A' ' 30' ' ' LEU . 0.5 OUTLIER -63.02 -46.14 89.03 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.453 -0.943 . . . . 4.57 108.453 178.025 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.471 ' O ' HD13 ' A' ' 32' ' ' LEU . . . -58.92 -47.5 90.3 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 108.425 -1.87 . . . . 2.3 108.425 178.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.94 -45.08 96.15 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.506 -0.997 . . . . 3.57 110.208 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.495 ' HG ' ' N ' ' A' ' 31' ' ' ILE . 0.2 OUTLIER -63.3 -37.32 86.8 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.442 -0.786 . . . . 4.87 109.697 179.238 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.495 ' N ' ' HG ' ' A' ' 30' ' ' LEU . 48.0 mt -71.2 -47.29 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.084 -1.01 . . . . 3.4 109.185 178.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.471 HD13 ' O ' ' A' ' 28' ' ' GLY . 6.8 mp -57.83 -49.86 75.25 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.79 -0.569 . . . . 3.0 109.626 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.825 0 N-CA-C 110.199 -1.16 . . . . 4.16 110.199 179.529 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.465 ' O ' ' CG ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 108.865 -0.791 . . . . 2.46 108.865 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -68.25 -47.65 67.2 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.43 -0.794 . . . . 4.21 109.864 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 69.6 m -55.19 -34.36 63.82 Favored 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 119.767 -0.773 . . . . 1.79 110.171 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -88.25 -46.44 9.23 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.202 -0.937 . . . . 1.52 110.835 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.465 ' CG ' ' O ' ' A' ' 66' ' ' GLN . 2.6 mmtp -64.56 -40.18 95.1 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.418 -0.801 . . . . 2.05 110.76 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -47.01 -64.88 2.5 Favored Glycine 0 N--CA 1.505 3.273 0 N-CA-C 110.006 -1.237 . . . . 2.25 110.006 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.59 -37.93 20.53 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 O-C-N 123.714 1.376 . . . . 1.98 110.379 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 5.0 t -62.71 -42.87 99.87 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.979 -1.076 . . . . 2.64 109.36 178.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.2 t -69.68 -44.77 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 109.048 -0.723 . . . . 3.45 109.048 178.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.477 ' HG3' ' N ' ' A' ' 76' ' ' ARG . 0.1 OUTLIER -59.15 -42.26 90.26 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.889 -0.782 . . . . 2.98 108.889 178.42 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.477 ' N ' ' HG3' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -64.0 -53.05 56.06 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.628 -0.67 . . . . 3.21 109.597 178.776 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.88 -48.28 81.95 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.674 -0.641 . . . . 3.88 109.95 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.47 -44.03 96.32 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.805 -0.56 . . . . 4.19 110.788 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.6 mmtp -68.75 -42.91 76.87 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.164 -0.96 . . . . 4.13 109.306 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.8 tp . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.447 0.641 . . . . 4.89 109.84 178.839 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.3 t . . . . . 0 N--CA 1.501 2.075 0 CA-C-O 121.278 0.561 . . . . 1.62 109.592 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.8 t -69.64 -43.42 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.107 -0.995 . . . . 1.78 108.981 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 49.3 m -56.69 -51.34 69.17 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.577 -0.702 . . . . 1.4 109.939 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.584 ' HA ' HG12 ' A' ' 20' ' ' ILE . 35.2 m -64.75 -39.13 84.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.526 -0.734 . . . . 1.46 110.278 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.479 HD11 HG21 ' A' ' 18' ' ' ILE . 6.7 mm -65.01 -36.72 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 120.819 -1.176 . . . . 1.63 109.569 178.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.1 t -66.31 -52.44 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 C-N-CA 119.689 -0.805 . . . . 1.52 109.135 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.584 HG12 ' HA ' ' A' ' 17' ' ' VAL . 27.1 pt -63.74 -36.5 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.114 -0.991 . . . . 1.59 109.38 178.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.493 ' N ' HG13 ' A' ' 20' ' ' ILE . 7.6 mt -64.27 -48.58 75.17 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.596 -0.89 . . . . 1.46 108.596 177.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.5 mm -59.04 -44.5 91.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.483 -0.76 . . . . 1.59 109.071 178.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.21 -44.9 95.53 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.625 -0.672 . . . . 1.37 109.908 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 44.5 mt -61.66 -46.51 96.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.403 -0.811 . . . . 1.36 108.825 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.93 -44.11 97.45 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.648 -0.658 . . . . 1.41 109.68 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.92 -45.41 93.82 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.423 -0.798 . . . . 1.32 109.152 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.546 ' HA ' HD22 ' A' ' 30' ' ' LEU . 0.5 OUTLIER -61.46 -46.67 89.07 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.042 -0.725 . . . . 1.55 109.042 178.269 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.45 -43.33 97.56 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 108.874 -1.69 . . . . 0.6 108.874 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.14 -43.96 93.63 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.492 -1.005 . . . . 1.31 110.009 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.546 HD22 ' HA ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -62.84 -37.6 87.45 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.56 -0.712 . . . . 1.52 109.272 178.904 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.494 ' N ' ' HG ' ' A' ' 30' ' ' LEU . 61.2 mt -71.62 -48.67 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.298 -0.876 . . . . 1.32 108.972 178.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.01 -46.32 85.44 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.656 -0.652 . . . . 1.62 109.774 178.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.659 0 N-CA-C 109.689 -1.364 . . . . 1.19 109.689 179.343 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.449 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.969 0 N-CA-C 109.346 -0.613 . . . . 1.7 109.346 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.445 ' HA ' ' HG2' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -66.64 -41.93 87.48 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.617 -0.677 . . . . 0.84 109.381 178.482 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.7 m -56.82 -38.17 72.25 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.803 -0.561 . . . . 1.14 109.744 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -82.38 -38.58 23.94 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.409 -0.807 . . . . 1.46 110.235 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.449 ' HB3' ' O ' ' A' ' 66' ' ' GLN . 5.5 ptpt -62.59 -37.52 86.58 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.476 -0.765 . . . . 0.94 110.49 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -47.5 -63.94 3.13 Favored Glycine 0 N--CA 1.503 3.145 0 N-CA-C 110.452 -1.059 . . . . 0.82 110.452 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.31 -38.7 19.71 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 123.673 1.354 . . . . 1.22 110.099 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 7.5 t -62.15 -47.67 83.5 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.175 -0.953 . . . . 1.66 109.9 178.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 45.7 t -66.27 -44.04 91.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.547 -0.721 . . . . 1.41 109.326 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -56.8 -42.35 79.37 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 108.732 -0.84 . . . . 1.35 108.732 178.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.406 ' NH2' ' HG2' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -62.94 -55.76 23.12 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.551 0.691 . . . . 3.16 109.859 178.78 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.94 -54.59 44.93 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.362 0.601 . . . . 3.3 110.754 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -53.09 -45.35 68.15 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.836 -0.54 . . . . 1.39 111.056 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.3 mttp -72.56 -41.54 65.64 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.497 -0.752 . . . . 2.21 110.748 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.4 tp . . . . . 0 N--CA 1.497 1.887 0 O-C-N 121.245 -0.909 . . . . 2.61 111.315 -179.534 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.437 ' HA ' HG23 ' A' ' 17' ' ' VAL . 34.9 m . . . . . 0 N--CA 1.496 1.83 0 CA-C-O 120.803 0.335 . . . . 4.47 110.111 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.9 t -68.76 -41.41 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 120.997 -1.064 . . . . 4.15 109.253 178.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.436 HG22 HD12 ' A' ' 20' ' ' ILE . 52.5 m -59.98 -52.19 66.44 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.709 -0.62 . . . . 3.71 109.966 179.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.491 HG22 ' N ' ' A' ' 18' ' ' ILE . 31.2 m -65.45 -34.6 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.536 -0.728 . . . . 4.05 110.176 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.551 ' HA ' HD22 ' A' ' 21' ' ' LEU . 21.7 mt -68.73 -41.38 82.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.093 -1.004 . . . . 4.09 109.216 178.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.5 t -64.41 -42.19 94.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.489 -0.93 . . . . 3.62 108.489 177.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.436 HD12 HG22 ' A' ' 16' ' ' THR . 83.3 mt -64.38 -48.97 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.525 -0.734 . . . . 3.54 109.272 178.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.577 ' HG ' ' N ' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -61.39 -43.23 99.23 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.675 -0.861 . . . . 3.66 108.675 178.788 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.577 ' N ' ' HG ' ' A' ' 21' ' ' LEU . 15.0 mt -60.33 -44.92 96.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.319 -0.863 . . . . 3.54 109.148 178.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.97 -46.03 86.48 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.724 -0.61 . . . . 2.97 109.731 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.442 ' HA ' HD12 ' A' ' 24' ' ' ILE . 18.3 mm -59.39 -45.6 93.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.41 -0.806 . . . . 3.13 109.146 178.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.78 -45.86 87.84 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.525 -0.734 . . . . 3.16 109.771 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.8 -41.89 96.51 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.732 -0.84 . . . . 2.85 108.732 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.41 ' CD1' ' C ' ' A' ' 27' ' ' LEU . 3.4 tm? -60.65 -53.49 56.75 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.899 -0.778 . . . . 2.8 108.899 178.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.62 -43.74 86.08 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 108.905 -1.678 . . . . 2.45 108.905 178.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.65 -44.65 95.73 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.414 -1.051 . . . . 2.83 109.74 178.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.4 mt -59.08 -41.17 87.37 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.649 -0.657 . . . . 2.82 109.481 178.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.486 HD13 HG21 ' A' ' 31' ' ' ILE . 5.7 mt -69.45 -40.93 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.544 -0.723 . . . . 2.71 109.658 178.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.29 -42.76 87.89 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.548 -0.72 . . . . 3.79 110.264 178.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.723 0 O-C-N 120.883 -1.135 . . . . 2.26 110.57 -179.802 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.539 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 5.2 mm-40 . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.008 -0.738 . . . . 3.91 109.008 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -65.51 -41.22 93.41 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.324 -0.621 . . . . 3.16 109.324 178.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.448 ' O ' ' CD ' ' A' ' 72' ' ' PRO . 63.5 m -55.38 -33.34 63.38 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 109.14 -0.689 . . . . 2.93 109.14 178.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -80.73 -40.57 25.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.646 -0.659 . . . . 3.61 109.393 178.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.539 ' HG2' ' O ' ' A' ' 66' ' ' GLN . 5.6 mmtm -58.97 -51.75 68.7 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.563 -0.71 . . . . 3.9 110.739 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -39.69 -64.87 0.96 Allowed Glycine 0 N--CA 1.505 3.294 0 N-CA-C 110.922 -0.871 . . . . 3.16 110.922 -179.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.566 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 39.6 Cg_endo -65.53 -39.42 21.59 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 O-C-N 123.834 1.439 . . . . 3.85 110.651 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 0.9 OUTLIER -63.44 -44.94 93.07 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.083 -1.01 . . . . 4.4 109.627 179.007 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.4 t -67.17 -47.31 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.711 -0.848 . . . . 3.78 108.711 178.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -58.03 -39.29 78.01 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.515 0.674 . . . . 4.37 109.332 178.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.566 ' HB2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -63.69 -64.26 0.95 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.749 -0.595 . . . . 5.08 110.389 178.902 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.468 ' HG3' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -59.57 -31.82 69.79 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 120.053 -0.659 . . . . 4.91 110.864 -179.46 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.468 ' N ' ' HG3' ' A' ' 77' ' ' LYS . . . -65.26 -43.25 91.89 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.183 -0.948 . . . . 4.37 108.972 178.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.1 mttt -72.26 -49.91 31.34 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.173 -0.677 . . . . 5.02 109.173 178.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.815 0 CA-C-O 121.348 0.594 . . . . 6.38 110.204 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.405 ' HA ' HG22 ' A' ' 17' ' ' VAL . 31.2 m . . . . . 0 N--CA 1.496 1.867 0 N-CA-C 110.026 -0.361 . . . . 1.86 110.026 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.0 t -68.54 -45.83 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.126 -0.984 . . . . 2.3 109.312 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 51.7 m -57.94 -51.37 69.93 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.717 -0.614 . . . . 2.17 109.943 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.405 HG22 ' HA ' ' A' ' 14' ' ' VAL . 25.4 m -64.77 -35.59 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.437 -0.789 . . . . 1.68 110.138 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.6 mm -67.98 -41.2 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 121.034 -1.041 . . . . 2.33 109.19 178.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 37.8 t -65.1 -44.58 95.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.466 -0.939 . . . . 2.42 108.466 178.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.436 HG21 HD13 ' A' ' 24' ' ' ILE . 21.7 mm -62.41 -46.98 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 108.99 -0.745 . . . . 1.97 108.99 178.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 11.4 mt -59.88 -49.4 77.85 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.833 -0.803 . . . . 2.01 108.833 178.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.414 ' HA ' HD12 ' A' ' 22' ' ' ILE . 11.5 mm -57.11 -43.66 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.591 -0.693 . . . . 2.61 109.313 178.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.63 -45.82 91.08 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.57 -0.706 . . . . 2.01 109.608 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.436 HD13 HG21 ' A' ' 20' ' ' ILE . 58.6 mt -59.34 -49.25 84.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.397 -0.814 . . . . 1.72 108.855 178.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.76 -43.67 97.7 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.648 -0.658 . . . . 2.46 110.023 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.28 -43.55 98.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.376 -0.827 . . . . 2.59 109.061 178.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.488 ' HG ' HD11 ' A' ' 31' ' ' ILE . 0.8 OUTLIER -62.38 -46.83 86.87 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.613 -0.884 . . . . 1.92 108.613 178.139 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.84 -48.14 80.67 Favored Glycine 0 N--CA 1.496 2.633 0 N-CA-C 108.654 -1.778 . . . . 1.9 108.654 178.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.22 -44.03 97.93 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.427 -1.043 . . . . 3.05 109.966 178.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.5 mt -60.53 -39.23 87.1 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.627 -0.671 . . . . 3.09 109.98 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.488 HD11 ' HG ' ' A' ' 27' ' ' LEU . 3.7 mt -72.79 -47.54 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.27 -0.894 . . . . 2.05 109.162 179.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.66 -46.52 84.14 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.364 -0.835 . . . . 3.03 109.637 178.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.726 0 N-CA-C 109.472 -1.451 . . . . 2.83 109.472 179.279 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.4 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.498 1.952 0 N-CA-C 108.965 -0.754 . . . . 2.83 108.965 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -78.03 -46.48 20.82 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.246 -0.649 . . . . 5.86 109.246 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 75.5 m -54.79 -33.55 61.57 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 122.083 -0.386 . . . . 4.08 110.071 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.558 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -87.72 -50.71 6.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.303 -0.873 . . . . 3.47 109.871 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.4 ' HG3' ' O ' ' A' ' 66' ' ' GLN . 22.1 mtmt -59.42 -51.57 69.33 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.771 -0.581 . . . . 2.46 111.712 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -40.91 -63.53 1.46 Allowed Glycine 0 N--CA 1.505 3.261 0 N-CA-C 110.352 -1.099 . . . . 2.68 110.352 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.522 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 41.9 Cg_endo -67.51 -43.15 6.11 Favored 'Trans proline' 0 C--N 1.315 -1.186 0 O-C-N 123.939 1.494 . . . . 3.94 110.275 178.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.558 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 1.2 t -56.0 -44.52 78.71 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.844 -1.16 . . . . 2.76 109.554 178.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 49.0 t -68.34 -50.61 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 108.899 -0.778 . . . . 2.21 108.899 178.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -52.01 -41.32 62.13 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.561 0.696 . . . . 4.17 109.918 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.522 ' HD2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -68.21 -56.11 9.87 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.757 -0.589 . . . . 4.97 111.587 -179.655 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.422 ' HG3' ' N ' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -64.31 -33.65 76.33 Favored 'General case' 0 N--CA 1.505 2.319 0 C-N-CA 119.075 -1.05 . . . . 2.52 110.46 -179.254 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.422 ' N ' ' HG3' ' A' ' 77' ' ' LYS . . . -67.07 -50.47 61.67 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.519 -0.738 . . . . 2.95 110.097 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.8 pttt -73.98 -32.87 63.63 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.153 -0.967 . . . . 5.01 111.216 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.5 tp . . . . . 0 N--CA 1.494 1.768 0 O-C-N 121.192 -0.942 . . . . 3.54 110.551 179.673 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 76.6 t . . . . . 0 N--CA 1.499 1.981 0 N-CA-C 108.702 -0.851 . . . . 2.12 108.702 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.7 t -64.71 -45.24 95.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.567 -0.708 . . . . 2.65 109.229 178.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 46.1 m -58.03 -46.78 84.76 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.651 -0.656 . . . . 3.48 109.283 178.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.7 t -65.82 -38.92 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 C-N-CA 119.586 -0.846 . . . . 2.8 109.242 178.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.556 ' HA ' HD22 ' A' ' 21' ' ' LEU . 10.0 mm -62.39 -41.41 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.016 -1.053 . . . . 2.06 109.077 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.9 t -66.06 -40.94 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.643 -0.873 . . . . 2.74 108.643 177.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 92.4 mt -65.7 -50.12 73.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.522 -0.736 . . . . 3.3 109.074 178.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.568 ' HA ' HG12 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -61.59 -42.84 99.44 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 119.914 -0.714 . . . . 2.3 109.383 178.711 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.552 ' N ' ' HG ' ' A' ' 21' ' ' LEU . 10.4 mm -62.7 -38.54 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 120.972 -1.08 . . . . 2.26 109.106 178.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.97 -50.58 54.93 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.481 -0.762 . . . . 2.59 110.724 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.568 HG12 ' HA ' ' A' ' 21' ' ' LEU . 29.3 pt -62.52 -37.26 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 120.955 -1.091 . . . . 2.77 109.283 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.532 ' N ' HG13 ' A' ' 24' ' ' ILE . . . -65.75 -46.98 76.83 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.435 -0.791 . . . . 1.98 108.909 178.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.05 -44.06 97.96 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.008 -0.738 . . . . 2.25 109.008 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.1 tt -61.22 -45.86 92.81 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.36 -0.838 . . . . 2.95 108.93 178.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.3 -46.47 92.87 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.003 -1.639 . . . . 1.92 109.003 178.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.89 -41.44 95.62 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.532 -0.981 . . . . 2.28 109.89 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.6 mt -59.11 -42.12 89.78 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.821 -0.807 . . . . 2.71 108.821 178.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.431 HD13 HG23 ' A' ' 31' ' ' ILE . 27.7 mm -70.07 -45.93 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 109.068 -0.716 . . . . 2.49 109.068 178.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.1 tt -56.31 -47.34 78.9 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.727 -0.608 . . . . 3.63 109.625 178.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.51 0 N-CA-C 109.85 -1.3 . . . . 2.2 109.85 179.399 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.476 ' O ' ' CG ' ' A' ' 70' ' ' LYS . 41.0 tt0 . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 108.534 -0.913 . . . . 2.79 108.534 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -63.32 -35.43 80.34 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.359 -0.838 . . . . 2.44 109.672 178.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.75 -42.2 98.67 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.603 -0.686 . . . . 3.32 110.553 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.504 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -88.22 -41.18 13.12 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.063 -1.023 . . . . 3.05 110.938 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.476 ' CG ' ' O ' ' A' ' 66' ' ' GLN . 5.4 mmtt -66.46 -42.01 88.21 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.651 -0.656 . . . . 3.04 110.042 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -44.91 -62.64 2.89 Favored Glycine 0 N--CA 1.502 3.063 0 N-CA-C 110.142 -1.183 . . . . 1.72 110.142 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -66.75 -37.8 19.86 Favored 'Trans proline' 0 C--N 1.314 -1.255 0 O-C-N 123.627 1.33 . . . . 2.41 110.756 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 0.4 OUTLIER -66.21 -43.8 85.71 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.04 -1.038 . . . . 2.95 109.8 179.075 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.3 t -70.72 -43.73 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.792 -0.568 . . . . 1.89 109.618 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -55.49 -43.11 75.31 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.57 0.7 . . . . 2.62 109.89 178.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.92 -48.27 63.7 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.488 0.661 . . . . 3.09 109.969 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 67.4 mttt -60.08 -55.13 37.74 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.545 0.688 . . . . 2.52 109.935 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -53.37 -50.73 64.48 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 122.032 -0.417 . . . . 1.46 110.524 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.421 ' HG3' ' N ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -67.87 -25.74 65.67 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.417 -0.802 . . . . 2.92 110.714 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.421 ' N ' ' HG3' ' A' ' 79' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.064 -1.022 . . . . 2.59 110.069 179.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.542 ' CG1' HD13 ' A' ' 18' ' ' ILE . 23.0 t . . . . . 0 N--CA 1.496 1.833 0 N-CA-C 109.35 -0.611 . . . . 4.97 109.35 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.0 t -67.78 -43.26 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 120.981 -1.075 . . . . 3.52 109.135 178.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 63.3 m -59.56 -51.87 68.0 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.613 -0.679 . . . . 3.21 109.954 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.588 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 31.2 m -64.42 -38.18 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 119.505 -0.878 . . . . 4.29 109.854 179.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.542 HD13 ' CG1' ' A' ' 14' ' ' VAL . 19.2 mt -65.21 -38.12 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 120.759 -1.213 . . . . 4.2 109.253 178.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.6 t -67.49 -48.05 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.237 -0.914 . . . . 2.55 109.584 178.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.585 HG12 ' HA ' ' A' ' 17' ' ' VAL . 3.3 pt -68.01 -34.87 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.886 -1.134 . . . . 3.46 109.968 179.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.588 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 0.1 OUTLIER -70.99 -42.65 69.38 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.815 -1.178 . . . . 3.98 108.308 177.73 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.528 ' N ' ' HG ' ' A' ' 21' ' ' LEU . 13.1 mt -60.77 -43.77 96.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.111 -0.993 . . . . 3.39 108.436 177.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.75 -46.38 85.56 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.608 -0.682 . . . . 2.01 109.731 178.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.407 HD12 HG22 ' A' ' 24' ' ' ILE . 8.1 mm -59.49 -47.2 91.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.131 -0.981 . . . . 2.88 109.005 178.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.27 -43.91 97.74 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.456 -0.778 . . . . 2.98 109.591 178.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.18 -42.65 99.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.466 -0.771 . . . . 2.65 109.274 178.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.2 tt -63.39 -46.38 86.69 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.678 -0.86 . . . . 2.25 108.678 178.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.77 -45.04 95.44 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 108.692 -1.763 . . . . 2.0 108.692 178.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.23 -44.03 93.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.507 -0.996 . . . . 3.09 109.468 178.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.2 mt -58.73 -41.61 86.85 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.023 -0.732 . . . . 3.05 109.023 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.44 HD13 ' HA ' ' A' ' 31' ' ' ILE . 22.4 mm -68.93 -50.12 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.489 -0.757 . . . . 2.0 109.38 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.62 -43.07 79.83 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.567 -0.708 . . . . 3.42 109.689 178.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.508 0 N-CA-C 109.491 -1.444 . . . . 2.91 109.491 178.977 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 107.911 -1.144 . . . . 2.74 107.911 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -69.22 -43.69 73.56 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.329 0.585 . . . . 3.24 109.646 178.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.437 ' O ' ' CD ' ' A' ' 72' ' ' PRO . 0.4 OUTLIER -59.35 -37.93 79.09 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.957 -0.464 . . . . 3.18 110.437 179.479 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.27 -43.74 13.48 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.046 -1.034 . . . . 1.94 110.15 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 32.5 mtmt -63.81 -46.67 84.12 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.577 -0.702 . . . . 2.91 110.635 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 75' ' ' GLU . . . -41.33 -64.87 1.23 Allowed Glycine 0 N--CA 1.506 3.334 0 N-CA-C 109.947 -1.261 . . . . 2.21 109.947 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.555 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 42.5 Cg_endo -68.42 -41.31 6.74 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 O-C-N 123.956 1.503 . . . . 2.36 110.083 178.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 35.1 t -58.33 -39.54 79.73 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.839 -1.163 . . . . 2.31 109.94 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.484 ' HA ' ' HG2' ' A' ' 77' ' ' LYS . 24.1 t -74.92 -48.39 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.435 -0.791 . . . . 2.85 109.089 178.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.627 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 1.0 OUTLIER -54.63 -43.94 72.72 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.89 -0.724 . . . . 3.37 109.178 178.349 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.555 ' HD2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -64.66 -48.62 74.11 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.581 -0.7 . . . . 3.21 110.157 179.126 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.625 ' HG3' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -62.46 -32.66 73.58 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.073 -1.017 . . . . 3.6 109.397 179.02 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.625 ' N ' ' HG3' ' A' ' 77' ' ' LYS . . . -72.2 -43.26 64.75 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.546 -0.721 . . . . 3.43 109.171 178.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.627 ' HG2' ' O ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -68.45 -34.04 75.24 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.637 -0.665 . . . . 4.26 109.502 178.673 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.567 -0.708 . . . . 4.08 110.416 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.499 HG23 ' N ' ' A' ' 15' ' ' VAL . 34.0 m . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 120.792 0.329 . . . . 2.4 110.171 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.499 ' N ' HG23 ' A' ' 14' ' ' VAL . 21.1 t -70.31 -43.06 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 120.983 -1.073 . . . . 2.77 109.264 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.424 HG22 HD11 ' A' ' 20' ' ' ILE . 54.9 m -58.95 -51.69 68.95 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.848 -0.532 . . . . 2.12 109.879 179.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.45 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 27.0 m -64.66 -35.73 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.468 -0.77 . . . . 1.86 110.116 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.502 HD12 HD23 ' A' ' 21' ' ' LEU . 7.0 mm -66.79 -43.88 89.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.013 -1.054 . . . . 2.63 109.366 178.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.3 t -63.28 -42.22 95.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 108.72 -0.844 . . . . 2.65 108.72 178.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.424 HD11 HG22 ' A' ' 16' ' ' THR . 79.1 mt -64.5 -48.56 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.506 -0.746 . . . . 1.91 109.464 178.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.533 ' HG ' ' N ' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -62.27 -43.13 99.53 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.783 -0.821 . . . . 2.28 108.783 178.818 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.533 ' N ' ' HG ' ' A' ' 21' ' ' LEU . 32.2 mt -59.49 -45.21 93.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.358 -0.839 . . . . 2.72 109.101 178.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.87 -46.53 84.53 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.541 -0.725 . . . . 1.99 109.836 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 55.6 mt -57.62 -46.81 86.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.511 -0.743 . . . . 1.87 109.247 178.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.21 -45.72 87.01 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.543 -0.723 . . . . 2.12 109.992 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.12 -46.04 89.35 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.44 -0.787 . . . . 2.33 108.97 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.51 ' O ' HG12 ' A' ' 31' ' ' ILE . 2.4 tt -61.69 -48.04 82.58 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.834 -0.802 . . . . 2.04 108.834 178.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.487 ' O ' HG13 ' A' ' 31' ' ' ILE . . . -53.76 -39.23 61.05 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 109.623 -1.391 . . . . 1.63 109.623 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.27 -41.93 47.29 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.233 -1.157 . . . . 2.4 109.517 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.6 mt -53.99 -45.88 71.57 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.148 0.499 . . . . 3.16 109.685 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' ' 27' ' ' LEU . 1.3 pt -77.13 -43.95 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.416 -0.803 . . . . 1.97 111.105 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.462 ' H ' HG13 ' A' ' 31' ' ' ILE . 1.3 tt -56.96 -45.42 82.87 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.047 -1.033 . . . . 2.96 109.103 178.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.443 0 N-CA-C 109.532 -1.427 . . . . 2.21 109.532 179.247 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.503 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 1.7 tt0 . . . . . 0 N--CA 1.488 1.431 0 N-CA-C 109.534 -0.543 . . . . 2.79 109.534 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.503 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 11.1 m-85 -74.38 -49.41 22.78 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.562 -0.711 . . . . 2.69 111.006 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.439 ' O ' ' CD ' ' A' ' 72' ' ' PRO . 0.8 OUTLIER -63.07 -34.19 77.07 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.378 -0.826 . . . . 2.69 110.62 -179.923 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -79.59 -43.47 22.88 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.025 -1.047 . . . . 2.34 110.078 179.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.503 ' HB3' ' O ' ' A' ' 66' ' ' GLN . 12.7 ptpt -68.82 -31.73 70.92 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.428 -0.795 . . . . 2.46 110.801 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -47.6 -63.93 3.17 Favored Glycine 0 N--CA 1.5 2.949 0 N-CA-C 109.228 -1.549 . . . . 1.67 109.228 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.528 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 41.5 Cg_endo -68.44 -41.1 6.96 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.886 1.466 . . . . 2.21 109.666 178.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 4.1 t -55.75 -43.81 77.0 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.013 -1.054 . . . . 2.48 109.236 178.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 37.9 t -74.5 -45.09 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.504 -0.747 . . . . 1.92 109.351 178.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -53.57 -43.21 68.31 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.708 0.766 . . . . 2.38 109.189 178.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.528 ' HD2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -71.06 -44.75 65.12 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.391 -0.596 . . . . 3.79 109.391 178.663 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.84 -40.28 79.69 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 120.223 -0.591 . . . . 3.32 110.231 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.65 -41.24 60.69 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.041 0.448 . . . . 2.21 110.322 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.2 mttp -65.52 -43.86 88.7 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 121.504 0.669 . . . . 2.7 109.325 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.687 -0.633 . . . . 3.9 109.974 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.487 ' O ' HG12 ' A' ' 18' ' ' ILE . 61.5 t . . . . . 0 N--CA 1.496 1.87 0 N-CA-C 109.529 -0.545 . . . . 2.46 109.529 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.601 ' HA ' HG12 ' A' ' 18' ' ' ILE . 43.6 t -71.11 -41.39 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.309 -0.869 . . . . 1.85 109.707 179.017 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.403 ' O ' HG12 ' A' ' 20' ' ' ILE . 50.2 m -59.81 -46.63 88.64 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.525 -0.734 . . . . 1.55 109.92 179.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.497 ' HA ' HG12 ' A' ' 20' ' ' ILE . 35.7 m -68.9 -42.67 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.436 -0.79 . . . . 2.03 111.312 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.601 HG12 ' HA ' ' A' ' 15' ' ' VAL . 15.6 pt -65.42 -31.64 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 120.166 -1.584 . . . . 2.31 109.608 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.449 ' N ' HG13 ' A' ' 18' ' ' ILE . 21.2 t -70.06 -48.88 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.476 -0.765 . . . . 1.61 109.342 178.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.497 HG12 ' HA ' ' A' ' 17' ' ' VAL . 2.5 pt -68.22 -31.35 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 120.638 -1.289 . . . . 1.89 108.847 178.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.469 ' N ' HG13 ' A' ' 20' ' ' ILE . 10.0 mt -66.66 -52.33 46.08 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.334 -0.854 . . . . 2.22 109.24 177.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.538 HG12 ' O ' ' A' ' 18' ' ' ILE . 30.9 pt -59.53 -42.38 87.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 C-N-CA 118.851 -1.139 . . . . 2.13 109.288 178.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.436 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -61.03 -46.8 89.24 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 120.294 -0.562 . . . . 1.46 109.707 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.1 mm -60.51 -45.53 96.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.256 -0.902 . . . . 1.63 108.952 178.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.38 -43.95 97.99 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.563 -0.711 . . . . 2.0 109.666 178.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.81 -44.31 96.51 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.116 -0.698 . . . . 1.97 109.116 178.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.05 -44.53 96.49 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.806 -0.813 . . . . 1.67 108.806 178.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.69 -45.9 94.93 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 108.756 -1.738 . . . . 1.08 108.756 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.99 -43.63 95.1 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.502 -0.999 . . . . 1.91 109.821 178.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.4 mt -58.27 -41.61 84.7 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.063 -0.717 . . . . 2.38 109.063 178.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 59.9 mt -70.07 -48.26 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.465 -0.772 . . . . 1.56 109.411 178.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.12 -48.83 77.69 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.429 -0.795 . . . . 2.56 110.255 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.836 0 N-CA-C 109.577 -1.409 . . . . 1.63 109.577 179.277 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.532 ' O ' ' HB2' ' A' ' 70' ' ' LYS . 1.8 mm100 . . . . . 0 N--CA 1.493 1.722 0 N-CA-C 108.245 -1.02 . . . . 1.19 108.245 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -71.37 -47.03 58.82 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.604 -0.685 . . . . 4.76 109.841 178.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.432 ' O ' ' CD ' ' A' ' 72' ' ' PRO . 65.0 m -54.56 -46.8 73.72 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.933 -0.479 . . . . 1.07 110.211 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.525 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -72.41 -57.58 4.07 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.202 -0.936 . . . . 1.27 111.308 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.532 ' HB2' ' O ' ' A' ' 66' ' ' GLN . 3.8 mptt -52.71 -60.49 3.19 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.432 -0.793 . . . . 1.18 112.914 -179.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 70' ' ' LYS . . . -31.74 -67.44 0.15 Allowed Glycine 0 N--CA 1.51 3.597 0 N-CA-C 111.55 -0.62 . . . . 1.15 111.55 -178.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.536 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 40.2 Cg_endo -66.28 -40.97 13.52 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.698 1.367 . . . . 1.28 110.649 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.525 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -58.9 -42.95 90.79 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.825 -1.172 . . . . 2.02 109.277 178.688 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 55.0 t -71.69 -45.04 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 109.327 -0.619 . . . . 1.84 109.327 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -57.08 -42.2 80.22 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 119.855 -0.738 . . . . 1.72 109.427 178.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.536 ' HD2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -66.99 -50.15 63.17 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.5 -0.75 . . . . 1.79 109.703 178.889 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.38 -41.62 85.24 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 120.01 -0.676 . . . . 2.6 109.595 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.96 -49.03 69.34 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.97 -0.456 . . . . 1.94 109.918 179.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.05 -49.26 76.69 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.206 -0.934 . . . . 2.15 109.807 179.016 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 24.3 tp . . . . . 0 N--CA 1.499 2.011 0 O-C-N 121.429 -0.795 . . . . 3.63 111.393 -179.701 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.612 ' O ' HG21 ' A' ' 17' ' ' VAL . 39.9 t . . . . . 0 N--CA 1.498 1.939 0 N-CA-C 109.109 -0.7 . . . . 2.04 109.109 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.585 ' HA ' HG12 ' A' ' 18' ' ' ILE . 34.2 t -70.73 -42.41 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.242 -0.912 . . . . 2.24 108.963 178.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.569 HG23 HD12 ' A' ' 20' ' ' ILE . 54.2 m -58.16 -46.78 85.1 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.487 -0.758 . . . . 2.33 109.979 179.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.612 HG21 ' O ' ' A' ' 14' ' ' VAL . 35.8 m -70.16 -41.21 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.271 -0.893 . . . . 2.23 111.188 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.585 HG12 ' HA ' ' A' ' 15' ' ' VAL . 4.8 pt -67.89 -33.92 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 120.163 -1.586 . . . . 2.34 109.676 178.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.533 ' HA ' HD12 ' A' ' 22' ' ' ILE . 20.8 t -67.7 -43.39 86.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 108.41 -0.959 . . . . 2.25 108.41 177.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.569 HD12 HG23 ' A' ' 16' ' ' THR . 87.5 mt -67.4 -40.24 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.117 -1.068 . . . . 2.34 108.117 177.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.7 mt -60.8 -52.79 63.58 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.87 -0.519 . . . . 2.54 109.817 178.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.541 HG12 ' O ' ' A' ' 18' ' ' ILE . 41.4 pt -59.9 -41.69 86.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 120.943 -1.098 . . . . 2.24 109.697 179.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.466 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -61.83 -45.76 92.43 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 120.146 -0.622 . . . . 2.3 109.594 178.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.8 mm -61.97 -44.5 99.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.313 -0.867 . . . . 2.65 108.758 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.74 -44.66 96.48 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.544 -0.722 . . . . 2.3 109.645 178.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.01 -46.96 88.66 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.972 -0.751 . . . . 2.36 108.972 178.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.1 tt -59.78 -45.89 90.88 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.808 -0.812 . . . . 2.89 108.808 178.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.07 -45.33 94.01 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 108.937 -1.665 . . . . 2.3 108.937 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.55 -44.03 95.36 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.451 -1.029 . . . . 2.34 109.967 179.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.1 mt -59.67 -41.32 90.35 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.089 -0.708 . . . . 2.8 109.089 178.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.424 ' HA ' HD12 ' A' ' 31' ' ' ILE . 24.7 mm -68.34 -48.15 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.65 -0.656 . . . . 2.97 109.374 178.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.17 -48.1 81.35 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.447 -0.783 . . . . 2.93 110.052 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.676 0 N-CA-C 109.816 -1.314 . . . . 2.23 109.816 179.506 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.762 0 N-CA-C 108.81 -0.811 . . . . 2.55 108.81 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -62.32 -52.62 62.94 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 108.477 -0.934 . . . . 1.4 108.477 177.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.42 ' O ' ' CD ' ' A' ' 72' ' ' PRO . 2.4 m -53.72 -38.41 64.29 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-N 115.808 -0.633 . . . . 1.95 111.388 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.36 -41.56 18.05 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.012 -1.055 . . . . 2.11 110.969 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.0 mmtp -67.24 -45.78 75.71 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.419 -0.801 . . . . 2.97 111.12 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.403 ' N ' ' HD2' ' A' ' 72' ' ' PRO . . . -43.25 -62.65 2.34 Favored Glycine 0 N--CA 1.506 3.33 0 N-CA-C 110.614 -0.994 . . . . 1.52 110.614 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.538 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 40.8 Cg_endo -66.92 -43.92 6.14 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 O-C-N 123.729 1.384 . . . . 1.94 110.03 179.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 31.5 t -54.52 -43.05 71.54 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.935 -1.103 . . . . 2.74 109.745 178.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 37.5 t -73.62 -47.0 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.555 -0.716 . . . . 2.27 109.552 178.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -54.1 -41.4 68.23 Favored 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 121.58 0.705 . . . . 2.0 109.641 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.538 ' HD2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -69.88 -49.14 55.25 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.832 -0.543 . . . . 3.19 110.637 179.496 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.578 ' HG3' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -63.99 -29.3 70.47 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.112 -0.992 . . . . 3.08 110.075 179.292 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.578 ' N ' ' HG3' ' A' ' 77' ' ' LYS . . . -75.4 -44.41 44.8 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.283 -0.886 . . . . 2.19 109.415 179.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.0 mttt -68.8 -40.59 79.5 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.32 0.581 . . . . 2.45 109.494 178.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.587 -0.696 . . . . 3.23 110.021 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.45 HG22 ' N ' ' A' ' 15' ' ' VAL . 31.1 m . . . . . 0 N--CA 1.495 1.777 0 CA-C-O 120.7 0.286 . . . . 2.46 110.261 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.45 ' N ' HG22 ' A' ' 14' ' ' VAL . 19.6 t -71.59 -42.37 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 120.98 -1.075 . . . . 2.19 109.138 178.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.418 ' O ' HG12 ' A' ' 20' ' ' ILE . 53.2 m -58.97 -51.73 68.78 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.711 -0.618 . . . . 2.61 109.771 179.099 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.602 ' HA ' HG12 ' A' ' 20' ' ' ILE . 35.0 m -64.02 -40.11 87.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.512 -0.743 . . . . 2.52 109.91 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.473 ' HA ' HD21 ' A' ' 21' ' ' LEU . 8.9 mm -63.36 -42.73 97.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.009 -1.057 . . . . 2.13 109.393 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.594 ' O ' HG13 ' A' ' 22' ' ' ILE . 38.4 t -63.93 -43.39 97.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 C-N-CA 119.974 -0.69 . . . . 2.32 110.173 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.602 HG12 ' HA ' ' A' ' 17' ' ' VAL . 22.2 pt -72.51 -34.77 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 120.52 -1.363 . . . . 2.76 109.45 178.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.581 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 0.1 OUTLIER -69.36 -45.69 68.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.23 -0.919 . . . . 2.08 109.428 178.55 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.594 HG13 ' O ' ' A' ' 19' ' ' VAL . 1.9 pp -63.73 -39.94 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 120.632 -1.293 . . . . 2.14 109.146 178.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.511 ' HB1' ' O ' ' A' ' 19' ' ' VAL . . . -62.26 -50.14 72.89 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.862 -0.523 . . . . 2.34 110.768 179.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.489 HG13 ' N ' ' A' ' 25' ' ' ALA . 40.0 pt -63.99 -36.83 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 120.853 -1.155 . . . . 2.59 109.155 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.489 ' N ' HG13 ' A' ' 24' ' ' ILE . . . -65.28 -44.64 87.39 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.046 -0.724 . . . . 2.02 109.046 178.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.22 -44.6 94.81 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.753 -0.832 . . . . 2.11 108.753 178.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.26 -45.12 95.83 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.894 -0.78 . . . . 2.97 108.894 178.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.62 -44.7 97.54 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 108.753 -1.739 . . . . 2.04 108.753 178.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.99 -41.64 97.45 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.492 -1.005 . . . . 1.93 109.848 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.5 mt -60.68 -41.31 94.84 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.051 -0.722 . . . . 2.89 109.051 178.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 69.4 mt -69.7 -48.15 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 109.002 -0.74 . . . . 2.79 109.002 178.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.95 -43.45 91.28 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.533 -0.729 . . . . 2.26 110.103 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.779 0 N-CA-C 109.342 -1.503 . . . . 2.29 109.342 179.285 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 . . . . . 0 N--CA 1.5 2.058 0 CA-C-O 121.456 0.646 . . . . 2.12 109.264 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.468 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 2.6 m-85 -69.59 -43.64 72.4 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.579 -0.701 . . . . 2.32 109.369 178.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 75.4 m -59.72 -32.43 70.53 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.951 -0.468 . . . . 2.03 110.588 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.99 -44.26 11.14 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.144 -0.972 . . . . 2.11 110.4 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.468 ' HE3' ' HA ' ' A' ' 67' ' ' TYR . 10.6 ptpt -65.55 -35.8 81.91 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.466 -0.771 . . . . 2.01 111.02 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.408 ' N ' ' HD2' ' A' ' 72' ' ' PRO . . . -49.78 -62.96 4.51 Favored Glycine 0 N--CA 1.501 2.975 0 N-CA-C 109.723 -1.351 . . . . 1.69 109.723 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 71' ' ' GLY . 40.4 Cg_endo -66.49 -33.71 36.19 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 123.79 1.416 . . . . 2.05 110.348 178.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 15.1 t -67.42 -47.37 70.45 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.253 -0.904 . . . . 2.2 109.939 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.7 t -66.48 -46.34 86.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.663 -0.648 . . . . 1.92 109.301 178.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -54.95 -42.37 72.25 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 121.367 0.603 . . . . 2.35 109.45 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.467 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -62.26 -54.91 33.9 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.499 0.666 . . . . 3.01 109.835 178.83 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.65 -51.51 69.63 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.2 0.524 . . . . 1.66 110.915 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.85 -47.42 80.42 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.882 -0.511 . . . . 2.11 110.68 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -70.27 -38.12 75.02 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.692 -0.803 . . . . 2.9 109.904 179.726 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 tp . . . . . 0 N--CA 1.495 1.814 0 O-C-N 121.429 -0.794 . . . . 2.73 109.396 178.454 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.6 ' O ' HG21 ' A' ' 17' ' ' VAL . 27.7 m . . . . . 0 N--CA 1.492 1.657 0 N-CA-C 109.94 -0.393 . . . . 1.77 109.94 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.579 ' HA ' HG12 ' A' ' 18' ' ' ILE . 37.3 t -72.03 -40.66 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.915 -1.116 . . . . 1.68 109.15 178.068 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 42.7 m -59.04 -49.78 76.59 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.267 -0.895 . . . . 1.74 109.66 178.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.6 HG21 ' O ' ' A' ' 14' ' ' VAL . 2.8 m -64.57 -43.41 96.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.604 -0.685 . . . . 2.1 111.492 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.579 HG12 ' HA ' ' A' ' 15' ' ' VAL . 2.1 pt -66.94 -32.34 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 120.153 -1.592 . . . . 1.73 110.037 179.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.467 ' N ' HG13 ' A' ' 18' ' ' ILE . 40.0 t -69.65 -47.63 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 108.044 -1.095 . . . . 1.61 108.044 177.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 69.6 mt -60.37 -46.2 95.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 N-CA-C 108.609 -0.885 . . . . 1.71 108.609 177.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.532 ' HA ' HG12 ' A' ' 24' ' ' ILE . 4.0 mt -59.36 -51.23 70.79 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.228 -0.656 . . . . 2.1 109.228 178.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.2 mt -56.46 -37.87 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.256 -0.902 . . . . 1.79 109.167 178.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.79 -52.0 42.21 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.585 -0.697 . . . . 1.68 110.797 179.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.532 HG12 ' HA ' ' A' ' 21' ' ' LEU . 39.4 pt -62.34 -37.27 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.872 -1.142 . . . . 1.87 109.201 179.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.477 ' N ' HG13 ' A' ' 24' ' ' ILE . . . -64.8 -45.84 84.58 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.533 -0.729 . . . . 1.62 109.118 178.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.03 -43.34 99.05 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.891 -0.781 . . . . 1.53 108.891 178.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.4 -47.08 87.42 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.909 -0.775 . . . . 2.0 108.909 178.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.0 -45.97 93.14 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 108.636 -1.786 . . . . 1.06 108.636 178.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.27 -44.83 96.59 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.595 -0.944 . . . . 1.5 109.623 178.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.6 mt -58.86 -40.1 83.3 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.787 -0.57 . . . . 1.8 109.503 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.7 mt -68.84 -46.64 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.498 -0.751 . . . . 1.78 109.323 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.05 -45.39 94.96 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.442 -0.786 . . . . 2.17 109.904 179.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.848 0 N-CA-C 109.494 -1.442 . . . . 0.78 109.494 179.232 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.489 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.136 0 CA-C-O 121.467 0.651 . . . . 2.77 109.332 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.506 ' HA ' ' HG2' ' A' ' 70' ' ' LYS . 9.0 m-85 -69.94 -39.04 76.31 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.556 -0.715 . . . . 1.85 109.539 178.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.4 t -57.82 -41.01 81.34 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.814 -0.554 . . . . 0.99 110.403 178.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.68 -47.2 8.85 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.159 -0.963 . . . . 1.28 110.964 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.506 ' HG2' ' HA ' ' A' ' 67' ' ' TYR . 6.3 ptpt -66.11 -34.88 79.06 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.396 -0.815 . . . . 1.86 111.306 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.411 ' N ' ' HD2' ' A' ' 72' ' ' PRO . . . -46.69 -63.31 3.19 Favored Glycine 0 N--CA 1.503 3.159 0 N-CA-C 109.543 -1.423 . . . . 0.78 109.543 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.551 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 40.5 Cg_endo -67.28 -47.83 2.04 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.929 1.489 . . . . 0.88 109.78 178.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.486 ' HB2' ' HA ' ' A' ' 70' ' ' LYS . 4.0 m -53.26 -39.95 64.25 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.15 -0.969 . . . . 1.37 110.053 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.445 ' N ' ' O ' ' A' ' 70' ' ' LYS . 24.1 t -74.32 -46.38 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 108.833 -0.803 . . . . 1.52 108.833 178.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.11 -43.23 70.25 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 121.505 0.669 . . . . 1.17 109.258 178.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.551 ' HD2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -63.3 -50.44 70.04 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.945 -0.761 . . . . 1.31 108.945 178.52 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.8 mttp -56.11 -44.84 79.48 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 109.167 -0.679 . . . . 1.23 109.167 178.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.6 -52.21 64.55 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.415 -0.587 . . . . 1.64 109.415 178.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 36.3 mtpt -58.88 -44.32 91.09 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.067 0.461 . . . . 1.63 109.837 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.497 1.923 0 CA-C-O 121.573 0.702 . . . . 3.06 110.692 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.479 ' O ' HG22 ' A' ' 17' ' ' VAL . 55.1 t . . . . . 0 N--CA 1.498 1.935 0 CA-C-O 121.301 0.572 . . . . 2.25 109.924 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.7 t -69.87 -51.67 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.102 -0.999 . . . . 3.26 110.462 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.423 ' O ' HG21 ' A' ' 19' ' ' VAL . 25.6 p -55.67 -49.77 72.03 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.806 -0.559 . . . . 3.51 110.252 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 14' ' ' VAL . 28.8 m -65.2 -35.31 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.136 -0.978 . . . . 2.3 110.081 179.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.47 ' CG2' HD11 ' A' ' 22' ' ' ILE . 5.6 mm -68.18 -48.69 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 120.958 -1.088 . . . . 2.59 110.431 179.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.423 HG21 ' O ' ' A' ' 16' ' ' THR . 32.6 m -63.52 -36.8 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 C-N-CA 118.973 -1.091 . . . . 3.11 108.966 178.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 58.9 mt -66.54 -48.77 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.268 -0.895 . . . . 2.86 108.678 177.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 13.1 mt -58.95 -49.31 78.34 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.928 -0.767 . . . . 2.08 108.928 178.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.47 HD11 ' CG2' ' A' ' 18' ' ' ILE . 29.7 mt -56.29 -43.61 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 C-N-CA 119.992 -0.683 . . . . 3.1 109.457 178.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.34 -45.95 85.59 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.474 -0.766 . . . . 2.84 109.731 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.4 mt -59.02 -46.5 91.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.394 -0.816 . . . . 2.22 109.021 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.54 -45.35 90.96 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.556 -0.715 . . . . 2.17 109.841 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.08 -43.94 95.12 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.549 -0.719 . . . . 2.75 109.312 178.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.4 ' HA ' ' CD2' ' A' ' 30' ' ' LEU . 0.4 OUTLIER -63.25 -47.13 83.73 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.876 -0.787 . . . . 2.72 108.876 178.333 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.61 -41.6 95.71 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 108.636 -1.786 . . . . 1.6 108.636 178.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.05 -47.0 75.8 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.517 -0.99 . . . . 2.51 110.306 179.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.52 ' HG ' ' N ' ' A' ' 31' ' ' ILE . 0.2 OUTLIER -62.27 -37.21 84.61 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.615 -0.678 . . . . 2.92 109.722 179.401 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.52 ' N ' ' HG ' ' A' ' 30' ' ' LEU . 9.7 mt -71.02 -46.95 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.304 -0.872 . . . . 2.58 109.002 178.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.4 tp -58.83 -46.86 86.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.651 -0.655 . . . . 2.63 109.704 178.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.687 0 N-CA-C 109.345 -1.502 . . . . 2.35 109.345 179.344 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.474 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 N-CA-C 108.764 -0.828 . . . . 2.82 108.764 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -62.55 -40.95 98.47 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.684 -0.635 . . . . 3.93 109.608 178.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.413 ' O ' ' CD ' ' A' ' 72' ' ' PRO . 71.2 m -59.93 -41.33 91.55 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.824 -0.547 . . . . 3.82 110.209 179.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -81.37 -41.79 21.46 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.206 -0.934 . . . . 2.79 110.488 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' A' ' 66' ' ' GLN . 1.8 mmtp -61.38 -47.16 87.09 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.467 -0.771 . . . . 2.41 110.687 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 75' ' ' GLU . . . -41.71 -66.45 0.99 Allowed Glycine 0 N--CA 1.503 3.116 0 N-CA-C 110.544 -1.022 . . . . 3.12 110.544 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.516 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 41.3 Cg_endo -65.81 -39.84 18.83 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.788 1.415 . . . . 3.17 110.56 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 6.5 t -60.63 -43.32 97.64 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.033 -1.042 . . . . 2.45 109.325 178.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 69.1 t -70.94 -44.98 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 109.112 -0.699 . . . . 3.22 109.112 178.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 0.6 OUTLIER -56.48 -42.48 78.35 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.614 0.721 . . . . 3.41 109.444 178.629 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.516 ' HD2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -66.09 -50.45 64.02 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.624 -0.673 . . . . 3.38 109.731 179.05 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -41.21 80.16 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 120.208 -0.597 . . . . 3.34 109.655 179.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.88 -43.23 84.04 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 122.062 -0.399 . . . . 3.25 110.044 179.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.459 ' HA ' ' CE ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -68.39 -48.54 64.42 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.607 -0.683 . . . . 3.53 109.893 179.326 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.1 tp . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.486 -0.759 . . . . 2.42 109.56 179.457 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.552 ' O ' HG21 ' A' ' 17' ' ' VAL . 53.8 t . . . . . 0 N--CA 1.498 1.944 0 CA-C-O 121.159 0.504 . . . . 1.73 109.89 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.522 ' O ' HG13 ' A' ' 18' ' ' ILE . 43.2 t -72.63 -37.43 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.031 -1.043 . . . . 1.94 109.416 178.998 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.415 ' O ' HG12 ' A' ' 20' ' ' ILE . 59.5 m -62.17 -50.25 72.59 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.286 -0.884 . . . . 1.68 109.712 178.588 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.552 HG21 ' O ' ' A' ' 14' ' ' VAL . 30.9 m -67.24 -41.86 87.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.655 -0.653 . . . . 1.5 111.643 -179.502 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.523 HG23 ' O ' ' A' ' 14' ' ' VAL . 2.1 pp -67.69 -30.42 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 120.303 -1.498 . . . . 1.76 109.764 179.138 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.6 t -68.99 -52.2 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.233 -0.917 . . . . 1.72 108.782 178.143 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.521 HG12 ' HA ' ' A' ' 17' ' ' VAL . 44.9 pt -63.96 -37.53 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.162 -0.961 . . . . 1.5 109.083 178.668 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.47 ' N ' HG13 ' A' ' 20' ' ' ILE . 9.9 mt -64.85 -48.34 74.68 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.395 -0.816 . . . . 1.55 109.0 178.028 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.467 HD12 HG23 ' A' ' 22' ' ' ILE . 8.0 mm -59.19 -43.57 89.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.317 -0.865 . . . . 1.9 108.873 178.481 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.85 -46.66 88.5 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.387 -0.597 . . . . 1.48 109.387 178.711 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.4 mm -59.97 -45.44 95.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.306 -0.871 . . . . 1.65 108.892 178.386 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.67 -45.4 94.18 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.579 -0.7 . . . . 1.38 109.613 178.751 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.74 -44.94 96.03 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.58 -0.7 . . . . 1.46 109.138 178.593 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.4 tt -61.96 -45.92 91.54 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.898 -0.779 . . . . 1.76 108.898 178.192 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.38 -44.09 95.39 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 108.712 -1.755 . . . . 1.11 108.712 178.651 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.28 -46.28 84.36 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.428 -1.042 . . . . 1.56 109.668 178.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.1 mt -56.89 -41.29 77.79 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 109.179 -0.675 . . . . 1.91 109.179 178.719 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 26.6 mm -70.2 -44.9 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.53 -0.731 . . . . 1.96 109.525 178.853 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.17 -48.52 80.05 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.508 -0.745 . . . . 2.72 109.891 179.285 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.838 0 N-CA-C 110.471 -1.051 . . . . 1.5 110.471 179.773 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.502 ' OE1' ' NZ ' ' A' ' 70' ' ' LYS . 2.6 mt-30 . . . . . 0 N--CA 1.499 2.025 0 N-CA-C 109.491 -0.559 . . . . 3.03 109.491 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -74.26 -41.42 61.31 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.654 0.74 . . . . 3.96 109.463 178.624 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 64.0 m -59.2 -28.54 66.74 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 122.002 -0.436 . . . . 1.33 110.938 179.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -95.59 -43.99 7.69 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.082 -1.011 . . . . 2.19 111.013 -179.651 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.502 ' NZ ' ' OE1' ' A' ' 66' ' ' GLN . 15.2 mtmt -70.06 -39.83 75.43 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.408 -0.808 . . . . 3.65 111.109 -179.394 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.414 ' N ' ' HD2' ' A' ' 72' ' ' PRO . . . -46.0 -61.11 4.11 Favored Glycine 0 N--CA 1.503 3.106 0 N-CA-C 109.603 -1.399 . . . . 1.15 109.603 179.821 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.586 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 42.1 Cg_endo -67.74 -43.37 5.45 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 O-C-N 123.801 1.421 . . . . 1.17 109.751 178.462 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 9.1 t -53.75 -44.77 70.23 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.906 -1.121 . . . . 2.51 110.202 179.055 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.5 t -72.68 -45.96 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.337 -0.852 . . . . 2.12 109.05 178.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -53.6 -42.59 67.83 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.6 0.714 . . . . 1.28 109.96 178.642 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.596 ' HA ' ' CD ' ' A' ' 79' ' ' LYS . 0.9 OUTLIER -72.74 -45.55 58.14 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.673 -0.642 . . . . 1.97 110.997 179.85 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.488 ' HG3' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -67.27 -28.79 68.32 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.121 -0.987 . . . . 2.1 109.984 179.594 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.488 ' N ' ' HG3' ' A' ' 77' ' ' LYS . . . -75.56 -52.36 10.79 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.426 -0.796 . . . . 1.71 109.485 179.265 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.596 ' CD ' ' HA ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -64.84 -28.95 69.9 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.622 -0.674 . . . . 2.37 111.332 179.903 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.547 ' N ' ' HG2' ' A' ' 79' ' ' LYS . 2.6 tp . . . . . 0 N--CA 1.495 1.809 0 O-C-N 121.23 -0.919 . . . . 2.5 112.166 -178.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 N--CA 1.499 2.003 0 N-CA-C 109.3 -0.63 . . . . 2.17 109.3 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.4 t -69.07 -42.69 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.338 -0.851 . . . . 1.8 109.037 178.434 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.415 HG22 HD11 ' A' ' 20' ' ' ILE . 53.9 m -57.31 -52.77 64.01 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.131 0.491 . . . . 1.56 110.007 179.137 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.3 m -64.29 -37.08 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.519 -0.738 . . . . 1.69 110.043 179.468 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.1 mt -66.28 -40.9 88.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.039 -1.038 . . . . 1.86 109.394 178.567 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.3 t -64.52 -45.35 95.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.533 -0.914 . . . . 1.68 108.533 178.158 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.415 HD11 HG22 ' A' ' 16' ' ' THR . 86.2 mt -62.15 -46.32 96.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.49 -0.756 . . . . 1.71 109.016 178.312 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.8 mt -60.07 -49.59 77.07 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.908 -0.775 . . . . 2.03 108.908 178.411 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.9 mt -56.76 -43.13 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.525 -0.735 . . . . 1.83 109.394 178.52 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.21 -46.55 83.41 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.669 -0.644 . . . . 1.49 109.908 179.032 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.5 mm -59.66 -46.29 93.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.232 -0.918 . . . . 1.82 109.02 178.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.96 -45.0 95.57 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.607 -0.683 . . . . 1.95 109.664 178.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.35 -43.84 98.19 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.556 -0.715 . . . . 1.76 109.093 178.59 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.74 -48.26 81.53 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.774 -0.824 . . . . 1.73 108.774 178.133 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.35 -44.65 93.43 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 108.857 -1.697 . . . . 1.25 108.857 178.767 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.32 -43.16 95.54 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.433 -1.04 . . . . 1.72 109.866 178.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.9 mt -60.27 -41.36 93.12 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.244 -0.651 . . . . 2.11 109.244 178.628 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 97.0 mt -69.11 -52.91 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.558 -0.714 . . . . 1.69 109.29 179.029 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.2 -46.91 72.54 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.491 -0.756 . . . . 2.6 109.763 178.867 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.734 0 N-CA-C 109.221 -1.552 . . . . 1.58 109.221 178.964 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.719 0 N-CA-C 109.404 -0.591 . . . . 4.77 109.404 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.432 ' HA ' ' CG ' ' A' ' 70' ' ' LYS . 0.4 OUTLIER -70.48 -42.88 70.82 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.604 -0.685 . . . . 4.18 109.483 178.457 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.42 ' O ' ' CD ' ' A' ' 72' ' ' PRO . 54.2 m -60.1 -37.39 79.83 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 109.963 -0.384 . . . . 2.18 109.963 178.872 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.88 -43.57 15.17 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.241 -0.912 . . . . 2.39 111.338 -179.711 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.432 ' CG ' ' HA ' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -70.33 -25.65 63.39 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.084 -1.01 . . . . 2.04 110.834 -179.795 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.517 ' O ' ' HB2' ' A' ' 75' ' ' GLU . . . -55.11 -64.68 4.15 Favored Glycine 0 N--CA 1.498 2.799 0 N-CA-C 109.063 -1.615 . . . . 1.68 109.063 178.918 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.42 ' CD ' ' O ' ' A' ' 68' ' ' SER . 39.6 Cg_endo -65.91 -37.09 28.2 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 124.085 1.571 . . . . 2.41 110.055 178.778 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 6.2 t -60.16 -46.21 90.45 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.992 -1.067 . . . . 2.52 109.656 178.725 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 39.2 t -72.24 -42.49 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.515 -0.741 . . . . 1.74 109.401 178.863 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.517 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -57.65 -41.66 81.9 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.717 0.77 . . . . 3.01 109.283 178.408 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.4 ttt85 -71.3 -45.32 63.34 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.578 -0.701 . . . . 4.11 110.371 179.36 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.25 -44.25 95.42 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.178 -0.951 . . . . 2.77 109.262 179.267 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.5 -49.06 72.83 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.526 0.679 . . . . 1.76 110.849 179.329 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.4 mttp -68.24 -46.57 70.12 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.276 -0.89 . . . . 3.45 111.502 -179.655 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.1 tp . . . . . 0 N--CA 1.495 1.801 0 O-C-N 121.226 -0.921 . . . . 3.19 112.3 -178.672 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.8 t . . . . . 0 N--CA 1.497 1.905 0 N-CA-C 109.346 -0.613 . . . . 2.23 109.346 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.6 t -69.99 -41.93 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.278 -0.889 . . . . 3.11 109.261 178.663 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.404 HG22 HD12 ' A' ' 20' ' ' ILE . 77.8 m -58.75 -51.57 69.42 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.699 -0.626 . . . . 2.81 109.928 179.155 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.41 HG23 ' N ' ' A' ' 18' ' ' ILE . 23.3 m -65.41 -36.43 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.471 -0.768 . . . . 1.92 109.911 179.42 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.41 ' N ' HG23 ' A' ' 17' ' ' VAL . 21.7 mt -66.58 -40.19 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 121.136 -0.977 . . . . 2.14 109.298 178.404 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 36.1 t -64.8 -43.51 96.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.036 -1.04 . . . . 2.93 108.474 177.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.404 HD12 HG22 ' A' ' 16' ' ' THR . 87.7 mt -63.68 -46.73 93.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 108.919 -0.771 . . . . 2.72 108.919 178.139 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 44.7 mt -59.56 -49.15 78.87 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.705 -0.85 . . . . 1.57 108.705 178.454 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 31.4 mt -56.27 -42.44 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.557 -0.714 . . . . 2.09 109.386 178.284 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.44 -45.52 83.5 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.461 -0.774 . . . . 2.52 109.663 178.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.0 mt -60.09 -46.11 94.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 108.438 -0.949 . . . . 2.31 108.438 178.367 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.62 -48.12 82.31 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.753 -0.462 . . . . 1.39 109.753 178.56 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.48 -44.19 89.27 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.47 -0.769 . . . . 1.96 109.078 178.712 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.452 ' HG ' HD12 ' A' ' 31' ' ' ILE . 0.5 OUTLIER -62.01 -46.32 89.7 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.844 -0.799 . . . . 3.11 108.844 178.116 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.98 -42.5 98.35 Favored Glycine 0 N--CA 1.497 2.717 0 N-CA-C 108.899 -1.68 . . . . 1.95 108.899 178.735 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.38 -44.15 95.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.549 -0.971 . . . . 1.29 109.315 178.72 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.4 mt -60.79 -40.84 94.11 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.003 -0.74 . . . . 2.39 109.003 178.289 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.452 HD12 ' HG ' ' A' ' 27' ' ' LEU . 30.1 mt -67.79 -48.54 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.375 -0.828 . . . . 3.34 109.208 178.445 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.99 -48.43 78.47 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.391 -0.818 . . . . 2.94 109.329 178.848 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.612 0 N-CA-C 110.908 -0.877 . . . . 1.27 110.908 179.876 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.447 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 3.0 mm-40 . . . . . 0 N--CA 1.496 1.832 0 N-CA-C 108.881 -0.785 . . . . 2.23 108.881 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -63.06 -42.06 99.6 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.355 -0.841 . . . . 3.67 109.359 178.277 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 70.4 m -56.26 -35.07 67.02 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.997 -0.44 . . . . 1.67 110.678 179.177 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -91.29 -40.94 11.22 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.166 -0.959 . . . . 1.77 110.777 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 66' ' ' GLN . 3.4 mmtp -64.59 -44.76 89.63 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.576 -0.702 . . . . 3.28 110.746 -179.851 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.4 ' N ' ' HD2' ' A' ' 72' ' ' PRO . . . -46.52 -63.56 3.02 Favored Glycine 0 N--CA 1.502 3.08 0 N-CA-C 110.455 -1.058 . . . . 1.1 110.455 -179.823 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 71' ' ' GLY . 40.2 Cg_endo -65.8 -38.15 24.87 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 O-C-N 123.736 1.387 . . . . 1.52 110.644 179.545 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 10.5 t -60.68 -43.38 97.77 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.023 -1.048 . . . . 1.94 109.496 178.841 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 54.1 t -74.26 -42.95 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.487 -0.758 . . . . 1.83 109.375 178.76 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -56.03 -44.62 78.92 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.701 -0.851 . . . . 1.5 108.701 178.318 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -66.78 -41.61 87.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.854 -0.529 . . . . 2.37 109.805 178.788 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.6 -50.12 75.13 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.432 -0.792 . . . . 3.71 110.095 179.135 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.32 -44.11 92.56 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.61 -0.681 . . . . 1.6 110.642 179.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -66.39 -33.63 76.15 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.522 -0.736 . . . . 1.69 110.162 179.488 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.496 1.828 0 O-C-N 121.196 -0.94 . . . . 3.13 111.119 -179.844 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.433 ' HA ' HG23 ' A' ' 17' ' ' VAL . 12.5 t . . . . . 0 N--CA 1.499 1.984 0 N-CA-C 109.465 -0.569 . . . . 3.37 109.465 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.3 t -67.45 -42.73 87.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.055 -1.028 . . . . 2.36 109.26 178.805 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 66.8 m -60.54 -52.6 64.5 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.685 -0.634 . . . . 2.03 109.812 179.08 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.463 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 23.6 m -64.32 -35.46 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 119.829 -0.748 . . . . 2.54 109.834 179.397 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.436 ' N ' HG22 ' A' ' 17' ' ' VAL . 9.8 mt -68.71 -41.78 82.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 120.935 -1.103 . . . . 3.38 109.042 178.432 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.8 t -64.04 -42.28 95.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.391 -0.966 . . . . 1.87 108.391 178.063 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 83.3 mt -64.68 -50.09 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.483 -0.761 . . . . 2.06 109.153 178.51 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.554 ' HG ' ' N ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -61.86 -41.16 97.5 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.878 -0.786 . . . . 2.9 108.878 178.827 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.554 ' N ' ' HG ' ' A' ' 21' ' ' LEU . 7.4 mm -60.97 -44.19 97.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.44 -0.948 . . . . 3.19 108.44 177.945 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.77 -44.86 88.7 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.546 -0.721 . . . . 2.15 109.689 178.817 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.416 HG22 HD11 ' A' ' 24' ' ' ILE . 20.9 mm -59.68 -49.59 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.421 -0.955 . . . . 2.35 108.421 178.434 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.1 -44.9 96.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.794 -0.566 . . . . 2.85 110.002 178.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.73 -43.44 98.84 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.571 -0.706 . . . . 2.96 109.251 178.683 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.1 tt -63.24 -46.97 84.44 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.029 -0.73 . . . . 2.81 109.029 178.24 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.38 -44.61 96.47 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 108.708 -1.757 . . . . 2.9 108.708 178.617 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.67 -40.9 96.2 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.609 -0.936 . . . . 3.66 109.573 178.691 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.5 mt -61.33 -43.13 99.4 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.105 -0.702 . . . . 4.16 109.105 178.536 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 35.4 mt -67.84 -49.26 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.451 -0.781 . . . . 3.42 109.469 179.005 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.72 -39.2 90.69 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.658 -0.652 . . . . 4.08 110.391 179.313 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.689 0 N-CA-C 110.244 -1.142 . . . . 4.46 110.244 179.86 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 . . . . . 0 N--CA 1.494 1.746 0 N-CA-C 108.911 -0.774 . . . . 4.83 108.911 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.29 -48.36 70.63 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.967 -0.753 . . . . 5.45 108.967 178.412 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.43 -30.71 60.99 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 116.31 -0.405 . . . . 1.9 111.269 179.746 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.577 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -92.87 -48.18 6.67 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.125 -0.984 . . . . 2.57 109.842 179.311 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.9 mmpp? -59.58 -51.41 69.95 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.685 -0.635 . . . . 4.04 111.511 -179.656 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.402 ' N ' ' HD2' ' A' ' 72' ' ' PRO . . . -42.87 -63.05 2.09 Favored Glycine 0 N--CA 1.504 3.231 0 N-CA-C 110.091 -1.203 . . . . 1.97 110.091 -179.631 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.514 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 41.1 Cg_endo -66.18 -40.21 16.03 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 O-C-N 123.721 1.379 . . . . 1.28 110.445 178.931 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.577 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 0.7 OUTLIER -62.28 -46.31 89.37 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.731 -1.23 . . . . 2.69 109.786 179.125 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.53 ' O ' ' HB3' ' A' ' 78' ' ' ALA . 39.0 t -64.85 -49.79 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.694 -0.854 . . . . 2.88 108.694 178.819 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -56.58 -40.67 75.63 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.221 0.534 . . . . 3.53 110.084 179.025 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.514 ' HB2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -63.7 -52.98 58.17 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.514 -0.741 . . . . 3.08 110.227 179.919 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.561 ' HG3' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -66.7 -31.87 72.81 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.334 -0.946 . . . . 3.68 109.778 179.552 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.561 ' N ' ' HG3' ' A' ' 77' ' ' LYS . . . -66.55 -46.69 75.26 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.202 -1.036 . . . . 2.77 108.202 177.678 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -66.43 -40.79 89.72 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.05 -0.722 . . . . 4.09 109.05 178.128 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.497 1.923 0 O-C-N 121.301 -0.875 . . . . 2.9 110.504 179.26 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.9 t . . . . . 0 N--CA 1.499 2.012 0 N-CA-C 109.477 -0.564 . . . . 1.99 109.477 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.2 t -68.16 -43.67 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.199 -0.938 . . . . 2.18 109.363 178.77 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 53.1 m -58.53 -50.99 71.78 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.628 -0.67 . . . . 2.36 110.164 179.436 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.508 HG21 ' N ' ' A' ' 18' ' ' ILE . 31.5 m -66.87 -33.68 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.371 -0.831 . . . . 2.04 110.271 179.654 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.508 ' N ' HG21 ' A' ' 17' ' ' VAL . 7.2 mm -69.25 -41.4 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 120.892 -1.13 . . . . 2.0 109.29 178.468 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.6 t -64.83 -44.15 96.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 108.413 -0.958 . . . . 2.15 108.413 177.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 21.8 mm -62.97 -46.91 95.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.479 -0.763 . . . . 2.54 109.059 178.29 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.8 mt -59.98 -48.82 80.13 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.912 -0.773 . . . . 2.11 108.912 178.378 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.5 mm -57.45 -44.03 83.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.533 -0.729 . . . . 1.96 109.412 178.503 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.47 -45.04 92.61 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.529 -0.732 . . . . 1.82 109.718 179.008 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 37.6 mt -60.55 -45.39 97.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.418 -0.801 . . . . 2.21 109.004 178.667 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.57 -45.57 89.87 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.48 -0.763 . . . . 1.72 109.753 178.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.68 -43.87 97.17 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.8 -0.815 . . . . 1.57 108.8 178.516 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.505 ' HA ' HD23 ' A' ' 27' ' ' LEU . 3.0 tm? -60.04 -52.06 66.99 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.834 -0.802 . . . . 2.39 108.834 178.076 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.91 -44.66 82.21 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.033 -1.627 . . . . 1.33 109.033 178.68 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.6 -43.57 96.53 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.496 -1.002 . . . . 1.58 109.878 179.071 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.8 mt -59.76 -40.78 89.35 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.498 -0.556 . . . . 2.16 109.498 178.967 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.523 HD13 HG23 ' A' ' 31' ' ' ILE . 8.7 mt -71.54 -44.89 70.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.464 -0.773 . . . . 2.72 109.385 178.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.37 -48.44 81.64 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.301 -0.875 . . . . 2.51 109.667 179.138 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.838 0 N-CA-C 109.663 -1.375 . . . . 1.29 109.663 179.252 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 . . . . . 0 N--CA 1.493 1.71 0 N-CA-C 108.783 -0.821 . . . . 2.4 108.783 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -66.06 -43.3 87.84 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.597 -0.689 . . . . 4.53 109.46 178.28 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 69.7 m -58.45 -40.5 82.78 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.9 -0.5 . . . . 2.17 110.393 179.342 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.501 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -83.71 -44.86 14.03 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.325 -0.86 . . . . 1.75 111.05 -179.948 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.3 mmtp -61.61 -45.7 92.96 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.384 -0.823 . . . . 2.28 111.128 -179.613 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -43.02 -64.9 1.56 Allowed Glycine 0 N--CA 1.506 3.319 0 N-CA-C 110.679 -0.968 . . . . 1.54 110.679 -179.397 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.409 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 40.6 Cg_endo -65.51 -38.59 24.81 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 O-C-N 123.779 1.41 . . . . 1.64 110.45 179.41 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.501 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -62.14 -46.36 89.38 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.964 -1.085 . . . . 1.84 109.571 178.8 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.7 t -68.37 -45.4 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 109.004 -0.739 . . . . 1.86 109.004 178.672 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' A' ' 79' ' ' LYS . 2.6 tm-20 -56.9 -43.38 81.29 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.502 0.668 . . . . 1.7 109.559 178.549 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -64.99 -48.32 74.38 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.728 -0.607 . . . . 2.77 109.683 178.925 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.58 -42.67 97.18 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.583 -0.698 . . . . 2.35 110.187 179.789 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.03 -41.98 97.25 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.866 -0.521 . . . . 1.57 109.657 179.125 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 75' ' ' GLU . 5.0 mttp -68.07 -47.58 67.91 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.29 -0.633 . . . . 2.41 109.29 178.67 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.712 0 O-C-N 121.425 -0.797 . . . . 2.24 109.63 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.758 0 N-CA-C 109.956 -1.258 . . . . 6.58 109.956 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.88 141.5 37.59 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.279 -1.13 . . . . 5.84 110.57 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.566 ' O ' ' HB3' ' A' ' 4' ' ' SER . 5.7 mtt -93.88 79.97 4.16 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.443 -0.786 . . . . 8.1 109.825 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.566 ' HB3' ' O ' ' A' ' 3' ' ' MET . 11.1 t 67.88 -60.6 0.4 Allowed 'General case' 0 N--CA 1.506 2.342 0 N-CA-C 109.192 -0.67 . . . . 7.65 109.192 -178.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.0 pp -82.53 -153.69 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 107.606 -1.257 . . . . 5.58 107.606 177.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.482 ' HB3' ' OG ' ' A' ' 9' ' ' SER . 8.3 mtt -124.63 63.63 1.11 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 119.623 -1.923 . . . . 4.47 112.127 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -67.22 -36.96 82.78 Favored 'General case' 0 N--CA 1.506 2.347 0 CA-C-O 121.532 0.682 . . . . 4.54 109.382 177.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -82.57 18.01 1.63 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.564 -0.71 . . . . 5.48 110.61 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.482 ' OG ' ' HB3' ' A' ' 6' ' ' MET . 9.1 p -113.3 159.39 35.24 Favored Pre-proline 0 N--CA 1.491 1.619 0 N-CA-C 108.198 -1.038 . . . . 2.0 108.198 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -74.34 43.17 0.85 Allowed 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 122.577 0.777 . . . . 3.3 111.615 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -65.15 -37.37 87.19 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.035 -1.041 . . . . 3.63 108.783 178.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.0 p -60.99 -38.32 85.59 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.25 -0.906 . . . . 2.57 108.71 177.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.06 -51.54 17.92 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 108.69 -1.764 . . . . 2.03 108.69 178.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.514 ' O ' HG23 ' A' ' 17' ' ' VAL . 54.2 t -55.79 -40.25 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.645 -0.915 . . . . 2.52 109.02 178.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.7 t -69.89 -42.84 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.202 -0.937 . . . . 2.26 109.036 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 49.6 m -58.98 -51.36 70.39 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.771 -0.581 . . . . 2.17 109.985 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 14' ' ' VAL . 29.1 m -66.95 -33.17 61.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.387 -0.821 . . . . 2.33 110.271 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.504 HG23 HD11 ' A' ' 18' ' ' ILE . 6.9 mm -69.64 -41.13 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 120.925 -1.109 . . . . 2.31 109.091 178.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.3 t -64.76 -45.07 96.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 108.291 -1.003 . . . . 2.15 108.291 177.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.461 HG21 HD13 ' A' ' 24' ' ' ILE . 23.6 mm -62.06 -46.79 95.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.85 -0.796 . . . . 2.11 108.85 178.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 13.1 mt -59.75 -49.67 76.81 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.849 -0.797 . . . . 2.26 108.849 178.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.445 HD12 HG21 ' A' ' 18' ' ' ILE . 30.0 mt -56.44 -43.1 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.575 -0.703 . . . . 2.36 109.293 178.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.68 -46.84 83.69 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.588 -0.695 . . . . 1.9 109.536 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.461 HD13 HG21 ' A' ' 20' ' ' ILE . 66.1 mt -58.64 -48.29 86.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.446 -0.783 . . . . 2.13 108.978 178.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.61 -45.37 94.27 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.62 -0.675 . . . . 2.03 109.937 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.4 -45.37 93.83 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 109.071 -0.714 . . . . 1.76 109.071 178.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.27 -47.1 87.55 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.014 -0.735 . . . . 2.14 109.014 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.15 -44.26 94.91 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 108.88 -1.688 . . . . 1.36 108.88 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.14 -45.73 92.14 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.409 -1.053 . . . . 1.8 109.414 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.475 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 6.4 mt -57.58 -41.8 81.85 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.297 -0.631 . . . . 2.07 109.297 178.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.604 HG23 ' HA ' ' A' ' 37' ' ' TYR . 45.6 mt -71.36 -36.04 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.302 -0.874 . . . . 1.83 110.09 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.458 ' HA ' ' N ' ' A' ' 37' ' ' TYR . 7.6 tt -68.06 -45.19 74.54 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.234 -0.916 . . . . 2.12 109.825 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -73.07 -40.33 51.29 Favored Glycine 0 N--CA 1.498 2.812 0 O-C-N 121.169 -0.957 . . . . 1.29 111.469 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -83.45 -33.98 25.53 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 120.854 -1.38 . . . . 1.67 112.015 -178.714 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.511 ' CD2' ' HG3' ' A' ' 39' ' ' ARG . 9.2 m0 -129.86 19.23 5.57 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.786 -1.196 . . . . 1.93 112.053 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 1.3 m 50.98 32.24 7.24 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.214 -0.929 . . . . 2.06 110.117 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.604 ' HA ' HG23 ' A' ' 31' ' ' ILE . 0.1 OUTLIER 54.46 25.52 6.21 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.521 -0.737 . . . . 1.72 110.67 -179.028 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 11.8 tp -128.44 -46.27 1.33 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.436 -0.79 . . . . 2.02 110.032 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.511 ' HG3' ' CD2' ' A' ' 35' ' ' TRP . 9.0 ttp-105 46.11 43.23 10.7 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.855 -0.528 . . . . 1.33 111.503 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 51.85 58.6 5.29 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.415 -0.803 . . . . 2.89 110.838 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -79.44 -14.17 59.1 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.108 -0.995 . . . . 1.43 111.077 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.29 -139.62 0.07 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.115 -0.99 . . . . 2.03 109.851 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.251 0.3 OUTLIER -62.84 -23.94 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 O-C-N 120.793 -1.192 . . . . 3.45 110.517 179.386 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.8 t 61.39 -163.02 0.27 Allowed 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.414 -0.804 . . . . 2.49 111.29 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 42.86 41.23 2.45 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.496 -0.753 . . . . 5.63 110.829 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 175.7 -42.11 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.693 -0.63 . . . . 2.97 109.816 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -63.59 148.65 48.31 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.767 -0.583 . . . . 2.23 110.669 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -102.74 -148.02 0.38 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.61 -0.681 . . . . 3.12 110.088 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.454 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 0.4 OUTLIER -73.74 122.69 22.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.949 -1.094 . . . . 2.37 109.994 179.85 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.402 ' HG2' ' HE2' ' A' ' 67' ' ' TYR . 42.0 tt0 -106.07 86.52 2.39 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.259 -0.9 . . . . 1.47 110.737 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.417 ' HB2' ' CE1' ' A' ' 37' ' ' TYR . 9.5 t -174.8 -40.72 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.411 0 O-C-N 121.322 -0.861 . . . . 1.82 110.263 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.6 mt -117.47 -58.57 3.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.658 -0.652 . . . . 3.04 109.984 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.588 HG13 ' N ' ' A' ' 54' ' ' GLY . 7.4 p -98.46 -36.04 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 O-C-N 121.468 -0.77 . . . . 2.93 111.743 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.588 ' N ' HG13 ' A' ' 53' ' ' VAL . . . -71.81 -34.88 62.17 Favored Glycine 0 N--CA 1.5 2.951 0 N-CA-C 108.975 -1.65 . . . . 1.75 108.975 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -168.23 109.76 0.56 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.775 -0.838 . . . . 1.56 109.76 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 155.99 -55.92 0.4 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.062 -1.615 . . . . 2.08 109.062 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -131.37 14.0 5.05 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.825 -0.809 . . . . 3.74 111.085 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.45 -45.59 92.4 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.046 -1.034 . . . . 2.89 110.359 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.424 ' O ' ' HB2' ' A' ' 60' ' ' GLU . 49.4 tttm -147.4 124.04 11.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.32 -0.862 . . . . 4.14 111.07 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 1.3 mp0 60.22 163.28 0.1 OUTLIER Pre-proline 0 N--CA 1.506 2.356 0 N-CA-C 112.535 0.569 . . . . 4.16 112.535 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -75.49 -7.21 18.54 Favored 'Trans proline' 0 CA--C 1.547 1.172 0 O-C-N 123.372 1.196 . . . . 2.72 110.167 178.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -55.39 -51.62 66.22 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.441 -0.787 . . . . 4.05 111.153 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 36.9 mt -60.27 -30.8 69.69 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.546 -0.721 . . . . 2.09 110.687 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.2 -59.2 5.84 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.437 -0.789 . . . . 3.23 109.808 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.466 HG23 ' N ' ' A' ' 66' ' ' GLN . 27.1 m -66.16 -31.35 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.247 -0.908 . . . . 2.81 109.757 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.466 ' N ' HG23 ' A' ' 65' ' ' VAL . 4.2 tt0 -61.9 -49.31 76.7 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.477 -0.765 . . . . 1.78 109.086 178.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.541 ' HA ' ' HG2' ' A' ' 70' ' ' LYS . 4.6 t80 -72.7 -35.61 67.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.781 -0.574 . . . . 1.57 109.48 178.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.0 t -61.71 -31.15 71.28 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.644 -0.66 . . . . 2.79 109.744 178.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.533 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -93.78 -50.29 5.43 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.253 -0.904 . . . . 2.54 110.868 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.541 ' HG2' ' HA ' ' A' ' 67' ' ' TYR . 5.0 pttt -70.68 -36.22 73.21 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.267 -0.896 . . . . 1.9 111.225 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.437 ' N ' ' HD2' ' A' ' 72' ' ' PRO . . . -46.6 -61.67 4.08 Favored Glycine 0 N--CA 1.498 2.83 0 N-CA-C 109.277 -1.529 . . . . 1.58 109.277 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.492 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 41.5 Cg_endo -67.23 -42.48 7.64 Favored 'Trans proline' 0 C--N 1.314 -1.242 0 O-C-N 124.039 1.547 . . . . 2.47 110.102 178.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -56.71 -44.54 81.66 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.959 -1.088 . . . . 3.05 109.815 178.876 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.0 t -71.05 -49.07 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.479 -0.763 . . . . 2.17 109.387 178.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 0.6 OUTLIER -55.26 -39.04 69.33 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.746 -0.596 . . . . 2.18 110.078 179.31 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.492 ' HD2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -68.37 -55.04 13.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.482 -0.761 . . . . 3.25 109.434 178.774 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.616 ' HG3' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -59.91 -31.27 69.67 Favored 'General case' 0 N--CA 1.505 2.282 0 C-N-CA 119.446 -0.902 . . . . 3.72 110.281 179.592 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.616 ' N ' ' HG3' ' A' ' 77' ' ' LYS . . . -71.13 -41.9 69.91 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.559 -0.713 . . . . 2.23 109.601 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 32.5 mttp -73.74 -34.58 64.82 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.441 -0.577 . . . . 2.74 109.441 178.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 71.6 mt -68.62 -38.84 80.88 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.987 -1.071 . . . . 4.1 110.131 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 5.2 ttt -86.68 -43.6 12.48 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.54 -0.725 . . . . 4.76 111.23 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.1 p -116.24 160.36 36.09 Favored Pre-proline 0 N--CA 1.51 2.574 0 O-C-N 121.037 -1.039 . . . . 3.25 110.626 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.9 -33.09 65.13 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 O-C-N 123.357 1.188 . . . . 2.51 111.903 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 51.42 25.42 2.62 Favored 'General case' 0 N--CA 1.508 2.458 0 O-C-N 121.476 -0.765 . . . . 2.86 111.674 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.402 ' HA2' ' HD2' ' A' ' 86' ' ' PRO . . . -126.87 100.33 0.56 Allowed Glycine 0 N--CA 1.499 2.848 0 N-CA-C 109.159 -1.576 . . . . 2.36 109.159 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.402 ' HD2' ' HA2' ' A' ' 85' ' ' GLY . 36.4 Cg_endo -58.72 -14.74 23.0 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 O-C-N 123.772 1.406 . . . . 3.59 111.64 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -65.95 -23.46 66.61 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.132 -0.98 . . . . 3.58 108.78 177.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 8.4 p -134.64 -16.78 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.474 -0.766 . . . . 4.14 111.519 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -175.63 174.65 2.21 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 120.631 -1.293 . . . . 4.35 111.585 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.456 0 N-CA-C 109.197 -1.561 . . . . 4.12 109.197 178.43 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.649 0 N-CA-C 109.309 -1.516 . . . . 3.67 109.309 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 57.81 44.87 19.52 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 121.632 -0.922 . . . . 5.6 110.667 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -97.99 167.4 10.93 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.15 -0.969 . . . . 3.5 110.814 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.3 p -81.36 -30.86 33.61 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.169 -0.957 . . . . 3.95 110.16 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.424 HG12 ' OG1' ' A' ' 16' ' ' THR . 1.8 pp -96.07 -156.37 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.586 -0.696 . . . . 3.53 109.72 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.74 111.82 1.59 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.807 -1.183 . . . . 4.12 110.609 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -65.29 -20.42 66.4 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.532 -0.73 . . . . 2.65 110.922 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -88.3 25.64 1.6 Allowed 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.173 -0.955 . . . . 3.72 110.59 178.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -123.08 104.11 35.68 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 120.931 -1.106 . . . . 2.2 110.802 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.38 -46.74 2.62 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 O-C-N 123.477 1.251 . . . . 1.77 110.993 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.4 p -68.76 -61.66 1.72 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.471 -0.768 . . . . 2.07 109.742 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.17 -36.85 63.82 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.441 -0.787 . . . . 1.84 110.362 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.95 -59.14 7.83 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.175 -1.57 . . . . 1.19 109.175 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 36.5 t -54.48 -40.82 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.481 -1.011 . . . . 1.73 109.347 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.7 t -62.81 -46.0 97.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.567 -0.708 . . . . 1.78 109.159 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.454 HG23 HD11 ' A' ' 20' ' ' ILE . 65.6 m -56.64 -46.66 80.9 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 121.206 0.527 . . . . 1.56 109.692 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.6 t -65.25 -40.71 89.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 C-N-CA 119.695 -0.802 . . . . 1.57 109.175 178.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.4 mm -60.98 -40.13 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.122 -0.986 . . . . 1.73 109.039 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 49.7 t -65.58 -45.58 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.181 -1.044 . . . . 1.49 108.181 177.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.454 HD11 HG23 ' A' ' 16' ' ' THR . 85.8 mt -61.28 -49.53 84.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.915 -0.772 . . . . 1.49 108.915 178.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 11.2 mt -57.71 -48.7 78.84 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.987 -0.746 . . . . 1.63 108.987 178.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.3 mt -56.95 -44.01 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 C-N-CA 119.845 -0.742 . . . . 1.62 109.195 178.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.36 -45.99 88.6 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.599 -0.688 . . . . 1.45 109.752 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.5 mt -59.2 -47.26 90.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.327 -0.858 . . . . 1.47 108.984 178.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.0 -44.95 95.64 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.591 -0.693 . . . . 1.41 109.849 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.97 -44.71 96.93 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.54 -0.725 . . . . 1.59 109.237 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.501 HD22 HD13 ' A' ' 31' ' ' ILE . 0.7 OUTLIER -62.56 -45.92 90.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.44 -0.788 . . . . 1.81 108.924 178.301 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.47 -43.98 95.6 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 108.69 -1.764 . . . . 1.01 108.69 178.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.68 -45.13 84.03 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.611 -0.935 . . . . 1.51 109.748 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.466 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 5.0 mt -58.52 -41.43 85.44 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.758 -0.589 . . . . 2.0 109.426 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.501 HD13 HD22 ' A' ' 27' ' ' LEU . 40.8 mt -69.32 -48.08 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.54 -0.725 . . . . 1.81 109.478 178.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.83 -49.8 75.45 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.585 -0.697 . . . . 2.33 110.189 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.75 -46.87 92.76 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 110.452 -1.059 . . . . 1.26 110.452 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -63.5 -35.37 80.24 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.317 -1.107 . . . . 2.11 111.054 -179.687 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 5.9 m95 -82.94 -58.81 2.71 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.227 -0.921 . . . . 2.29 110.8 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 41.97 45.9 3.41 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.72 -0.612 . . . . 1.8 111.971 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -177.65 -39.44 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.387 0 O-C-N 121.437 -0.789 . . . . 1.31 110.717 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.404 ' O ' ' CB ' ' A' ' 39' ' ' ARG . 6.6 tp -127.63 -57.2 1.28 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.176 -0.952 . . . . 1.79 109.887 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.502 ' CZ ' ' HB3' ' A' ' 39' ' ' ARG . 0.0 OUTLIER 68.07 95.87 0.06 Allowed 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.604 0.716 . . . . 1.44 110.977 179.582 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.402 ' HG ' ' HB2' ' A' ' 44' ' ' SER . 0.2 OUTLIER -60.47 84.96 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.501 -0.75 . . . . 2.47 110.251 179.564 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.08 -24.65 58.2 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.326 -0.859 . . . . 2.04 111.327 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.53 -125.42 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.195 -0.94 . . . . 3.15 110.171 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.253 0.1 OUTLIER -67.59 -23.08 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 120.892 -1.13 . . . . 3.12 111.294 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.402 ' HB2' ' HG ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER 62.2 79.58 0.25 Allowed 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.429 -0.794 . . . . 2.25 110.652 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -96.37 32.08 2.08 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.298 -0.877 . . . . 2.36 110.288 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 61.96 50.26 4.23 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.642 -0.661 . . . . 1.59 109.486 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.706 ' HA ' ' SG ' ' A' ' 73' ' ' CYS . 1.0 OUTLIER -104.27 171.39 7.36 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.547 0.689 . . . . 1.46 111.887 -178.722 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -78.2 112.52 15.26 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.359 -0.838 . . . . 1.65 110.591 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.01 175.0 10.78 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.266 -0.896 . . . . 1.38 110.973 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.429 ' HG3' HG13 ' A' ' 53' ' ' VAL . 0.4 OUTLIER 61.59 92.68 0.05 Allowed 'General case' 0 N--CA 1.502 2.139 0 CA-C-O 121.498 0.666 . . . . 1.22 110.962 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.4 p -106.01 -74.65 0.65 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.034 -1.041 . . . . 2.53 111.075 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.423 HG13 ' N ' ' A' ' 53' ' ' VAL . 16.3 pt -53.98 -39.16 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.591 -0.693 . . . . 2.47 111.723 -178.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.429 HG13 ' HG3' ' A' ' 50' ' ' GLU . 13.5 p -94.58 -27.31 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 121.087 -1.008 . . . . 2.1 111.076 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.08 77.0 0.57 Allowed Glycine 0 N--CA 1.497 2.746 0 N-CA-C 109.501 -1.44 . . . . 1.13 109.501 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.7 t70 67.07 -64.2 0.26 Allowed 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.987 -0.714 . . . . 2.02 110.872 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 121.22 -44.85 1.29 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 106.568 -2.613 . . . . 2.38 106.568 -178.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.513 ' O ' ' HB ' ' A' ' 58' ' ' THR . 2.0 pt-20 -125.06 -16.09 6.15 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 122.177 -0.602 . . . . 3.17 110.805 178.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.513 ' HB ' ' O ' ' A' ' 57' ' ' GLU . 31.8 m 72.22 124.93 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.518 0 CA-C-O 121.595 0.712 . . . . 2.06 110.515 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.422 ' HB3' ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -71.68 161.01 31.65 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.103 -0.998 . . . . 2.3 111.11 -179.097 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.598 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -48.76 -54.06 30.96 Favored Pre-proline 0 N--CA 1.504 2.23 0 O-C-N 121.546 -0.721 . . . . 2.74 111.693 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.598 ' HD3' ' HB3' ' A' ' 60' ' ' GLU . 39.8 Cg_endo -65.55 -25.31 55.18 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 O-C-N 123.29 1.153 . . . . 1.9 110.962 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.471 ' O ' ' HB2' ' A' ' 66' ' ' GLN . 2.8 m-85 -83.19 -41.69 18.14 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.036 -1.04 . . . . 3.15 110.621 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.496 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 0.9 OUTLIER -66.91 -30.6 70.8 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.185 -0.947 . . . . 2.27 109.957 179.28 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.418 ' N ' ' HG ' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -61.62 -53.55 54.68 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.667 -0.646 . . . . 3.08 110.385 179.349 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.4 HG21 ' O ' ' A' ' 62' ' ' PHE . 30.0 m -72.65 -31.59 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.018 -1.051 . . . . 2.19 109.998 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.471 ' HB2' ' O ' ' A' ' 62' ' ' PHE . 2.0 tt0 -65.27 -44.84 86.75 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.434 -0.792 . . . . 1.61 109.35 178.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.499 ' HA ' ' HG2' ' A' ' 70' ' ' LYS . 0.5 OUTLIER -68.84 -41.77 78.08 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.885 -0.783 . . . . 3.45 108.885 178.201 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 68.4 m -60.33 -37.89 82.03 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 116.19 -0.459 . . . . 1.84 110.375 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.62 -41.58 16.23 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.278 -0.889 . . . . 1.9 110.726 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.559 ' HA ' ' HB3' ' A' ' 73' ' ' CYS . 0.2 OUTLIER -65.82 -35.08 79.67 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.38 -0.825 . . . . 1.21 111.5 -179.59 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.425 ' N ' ' HD2' ' A' ' 72' ' ' PRO . . . -48.97 -61.36 5.37 Favored Glycine 0 N--CA 1.505 3.259 0 N-CA-C 109.715 -1.354 . . . . 1.34 109.715 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 71' ' ' GLY . 40.9 Cg_endo -66.97 -39.54 13.78 Favored 'Trans proline' 0 C--N 1.315 -1.225 0 O-C-N 123.755 1.397 . . . . 1.69 109.864 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.706 ' SG ' ' HA ' ' A' ' 47' ' ' GLU . 2.6 t -62.17 -48.5 79.78 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.878 -1.139 . . . . 1.7 109.609 178.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.696 ' HA ' ' HE3' ' A' ' 77' ' ' LYS . 25.4 t -57.98 -49.93 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.286 -1.005 . . . . 1.53 108.286 178.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -57.47 -40.05 77.7 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.763 -0.775 . . . . 1.58 109.318 177.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.9 ttm180 -63.78 -54.88 28.21 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.694 -0.629 . . . . 1.81 111.187 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.696 ' HE3' ' HA ' ' A' ' 74' ' ' VAL . 1.6 pttt -70.62 -33.12 70.68 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.02 -1.05 . . . . 2.32 110.605 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.07 -47.77 67.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.327 -0.858 . . . . 1.58 109.636 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 16.4 mmtm -67.23 -44.53 79.26 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.377 -0.827 . . . . 1.79 109.805 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 tp -61.99 -34.42 76.14 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.628 -0.67 . . . . 2.91 111.155 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.2 ttt -95.36 -60.8 1.59 Allowed 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.354 -0.841 . . . . 4.29 110.376 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.5 t -177.69 104.46 0.22 Allowed Pre-proline 0 N--CA 1.503 2.185 0 O-C-N 121.518 -0.739 . . . . 2.7 110.078 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -69.31 -6.15 17.66 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 O-C-N 123.822 1.433 . . . . 1.78 111.383 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 53.99 26.0 5.97 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.269 -0.894 . . . . 3.57 110.515 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -128.66 -159.08 9.86 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.93 -1.268 . . . . 2.32 109.93 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -74.09 -20.33 19.29 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 O-C-N 123.684 1.36 . . . . 3.09 112.132 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -50.59 -51.02 52.22 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.358 -0.839 . . . . 2.65 109.79 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -112.34 2.09 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.623 -0.673 . . . . 2.97 110.637 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 3.3 m80 56.35 47.33 19.26 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.367 -0.833 . . . . 3.78 110.892 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 3.015 0 CA-C-O 118.349 -1.25 . . . . 3.68 110.209 179.816 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.767 0 N-CA-C 109.963 -1.255 . . . . 2.36 109.963 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.455 ' HB3' HG13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -87.68 160.23 18.2 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.177 -1.19 . . . . 3.47 110.369 179.574 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.45 71.79 8.46 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.112 -0.993 . . . . 3.09 111.772 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 46.37 50.22 12.53 Favored 'General case' 0 N--CA 1.509 2.52 0 O-C-N 121.559 -0.713 . . . . 2.37 112.58 178.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.515 ' CD1' ' HB2' ' A' ' 6' ' ' MET . 2.0 pp -99.7 -167.96 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 120.914 -1.116 . . . . 1.9 110.513 178.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.515 ' HB2' ' CD1' ' A' ' 5' ' ' ILE . 0.1 OUTLIER 60.1 -154.1 0.37 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.415 -0.803 . . . . 2.96 110.77 -179.57 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 55.66 27.09 10.08 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.388 -0.82 . . . . 2.13 111.214 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.476 ' ND1' ' HA ' ' A' ' 87' ' ' GLU . 2.9 t-160 -60.5 -27.88 67.94 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 121.222 -0.923 . . . . 1.46 111.467 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.487 ' O ' HG21 ' A' ' 12' ' ' THR . 12.0 t -167.14 151.54 6.65 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.319 -0.863 . . . . 2.53 110.191 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.76 -17.75 47.43 Favored 'Trans proline' 0 N--CA 1.491 1.331 0 O-C-N 123.562 1.296 . . . . 1.78 110.523 179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.3 p -59.33 -51.6 69.26 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.476 -0.765 . . . . 2.04 109.939 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.487 HG21 ' O ' ' A' ' 9' ' ' SER . 4.9 t -61.31 -31.6 71.45 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.357 -0.84 . . . . 2.08 109.961 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.5 ' O ' HG21 ' A' ' 17' ' ' VAL . . . -70.81 -53.83 10.86 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 108.024 -2.031 . . . . 1.45 108.024 178.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.575 ' O ' HG23 ' A' ' 17' ' ' VAL . 37.9 t -55.11 -39.49 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.852 -0.793 . . . . 2.12 109.289 178.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.585 ' HA ' HG12 ' A' ' 18' ' ' ILE . 25.0 t -67.09 -37.73 79.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.326 -0.859 . . . . 2.0 109.468 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 98.4 m -64.61 -44.07 91.74 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.377 -0.827 . . . . 2.46 110.29 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 14' ' ' VAL . 0.5 OUTLIER -71.48 -37.39 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 C-N-CA 119.133 -1.027 . . . . 2.48 110.908 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.585 HG12 ' HA ' ' A' ' 15' ' ' VAL . 8.7 pt -69.19 -33.74 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 120.299 -1.501 . . . . 2.38 109.52 178.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.492 ' N ' HG13 ' A' ' 18' ' ' ILE . 38.6 t -69.63 -44.3 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.287 -1.005 . . . . 1.97 108.287 177.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.433 HD12 HG21 ' A' ' 20' ' ' ILE . 2.6 mm -63.52 -46.78 94.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.401 -0.812 . . . . 2.16 109.027 178.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.577 ' HA ' HG12 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -63.28 -43.47 97.82 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.515 -0.74 . . . . 2.1 109.031 178.811 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.551 ' N ' ' HG ' ' A' ' 21' ' ' LEU . 7.5 mm -62.14 -39.07 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.029 -1.044 . . . . 2.21 109.0 178.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.29 -51.0 61.74 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.549 -0.719 . . . . 1.79 110.715 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.577 HG12 ' HA ' ' A' ' 21' ' ' LEU . 40.8 pt -62.36 -37.12 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.807 -1.183 . . . . 2.15 109.266 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.495 ' N ' HG13 ' A' ' 24' ' ' ILE . . . -65.15 -46.59 80.27 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.418 -0.801 . . . . 1.97 109.192 178.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 22' ' ' ILE . . . -61.6 -43.08 99.53 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.697 -0.853 . . . . 1.94 108.697 178.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.3 tt -60.38 -48.17 82.91 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.953 -0.758 . . . . 2.12 108.953 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.72 -46.58 92.07 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 108.839 -1.705 . . . . 1.4 108.839 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.69 -42.98 99.66 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.456 -1.026 . . . . 1.97 109.558 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.447 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 6.4 mt -61.2 -41.3 96.58 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 109.085 -0.709 . . . . 2.29 109.085 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 23.5 mm -65.35 -46.14 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.519 -0.738 . . . . 1.81 109.142 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.48 ' O ' ' HB2' ' A' ' 36' ' ' CYS . 0.2 OUTLIER -61.18 -48.61 80.77 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.543 -0.723 . . . . 2.52 109.63 178.846 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.52 -37.01 92.64 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 110.017 -1.233 . . . . 1.53 110.017 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -74.68 -42.9 57.6 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.447 -1.031 . . . . 1.53 111.049 -179.82 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.415 ' CZ2' ' HA ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -153.9 58.25 0.73 Allowed 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.364 -0.835 . . . . 1.64 112.45 -179.011 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 32' ' ' LEU . 49.6 t -61.78 -26.61 68.2 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 120.65 -1.281 . . . . 1.9 111.527 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.31 -169.0 2.29 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.107 -0.995 . . . . 3.76 109.371 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.9 tp -51.07 -36.33 39.5 Favored 'General case' 0 N--CA 1.508 2.452 0 O-C-N 120.954 -1.091 . . . . 2.42 110.67 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 45.44 72.61 0.2 Allowed 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 121.587 0.708 . . . . 2.1 111.748 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.53 -34.52 50.23 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.408 -0.807 . . . . 2.67 110.977 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.467 ' HG3' ' HA ' ' A' ' 44' ' ' SER . 26.8 tt0 -71.94 55.97 0.3 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.04 -1.038 . . . . 2.3 109.741 178.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.415 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . 0.7 OUTLIER -60.32 -76.77 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.411 -0.805 . . . . 1.64 108.989 179.625 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.407 ' O ' ' HB3' ' A' ' 44' ' ' SER 0.27 0.3 OUTLIER -76.88 -22.48 14.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.633 -0.667 . . . . 2.44 110.248 178.834 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.467 ' HA ' ' HG3' ' A' ' 41' ' ' GLN . 10.6 t 64.42 -67.59 0.11 Allowed 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.491 -0.755 . . . . 1.56 111.493 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.402 ' HB2' ' OE1' ' A' ' 47' ' ' GLU . 0.7 OUTLIER -99.39 -89.13 0.33 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.815 -1.178 . . . . 2.21 111.063 -179.69 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.4 m 178.46 50.29 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.375 0 O-C-N 121.016 -1.053 . . . . 2.44 110.677 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.402 ' OE1' ' HB2' ' A' ' 45' ' ' GLN . 1.3 pm0 -111.95 -164.14 0.9 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.257 -0.902 . . . . 2.36 110.577 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.04 143.3 26.94 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.846 -1.159 . . . . 2.84 110.418 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.46 ' HG2' ' N ' ' A' ' 50' ' ' GLU . 22.7 tt0 -160.94 157.74 26.94 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.108 -0.995 . . . . 1.56 111.82 -178.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.46 ' N ' ' HG2' ' A' ' 49' ' ' GLU . 1.9 tt0 -95.09 -110.49 0.13 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.476 -0.765 . . . . 1.16 110.173 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.0 m -162.03 -39.64 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.343 0 O-C-N 120.393 -1.442 . . . . 1.5 111.838 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.5 mt -106.2 -51.07 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.348 -0.845 . . . . 1.89 110.146 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.3 m -134.01 -47.67 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 O-C-N 121.522 -0.736 . . . . 1.58 111.17 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.71 -66.02 3.39 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 109.88 -1.288 . . . . 1.19 109.88 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -100.0 158.35 15.89 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.421 -1.047 . . . . 2.79 110.523 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.43 55.34 0.4 Allowed Glycine 0 N--CA 1.497 2.764 0 N-CA-C 109.112 -1.595 . . . . 1.88 109.112 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 52.84 44.75 29.93 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.813 -0.816 . . . . 2.3 110.582 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.59 58.39 0.09 Allowed 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.348 -0.845 . . . . 1.68 110.794 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.2 105.83 5.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.154 -0.966 . . . . 2.4 109.918 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.06 122.61 10.04 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.493 -0.754 . . . . 2.46 110.868 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.521 ' O ' ' HB2' ' A' ' 62' ' ' PHE . 38.3 Cg_endo -66.46 -41.45 11.83 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.658 1.346 . . . . 2.48 110.565 178.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.521 ' HB2' ' O ' ' A' ' 61' ' ' PRO . 1.2 t80 171.28 164.08 0.09 Allowed 'General case' 0 N--CA 1.507 2.413 0 O-C-N 121.494 -0.754 . . . . 3.93 110.549 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 mt -64.08 -39.82 94.9 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.382 -0.824 . . . . 3.9 109.624 178.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.13 -42.07 97.86 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.724 -0.61 . . . . 4.31 109.519 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.429 ' HB ' ' HG2' ' A' ' 61' ' ' PRO . 11.8 t -74.52 -38.98 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.226 -0.922 . . . . 2.74 109.125 178.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.427 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 6.0 tt0 -57.7 -42.77 84.38 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.758 -0.83 . . . . 2.64 108.758 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.407 ' HA ' ' HG2' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -74.44 -45.8 44.0 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 109.259 -0.645 . . . . 4.3 109.259 178.106 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 69.9 m -59.21 -37.09 76.6 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.748 -0.595 . . . . 2.42 110.488 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.432 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -84.68 -46.48 11.43 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.054 -1.028 . . . . 1.73 111.243 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.427 ' HB3' ' O ' ' A' ' 66' ' ' GLN . 12.3 ptpt -65.17 -35.66 81.78 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.338 -0.851 . . . . 2.75 111.213 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -49.07 -64.22 3.44 Favored Glycine 0 N--CA 1.502 3.068 0 N-CA-C 109.795 -1.322 . . . . 1.66 109.795 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.11 -37.15 26.5 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.734 1.386 . . . . 1.66 110.245 179.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 2.5 t -62.41 -46.04 90.39 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.039 -1.038 . . . . 1.76 109.593 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.5 t -68.66 -47.41 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.561 -0.712 . . . . 1.82 109.311 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -57.41 -40.59 78.61 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 119.799 -0.76 . . . . 1.5 109.405 178.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.8 ttm180 -65.11 -44.22 89.47 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.53 -0.731 . . . . 2.9 109.473 178.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.83 -38.7 89.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -0.871 . . . . 3.29 109.786 178.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.04 -50.71 53.59 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.377 0.608 . . . . 1.54 110.087 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.408 ' O ' HG23 ' A' ' 82' ' ' THR . 0.3 OUTLIER -65.64 -30.8 71.56 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.693 -0.63 . . . . 1.99 110.109 179.469 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -76.98 -26.86 54.41 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.245 -0.909 . . . . 2.72 109.881 178.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 3.7 ttt -86.85 -40.34 14.99 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.369 -0.832 . . . . 3.37 110.756 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.408 HG23 ' O ' ' A' ' 79' ' ' LYS . 14.5 t -61.15 146.63 88.0 Favored Pre-proline 0 N--CA 1.509 2.487 0 O-C-N 121.367 -0.833 . . . . 1.89 111.163 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -78.74 9.95 3.05 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 O-C-N 123.552 1.29 . . . . 1.75 112.849 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 41.51 29.45 0.1 Allowed 'General case' 0 N--CA 1.511 2.584 0 O-C-N 121.437 -0.789 . . . . 2.25 112.192 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -132.34 -93.61 0.57 Allowed Glycine 0 N--CA 1.498 2.791 0 N-CA-C 109.448 -1.461 . . . . 1.81 109.448 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.413 ' O ' ' N ' ' A' ' 88' ' ' VAL . 53.6 Cg_endo -80.72 -108.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.28 0 O-C-N 123.848 1.446 . . . . 2.22 110.106 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.476 ' HA ' ' ND1' ' A' ' 8' ' ' HIS . 0.5 OUTLIER 65.14 -57.76 0.28 Allowed 'General case' 0 N--CA 1.507 2.38 0 O-C-N 120.979 -1.076 . . . . 1.41 110.86 -179.526 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.413 ' N ' ' O ' ' A' ' 86' ' ' PRO . 11.5 p -110.54 -20.84 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.748 -0.595 . . . . 2.61 110.121 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -119.5 157.45 28.29 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.265 -0.897 . . . . 3.34 109.653 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.657 0 CA-C-O 117.848 -1.529 . . . . 2.84 109.707 179.18 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.5 ' HA2' ' OE2' ' A' ' 57' ' ' GLU . . . . . . . . 0 N--CA 1.496 2.692 0 N-CA-C 111.485 -0.646 . . . . 3.15 111.485 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 m -78.3 47.64 0.7 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.194 -1.18 . . . . 4.02 110.617 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -75.87 -20.62 57.94 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 121.219 -0.926 . . . . 6.42 111.306 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 80.4 p -129.47 -65.55 0.84 Allowed 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.598 -0.89 . . . . 6.51 108.598 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.0 pp -98.05 -174.73 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-O 121.25 0.547 . . . . 6.13 110.107 178.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.2 71.05 1.22 Allowed 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 122.067 0.937 . . . . 6.16 110.492 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -65.74 -18.51 65.38 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.524 -0.735 . . . . 3.05 109.767 178.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.707 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 5.5 m80 -79.05 -5.31 53.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.64 -0.662 . . . . 2.99 110.867 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.448 ' CB ' ' CD ' ' A' ' 10' ' ' PRO . 0.5 OUTLIER -61.49 -57.73 23.17 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.168 -0.957 . . . . 3.99 110.652 179.706 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.448 ' CD ' ' CB ' ' A' ' 9' ' ' SER . 49.6 Cg_endo -73.82 109.51 2.88 Favored 'Trans proline' 0 N--CA 1.488 1.203 0 O-C-N 123.54 1.284 . . . . 3.54 110.679 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.3 p -57.2 -46.68 82.66 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.393 -0.817 . . . . 4.47 110.412 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.521 ' O ' HG23 ' A' ' 15' ' ' VAL . 1.3 p -59.03 -33.12 70.39 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.417 -0.802 . . . . 4.69 109.235 178.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.408 ' O ' HG22 ' A' ' 17' ' ' VAL . . . -75.32 -50.13 8.66 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 108.342 -1.903 . . . . 3.39 108.342 178.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.707 ' CG2' ' HA ' ' A' ' 8' ' ' HIS . 72.1 t -49.99 -45.68 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 121.964 -0.727 . . . . 2.86 110.16 178.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 12' ' ' THR . 17.2 m -71.89 -42.42 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.2 -0.938 . . . . 3.86 109.847 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 56.7 m -58.22 -50.65 72.82 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.554 -0.717 . . . . 3.42 110.175 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.431 HG22 ' O ' ' A' ' 14' ' ' VAL . 27.4 m -66.03 -39.63 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.45 -0.781 . . . . 2.59 110.104 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.559 ' O ' HG12 ' A' ' 22' ' ' ILE . 10.9 mm -64.98 -43.52 96.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 O-C-N 120.994 -1.066 . . . . 2.65 109.445 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.496 ' HA ' HG12 ' A' ' 22' ' ' ILE . 32.2 t -61.78 -40.43 86.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 119.743 -0.783 . . . . 3.25 108.955 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.407 HD13 ' HA ' ' A' ' 20' ' ' ILE . 27.4 mm -69.43 -41.24 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.26 -0.9 . . . . 2.91 108.746 178.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.432 HD11 ' O ' ' A' ' 56' ' ' GLY . 39.6 mt -61.99 -50.62 71.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.712 -0.617 . . . . 1.73 109.491 178.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.559 HG12 ' O ' ' A' ' 18' ' ' ILE . 43.5 pt -61.99 -41.16 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 120.815 -1.178 . . . . 2.87 109.409 178.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.533 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -60.27 -45.86 91.85 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.04 -0.726 . . . . 2.38 109.04 178.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 39.0 mt -59.27 -48.26 87.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.689 -0.856 . . . . 1.92 108.689 178.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.98 -42.5 94.32 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.697 -0.627 . . . . 1.8 109.878 178.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.84 -45.53 92.17 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.922 -0.769 . . . . 2.13 108.922 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.68 -45.55 93.51 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.806 -0.813 . . . . 2.01 108.806 178.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.441 ' HA3' ' HG2' ' A' ' 60' ' ' GLU . . . -58.84 -45.54 94.84 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 108.54 -1.824 . . . . 1.13 108.54 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.5 -44.73 95.67 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.507 -0.996 . . . . 1.97 109.36 178.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.438 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 5.3 mt -56.78 -42.87 80.19 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.088 -0.708 . . . . 2.37 109.088 178.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.8 mt -68.83 -49.18 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 109.07 -0.715 . . . . 1.81 109.07 178.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.83 -46.05 71.07 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.496 -0.753 . . . . 3.49 109.527 178.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.3 -40.21 70.26 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.925 -1.27 . . . . 1.97 109.925 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 6.9 t -62.7 -44.88 95.09 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.339 -1.095 . . . . 1.97 110.955 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.457 ' O ' ' N ' ' A' ' 37' ' ' TYR . 2.0 t-105 -165.23 40.08 0.07 Allowed 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.024 -1.048 . . . . 3.13 112.334 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.518 ' SG ' ' CD1' ' A' ' 63' ' ' LEU . 38.1 t 62.38 -64.46 0.09 Allowed 'General case' 0 N--CA 1.51 2.545 0 O-C-N 121.232 -0.918 . . . . 2.92 112.234 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.53 ' HB3' ' HG2' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -153.64 -66.92 0.15 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.82 -1.175 . . . . 6.05 110.363 -178.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -136.65 -62.54 0.65 Allowed 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.413 -0.958 . . . . 2.84 108.413 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.8 mtm-85 171.73 54.42 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.072 0.463 . . . . 2.32 110.239 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.58 20.57 8.63 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.95 -1.094 . . . . 3.16 111.95 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -96.89 38.31 1.24 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.862 -1.149 . . . . 2.61 110.476 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? -112.01 -64.38 1.3 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.184 -0.947 . . . . 3.4 111.158 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.504 HG13 ' H ' ' A' ' 44' ' ' SER . 3.0 pt -94.51 -39.08 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 CA-C-O 121.802 0.811 . . . . 3.35 110.468 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.504 ' H ' HG13 ' A' ' 43' ' ' ILE . 1.1 m -168.99 125.39 0.93 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.522 -0.548 . . . . 3.46 109.522 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -66.64 162.06 21.94 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.583 0.706 . . . . 2.99 110.924 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.1 m -170.67 45.72 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.408 -0.807 . . . . 2.76 109.664 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.53 ' HG2' ' HB3' ' A' ' 37' ' ' TYR . 1.9 mp0 -111.04 166.01 11.41 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.634 -0.666 . . . . 2.43 110.42 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.19 80.19 1.29 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.445 -0.784 . . . . 3.96 110.449 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -98.06 82.16 2.93 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.437 -0.579 . . . . 2.23 109.437 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.86 -175.28 3.13 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 122.253 1.025 . . . . 3.28 111.07 -179.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.5 t -137.86 -37.22 0.6 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.793 -0.567 . . . . 3.06 110.514 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 38.2 mt -76.98 -48.42 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.115 -0.991 . . . . 3.17 109.647 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.418 ' CG1' ' N ' ' A' ' 54' ' ' GLY . 1.0 OUTLIER -55.21 -56.91 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-O 121.391 0.615 . . . . 3.13 109.669 178.894 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.418 ' N ' ' CG1' ' A' ' 53' ' ' VAL . . . -73.63 73.99 1.14 Allowed Glycine 0 N--CA 1.497 2.759 0 N-CA-C 109.818 -1.313 . . . . 2.38 109.818 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -115.98 -162.79 0.86 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.514 -0.992 . . . . 2.38 110.417 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' A' ' 57' ' ' GLU . . . 111.26 48.32 0.71 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 108.117 -1.993 . . . . 2.38 108.117 -178.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.5 ' OE2' ' HA2' ' A' ' 1' ' ' GLY . 0.9 OUTLIER 62.02 14.91 6.84 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.927 -0.749 . . . . 2.71 111.035 -178.586 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.6 t -154.32 144.63 22.1 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.974 -1.079 . . . . 2.49 110.296 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -137.39 121.01 17.28 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.437 -0.79 . . . . 2.6 110.021 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.441 ' HG2' ' HA3' ' A' ' 28' ' ' GLY . 0.3 OUTLIER -64.37 144.67 98.5 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.426 -0.796 . . . . 2.53 110.339 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -69.85 58.02 1.56 Allowed 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.719 1.379 . . . . 2.06 110.429 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.488 ' O ' HG23 ' A' ' 65' ' ' VAL . 55.2 m-85 -55.29 155.22 5.21 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.639 -0.663 . . . . 2.82 110.371 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.518 ' CD1' ' SG ' ' A' ' 36' ' ' CYS . 0.5 OUTLIER -59.97 -36.72 77.74 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.861 -1.149 . . . . 2.45 110.668 179.592 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.91 -58.07 10.25 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.368 -0.833 . . . . 2.81 110.049 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 62' ' ' PHE . 33.5 m -68.99 -31.57 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.224 -0.923 . . . . 2.85 109.821 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.446 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 6.5 tp-100 -63.05 -55.25 27.15 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.363 -0.836 . . . . 2.64 108.918 178.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -62.71 -42.45 99.66 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.518 -0.738 . . . . 2.79 109.459 178.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.2 m -56.72 -35.48 68.6 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-O 120.928 0.394 . . . . 2.94 110.703 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -91.69 -41.66 10.59 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.22 -0.925 . . . . 2.84 110.601 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' A' ' 66' ' ' GLN . 1.6 mmtp -65.23 -44.3 88.69 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.528 -0.733 . . . . 2.85 110.392 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -45.58 -63.68 2.67 Favored Glycine 0 N--CA 1.503 3.109 0 N-CA-C 110.22 -1.152 . . . . 1.93 110.22 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -66.65 -39.08 16.56 Favored 'Trans proline' 0 C--N 1.316 -1.18 0 O-C-N 123.783 1.412 . . . . 2.64 110.419 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 36.7 t -60.64 -43.9 97.02 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.997 -1.064 . . . . 3.08 109.679 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.8 t -70.46 -49.42 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.682 -0.636 . . . . 2.25 109.424 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.21 -31.21 68.83 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.536 0.684 . . . . 2.39 110.3 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.42 ' CZ ' HD13 ' A' ' 80' ' ' LEU . 2.2 tpt180 -75.28 -49.02 20.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.356 -0.84 . . . . 4.52 109.542 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.535 ' HG3' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -69.25 -26.95 65.04 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.364 -0.835 . . . . 3.83 109.662 179.237 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.535 ' N ' ' HG3' ' A' ' 77' ' ' LYS . . . -71.91 -52.28 18.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.451 -0.781 . . . . 2.19 108.946 178.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -68.45 -24.74 64.76 Favored 'General case' 0 N--CA 1.5 2.067 0 C-N-CA 120.48 -0.488 . . . . 2.58 110.312 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.42 HD13 ' CZ ' ' A' ' 76' ' ' ARG . 2.5 tp -78.02 -39.91 40.61 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.23 -0.918 . . . . 4.04 109.53 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 12.0 ttt -78.37 -50.34 11.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.623 -0.673 . . . . 4.58 109.909 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 5.1 t -79.92 144.58 59.86 Favored Pre-proline 0 N--CA 1.492 1.633 0 C-N-CA 119.612 -0.835 . . . . 2.88 109.186 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.405 ' HG3' ' HB3' ' A' ' 89' ' ' HIS . 44.5 Cg_endo -73.16 -3.54 13.85 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 123.521 1.274 . . . . 3.64 110.531 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.23 19.37 10.91 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.32 -0.862 . . . . 4.08 109.64 -178.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -151.89 101.44 0.21 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 107.979 -2.048 . . . . 4.33 107.979 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.546 ' HA ' ' O ' ' A' ' 89' ' ' HIS . 39.0 Cg_endo -62.51 -10.22 18.39 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 O-C-N 123.573 1.301 . . . . 5.67 111.775 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -60.84 -26.3 67.26 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.235 -0.915 . . . . 7.2 110.733 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.7 p -113.84 -23.94 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 O-C-N 121.126 -0.984 . . . . 6.18 111.373 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.546 ' O ' ' HA ' ' A' ' 86' ' ' PRO . 58.1 t-80 -149.47 141.52 23.91 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.902 -1.123 . . . . 4.74 111.017 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.617 0 N-CA-C 109.998 -1.241 . . . . 4.61 109.998 178.985 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.685 0 N-CA-C 109.555 -1.418 . . . . 3.16 109.555 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -176.95 62.18 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.478 -1.013 . . . . 2.98 110.823 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.0 mtt -100.1 -96.54 0.25 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.114 -0.991 . . . . 4.27 109.95 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 81.2 p -129.63 -50.45 1.16 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.04 -1.037 . . . . 2.91 110.257 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.402 ' CD1' ' C ' ' A' ' 5' ' ' ILE . 1.6 pp -71.88 -165.26 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 CA-C-O 121.267 0.555 . . . . 3.38 110.529 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 2.0 mtt -72.05 84.0 0.99 Allowed 'General case' 0 N--CA 1.503 2.19 0 O-C-N 120.66 -1.275 . . . . 3.95 111.419 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.07 33.43 1.52 Allowed 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.278 -0.889 . . . . 2.67 110.434 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 62.02 34.06 16.84 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.288 -0.883 . . . . 3.33 109.662 -178.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -161.57 170.54 8.02 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.677 -0.639 . . . . 1.97 109.296 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -74.33 56.18 3.78 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 O-C-N 123.537 1.283 . . . . 2.01 110.914 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 21.6 p -64.43 -51.45 63.09 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.425 -0.797 . . . . 1.84 110.759 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.3 p -56.1 -36.99 68.79 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.446 -0.784 . . . . 2.35 110.438 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.33 -52.79 11.82 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 109.133 -1.587 . . . . 1.5 109.133 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.546 ' O ' HG12 ' A' ' 18' ' ' ILE . 28.1 t -56.53 -40.43 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.701 -0.882 . . . . 1.91 109.222 178.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.558 ' HA ' HG12 ' A' ' 18' ' ' ILE . 49.8 t -68.25 -41.38 83.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.261 -0.899 . . . . 1.83 109.528 178.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 52.9 m -60.51 -47.5 85.9 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.403 -0.81 . . . . 2.29 109.785 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.466 HG21 ' O ' ' A' ' 14' ' ' VAL . 32.6 m -67.54 -41.65 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.465 -0.772 . . . . 2.2 111.272 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.558 HG12 ' HA ' ' A' ' 15' ' ' VAL . 4.0 pt -68.57 -33.56 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 120.292 -1.505 . . . . 1.82 109.925 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.482 ' N ' HG13 ' A' ' 18' ' ' ILE . 17.7 t -68.44 -44.39 83.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.24 -1.022 . . . . 1.84 108.24 177.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.452 HG22 HD13 ' A' ' 24' ' ' ILE . 69.5 mt -63.69 -49.23 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 108.843 -0.799 . . . . 2.37 108.843 178.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.546 ' HG ' ' N ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -60.71 -42.66 97.7 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 119.926 -0.71 . . . . 2.1 109.106 178.698 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.546 ' N ' ' HG ' ' A' ' 21' ' ' LEU . 14.9 mt -61.24 -44.13 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.226 -0.921 . . . . 1.65 109.131 178.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.9 -45.74 87.94 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.514 -0.741 . . . . 1.7 109.593 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.452 HD13 HG22 ' A' ' 20' ' ' ILE . 54.6 mt -58.79 -47.77 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.437 -0.789 . . . . 2.4 108.993 178.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.95 -44.83 95.94 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.561 -0.712 . . . . 1.72 109.935 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.57 -45.64 93.17 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 109.149 -0.685 . . . . 1.47 109.149 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.35 -45.96 92.2 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.488 -0.758 . . . . 2.38 108.978 178.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.22 -45.35 94.2 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 108.617 -1.793 . . . . 1.57 108.617 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.25 -44.94 93.77 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.639 -0.918 . . . . 1.72 109.888 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.462 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 6.7 mt -58.82 -41.28 86.49 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.618 -0.676 . . . . 2.0 109.516 178.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 53.2 mt -68.22 -47.0 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.272 -0.893 . . . . 2.11 109.305 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 36' ' ' CYS . 0.3 OUTLIER -62.71 -39.37 93.81 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.358 -0.839 . . . . 2.72 110.42 179.043 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -75.49 -37.8 39.95 Favored Glycine 0 N--CA 1.498 2.781 0 O-C-N 120.948 -1.095 . . . . 1.42 111.142 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.531 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 0.1 OUTLIER -84.19 -32.63 24.45 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.942 -1.328 . . . . 1.91 111.859 -179.033 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.531 ' CE3' ' HB3' ' A' ' 34' ' ' CYS . 7.0 m-90 -125.51 1.02 7.62 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 120.979 -1.076 . . . . 2.15 112.393 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER 64.68 -69.49 0.09 Allowed 'General case' 0 N--CA 1.511 2.576 0 O-C-N 121.059 -1.025 . . . . 2.58 112.044 179.435 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.491 ' CB ' HD22 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -131.05 96.55 4.07 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.326 -0.859 . . . . 5.69 109.957 -179.256 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.406 ' HB3' ' O ' ' A' ' 37' ' ' TYR . 34.1 tp 62.94 -66.87 0.09 Allowed 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.561 -0.712 . . . . 4.29 111.117 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.474 ' N ' ' O ' ' A' ' 37' ' ' TYR . 2.1 mmt180 -140.32 -48.51 0.44 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.662 -0.649 . . . . 3.28 110.49 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.492 ' CD1' ' HA ' ' A' ' 44' ' ' SER . 0.2 OUTLIER 46.4 52.06 11.06 Favored 'General case' 0 N--CA 1.504 2.231 0 CA-C-O 121.64 0.734 . . . . 2.37 111.271 -179.977 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.8 pm0 -96.16 19.65 11.45 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.66 -0.65 . . . . 4.42 111.562 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.446 ' HG3' HG12 ' A' ' 43' ' ' ILE . 0.6 OUTLIER -100.62 -147.51 0.35 Allowed 'General case' 0 N--CA 1.485 1.313 0 O-C-N 120.739 -1.226 . . . . 3.4 108.645 178.998 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.446 HG12 ' HG3' ' A' ' 42' ' ' ARG . 16.7 pt -48.8 -33.66 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.36 -0.838 . . . . 2.8 110.175 178.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.492 ' HA ' ' CD1' ' A' ' 40' ' ' LEU . 0.4 OUTLIER 71.44 117.59 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.263 0 CA-C-O 121.382 0.61 . . . . 1.83 110.849 179.798 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.18 -1.59 21.73 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.1 -1.0 . . . . 2.03 110.952 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.406 ' HB2' ' HB2' ' A' ' 80' ' ' LEU . 0.1 OUTLIER 59.56 39.23 21.78 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.176 -0.953 . . . . 2.52 110.369 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.4 ' O ' ' HG2' ' A' ' 47' ' ' GLU . 5.7 pm0 -83.26 146.89 28.3 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.189 -0.944 . . . . 1.66 111.493 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -160.8 -57.05 0.05 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.906 -0.496 . . . . 1.52 110.07 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.506 ' HB2' ' NH2' ' A' ' 76' ' ' ARG . 1.4 tt0 -69.3 124.93 25.16 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.432 -0.792 . . . . 1.91 110.272 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.429 ' OE2' HG12 ' A' ' 53' ' ' VAL . 0.2 OUTLIER 70.65 165.99 0.29 Allowed 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.76 0.791 . . . . 2.27 110.301 -179.236 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.0 p -141.66 -28.7 0.64 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.421 -0.799 . . . . 2.62 111.59 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 67.9 mt -74.31 -51.52 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.186 -0.946 . . . . 3.26 110.447 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.44 ' O ' ' N ' ' A' ' 55' ' ' ASP . 13.9 p -134.96 -33.96 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.294 -0.879 . . . . 2.97 112.164 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.42 ' HA2' ' HB3' ' A' ' 50' ' ' GLU . . . 66.53 -65.24 0.17 Allowed Glycine 0 N--CA 1.505 3.245 0 O-C-N 120.918 -1.114 . . . . 1.93 110.761 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.44 ' N ' ' O ' ' A' ' 53' ' ' VAL . 16.8 t70 -88.39 149.4 23.74 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.386 -1.067 . . . . 2.52 110.182 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 175.41 -62.12 0.11 Allowed Glycine 0 N--CA 1.496 2.672 0 N-CA-C 108.883 -1.687 . . . . 2.6 108.883 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -112.17 25.84 11.16 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.585 -0.95 . . . . 2.76 110.187 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.12 62.78 0.32 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.32 -0.862 . . . . 2.5 110.195 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.4 mttt -113.44 152.62 29.85 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.302 -0.874 . . . . 2.43 110.246 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.638 ' HB3' ' HG2' ' A' ' 66' ' ' GLN . 1.7 mp0 -113.5 73.77 2.08 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.367 -0.833 . . . . 1.73 110.302 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.62 -33.4 17.19 Favored 'Trans proline' 0 N--CA 1.491 1.334 0 O-C-N 123.602 1.317 . . . . 2.17 111.356 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -127.35 163.3 24.31 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.985 -1.072 . . . . 3.36 110.367 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 pp -56.96 -33.21 66.83 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.254 -0.904 . . . . 2.55 110.462 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.17 -49.1 71.1 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.574 -0.704 . . . . 2.84 109.422 178.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.463 ' HA ' ' HB2' ' A' ' 68' ' ' SER . 4.1 t -70.67 -32.71 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.158 -0.964 . . . . 2.22 109.124 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.638 ' HG2' ' HB3' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -57.17 -55.74 30.8 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.475 -0.935 . . . . 1.39 108.475 178.559 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -62.77 -41.45 99.23 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.586 -0.696 . . . . 3.01 109.473 178.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.463 ' HB2' ' HA ' ' A' ' 65' ' ' VAL . 63.7 m -60.39 -37.56 81.2 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 122.035 -0.416 . . . . 1.53 110.308 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -81.58 -39.82 23.98 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.163 -0.961 . . . . 1.58 110.221 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 66' ' ' GLN . 2.6 mmpp? -61.57 -42.63 99.12 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.577 -0.702 . . . . 1.26 110.54 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -43.09 -66.23 1.23 Allowed Glycine 0 N--CA 1.505 3.244 0 N-CA-C 110.526 -1.03 . . . . 0.95 110.526 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.406 ' HA ' ' HB3' ' A' ' 75' ' ' GLU . 40.5 Cg_endo -66.32 -38.73 19.54 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.753 1.396 . . . . 1.13 110.235 179.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.497 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -58.38 -44.82 89.07 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.039 -1.038 . . . . 1.98 109.487 178.495 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 69.6 t -74.39 -41.76 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.55 -0.718 . . . . 1.33 109.233 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.406 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 1.0 OUTLIER -54.75 -46.12 74.27 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 121.529 0.681 . . . . 1.06 109.474 178.532 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.506 ' NH2' ' HB2' ' A' ' 49' ' ' GLU . 6.7 mpt_? -69.09 -46.35 67.99 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.719 -0.613 . . . . 1.17 110.124 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.13 -36.29 79.36 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.531 -0.73 . . . . 2.37 110.099 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.657 ' HA ' ' HA ' ' A' ' 82' ' ' THR . . . -67.25 -46.65 73.11 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.972 -0.751 . . . . 1.37 108.972 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 35.0 mtpt -62.48 -37.37 85.69 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.206 0.527 . . . . 1.54 110.559 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.411 HD11 ' O ' ' A' ' 44' ' ' SER . 9.2 tp -79.5 -50.05 11.33 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.607 -0.683 . . . . 2.32 112.11 -178.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.8 ttm -131.78 -7.2 3.59 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.177 -0.952 . . . . 4.33 112.785 -178.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.657 ' HA ' ' HA ' ' A' ' 78' ' ' ALA . 10.4 m 49.41 84.51 0.2 Allowed Pre-proline 0 N--CA 1.51 2.552 0 O-C-N 121.014 -1.054 . . . . 1.74 111.503 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -73.59 17.85 0.44 Allowed 'Trans proline' 0 N--CA 1.494 1.51 0 O-C-N 123.394 1.207 . . . . 1.33 112.541 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -71.71 53.42 0.23 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.681 -1.262 . . . . 2.42 109.948 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 169.45 -82.89 0.09 OUTLIER Glycine 0 N--CA 1.498 2.781 0 N-CA-C 110.101 -1.2 . . . . 2.09 110.101 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -81.85 -174.48 2.16 Favored 'Trans proline' 0 C--N 1.316 -1.17 0 O-C-N 123.526 1.277 . . . . 2.16 111.114 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 67.97 -55.27 0.5 Allowed 'General case' 0 N--CA 1.506 2.372 0 CA-C-O 121.707 0.765 . . . . 2.45 110.045 -178.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.7 p -105.89 -9.75 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.921 -0.487 . . . . 2.74 110.249 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 62.24 51.15 3.57 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.388 -0.82 . . . . 5.33 110.443 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.691 0 CA-C-O 118.053 -1.415 . . . . 2.72 109.777 179.668 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 7' ' ' ASP . . . . . . . . 0 N--CA 1.498 2.804 0 N-CA-C 109.772 -1.331 . . . . 4.47 109.772 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.608 ' CB ' ' HA ' ' A' ' 7' ' ' ASP . 9.6 t -150.19 177.38 9.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.362 -1.081 . . . . 4.99 110.39 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.4 ptt? -97.38 -18.21 19.25 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.659 -0.651 . . . . 7.07 110.857 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 98.9 p -146.77 -83.75 0.12 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.048 -1.033 . . . . 5.5 110.634 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.429 ' CD1' ' HB2' ' A' ' 6' ' ' MET . 2.4 pp -103.78 -174.44 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.21 -0.932 . . . . 4.34 110.929 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.469 ' O ' ' HB3' ' A' ' 7' ' ' ASP . 0.8 OUTLIER 67.46 -82.26 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.774 -0.579 . . . . 4.19 111.383 179.813 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.608 ' HA ' ' CB ' ' A' ' 2' ' ' SER . 24.0 t70 65.43 -56.08 0.32 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.774 -0.579 . . . . 3.57 111.078 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.429 ' N ' ' O ' ' A' ' 6' ' ' MET . 9.5 m80 -131.41 23.59 4.78 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.523 -0.736 . . . . 3.31 109.329 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 46.73 64.51 8.25 Favored Pre-proline 0 N--CA 1.501 2.114 0 O-C-N 121.681 -0.637 . . . . 3.09 111.112 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -70.84 98.17 0.77 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.552 1.29 . . . . 2.1 110.861 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 19.8 p -57.24 -50.93 71.33 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.4 -0.812 . . . . 2.67 109.727 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.2 p -58.43 -48.21 81.44 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.609 -0.682 . . . . 2.79 109.704 178.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.65 -53.86 42.51 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 109.234 -1.546 . . . . 1.93 109.234 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.557 ' O ' HG23 ' A' ' 17' ' ' VAL . 33.4 t -54.96 -38.79 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.501 -1.0 . . . . 2.46 109.265 178.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.458 ' HA ' HG12 ' A' ' 18' ' ' ILE . 33.9 t -68.21 -47.4 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.175 -0.953 . . . . 2.86 110.123 179.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.3 p -60.1 -37.98 81.58 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.522 -0.736 . . . . 2.77 110.987 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 14' ' ' VAL . 33.0 m -76.11 -37.71 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 120.946 -1.096 . . . . 2.21 111.095 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.525 HG12 ' O ' ' A' ' 14' ' ' VAL . 45.1 pt -70.54 -38.89 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.465 -1.397 . . . . 2.81 110.234 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.445 ' N ' HG13 ' A' ' 18' ' ' ILE . 33.7 m -68.95 -39.98 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 120.887 -1.133 . . . . 2.83 108.755 178.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.462 HG23 HD11 ' A' ' 20' ' ' ILE . 14.6 mm -65.99 -47.32 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.037 -1.039 . . . . 2.64 108.669 177.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.7 mt -59.09 -48.69 80.7 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.841 -0.8 . . . . 2.44 108.841 178.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.1 mt -56.65 -43.79 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.578 -0.702 . . . . 3.15 109.273 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.57 -46.0 87.88 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.621 -0.674 . . . . 2.53 109.779 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.462 HD12 HG21 ' A' ' 20' ' ' ILE . 71.0 mt -59.62 -46.67 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.356 -0.84 . . . . 2.37 108.893 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.65 -43.81 97.86 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.543 -0.723 . . . . 2.47 109.869 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.67 -44.29 96.62 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.532 -0.73 . . . . 2.7 109.141 178.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.2 tt -62.23 -45.94 91.1 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.839 -0.8 . . . . 2.67 108.839 178.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.45 -46.03 93.64 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 108.694 -1.762 . . . . 2.12 108.694 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.41 -43.6 97.06 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.504 -0.998 . . . . 2.77 109.915 179.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.6 mt -59.46 -41.08 88.87 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.595 -0.691 . . . . 3.2 109.613 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 17.7 mt -70.1 -45.73 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.303 -0.873 . . . . 2.58 109.546 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.456 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -60.75 -50.25 74.22 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.668 -0.645 . . . . 3.17 110.01 179.232 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.8 -42.24 99.72 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 109.817 -1.313 . . . . 2.66 109.817 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 46.8 t -56.25 -47.56 78.29 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.456 -1.026 . . . . 2.93 109.984 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.595 ' HB3' ' CG ' ' A' ' 39' ' ' ARG . 1.0 OUTLIER -178.68 65.61 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.503 -0.748 . . . . 3.48 110.982 179.453 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 3.1 m 50.92 -95.94 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.916 -0.49 . . . . 2.77 111.458 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -153.39 -62.2 0.14 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.597 -1.314 . . . . 3.44 112.229 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.68 -5.37 53.86 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 120.968 -1.082 . . . . 2.58 112.201 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.595 ' CG ' ' HB3' ' A' ' 35' ' ' TRP . 0.0 OUTLIER 52.0 68.23 0.84 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.194 -0.941 . . . . 3.2 111.593 179.224 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.465 ' HB3' ' CG1' ' A' ' 43' ' ' ILE . 0.3 OUTLIER -65.53 112.95 3.84 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.413 -0.804 . . . . 2.65 109.377 178.798 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.5 -14.54 8.17 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.24 -0.912 . . . . 3.86 111.656 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.597 ' HG3' ' N ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -78.43 -63.28 1.44 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.093 -1.004 . . . . 3.36 109.264 179.285 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.597 ' N ' ' HG3' ' A' ' 42' ' ' ARG . 1.5 pp -64.36 -37.86 81.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 109.145 -0.687 . . . . 2.7 109.145 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.431 ' H ' HG13 ' A' ' 43' ' ' ILE . 38.3 t 48.93 -84.34 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.288 0 CA-C-N 116.226 -0.443 . . . . 3.6 110.947 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.478 ' N ' ' O ' ' A' ' 43' ' ' ILE . 1.2 pm0 -135.27 -8.28 2.27 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.385 -0.822 . . . . 4.47 112.153 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 p -84.95 -50.29 7.62 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.646 -1.283 . . . . 3.93 110.705 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.574 ' HB2' ' CG2' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -95.88 156.81 16.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.484 -0.76 . . . . 3.42 109.816 179.824 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.42 148.25 30.64 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.296 -0.877 . . . . 2.92 111.294 -179.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -77.79 102.04 7.0 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.1 -1.0 . . . . 2.32 109.92 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 66.43 -176.55 0.19 Allowed 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 122.428 1.109 . . . . 2.15 110.367 -179.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.3 m -173.13 -48.22 0.02 OUTLIER 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.599 -0.728 . . . . 3.84 109.843 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.593 HG22 ' N ' ' A' ' 53' ' ' VAL . 2.1 tp -53.31 -36.35 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.758 -0.589 . . . . 4.68 110.875 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.593 ' N ' HG22 ' A' ' 52' ' ' ILE . 11.6 p -60.52 -29.22 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.319 -0.863 . . . . 3.74 110.405 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.547 ' N ' HG11 ' A' ' 53' ' ' VAL . . . -98.78 11.0 62.65 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.502 -1.439 . . . . 4.75 109.502 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.487 ' OD1' ' HB ' ' A' ' 58' ' ' THR . 4.4 t70 -86.21 -147.82 0.12 Allowed 'General case' 0 N--CA 1.483 1.208 0 O-C-N 121.437 -1.037 . . . . 5.08 109.717 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.8 -34.83 2.23 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 108.465 -1.854 . . . . 6.38 108.465 -179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -135.11 7.64 3.42 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.738 -0.86 . . . . 7.79 112.771 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.487 ' HB ' ' OD1' ' A' ' 55' ' ' ASP . 2.4 m -59.95 116.84 4.42 Favored 'General case' 0 N--CA 1.507 2.398 0 O-C-N 120.4 -1.438 . . . . 5.8 110.367 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.69 159.42 41.32 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.44 -0.788 . . . . 6.76 110.795 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.429 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 1.1 tt0 46.07 56.15 15.86 Favored Pre-proline 0 N--CA 1.499 2.014 0 O-C-N 121.876 -0.515 . . . . 5.67 111.203 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.45 143.91 89.35 Favored 'Trans proline' 0 N--CA 1.49 1.283 0 O-C-N 123.264 1.139 . . . . 5.3 109.871 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.483 ' O ' ' HB2' ' A' ' 66' ' ' GLN . 18.9 t80 69.44 -52.87 0.6 Allowed 'General case' 0 N--CA 1.506 2.343 0 O-C-N 121.745 -0.597 . . . . 4.71 109.5 -177.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.7 mt -61.95 -41.83 98.42 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.596 -0.69 . . . . 5.09 111.091 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 60' ' ' GLU . 0.4 OUTLIER -57.64 -57.19 13.8 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.297 -0.877 . . . . 5.08 110.155 179.759 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 31.4 m -64.77 -34.6 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.118 -0.989 . . . . 3.72 109.904 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.483 ' HB2' ' O ' ' A' ' 62' ' ' PHE . 5.3 tt0 -61.11 -48.39 81.88 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.834 -0.802 . . . . 3.71 108.834 178.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.66 ' HA ' ' HG2' ' A' ' 70' ' ' LYS . 6.9 m-85 -69.12 -40.91 78.03 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.712 -0.617 . . . . 4.16 109.877 178.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -61.93 -37.88 86.34 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.626 -0.671 . . . . 3.49 110.194 179.049 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.529 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -83.02 -41.99 18.03 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.289 -0.882 . . . . 2.5 109.836 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.66 ' HG2' ' HA ' ' A' ' 67' ' ' TYR . 8.1 ptpt -65.78 -35.48 80.82 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.538 -0.726 . . . . 2.95 110.652 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 70' ' ' LYS . . . -43.52 -64.21 1.9 Allowed Glycine 0 N--CA 1.501 2.996 0 N-CA-C 109.384 -1.486 . . . . 2.29 109.384 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.613 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 43.2 Cg_endo -69.44 -45.54 1.72 Allowed 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.963 1.507 . . . . 2.68 110.054 178.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.529 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -55.29 -42.58 73.82 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 120.942 -1.098 . . . . 2.64 110.11 179.281 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.482 ' HA ' ' HG2' ' A' ' 77' ' ' LYS . 56.0 t -73.59 -45.21 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.831 -0.803 . . . . 2.25 108.831 178.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.57 ' HG2' ' HD2' ' A' ' 79' ' ' LYS . 1.6 tt0 -51.34 -45.19 62.24 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.872 0.844 . . . . 3.28 108.902 177.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.613 ' HD2' ' O ' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -73.55 -49.32 27.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.847 -0.533 . . . . 4.04 110.868 179.447 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.599 ' HE3' ' HD3' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -66.82 -19.24 65.7 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.803 -1.185 . . . . 3.33 110.89 179.757 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.627 ' HA ' ' HA ' ' A' ' 82' ' ' THR . . . -86.58 -39.96 15.66 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.775 -0.824 . . . . 2.37 108.775 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.57 ' HD2' ' HG2' ' A' ' 75' ' ' GLU . 13.3 mttt -68.29 -37.79 81.02 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.222 -1.029 . . . . 3.98 108.222 177.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.9 tp -81.23 -38.01 27.65 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.924 -0.485 . . . . 4.14 110.494 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.481 ' O ' ' NZ ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -152.58 63.79 0.8 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.422 -0.799 . . . . 5.28 110.802 179.895 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.627 ' HA ' ' HA ' ' A' ' 78' ' ' ALA . 1.7 m -37.06 121.73 0.84 Allowed Pre-proline 0 N--CA 1.513 2.702 0 O-C-N 121.694 -0.628 . . . . 2.97 111.855 -179.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.599 ' HD3' ' HE3' ' A' ' 77' ' ' LYS . 52.0 Cg_endo -74.9 -3.24 13.61 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 O-C-N 123.893 1.47 . . . . 3.16 112.026 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.438 ' CB ' ' O ' ' A' ' 83' ' ' PRO . 0.5 OUTLIER 71.25 -5.91 1.46 Allowed 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.259 -0.901 . . . . 3.67 111.594 -179.237 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -173.14 71.0 0.1 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 108.712 -1.755 . . . . 3.2 108.712 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -61.84 -19.47 65.73 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 O-C-N 123.907 1.477 . . . . 2.53 111.277 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -57.66 -30.59 65.55 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.396 -0.815 . . . . 3.43 110.106 178.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.6 p -108.67 -5.22 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.384 -0.823 . . . . 4.43 111.06 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -142.05 74.88 1.47 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.853 -1.154 . . . . 4.17 110.263 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.446 ' HA2' HG21 ' A' ' 74' ' ' VAL . . . . . . . . 0 N--CA 1.493 2.472 0 CA-C-O 118.102 -1.388 . . . . 2.7 109.784 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 4' ' ' SER . . . . . . . . 0 N--CA 1.492 2.427 0 N-CA-C 109.572 -1.411 . . . . 5.44 109.572 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.8 t -55.46 124.65 17.91 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.558 -0.966 . . . . 6.3 109.379 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.6 mtt 49.05 26.47 1.4 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.776 -0.578 . . . . 6.84 110.731 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.47 ' O ' ' N ' ' A' ' 1' ' ' GLY . 4.1 p -151.36 83.7 1.31 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.328 -0.857 . . . . 5.92 109.518 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.556 HD11 ' HB2' ' A' ' 6' ' ' MET . 1.5 pp -57.46 179.6 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.364 -0.835 . . . . 5.79 110.982 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.556 ' HB2' HD11 ' A' ' 5' ' ' ILE . 0.0 OUTLIER 63.87 -68.16 0.09 Allowed 'General case' 0 N--CA 1.506 2.341 0 O-C-N 121.634 -0.666 . . . . 6.29 110.971 -179.467 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.441 ' N ' ' O ' ' A' ' 5' ' ' ILE . 8.5 t70 62.65 -57.86 0.14 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.832 -0.543 . . . . 5.36 110.949 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.522 ' N ' ' O ' ' A' ' 6' ' ' MET . 11.3 m80 -129.48 -0.05 5.01 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.481 -0.762 . . . . 6.35 110.522 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.493 ' HB2' ' SD ' ' A' ' 6' ' ' MET . 21.6 t 46.35 69.72 2.47 Favored Pre-proline 0 N--CA 1.502 2.16 0 O-C-N 121.266 -0.897 . . . . 4.33 110.41 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -68.62 63.78 1.21 Allowed 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 123.776 1.408 . . . . 3.92 111.3 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.9 t -57.42 -39.52 76.36 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.398 -0.814 . . . . 3.3 109.737 179.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.1 p -63.74 -42.01 97.93 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.991 -1.068 . . . . 3.81 109.448 178.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.23 -51.18 18.75 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 108.929 -1.668 . . . . 3.35 108.929 178.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.57 ' O ' HG12 ' A' ' 18' ' ' ILE . 26.0 t -56.8 -40.58 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.644 -0.915 . . . . 3.07 109.265 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.62 ' HA ' HG12 ' A' ' 18' ' ' ILE . 16.5 t -70.45 -41.97 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.231 -0.918 . . . . 2.48 109.116 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.484 ' O ' HG12 ' A' ' 20' ' ' ILE . 40.7 m -57.16 -49.68 75.19 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.439 -0.788 . . . . 3.38 109.642 178.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.576 ' HA ' HG12 ' A' ' 20' ' ' ILE . 35.8 m -66.82 -44.04 89.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 C-N-CA 119.814 -0.754 . . . . 3.22 111.424 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.62 HG12 ' HA ' ' A' ' 15' ' ' VAL . 5.1 pt -66.14 -30.01 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 120.236 -1.54 . . . . 2.23 109.679 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.45 ' N ' HG13 ' A' ' 18' ' ' ILE . 8.3 t -70.59 -51.82 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.233 -0.917 . . . . 2.64 108.829 178.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.576 HG12 ' HA ' ' A' ' 17' ' ' VAL . 30.1 pt -64.46 -36.27 76.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.028 -1.045 . . . . 3.13 109.173 178.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.472 ' N ' HG13 ' A' ' 20' ' ' ILE . 13.0 mt -66.32 -47.22 74.25 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.378 -0.826 . . . . 2.4 108.831 177.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.4 HD11 ' HA ' ' A' ' 22' ' ' ILE . 7.3 mm -60.8 -41.35 88.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 108.724 -0.843 . . . . 2.38 108.724 178.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.53 -46.08 84.38 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.749 -0.595 . . . . 2.94 109.454 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 43.5 mt -61.14 -45.12 99.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.344 -0.848 . . . . 2.71 108.81 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.82 -44.87 91.95 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.519 -0.738 . . . . 2.24 109.671 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.28 -41.55 98.58 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.722 -0.844 . . . . 2.84 108.722 178.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.408 ' CD1' ' C ' ' A' ' 27' ' ' LEU . 3.2 tm? -61.91 -52.52 63.74 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.478 -0.934 . . . . 3.42 108.478 177.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.14 -43.96 83.71 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.166 -1.574 . . . . 2.34 109.166 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.29 -41.06 90.32 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.396 -1.061 . . . . 2.94 109.808 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.496 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 10.3 mt -62.38 -40.07 95.27 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.981 -0.748 . . . . 4.04 108.981 178.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.415 HD13 HG21 ' A' ' 31' ' ' ILE . 27.7 mm -71.05 -49.27 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.641 -0.662 . . . . 3.39 109.292 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.75 -46.09 84.98 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.542 -0.724 . . . . 3.45 109.616 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.16 -48.14 82.24 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 109.58 -1.408 . . . . 3.5 109.58 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -58.49 -46.23 87.08 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.523 -0.986 . . . . 4.16 109.887 179.343 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.409 ' O ' ' N ' ' A' ' 37' ' ' TYR . 5.2 t-105 -65.66 -55.4 17.73 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.554 -0.716 . . . . 3.13 109.843 179.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 64.48 -57.9 0.24 Allowed 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.984 -0.448 . . . . 3.99 111.776 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.474 ' CD2' HD23 ' A' ' 38' ' ' LEU . 12.3 t80 -151.33 -55.19 0.14 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.99 -1.069 . . . . 3.42 111.347 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.576 ' CD2' ' HG3' ' A' ' 49' ' ' GLU . 5.6 mt -97.53 -55.43 2.83 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.079 -1.013 . . . . 4.16 110.712 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.2 mtm180 179.62 -50.92 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 121.021 0.438 . . . . 3.43 111.102 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.561 ' HB3' HG12 ' A' ' 43' ' ' ILE . 1.5 mt -124.94 70.05 1.14 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.469 -0.77 . . . . 4.65 110.384 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -58.06 -15.46 9.42 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.185 -0.947 . . . . 4.36 111.351 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.493 ' HG3' ' N ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -64.92 -62.49 1.53 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.148 -0.97 . . . . 6.76 108.948 178.7 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.561 HG12 ' HB3' ' A' ' 40' ' ' LEU . 3.4 pt -71.7 -30.81 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-O 121.865 0.84 . . . . 5.19 108.892 178.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.461 ' N ' HG13 ' A' ' 43' ' ' ILE . 0.9 OUTLIER 76.93 96.17 0.07 Allowed 'General case' 0 N--CA 1.503 2.206 0 CA-C-N 115.337 -0.847 . . . . 5.0 111.1 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.412 ' O ' ' CD1' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -103.83 146.87 28.0 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.745 -0.597 . . . . 4.5 110.122 179.349 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 77.4 p -92.5 -74.78 0.51 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.006 -1.059 . . . . 4.85 110.208 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 63.54 -176.17 0.16 Allowed 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.902 -0.499 . . . . 4.2 110.726 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -82.22 -43.89 17.07 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.068 -1.02 . . . . 3.56 110.247 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.576 ' HG3' ' CD2' ' A' ' 38' ' ' LEU . 0.5 OUTLIER 67.33 138.52 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.438 0 CA-C-O 121.518 0.675 . . . . 4.27 111.728 179.296 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -85.31 72.03 10.76 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.926 -1.109 . . . . 3.43 110.617 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 59.8 p -152.65 -56.88 0.13 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.439 -0.788 . . . . 3.54 110.022 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.9 pt -51.47 -34.72 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 CA-C-O 121.263 0.554 . . . . 3.89 110.398 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.9 p -54.58 -29.56 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 121.689 -0.632 . . . . 3.53 110.993 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.12 -35.93 3.09 Favored Glycine 0 N--CA 1.499 2.862 0 N-CA-C 110.023 -1.231 . . . . 3.75 110.023 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -81.26 154.76 26.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.425 -1.044 . . . . 3.51 110.764 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.96 -58.49 0.05 OUTLIER Glycine 0 N--CA 1.496 2.66 0 N-CA-C 108.947 -1.661 . . . . 3.63 108.947 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -117.84 1.66 12.13 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.551 -0.97 . . . . 5.55 111.694 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.494 ' O ' ' HD3' ' A' ' 61' ' ' PRO . 4.1 m -50.68 140.19 15.0 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.054 -1.028 . . . . 3.42 110.691 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 12.7 ttpp -63.47 134.04 54.96 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.236 -0.915 . . . . 3.5 109.76 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 46.25 61.48 12.86 Favored Pre-proline 0 N--CA 1.502 2.155 0 O-C-N 121.544 -0.723 . . . . 2.82 110.586 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.494 ' HD3' ' O ' ' A' ' 58' ' ' THR . 40.6 Cg_endo -70.24 -34.29 13.26 Favored 'Trans proline' 0 N--CA 1.488 1.164 0 O-C-N 123.51 1.268 . . . . 2.31 111.327 -179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 12.3 t80 62.17 -66.11 0.08 Allowed 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.462 -0.774 . . . . 3.15 111.132 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.491 ' N ' ' O ' ' A' ' 61' ' ' PRO . 2.6 pp -60.25 -32.79 71.49 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.38 -0.825 . . . . 3.2 110.204 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.9 tp -65.78 -48.81 70.52 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.372 -0.83 . . . . 3.33 109.243 178.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.496 ' HA ' ' HB3' ' A' ' 68' ' ' SER . 9.1 t -67.05 -33.63 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 108.324 -0.991 . . . . 2.05 108.324 178.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.578 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 9.4 mm-40 -60.76 -58.35 8.81 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.674 -0.862 . . . . 3.08 108.674 178.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -63.04 -41.36 99.48 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.404 -0.961 . . . . 2.43 108.404 178.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.508 ' O ' ' HD2' ' A' ' 72' ' ' PRO . 29.0 t -53.5 -42.63 67.53 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.496 -0.927 . . . . 1.93 108.496 178.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.05 -38.63 69.46 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 119.581 -0.848 . . . . 2.22 109.246 177.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.578 ' HG2' ' O ' ' A' ' 66' ' ' GLN . 4.6 mmtm -58.18 -52.34 65.97 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.425 -0.797 . . . . 2.79 110.245 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 70' ' ' LYS . . . -34.68 -68.38 0.23 Allowed Glycine 0 N--CA 1.51 3.602 0 N-CA-C 110.911 -0.876 . . . . 1.75 110.911 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.508 ' HD2' ' O ' ' A' ' 68' ' ' SER . 39.4 Cg_endo -66.51 -38.28 19.88 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.831 1.438 . . . . 2.86 110.219 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 34.3 t -61.99 -40.98 97.49 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.995 -1.065 . . . . 3.97 109.386 178.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 55.8 t -75.53 -48.22 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.655 -0.653 . . . . 3.09 109.511 178.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -57.44 -41.26 80.15 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.575 -0.898 . . . . 3.24 108.575 178.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.447 ' HB3' ' O ' ' A' ' 72' ' ' PRO . 0.3 OUTLIER -65.53 -46.72 78.49 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.675 -0.64 . . . . 5.8 109.736 178.465 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.0 -39.52 94.29 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.134 -0.978 . . . . 5.85 109.703 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.83 -46.74 64.97 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.947 -0.471 . . . . 4.18 110.278 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 76' ' ' ARG . 0.1 OUTLIER -69.53 -38.88 77.7 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.608 -0.683 . . . . 4.81 109.48 179.353 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.71 -39.67 94.05 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.441 -0.787 . . . . 6.21 109.256 178.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 13.8 ttt -77.16 -38.84 50.95 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.55 -0.719 . . . . 6.65 109.796 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 8.0 m 56.75 91.29 0.08 OUTLIER Pre-proline 0 N--CA 1.507 2.389 0 O-C-N 121.837 -0.539 . . . . 5.48 110.75 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -74.75 15.28 0.71 Allowed 'Trans proline' 0 N--CA 1.492 1.393 0 O-C-N 123.261 1.137 . . . . 5.49 112.405 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -72.6 48.51 0.2 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.696 -1.252 . . . . 5.64 109.584 178.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 56.34 57.24 20.25 Favored Glycine 0 N--CA 1.499 2.862 0 N-CA-C 110.4 -1.08 . . . . 6.66 110.4 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.12 -24.44 66.24 Favored 'Trans proline' 0 N--CA 1.488 1.174 0 O-C-N 123.353 1.186 . . . . 7.72 110.935 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -65.99 -28.0 68.56 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.368 -0.975 . . . . 8.76 108.368 177.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 60.1 t -100.68 -34.01 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.892 -0.505 . . . . 8.35 109.741 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 -81.63 -52.34 7.29 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.428 -0.795 . . . . 7.95 110.748 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.672 0 CA-C-O 117.912 -1.493 . . . . 8.44 109.581 -179.146 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.777 0 N-CA-C 110.57 -1.012 . . . . 4.09 110.57 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.1 t -64.33 121.34 14.07 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.223 -1.163 . . . . 3.7 111.594 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -81.43 66.09 6.84 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.092 -1.005 . . . . 4.71 108.72 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.411 ' OG ' ' N ' ' A' ' 5' ' ' ILE . 87.6 p -151.46 -68.31 0.18 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.521 -0.737 . . . . 2.98 110.191 -178.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.457 ' CD1' ' HB3' ' A' ' 7' ' ' ASP . 1.8 pp -98.85 -169.49 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.579 -0.701 . . . . 3.8 110.66 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.42 59.81 5.86 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.064 -1.022 . . . . 3.69 111.272 -179.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.457 ' HB3' ' CD1' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -73.39 -26.71 61.11 Favored 'General case' 0 N--CA 1.508 2.43 0 O-C-N 121.032 -1.042 . . . . 3.04 109.768 178.676 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.445 ' O ' ' CB ' ' A' ' 9' ' ' SER . 0.2 OUTLIER -136.09 70.19 1.42 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.598 -0.689 . . . . 3.87 109.732 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER 72.79 176.77 0.06 OUTLIER Pre-proline 0 N--CA 1.517 2.919 0 O-C-N 121.42 -0.8 . . . . 2.0 110.439 -179.308 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.54 -9.86 26.73 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 O-C-N 123.068 1.036 . . . . 2.62 111.074 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.7 p -59.67 -43.34 94.0 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.248 -0.908 . . . . 2.76 111.201 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.08 -37.31 71.69 Favored 'General case' 0 N--CA 1.507 2.421 0 O-C-N 121.345 -0.847 . . . . 2.26 110.14 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.59 -51.89 14.55 Favored Glycine 0 N--CA 1.498 2.769 0 N-CA-C 108.81 -1.716 . . . . 1.42 108.81 178.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.476 ' O ' HG21 ' A' ' 17' ' ' VAL . 51.1 t -54.87 -39.63 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.692 -0.887 . . . . 2.72 109.569 178.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.5 t -70.59 -43.15 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.073 -1.017 . . . . 2.38 109.394 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 87.7 m -59.32 -50.81 72.55 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.735 -0.603 . . . . 1.73 110.009 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.476 HG21 ' O ' ' A' ' 14' ' ' VAL . 33.1 m -66.78 -34.9 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.489 -0.757 . . . . 2.08 110.156 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.412 HD11 ' HA ' ' A' ' 18' ' ' ILE . 6.7 mm -68.08 -41.21 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 120.907 -1.121 . . . . 2.61 109.632 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.4 t -64.89 -44.74 96.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 108.289 -1.004 . . . . 2.14 108.289 177.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.608 HG23 HD12 ' A' ' 24' ' ' ILE . 23.2 mm -61.82 -46.92 95.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.519 -0.738 . . . . 1.83 109.056 178.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 11.3 mt -60.6 -49.18 78.55 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.868 -0.79 . . . . 2.32 108.868 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.2 mt -56.62 -43.83 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 C-N-CA 119.837 -0.745 . . . . 2.56 109.387 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.27 -46.08 85.28 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.615 -0.678 . . . . 1.9 110.176 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.608 HD12 HG23 ' A' ' 20' ' ' ILE . 40.6 mt -59.22 -48.15 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 108.852 -0.795 . . . . 1.89 108.852 178.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.59 -45.18 95.21 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.747 -0.595 . . . . 2.14 110.159 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.63 -49.78 76.16 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 109.086 -0.709 . . . . 2.07 109.086 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.19 -46.12 86.36 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.016 -0.735 . . . . 1.86 109.016 178.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.87 -46.18 92.72 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.073 -1.611 . . . . 1.46 109.073 178.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.13 -42.6 96.77 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.59 -0.947 . . . . 2.2 109.963 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.525 HD12 HG22 ' A' ' 53' ' ' VAL . 8.8 mt -61.3 -41.2 96.58 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.16 -0.682 . . . . 2.19 109.16 178.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 95.3 mt -67.32 -51.84 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.467 -0.771 . . . . 2.29 109.154 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.94 -45.5 78.8 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.597 -0.689 . . . . 2.58 109.921 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.5 -53.86 35.93 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.813 -1.315 . . . . 1.82 109.813 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -56.28 -39.6 72.91 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.4 -1.059 . . . . 2.05 109.972 179.531 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.622 ' HA ' ' CE3' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -72.55 -65.65 0.76 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.255 -0.903 . . . . 1.85 110.666 179.584 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 36.7 t 52.05 -76.6 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.396 0 O-C-N 121.892 -0.505 . . . . 2.39 112.189 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.504 ' N ' ' O ' ' A' ' 35' ' ' TRP . 0.2 OUTLIER -98.92 -24.18 15.05 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.937 -1.102 . . . . 4.0 110.747 179.832 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.454 ' O ' ' HG2' ' A' ' 39' ' ' ARG . 52.9 tp -80.21 -46.53 16.14 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.151 -0.968 . . . . 1.98 110.479 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 38' ' ' LEU . 0.2 OUTLIER 26.26 63.2 0.08 Allowed 'General case' 0 N--CA 1.512 2.653 0 N-CA-C 113.344 0.868 . . . . 2.84 113.344 179.852 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.594 ' HG ' ' HA ' ' A' ' 44' ' ' SER . 0.1 OUTLIER 58.87 14.57 3.35 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 121.538 -0.726 . . . . 2.33 112.903 178.644 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.426 ' OE1' ' NH2' ' A' ' 42' ' ' ARG . 3.4 tt0 -81.07 3.58 22.79 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 120.453 -1.405 . . . . 3.15 110.936 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.426 ' NH2' ' OE1' ' A' ' 41' ' ' GLN . 0.1 OUTLIER -134.86 -86.07 0.4 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.677 -1.264 . . . . 3.93 110.535 179.564 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.434 ' O ' ' HB3' ' A' ' 44' ' ' SER . 0.9 OUTLIER -54.95 -34.29 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.304 -0.872 . . . . 3.03 110.109 179.208 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.594 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 29.4 t 61.74 -106.5 0.23 Allowed 'General case' 0 N--CA 1.507 2.412 0 CA-C-N 115.986 -0.552 . . . . 2.21 110.772 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -101.92 19.98 17.33 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 120.789 -1.195 . . . . 3.44 111.042 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.427 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 0.5 OUTLIER -84.15 49.65 1.69 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.982 -1.074 . . . . 2.96 111.369 -179.482 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.483 ' HG3' ' HB3' ' A' ' 69' ' ' ALA . 0.0 OUTLIER 54.09 -160.31 0.15 Allowed 'General case' 0 N--CA 1.506 2.374 0 O-C-N 121.424 -0.798 . . . . 3.39 111.413 179.589 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 58.09 24.47 11.26 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.671 -0.643 . . . . 1.86 111.581 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.488 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . 0.9 OUTLIER -76.12 -39.41 55.23 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.057 -1.027 . . . . 1.81 108.968 178.149 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -139.58 153.11 47.33 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.353 -0.98 . . . . 1.53 108.353 178.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.5 m -166.49 24.52 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.254 0 O-C-N 120.957 -1.09 . . . . 1.13 110.494 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.4 mt -119.11 -42.71 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 108.472 -0.936 . . . . 1.95 108.472 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.525 HG22 HD12 ' A' ' 30' ' ' LEU . 94.5 t -104.21 -76.04 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.917 -0.49 . . . . 1.86 110.317 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.81 -62.15 1.62 Allowed Glycine 0 N--CA 1.5 2.964 0 N-CA-C 110.12 -1.192 . . . . 1.65 110.12 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.38 -176.05 3.9 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.6 -0.941 . . . . 1.79 110.521 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -160.9 -47.41 0.02 OUTLIER Glycine 0 N--CA 1.495 2.573 0 N-CA-C 107.511 -2.235 . . . . 1.84 107.511 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.555 ' O ' ' HB ' ' A' ' 58' ' ' THR . 2.8 pm0 -89.62 -7.41 54.8 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.871 -0.782 . . . . 1.99 110.265 178.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.555 ' HB ' ' O ' ' A' ' 57' ' ' GLU . 87.2 m 70.81 82.96 0.15 Allowed 'General case' 0 N--CA 1.508 2.461 0 O-C-N 121.642 -0.661 . . . . 2.41 109.823 -179.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.7 ptpp? -119.7 158.42 26.5 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.547 -0.721 . . . . 2.53 111.597 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.552 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 1.5 tt0 -63.05 -50.63 75.52 Favored Pre-proline 0 N--CA 1.502 2.151 0 O-C-N 121.554 -0.716 . . . . 2.09 111.583 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.552 ' HD3' ' HB3' ' A' ' 60' ' ' GLU . 43.6 Cg_endo -68.39 162.94 38.46 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 O-C-N 123.163 1.086 . . . . 1.85 111.113 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.501 ' O ' HG22 ' A' ' 65' ' ' VAL . 0.1 OUTLIER 70.13 -60.66 0.48 Allowed 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.563 -0.71 . . . . 3.28 110.822 -179.626 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.9 mt -62.45 -44.39 96.52 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.393 -0.817 . . . . 2.03 110.586 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' A' ' 60' ' ' GLU . 0.2 OUTLIER -55.28 -56.18 23.0 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.75 -0.594 . . . . 2.65 110.633 -179.844 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 62' ' ' PHE . 28.5 m -67.22 -34.24 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.046 -1.034 . . . . 2.3 110.633 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -61.07 -51.36 69.47 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.329 -0.857 . . . . 2.16 109.231 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -67.31 -40.14 85.99 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.751 -0.593 . . . . 2.37 109.868 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 71.1 m -60.47 -32.37 71.35 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.872 -0.517 . . . . 1.78 110.686 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.483 ' HB3' ' HG3' ' A' ' 47' ' ' GLU . . . -94.07 -51.05 5.02 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.264 -0.897 . . . . 1.98 110.528 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.429 ' HG2' ' OE2' ' A' ' 47' ' ' GLU . 3.0 mmpt? -56.42 -43.93 79.88 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.44 -0.787 . . . . 1.73 110.93 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -46.64 -64.76 2.47 Favored Glycine 0 N--CA 1.503 3.108 0 N-CA-C 110.507 -1.037 . . . . 1.3 110.507 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -66.46 -40.35 14.36 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.844 1.444 . . . . 1.39 110.303 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 34.3 t -59.31 -45.3 91.68 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.058 -1.026 . . . . 2.06 109.816 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.9 t -70.61 -46.17 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.545 -0.722 . . . . 2.08 109.182 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -55.77 -40.81 73.15 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 121.637 0.732 . . . . 2.17 109.751 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.53 -47.7 59.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.85 -0.531 . . . . 1.91 110.622 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.602 ' HG3' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -67.11 -31.3 71.68 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.997 -1.064 . . . . 2.98 110.057 179.573 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.602 ' N ' ' HG3' ' A' ' 77' ' ' LYS . . . -70.61 -47.84 58.09 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.173 -0.954 . . . . 2.26 109.351 179.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.483 ' HG3' ' CA ' ' A' ' 90' ' ' GLY . 6.9 ptpt -71.15 -34.75 71.28 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.827 -0.749 . . . . 2.55 109.764 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.08 -45.89 86.71 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.986 -1.071 . . . . 2.46 109.948 179.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 19.7 ttt -74.44 -41.28 61.1 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.405 -0.809 . . . . 3.82 110.319 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -123.73 67.14 39.48 Favored Pre-proline 0 N--CA 1.502 2.146 0 O-C-N 121.293 -0.88 . . . . 3.24 110.686 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.418 ' O ' ' CB ' ' A' ' 84' ' ' ASN . 52.1 Cg_endo -78.0 -9.94 16.69 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 O-C-N 123.588 1.309 . . . . 2.61 112.13 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' A' ' 83' ' ' PRO . 2.7 t-20 70.2 -51.76 0.65 Allowed 'General case' 0 N--CA 1.507 2.386 0 O-C-N 121.339 -0.85 . . . . 3.61 109.854 -178.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -126.4 132.11 7.64 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.111 -1.596 . . . . 2.95 109.111 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -66.09 -16.85 53.73 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 O-C-N 123.323 1.17 . . . . 3.29 111.096 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.436 ' HG2' ' H ' ' A' ' 88' ' ' VAL . 1.9 pm0 -49.37 -42.69 42.87 Favored 'General case' 0 N--CA 1.508 2.442 0 O-C-N 121.463 -0.773 . . . . 4.3 110.693 178.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.442 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 6.4 p -90.69 -22.98 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.783 -0.573 . . . . 3.56 110.743 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.442 ' HB2' ' O ' ' A' ' 88' ' ' VAL . 0.3 OUTLIER 66.92 -57.3 0.41 Allowed 'General case' 0 N--CA 1.508 2.458 0 O-C-N 121.61 -0.681 . . . . 3.53 110.548 -179.56 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.483 ' CA ' ' HG3' ' A' ' 79' ' ' LYS . . . . . . . . 0 N--CA 1.497 2.702 0 O-C-N 121.232 -0.917 . . . . 2.06 110.892 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.922 0 N-CA-C 109.762 -1.335 . . . . 5.85 109.762 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.0 p -76.54 -48.2 20.12 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.393 -1.063 . . . . 4.98 110.783 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.1 -176.88 4.4 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.577 -0.702 . . . . 5.91 110.439 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.46 ' HA ' HG21 ' A' ' 11' ' ' THR . 0.3 OUTLIER 52.3 40.56 29.4 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.598 -0.689 . . . . 4.12 110.589 -179.297 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.429 ' O ' ' CB ' ' A' ' 6' ' ' MET . 0.0 OUTLIER -97.39 -115.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.428 -0.795 . . . . 3.74 109.458 179.595 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.429 ' CB ' ' O ' ' A' ' 5' ' ' ILE . 2.4 ttp 71.48 164.93 0.28 Allowed 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.321 -0.862 . . . . 4.11 110.583 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.62 ' HB3' HG11 ' A' ' 14' ' ' VAL . 4.3 m-20 43.41 33.8 0.67 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.61 -0.681 . . . . 3.34 111.439 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 48.02 45.03 19.26 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-O 121.674 0.75 . . . . 6.54 111.541 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.549 ' HB3' HG13 ' A' ' 14' ' ' VAL . 0.4 OUTLIER -179.58 -177.85 0.23 Allowed Pre-proline 0 N--CA 1.492 1.659 0 N-CA-C 108.927 -0.768 . . . . 4.1 108.927 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.47 ' HB2' HG22 ' A' ' 12' ' ' THR . 44.1 Cg_endo -75.21 146.04 31.44 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 N-CA-C 109.442 -1.022 . . . . 4.54 109.442 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.46 HG21 ' HA ' ' A' ' 4' ' ' SER . 25.3 p -49.41 -46.88 48.09 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 121.611 0.72 . . . . 3.73 109.479 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.47 HG22 ' HB2' ' A' ' 10' ' ' PRO . 8.3 t -64.69 -35.29 80.55 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.698 -0.626 . . . . 5.47 110.275 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.506 ' O ' HG13 ' A' ' 17' ' ' VAL . . . -67.79 -56.22 11.82 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.832 -1.307 . . . . 4.1 109.832 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.62 HG11 ' HB3' ' A' ' 7' ' ' ASP . 14.5 m -63.71 -33.08 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.245 -1.15 . . . . 2.87 110.273 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.4 t -71.44 -48.32 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 120.945 -1.097 . . . . 4.51 110.075 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 16.6 p -60.04 -49.29 78.23 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.365 -0.834 . . . . 5.14 109.94 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.506 HG13 ' O ' ' A' ' 13' ' ' GLY . 21.6 m -63.79 -36.97 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 C-N-CA 119.384 -0.926 . . . . 3.95 109.855 178.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.417 ' HA ' HD11 ' A' ' 18' ' ' ILE . 6.0 mm -67.93 -38.64 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 120.792 -1.192 . . . . 2.85 109.012 178.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 51.0 t -65.84 -43.07 93.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.382 -0.969 . . . . 4.96 108.382 177.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 57.7 mt -63.87 -47.3 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 108.728 -0.842 . . . . 4.76 108.728 178.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 11.6 mt -59.37 -48.8 80.26 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.987 -0.745 . . . . 2.46 108.987 178.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.0 mt -56.33 -43.05 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 121.549 -0.719 . . . . 4.03 109.39 178.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.67 -45.47 78.79 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.461 -0.775 . . . . 4.24 110.072 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 33.0 mt -60.65 -45.7 97.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.226 -0.921 . . . . 3.41 109.264 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.95 -42.95 97.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.401 -0.812 . . . . 2.23 109.528 178.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.87 -42.58 97.49 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.368 -0.832 . . . . 3.93 109.176 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.439 ' HA ' ' CD2' ' A' ' 30' ' ' LEU . 0.5 OUTLIER -63.02 -46.14 89.03 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.453 -0.943 . . . . 4.57 108.453 178.025 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.471 ' O ' HD13 ' A' ' 32' ' ' LEU . . . -58.92 -47.5 90.3 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 108.425 -1.87 . . . . 2.3 108.425 178.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.94 -45.08 96.15 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.506 -0.997 . . . . 3.57 110.208 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.495 ' HG ' ' N ' ' A' ' 31' ' ' ILE . 0.2 OUTLIER -63.3 -37.32 86.8 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.442 -0.786 . . . . 4.87 109.697 179.238 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.495 ' N ' ' HG ' ' A' ' 30' ' ' LEU . 48.0 mt -71.2 -47.29 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.084 -1.01 . . . . 3.4 109.185 178.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.754 ' HG ' ' HA ' ' A' ' 38' ' ' LEU . 6.8 mp -57.83 -49.86 75.25 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.79 -0.569 . . . . 3.0 109.626 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.48 -45.59 76.89 Favored Glycine 0 N--CA 1.498 2.825 0 N-CA-C 110.199 -1.16 . . . . 4.16 110.199 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 50.4 t -55.34 -40.44 71.21 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.479 -1.012 . . . . 4.72 110.309 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.506 ' HA ' ' CE3' ' A' ' 35' ' ' TRP . 1.5 m95 -72.48 -55.58 6.76 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.178 -0.951 . . . . 3.39 109.778 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.441 ' CB ' ' O ' ' A' ' 35' ' ' TRP . 0.0 OUTLIER 168.59 -39.71 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.539 0 CA-C-O 121.43 0.633 . . . . 4.25 109.733 179.698 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -161.22 -61.46 0.05 Allowed 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.806 -0.812 . . . . 6.24 108.806 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.754 ' HA ' ' HG ' ' A' ' 32' ' ' LEU . 6.6 tp -115.94 -65.5 1.18 Allowed 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.543 -0.91 . . . . 4.03 108.543 177.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.431 ' NH2' ' HB2' ' A' ' 41' ' ' GLN . 0.1 OUTLIER -155.02 -55.75 0.1 Allowed 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.645 -0.872 . . . . 2.84 108.645 178.553 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 48.76 -149.06 0.2 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.748 -0.595 . . . . 3.56 111.306 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.431 ' HB2' ' NH2' ' A' ' 39' ' ' ARG . 3.2 tt0 50.93 26.57 2.74 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.379 -0.826 . . . . 3.68 110.403 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.412 ' NH1' ' OH ' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -73.34 -51.04 18.88 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.59 0.71 . . . . 3.68 109.223 179.618 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.479 HG22 HD13 ' A' ' 43' ' ' ILE 0.275 0.1 OUTLIER -86.41 -20.16 7.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 109.29 -0.633 . . . . 4.34 109.29 178.789 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 47.45 61.2 3.03 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 121.765 0.793 . . . . 3.74 110.112 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 51.65 -108.22 0.36 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.966 -0.459 . . . . 4.14 111.11 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 51.86 30.9 7.6 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 120.909 -1.12 . . . . 3.45 109.606 -178.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -57.53 150.09 19.75 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.671 -0.643 . . . . 3.33 111.709 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.436 ' O ' ' N ' ' A' ' 50' ' ' GLU . 7.5 t70 66.6 -63.99 0.24 Allowed 'General case' 0 N--CA 1.504 2.232 0 O-C-N 122.001 -0.437 . . . . 2.52 110.859 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 65.16 -65.16 0.16 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.988 -0.445 . . . . 2.55 110.1 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 48' ' ' ASP . 10.6 tt0 -149.22 71.81 1.14 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.352 -0.843 . . . . 2.5 110.207 178.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.3 t -129.71 -71.67 0.61 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.375 -0.828 . . . . 2.62 109.735 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.466 HG23 HD12 ' A' ' 52' ' ' ILE . 27.2 pt -62.54 -37.58 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.351 -0.843 . . . . 3.44 109.898 179.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.498 HG12 ' N ' ' A' ' 54' ' ' GLY . 14.5 p -74.32 -31.14 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 121.625 -0.672 . . . . 3.39 110.607 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.498 ' N ' HG12 ' A' ' 53' ' ' VAL . . . -95.06 64.27 1.41 Allowed Glycine 0 N--CA 1.498 2.815 0 N-CA-C 109.021 -1.632 . . . . 3.19 109.021 179.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -49.65 135.68 18.39 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.798 -0.825 . . . . 5.45 111.91 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 142.05 58.49 0.03 OUTLIER Glycine 0 N--CA 1.497 2.704 0 N-CA-C 109.29 -1.524 . . . . 4.2 109.29 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 58.42 30.34 19.52 Favored 'General case' 0 N--CA 1.507 2.418 0 O-C-N 121.637 -0.919 . . . . 4.6 110.429 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.39 62.13 3.64 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.198 -0.939 . . . . 2.97 110.654 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 19.7 ttpp -63.6 149.49 46.29 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.332 -0.855 . . . . 3.63 110.772 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 62.04 171.3 0.08 OUTLIER Pre-proline 0 N--CA 1.502 2.135 0 O-C-N 121.949 -0.47 . . . . 3.01 111.333 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -74.07 146.35 36.7 Favored 'Trans proline' 0 C--N 1.313 -1.311 0 O-C-N 123.619 1.326 . . . . 2.34 109.719 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -67.42 -17.93 64.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.389 -0.819 . . . . 2.02 110.229 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.3 mt -44.8 -38.61 4.63 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.727 -0.608 . . . . 3.47 112.289 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.6 -49.21 75.6 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.292 -0.88 . . . . 3.19 109.758 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.4 t -81.44 -39.89 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 121.436 -0.79 . . . . 2.54 109.468 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.465 ' O ' ' CG ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -55.21 -51.87 65.19 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.865 -0.791 . . . . 2.46 108.865 178.881 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.412 ' OH ' ' NH1' ' A' ' 42' ' ' ARG . 6.4 t80 -68.25 -47.65 67.2 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.43 -0.794 . . . . 4.21 109.864 178.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 69.6 m -55.19 -34.36 63.82 Favored 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 119.767 -0.773 . . . . 1.79 110.171 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -88.25 -46.44 9.23 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.202 -0.937 . . . . 1.52 110.835 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.465 ' CG ' ' O ' ' A' ' 66' ' ' GLN . 2.6 mmtp -64.56 -40.18 95.1 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.418 -0.801 . . . . 2.05 110.76 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -47.01 -64.88 2.5 Favored Glycine 0 N--CA 1.505 3.273 0 N-CA-C 110.006 -1.237 . . . . 2.25 110.006 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.59 -37.93 20.53 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 O-C-N 123.714 1.376 . . . . 1.98 110.379 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 5.0 t -62.71 -42.87 99.87 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.979 -1.076 . . . . 2.64 109.36 178.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.2 t -69.68 -44.77 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 109.048 -0.723 . . . . 3.45 109.048 178.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.477 ' HG3' ' N ' ' A' ' 76' ' ' ARG . 0.1 OUTLIER -59.15 -42.26 90.26 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.889 -0.782 . . . . 2.98 108.889 178.42 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.477 ' N ' ' HG3' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -64.0 -53.05 56.06 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.628 -0.67 . . . . 3.21 109.597 178.776 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.88 -48.28 81.95 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.674 -0.641 . . . . 3.88 109.95 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.47 -44.03 96.32 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.805 -0.56 . . . . 4.19 110.788 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.6 mmtp -68.75 -42.91 76.87 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.164 -0.96 . . . . 4.13 109.306 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.503 ' HG ' ' CD2' ' A' ' 89' ' ' HIS . 1.8 tp -64.7 -35.24 80.42 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.447 0.641 . . . . 4.89 109.84 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 8.6 ttt -84.56 -22.85 29.95 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.66 -0.65 . . . . 6.2 111.12 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.527 ' N ' ' HD2' ' A' ' 83' ' ' PRO . 8.9 m -46.19 -51.41 33.42 Favored Pre-proline 0 N--CA 1.51 2.565 0 O-C-N 121.376 -0.828 . . . . 5.53 111.974 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 82' ' ' THR . 45.1 Cg_endo -67.83 -8.26 21.99 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 O-C-N 123.422 1.222 . . . . 5.89 110.591 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 55.0 24.21 5.75 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.577 -0.702 . . . . 7.91 111.341 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -111.96 75.78 0.22 Allowed Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.943 -1.263 . . . . 6.13 109.943 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.408 ' HA ' ' O ' ' A' ' 89' ' ' HIS . 43.6 Cg_endo -67.85 -15.05 43.23 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 O-C-N 123.722 1.38 . . . . 6.47 111.02 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -54.13 -34.14 59.61 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.364 -0.835 . . . . 7.06 109.939 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.6 t -92.53 -36.53 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.737 -0.602 . . . . 6.05 109.533 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.503 ' CD2' ' HG ' ' A' ' 80' ' ' LEU . 0.9 OUTLIER -161.35 124.74 3.24 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.328 -0.858 . . . . 5.08 110.718 179.44 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.876 0 CA-C-O 117.893 -1.504 . . . . 4.54 110.075 -179.82 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.706 0 N-CA-C 109.394 -1.482 . . . . 1.18 109.394 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.5 p -78.03 -83.68 0.08 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.962 -1.316 . . . . 1.3 109.768 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.1 58.69 0.37 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.373 -0.829 . . . . 3.07 109.791 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.541 ' HB2' ' HB2' ' A' ' 7' ' ' ASP . 53.3 p -148.45 87.45 1.58 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.064 -1.023 . . . . 1.47 109.82 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -38.73 -54.92 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.294 0 O-C-N 121.786 -0.572 . . . . 2.73 112.041 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.501 ' O ' ' HB3' ' A' ' 7' ' ' ASP . 0.3 OUTLIER -99.41 -80.3 0.47 Allowed 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.503 -0.748 . . . . 3.75 110.309 179.405 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.541 ' HB2' ' HB2' ' A' ' 4' ' ' SER . 32.7 t70 63.6 -52.97 0.22 Allowed 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.638 -0.664 . . . . 1.94 111.433 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.472 ' N ' ' O ' ' A' ' 6' ' ' MET . 8.2 m80 -139.15 -42.51 0.46 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.194 -0.941 . . . . 2.34 111.089 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -176.01 172.52 0.98 Allowed Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.536 -0.728 . . . . 2.16 110.676 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.04 64.46 1.38 Allowed 'Trans proline' 0 N--CA 1.49 1.297 0 O-C-N 123.861 1.453 . . . . 1.99 110.806 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.0 t -155.63 -38.81 0.08 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.609 -0.682 . . . . 1.91 111.009 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.3 t -52.93 -34.41 55.28 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 121.0 -1.063 . . . . 1.51 110.602 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.401 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -74.15 -52.46 7.77 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.02 -1.632 . . . . 1.0 109.02 178.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.3 t -56.48 -38.66 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 121.76 -0.847 . . . . 1.62 109.592 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.8 t -69.64 -43.42 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.107 -0.995 . . . . 1.78 108.981 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 49.3 m -56.69 -51.34 69.17 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.577 -0.702 . . . . 1.4 109.939 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.584 ' HA ' HG12 ' A' ' 20' ' ' ILE . 35.2 m -64.75 -39.13 84.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.526 -0.734 . . . . 1.46 110.278 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.479 HG21 HD11 ' A' ' 18' ' ' ILE . 6.7 mm -65.01 -36.72 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 120.819 -1.176 . . . . 1.63 109.569 178.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.1 t -66.31 -52.44 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 C-N-CA 119.689 -0.805 . . . . 1.52 109.135 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.584 HG12 ' HA ' ' A' ' 17' ' ' VAL . 27.1 pt -63.74 -36.5 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.114 -0.991 . . . . 1.59 109.38 178.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.493 ' N ' HG13 ' A' ' 20' ' ' ILE . 7.6 mt -64.27 -48.58 75.17 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.596 -0.89 . . . . 1.46 108.596 177.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.5 mm -59.04 -44.5 91.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.483 -0.76 . . . . 1.59 109.071 178.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.21 -44.9 95.53 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.625 -0.672 . . . . 1.37 109.908 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 44.5 mt -61.66 -46.51 96.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.403 -0.811 . . . . 1.36 108.825 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.93 -44.11 97.45 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.648 -0.658 . . . . 1.41 109.68 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.92 -45.41 93.82 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.423 -0.798 . . . . 1.32 109.152 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.546 ' HA ' HD22 ' A' ' 30' ' ' LEU . 0.5 OUTLIER -61.46 -46.67 89.07 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.042 -0.725 . . . . 1.55 109.042 178.269 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.45 -43.33 97.56 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 108.874 -1.69 . . . . 0.6 108.874 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.14 -43.96 93.63 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.492 -1.005 . . . . 1.31 110.009 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.546 HD22 ' HA ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -62.84 -37.6 87.45 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.56 -0.712 . . . . 1.52 109.272 178.904 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.494 ' N ' ' HG ' ' A' ' 30' ' ' LEU . 61.2 mt -71.62 -48.67 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.298 -0.876 . . . . 1.32 108.972 178.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 0.6 OUTLIER -58.01 -46.32 85.44 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.656 -0.652 . . . . 1.62 109.774 178.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.96 -44.7 95.6 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 109.689 -1.364 . . . . 1.19 109.689 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.9 t -58.37 -48.92 79.04 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.499 -1.001 . . . . 1.69 110.593 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 1.4 t-105 -172.9 44.0 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.115 -0.991 . . . . 2.4 111.327 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER 65.26 -60.6 0.25 Allowed 'General case' 0 N--CA 1.509 2.484 0 O-C-N 121.528 -0.732 . . . . 1.76 111.264 179.746 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.44 ' CE2' ' HG2' ' A' ' 47' ' ' GLU . 0.1 OUTLIER -167.4 -61.12 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.269 -0.894 . . . . 1.71 110.219 179.791 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.8 tp -122.74 -67.9 0.92 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.362 -0.837 . . . . 3.01 109.944 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -145.35 29.43 1.16 Allowed 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.635 -0.666 . . . . 2.71 111.093 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 49.56 41.86 22.01 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.4 -0.812 . . . . 2.46 111.108 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -121.91 29.41 7.11 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.364 -0.835 . . . . 3.03 110.778 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.88 -148.04 0.25 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.865 -1.147 . . . . 3.42 109.972 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.531 ' O ' ' HB3' ' A' ' 44' ' ' SER . 14.8 pt -42.66 -36.12 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 O-C-N 121.448 -0.783 . . . . 2.54 111.621 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.531 ' HB3' ' O ' ' A' ' 43' ' ' ILE . 6.2 t 63.97 -73.11 0.05 Allowed 'General case' 0 N--CA 1.506 2.356 0 O-C-N 122.116 -0.365 . . . . 2.07 111.197 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -85.53 95.25 9.25 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.993 -1.067 . . . . 2.16 110.487 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.1 m -166.06 44.1 0.07 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.272 -0.893 . . . . 1.42 110.216 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.44 ' HG2' ' CE2' ' A' ' 37' ' ' TYR . 2.4 mm-40 -141.11 -159.46 0.96 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.377 -0.827 . . . . 1.85 110.763 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 59.67 44.22 14.59 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.414 0.625 . . . . 1.23 110.988 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 50.73 48.97 21.88 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.531 -0.731 . . . . 0.78 111.635 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -83.74 134.89 34.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.683 -1.261 . . . . 1.69 110.38 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.445 ' OG ' ' NZ ' ' A' ' 70' ' ' LYS . 75.4 m -158.46 21.4 0.23 Allowed 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.537 -0.727 . . . . 0.95 110.847 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.494 HG12 ' HB3' ' A' ' 63' ' ' LEU . 3.0 mt -122.9 -44.6 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 107.569 -1.271 . . . . 1.65 107.569 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.509 HG22 ' N ' ' A' ' 54' ' ' GLY . 1.3 m 57.03 -34.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.717 0 N-CA-C 113.147 0.795 . . . . 1.84 113.147 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.509 ' N ' HG22 ' A' ' 53' ' ' VAL . . . -127.51 51.05 0.86 Allowed Glycine 0 N--CA 1.497 2.716 0 N-CA-C 109.596 -1.402 . . . . 1.68 109.596 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -59.12 147.48 34.87 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.634 -0.921 . . . . 1.82 110.961 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -120.98 -54.17 0.23 Allowed Glycine 0 N--CA 1.495 2.58 0 N-CA-C 107.729 -2.148 . . . . 2.0 107.729 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -141.52 34.96 1.64 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.766 -0.843 . . . . 2.71 109.744 178.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.4 m 48.24 33.61 3.85 Favored 'General case' 0 N--CA 1.505 2.283 0 CA-C-O 121.421 0.629 . . . . 2.11 111.149 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 7.6 ttpp -156.64 72.58 0.74 Allowed 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.316 -0.865 . . . . 2.03 108.883 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -134.29 160.58 67.95 Favored Pre-proline 0 N--CA 1.497 1.89 0 CA-C-N 116.045 -0.525 . . . . 1.68 110.608 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.428 ' O ' HG22 ' A' ' 65' ' ' VAL . 41.7 Cg_endo -68.75 -30.98 26.54 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 O-C-N 123.838 1.441 . . . . 1.49 111.063 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.462 ' O ' ' HB2' ' A' ' 66' ' ' GLN . 0.5 OUTLIER -52.31 -64.15 0.91 Allowed 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.589 -0.694 . . . . 2.81 111.063 179.879 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.494 ' HB3' HG12 ' A' ' 52' ' ' ILE . 3.2 pp -64.43 -27.23 68.85 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.242 -0.911 . . . . 1.78 110.424 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.3 -51.05 69.23 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.535 -0.728 . . . . 2.24 109.55 178.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.461 HG21 ' N ' ' A' ' 66' ' ' GLN . 32.7 m -74.45 -35.18 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.235 -0.916 . . . . 1.61 109.645 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.462 ' HB2' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -61.04 -49.9 75.52 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.577 -0.702 . . . . 1.7 109.346 178.672 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.494 ' HB2' ' O ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -66.64 -41.93 87.48 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.617 -0.677 . . . . 0.84 109.381 178.482 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.7 m -56.82 -38.17 72.25 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.803 -0.561 . . . . 1.14 109.744 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -82.38 -38.58 23.94 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.409 -0.807 . . . . 1.46 110.235 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.449 ' HB3' ' O ' ' A' ' 66' ' ' GLN . 5.5 ptpt -62.59 -37.52 86.58 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.476 -0.765 . . . . 0.94 110.49 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -47.5 -63.94 3.13 Favored Glycine 0 N--CA 1.503 3.145 0 N-CA-C 110.452 -1.059 . . . . 0.82 110.452 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.31 -38.7 19.71 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 123.673 1.354 . . . . 1.22 110.099 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 7.5 t -62.15 -47.67 83.5 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.175 -0.953 . . . . 1.66 109.9 178.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 45.7 t -66.27 -44.04 91.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.547 -0.721 . . . . 1.41 109.326 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -56.8 -42.35 79.37 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 108.732 -0.84 . . . . 1.35 108.732 178.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.406 ' NH2' ' HG2' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -62.94 -55.76 23.12 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.551 0.691 . . . . 3.16 109.859 178.78 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.94 -54.59 44.93 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.362 0.601 . . . . 3.3 110.754 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -53.09 -45.35 68.15 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.836 -0.54 . . . . 1.39 111.056 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.3 mttp -72.56 -41.54 65.64 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.497 -0.752 . . . . 2.21 110.748 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.4 tp -68.82 -41.37 78.71 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.245 -0.909 . . . . 2.61 111.315 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 3.1 ttt -88.98 -24.37 22.41 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.326 -0.859 . . . . 3.12 111.301 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 14.6 m 53.54 60.77 11.44 Favored Pre-proline 0 N--CA 1.505 2.281 0 O-C-N 121.419 -0.8 . . . . 1.73 110.478 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -79.56 19.65 0.95 Allowed 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.731 1.385 . . . . 1.61 111.099 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.573 ' HA ' ' CD ' ' A' ' 87' ' ' GLU . 26.7 m120 -73.9 45.91 0.21 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.952 -1.092 . . . . 1.8 110.635 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.433 ' N ' ' HD2' ' A' ' 86' ' ' PRO . . . -67.95 -61.19 5.09 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.875 -1.29 . . . . 2.07 109.875 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 85' ' ' GLY . 42.2 Cg_endo -67.08 -29.75 39.58 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.776 1.408 . . . . 2.76 111.016 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.573 ' CD ' ' HA ' ' A' ' 84' ' ' ASN . 1.5 mp0 -57.85 -34.74 70.06 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.412 -0.805 . . . . 2.95 110.176 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.5 p -108.57 -15.05 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.489 -0.757 . . . . 3.85 111.117 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -154.12 102.8 2.5 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.987 -1.071 . . . . 4.72 110.003 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.879 0 CA-C-O 118.016 -1.435 . . . . 4.72 109.827 -179.541 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.726 0 N-CA-C 108.892 -1.683 . . . . 7.94 108.892 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.04 -42.05 72.17 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 122.344 1.068 . . . . 7.73 108.123 177.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.6 ptt? -112.54 -179.52 3.69 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.473 -1.306 . . . . 5.79 107.473 177.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.8 t -173.76 -40.86 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.214 -0.929 . . . . 5.11 110.657 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.687 HD12 ' N ' ' A' ' 6' ' ' MET . 2.7 pp -117.55 -147.43 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 N-CA-C 109.477 -0.564 . . . . 4.29 109.477 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.687 ' N ' HD12 ' A' ' 5' ' ' ILE . 4.2 tpt -78.21 42.37 0.41 Allowed 'General case' 0 C--N 1.296 -1.722 0 O-C-N 120.832 -1.168 . . . . 5.3 110.945 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.416 ' CG ' HD13 ' A' ' 5' ' ' ILE . 15.8 m-20 -51.58 -38.41 54.31 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.939 0.876 . . . . 6.6 109.147 178.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -63.21 -49.4 74.35 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.614 0.721 . . . . 10.57 111.89 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.432 ' O ' ' HG2' ' A' ' 6' ' ' MET . 0.3 OUTLIER -136.48 65.25 55.03 Favored Pre-proline 0 C--N 1.302 -1.473 0 O-C-N 121.649 -0.657 . . . . 6.48 111.574 -178.108 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 6' ' ' MET . 47.4 Cg_endo -72.05 171.82 15.96 Favored 'Trans proline' 0 C--N 1.301 -1.971 0 N-CA-C 108.259 -1.477 . . . . 6.35 108.259 178.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.0 p -49.63 -44.41 47.45 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.995 -1.066 . . . . 4.71 109.05 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.8 p -64.9 -39.3 93.32 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.634 -0.666 . . . . 4.37 110.558 177.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.77 -60.35 7.03 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 110.011 -1.235 . . . . 4.02 110.011 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.437 ' HA ' HG23 ' A' ' 17' ' ' VAL . 34.9 m -58.04 -36.56 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.402 -1.058 . . . . 4.47 110.111 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.9 t -68.76 -41.41 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 120.997 -1.064 . . . . 4.15 109.253 178.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.436 HG22 HD12 ' A' ' 20' ' ' ILE . 52.5 m -59.98 -52.19 66.44 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.709 -0.62 . . . . 3.71 109.966 179.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.491 HG22 ' N ' ' A' ' 18' ' ' ILE . 31.2 m -65.45 -34.6 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.536 -0.728 . . . . 4.05 110.176 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.551 ' HA ' HD22 ' A' ' 21' ' ' LEU . 21.7 mt -68.73 -41.38 82.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.093 -1.004 . . . . 4.09 109.216 178.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.5 t -64.41 -42.19 94.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.489 -0.93 . . . . 3.62 108.489 177.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.436 HD12 HG22 ' A' ' 16' ' ' THR . 83.3 mt -64.38 -48.97 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.525 -0.734 . . . . 3.54 109.272 178.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.577 ' HG ' ' N ' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -61.39 -43.23 99.23 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.675 -0.861 . . . . 3.66 108.675 178.788 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.577 ' N ' ' HG ' ' A' ' 21' ' ' LEU . 15.0 mt -60.33 -44.92 96.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.319 -0.863 . . . . 3.54 109.148 178.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.97 -46.03 86.48 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.724 -0.61 . . . . 2.97 109.731 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.442 ' HA ' HD12 ' A' ' 24' ' ' ILE . 18.3 mm -59.39 -45.6 93.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.41 -0.806 . . . . 3.13 109.146 178.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.78 -45.86 87.84 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.525 -0.734 . . . . 3.16 109.771 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.8 -41.89 96.51 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.732 -0.84 . . . . 2.85 108.732 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.41 ' CD1' ' C ' ' A' ' 27' ' ' LEU . 3.4 tm? -60.65 -53.49 56.75 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.899 -0.778 . . . . 2.8 108.899 178.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.62 -43.74 86.08 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 108.905 -1.678 . . . . 2.45 108.905 178.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.65 -44.65 95.73 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.414 -1.051 . . . . 2.83 109.74 178.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.498 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 7.4 mt -59.08 -41.17 87.37 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.649 -0.657 . . . . 2.82 109.481 178.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.486 HD13 HG21 ' A' ' 31' ' ' ILE . 5.7 mt -69.45 -40.93 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.544 -0.723 . . . . 2.71 109.658 178.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.29 -42.76 87.89 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.548 -0.72 . . . . 3.79 110.264 178.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -71.2 -38.97 63.01 Favored Glycine 0 N--CA 1.497 2.723 0 O-C-N 120.883 -1.135 . . . . 2.26 110.57 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.498 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -82.98 -33.14 26.69 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.125 -1.22 . . . . 2.54 112.015 -179.041 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.639 ' CG ' ' HA ' ' A' ' 39' ' ' ARG . 5.0 m0 -123.31 13.82 9.6 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.816 -1.178 . . . . 2.56 112.509 -178.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 64.18 -61.78 0.18 Allowed 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.362 -0.836 . . . . 2.76 111.806 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.457 ' N ' ' O ' ' A' ' 35' ' ' TRP . 0.7 OUTLIER -119.44 -75.48 0.58 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.295 -0.878 . . . . 5.6 110.384 -179.699 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.28 -55.69 2.21 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.694 -0.854 . . . . 2.38 108.694 179.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.639 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -150.36 34.79 0.64 Allowed 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.209 0.528 . . . . 2.13 111.092 179.256 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.548 ' HG ' ' HB2' ' A' ' 47' ' ' GLU . 3.6 mp -80.27 86.75 5.62 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.019 -1.051 . . . . 2.01 109.106 179.124 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -101.1 12.39 37.72 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.3 -0.875 . . . . 3.08 111.981 -178.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.13 -129.17 0.25 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.904 -1.123 . . . . 2.82 109.877 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.408 HG13 ' N ' ' A' ' 44' ' ' SER . 20.1 pt -53.59 -34.37 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.092 -1.005 . . . . 2.61 110.746 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.442 ' C ' ' HG2' ' A' ' 45' ' ' GLN . 0.9 OUTLIER 69.95 48.93 0.52 Allowed 'General case' 0 N--CA 1.502 2.15 0 CA-C-O 122.044 0.926 . . . . 2.07 109.379 -179.138 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.442 ' HG2' ' C ' ' A' ' 44' ' ' SER . 4.2 mm-40 -136.21 -34.22 0.8 Allowed 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 115.943 -0.572 . . . . 2.29 110.697 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 56.8 m -147.36 54.21 1.07 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.553 -0.717 . . . . 1.67 110.967 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.548 ' HB2' ' HG ' ' A' ' 40' ' ' LEU . 1.4 mp0 -122.03 144.37 48.94 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.928 -1.108 . . . . 1.37 111.257 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 50' ' ' GLU . 0.5 OUTLIER 51.93 -148.67 0.38 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 122.026 -0.421 . . . . 1.55 111.073 179.457 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 66.37 -61.63 0.29 Allowed 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.471 -0.768 . . . . 2.25 111.345 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' A' ' 48' ' ' ASP . 0.1 OUTLIER -111.01 -163.01 0.82 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.199 -0.938 . . . . 2.2 110.548 -179.915 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.86 -39.25 0.87 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.291 -0.88 . . . . 3.03 110.859 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 24.2 mt -87.34 -53.96 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.421 -0.8 . . . . 3.22 109.81 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.582 HG12 ' HB2' ' A' ' 55' ' ' ASP . 47.1 t -89.91 -68.66 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.744 -0.598 . . . . 2.82 109.606 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.75 -6.92 82.73 Favored Glycine 0 N--CA 1.501 3.001 0 N-CA-C 109.632 -1.387 . . . . 1.26 109.632 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.582 ' HB2' HG12 ' A' ' 53' ' ' VAL . 0.4 OUTLIER -67.24 157.1 34.67 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.732 -0.863 . . . . 1.98 110.642 -179.948 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.449 ' O ' ' HB2' ' A' ' 62' ' ' PHE . . . -157.66 -52.57 0.01 OUTLIER Glycine 0 N--CA 1.487 2.055 0 N-CA-C 108.898 -1.681 . . . . 1.82 108.898 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.407 ' HB3' ' NE2' ' A' ' 45' ' ' GLN . 3.6 tp10 -126.11 -5.18 6.75 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.634 -0.921 . . . . 2.5 112.431 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.9 m -58.95 -50.93 72.21 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 120.615 -1.303 . . . . 1.7 110.879 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.0 pttp -133.91 27.73 3.9 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.168 -0.958 . . . . 3.02 110.732 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -133.31 131.52 21.63 Favored Pre-proline 0 C--N 1.297 -1.696 0 O-C-N 121.86 -0.525 . . . . 3.24 110.075 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.02 53.56 2.92 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.637 1.335 . . . . 2.34 109.75 178.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.475 ' O ' HG22 ' A' ' 65' ' ' VAL . 34.8 t80 -63.01 -50.75 69.5 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.477 -0.765 . . . . 3.96 110.293 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.5 mt -62.23 -33.92 75.5 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.45 -0.782 . . . . 3.22 109.365 178.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.87 -57.27 12.43 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.615 -0.513 . . . . 3.12 109.615 178.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 62' ' ' PHE . 32.8 m -69.18 -32.17 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.292 -0.88 . . . . 2.89 109.807 179.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.539 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 5.2 mm-40 -61.24 -54.71 40.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.44 -0.787 . . . . 3.91 109.008 178.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -65.51 -41.22 93.41 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.324 -0.621 . . . . 3.16 109.324 178.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.448 ' O ' ' CD ' ' A' ' 72' ' ' PRO . 63.5 m -55.38 -33.34 63.38 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 109.14 -0.689 . . . . 2.93 109.14 178.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -80.73 -40.57 25.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.646 -0.659 . . . . 3.61 109.393 178.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.539 ' HG2' ' O ' ' A' ' 66' ' ' GLN . 5.6 mmtm -58.97 -51.75 68.7 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.563 -0.71 . . . . 3.9 110.739 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -39.69 -64.87 0.96 Allowed Glycine 0 N--CA 1.505 3.294 0 N-CA-C 110.922 -0.871 . . . . 3.16 110.922 -179.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.566 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 39.6 Cg_endo -65.53 -39.42 21.59 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 O-C-N 123.834 1.439 . . . . 3.85 110.651 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 0.9 OUTLIER -63.44 -44.94 93.07 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.083 -1.01 . . . . 4.4 109.627 179.007 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.4 t -67.17 -47.31 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.711 -0.848 . . . . 3.78 108.711 178.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -58.03 -39.29 78.01 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.515 0.674 . . . . 4.37 109.332 178.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.566 ' HB2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -63.69 -64.26 0.95 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.749 -0.595 . . . . 5.08 110.389 178.902 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.554 ' O ' ' HB2' ' A' ' 81' ' ' MET . 0.0 OUTLIER -59.57 -31.82 69.79 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 120.053 -0.659 . . . . 4.91 110.864 -179.46 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.468 ' N ' ' HG3' ' A' ' 77' ' ' LYS . . . -65.26 -43.25 91.89 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.183 -0.948 . . . . 4.37 108.972 178.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.1 mttt -72.26 -49.91 31.34 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.173 -0.677 . . . . 5.02 109.173 178.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.87 -40.21 66.37 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.348 0.594 . . . . 6.38 110.204 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.554 ' HB2' ' O ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -80.71 -46.23 15.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.572 -0.705 . . . . 6.04 109.173 178.893 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.552 HG23 ' HD2' ' A' ' 83' ' ' PRO . 0.1 OUTLIER 54.46 -173.67 0.02 OUTLIER Pre-proline 0 N--CA 1.498 1.948 0 N-CA-C 109.853 -0.425 . . . . 5.14 109.853 179.342 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.552 ' HD2' HG23 ' A' ' 82' ' ' THR . 53.2 Cg_endo -80.68 14.08 2.13 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 O-C-N 122.71 0.847 . . . . 5.3 110.604 179.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.428 ' CB ' ' O ' ' A' ' 83' ' ' PRO . 0.4 OUTLIER 73.26 -27.86 0.19 Allowed 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.512 -0.743 . . . . 6.5 111.825 -179.392 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -75.22 140.18 26.05 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.18 -1.568 . . . . 6.02 109.18 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.414 ' HA ' ' O ' ' A' ' 89' ' ' HIS . 39.6 Cg_endo -63.79 -17.66 60.8 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 O-C-N 123.712 1.375 . . . . 6.85 111.467 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -57.07 -34.87 68.7 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.205 -0.935 . . . . 6.37 109.21 178.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.0 t -110.12 -30.09 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.757 -0.589 . . . . 5.61 110.081 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.414 ' O ' ' HA ' ' A' ' 86' ' ' PRO . 12.0 t60 -104.81 95.76 6.1 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.177 -0.952 . . . . 6.89 110.149 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.579 0 CA-C-O 118.116 -1.38 . . . . 6.61 110.084 -179.823 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.505 ' N ' ' OG ' ' A' ' 9' ' ' SER . . . . . . . . 0 N--CA 1.495 2.6 0 N-CA-C 109.307 -1.517 . . . . 3.69 109.307 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.458 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 3.4 t 73.86 87.8 0.1 Allowed 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.918 -0.754 . . . . 5.07 110.24 -179.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.89 86.54 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.149 0 CA-C-O 121.673 0.749 . . . . 4.13 110.265 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 65.6 p -150.75 -78.67 0.13 Allowed 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.182 -0.673 . . . . 4.35 109.182 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.456 HD12 HG22 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -94.71 -125.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 108.129 -1.063 . . . . 4.37 108.129 178.263 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.517 ' O ' ' HB3' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -52.14 -52.83 49.28 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.87 -1.144 . . . . 4.08 111.035 178.829 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.517 ' HB3' ' O ' ' A' ' 6' ' ' MET . 2.5 t70 63.39 -52.6 0.21 Allowed 'General case' 0 N--CA 1.501 2.123 0 CA-C-N 118.084 0.402 . . . . 3.05 110.198 -178.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.447 ' N ' ' O ' ' A' ' 6' ' ' MET . 0.9 OUTLIER 48.96 32.01 3.59 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.447 -0.783 . . . . 2.79 112.377 179.227 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.505 ' OG ' ' N ' ' A' ' 1' ' ' GLY . 0.4 OUTLIER -74.5 -55.33 2.76 Favored Pre-proline 0 N--CA 1.5 2.044 0 O-C-N 120.639 -1.288 . . . . 2.95 111.258 179.782 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 9' ' ' SER . 41.0 Cg_endo -66.2 -38.35 21.59 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 O-C-N 123.434 1.228 . . . . 1.81 111.335 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.427 ' O ' HG23 ' A' ' 14' ' ' VAL . 0.8 OUTLIER -65.91 -50.71 63.48 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.527 -0.733 . . . . 2.21 109.736 179.156 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.1 m -59.36 -34.12 72.0 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.107 -0.996 . . . . 2.59 109.973 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.48 -60.96 5.41 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.686 -1.365 . . . . 1.52 109.686 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 11' ' ' THR . 31.2 m -57.37 -35.45 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.472 -1.016 . . . . 1.86 110.026 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.0 t -68.54 -45.83 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.126 -0.984 . . . . 2.3 109.312 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 51.7 m -57.94 -51.37 69.93 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.717 -0.614 . . . . 2.17 109.943 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.405 HG22 ' HA ' ' A' ' 14' ' ' VAL . 25.4 m -64.77 -35.59 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.437 -0.789 . . . . 1.68 110.138 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.6 mm -67.98 -41.2 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 121.034 -1.041 . . . . 2.33 109.19 178.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 37.8 t -65.1 -44.58 95.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.466 -0.939 . . . . 2.42 108.466 178.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.436 HG21 HD13 ' A' ' 24' ' ' ILE . 21.7 mm -62.41 -46.98 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 108.99 -0.745 . . . . 1.97 108.99 178.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 11.4 mt -59.88 -49.4 77.85 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.833 -0.803 . . . . 2.01 108.833 178.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.414 ' HA ' HD12 ' A' ' 22' ' ' ILE . 11.5 mm -57.11 -43.66 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.591 -0.693 . . . . 2.61 109.313 178.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.63 -45.82 91.08 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.57 -0.706 . . . . 2.01 109.608 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.436 HD13 HG21 ' A' ' 20' ' ' ILE . 58.6 mt -59.34 -49.25 84.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.397 -0.814 . . . . 1.72 108.855 178.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.76 -43.67 97.7 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.648 -0.658 . . . . 2.46 110.023 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.28 -43.55 98.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.376 -0.827 . . . . 2.59 109.061 178.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.488 ' HG ' HD11 ' A' ' 31' ' ' ILE . 0.8 OUTLIER -62.38 -46.83 86.87 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.613 -0.884 . . . . 1.92 108.613 178.139 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.84 -48.14 80.67 Favored Glycine 0 N--CA 1.496 2.633 0 N-CA-C 108.654 -1.778 . . . . 1.9 108.654 178.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.22 -44.03 97.93 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.427 -1.043 . . . . 3.05 109.966 178.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.5 mt -60.53 -39.23 87.1 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.627 -0.671 . . . . 3.09 109.98 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.488 HD11 ' HG ' ' A' ' 27' ' ' LEU . 3.7 mt -72.79 -47.54 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.27 -0.894 . . . . 2.05 109.162 179.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.48 HD13 ' HB3' ' A' ' 55' ' ' ASP . 1.0 OUTLIER -57.66 -46.52 84.14 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.364 -0.835 . . . . 3.03 109.637 178.796 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.26 -55.3 28.51 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.472 -1.451 . . . . 2.83 109.472 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.6 t -55.56 -39.91 71.26 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.427 -1.043 . . . . 2.88 109.531 179.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.5 ' O ' ' N ' ' A' ' 37' ' ' TYR . 56.3 t90 -64.29 -62.05 1.85 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.707 -0.621 . . . . 2.59 109.352 178.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 60.75 -61.85 0.07 Allowed 'General case' 0 N--CA 1.508 2.459 0 O-C-N 121.745 -0.597 . . . . 3.53 111.736 178.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.5 ' N ' ' O ' ' A' ' 35' ' ' TRP . 0.2 OUTLIER -114.83 169.5 9.03 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.313 -0.867 . . . . 5.37 109.372 179.517 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.88 39.85 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.543 0 O-C-N 120.938 -1.102 . . . . 3.37 112.144 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.474 ' HG3' ' N ' ' A' ' 40' ' ' LEU . 8.1 ptt180 -90.73 -32.16 16.26 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.622 -1.299 . . . . 3.05 111.196 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.474 ' N ' ' HG3' ' A' ' 39' ' ' ARG . 0.2 OUTLIER -120.88 59.29 0.93 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.426 -0.797 . . . . 2.66 109.949 -179.891 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 43' ' ' ILE . 7.1 tp60 -67.13 -5.95 15.61 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.567 -0.708 . . . . 3.13 111.745 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.503 ' HB3' ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER 61.16 -62.4 0.08 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.555 -0.715 . . . . 3.75 110.744 179.837 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.525 ' N ' ' O ' ' A' ' 41' ' ' GLN 0.268 0.0 OUTLIER -68.2 -17.35 22.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 O-C-N 121.475 -0.766 . . . . 3.41 109.149 177.941 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.497 ' HB3' ' O ' ' A' ' 43' ' ' ILE . 24.5 t 66.69 -159.52 0.25 Allowed 'General case' 0 N--CA 1.501 2.111 0 CA-C-O 121.354 0.597 . . . . 2.85 111.705 179.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 50.25 -115.45 0.83 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 122.01 -0.431 . . . . 3.81 110.388 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -150.95 37.52 0.64 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.603 -1.31 . . . . 3.51 110.41 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -120.68 145.98 46.9 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.349 -0.844 . . . . 2.98 110.84 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.44 ' O ' ' NZ ' ' A' ' 59' ' ' LYS . 11.1 t70 -138.94 21.51 2.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.486 -0.759 . . . . 2.31 110.465 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.48 60.93 2.17 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.225 -0.922 . . . . 2.7 110.233 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -122.01 -129.68 0.27 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.517 -0.74 . . . . 1.84 109.746 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.26 -44.31 0.08 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.653 -1.28 . . . . 2.39 110.906 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 38.8 mt -74.3 -47.85 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.595 -0.691 . . . . 1.73 109.569 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.516 HG21 ' N ' ' A' ' 54' ' ' GLY . 19.6 m -75.69 -30.39 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.609 -0.682 . . . . 2.1 110.386 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.516 ' N ' HG21 ' A' ' 53' ' ' VAL . . . -103.91 57.97 0.53 Allowed Glycine 0 N--CA 1.498 2.771 0 N-CA-C 109.632 -1.387 . . . . 1.92 109.632 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.48 ' HB3' HD13 ' A' ' 32' ' ' LEU . 25.4 t70 -69.5 137.65 52.72 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.63 -0.923 . . . . 2.15 110.548 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.63 55.55 0.52 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 108.328 -1.909 . . . . 2.62 108.328 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.539 ' O ' ' HB ' ' A' ' 58' ' ' THR . 3.1 mm-40 61.82 46.86 6.54 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 122.193 -0.592 . . . . 4.21 110.759 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.539 ' HB ' ' O ' ' A' ' 57' ' ' GLU . 24.7 m 66.47 -57.85 0.37 Allowed 'General case' 0 N--CA 1.509 2.494 0 O-C-N 121.661 -0.649 . . . . 2.94 110.528 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.533 ' O ' ' HD3' ' A' ' 61' ' ' PRO . 0.7 OUTLIER -172.48 178.55 2.72 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.05 -0.722 . . . . 3.14 109.05 179.294 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.17 109.13 6.77 Favored Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 121.224 -0.923 . . . . 4.19 111.328 -178.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.533 ' HD3' ' O ' ' A' ' 59' ' ' LYS . 47.8 Cg_endo -73.01 -31.44 9.8 Favored 'Trans proline' 0 C--N 1.316 -1.179 0 O-C-N 123.698 1.367 . . . . 5.02 110.968 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -65.91 -29.18 69.56 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.924 -1.11 . . . . 5.73 109.931 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.2 mt -55.51 -37.11 67.45 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.501 -0.75 . . . . 3.06 109.596 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.414 ' HB2' ' O ' ' A' ' 61' ' ' PRO . 0.1 OUTLIER -55.67 -47.02 77.41 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.359 -0.608 . . . . 4.33 109.359 179.055 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.444 ' HA ' ' HB2' ' A' ' 68' ' ' SER . 3.8 t -77.81 -40.76 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 121.512 -0.743 . . . . 4.62 109.428 178.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.4 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -52.68 -41.7 64.09 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.965 -0.754 . . . . 2.83 108.965 178.735 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -78.03 -46.48 20.82 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.246 -0.649 . . . . 5.86 109.246 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.444 ' HB2' ' HA ' ' A' ' 65' ' ' VAL . 75.5 m -54.79 -33.55 61.57 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 122.083 -0.386 . . . . 4.08 110.071 179.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.558 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -87.72 -50.71 6.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.303 -0.873 . . . . 3.47 109.871 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.4 ' HG3' ' O ' ' A' ' 66' ' ' GLN . 22.1 mtmt -59.42 -51.57 69.33 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.771 -0.581 . . . . 2.46 111.712 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -40.91 -63.53 1.46 Allowed Glycine 0 N--CA 1.505 3.261 0 N-CA-C 110.352 -1.099 . . . . 2.68 110.352 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.522 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 41.9 Cg_endo -67.51 -43.15 6.11 Favored 'Trans proline' 0 C--N 1.315 -1.186 0 O-C-N 123.939 1.494 . . . . 3.94 110.275 178.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.558 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 1.2 t -56.0 -44.52 78.71 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.844 -1.16 . . . . 2.76 109.554 178.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 49.0 t -68.34 -50.61 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 108.899 -0.778 . . . . 2.21 108.899 178.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -52.01 -41.32 62.13 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.561 0.696 . . . . 4.17 109.918 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.522 ' HD2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -68.21 -56.11 9.87 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.757 -0.589 . . . . 4.97 111.587 -179.655 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.422 ' HG3' ' N ' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -64.31 -33.65 76.33 Favored 'General case' 0 N--CA 1.505 2.319 0 C-N-CA 119.075 -1.05 . . . . 2.52 110.46 -179.254 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.511 ' O ' ' HD2' ' A' ' 83' ' ' PRO . . . -67.07 -50.47 61.67 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.519 -0.738 . . . . 2.95 110.097 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.8 pttt -73.98 -32.87 63.63 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.153 -0.967 . . . . 5.01 111.216 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.5 tp -72.24 -55.1 7.77 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.192 -0.942 . . . . 3.54 110.551 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.1 mtt -80.49 -15.74 55.99 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.674 -0.641 . . . . 3.2 110.813 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.454 ' N ' ' HD3' ' A' ' 83' ' ' PRO . 47.1 p 47.61 53.37 13.92 Favored Pre-proline 0 N--CA 1.504 2.254 0 O-C-N 121.587 -0.695 . . . . 4.27 111.538 -179.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.667 ' HB2' ' HD3' ' A' ' 86' ' ' PRO . 54.3 Cg_endo -78.61 16.91 1.19 Allowed 'Trans proline' 0 N--CA 1.488 1.147 0 O-C-N 123.432 1.227 . . . . 4.68 111.162 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.3 t30 66.44 -52.84 0.43 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.197 -0.939 . . . . 7.59 111.053 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.473 ' O ' HG13 ' A' ' 88' ' ' VAL . . . 166.49 70.41 0.03 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.32 -1.512 . . . . 5.7 109.32 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.667 ' HD3' ' HB2' ' A' ' 83' ' ' PRO . 39.4 Cg_endo -65.53 -17.38 57.13 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 O-C-N 123.701 1.369 . . . . 6.22 109.458 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.425 ' OE2' ' HG2' ' A' ' 86' ' ' PRO . 14.5 mp0 -69.91 -31.18 68.82 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.583 -0.895 . . . . 7.01 108.583 177.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 85' ' ' GLY . 1.5 p -108.99 -19.88 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.685 -0.634 . . . . 7.92 110.845 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.596 ' O ' ' HA ' ' A' ' 86' ' ' PRO . 44.8 t-80 -150.67 119.49 6.61 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.958 -1.089 . . . . 8.96 110.737 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.775 0 CA-C-O 117.642 -1.643 . . . . 7.54 110.037 179.38 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.711 0 N-CA-C 109.221 -1.552 . . . . 6.14 109.221 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.5 t -165.8 -161.16 0.49 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.366 -1.079 . . . . 6.45 110.295 179.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.3 ptt? -123.49 155.33 37.73 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.157 -0.964 . . . . 6.75 111.005 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -115.38 51.73 0.91 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.38 -0.825 . . . . 6.5 111.088 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -52.61 -44.71 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.273 -0.892 . . . . 4.78 109.968 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.8 mtp 52.41 28.84 6.21 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-N 115.897 -0.592 . . . . 5.55 110.99 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -68.28 -20.01 64.74 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.146 -0.971 . . . . 2.86 110.653 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 57.27 33.81 23.84 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.591 -0.693 . . . . 2.74 109.961 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.19 173.88 5.24 Favored Pre-proline 0 N--CA 1.483 1.195 0 O-C-N 121.471 -0.768 . . . . 2.03 110.177 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -76.07 57.53 5.25 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.414 1.218 . . . . 2.89 110.907 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.2 t -53.83 -37.77 63.94 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.4 -0.812 . . . . 2.64 110.43 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.7 t -55.01 -30.03 58.64 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.462 -0.774 . . . . 3.77 110.213 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.67 -55.43 6.63 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 108.544 -1.822 . . . . 2.75 108.544 178.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 76.6 t -54.92 -42.17 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.721 -0.87 . . . . 2.12 108.702 178.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.7 t -64.71 -45.24 95.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.567 -0.708 . . . . 2.65 109.229 178.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 46.1 m -58.03 -46.78 84.76 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.651 -0.656 . . . . 3.48 109.283 178.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.7 t -65.82 -38.92 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 C-N-CA 119.586 -0.846 . . . . 2.8 109.242 178.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.556 ' HA ' HD22 ' A' ' 21' ' ' LEU . 10.0 mm -62.39 -41.41 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.016 -1.053 . . . . 2.06 109.077 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.9 t -66.06 -40.94 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.643 -0.873 . . . . 2.74 108.643 177.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 92.4 mt -65.7 -50.12 73.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.522 -0.736 . . . . 3.3 109.074 178.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.568 ' HA ' HG12 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -61.59 -42.84 99.44 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 119.914 -0.714 . . . . 2.3 109.383 178.711 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.552 ' N ' ' HG ' ' A' ' 21' ' ' LEU . 10.4 mm -62.7 -38.54 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 120.972 -1.08 . . . . 2.26 109.106 178.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.97 -50.58 54.93 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.481 -0.762 . . . . 2.59 110.724 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.568 HG12 ' HA ' ' A' ' 21' ' ' LEU . 29.3 pt -62.52 -37.26 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 120.955 -1.091 . . . . 2.77 109.283 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.532 ' N ' HG13 ' A' ' 24' ' ' ILE . . . -65.75 -46.98 76.83 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.435 -0.791 . . . . 1.98 108.909 178.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.05 -44.06 97.96 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.008 -0.738 . . . . 2.25 109.008 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.1 tt -61.22 -45.86 92.81 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.36 -0.838 . . . . 2.95 108.93 178.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.3 -46.47 92.87 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.003 -1.639 . . . . 1.92 109.003 178.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.89 -41.44 95.62 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.532 -0.981 . . . . 2.28 109.89 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.488 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 6.6 mt -59.11 -42.12 89.78 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.821 -0.807 . . . . 2.71 108.821 178.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.431 HG23 HD13 ' A' ' 31' ' ' ILE . 27.7 mm -70.07 -45.93 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 109.068 -0.716 . . . . 2.49 109.068 178.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.595 ' HG ' ' HB2' ' A' ' 36' ' ' CYS . 1.1 tt -56.31 -47.34 78.9 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.727 -0.608 . . . . 3.63 109.625 178.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.73 -43.13 76.92 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.85 -1.3 . . . . 2.2 109.85 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 2.5 t -56.45 -51.49 68.23 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.485 -1.009 . . . . 2.37 110.19 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.407 ' CH2' ' HA ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -168.72 57.62 0.05 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.379 -0.826 . . . . 2.65 111.838 179.665 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.595 ' HB2' ' HG ' ' A' ' 32' ' ' LEU . 47.7 t -56.13 -35.43 67.09 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.077 -1.014 . . . . 3.19 109.906 178.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -123.6 164.4 19.11 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.726 -0.608 . . . . 4.45 109.366 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.407 ' HA ' ' CH2' ' A' ' 35' ' ' TRP . 0.8 OUTLIER -68.49 1.46 3.06 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.975 -1.078 . . . . 3.34 111.834 179.931 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.13 9.25 12.6 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.747 -1.221 . . . . 2.57 111.074 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -77.06 157.18 31.25 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.851 -1.156 . . . . 2.43 110.786 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 60.88 13.96 4.86 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 121.725 -0.609 . . . . 2.46 111.515 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.457 ' HD3' ' HA ' ' A' ' 88' ' ' VAL . 1.7 tpm_? -145.19 -74.81 0.23 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.038 -1.039 . . . . 1.78 109.562 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.631 ' HA ' ' HA ' ' A' ' 47' ' ' GLU 0.271 0.1 OUTLIER -89.24 -39.61 12.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 109.63 -0.508 . . . . 2.01 109.63 179.873 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.7 m 42.77 -97.24 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.222 0 O-C-N 122.016 -0.428 . . . . 2.36 111.322 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' A' ' 46' ' ' SER . 1.8 pt20 -120.7 -31.68 4.2 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.853 -1.154 . . . . 2.39 111.226 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' A' ' 45' ' ' GLN . 0.9 OUTLIER -145.61 46.75 1.28 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.284 -0.885 . . . . 1.31 109.193 179.171 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.631 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 2.1 mm-40 64.8 -160.03 0.29 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.694 -0.629 . . . . 1.27 110.187 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.493 ' CB ' HD13 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -39.94 -46.58 2.07 Favored 'General case' 0 N--CA 1.51 2.552 0 O-C-N 121.378 -0.827 . . . . 1.43 111.442 -179.086 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.427 ' HA ' HG12 ' A' ' 74' ' ' VAL . 0.5 OUTLIER 51.2 -96.65 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.46 -0.775 . . . . 1.94 111.872 178.72 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -67.56 75.39 0.17 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.267 -0.895 . . . . 2.92 110.88 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.1 t 177.72 -65.27 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.822 0.82 . . . . 2.4 109.077 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.493 HD13 ' CB ' ' A' ' 48' ' ' ASP . 5.6 pt -81.18 -37.83 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.648 -0.657 . . . . 2.15 110.477 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.409 ' N ' ' CG1' ' A' ' 52' ' ' ILE . 9.5 p -45.95 -36.28 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.683 -0.636 . . . . 2.34 111.404 -179.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.64 -62.08 1.2 Allowed Glycine 0 N--CA 1.498 2.792 0 N-CA-C 109.231 -1.547 . . . . 2.8 109.231 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.43 ' O ' ' NZ ' ' A' ' 70' ' ' LYS . 26.0 t70 -73.23 103.67 4.02 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.745 -0.856 . . . . 2.91 109.767 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.88 37.42 0.14 Allowed Glycine 0 N--CA 1.497 2.746 0 N-CA-C 108.125 -1.99 . . . . 2.82 108.125 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.4 -37.91 0.08 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 122.188 -0.595 . . . . 3.72 110.698 -179.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.4 t -81.3 -148.06 0.06 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.192 -0.943 . . . . 4.04 110.735 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.14 137.33 34.12 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.103 -0.998 . . . . 3.67 110.337 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -144.26 137.82 14.3 Favored Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 121.169 -0.957 . . . . 3.15 111.002 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.519 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 55.6 Cg_endo -82.74 -178.81 4.11 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 O-C-N 123.982 1.517 . . . . 3.25 110.407 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -55.41 155.45 5.25 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.136 -0.978 . . . . 5.27 110.232 179.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.7 pp -51.88 -31.02 26.36 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 121.16 -0.963 . . . . 3.4 111.203 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.53 ' O ' ' HB2' ' A' ' 68' ' ' SER . 0.0 OUTLIER -61.89 -58.53 7.6 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.304 -0.873 . . . . 3.86 109.402 178.563 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.519 ' HB ' ' HB2' ' A' ' 61' ' ' PRO . 16.1 t -66.43 -33.11 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 108.96 -0.755 . . . . 3.69 108.96 178.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.476 ' O ' ' CG ' ' A' ' 70' ' ' LYS . 41.0 tt0 -57.77 -59.71 4.8 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.534 -0.913 . . . . 2.79 108.534 178.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -63.32 -35.43 80.34 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.359 -0.838 . . . . 2.44 109.672 178.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.53 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 0.4 OUTLIER -61.75 -42.2 98.67 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.603 -0.686 . . . . 3.32 110.553 179.256 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.504 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -88.22 -41.18 13.12 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.063 -1.023 . . . . 3.05 110.938 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.476 ' CG ' ' O ' ' A' ' 66' ' ' GLN . 5.4 mmtt -66.46 -42.01 88.21 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.651 -0.656 . . . . 3.04 110.042 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -44.91 -62.64 2.89 Favored Glycine 0 N--CA 1.502 3.063 0 N-CA-C 110.142 -1.183 . . . . 1.72 110.142 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -66.75 -37.8 19.86 Favored 'Trans proline' 0 C--N 1.314 -1.255 0 O-C-N 123.627 1.33 . . . . 2.41 110.756 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 0.4 OUTLIER -66.21 -43.8 85.71 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.04 -1.038 . . . . 2.95 109.8 179.075 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.427 HG12 ' HA ' ' A' ' 49' ' ' GLU . 47.3 t -70.72 -43.73 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.792 -0.568 . . . . 1.89 109.618 179.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -55.49 -43.11 75.31 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.57 0.7 . . . . 2.62 109.89 178.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.92 -48.27 63.7 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.488 0.661 . . . . 3.09 109.969 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.44 ' HD3' ' O ' ' A' ' 52' ' ' ILE . 67.4 mttt -60.08 -55.13 37.74 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.545 0.688 . . . . 2.52 109.935 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.445 ' N ' HD11 ' A' ' 52' ' ' ILE . . . -53.37 -50.73 64.48 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 122.032 -0.417 . . . . 1.46 110.524 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.452 ' HB2' ' OD1' ' A' ' 84' ' ' ASN . 0.0 OUTLIER -67.87 -25.74 65.67 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.417 -0.802 . . . . 2.92 110.714 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.421 ' N ' ' HG3' ' A' ' 79' ' ' LYS . 0.6 OUTLIER -80.54 -30.76 37.1 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.064 -1.022 . . . . 2.59 110.069 179.059 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.87 -47.26 8.0 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.529 -0.732 . . . . 3.09 110.006 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.522 ' HB ' ' HD2' ' A' ' 83' ' ' PRO . 29.0 p -82.6 169.12 19.1 Favored Pre-proline 0 N--CA 1.499 2.024 0 O-C-N 121.525 -0.734 . . . . 1.88 109.503 179.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.534 ' HB2' ' HD2' ' A' ' 86' ' ' PRO . 50.3 Cg_endo -76.25 6.01 4.21 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.42 1.221 . . . . 1.93 113.147 -178.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.452 ' OD1' ' HB2' ' A' ' 79' ' ' LYS . 0.1 OUTLIER 55.51 21.64 4.54 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 121.08 -1.013 . . . . 2.62 111.287 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -158.09 -82.69 0.04 OUTLIER Glycine 0 N--CA 1.502 3.1 0 N-CA-C 109.09 -1.604 . . . . 2.33 109.09 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.534 ' HD2' ' HB2' ' A' ' 83' ' ' PRO . 50.2 Cg_endo -72.72 -177.09 2.62 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 O-C-N 123.845 1.445 . . . . 2.78 108.818 178.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.419 ' HB3' ' O ' ' A' ' 86' ' ' PRO . 0.5 OUTLIER 67.6 -60.0 0.4 Allowed 'General case' 0 N--CA 1.507 2.381 0 N-CA-C 108.266 -1.013 . . . . 2.53 108.266 -177.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.457 ' HA ' ' HD3' ' A' ' 42' ' ' ARG . 87.4 t -82.83 -29.33 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 108.781 -0.822 . . . . 2.08 108.781 177.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 69.8 m80 54.26 56.85 6.45 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.337 0.589 . . . . 3.19 110.985 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.666 0 CA-C-O 118.059 -1.412 . . . . 2.4 110.044 179.698 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 4' ' ' SER . . . . . . . . 0 N--CA 1.5 2.927 0 N-CA-C 110.198 -1.161 . . . . 3.99 110.198 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.461 ' HB3' ' O ' ' A' ' 1' ' ' GLY . 40.8 t 58.15 -148.57 0.48 Allowed 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.386 -1.067 . . . . 4.67 110.164 -179.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 10.8 ptt? -54.01 -34.06 58.88 Favored 'General case' 0 N--CA 1.505 2.319 0 N-CA-C 108.231 -1.025 . . . . 3.83 108.231 178.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.589 ' HA ' HG22 ' A' ' 12' ' ' THR . 7.5 t -82.49 53.42 2.32 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.196 -1.038 . . . . 3.36 108.196 177.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.487 ' C ' ' O ' ' A' ' 4' ' ' SER . 0.0 OUTLIER -25.95 -68.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.383 0 CA-C-O 121.366 0.603 . . . . 3.57 110.728 -178.47 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.59 ' HB3' ' HB3' ' A' ' 9' ' ' SER . 0.0 OUTLIER -102.16 98.54 8.69 Favored 'General case' 0 C--N 1.287 -2.133 0 C-N-CA 120.016 -0.673 . . . . 5.38 109.207 178.195 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -58.43 -24.6 60.61 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.502 -0.925 . . . . 4.81 108.502 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -86.02 34.85 0.62 Allowed 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.953 -0.758 . . . . 6.52 108.953 176.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.59 ' HB3' ' HB3' ' A' ' 6' ' ' MET . 21.5 p -145.75 157.56 51.09 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 120.894 -1.129 . . . . 5.56 110.547 -179.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.499 ' HB2' HG22 ' A' ' 14' ' ' VAL . 57.6 Cg_endo -80.82 15.91 1.72 Allowed 'Trans proline' 0 C--N 1.313 -1.29 0 O-C-N 123.528 1.278 . . . . 6.3 111.144 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.8 p -62.59 -63.53 1.2 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.908 -1.12 . . . . 4.68 109.869 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.589 HG22 ' HA ' ' A' ' 4' ' ' SER . 0.1 OUTLIER -62.42 -33.08 74.09 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.499 -0.751 . . . . 3.44 110.281 179.317 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.63 -53.16 21.7 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 108.829 -1.708 . . . . 4.0 108.829 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.542 ' CG1' HD13 ' A' ' 18' ' ' ILE . 23.0 t -62.29 -36.79 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.684 -0.892 . . . . 4.97 109.35 178.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.0 t -67.78 -43.26 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 120.981 -1.075 . . . . 3.52 109.135 178.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 63.3 m -59.56 -51.87 68.0 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.613 -0.679 . . . . 3.21 109.954 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.588 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 31.2 m -64.42 -38.18 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 119.505 -0.878 . . . . 4.29 109.854 179.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.542 HD13 ' CG1' ' A' ' 14' ' ' VAL . 19.2 mt -65.21 -38.12 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 120.759 -1.213 . . . . 4.2 109.253 178.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.6 t -67.49 -48.05 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.237 -0.914 . . . . 2.55 109.584 178.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.585 HG12 ' HA ' ' A' ' 17' ' ' VAL . 3.3 pt -68.01 -34.87 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.886 -1.134 . . . . 3.46 109.968 179.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.588 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 0.1 OUTLIER -70.99 -42.65 69.38 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.815 -1.178 . . . . 3.98 108.308 177.73 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.528 ' N ' ' HG ' ' A' ' 21' ' ' LEU . 13.1 mt -60.77 -43.77 96.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.111 -0.993 . . . . 3.39 108.436 177.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.75 -46.38 85.56 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.608 -0.682 . . . . 2.01 109.731 178.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.407 HD12 HG22 ' A' ' 24' ' ' ILE . 8.1 mm -59.49 -47.2 91.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.131 -0.981 . . . . 2.88 109.005 178.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.27 -43.91 97.74 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.456 -0.778 . . . . 2.98 109.591 178.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.18 -42.65 99.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.466 -0.771 . . . . 2.65 109.274 178.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.2 tt -63.39 -46.38 86.69 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.678 -0.86 . . . . 2.25 108.678 178.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.77 -45.04 95.44 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 108.692 -1.763 . . . . 2.0 108.692 178.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.23 -44.03 93.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.507 -0.996 . . . . 3.09 109.468 178.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.2 mt -58.73 -41.61 86.85 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.023 -0.732 . . . . 3.05 109.023 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.44 HD13 ' HA ' ' A' ' 31' ' ' ILE . 22.4 mm -68.93 -50.12 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.489 -0.757 . . . . 2.0 109.38 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.62 -43.07 79.83 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.567 -0.708 . . . . 3.42 109.689 178.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.9 -39.18 75.51 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.491 -1.444 . . . . 2.91 109.491 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 40.1 t -61.19 -47.8 84.48 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.389 -1.065 . . . . 2.65 110.389 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.43 ' CG ' ' HB3' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -168.88 45.76 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.39 -0.819 . . . . 2.33 111.178 179.792 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.679 ' HB2' ' HG3' ' A' ' 49' ' ' GLU . 0.0 OUTLIER 57.74 -81.71 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.672 -0.643 . . . . 2.86 111.772 179.53 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -153.06 -64.88 0.15 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.763 -1.211 . . . . 4.46 111.587 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.466 ' HG ' ' OE2' ' A' ' 49' ' ' GLU . 0.7 OUTLIER -108.52 17.45 22.02 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.821 -1.175 . . . . 2.0 111.368 -179.83 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.46 ' HG2' ' C ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER 29.93 50.93 0.08 Allowed 'General case' 0 N--CA 1.508 2.447 0 CA-C-O 121.45 0.643 . . . . 3.26 112.5 179.799 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.6 mt 42.57 48.36 4.64 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.251 0.548 . . . . 2.24 111.525 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -72.38 42.91 0.1 Allowed 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.149 -0.969 . . . . 2.6 111.325 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.523 ' HG3' HG21 ' A' ' 43' ' ' ILE . 0.5 OUTLIER -141.88 -66.06 0.41 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.909 -1.119 . . . . 3.69 110.306 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.523 HG21 ' HG3' ' A' ' 42' ' ' ARG . 20.2 pt -101.44 -38.83 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.719 -0.613 . . . . 3.09 109.847 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.471 ' N ' HG13 ' A' ' 43' ' ' ILE . 1.4 t 75.45 110.02 0.07 Allowed 'General case' 0 N--CA 1.506 2.366 0 CA-C-O 121.537 0.684 . . . . 3.03 111.081 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -120.77 177.05 5.23 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.483 -0.76 . . . . 2.96 110.195 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.73 -52.66 9.97 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.445 -0.784 . . . . 3.93 110.711 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.439 ' O ' ' HB3' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -117.13 -175.6 2.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 3.26 110.976 -179.655 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.511 ' HA ' ' HG3' ' A' ' 61' ' ' PRO . 20.2 t0 60.92 173.76 0.1 Allowed 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 121.954 0.883 . . . . 2.33 111.547 179.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.679 ' HG3' ' HB2' ' A' ' 36' ' ' CYS . 0.7 OUTLIER -148.75 -60.18 0.23 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.344 -0.847 . . . . 1.87 109.511 179.697 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -110.7 113.01 25.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.424 -0.797 . . . . 2.93 110.221 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 78.6 p -158.9 -71.25 0.09 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.498 -0.751 . . . . 1.99 110.709 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.5 mt -50.16 -56.94 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 O-C-N 121.746 -0.596 . . . . 2.99 110.903 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.2 p -85.6 -33.03 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 O-C-N 121.406 -0.809 . . . . 2.89 111.094 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -109.23 65.32 0.25 Allowed Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.911 -1.276 . . . . 2.26 109.911 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -92.08 -156.11 0.45 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.329 -1.101 . . . . 2.39 110.267 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 137.76 -41.13 1.41 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 107.957 -2.057 . . . . 2.69 107.957 -179.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -139.0 37.46 2.14 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 122.039 -0.683 . . . . 3.57 109.645 178.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.1 t 36.54 54.94 1.11 Allowed 'General case' 0 N--CA 1.511 2.597 0 CA-C-O 121.387 0.613 . . . . 2.28 111.139 -178.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.36 88.64 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.481 -0.762 . . . . 2.05 110.607 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.539 ' HB3' HD11 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -99.53 105.49 33.88 Favored Pre-proline 0 N--CA 1.494 1.737 0 CA-C-N 116.254 -0.43 . . . . 2.06 110.212 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.511 ' HG3' ' HA ' ' A' ' 48' ' ' ASP . 44.6 Cg_endo -71.53 -34.48 9.33 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 O-C-N 123.773 1.407 . . . . 2.85 110.949 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -61.7 -38.84 89.33 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.307 -0.871 . . . . 3.56 110.646 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.539 HD11 ' HB3' ' A' ' 60' ' ' GLU . 3.6 mt -52.2 -37.59 55.33 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.479 -0.763 . . . . 2.61 110.302 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.49 ' O ' ' HB2' ' A' ' 68' ' ' SER . 0.0 OUTLIER -61.33 -53.49 55.97 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.475 -0.565 . . . . 3.88 109.475 178.912 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.0 t -67.72 -31.59 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.461 -0.774 . . . . 2.77 109.321 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.03 -51.54 69.63 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.911 -1.144 . . . . 2.74 107.911 178.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -69.22 -43.69 73.56 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.329 0.585 . . . . 3.24 109.646 178.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.49 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 0.4 OUTLIER -59.35 -37.93 79.09 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.957 -0.464 . . . . 3.18 110.437 179.479 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.27 -43.74 13.48 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.046 -1.034 . . . . 1.94 110.15 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 32.5 mtmt -63.81 -46.67 84.12 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.577 -0.702 . . . . 2.91 110.635 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 75' ' ' GLU . . . -41.33 -64.87 1.23 Allowed Glycine 0 N--CA 1.506 3.334 0 N-CA-C 109.947 -1.261 . . . . 2.21 109.947 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.555 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 42.5 Cg_endo -68.42 -41.31 6.74 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 O-C-N 123.956 1.503 . . . . 2.36 110.083 178.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 35.1 t -58.33 -39.54 79.73 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.839 -1.163 . . . . 2.31 109.94 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.484 ' HA ' ' HG2' ' A' ' 77' ' ' LYS . 24.1 t -74.92 -48.39 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.435 -0.791 . . . . 2.85 109.089 178.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.627 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 1.0 OUTLIER -54.63 -43.94 72.72 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.89 -0.724 . . . . 3.37 109.178 178.349 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.555 ' HD2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -64.66 -48.62 74.11 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.581 -0.7 . . . . 3.21 110.157 179.126 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.625 ' HG3' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -62.46 -32.66 73.58 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.073 -1.017 . . . . 3.6 109.397 179.02 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.625 ' N ' ' HG3' ' A' ' 77' ' ' LYS . . . -72.2 -43.26 64.75 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.546 -0.721 . . . . 3.43 109.171 178.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.627 ' HG2' ' O ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -68.45 -34.04 75.24 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.637 -0.665 . . . . 4.26 109.502 178.673 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.72 -32.62 62.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.567 -0.708 . . . . 4.08 110.416 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 15.0 ttt -84.47 -44.18 13.89 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.429 -0.794 . . . . 5.17 110.4 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.542 ' HB ' ' HD2' ' A' ' 83' ' ' PRO . 48.3 p -86.34 170.3 12.95 Favored Pre-proline 0 N--CA 1.503 2.224 0 O-C-N 121.468 -0.77 . . . . 4.34 109.827 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.542 ' HD2' ' HB ' ' A' ' 82' ' ' THR . 46.5 Cg_endo -75.85 2.2 7.3 Favored 'Trans proline' 0 C--N 1.316 -1.148 0 O-C-N 123.251 1.132 . . . . 5.21 111.371 178.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.601 ' HB3' ' HD3' ' A' ' 79' ' ' LYS . 3.3 t-20 -73.26 39.13 0.09 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.199 -0.938 . . . . 4.81 110.069 179.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.441 ' H ' ' C ' ' A' ' 83' ' ' PRO . . . -70.9 -60.91 4.29 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.461 -1.056 . . . . 4.54 110.461 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -71.31 -34.22 10.13 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 O-C-N 123.731 1.385 . . . . 5.83 111.535 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.43 ' CD ' ' HA ' ' A' ' 84' ' ' ASN . 1.5 mp0 -51.42 -40.35 59.17 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.408 -0.808 . . . . 5.72 109.48 179.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 89' ' ' HIS . 4.2 p -103.14 -20.53 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.932 -0.48 . . . . 4.82 110.505 178.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.514 ' N ' HG12 ' A' ' 88' ' ' VAL . 0.6 OUTLIER 60.21 54.83 3.86 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.523 -0.736 . . . . 6.49 111.26 179.838 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.534 0 CA-C-O 118.323 -1.265 . . . . 4.11 110.205 178.966 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.641 0 N-CA-C 109.332 -1.507 . . . . 4.02 109.332 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.0 p -131.07 -41.55 1.12 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.571 -0.958 . . . . 3.33 111.419 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.503 ' SD ' HD13 ' A' ' 5' ' ' ILE . 2.0 mmt -104.81 90.53 3.51 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.305 -0.872 . . . . 4.71 110.561 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.8 p -51.57 -30.45 20.91 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.582 -0.699 . . . . 4.8 110.944 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.503 HD13 ' SD ' ' A' ' 3' ' ' MET . 0.6 OUTLIER -58.5 -40.1 77.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 CA-C-O 121.653 0.739 . . . . 4.72 110.528 179.446 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.425 ' O ' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -140.98 -74.85 0.32 Allowed 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 116.258 -0.428 . . . . 3.3 110.812 179.833 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.49 ' HB2' ' O ' ' A' ' 3' ' ' MET . 3.7 t70 65.72 -48.0 0.39 Allowed 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.489 -0.757 . . . . 2.86 110.854 -179.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.515 ' O ' ' HB3' ' A' ' 9' ' ' SER . 0.1 OUTLIER -145.18 27.06 1.29 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.117 -0.989 . . . . 3.47 110.058 179.393 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.515 ' HB3' ' O ' ' A' ' 8' ' ' HIS . 43.5 t 66.92 149.29 0.12 Allowed Pre-proline 0 N--CA 1.505 2.322 0 O-C-N 121.749 -0.594 . . . . 2.19 111.076 -179.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.404 ' HD2' ' OG ' ' A' ' 9' ' ' SER . 42.9 Cg_endo -68.32 -24.41 37.36 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.679 1.357 . . . . 1.92 110.12 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.47 ' O ' HG23 ' A' ' 14' ' ' VAL . 5.1 p -61.12 -54.45 44.45 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.741 -0.599 . . . . 2.83 109.898 179.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -59.44 -30.16 68.3 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.325 -0.859 . . . . 2.97 110.339 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -70.37 -57.46 6.72 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.532 -1.427 . . . . 1.65 109.532 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.499 HG23 ' N ' ' A' ' 15' ' ' VAL . 34.0 m -61.47 -32.6 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.418 -1.048 . . . . 2.4 110.171 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.499 ' N ' HG23 ' A' ' 14' ' ' VAL . 21.1 t -70.31 -43.06 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 120.983 -1.073 . . . . 2.77 109.264 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.424 HG22 HD11 ' A' ' 20' ' ' ILE . 54.9 m -58.95 -51.69 68.95 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.848 -0.532 . . . . 2.12 109.879 179.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.45 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 27.0 m -64.66 -35.73 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.468 -0.77 . . . . 1.86 110.116 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.502 HD12 HD23 ' A' ' 21' ' ' LEU . 7.0 mm -66.79 -43.88 89.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.013 -1.054 . . . . 2.63 109.366 178.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.3 t -63.28 -42.22 95.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 108.72 -0.844 . . . . 2.65 108.72 178.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.424 HD11 HG22 ' A' ' 16' ' ' THR . 79.1 mt -64.5 -48.56 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.506 -0.746 . . . . 1.91 109.464 178.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.533 ' HG ' ' N ' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -62.27 -43.13 99.53 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.783 -0.821 . . . . 2.28 108.783 178.818 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.533 ' N ' ' HG ' ' A' ' 21' ' ' LEU . 32.2 mt -59.49 -45.21 93.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.358 -0.839 . . . . 2.72 109.101 178.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.87 -46.53 84.53 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.541 -0.725 . . . . 1.99 109.836 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 55.6 mt -57.62 -46.81 86.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.511 -0.743 . . . . 1.87 109.247 178.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.21 -45.72 87.01 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.543 -0.723 . . . . 2.12 109.992 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.12 -46.04 89.35 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.44 -0.787 . . . . 2.33 108.97 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.51 ' O ' HG12 ' A' ' 31' ' ' ILE . 2.4 tt -61.69 -48.04 82.58 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.834 -0.802 . . . . 2.04 108.834 178.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.487 ' O ' HG13 ' A' ' 31' ' ' ILE . . . -53.76 -39.23 61.05 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 109.623 -1.391 . . . . 1.63 109.623 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.27 -41.93 47.29 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.233 -1.157 . . . . 2.4 109.517 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.414 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 1.6 mt -53.99 -45.88 71.57 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.148 0.499 . . . . 3.16 109.685 178.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' ' 27' ' ' LEU . 1.3 pt -77.13 -43.95 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.416 -0.803 . . . . 1.97 111.105 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.524 ' HB2' HD13 ' A' ' 52' ' ' ILE . 1.3 tt -56.96 -45.42 82.87 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.047 -1.033 . . . . 2.96 109.103 178.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.78 -55.65 21.22 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.532 -1.427 . . . . 2.21 109.532 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -56.51 -36.76 69.55 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.272 -1.134 . . . . 2.47 111.001 179.955 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.64 ' CH2' ' HG3' ' A' ' 41' ' ' GLN . 1.9 t90 -77.4 -50.97 11.6 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.333 -0.855 . . . . 1.69 111.371 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 18.2 t -74.59 -25.96 59.61 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.481 -0.762 . . . . 2.64 112.074 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -92.0 -50.39 5.72 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.902 -1.124 . . . . 3.52 110.144 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.466 ' O ' ' CB ' ' A' ' 39' ' ' ARG . 7.0 tp -98.2 -70.24 0.73 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.312 -0.868 . . . . 2.61 109.945 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.466 ' CB ' ' O ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER 167.81 -57.49 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.53 -0.544 . . . . 1.92 109.53 -179.773 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.8 tp 65.13 170.04 0.2 Allowed 'General case' 0 N--CA 1.505 2.294 0 CA-C-O 121.501 0.667 . . . . 2.28 111.065 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.64 ' HG3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER 53.39 35.27 20.01 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.212 -0.93 . . . . 2.4 110.75 -179.17 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.46 -48.78 7.36 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.347 -0.845 . . . . 2.08 109.679 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.279 0.4 OUTLIER -67.09 -16.13 20.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 CA-C-O 121.497 0.665 . . . . 3.13 110.2 179.393 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.432 ' OG ' ' N ' ' A' ' 45' ' ' GLN . 17.7 t -99.82 -163.44 1.03 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.684 -0.635 . . . . 2.21 110.573 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.432 ' N ' ' OG ' ' A' ' 44' ' ' SER . 52.9 mm-40 -118.7 178.04 4.62 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.204 -0.935 . . . . 3.45 110.888 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.6 t 59.09 59.15 2.86 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.472 -0.768 . . . . 3.04 110.902 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -74.46 153.96 38.93 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.423 -0.798 . . . . 2.49 110.962 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -157.36 173.24 17.23 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.749 -0.595 . . . . 3.05 110.415 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -65.35 -31.94 73.32 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.137 0.494 . . . . 3.02 110.48 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -154.52 -165.36 2.05 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.565 -0.709 . . . . 2.61 109.911 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.581 ' HB3' ' CZ3' ' A' ' 35' ' ' TRP . 21.0 p -145.29 -53.92 0.29 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.223 -0.923 . . . . 3.73 110.14 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.524 HD13 ' HB2' ' A' ' 32' ' ' LEU . 17.2 pt -79.09 -36.32 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.647 -0.658 . . . . 2.46 109.937 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.409 ' N ' HG13 ' A' ' 52' ' ' ILE . 0.9 OUTLIER -68.12 -55.08 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.528 -0.733 . . . . 3.46 109.453 179.228 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.515 ' O ' ' HB3' ' A' ' 55' ' ' ASP . . . 85.52 -57.65 4.9 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.339 -1.504 . . . . 2.61 109.339 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.515 ' HB3' ' O ' ' A' ' 54' ' ' GLY . 19.1 t70 65.13 162.66 0.14 Allowed 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 122.193 0.997 . . . . 3.15 111.557 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' A' ' 57' ' ' GLU . . . -133.59 45.7 1.1 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 106.557 -2.617 . . . . 3.63 106.557 178.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 56' ' ' GLY . 10.3 mm-40 63.76 36.54 10.49 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.787 0.803 . . . . 3.87 109.875 -177.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.65 47.4 1.18 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.439 -0.788 . . . . 5.0 109.857 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.451 ' HG2' ' HD3' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -150.0 -174.6 4.76 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.033 -1.042 . . . . 3.69 110.872 -179.436 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.741 ' HB3' HG22 ' A' ' 65' ' ' VAL . 5.4 mt-10 -123.99 74.57 57.41 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.335 -0.853 . . . . 3.39 110.563 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.451 ' HD3' ' HG2' ' A' ' 59' ' ' LYS . 43.1 Cg_endo -75.14 -46.44 0.23 Allowed 'Trans proline' 0 N--CA 1.486 1.074 0 O-C-N 123.773 1.407 . . . . 2.8 111.941 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -165.51 -67.35 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.864 -1.148 . . . . 3.75 111.485 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.5 mt -58.36 -47.18 84.65 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.438 -0.789 . . . . 3.02 110.293 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.452 ' O ' ' HB3' ' A' ' 68' ' ' SER . 0.2 OUTLIER -59.22 -39.24 82.06 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.403 -0.592 . . . . 3.68 109.403 178.838 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.741 HG22 ' HB3' ' A' ' 60' ' ' GLU . 5.4 t -67.76 -43.91 86.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 N-CA-C 108.646 -0.872 . . . . 2.76 108.646 177.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.503 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 1.7 tt0 -55.9 -44.81 78.57 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.735 -0.603 . . . . 2.79 109.534 179.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.503 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 11.1 m-85 -74.38 -49.41 22.78 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.562 -0.711 . . . . 2.69 111.006 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.452 ' HB3' ' O ' ' A' ' 64' ' ' LEU . 0.8 OUTLIER -63.07 -34.19 77.07 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.378 -0.826 . . . . 2.69 110.62 -179.923 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -79.59 -43.47 22.88 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.025 -1.047 . . . . 2.34 110.078 179.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.503 ' HB3' ' O ' ' A' ' 66' ' ' GLN . 12.7 ptpt -68.82 -31.73 70.92 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.428 -0.795 . . . . 2.46 110.801 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -47.6 -63.93 3.17 Favored Glycine 0 N--CA 1.5 2.949 0 N-CA-C 109.228 -1.549 . . . . 1.67 109.228 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.528 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 41.5 Cg_endo -68.44 -41.1 6.96 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.886 1.466 . . . . 2.21 109.666 178.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 4.1 t -55.75 -43.81 77.0 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.013 -1.054 . . . . 2.48 109.236 178.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 37.9 t -74.5 -45.09 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.504 -0.747 . . . . 1.92 109.351 178.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -53.57 -43.21 68.31 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.708 0.766 . . . . 2.38 109.189 178.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.528 ' HD2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -71.06 -44.75 65.12 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.391 -0.596 . . . . 3.79 109.391 178.663 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.84 -40.28 79.69 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 120.223 -0.591 . . . . 3.32 110.231 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.65 -41.24 60.69 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.041 0.448 . . . . 2.21 110.322 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.494 ' HD3' HG21 ' A' ' 88' ' ' VAL . 4.2 mttp -65.52 -43.86 88.7 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 121.504 0.669 . . . . 2.7 109.325 179.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.87 -42.31 85.82 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.687 -0.633 . . . . 3.9 109.974 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 8.1 ttt -69.5 -44.99 69.96 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.439 0.637 . . . . 4.68 110.093 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.62 103.37 40.92 Favored Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.652 -0.655 . . . . 3.32 109.375 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.17 15.87 0.47 Allowed 'Trans proline' 0 N--CA 1.492 1.418 0 O-C-N 123.706 1.372 . . . . 3.59 112.685 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -73.68 50.16 0.33 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.552 -1.343 . . . . 3.25 110.023 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -162.37 160.44 32.65 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.76 -1.336 . . . . 2.96 109.76 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.449 ' O ' ' CB ' ' A' ' 87' ' ' GLU . 49.5 Cg_endo -72.01 -172.29 0.82 Allowed 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.69 1.363 . . . . 3.51 111.165 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.449 ' CB ' ' O ' ' A' ' 86' ' ' PRO . 3.7 tt0 72.78 -58.73 0.59 Allowed 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 108.605 -0.887 . . . . 4.0 108.605 -178.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.506 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 92.4 t -85.51 -35.94 10.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 108.739 -0.838 . . . . 4.11 108.739 177.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.506 ' HB2' ' O ' ' A' ' 88' ' ' VAL . 67.6 m80 64.16 -59.75 0.2 Allowed 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.895 -0.503 . . . . 4.55 111.808 178.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 88' ' ' VAL . . . . . . . . 0 N--CA 1.493 2.459 0 CA-C-O 117.895 -1.503 . . . . 4.94 109.786 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.705 0 N-CA-C 109.904 -1.278 . . . . 2.88 109.904 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 56.26 56.69 5.56 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.589 -0.947 . . . . 4.26 109.936 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.605 ' SD ' ' HB3' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -141.54 170.09 16.37 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.31 -0.869 . . . . 2.69 111.137 -179.155 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.2 p -88.31 -28.51 21.0 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.525 -0.734 . . . . 2.8 110.617 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -85.19 -144.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.326 -0.859 . . . . 2.32 110.96 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.527 ' O ' ' HB3' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -87.77 -73.34 0.49 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.19 -0.944 . . . . 2.85 111.101 -179.626 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.605 ' HB3' ' SD ' ' A' ' 3' ' ' MET . 1.2 t70 65.0 -52.88 0.33 Allowed 'General case' 0 N--CA 1.51 2.556 0 O-C-N 121.625 -0.672 . . . . 1.77 110.203 -179.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.468 ' N ' ' O ' ' A' ' 6' ' ' MET . 0.8 OUTLIER -91.09 46.05 1.29 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.191 -0.943 . . . . 2.02 110.039 179.201 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.6 t -159.83 143.89 10.77 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.203 -0.935 . . . . 1.58 110.254 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.24 -17.56 50.08 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 O-C-N 124.029 1.541 . . . . 2.36 111.502 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.9 t -66.25 -29.94 70.28 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.145 -0.972 . . . . 1.98 109.954 179.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.9 m -51.26 -35.31 36.6 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.586 -0.696 . . . . 1.51 110.36 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.34 -53.3 9.02 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 108.952 -1.659 . . . . 1.57 108.952 179.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.487 ' O ' HG12 ' A' ' 18' ' ' ILE . 61.5 t -55.81 -39.17 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.868 -0.784 . . . . 2.46 109.529 178.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.601 ' HA ' HG12 ' A' ' 18' ' ' ILE . 43.6 t -71.11 -41.39 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.309 -0.869 . . . . 1.85 109.707 179.017 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.403 ' O ' HG12 ' A' ' 20' ' ' ILE . 50.2 m -59.81 -46.63 88.64 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.525 -0.734 . . . . 1.55 109.92 179.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.497 ' HA ' HG12 ' A' ' 20' ' ' ILE . 35.7 m -68.9 -42.67 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.436 -0.79 . . . . 2.03 111.312 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.601 HG12 ' HA ' ' A' ' 15' ' ' VAL . 15.6 pt -65.42 -31.64 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 120.166 -1.584 . . . . 2.31 109.608 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.449 ' N ' HG13 ' A' ' 18' ' ' ILE . 21.2 t -70.06 -48.88 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.476 -0.765 . . . . 1.61 109.342 178.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.497 HG12 ' HA ' ' A' ' 17' ' ' VAL . 2.5 pt -68.22 -31.35 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 120.638 -1.289 . . . . 1.89 108.847 178.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.469 ' N ' HG13 ' A' ' 20' ' ' ILE . 10.0 mt -66.66 -52.33 46.08 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.334 -0.854 . . . . 2.22 109.24 177.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.538 HG12 ' O ' ' A' ' 18' ' ' ILE . 30.9 pt -59.53 -42.38 87.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 C-N-CA 118.851 -1.139 . . . . 2.13 109.288 178.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.436 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -61.03 -46.8 89.24 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 120.294 -0.562 . . . . 1.46 109.707 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 6.1 mm -60.51 -45.53 96.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.256 -0.902 . . . . 1.63 108.952 178.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.38 -43.95 97.99 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.563 -0.711 . . . . 2.0 109.666 178.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.81 -44.31 96.51 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.116 -0.698 . . . . 1.97 109.116 178.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.05 -44.53 96.49 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.806 -0.813 . . . . 1.67 108.806 178.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.69 -45.9 94.93 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 108.756 -1.738 . . . . 1.08 108.756 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.99 -43.63 95.1 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.502 -0.999 . . . . 1.91 109.821 178.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 7.4 mt -58.27 -41.61 84.7 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.063 -0.717 . . . . 2.38 109.063 178.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 59.9 mt -70.07 -48.26 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.465 -0.772 . . . . 1.56 109.411 178.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.12 -48.83 77.69 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.429 -0.795 . . . . 2.56 110.255 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.01 -46.8 93.32 Favored Glycine 0 N--CA 1.499 2.836 0 N-CA-C 109.577 -1.409 . . . . 1.63 109.577 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.647 ' HB3' HD13 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -63.81 -31.63 72.87 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.329 -1.101 . . . . 2.42 110.588 179.564 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.539 ' CH2' HD13 ' A' ' 52' ' ' ILE . 6.7 m0 -81.58 -59.7 2.52 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.105 -0.997 . . . . 1.38 110.059 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 36.75 -95.36 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.415 0 N-CA-C 112.212 0.449 . . . . 1.9 112.212 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.54 -1.6 11.65 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.582 -1.324 . . . . 3.71 111.102 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -111.87 -11.8 13.87 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.948 -1.095 . . . . 1.83 111.159 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.473 ' HD2' ' CE1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER 49.55 44.78 24.36 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.095 -1.003 . . . . 1.32 109.981 -179.479 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.647 HD13 ' HB3' ' A' ' 34' ' ' CYS . 0.1 OUTLIER 44.75 39.37 3.41 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.801 -0.562 . . . . 2.18 111.298 -179.619 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.428 ' O ' ' NZ ' ' A' ' 70' ' ' LYS . 9.7 pt20 -81.49 37.51 0.46 Allowed 'General case' 0 N--CA 1.502 2.163 0 O-C-N 120.927 -1.108 . . . . 1.56 111.627 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.57 -63.44 1.25 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.693 -1.254 . . . . 3.31 109.138 178.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.465 HG13 ' N ' ' A' ' 44' ' ' SER . 9.3 pt -59.3 -35.33 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-O 121.556 0.693 . . . . 2.06 110.286 178.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.465 ' N ' HG13 ' A' ' 43' ' ' ILE . 1.8 t 68.18 64.38 0.36 Allowed 'General case' 0 N--CA 1.504 2.26 0 CA-C-O 121.527 0.68 . . . . 1.32 110.76 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.406 ' HG2' ' N ' ' A' ' 46' ' ' SER . 11.1 pm0 -68.69 -19.93 64.4 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.515 -0.741 . . . . 1.6 111.279 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.406 ' N ' ' HG2' ' A' ' 45' ' ' GLN . 0.3 OUTLIER 54.08 52.26 13.09 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.251 -0.906 . . . . 2.52 110.928 179.843 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.18 169.63 17.19 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.469 -0.769 . . . . 1.96 110.996 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.9 -42.58 3.55 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.215 -0.928 . . . . 2.72 110.879 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.01 161.76 29.17 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.008 -1.057 . . . . 4.16 111.224 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -153.8 147.36 25.08 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.539 -0.726 . . . . 2.37 109.354 179.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.1 m -162.12 21.36 0.1 Allowed 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.108 -0.995 . . . . 2.84 111.302 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.539 HD13 ' CH2' ' A' ' 35' ' ' TRP . 12.2 mt -121.04 -43.71 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.568 -0.901 . . . . 2.98 108.568 179.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 38.0 t -86.69 -63.45 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-O 121.427 0.632 . . . . 2.02 109.389 178.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.65 -52.89 3.37 Favored Glycine 0 N--CA 1.499 2.834 0 N-CA-C 109.713 -1.355 . . . . 1.86 109.713 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.0 t70 62.53 -155.59 0.34 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 122.05 -0.677 . . . . 1.6 111.016 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.87 -42.52 0.59 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 108.348 -1.901 . . . . 1.78 108.348 -179.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -112.48 -39.46 4.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.58 -0.953 . . . . 2.44 111.311 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.548 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 0.2 OUTLIER -57.55 -40.68 79.42 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 120.832 -1.168 . . . . 2.08 109.825 179.602 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.548 ' HB2' ' O ' ' A' ' 58' ' ' THR . 2.2 mttt 68.19 120.66 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 CA-C-O 121.602 0.715 . . . . 1.94 111.048 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.525 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 1.1 mp0 46.59 57.8 16.85 Favored Pre-proline 0 N--CA 1.499 1.995 0 O-C-N 121.587 -0.696 . . . . 1.5 111.433 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -65.85 -29.63 49.93 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 O-C-N 123.524 1.276 . . . . 1.12 111.578 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.473 ' CE1' ' HD2' ' A' ' 39' ' ' ARG . 3.3 m-30 -60.88 -66.41 0.54 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.459 -0.775 . . . . 1.44 110.965 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.529 ' HA ' ' HB2' ' A' ' 66' ' ' GLN . 2.5 pp -65.49 -28.16 69.0 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.493 -0.754 . . . . 1.73 111.0 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.525 ' HB2' ' O ' ' A' ' 60' ' ' GLU . 0.5 OUTLIER -58.08 -57.13 14.2 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.332 -0.855 . . . . 2.11 109.692 179.321 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.486 ' HA ' ' HB2' ' A' ' 68' ' ' SER . 9.0 p -73.51 -29.52 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 C-N-CA 119.387 -0.925 . . . . 1.33 109.877 178.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.532 ' O ' ' HB2' ' A' ' 70' ' ' LYS . 1.8 mm100 -59.36 -49.8 76.41 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.245 -1.02 . . . . 1.19 108.245 177.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -71.37 -47.03 58.82 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.604 -0.685 . . . . 4.76 109.841 178.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.486 ' HB2' ' HA ' ' A' ' 65' ' ' VAL . 65.0 m -54.56 -46.8 73.72 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.933 -0.479 . . . . 1.07 110.211 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.525 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -72.41 -57.58 4.07 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.202 -0.936 . . . . 1.27 111.308 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.532 ' HB2' ' O ' ' A' ' 66' ' ' GLN . 3.8 mptt -52.71 -60.49 3.19 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.432 -0.793 . . . . 1.18 112.914 -179.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 70' ' ' LYS . . . -31.74 -67.44 0.15 Allowed Glycine 0 N--CA 1.51 3.597 0 N-CA-C 111.55 -0.62 . . . . 1.15 111.55 -178.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.536 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 40.2 Cg_endo -66.28 -40.97 13.52 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.698 1.367 . . . . 1.28 110.649 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.525 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -58.9 -42.95 90.79 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.825 -1.172 . . . . 2.02 109.277 178.688 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 55.0 t -71.69 -45.04 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 109.327 -0.619 . . . . 1.84 109.327 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -57.08 -42.2 80.22 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 119.855 -0.738 . . . . 1.72 109.427 178.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.536 ' HD2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -66.99 -50.15 63.17 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.5 -0.75 . . . . 1.79 109.703 178.889 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.38 -41.62 85.24 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 120.01 -0.676 . . . . 2.6 109.595 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.41 ' O ' ' HD3' ' A' ' 83' ' ' PRO . . . -65.96 -49.03 69.34 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.97 -0.456 . . . . 1.94 109.918 179.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.05 -49.26 76.69 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.206 -0.934 . . . . 2.15 109.807 179.016 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 24.3 tp -59.27 -41.86 89.88 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.429 -0.795 . . . . 3.63 111.393 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 5.4 ttt -81.6 -28.2 33.86 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.137 -0.977 . . . . 4.19 110.227 179.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 90.4 m 57.49 79.55 0.32 Allowed Pre-proline 0 N--CA 1.502 2.144 0 O-C-N 121.786 -0.571 . . . . 2.14 109.922 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 78' ' ' ALA . 43.4 Cg_endo -68.45 -1.34 7.21 Favored 'Trans proline' 0 N--CA 1.491 1.352 0 O-C-N 123.791 1.416 . . . . 2.5 111.871 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 57.45 23.3 8.91 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.32 -0.863 . . . . 3.98 110.985 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.409 ' O ' ' ND1' ' A' ' 89' ' ' HIS . . . -92.59 -91.02 1.5 Allowed Glycine 0 N--CA 1.498 2.793 0 N-CA-C 109.255 -1.538 . . . . 2.55 109.255 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.11 -25.52 19.12 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 O-C-N 123.954 1.502 . . . . 2.72 110.659 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.0 mp0 -54.87 -38.53 67.61 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.71 -0.619 . . . . 3.08 110.293 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.5 p -105.23 -15.98 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.271 -0.893 . . . . 4.38 111.083 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.409 ' ND1' ' O ' ' A' ' 85' ' ' GLY . 41.4 m80 -94.2 -35.59 12.42 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.757 -1.214 . . . . 4.44 110.931 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.417 0 CA-C-O 118.024 -1.431 . . . . 5.22 109.848 -179.97 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.987 0 N-CA-C 110.067 -1.213 . . . . 5.2 110.067 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.448 ' OG ' ' N ' ' A' ' 3' ' ' MET . 0.1 OUTLIER -71.07 -172.73 0.73 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.477 -1.013 . . . . 3.92 111.2 -179.752 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.448 ' N ' ' OG ' ' A' ' 2' ' ' SER . 3.7 ptt? -84.63 -27.02 27.46 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 120.963 -1.086 . . . . 4.25 110.79 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.97 52.58 0.71 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.86 -1.15 . . . . 2.72 109.964 178.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.548 HD11 ' CE1' ' A' ' 8' ' ' HIS . 1.5 pp -101.19 -164.93 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.619 -0.675 . . . . 3.62 110.388 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.474 ' HG3' ' C ' ' A' ' 5' ' ' ILE . 24.1 mtp -139.51 4.76 2.19 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.102 -0.999 . . . . 5.16 111.467 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -65.06 -25.43 67.81 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.825 -1.172 . . . . 3.74 110.855 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.548 ' CE1' HD11 ' A' ' 5' ' ' ILE . 27.6 p-80 -146.47 -9.05 0.49 Allowed 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.271 -0.893 . . . . 3.64 112.758 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.3 123.25 6.41 Favored Pre-proline 0 N--CA 1.487 1.402 0 O-C-N 120.802 -1.186 . . . . 4.08 109.66 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.85 82.0 1.81 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.754 1.397 . . . . 2.71 110.295 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.7 t -54.33 -39.12 66.77 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.055 -1.028 . . . . 2.44 109.765 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 p -60.61 -40.8 93.21 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.151 -0.968 . . . . 2.86 109.367 177.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -70.41 -50.82 24.58 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 108.902 -1.679 . . . . 1.8 108.902 178.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.612 ' O ' HG21 ' A' ' 17' ' ' VAL . 39.9 t -56.48 -40.21 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.663 -0.904 . . . . 2.04 109.109 178.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.585 ' HA ' HG12 ' A' ' 18' ' ' ILE . 34.2 t -70.73 -42.41 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.242 -0.912 . . . . 2.24 108.963 178.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.569 HG23 HD12 ' A' ' 20' ' ' ILE . 54.2 m -58.16 -46.78 85.1 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.487 -0.758 . . . . 2.33 109.979 179.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.612 HG21 ' O ' ' A' ' 14' ' ' VAL . 35.8 m -70.16 -41.21 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.271 -0.893 . . . . 2.23 111.188 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.585 HG12 ' HA ' ' A' ' 15' ' ' VAL . 4.8 pt -67.89 -33.92 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 120.163 -1.586 . . . . 2.34 109.676 178.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.533 ' HA ' HD12 ' A' ' 22' ' ' ILE . 20.8 t -67.7 -43.39 86.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 108.41 -0.959 . . . . 2.25 108.41 177.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.569 HD12 HG23 ' A' ' 16' ' ' THR . 87.5 mt -67.4 -40.24 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.117 -1.068 . . . . 2.34 108.117 177.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 10.7 mt -60.8 -52.79 63.58 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.87 -0.519 . . . . 2.54 109.817 178.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.541 HG12 ' O ' ' A' ' 18' ' ' ILE . 41.4 pt -59.9 -41.69 86.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 120.943 -1.098 . . . . 2.24 109.697 179.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.466 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -61.83 -45.76 92.43 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 120.146 -0.622 . . . . 2.3 109.594 178.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.8 mm -61.97 -44.5 99.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.313 -0.867 . . . . 2.65 108.758 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.74 -44.66 96.48 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.544 -0.722 . . . . 2.3 109.645 178.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.01 -46.96 88.66 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.972 -0.751 . . . . 2.36 108.972 178.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.1 tt -59.78 -45.89 90.88 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.808 -0.812 . . . . 2.89 108.808 178.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.07 -45.33 94.01 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 108.937 -1.665 . . . . 2.3 108.937 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.55 -44.03 95.36 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.451 -1.029 . . . . 2.34 109.967 179.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.1 mt -59.67 -41.32 90.35 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.089 -0.708 . . . . 2.8 109.089 178.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.424 ' HA ' HD12 ' A' ' 31' ' ' ILE . 24.7 mm -68.34 -48.15 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.65 -0.656 . . . . 2.97 109.374 178.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.17 -48.1 81.35 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.447 -0.783 . . . . 2.93 110.052 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.07 -47.5 90.88 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 109.816 -1.314 . . . . 2.23 109.816 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 17.9 t -61.99 -43.38 98.96 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.633 -0.922 . . . . 2.98 109.994 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -66.48 -47.0 74.43 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.398 -0.814 . . . . 3.15 109.63 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.5 t -149.01 108.02 3.89 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.418 -0.801 . . . . 2.72 108.935 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.517 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -47.2 121.56 3.88 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.448 -0.782 . . . . 3.06 110.921 -178.772 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 37' ' ' TYR . 0.3 OUTLIER 42.0 28.41 0.1 Allowed 'General case' 0 N--CA 1.503 2.219 0 CA-C-O 121.245 0.545 . . . . 2.84 111.393 -178.794 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.89 28.58 12.73 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.52 -0.738 . . . . 4.56 111.44 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.412 ' HG ' ' OG ' ' A' ' 44' ' ' SER . 0.1 OUTLIER 48.15 46.1 19.69 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.366 -0.834 . . . . 3.34 110.564 -179.815 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -104.05 10.78 35.89 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.225 -0.922 . . . . 4.0 111.886 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.84 -142.35 0.1 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.635 -1.29 . . . . 4.8 109.649 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.419 ' O ' ' HB3' ' A' ' 44' ' ' SER . 0.8 OUTLIER -47.49 -36.62 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 121.089 -1.007 . . . . 3.36 110.904 179.399 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.514 ' HA ' HD21 ' A' ' 38' ' ' LEU . 8.6 t 66.31 -57.35 0.37 Allowed 'General case' 0 N--CA 1.504 2.235 0 O-C-N 122.111 -0.368 . . . . 2.16 111.281 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.645 ' HA ' ' CZ ' ' A' ' 67' ' ' TYR . 74.3 mt-30 -70.37 96.84 1.18 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.126 -0.984 . . . . 2.51 110.221 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 45.9 t -108.14 -79.6 0.58 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.44 -0.787 . . . . 2.38 108.955 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.473 ' O ' ' HB2' ' A' ' 48' ' ' ASP . 1.2 mp0 -83.21 162.09 21.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.092 -1.005 . . . . 2.3 109.155 178.366 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.651 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 5.0 m-20 65.29 130.46 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.324 0 CA-C-O 121.65 0.738 . . . . 1.95 109.909 -179.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -113.75 129.23 56.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.943 -1.098 . . . . 2.52 111.336 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.68 ' HB3' ' HG ' ' A' ' 64' ' ' LEU . 1.0 OUTLIER -133.88 28.21 3.88 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.31 -0.869 . . . . 2.25 111.104 179.357 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.9 p -133.13 -49.12 0.86 Allowed 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.997 -1.064 . . . . 3.1 111.518 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.7 mm -83.96 -53.68 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.583 -0.698 . . . . 3.73 110.436 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.6 p -112.69 -35.91 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.294 -0.879 . . . . 3.08 111.087 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.672 ' HA2' ' HA ' ' A' ' 50' ' ' GLU . . . 73.09 -71.41 1.18 Allowed Glycine 0 N--CA 1.498 2.827 0 N-CA-C 109.923 -1.271 . . . . 2.42 109.923 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -120.43 -174.22 2.75 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.271 -1.135 . . . . 2.8 110.637 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 131.41 -65.72 0.59 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 107.157 -2.377 . . . . 2.73 107.157 -179.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.443 ' HA ' ' NZ ' ' A' ' 59' ' ' LYS . 2.9 mm-40 -128.12 -1.36 5.8 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.937 -0.743 . . . . 3.07 110.835 177.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.47 ' O ' ' HD3' ' A' ' 61' ' ' PRO . 0.1 OUTLIER -76.43 59.96 1.52 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.909 -1.119 . . . . 2.26 109.722 179.204 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.443 ' NZ ' ' HA ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -66.91 135.33 53.68 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.277 -0.889 . . . . 3.44 109.81 179.99 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 45.86 58.64 15.7 Favored Pre-proline 0 N--CA 1.502 2.17 0 O-C-N 121.557 -0.714 . . . . 4.05 110.557 -179.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 58' ' ' THR . 43.8 Cg_endo -74.17 159.55 43.9 Favored 'Trans proline' 0 N--CA 1.49 1.268 0 O-C-N 123.765 1.403 . . . . 2.38 111.508 -179.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -127.35 -56.27 1.32 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.515 -0.741 . . . . 4.48 109.931 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.651 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 0.9 OUTLIER -61.49 -31.57 71.56 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.316 -0.865 . . . . 2.1 108.882 178.297 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.68 ' HG ' ' HB3' ' A' ' 50' ' ' GLU . 5.6 tt -54.89 -54.72 38.9 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.125 -0.694 . . . . 2.46 109.125 178.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.2 t -65.3 -32.92 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.316 -0.865 . . . . 2.4 108.763 178.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.4 ' HB2' ' HA ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -59.58 -49.4 77.91 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.81 -0.811 . . . . 2.55 108.81 178.609 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.645 ' CZ ' ' HA ' ' A' ' 45' ' ' GLN . 10.8 m-85 -62.32 -52.62 62.94 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 108.477 -0.934 . . . . 1.4 108.477 177.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.42 ' O ' ' CD ' ' A' ' 72' ' ' PRO . 2.4 m -53.72 -38.41 64.29 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-N 115.808 -0.633 . . . . 1.95 111.388 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.36 -41.56 18.05 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.012 -1.055 . . . . 2.11 110.969 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.0 mmtp -67.24 -45.78 75.71 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.419 -0.801 . . . . 2.97 111.12 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.403 ' N ' ' HD2' ' A' ' 72' ' ' PRO . . . -43.25 -62.65 2.34 Favored Glycine 0 N--CA 1.506 3.33 0 N-CA-C 110.614 -0.994 . . . . 1.52 110.614 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.538 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 40.8 Cg_endo -66.92 -43.92 6.14 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 O-C-N 123.729 1.384 . . . . 1.94 110.03 179.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 31.5 t -54.52 -43.05 71.54 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.935 -1.103 . . . . 2.74 109.745 178.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 37.5 t -73.62 -47.0 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.555 -0.716 . . . . 2.27 109.552 178.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -54.1 -41.4 68.23 Favored 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 121.58 0.705 . . . . 2.0 109.641 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.538 ' HD2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -69.88 -49.14 55.25 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.832 -0.543 . . . . 3.19 110.637 179.496 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.578 ' HG3' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -63.99 -29.3 70.47 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.112 -0.992 . . . . 3.08 110.075 179.292 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.578 ' N ' ' HG3' ' A' ' 77' ' ' LYS . . . -75.4 -44.41 44.8 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.283 -0.886 . . . . 2.19 109.415 179.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.0 mttt -68.8 -40.59 79.5 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.32 0.581 . . . . 2.45 109.494 178.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.13 -47.6 79.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.587 -0.696 . . . . 3.23 110.021 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 12.5 ttt -69.65 -49.87 49.53 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.444 -0.785 . . . . 4.45 110.363 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.6 85.59 38.62 Favored Pre-proline 0 N--CA 1.499 1.981 0 O-C-N 121.485 -0.76 . . . . 2.99 109.334 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -69.84 -30.91 21.16 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 O-C-N 123.865 1.455 . . . . 2.62 112.605 -178.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.5 t30 68.44 -51.98 0.55 Allowed 'General case' 0 N--CA 1.507 2.394 0 O-C-N 121.679 -0.638 . . . . 3.33 110.813 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 174.09 -113.75 0.48 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.594 -1.402 . . . . 2.55 109.594 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.89 -17.33 25.5 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.847 1.446 . . . . 3.53 111.638 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -54.05 -32.28 54.06 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.326 -0.859 . . . . 3.27 111.175 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 89' ' ' HIS . 7.5 p -98.97 -26.93 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.707 -0.621 . . . . 3.38 111.427 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.467 ' N ' HG12 ' A' ' 88' ' ' VAL . 55.7 t-80 -94.31 60.28 2.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.308 -0.87 . . . . 4.67 110.402 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.502 3.091 0 N-CA-C 109.511 -1.435 . . . . 7.02 109.511 -179.871 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.821 0 N-CA-C 109.063 -1.615 . . . . 5.23 109.063 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.5 m 53.62 48.27 21.98 Favored 'General case' 0 N--CA 1.508 2.475 0 O-C-N 121.083 -1.245 . . . . 4.27 111.12 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.446 ' O ' ' CB ' ' A' ' 4' ' ' SER . 24.0 mtp -121.11 176.76 5.43 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.06 -1.025 . . . . 3.91 110.25 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.446 ' CB ' ' O ' ' A' ' 3' ' ' MET . 0.2 OUTLIER 71.77 -51.02 0.7 Allowed 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 121.181 0.515 . . . . 3.34 110.538 -179.504 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.406 HD12 HG23 ' A' ' 5' ' ' ILE . 0.5 OUTLIER -49.14 -43.93 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 CA-C-O 121.516 0.674 . . . . 2.79 110.919 179.616 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.552 ' HG3' ' HG3' ' A' ' 81' ' ' MET . 0.0 OUTLIER -125.04 35.08 4.84 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.667 0.746 . . . . 2.99 110.092 178.845 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -121.07 10.33 10.72 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.434 -0.791 . . . . 1.83 110.004 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -103.1 52.77 0.78 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.584 -0.698 . . . . 4.76 110.519 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.26 133.86 95.78 Favored Pre-proline 0 N--CA 1.5 2.043 0 O-C-N 121.098 -1.001 . . . . 2.56 111.019 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.96 157.68 57.42 Favored 'Trans proline' 0 C--N 1.316 -1.18 0 O-C-N 123.927 1.488 . . . . 2.69 110.758 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.4 t -53.23 -36.68 61.31 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.451 -0.78 . . . . 2.53 110.309 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 p -64.68 -35.16 80.15 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.068 -1.02 . . . . 2.65 110.112 178.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -69.78 -57.2 7.37 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.655 -1.378 . . . . 2.23 109.655 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.45 HG22 ' N ' ' A' ' 15' ' ' VAL . 31.1 m -59.95 -34.11 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.501 -1.0 . . . . 2.46 110.261 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.45 ' N ' HG22 ' A' ' 14' ' ' VAL . 19.6 t -71.59 -42.37 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 120.98 -1.075 . . . . 2.19 109.138 178.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.418 ' O ' HG12 ' A' ' 20' ' ' ILE . 53.2 m -58.97 -51.73 68.78 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.711 -0.618 . . . . 2.61 109.771 179.099 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.602 ' HA ' HG12 ' A' ' 20' ' ' ILE . 35.0 m -64.02 -40.11 87.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.512 -0.743 . . . . 2.52 109.91 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.473 ' HA ' HD21 ' A' ' 21' ' ' LEU . 8.9 mm -63.36 -42.73 97.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.009 -1.057 . . . . 2.13 109.393 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.594 ' O ' HG13 ' A' ' 22' ' ' ILE . 38.4 t -63.93 -43.39 97.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 C-N-CA 119.974 -0.69 . . . . 2.32 110.173 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.602 HG12 ' HA ' ' A' ' 17' ' ' VAL . 22.2 pt -72.51 -34.77 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 120.52 -1.363 . . . . 2.76 109.45 178.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.581 ' HB3' ' O ' ' A' ' 17' ' ' VAL . 0.1 OUTLIER -69.36 -45.69 68.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.23 -0.919 . . . . 2.08 109.428 178.55 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.594 HG13 ' O ' ' A' ' 19' ' ' VAL . 1.9 pp -63.73 -39.94 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 120.632 -1.293 . . . . 2.14 109.146 178.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.511 ' HB1' ' O ' ' A' ' 19' ' ' VAL . . . -62.26 -50.14 72.89 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.862 -0.523 . . . . 2.34 110.768 179.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.489 HG13 ' N ' ' A' ' 25' ' ' ALA . 40.0 pt -63.99 -36.83 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 120.853 -1.155 . . . . 2.59 109.155 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.489 ' N ' HG13 ' A' ' 24' ' ' ILE . . . -65.28 -44.64 87.39 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.046 -0.724 . . . . 2.02 109.046 178.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.22 -44.6 94.81 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.753 -0.832 . . . . 2.11 108.753 178.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.26 -45.12 95.83 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.894 -0.78 . . . . 2.97 108.894 178.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.62 -44.7 97.54 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 108.753 -1.739 . . . . 2.04 108.753 178.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.99 -41.64 97.45 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.492 -1.005 . . . . 1.93 109.848 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.5 mt -60.68 -41.31 94.84 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.051 -0.722 . . . . 2.89 109.051 178.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 69.4 mt -69.7 -48.15 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 109.002 -0.74 . . . . 2.79 109.002 178.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.95 -43.45 91.28 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.533 -0.729 . . . . 2.26 110.103 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.42 -50.56 49.12 Favored Glycine 0 N--CA 1.498 2.779 0 N-CA-C 109.342 -1.503 . . . . 2.29 109.342 179.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 18.4 t -60.53 -40.37 91.24 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.545 -0.974 . . . . 3.21 110.145 179.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.456 ' CD1' ' HA ' ' A' ' 39' ' ' ARG . 0.6 OUTLIER -71.89 -42.67 66.51 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.202 -0.936 . . . . 4.09 109.548 179.28 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 45.6 t 53.7 -94.55 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.893 -0.505 . . . . 2.73 111.209 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -111.54 -24.53 10.07 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.836 -1.165 . . . . 2.69 112.235 -179.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pp -73.91 7.43 2.6 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.042 -1.036 . . . . 3.17 112.106 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.456 ' HA ' ' CD1' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -56.9 -30.15 63.68 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.119 -0.988 . . . . 2.78 112.097 -179.7 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.464 ' O ' ' N ' ' A' ' 42' ' ' ARG . 1.4 mm? 50.79 -100.82 0.09 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.457 -0.777 . . . . 3.43 110.433 -179.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.87 -50.33 0.33 Allowed 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.199 -0.938 . . . . 3.63 111.09 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.464 ' N ' ' O ' ' A' ' 40' ' ' LEU . 3.1 ttm180 -155.44 -119.59 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.981 -1.075 . . . . 5.22 108.691 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.406 HG13 ' H ' ' A' ' 44' ' ' SER . 0.8 OUTLIER -65.42 -37.26 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.702 -1.249 . . . . 3.28 109.775 178.478 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.406 ' H ' HG13 ' A' ' 43' ' ' ILE . 5.5 t 69.79 -65.94 0.29 Allowed 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 109.764 -0.458 . . . . 2.76 109.764 -179.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.65 100.33 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.389 -0.819 . . . . 3.38 110.055 179.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 6.6 p -148.12 -73.13 0.2 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.522 -0.736 . . . . 2.13 109.694 -178.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 46' ' ' SER . 2.8 mp0 57.7 -167.98 0.13 Allowed 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.329 0.585 . . . . 2.31 111.715 178.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.12 84.64 1.83 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.248 -0.907 . . . . 3.13 110.154 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -127.96 173.26 10.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.988 -1.07 . . . . 2.12 111.091 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -131.01 74.42 1.6 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.406 -0.809 . . . . 2.7 110.528 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.417 ' OG ' HG13 ' A' ' 52' ' ' ILE . 4.9 p -169.99 -46.25 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.821 -1.174 . . . . 3.37 111.565 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.417 HG13 ' OG ' ' A' ' 51' ' ' SER . 46.0 mt -104.48 -57.96 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.566 -0.708 . . . . 3.36 110.418 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.4 p -95.27 -33.5 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.406 -0.808 . . . . 2.68 109.89 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.695 ' HA3' HG21 ' A' ' 58' ' ' THR . . . -77.21 63.31 3.29 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.264 -1.534 . . . . 2.52 109.264 179.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -85.81 126.74 34.25 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.426 -1.043 . . . . 4.46 110.806 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.57 36.34 2.65 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 108.386 -1.885 . . . . 3.68 108.386 -179.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 58.16 24.99 11.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.842 -0.799 . . . . 3.67 109.877 -178.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.695 HG21 ' HA3' ' A' ' 54' ' ' GLY . 15.7 p 40.39 -112.57 0.14 Allowed 'General case' 0 N--CA 1.51 2.559 0 O-C-N 121.678 -0.639 . . . . 2.82 111.026 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.474 ' N ' ' OG1' ' A' ' 58' ' ' THR . 0.0 OUTLIER 51.53 -166.24 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.335 -0.853 . . . . 3.83 111.452 179.324 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.25 97.95 15.05 Favored Pre-proline 0 N--CA 1.487 1.397 0 O-C-N 121.28 -0.888 . . . . 3.06 109.259 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.707 ' HB2' ' HB2' ' A' ' 64' ' ' LEU . 40.2 Cg_endo -66.68 -26.81 45.61 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 124.102 1.58 . . . . 2.81 111.49 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.437 ' O ' ' HB2' ' A' ' 66' ' ' GLN . 58.6 t80 59.29 -73.04 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.64 -0.663 . . . . 3.63 111.652 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.485 ' N ' ' O ' ' A' ' 61' ' ' PRO . 2.7 pp -63.13 -32.5 73.9 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.062 -1.024 . . . . 3.01 111.26 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.707 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -63.28 -52.17 63.11 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.108 -0.995 . . . . 2.86 109.584 179.333 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.7 m -71.44 -36.08 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.392 -0.817 . . . . 2.31 109.383 178.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.437 ' HB2' ' O ' ' A' ' 62' ' ' PHE . 5.2 tt0 -59.37 -48.39 81.83 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.419 -0.801 . . . . 2.12 109.264 178.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.468 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 2.6 m-85 -69.59 -43.64 72.4 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.579 -0.701 . . . . 2.32 109.369 178.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 75.4 m -59.72 -32.43 70.53 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.951 -0.468 . . . . 2.03 110.588 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.99 -44.26 11.14 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.144 -0.972 . . . . 2.11 110.4 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.468 ' HE3' ' HA ' ' A' ' 67' ' ' TYR . 10.6 ptpt -65.55 -35.8 81.91 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.466 -0.771 . . . . 2.01 111.02 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.408 ' N ' ' HD2' ' A' ' 72' ' ' PRO . . . -49.78 -62.96 4.51 Favored Glycine 0 N--CA 1.501 2.975 0 N-CA-C 109.723 -1.351 . . . . 1.69 109.723 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.408 ' HD2' ' N ' ' A' ' 71' ' ' GLY . 40.4 Cg_endo -66.49 -33.71 36.19 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 123.79 1.416 . . . . 2.05 110.348 178.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 15.1 t -67.42 -47.37 70.45 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.253 -0.904 . . . . 2.2 109.939 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.7 t -66.48 -46.34 86.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.663 -0.648 . . . . 1.92 109.301 178.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -54.95 -42.37 72.25 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 121.367 0.603 . . . . 2.35 109.45 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.467 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -62.26 -54.91 33.9 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.499 0.666 . . . . 3.01 109.835 178.83 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.448 ' NZ ' ' O ' ' A' ' 6' ' ' MET . 0.0 OUTLIER -58.65 -51.51 69.63 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.2 0.524 . . . . 1.66 110.915 -179.697 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.85 -47.42 80.42 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.882 -0.511 . . . . 2.11 110.68 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -70.27 -38.12 75.02 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.692 -0.803 . . . . 2.9 109.904 179.726 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.401 HD22 ' SD ' ' A' ' 6' ' ' MET . 1.1 tp -62.41 -39.65 93.97 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.429 -0.794 . . . . 2.73 109.396 178.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.552 ' HG3' ' HG3' ' A' ' 6' ' ' MET . 3.1 ttt -74.17 -36.11 64.06 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.749 -0.834 . . . . 3.03 108.749 178.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.416 ' HA ' ' CD ' ' A' ' 87' ' ' GLU . 4.4 m 58.52 71.35 1.02 Allowed Pre-proline 0 N--CA 1.498 1.949 0 O-C-N 121.86 -0.525 . . . . 3.14 111.834 179.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.56 ' HG2' ' HD2' ' A' ' 86' ' ' PRO . 49.3 Cg_endo -75.33 12.49 1.29 Allowed 'Trans proline' 0 C--N 1.315 -1.2 0 O-C-N 123.388 1.204 . . . . 2.96 111.13 178.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 60.49 21.53 11.24 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.205 -0.935 . . . . 4.22 110.506 -179.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -111.51 -76.8 0.84 Allowed Glycine 0 N--CA 1.497 2.718 0 N-CA-C 110.088 -1.205 . . . . 4.03 110.088 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.56 ' HD2' ' HG2' ' A' ' 83' ' ' PRO . 46.9 Cg_endo -80.55 -84.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.223 0 O-C-N 123.842 1.443 . . . . 4.01 111.124 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.439 ' HB2' ' O ' ' A' ' 86' ' ' PRO . 0.4 OUTLIER 64.34 -56.95 0.24 Allowed 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 121.518 0.675 . . . . 3.94 109.86 -179.05 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.515 ' N ' ' O ' ' A' ' 86' ' ' PRO . 8.1 p -102.32 -19.6 5.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 O-C-N 122.021 -0.424 . . . . 5.34 110.009 178.007 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.519 ' CE1' ' HB2' ' A' ' 86' ' ' PRO . 22.7 m80 54.17 47.92 22.08 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.37 -0.831 . . . . 5.56 111.061 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.731 0 CA-C-O 118.018 -1.434 . . . . 6.57 109.636 179.699 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.901 0 N-CA-C 109.576 -1.41 . . . . 2.74 109.576 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.2 p -51.94 -52.47 49.93 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 121.39 -1.065 . . . . 4.19 108.789 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.7 mtt -96.78 127.56 42.88 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.06 -1.089 . . . . 4.58 108.06 177.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 64.9 94.8 0.06 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.407 -0.808 . . . . 2.4 109.294 -178.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.456 HD12 ' HB2' ' A' ' 6' ' ' MET . 1.3 pp -80.12 -165.45 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.394 -0.816 . . . . 2.43 110.275 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.456 ' HB2' HD12 ' A' ' 5' ' ' ILE . 0.0 OUTLIER 59.4 45.52 13.67 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.284 -0.885 . . . . 3.23 110.689 179.894 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -53.66 -24.32 13.96 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.431 -0.793 . . . . 1.65 111.245 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -93.74 57.47 2.52 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.16 -0.963 . . . . 4.18 109.847 179.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.414 ' CB ' ' CD ' ' A' ' 10' ' ' PRO . 2.4 m -160.39 -59.5 0.02 OUTLIER Pre-proline 0 N--CA 1.499 1.976 0 O-C-N 121.066 -1.021 . . . . 1.75 112.075 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.479 ' HG2' HG22 ' A' ' 12' ' ' THR . 47.8 Cg_endo -72.26 -155.06 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.615 0 O-C-N 123.318 1.168 . . . . 1.44 111.7 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.7 p -55.11 -51.53 66.13 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.247 -0.908 . . . . 2.07 110.303 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.479 HG22 ' HG2' ' A' ' 10' ' ' PRO . 10.7 t -57.46 -28.46 63.39 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.383 -0.823 . . . . 1.68 110.075 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.424 ' N ' HG21 ' A' ' 12' ' ' THR . . . -75.14 -58.71 3.88 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.501 -1.44 . . . . 1.06 109.501 179.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.6 ' O ' HG21 ' A' ' 17' ' ' VAL . 27.7 m -57.79 -33.06 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.612 -0.934 . . . . 1.77 109.94 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.579 ' HA ' HG12 ' A' ' 18' ' ' ILE . 37.3 t -72.03 -40.66 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.915 -1.116 . . . . 1.68 109.15 178.068 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 42.7 m -59.04 -49.78 76.59 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.267 -0.895 . . . . 1.74 109.66 178.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.6 HG21 ' O ' ' A' ' 14' ' ' VAL . 2.8 m -64.57 -43.41 96.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.604 -0.685 . . . . 2.1 111.492 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.579 HG12 ' HA ' ' A' ' 15' ' ' VAL . 2.1 pt -66.94 -32.34 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 120.153 -1.592 . . . . 1.73 110.037 179.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.467 ' N ' HG13 ' A' ' 18' ' ' ILE . 40.0 t -69.65 -47.63 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 108.044 -1.095 . . . . 1.61 108.044 177.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 69.6 mt -60.37 -46.2 95.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 N-CA-C 108.609 -0.885 . . . . 1.71 108.609 177.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.532 ' HA ' HG12 ' A' ' 24' ' ' ILE . 4.0 mt -59.36 -51.23 70.79 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.228 -0.656 . . . . 2.1 109.228 178.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.2 mt -56.46 -37.87 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.256 -0.902 . . . . 1.79 109.167 178.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.79 -52.0 42.21 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.585 -0.697 . . . . 1.68 110.797 179.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.532 HG12 ' HA ' ' A' ' 21' ' ' LEU . 39.4 pt -62.34 -37.27 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.872 -1.142 . . . . 1.87 109.201 179.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.477 ' N ' HG13 ' A' ' 24' ' ' ILE . . . -64.8 -45.84 84.58 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.533 -0.729 . . . . 1.62 109.118 178.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.03 -43.34 99.05 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.891 -0.781 . . . . 1.53 108.891 178.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.4 -47.08 87.42 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.909 -0.775 . . . . 2.0 108.909 178.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.0 -45.97 93.14 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 108.636 -1.786 . . . . 1.06 108.636 178.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.27 -44.83 96.59 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.595 -0.944 . . . . 1.5 109.623 178.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.6 mt -58.86 -40.1 83.3 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.787 -0.57 . . . . 1.8 109.503 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.7 mt -68.84 -46.64 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.498 -0.751 . . . . 1.78 109.323 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.05 -45.39 94.96 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.442 -0.786 . . . . 2.17 109.904 179.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.7 -49.13 75.87 Favored Glycine 0 N--CA 1.499 2.848 0 N-CA-C 109.494 -1.442 . . . . 0.78 109.494 179.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.7 t -60.82 -40.45 92.82 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.526 -0.985 . . . . 2.01 109.531 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.578 ' HA ' HD22 ' A' ' 38' ' ' LEU . 61.1 t90 -66.21 -51.34 58.61 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.391 -0.818 . . . . 1.31 109.86 179.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 62.57 -67.35 0.08 Allowed 'General case' 0 N--CA 1.506 2.358 0 O-C-N 121.991 -0.443 . . . . 1.62 111.079 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.434 ' N ' ' O ' ' A' ' 35' ' ' TRP . 0.2 OUTLIER 179.66 38.85 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.712 -0.618 . . . . 2.21 110.206 179.577 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.578 HD22 ' HA ' ' A' ' 35' ' ' TRP . 0.9 OUTLIER -85.42 -10.69 55.86 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.996 -1.065 . . . . 2.06 111.487 -179.709 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.505 ' HG2' HD13 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -143.43 -104.16 0.12 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.947 -1.095 . . . . 3.02 110.51 179.277 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -156.79 22.6 0.33 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.784 -1.197 . . . . 2.44 112.032 -179.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -80.02 43.39 0.6 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.854 -1.154 . . . . 2.21 111.041 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.481 ' NH2' ' OG ' ' A' ' 68' ' ' SER . 2.2 tpm_? -84.63 -65.92 0.95 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.036 -1.04 . . . . 1.33 109.358 179.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.462 HG13 ' H ' ' A' ' 44' ' ' SER . 1.2 pt -65.92 -33.62 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 122.115 0.96 . . . . 2.06 109.552 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.462 ' H ' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -73.62 72.39 1.44 Allowed 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 115.589 -0.732 . . . . 1.67 110.622 -179.958 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -76.2 -23.43 54.65 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.45 -0.781 . . . . 1.46 110.423 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 50.23 39.04 18.89 Favored 'General case' 0 N--CA 1.506 2.361 0 O-C-N 121.365 -0.834 . . . . 1.72 111.922 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.43 ' HG2' ' NH2' ' A' ' 76' ' ' ARG . 1.4 pm0 -81.74 -177.66 6.65 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.253 -0.904 . . . . 1.16 110.229 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -68.79 -179.88 1.57 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.999 -1.063 . . . . 2.3 110.381 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.495 ' HA ' ' HG2' ' A' ' 76' ' ' ARG . 43.6 mm-40 -74.51 100.84 3.98 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.951 -1.093 . . . . 1.46 109.808 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.453 ' CD ' HG22 ' A' ' 53' ' ' VAL . 2.5 tm-20 -116.44 155.01 29.3 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 122.134 0.969 . . . . 1.89 111.231 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -174.25 -10.49 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.417 0 N-CA-C 112.842 0.682 . . . . 1.39 112.842 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 39.6 mm -82.62 -42.21 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.566 -1.333 . . . . 2.26 110.211 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.503 HG21 ' N ' ' A' ' 54' ' ' GLY . 12.4 m -95.97 -40.93 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.228 -0.92 . . . . 2.2 111.151 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.573 ' HA3' ' SG ' ' A' ' 73' ' ' CYS . . . -50.88 -44.53 49.55 Favored Glycine 0 N--CA 1.5 2.951 0 N-CA-C 110.414 -1.074 . . . . 1.19 110.414 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -105.9 27.72 8.27 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.355 -1.085 . . . . 0.95 110.159 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -133.43 -34.01 0.33 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.799 -1.72 . . . . 0.91 108.799 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.47 -36.25 68.87 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.43 -1.041 . . . . 2.49 110.179 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.0 m 52.36 44.48 29.81 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.414 -0.804 . . . . 1.85 110.299 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.53 179.29 4.5 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.543 -0.723 . . . . 2.08 110.082 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.527 ' HB3' HG22 ' A' ' 65' ' ' VAL . 0.9 OUTLIER 53.12 79.25 0.35 Allowed Pre-proline 0 N--CA 1.503 2.19 0 O-C-N 121.589 -0.695 . . . . 1.66 111.202 179.257 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -74.58 11.47 1.32 Allowed 'Trans proline' 0 N--CA 1.493 1.45 0 O-C-N 123.502 1.264 . . . . 1.81 112.866 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.471 ' O ' ' HB2' ' A' ' 66' ' ' GLN . 45.2 m-85 -88.77 144.2 26.4 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.467 -1.395 . . . . 3.45 110.441 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.1 mt -58.16 -37.62 75.04 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.165 -0.959 . . . . 2.03 110.963 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.466 ' O ' ' HB2' ' A' ' 68' ' ' SER . 0.1 OUTLIER -53.97 -59.01 5.2 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.826 -0.546 . . . . 2.16 109.977 179.363 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.527 HG22 ' HB3' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -69.12 -36.49 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.549 -0.719 . . . . 2.25 110.225 179.606 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.489 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -56.33 -52.88 62.93 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.463 -0.773 . . . . 2.77 109.332 178.793 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.506 ' HA ' ' HG2' ' A' ' 70' ' ' LYS . 9.0 m-85 -69.94 -39.04 76.31 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.556 -0.715 . . . . 1.85 109.539 178.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.481 ' OG ' ' NH2' ' A' ' 42' ' ' ARG . 8.4 t -57.82 -41.01 81.34 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.814 -0.554 . . . . 0.99 110.403 178.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.68 -47.2 8.85 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.159 -0.963 . . . . 1.28 110.964 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.506 ' HG2' ' HA ' ' A' ' 67' ' ' TYR . 6.3 ptpt -66.11 -34.88 79.06 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.396 -0.815 . . . . 1.86 111.306 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.411 ' N ' ' HD2' ' A' ' 72' ' ' PRO . . . -46.69 -63.31 3.19 Favored Glycine 0 N--CA 1.503 3.159 0 N-CA-C 109.543 -1.423 . . . . 0.78 109.543 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.551 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 40.5 Cg_endo -67.28 -47.83 2.04 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.929 1.489 . . . . 0.88 109.78 178.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.573 ' SG ' ' HA3' ' A' ' 54' ' ' GLY . 4.0 m -53.26 -39.95 64.25 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.15 -0.969 . . . . 1.37 110.053 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.487 HG11 ' HB3' ' A' ' 83' ' ' PRO . 24.1 t -74.32 -46.38 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 108.833 -0.803 . . . . 1.52 108.833 178.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.11 -43.23 70.25 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 121.505 0.669 . . . . 1.17 109.258 178.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.551 ' HD2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -63.3 -50.44 70.04 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.945 -0.761 . . . . 1.31 108.945 178.52 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.8 mttp -56.11 -44.84 79.48 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 109.167 -0.679 . . . . 1.23 109.167 178.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.467 ' HA ' ' C ' ' A' ' 82' ' ' THR . . . -55.6 -52.21 64.55 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.415 -0.587 . . . . 1.64 109.415 178.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 36.3 mtpt -58.88 -44.32 91.09 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.067 0.461 . . . . 1.63 109.837 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.87 -62.88 1.29 Allowed 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.573 0.702 . . . . 3.06 110.692 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.451 ' C ' HG21 ' A' ' 82' ' ' THR . 1.5 ttt -158.63 60.41 0.43 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.527 -0.733 . . . . 3.47 109.829 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.467 ' C ' ' HA ' ' A' ' 78' ' ' ALA . 3.5 p 67.83 147.14 0.11 Allowed Pre-proline 0 N--CA 1.517 2.908 0 O-C-N 121.928 -0.482 . . . . 1.98 110.765 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.487 ' HB3' HG11 ' A' ' 74' ' ' VAL . 50.6 Cg_endo -76.2 -22.24 12.96 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.742 1.391 . . . . 1.7 111.17 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 53.87 28.67 8.71 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.677 -0.64 . . . . 2.15 110.374 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -138.51 99.03 0.26 Allowed Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.048 -1.221 . . . . 1.45 110.048 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.05 -18.13 56.25 Favored 'Trans proline' 0 N--CA 1.491 1.366 0 O-C-N 123.754 1.397 . . . . 1.79 111.224 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -53.85 -34.8 60.43 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.226 -0.921 . . . . 1.55 109.999 178.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.41 HG12 ' CG1' ' A' ' 74' ' ' VAL . 7.2 p -114.45 -25.53 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.871 -0.518 . . . . 2.59 110.64 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -162.94 -72.09 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.966 -1.084 . . . . 3.8 110.603 179.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.705 0 CA-C-O 117.865 -1.52 . . . . 1.94 109.929 -179.762 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.935 0 N-CA-C 109.311 -1.516 . . . . 8.07 109.311 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.3 m -86.78 149.12 25.07 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.881 -1.364 . . . . 6.0 110.571 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.472 ' SD ' HD13 ' A' ' 5' ' ' ILE . 1.9 mmt -104.7 118.71 37.26 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.077 -1.014 . . . . 8.88 113.401 -177.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.6 m -111.39 6.19 20.18 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.303 -1.369 . . . . 4.53 107.303 175.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.472 HD13 ' SD ' ' A' ' 3' ' ' MET . 0.6 OUTLIER -77.63 -153.41 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.578 -0.701 . . . . 4.03 109.87 179.843 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 50.12 25.48 1.75 Allowed 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.85 -0.796 . . . . 5.16 108.85 -179.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.551 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 0.8 OUTLIER -58.22 -29.23 65.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.72 -0.613 . . . . 2.92 110.377 -178.812 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.511 ' CB ' ' O ' ' A' ' 7' ' ' ASP . 6.9 t-80 77.69 4.23 2.99 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 122.076 -0.39 . . . . 2.94 110.754 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.528 ' N ' ' HD3' ' A' ' 10' ' ' PRO . 3.3 t 47.99 48.22 5.63 Favored Pre-proline 0 N--CA 1.497 1.921 0 O-C-N 121.52 -0.737 . . . . 2.91 112.324 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.551 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 52.0 Cg_endo -81.09 -46.65 0.08 OUTLIER 'Trans proline' 0 C--N 1.32 -0.972 0 O-C-N 123.379 1.2 . . . . 2.85 109.756 179.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.9 t -147.69 -44.76 0.17 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.978 -0.451 . . . . 3.5 109.818 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.68 -45.74 81.56 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.318 -0.864 . . . . 3.78 110.349 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -62.16 -48.68 81.22 Favored Glycine 0 N--CA 1.499 2.863 0 N-CA-C 109.249 -1.541 . . . . 2.4 109.249 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.479 ' O ' HG22 ' A' ' 17' ' ' VAL . 55.1 t -62.33 -37.14 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.513 -0.993 . . . . 2.25 109.924 179.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.7 t -69.87 -51.67 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.102 -0.999 . . . . 3.26 110.462 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.423 ' O ' HG21 ' A' ' 19' ' ' VAL . 25.6 p -55.67 -49.77 72.03 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.806 -0.559 . . . . 3.51 110.252 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 14' ' ' VAL . 28.8 m -65.2 -35.31 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.136 -0.978 . . . . 2.3 110.081 179.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.47 ' CG2' HD11 ' A' ' 22' ' ' ILE . 5.6 mm -68.18 -48.69 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 120.958 -1.088 . . . . 2.59 110.431 179.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.423 HG21 ' O ' ' A' ' 16' ' ' THR . 32.6 m -63.52 -36.8 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 C-N-CA 118.973 -1.091 . . . . 3.11 108.966 178.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 58.9 mt -66.54 -48.77 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.268 -0.895 . . . . 2.86 108.678 177.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 13.1 mt -58.95 -49.31 78.34 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.928 -0.767 . . . . 2.08 108.928 178.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.47 HD11 ' CG2' ' A' ' 18' ' ' ILE . 29.7 mt -56.29 -43.61 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 C-N-CA 119.992 -0.683 . . . . 3.1 109.457 178.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.34 -45.95 85.59 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.474 -0.766 . . . . 2.84 109.731 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.4 mt -59.02 -46.5 91.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.394 -0.816 . . . . 2.22 109.021 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.54 -45.35 90.96 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.556 -0.715 . . . . 2.17 109.841 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.08 -43.94 95.12 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.549 -0.719 . . . . 2.75 109.312 178.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.4 ' HA ' ' CD2' ' A' ' 30' ' ' LEU . 0.4 OUTLIER -63.25 -47.13 83.73 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.876 -0.787 . . . . 2.72 108.876 178.333 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.61 -41.6 95.71 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 108.636 -1.786 . . . . 1.6 108.636 178.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.05 -47.0 75.8 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.517 -0.99 . . . . 2.51 110.306 179.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.52 ' HG ' ' N ' ' A' ' 31' ' ' ILE . 0.2 OUTLIER -62.27 -37.21 84.61 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.615 -0.678 . . . . 2.92 109.722 179.401 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.52 ' N ' ' HG ' ' A' ' 30' ' ' LEU . 9.7 mt -71.02 -46.95 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.304 -0.872 . . . . 2.58 109.002 178.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.45 ' CD1' HD13 ' A' ' 52' ' ' ILE . 1.4 tp -58.83 -46.86 86.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.651 -0.655 . . . . 2.63 109.704 178.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.426 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -60.49 -57.9 16.66 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 109.345 -1.502 . . . . 2.35 109.345 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.501 ' SG ' HD13 ' A' ' 38' ' ' LEU . 0.5 OUTLIER -53.59 -42.33 67.52 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.406 -1.055 . . . . 3.39 110.273 179.314 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.52 ' HA ' ' HA ' ' A' ' 39' ' ' ARG . 57.3 t90 -67.27 -56.24 10.65 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.493 -0.755 . . . . 2.01 111.115 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -63.35 -24.09 67.7 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.307 -0.871 . . . . 2.73 111.937 -179.388 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.426 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 0.3 OUTLIER -98.47 -48.04 5.17 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.958 -1.089 . . . . 4.47 111.374 -179.345 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.586 ' HB3' HD11 ' A' ' 40' ' ' LEU . 2.5 mt -109.67 -37.72 5.6 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.113 -0.992 . . . . 3.14 110.715 -179.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.52 ' HA ' ' HA ' ' A' ' 35' ' ' TRP . 0.0 OUTLIER 52.79 47.35 24.87 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.772 -0.58 . . . . 2.09 110.622 -179.513 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.586 HD11 ' HB3' ' A' ' 38' ' ' LEU . 0.5 OUTLIER -80.24 -63.91 1.3 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.015 -1.053 . . . . 3.48 111.887 -179.409 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.415 ' CB ' ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER 68.84 -49.27 0.58 Allowed 'General case' 0 N--CA 1.506 2.368 0 O-C-N 121.342 -0.849 . . . . 2.69 109.584 -177.708 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.4 ttm105 -149.03 -146.95 0.21 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.436 -0.95 . . . . 3.56 108.436 178.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.449 HD11 HG22 ' A' ' 43' ' ' ILE 0.259 0.3 OUTLIER -62.39 -24.02 33.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 O-C-N 120.77 -1.206 . . . . 3.85 110.1 178.805 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.41 ' OG ' ' N ' ' A' ' 45' ' ' GLN . 88.8 p -172.9 -64.86 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.776 -0.577 . . . . 2.81 109.621 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.41 ' N ' ' OG ' ' A' ' 44' ' ' SER . 0.0 OUTLIER 46.63 58.57 4.53 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.77 -0.581 . . . . 2.67 111.386 179.469 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.02 35.86 0.54 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.83 -1.169 . . . . 2.96 110.976 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -94.9 -177.36 4.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.003 -1.061 . . . . 2.92 110.809 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.76 98.79 0.07 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.43 -0.794 . . . . 2.9 109.989 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -145.12 146.78 31.94 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.275 -0.891 . . . . 2.44 110.576 -179.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.474 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -134.79 -175.34 3.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.291 -0.881 . . . . 2.17 110.891 -179.57 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.2 t -133.95 -34.3 1.0 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.6 -0.688 . . . . 2.28 111.087 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.45 HD13 ' CD1' ' A' ' 32' ' ' LEU . 37.1 mm -88.76 -53.66 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.252 -0.905 . . . . 2.69 110.19 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 96.0 t -92.31 -66.77 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.507 -0.746 . . . . 2.48 109.401 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.31 -62.25 2.65 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 108.589 -1.805 . . . . 1.77 108.589 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -79.83 -163.72 0.57 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.761 -0.847 . . . . 2.28 109.705 178.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 140.89 -58.8 0.57 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 108.874 -1.69 . . . . 2.06 108.874 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -124.81 20.66 8.43 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.68 -0.894 . . . . 2.53 110.505 179.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.8 m -70.42 56.02 0.16 Allowed 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.122 -0.986 . . . . 2.06 110.288 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.97 -162.15 1.1 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.405 -0.961 . . . . 3.67 108.405 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 60.96 105.76 0.03 OUTLIER Pre-proline 0 N--CA 1.502 2.142 0 O-C-N 121.37 -0.832 . . . . 4.83 111.171 178.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -68.23 55.66 0.79 Allowed 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 120.83 1.02 . . . . 3.11 110.512 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.464 ' O ' ' HB2' ' A' ' 66' ' ' GLN . 1.1 m-85 -74.24 163.49 27.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.315 -0.865 . . . . 5.6 109.553 179.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.2 mt -54.89 -40.45 69.79 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.914 -1.117 . . . . 3.66 110.554 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.21 -52.63 64.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.707 -0.621 . . . . 5.12 110.025 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.8 t -68.64 -33.67 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.259 -0.9 . . . . 3.99 109.392 179.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.474 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -59.25 -57.84 11.26 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.764 -0.828 . . . . 2.82 108.764 179.107 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -62.55 -40.95 98.47 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.684 -0.635 . . . . 3.93 109.608 178.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.413 ' O ' ' CD ' ' A' ' 72' ' ' PRO . 71.2 m -59.93 -41.33 91.55 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.824 -0.547 . . . . 3.82 110.209 179.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -81.37 -41.79 21.46 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.206 -0.934 . . . . 2.79 110.488 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' A' ' 66' ' ' GLN . 1.8 mmtp -61.38 -47.16 87.09 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.467 -0.771 . . . . 2.41 110.687 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 75' ' ' GLU . . . -41.71 -66.45 0.99 Allowed Glycine 0 N--CA 1.503 3.116 0 N-CA-C 110.544 -1.022 . . . . 3.12 110.544 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.516 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 41.3 Cg_endo -65.81 -39.84 18.83 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.788 1.415 . . . . 3.17 110.56 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 6.5 t -60.63 -43.32 97.64 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.033 -1.042 . . . . 2.45 109.325 178.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 69.1 t -70.94 -44.98 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 109.112 -0.699 . . . . 3.22 109.112 178.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 0.6 OUTLIER -56.48 -42.48 78.35 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.614 0.721 . . . . 3.41 109.444 178.629 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.516 ' HD2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -66.09 -50.45 64.02 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.624 -0.673 . . . . 3.38 109.731 179.05 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -41.21 80.16 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 120.208 -0.597 . . . . 3.34 109.655 179.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.88 -43.23 84.04 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 122.062 -0.399 . . . . 3.25 110.044 179.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.459 ' HA ' ' CE ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -68.39 -48.54 64.42 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.607 -0.683 . . . . 3.53 109.893 179.326 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.1 tp -57.17 -47.1 82.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.486 -0.759 . . . . 2.42 109.56 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -68.63 -55.02 12.9 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.591 0.71 . . . . 4.1 109.514 178.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.75 98.54 27.84 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.775 -0.578 . . . . 4.91 109.453 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.404 ' O ' ' CB ' ' A' ' 84' ' ' ASN . 43.7 Cg_endo -67.95 -10.11 27.81 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.465 1.245 . . . . 3.66 110.413 178.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.53 ' HB3' ' HB2' ' A' ' 87' ' ' GLU . 2.0 t-20 71.22 -45.83 0.62 Allowed 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.686 -0.634 . . . . 4.98 110.656 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.73 -85.42 0.39 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 108.719 -1.753 . . . . 5.12 108.719 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -76.76 -21.05 12.99 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.734 1.386 . . . . 6.38 111.39 179.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.53 ' HB2' ' HB3' ' A' ' 84' ' ' ASN . 1.1 tt0 -58.58 -44.99 89.97 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.862 -1.149 . . . . 5.07 110.36 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.5 m -92.7 -9.89 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.499 -0.751 . . . . 5.62 110.687 178.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -111.23 -61.24 1.72 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.214 -0.929 . . . . 7.85 110.706 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.474 0 N-CA-C 109.08 -1.608 . . . . 6.79 109.08 -179.141 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.508 ' N ' ' OG1' ' A' ' 16' ' ' THR . . . . . . . . 0 N--CA 1.494 2.53 0 N-CA-C 110.402 -1.079 . . . . 2.84 110.402 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.9 p -104.61 5.44 33.73 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.186 -1.185 . . . . 4.28 111.826 -179.431 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.1 mtt -106.46 161.49 14.54 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.947 -1.096 . . . . 4.32 110.09 179.835 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.71 29.16 0.92 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.072 -1.017 . . . . 2.91 111.233 -179.877 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.43 HG22 HD11 ' A' ' 5' ' ' ILE . 0.5 OUTLIER -53.1 -43.14 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.509 -0.744 . . . . 2.48 111.112 179.367 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.4 mmt 53.2 59.73 4.22 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.379 0.609 . . . . 3.55 110.663 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.449 ' HB3' ' CG ' ' A' ' 10' ' ' PRO . 8.1 m-20 -57.22 -33.06 67.14 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.394 -0.817 . . . . 2.85 110.18 179.643 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 28.0 t-80 50.31 46.97 24.51 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.745 -0.597 . . . . 2.73 111.593 179.391 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.497 ' CB ' ' CD ' ' A' ' 10' ' ' PRO . 0.9 OUTLIER -177.0 -63.03 0.0 OUTLIER Pre-proline 0 N--CA 1.499 2.002 0 O-C-N 121.325 -0.859 . . . . 2.18 110.806 179.275 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 9' ' ' SER . 47.7 Cg_endo -73.28 170.44 19.87 Favored 'Trans proline' 0 N--CA 1.487 1.146 0 O-C-N 123.33 1.173 . . . . 2.17 110.899 179.771 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.9 t -59.86 -30.13 68.76 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.247 -0.908 . . . . 2.41 110.867 179.8 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.6 p -60.1 -35.65 75.69 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.93 -1.107 . . . . 2.41 109.751 178.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.84 -51.91 8.7 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 108.743 -1.743 . . . . 1.58 108.743 178.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.552 ' O ' HG21 ' A' ' 17' ' ' VAL . 53.8 t -57.18 -37.99 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.705 -0.88 . . . . 1.73 109.89 178.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.522 ' O ' HG13 ' A' ' 18' ' ' ILE . 43.2 t -72.63 -37.43 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.031 -1.043 . . . . 1.94 109.416 178.998 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.508 ' OG1' ' N ' ' A' ' 1' ' ' GLY . 59.5 m -62.17 -50.25 72.59 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.286 -0.884 . . . . 1.68 109.712 178.588 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.552 HG21 ' O ' ' A' ' 14' ' ' VAL . 30.9 m -67.24 -41.86 87.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.655 -0.653 . . . . 1.5 111.643 -179.502 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.523 HG23 ' O ' ' A' ' 14' ' ' VAL . 2.1 pp -67.69 -30.42 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 120.303 -1.498 . . . . 1.76 109.764 179.138 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.6 t -68.99 -52.2 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.233 -0.917 . . . . 1.72 108.782 178.143 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.521 HG12 ' HA ' ' A' ' 17' ' ' VAL . 44.9 pt -63.96 -37.53 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.162 -0.961 . . . . 1.5 109.083 178.668 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.47 ' N ' HG13 ' A' ' 20' ' ' ILE . 9.9 mt -64.85 -48.34 74.68 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.395 -0.816 . . . . 1.55 109.0 178.028 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.467 HG23 HD12 ' A' ' 22' ' ' ILE . 8.0 mm -59.19 -43.57 89.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.317 -0.865 . . . . 1.9 108.873 178.481 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.85 -46.66 88.5 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.387 -0.597 . . . . 1.48 109.387 178.711 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.4 mm -59.97 -45.44 95.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.306 -0.871 . . . . 1.65 108.892 178.386 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.67 -45.4 94.18 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.579 -0.7 . . . . 1.38 109.613 178.751 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.74 -44.94 96.03 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.58 -0.7 . . . . 1.46 109.138 178.593 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.4 tt -61.96 -45.92 91.54 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.898 -0.779 . . . . 1.76 108.898 178.192 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.38 -44.09 95.39 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 108.712 -1.755 . . . . 1.11 108.712 178.651 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.28 -46.28 84.36 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.428 -1.042 . . . . 1.56 109.668 178.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.1 mt -56.89 -41.29 77.79 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 109.179 -0.675 . . . . 1.91 109.179 178.719 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 26.6 mm -70.2 -44.9 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.53 -0.731 . . . . 1.96 109.525 178.853 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.457 ' HA ' ' HD1' ' A' ' 35' ' ' TRP . 0.2 OUTLIER -58.17 -48.52 80.05 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.508 -0.745 . . . . 2.72 109.891 179.285 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.03 -41.68 86.78 Favored Glycine 0 N--CA 1.499 2.838 0 N-CA-C 110.471 -1.051 . . . . 1.5 110.471 179.773 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 9.8 t -64.38 -41.41 96.7 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.395 -1.062 . . . . 2.29 111.011 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.457 ' HD1' ' HA ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -84.53 -34.43 23.3 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.094 -1.004 . . . . 3.0 110.764 -179.808 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.414 ' HB2' ' CE2' ' A' ' 35' ' ' TRP . 2.5 t -128.27 101.72 6.36 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.006 -1.059 . . . . 2.44 109.995 179.414 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -52.78 -43.15 65.65 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.308 -0.87 . . . . 4.92 110.826 -179.784 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.48 -10.69 59.81 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.933 -1.104 . . . . 2.85 111.074 179.499 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 10.2 mtm105 43.64 41.18 3.36 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.621 -0.674 . . . . 2.19 111.254 179.235 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 46.75 46.83 15.17 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.649 -0.657 . . . . 3.06 110.921 -179.673 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -69.33 -1.07 7.28 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.035 -1.041 . . . . 2.92 112.118 -179.533 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.58 -60.03 2.47 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.627 -1.296 . . . . 4.29 108.723 178.549 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.479 HG13 ' N ' ' A' ' 44' ' ' SER . 13.7 pt -103.32 -38.46 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.534 -0.729 . . . . 3.39 110.141 178.782 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.479 ' N ' HG13 ' A' ' 43' ' ' ILE . 5.1 t 61.84 -76.6 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.498 0 O-C-N 122.154 -0.342 . . . . 3.02 110.923 -179.474 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -165.72 -176.3 3.83 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.149 -0.97 . . . . 2.63 110.241 179.655 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.5 m -155.3 35.5 0.38 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.852 -1.155 . . . . 3.47 110.606 179.736 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -98.92 162.38 13.12 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.313 -0.867 . . . . 2.76 109.63 179.573 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.415 ' O ' ' N ' ' A' ' 50' ' ' GLU . 21.6 t70 -65.05 -57.29 9.02 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.233 -0.917 . . . . 2.31 109.646 179.389 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 62.39 -64.68 0.09 Allowed 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.896 -0.502 . . . . 2.68 111.897 179.161 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 48' ' ' ASP . 3.8 tp10 -136.8 120.79 17.65 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.006 -1.059 . . . . 2.36 110.706 179.958 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 96.0 p -155.22 -57.52 0.1 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.351 -0.843 . . . . 2.06 111.56 -179.406 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.7 mt -78.09 -59.7 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.655 -0.653 . . . . 2.57 111.081 -178.673 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.1 p -66.91 -46.81 84.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.496 -0.752 . . . . 2.29 110.985 -179.244 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 63.48 30.12 76.64 Favored Glycine 0 N--CA 1.496 2.664 0 N-CA-C 109.519 -1.433 . . . . 1.49 109.519 -179.499 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 54.42 84.55 0.07 Allowed 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 121.953 0.882 . . . . 2.06 110.698 -179.551 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -165.25 -48.33 0.02 OUTLIER Glycine 0 N--CA 1.496 2.653 0 N-CA-C 108.227 -1.949 . . . . 1.23 108.227 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -96.45 -48.8 5.42 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.776 -0.837 . . . . 2.17 109.249 178.529 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -119.58 179.12 4.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.627 -0.671 . . . . 1.68 109.228 178.699 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.501 ' C ' HG22 ' A' ' 18' ' ' ILE . 0.0 OUTLIER 62.11 -156.57 0.34 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.522 -0.736 . . . . 2.25 109.581 -179.356 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.489 ' HG2' ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -63.36 144.35 97.58 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 121.005 -1.059 . . . . 1.62 110.398 -179.742 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.489 ' HD2' ' HG2' ' A' ' 60' ' ' GLU . 38.1 Cg_endo -63.62 -33.12 68.24 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 O-C-N 123.424 1.223 . . . . 1.12 110.444 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.51 ' O ' HG22 ' A' ' 65' ' ' VAL . 24.6 t80 32.55 -90.85 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.346 0 N-CA-C 112.334 0.494 . . . . 2.9 112.334 178.933 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.417 ' N ' ' O ' ' A' ' 61' ' ' PRO . 1.6 mt -57.36 -33.21 67.55 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.997 -1.065 . . . . 2.4 111.099 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.1 -56.52 20.65 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.445 -0.784 . . . . 2.01 109.844 179.347 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.51 HG22 ' O ' ' A' ' 62' ' ' PHE . 33.7 m -71.52 -32.0 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.041 -1.037 . . . . 1.68 110.034 179.137 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.502 ' OE1' ' NZ ' ' A' ' 70' ' ' LYS . 2.6 mt-30 -60.66 -45.48 93.97 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.362 -0.836 . . . . 3.03 109.491 178.465 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -74.26 -41.42 61.31 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.654 0.74 . . . . 3.96 109.463 178.624 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 64.0 m -59.2 -28.54 66.74 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 122.002 -0.436 . . . . 1.33 110.938 179.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -95.59 -43.99 7.69 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.082 -1.011 . . . . 2.19 111.013 -179.651 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.502 ' NZ ' ' OE1' ' A' ' 66' ' ' GLN . 15.2 mtmt -70.06 -39.83 75.43 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.408 -0.808 . . . . 3.65 111.109 -179.394 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.414 ' N ' ' HD2' ' A' ' 72' ' ' PRO . . . -46.0 -61.11 4.11 Favored Glycine 0 N--CA 1.503 3.106 0 N-CA-C 109.603 -1.399 . . . . 1.15 109.603 179.821 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.586 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 42.1 Cg_endo -67.74 -43.37 5.45 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 O-C-N 123.801 1.421 . . . . 1.17 109.751 178.462 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 9.1 t -53.75 -44.77 70.23 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.906 -1.121 . . . . 2.51 110.202 179.055 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.5 t -72.68 -45.96 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.337 -0.852 . . . . 2.12 109.05 178.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -53.6 -42.59 67.83 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.6 0.714 . . . . 1.28 109.96 178.642 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.596 ' HA ' ' CD ' ' A' ' 79' ' ' LYS . 0.9 OUTLIER -72.74 -45.55 58.14 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.673 -0.642 . . . . 1.97 110.997 179.85 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.488 ' HG3' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -67.27 -28.79 68.32 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.121 -0.987 . . . . 2.1 109.984 179.594 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.488 ' N ' ' HG3' ' A' ' 77' ' ' LYS . . . -75.56 -52.36 10.79 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.426 -0.796 . . . . 1.71 109.485 179.265 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.596 ' CD ' ' HA ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -64.84 -28.95 69.9 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.622 -0.674 . . . . 2.37 111.332 179.903 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.547 ' N ' ' HG2' ' A' ' 79' ' ' LYS . 2.6 tp -87.93 -36.58 17.04 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.23 -0.919 . . . . 2.5 112.166 -178.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -110.88 -38.76 5.02 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.91 -1.119 . . . . 3.91 112.425 -178.659 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 37.0 p -132.27 68.02 79.42 Favored Pre-proline 0 N--CA 1.506 2.352 0 O-C-N 120.533 -1.354 . . . . 2.28 111.687 -179.303 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -64.48 -23.9 64.28 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 O-C-N 123.505 1.266 . . . . 2.1 111.086 179.397 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.5 t30 66.05 -53.52 0.39 Allowed 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.774 -0.579 . . . . 3.45 110.46 -179.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -138.6 86.28 0.22 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.104 -1.598 . . . . 3.15 109.104 179.237 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -61.15 -17.45 52.45 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 O-C-N 123.676 1.356 . . . . 3.33 110.575 179.361 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -55.77 -37.52 68.67 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.53 -0.732 . . . . 4.65 109.474 178.253 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 89' ' ' HIS . 0.9 OUTLIER -98.11 -24.6 4.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.739 -0.601 . . . . 4.97 110.107 179.891 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.427 ' O ' HG23 ' A' ' 88' ' ' VAL . 0.3 OUTLIER 57.64 -161.39 0.23 Allowed 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.556 -0.715 . . . . 3.58 110.14 -179.797 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.207 0 N-CA-C 109.471 -1.452 . . . . 2.6 109.471 -179.723 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 3.279 0 N-CA-C 110.464 -1.055 . . . . 5.26 110.464 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.9 t 50.82 -144.88 0.52 Allowed 'General case' 0 N--CA 1.506 2.332 0 O-C-N 121.442 -1.034 . . . . 5.83 109.795 -179.403 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -77.71 46.24 0.54 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.824 -1.172 . . . . 5.6 109.581 178.74 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.6 m -155.08 86.18 1.1 Allowed 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.102 -0.703 . . . . 3.57 109.102 -179.759 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.526 HG21 HD12 ' A' ' 5' ' ' ILE . 0.6 OUTLIER -77.71 -143.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.767 -0.827 . . . . 3.95 108.767 179.761 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.402 ' O ' ' N ' ' A' ' 8' ' ' HIS . 0.1 OUTLIER 64.5 -60.7 0.21 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.372 -0.83 . . . . 3.88 111.95 179.142 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.447 ' N ' ' O ' ' A' ' 5' ' ' ILE . 0.2 OUTLIER 66.26 -45.45 0.42 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.768 -0.583 . . . . 3.49 110.376 -178.684 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.402 ' N ' ' O ' ' A' ' 6' ' ' MET . 0.3 OUTLIER -66.64 -28.64 68.64 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.918 -1.114 . . . . 5.46 110.408 178.276 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.99 64.78 3.46 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.76 -0.587 . . . . 2.97 110.794 -179.655 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -72.18 88.4 0.84 Allowed 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.331 1.174 . . . . 2.07 110.428 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.0 t -54.63 -40.69 69.2 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.316 -0.865 . . . . 2.08 110.254 179.921 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.7 p -61.61 -38.97 89.55 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.311 -0.868 . . . . 1.91 109.615 178.46 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -70.56 -51.33 21.33 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 108.69 -1.764 . . . . 1.18 108.69 178.606 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.7 t -55.4 -40.3 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.838 -0.801 . . . . 2.17 109.3 178.649 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.4 t -69.07 -42.69 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.338 -0.851 . . . . 1.8 109.037 178.434 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.415 HG22 HD11 ' A' ' 20' ' ' ILE . 53.9 m -57.31 -52.77 64.01 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.131 0.491 . . . . 1.56 110.007 179.137 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.3 m -64.29 -37.08 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.519 -0.738 . . . . 1.69 110.043 179.468 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.1 mt -66.28 -40.9 88.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.039 -1.038 . . . . 1.86 109.394 178.567 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.3 t -64.52 -45.35 95.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.533 -0.914 . . . . 1.68 108.533 178.158 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.415 HD11 HG22 ' A' ' 16' ' ' THR . 86.2 mt -62.15 -46.32 96.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.49 -0.756 . . . . 1.71 109.016 178.312 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.8 mt -60.07 -49.59 77.07 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.908 -0.775 . . . . 2.03 108.908 178.411 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.9 mt -56.76 -43.13 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.525 -0.735 . . . . 1.83 109.394 178.52 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.21 -46.55 83.41 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.669 -0.644 . . . . 1.49 109.908 179.032 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.5 mm -59.66 -46.29 93.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.232 -0.918 . . . . 1.82 109.02 178.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.96 -45.0 95.57 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.607 -0.683 . . . . 1.95 109.664 178.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.35 -43.84 98.19 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.556 -0.715 . . . . 1.76 109.093 178.59 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.74 -48.26 81.53 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.774 -0.824 . . . . 1.73 108.774 178.133 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.35 -44.65 93.43 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 108.857 -1.697 . . . . 1.25 108.857 178.767 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.32 -43.16 95.54 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.433 -1.04 . . . . 1.72 109.866 178.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.453 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 6.9 mt -60.27 -41.36 93.12 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.244 -0.651 . . . . 2.11 109.244 178.628 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.573 ' CG2' ' HB2' ' A' ' 49' ' ' GLU . 97.0 mt -69.11 -52.91 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.558 -0.714 . . . . 1.69 109.29 179.029 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.2 -46.91 72.54 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.491 -0.756 . . . . 2.6 109.763 178.867 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.63 -47.53 89.94 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 109.221 -1.552 . . . . 1.58 109.221 178.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -57.86 -41.71 83.0 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.557 -0.967 . . . . 2.39 109.618 178.876 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.483 ' O ' ' N ' ' A' ' 37' ' ' TYR . 1.2 m-90 -68.29 -42.1 79.99 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.289 -0.882 . . . . 1.6 109.728 178.868 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.458 ' O ' ' NH1' ' A' ' 39' ' ' ARG . 4.0 t 55.41 -75.58 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.904 -0.498 . . . . 2.28 111.739 179.082 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.483 ' N ' ' O ' ' A' ' 35' ' ' TRP . 0.2 OUTLIER -146.73 14.22 1.2 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.915 -1.116 . . . . 3.49 111.946 179.912 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.457 HD21 ' HA ' ' A' ' 35' ' ' TRP . 2.6 pp -91.77 22.55 4.1 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.83 -1.169 . . . . 2.12 110.886 179.457 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.458 ' NH1' ' O ' ' A' ' 36' ' ' CYS . 68.9 mtt85 -50.3 -48.69 55.01 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.296 -0.878 . . . . 1.55 111.206 179.669 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.74 54.19 0.35 Allowed 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.328 -0.857 . . . . 3.19 110.92 -179.788 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -90.74 -16.84 27.73 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.173 -0.954 . . . . 2.75 110.943 179.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.2 tpp180 -159.04 -134.64 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.16 -0.963 . . . . 3.05 109.88 -179.731 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.46 HG13 ' N ' ' A' ' 44' ' ' SER . 5.2 pt -53.34 -33.31 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 O-C-N 121.095 -1.003 . . . . 2.66 110.813 179.24 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.46 ' N ' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -53.1 102.1 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 121.259 0.552 . . . . 1.59 111.107 -179.943 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -84.51 -25.01 29.13 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.484 -0.76 . . . . 2.91 111.142 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 23.1 t -116.06 -68.98 0.88 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.968 -1.083 . . . . 1.91 110.217 179.68 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -115.67 169.26 9.33 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.248 -0.907 . . . . 1.95 110.808 179.545 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.446 ' HB3' ' CD1' ' A' ' 35' ' ' TRP . 24.2 t70 -139.02 -33.64 0.63 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.778 -0.576 . . . . 1.07 110.738 -179.916 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.573 ' HB2' ' CG2' ' A' ' 31' ' ' ILE . 0.9 OUTLIER -73.83 -135.88 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.224 -0.922 . . . . 1.16 111.621 -179.852 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.56 80.05 1.97 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.494 -1.379 . . . . 2.65 112.285 -178.567 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 42.5 t -161.11 -69.88 0.06 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.391 -0.818 . . . . 1.85 109.655 178.343 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.534 ' O ' ' HB2' ' A' ' 55' ' ' ASP . 1.1 pp -68.15 -27.77 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.388 -0.82 . . . . 2.52 109.771 178.832 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.444 ' N ' HG13 ' A' ' 52' ' ' ILE . 33.1 m -57.7 -33.41 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.376 -0.828 . . . . 2.54 109.033 178.162 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -103.72 42.12 1.97 Allowed Glycine 0 N--CA 1.498 2.805 0 N-CA-C 108.668 -1.773 . . . . 2.4 108.668 178.364 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.534 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 2.5 t0 -101.62 95.31 6.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.6 -0.941 . . . . 2.75 110.381 -179.283 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -157.04 -53.98 0.01 OUTLIER Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.828 -1.709 . . . . 2.65 108.828 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -95.95 -23.46 16.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.801 -0.823 . . . . 2.93 110.343 178.82 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.436 ' O ' ' NZ ' ' A' ' 59' ' ' LYS . 9.4 p -69.44 60.7 0.14 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.517 -0.739 . . . . 3.32 110.908 179.908 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.436 ' NZ ' ' O ' ' A' ' 58' ' ' THR . 3.1 mmtt -124.43 -156.28 0.71 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.105 -0.997 . . . . 3.19 110.64 -179.581 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.492 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 0.8 OUTLIER -80.05 114.88 50.2 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.641 -0.662 . . . . 3.42 109.512 179.264 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -65.03 -38.13 29.89 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.751 1.395 . . . . 3.18 111.758 -178.795 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.49 ' HB3' ' OE1' ' A' ' 60' ' ' GLU . 59.1 t80 -62.84 -55.29 27.59 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.941 -1.099 . . . . 4.03 109.776 179.493 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.467 ' HB2' ' HB3' ' A' ' 60' ' ' GLU . 4.3 mt -59.86 -37.78 80.28 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.473 -0.767 . . . . 3.47 109.948 178.848 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.492 ' HB2' ' O ' ' A' ' 60' ' ' GLU . 0.3 OUTLIER -58.83 -49.25 78.41 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.713 -0.617 . . . . 2.98 109.933 179.356 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.5 t -73.07 -36.54 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.138 -0.976 . . . . 2.83 109.186 178.821 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.85 -46.73 84.36 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 120.138 -0.625 . . . . 4.77 109.404 179.463 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.432 ' HA ' ' CG ' ' A' ' 70' ' ' LYS . 0.4 OUTLIER -70.48 -42.88 70.82 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.604 -0.685 . . . . 4.18 109.483 178.457 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.42 ' O ' ' CD ' ' A' ' 72' ' ' PRO . 54.2 m -60.1 -37.39 79.83 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 109.963 -0.384 . . . . 2.18 109.963 178.872 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.88 -43.57 15.17 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.241 -0.912 . . . . 2.39 111.338 -179.711 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.432 ' CG ' ' HA ' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -70.33 -25.65 63.39 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.084 -1.01 . . . . 2.04 110.834 -179.795 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.517 ' O ' ' HB2' ' A' ' 75' ' ' GLU . . . -55.11 -64.68 4.15 Favored Glycine 0 N--CA 1.498 2.799 0 N-CA-C 109.063 -1.615 . . . . 1.68 109.063 178.918 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.42 ' CD ' ' O ' ' A' ' 68' ' ' SER . 39.6 Cg_endo -65.91 -37.09 28.2 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 124.085 1.571 . . . . 2.41 110.055 178.778 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 6.2 t -60.16 -46.21 90.45 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.992 -1.067 . . . . 2.52 109.656 178.725 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 39.2 t -72.24 -42.49 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.515 -0.741 . . . . 1.74 109.401 178.863 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.517 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -57.65 -41.66 81.9 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.717 0.77 . . . . 3.01 109.283 178.408 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.4 ttt85 -71.3 -45.32 63.34 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.578 -0.701 . . . . 4.11 110.371 179.36 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.25 -44.25 95.42 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.178 -0.951 . . . . 2.77 109.262 179.267 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.601 ' HA ' ' CD ' ' A' ' 83' ' ' PRO . . . -64.5 -49.06 72.83 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.526 0.679 . . . . 1.76 110.849 179.329 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.4 mttp -68.24 -46.57 70.12 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.276 -0.89 . . . . 3.45 111.502 -179.655 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.1 tp -70.69 -53.06 17.14 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.226 -0.921 . . . . 3.19 112.3 -178.672 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' MET . . . . . 0.421 ' CG ' ' HG3' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -100.2 -24.66 14.5 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.214 -0.929 . . . . 3.52 112.174 -178.596 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 78' ' ' ALA . 86.8 m 53.62 81.47 0.26 Allowed Pre-proline 0 N--CA 1.504 2.255 0 O-C-N 121.223 -0.923 . . . . 3.29 111.509 179.567 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.601 ' CD ' ' HA ' ' A' ' 78' ' ' ALA . 50.1 Cg_endo -73.14 17.97 0.39 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.842 1.443 . . . . 2.72 112.505 179.428 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -71.54 53.22 0.21 Allowed 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.458 -1.401 . . . . 4.24 108.875 178.487 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 140.19 -75.16 0.36 Allowed Glycine 0 N--CA 1.494 2.538 0 N-CA-C 108.34 -1.904 . . . . 3.7 108.34 -178.617 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -79.23 -173.53 1.91 Allowed 'Trans proline' 0 C--N 1.315 -1.217 0 O-C-N 123.645 1.34 . . . . 2.77 110.321 178.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.421 ' HG3' ' CG ' ' A' ' 81' ' ' MET . 0.1 OUTLIER 67.63 -50.39 0.51 Allowed 'General case' 0 N--CA 1.51 2.532 0 O-C-N 121.375 -0.828 . . . . 3.25 110.229 -178.31 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.0 p -109.97 -6.08 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.706 -0.622 . . . . 4.71 110.932 179.057 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 60.75 51.26 4.94 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.158 -0.964 . . . . 4.96 110.197 -179.565 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.877 0 CA-C-O 118.105 -1.386 . . . . 5.17 110.02 179.85 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.652 0 N-CA-C 109.575 -1.41 . . . . 1.8 109.575 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 90.1 p -161.37 -81.98 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.386 -1.067 . . . . 3.23 110.493 179.26 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.3 mtt -130.16 73.7 1.55 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.548 -0.72 . . . . 3.77 110.534 -179.47 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.4 m -121.05 29.22 7.46 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.351 -0.843 . . . . 2.23 110.553 179.852 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.58 -124.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.156 -0.965 . . . . 1.89 110.136 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 5.4 mmt -97.02 39.03 1.19 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.309 -1.494 . . . . 3.11 110.521 179.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -60.55 -30.26 69.66 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.519 -0.738 . . . . 1.43 110.924 179.827 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -102.42 35.08 2.54 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.083 -1.011 . . . . 3.94 110.54 179.795 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.6 t -95.05 142.2 24.29 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.151 -0.968 . . . . 1.87 110.37 179.722 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.58 170.94 16.36 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 123.633 1.333 . . . . 2.6 110.554 179.729 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.7 t -52.47 -38.77 60.12 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.199 -0.938 . . . . 3.67 110.126 179.831 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 p -65.72 -42.03 91.55 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.27 -0.894 . . . . 3.74 109.397 178.289 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.444 ' O ' HG21 ' A' ' 17' ' ' VAL . . . -70.31 -51.02 24.1 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.13 -1.588 . . . . 2.37 109.13 178.988 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.8 t -53.97 -41.52 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.714 -0.874 . . . . 2.23 109.346 178.747 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.6 t -69.99 -41.93 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.278 -0.889 . . . . 3.11 109.261 178.663 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.404 HG22 HD12 ' A' ' 20' ' ' ILE . 77.8 m -58.75 -51.57 69.42 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.699 -0.626 . . . . 2.81 109.928 179.155 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.444 HG21 ' O ' ' A' ' 13' ' ' GLY . 23.3 m -65.41 -36.43 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.471 -0.768 . . . . 1.92 109.911 179.42 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.41 ' N ' HG23 ' A' ' 17' ' ' VAL . 21.7 mt -66.58 -40.19 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 121.136 -0.977 . . . . 2.14 109.298 178.404 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 36.1 t -64.8 -43.51 96.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.036 -1.04 . . . . 2.93 108.474 177.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.404 HD12 HG22 ' A' ' 16' ' ' THR . 87.7 mt -63.68 -46.73 93.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 108.919 -0.771 . . . . 2.72 108.919 178.139 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 44.7 mt -59.56 -49.15 78.87 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.705 -0.85 . . . . 1.57 108.705 178.454 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 31.4 mt -56.27 -42.44 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.557 -0.714 . . . . 2.09 109.386 178.284 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.44 -45.52 83.5 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.461 -0.774 . . . . 2.52 109.663 178.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.0 mt -60.09 -46.11 94.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 108.438 -0.949 . . . . 2.31 108.438 178.367 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.62 -48.12 82.31 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.753 -0.462 . . . . 1.39 109.753 178.56 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.48 -44.19 89.27 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.47 -0.769 . . . . 1.96 109.078 178.712 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.452 ' HG ' HD12 ' A' ' 31' ' ' ILE . 0.5 OUTLIER -62.01 -46.32 89.7 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.844 -0.799 . . . . 3.11 108.844 178.116 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.98 -42.5 98.35 Favored Glycine 0 N--CA 1.497 2.717 0 N-CA-C 108.899 -1.68 . . . . 1.95 108.899 178.735 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.38 -44.15 95.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.549 -0.971 . . . . 1.29 109.315 178.72 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.492 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 6.4 mt -60.79 -40.84 94.11 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.003 -0.74 . . . . 2.39 109.003 178.289 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.452 HD12 ' HG ' ' A' ' 27' ' ' LEU . 30.1 mt -67.79 -48.54 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.375 -0.828 . . . . 3.34 109.208 178.445 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.584 ' HA ' ' HD1' ' A' ' 35' ' ' TRP . 0.2 OUTLIER -56.99 -48.43 78.47 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.391 -0.818 . . . . 2.94 109.329 178.848 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.482 ' HA2' ' CZ ' ' A' ' 39' ' ' ARG . . . -64.35 -35.79 92.39 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 110.908 -0.877 . . . . 1.27 110.908 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -79.44 -29.58 41.87 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.983 -1.304 . . . . 2.71 111.319 -179.515 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.584 ' HD1' ' HA ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -89.24 -31.09 18.06 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.902 -1.124 . . . . 4.18 111.29 -179.694 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.52 ' HB2' ' NE1' ' A' ' 35' ' ' TRP . 6.5 t -127.58 150.37 49.74 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.785 -1.197 . . . . 3.12 110.931 -179.541 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -80.23 -38.19 31.55 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.481 -0.762 . . . . 3.94 109.657 179.229 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.474 ' O ' ' C ' ' A' ' 39' ' ' ARG . 6.5 mt -85.03 -61.27 1.81 Allowed 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.309 -0.87 . . . . 3.56 110.688 179.821 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.52 ' HD2' ' O ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER 28.77 71.2 0.06 Allowed 'General case' 0 N--CA 1.511 2.621 0 CA-C-O 122.005 0.907 . . . . 2.43 110.878 -179.203 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.9 85.48 6.75 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.412 -0.805 . . . . 4.14 111.136 -178.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -54.17 -19.99 6.01 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.453 -0.78 . . . . 3.0 110.373 178.673 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.482 ' CZ ' ' HA ' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -157.39 -145.4 0.14 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.345 -0.847 . . . . 3.62 109.616 179.373 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.478 HG22 ' N ' ' A' ' 44' ' ' SER 0.258 0.4 OUTLIER -54.88 -26.92 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 O-C-N 120.909 -1.12 . . . . 5.55 110.941 179.316 . . . . . . . . 4 4 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.478 ' N ' HG22 ' A' ' 43' ' ' ILE . 2.6 m -178.86 78.77 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.46 -0.775 . . . . 4.57 109.354 179.734 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 43.41 58.71 3.31 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.606 -0.684 . . . . 2.47 110.908 -179.602 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 36.6 m -142.22 77.9 1.6 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.066 -1.021 . . . . 3.85 111.841 -179.274 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.482 ' HA ' ' CZ ' ' A' ' 42' ' ' ARG . 1.7 pm0 -96.39 154.49 17.24 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.366 -0.834 . . . . 2.18 109.833 178.633 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.21 -54.4 3.08 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.145 -0.972 . . . . 2.3 110.613 -179.597 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.81 163.01 40.1 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.175 -0.953 . . . . 1.64 110.974 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -94.71 91.35 6.47 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.435 -0.79 . . . . 2.01 110.304 179.432 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.403 ' OG ' ' N ' ' A' ' 52' ' ' ILE . 96.4 p -145.82 -79.54 0.17 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.048 -1.032 . . . . 2.28 110.498 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.403 ' N ' ' OG ' ' A' ' 51' ' ' SER . 15.2 pt -70.71 -34.5 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.379 -0.826 . . . . 2.79 110.472 -179.781 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.529 HG23 ' N ' ' A' ' 54' ' ' GLY . 33.2 m -75.87 -33.21 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 O-C-N 121.361 -0.837 . . . . 2.32 110.405 179.544 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.529 ' N ' HG23 ' A' ' 53' ' ' VAL . . . -86.32 -24.95 38.13 Favored Glycine 0 N--CA 1.498 2.794 0 N-CA-C 110.031 -1.228 . . . . 1.72 110.031 179.855 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.8 t70 62.44 -165.53 0.23 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.66 -0.906 . . . . 2.16 111.245 179.891 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.487 ' HA2' ' CD1' ' A' ' 64' ' ' LEU . . . 149.43 -54.53 0.5 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 108.326 -1.91 . . . . 1.16 108.326 -179.308 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -117.79 -33.64 4.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.834 -0.804 . . . . 1.5 111.381 179.346 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.88 97.61 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.19 -0.944 . . . . 2.13 110.433 179.945 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.472 ' CG ' ' N ' ' A' ' 60' ' ' GLU . 0.0 OUTLIER 68.88 -176.56 0.21 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.24 -0.652 . . . . 2.29 109.24 -178.535 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.472 ' N ' ' CG ' ' A' ' 59' ' ' LYS . 0.4 OUTLIER -99.08 102.49 15.71 Favored Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 120.785 -1.197 . . . . 1.54 110.546 -179.552 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.605 ' HG2' ' HB3' ' A' ' 64' ' ' LEU . 48.4 Cg_endo -73.17 142.9 34.81 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 O-C-N 123.616 1.324 . . . . 1.24 111.048 -179.958 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -77.67 -48.1 17.59 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.543 -0.723 . . . . 3.24 111.172 -179.751 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 63' ' ' LEU . 81.3 mt -62.82 -35.25 79.28 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.467 -0.77 . . . . 2.8 110.812 -179.657 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.605 ' HB3' ' HG2' ' A' ' 61' ' ' PRO . 0.5 OUTLIER -60.9 -55.63 30.73 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.19 -0.944 . . . . 2.84 109.975 179.394 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.47 HG21 ' N ' ' A' ' 66' ' ' GLN . 34.4 m -68.93 -32.96 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.113 -0.992 . . . . 1.75 110.119 179.813 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.47 ' N ' HG21 ' A' ' 65' ' ' VAL . 3.0 mm-40 -61.92 -53.52 54.58 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.239 -0.913 . . . . 2.23 108.881 178.257 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -63.06 -42.06 99.6 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.355 -0.841 . . . . 3.67 109.359 178.277 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 70.4 m -56.26 -35.07 67.02 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.997 -0.44 . . . . 1.67 110.678 179.177 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -91.29 -40.94 11.22 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.166 -0.959 . . . . 1.77 110.777 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 66' ' ' GLN . 3.4 mmtp -64.59 -44.76 89.63 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.576 -0.702 . . . . 3.28 110.746 -179.851 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.4 ' N ' ' HD2' ' A' ' 72' ' ' PRO . . . -46.52 -63.56 3.02 Favored Glycine 0 N--CA 1.502 3.08 0 N-CA-C 110.455 -1.058 . . . . 1.1 110.455 -179.823 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 71' ' ' GLY . 40.2 Cg_endo -65.8 -38.15 24.87 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 O-C-N 123.736 1.387 . . . . 1.52 110.644 179.545 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 10.5 t -60.68 -43.38 97.77 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.023 -1.048 . . . . 1.94 109.496 178.841 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 54.1 t -74.26 -42.95 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.487 -0.758 . . . . 1.83 109.375 178.76 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -56.03 -44.62 78.92 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.701 -0.851 . . . . 1.5 108.701 178.318 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -66.78 -41.61 87.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.854 -0.529 . . . . 2.37 109.805 178.788 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.6 -50.12 75.13 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.432 -0.792 . . . . 3.71 110.095 179.135 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.32 -44.11 92.56 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.61 -0.681 . . . . 1.6 110.642 179.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.647 ' HD2' ' HB3' ' A' ' 84' ' ' ASN . 3.0 mmmm -66.39 -33.63 76.15 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.522 -0.736 . . . . 1.69 110.162 179.488 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.37 -34.24 58.9 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.196 -0.94 . . . . 3.13 111.119 -179.844 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.93 -39.62 25.9 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.368 -0.832 . . . . 3.59 110.372 179.793 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.611 ' HB ' ' HD2' ' A' ' 83' ' ' PRO . 46.1 p -91.09 174.23 4.68 Favored Pre-proline 0 N--CA 1.502 2.174 0 O-C-N 121.339 -0.85 . . . . 1.9 109.977 179.571 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.611 ' HD2' ' HB ' ' A' ' 82' ' ' THR . 46.8 Cg_endo -77.43 8.96 3.05 Favored 'Trans proline' 0 C--N 1.316 -1.139 0 O-C-N 123.225 1.118 . . . . 1.75 111.651 179.049 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.647 ' HB3' ' HD2' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -76.37 51.03 0.68 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.902 -1.124 . . . . 2.01 109.116 179.178 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -80.71 -150.46 6.93 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 110.716 -0.954 . . . . 2.09 110.716 -179.083 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.1 -16.53 40.41 Favored 'Trans proline' 0 N--CA 1.49 1.279 0 O-C-N 123.912 1.48 . . . . 3.12 111.225 -179.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -63.92 -32.23 73.68 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.229 -0.919 . . . . 4.56 108.627 178.512 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 48.8 t -102.92 -32.03 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.612 -0.68 . . . . 3.19 109.813 178.284 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -169.87 -58.03 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.096 -1.003 . . . . 3.26 111.467 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.793 0 N-CA-C 110.202 -1.159 . . . . 2.4 110.202 -179.113 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.815 0 N-CA-C 110.492 -1.043 . . . . 7.23 110.492 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.482 ' OG ' ' N ' ' A' ' 3' ' ' MET . 30.0 t 52.5 -143.0 0.73 Allowed 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.911 -0.758 . . . . 6.48 111.023 -179.966 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.482 ' N ' ' OG ' ' A' ' 2' ' ' SER . 0.6 OUTLIER -68.71 66.71 0.13 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.34 -0.85 . . . . 4.41 110.446 179.876 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.5 m -79.39 11.56 2.91 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.181 -0.95 . . . . 6.05 110.465 179.217 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.496 HD11 ' HB2' ' A' ' 8' ' ' HIS . 1.4 pp -82.91 -170.07 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 O-C-N 121.616 -0.677 . . . . 5.14 109.41 178.643 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.577 ' O ' ' HB3' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -109.69 -172.38 2.03 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.272 -0.892 . . . . 5.75 110.648 179.906 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.577 ' HB3' ' O ' ' A' ' 6' ' ' MET . 1.3 t70 66.58 -43.34 0.41 Allowed 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.899 -0.5 . . . . 3.98 111.002 -178.789 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.496 ' HB2' HD11 ' A' ' 5' ' ' ILE . 0.9 OUTLIER -97.02 -34.19 11.27 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.704 -1.247 . . . . 3.33 111.469 -179.754 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.478 ' OG ' ' HD3' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -59.71 -52.86 70.93 Favored Pre-proline 0 N--CA 1.503 2.196 0 O-C-N 121.05 -1.031 . . . . 3.79 112.094 -179.609 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.478 ' HD3' ' OG ' ' A' ' 9' ' ' SER . 44.7 Cg_endo -70.4 -38.18 6.73 Favored 'Trans proline' 0 N--CA 1.49 1.292 0 O-C-N 123.039 1.021 . . . . 3.76 111.367 -179.418 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.0 p -69.6 -57.89 4.63 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.372 -0.83 . . . . 3.16 110.198 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.3 p -59.52 -37.44 78.35 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.156 -0.965 . . . . 2.36 109.626 179.46 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.443 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -65.44 -57.3 11.72 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.285 -1.526 . . . . 2.49 109.285 179.176 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.433 ' HA ' HG23 ' A' ' 17' ' ' VAL . 12.5 t -56.3 -39.71 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.685 -0.891 . . . . 3.37 109.465 179.042 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.3 t -67.45 -42.73 87.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.055 -1.028 . . . . 2.36 109.26 178.805 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 66.8 m -60.54 -52.6 64.5 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.685 -0.634 . . . . 2.03 109.812 179.08 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.463 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 23.6 m -64.32 -35.46 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 119.829 -0.748 . . . . 2.54 109.834 179.397 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.436 ' N ' HG22 ' A' ' 17' ' ' VAL . 9.8 mt -68.71 -41.78 82.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 120.935 -1.103 . . . . 3.38 109.042 178.432 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.8 t -64.04 -42.28 95.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.391 -0.966 . . . . 1.87 108.391 178.063 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 83.3 mt -64.68 -50.09 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.483 -0.761 . . . . 2.06 109.153 178.51 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.554 ' HG ' ' N ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -61.86 -41.16 97.5 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.878 -0.786 . . . . 2.9 108.878 178.827 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.554 ' N ' ' HG ' ' A' ' 21' ' ' LEU . 7.4 mm -60.97 -44.19 97.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.44 -0.948 . . . . 3.19 108.44 177.945 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.77 -44.86 88.7 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.546 -0.721 . . . . 2.15 109.689 178.817 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.416 HG22 HD11 ' A' ' 24' ' ' ILE . 20.9 mm -59.68 -49.59 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.421 -0.955 . . . . 2.35 108.421 178.434 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.1 -44.9 96.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.794 -0.566 . . . . 2.85 110.002 178.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.73 -43.44 98.84 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.571 -0.706 . . . . 2.96 109.251 178.683 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.1 tt -63.24 -46.97 84.44 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.029 -0.73 . . . . 2.81 109.029 178.24 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.38 -44.61 96.47 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 108.708 -1.757 . . . . 2.9 108.708 178.617 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.67 -40.9 96.2 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.609 -0.936 . . . . 3.66 109.573 178.691 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.465 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 6.5 mt -61.33 -43.13 99.4 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.105 -0.702 . . . . 4.16 109.105 178.536 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 35.4 mt -67.84 -49.26 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.451 -0.781 . . . . 3.42 109.469 179.005 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.72 -39.2 90.69 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.658 -0.652 . . . . 4.08 110.391 179.313 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.91 -42.19 31.05 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 110.244 -1.142 . . . . 4.46 110.244 179.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 1.9 t -70.92 -40.97 71.79 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.054 -1.262 . . . . 4.86 110.734 -179.858 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.406 ' CD1' ' HG3' ' A' ' 39' ' ' ARG . 0.3 OUTLIER -94.22 -10.91 31.49 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.285 -0.884 . . . . 3.97 111.815 -179.491 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.416 ' O ' ' NH2' ' A' ' 39' ' ' ARG . 0.8 OUTLIER 62.62 172.68 0.14 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 122.192 0.996 . . . . 4.52 111.435 -179.89 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -82.85 -30.03 28.95 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 121.334 -0.854 . . . . 4.05 110.888 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.45 HD13 ' CB ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -111.94 11.27 20.65 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.264 -0.898 . . . . 3.39 112.005 -179.479 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.416 ' NH2' ' O ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER 53.08 24.63 3.64 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 121.025 -1.047 . . . . 3.41 112.02 179.238 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.45 ' CB ' HD13 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -143.15 168.13 20.47 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.232 -0.918 . . . . 3.46 110.268 179.613 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 57.32 33.41 23.26 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.506 -0.746 . . . . 2.7 109.451 -178.749 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -146.01 -58.21 0.31 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.395 -0.816 . . . . 4.26 111.321 -178.801 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.442 HG13 ' OE2' ' A' ' 47' ' ' GLU . 23.2 pt -55.06 -31.45 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 CA-C-O 121.655 0.741 . . . . 4.05 110.537 -179.781 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 71.56 49.87 0.28 Allowed 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 121.816 0.817 . . . . 3.13 109.446 -179.179 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -125.65 -63.11 1.15 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.872 -0.518 . . . . 4.25 109.723 -179.611 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.7 p -79.59 -23.9 42.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.506 -0.746 . . . . 2.74 110.102 179.253 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.442 ' OE2' HG13 ' A' ' 43' ' ' ILE . 0.8 OUTLIER -100.01 172.04 7.46 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-O 121.682 0.753 . . . . 3.16 110.618 179.593 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.438 ' N ' ' OG ' ' A' ' 68' ' ' SER . 4.7 m-20 -86.39 -37.74 18.1 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.659 -0.651 . . . . 1.97 111.258 -178.567 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.408 ' HB3' HG11 ' A' ' 65' ' ' VAL . 2.9 tm-20 -144.45 174.9 10.53 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.376 -0.828 . . . . 2.09 111.363 -178.792 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.78 -67.17 0.8 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.539 -0.725 . . . . 3.4 110.556 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.431 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 0.6 OUTLIER -173.39 81.44 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.563 -0.711 . . . . 3.39 110.062 -179.984 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.556 HG21 ' HG3' ' A' ' 60' ' ' GLU . 27.8 mm 65.41 -44.93 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.703 -0.623 . . . . 3.61 112.106 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.414 ' O ' ' N ' ' A' ' 55' ' ' ASP . 33.7 m -50.37 -33.05 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.304 0 O-C-N 121.324 -0.86 . . . . 3.49 111.596 -179.669 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -66.83 61.37 0.2 Allowed Glycine 0 N--CA 1.5 2.918 0 N-CA-C 110.88 -0.888 . . . . 2.1 110.88 -179.265 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 53' ' ' VAL . 31.3 m-20 -86.13 146.42 26.6 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.427 -1.043 . . . . 3.44 110.226 179.425 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 179.11 -49.74 0.09 OUTLIER Glycine 0 N--CA 1.5 2.954 0 N-CA-C 108.019 -2.033 . . . . 2.47 108.019 -179.835 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.67 -50.63 3.37 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 122.046 -0.679 . . . . 4.25 109.299 178.554 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.7 m -122.93 124.28 42.85 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.427 -0.796 . . . . 4.5 109.477 179.136 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.13 129.17 39.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.263 -0.898 . . . . 4.53 109.005 179.096 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.556 ' HG3' HG21 ' A' ' 52' ' ' ILE . 0.4 OUTLIER 64.04 63.9 1.33 Allowed Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.89 -0.506 . . . . 4.78 110.209 -179.068 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.496 ' HB2' ' HB2' ' A' ' 64' ' ' LEU . 43.2 Cg_endo -68.27 55.9 0.82 Allowed 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 121.236 1.29 . . . . 3.2 110.878 179.589 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -56.68 -46.01 81.39 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.287 -0.883 . . . . 5.64 111.229 -179.544 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.449 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 2.2 mt -62.89 -37.33 86.51 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.588 -0.695 . . . . 5.16 110.204 179.836 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.498 ' O ' ' HB2' ' A' ' 68' ' ' SER . 0.0 OUTLIER -58.82 -59.29 5.68 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.31 -0.626 . . . . 3.37 109.31 178.871 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.503 HG21 ' N ' ' A' ' 66' ' ' GLN . 34.1 m -66.14 -34.65 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.397 -0.814 . . . . 3.42 110.154 179.137 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.503 ' N ' HG21 ' A' ' 65' ' ' VAL . 8.1 tp-100 -61.62 -48.11 82.36 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.142 -0.974 . . . . 4.83 108.911 178.439 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.449 ' HB2' ' O ' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -66.29 -48.36 70.63 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.967 -0.753 . . . . 5.45 108.967 178.412 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.498 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -55.43 -30.71 60.99 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 116.31 -0.405 . . . . 1.9 111.269 179.746 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.577 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -92.87 -48.18 6.67 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.125 -0.984 . . . . 2.57 109.842 179.311 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.9 mmpp? -59.58 -51.41 69.95 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.685 -0.635 . . . . 4.04 111.511 -179.656 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.402 ' N ' ' HD2' ' A' ' 72' ' ' PRO . . . -42.87 -63.05 2.09 Favored Glycine 0 N--CA 1.504 3.231 0 N-CA-C 110.091 -1.203 . . . . 1.97 110.091 -179.631 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.514 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 41.1 Cg_endo -66.18 -40.21 16.03 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 O-C-N 123.721 1.379 . . . . 1.28 110.445 178.931 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.577 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 0.7 OUTLIER -62.28 -46.31 89.37 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.731 -1.23 . . . . 2.69 109.786 179.125 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.53 ' O ' ' HB3' ' A' ' 78' ' ' ALA . 39.0 t -64.85 -49.79 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.694 -0.854 . . . . 2.88 108.694 178.819 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -56.58 -40.67 75.63 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.221 0.534 . . . . 3.53 110.084 179.025 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.514 ' HB2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -63.7 -52.98 58.17 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.514 -0.741 . . . . 3.08 110.227 179.919 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.561 ' HG3' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -66.7 -31.87 72.81 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.334 -0.946 . . . . 3.68 109.778 179.552 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.561 ' N ' ' HG3' ' A' ' 77' ' ' LYS . . . -66.55 -46.69 75.26 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.202 -1.036 . . . . 2.77 108.202 177.678 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.544 ' HE2' ' O ' ' A' ' 84' ' ' ASN . 7.8 mmtp -66.43 -40.79 89.72 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.05 -0.722 . . . . 4.09 109.05 178.128 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.51 -49.36 78.07 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.301 -0.875 . . . . 2.9 110.504 179.26 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.47 -52.46 10.63 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.45 0.643 . . . . 4.33 110.496 -179.725 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.408 ' C ' ' H ' ' A' ' 84' ' ' ASN . 0.3 OUTLIER -101.43 122.75 46.95 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.486 -0.759 . . . . 4.13 110.081 -179.649 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -71.1 19.97 0.23 Allowed 'Trans proline' 0 N--CA 1.495 1.604 0 O-C-N 123.581 1.306 . . . . 4.58 112.046 178.958 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.544 ' O ' ' HE2' ' A' ' 79' ' ' LYS . 0.5 OUTLIER -70.84 45.49 0.09 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 120.973 -1.079 . . . . 5.31 110.535 179.201 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 154.64 96.07 0.12 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 108.916 -1.674 . . . . 4.69 108.916 -179.361 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.461 ' O ' ' HB3' ' A' ' 87' ' ' GLU . 46.0 Cg_endo -68.18 -166.39 0.14 Allowed 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 124.156 1.608 . . . . 5.66 109.873 -179.747 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.461 ' HB3' ' O ' ' A' ' 86' ' ' PRO . 3.4 tt0 69.46 -53.77 0.6 Allowed 'General case' 0 N--CA 1.509 2.522 0 O-C-N 121.143 -0.973 . . . . 5.95 109.685 -178.384 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.529 HG21 ' HD2' ' A' ' 79' ' ' LYS . 17.4 m -103.83 -1.84 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.689 -0.632 . . . . 4.01 110.817 178.919 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 50.3 t60 -84.37 -43.87 14.29 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.844 -1.16 . . . . 4.27 108.988 178.757 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.261 0 N-CA-C 108.749 -1.74 . . . . 3.96 108.749 178.828 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 6' ' ' MET . . . . . . . . 0 N--CA 1.495 2.578 0 N-CA-C 110.41 -1.076 . . . . 2.52 110.41 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.523 ' HB3' ' O ' ' A' ' 5' ' ' ILE . 41.0 t -98.17 -166.65 1.4 Allowed 'General case' 0 N--CA 1.483 1.216 0 O-C-N 121.034 -1.274 . . . . 2.9 109.935 179.435 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.8 mmt -77.91 -38.17 46.23 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.509 -0.744 . . . . 4.17 110.429 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 75.4 p -120.62 -76.28 0.58 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.263 -0.898 . . . . 3.53 110.659 -179.739 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.523 ' O ' ' HB3' ' A' ' 2' ' ' SER . 0.2 OUTLIER -95.94 -143.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.814 -0.554 . . . . 4.14 110.518 -179.328 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.4 ' O ' ' N ' ' A' ' 1' ' ' GLY . 1.8 mtt 51.49 65.22 1.55 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.289 -0.882 . . . . 4.57 110.988 179.776 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.487 ' HB2' ' HD2' ' A' ' 10' ' ' PRO . 2.7 p30 -55.81 -35.01 65.87 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.229 -0.92 . . . . 1.75 109.301 179.201 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 55.72 31.81 18.18 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.125 0.488 . . . . 3.44 111.132 179.32 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.599 ' HB3' ' CD ' ' A' ' 10' ' ' PRO . 8.2 t -154.67 -68.22 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.413 -0.804 . . . . 2.12 110.227 179.453 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.599 ' CD ' ' HB3' ' A' ' 9' ' ' SER . 39.4 Cg_endo -65.07 -48.64 3.43 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 O-C-N 123.076 1.04 . . . . 1.77 111.599 179.38 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.1 m -64.53 -50.88 65.61 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.013 -1.055 . . . . 2.29 110.229 179.792 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -60.32 -37.31 80.2 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.342 -0.849 . . . . 2.49 109.84 179.032 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -69.13 -52.66 22.0 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 108.947 -1.661 . . . . 1.43 108.947 178.849 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.9 t -56.0 -40.25 62.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.785 -0.833 . . . . 1.99 109.477 178.95 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.2 t -68.16 -43.67 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.199 -0.938 . . . . 2.18 109.363 178.77 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 53.1 m -58.53 -50.99 71.78 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.628 -0.67 . . . . 2.36 110.164 179.436 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.508 HG21 ' N ' ' A' ' 18' ' ' ILE . 31.5 m -66.87 -33.68 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.371 -0.831 . . . . 2.04 110.271 179.654 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.508 ' N ' HG21 ' A' ' 17' ' ' VAL . 7.2 mm -69.25 -41.4 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 120.892 -1.13 . . . . 2.0 109.29 178.468 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.6 t -64.83 -44.15 96.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 108.413 -0.958 . . . . 2.15 108.413 177.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 21.8 mm -62.97 -46.91 95.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.479 -0.763 . . . . 2.54 109.059 178.29 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.8 mt -59.98 -48.82 80.13 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.912 -0.773 . . . . 2.11 108.912 178.378 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.5 mm -57.45 -44.03 83.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.533 -0.729 . . . . 1.96 109.412 178.503 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.47 -45.04 92.61 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.529 -0.732 . . . . 1.82 109.718 179.008 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 37.6 mt -60.55 -45.39 97.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.418 -0.801 . . . . 2.21 109.004 178.667 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.57 -45.57 89.87 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.48 -0.763 . . . . 1.72 109.753 178.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.68 -43.87 97.17 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.8 -0.815 . . . . 1.57 108.8 178.516 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.505 ' HA ' HD23 ' A' ' 27' ' ' LEU . 3.0 tm? -60.04 -52.06 66.99 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.834 -0.802 . . . . 2.39 108.834 178.076 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.91 -44.66 82.21 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.033 -1.627 . . . . 1.33 109.033 178.68 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.6 -43.57 96.53 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.496 -1.002 . . . . 1.58 109.878 179.071 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.8 mt -59.76 -40.78 89.35 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.498 -0.556 . . . . 2.16 109.498 178.967 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.523 HG23 HD13 ' A' ' 31' ' ' ILE . 8.7 mt -71.54 -44.89 70.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.464 -0.773 . . . . 2.72 109.385 178.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.454 ' O ' ' HB2' ' A' ' 36' ' ' CYS . 0.4 OUTLIER -59.37 -48.44 81.64 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.301 -0.875 . . . . 2.51 109.667 179.138 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.32 -55.63 28.13 Favored Glycine 0 N--CA 1.499 2.838 0 N-CA-C 109.663 -1.375 . . . . 1.29 109.663 179.252 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 44.4 t -51.25 -49.19 61.64 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.493 -1.004 . . . . 1.48 109.976 179.195 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 40.4 t90 -63.03 -49.24 75.37 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.294 -0.879 . . . . 3.68 110.056 179.224 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -58.33 -33.64 69.75 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.239 -0.913 . . . . 2.34 110.585 179.475 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -79.09 -42.57 26.02 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.36 -0.837 . . . . 2.66 110.62 179.864 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.669 HD22 ' HA ' ' A' ' 44' ' ' SER . 6.5 tp -85.25 -44.46 12.87 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.712 -0.617 . . . . 1.79 111.974 -179.261 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.529 ' HB2' ' CZ ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER 66.57 -52.4 0.44 Allowed 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.648 -0.658 . . . . 2.09 111.2 -179.244 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.8 mt -76.56 70.3 3.08 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.282 -0.886 . . . . 2.78 111.123 -179.722 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -67.82 -12.24 60.2 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.085 -1.009 . . . . 3.23 111.313 179.509 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.476 ' HG3' ' N ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -69.01 -61.61 1.72 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.115 -0.991 . . . . 4.01 109.1 179.744 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.476 ' N ' ' HG3' ' A' ' 42' ' ' ARG . 7.6 pt -81.24 -32.18 12.06 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-O 121.842 0.829 . . . . 2.46 108.982 178.277 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.669 ' HA ' HD22 ' A' ' 38' ' ' LEU . 0.1 OUTLIER 61.21 40.87 14.13 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 115.857 -0.61 . . . . 2.16 109.657 -179.462 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.505 ' HG3' ' CD1' ' A' ' 38' ' ' LEU . 3.7 mt-30 59.41 -82.54 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 122.185 -0.322 . . . . 2.43 110.487 -179.425 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.4 m 45.76 34.99 2.0 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.443 -0.786 . . . . 2.47 111.679 179.291 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -79.78 165.44 22.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.162 -0.961 . . . . 2.87 110.684 -179.658 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.93 86.43 6.53 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.388 -0.82 . . . . 4.47 110.482 -179.746 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.75 169.32 10.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.109 -0.994 . . . . 4.7 110.208 179.813 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.53 ' HB3' HG22 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -77.81 -64.41 1.16 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.22 -0.925 . . . . 4.93 110.181 -179.988 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 m -179.76 -44.74 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.746 -0.596 . . . . 4.88 110.491 -179.941 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.465 HD13 HG21 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -125.44 -30.16 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.588 -0.695 . . . . 3.72 110.817 -179.589 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.53 HG22 ' HB3' ' A' ' 50' ' ' GLU . 21.7 m -58.75 -34.72 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.405 0 O-C-N 120.653 -1.279 . . . . 3.9 110.889 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -90.75 33.87 4.45 Favored Glycine 0 N--CA 1.499 2.839 0 N-CA-C 110.243 -1.143 . . . . 2.39 110.243 179.763 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 22.7 t70 -76.32 164.96 25.52 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.319 -1.106 . . . . 2.05 111.133 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 153.25 -50.9 0.49 Allowed Glycine 0 N--CA 1.495 2.593 0 N-CA-C 108.192 -1.963 . . . . 1.83 108.192 -179.84 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -126.17 31.27 5.46 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.886 -0.773 . . . . 2.44 109.76 178.652 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.0 62.38 2.77 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.219 -0.925 . . . . 2.02 110.577 -179.718 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.43 151.22 25.83 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.162 -0.961 . . . . 3.0 110.19 179.768 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -85.76 115.56 62.14 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.23 -0.919 . . . . 2.5 110.145 179.87 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -80.69 31.48 0.5 Allowed 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.534 1.281 . . . . 4.07 111.581 -179.941 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.7 t80 70.55 -30.17 0.2 Allowed 'General case' 0 N--CA 1.508 2.44 0 O-C-N 121.181 -0.949 . . . . 3.05 112.73 -179.851 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.0 mt -56.07 -41.03 74.48 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.959 -1.088 . . . . 3.11 111.721 -179.384 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.37 -47.46 84.06 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.686 -0.806 . . . . 3.43 110.031 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.6 t -70.46 -34.38 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.097 -1.002 . . . . 2.25 109.161 178.637 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -58.86 -52.28 66.39 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.783 -0.821 . . . . 2.4 108.783 178.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -66.06 -43.3 87.84 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.597 -0.689 . . . . 4.53 109.46 178.28 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 69.7 m -58.45 -40.5 82.78 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.9 -0.5 . . . . 2.17 110.393 179.342 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.501 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -83.71 -44.86 14.03 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.325 -0.86 . . . . 1.75 111.05 -179.948 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.3 mmtp -61.61 -45.7 92.96 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.384 -0.823 . . . . 2.28 111.128 -179.613 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -43.02 -64.9 1.56 Allowed Glycine 0 N--CA 1.506 3.319 0 N-CA-C 110.679 -0.968 . . . . 1.54 110.679 -179.397 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.409 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 40.6 Cg_endo -65.51 -38.59 24.81 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 O-C-N 123.779 1.41 . . . . 1.64 110.45 179.41 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.501 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -62.14 -46.36 89.38 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.964 -1.085 . . . . 1.84 109.571 178.8 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.7 t -68.37 -45.4 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 109.004 -0.739 . . . . 1.86 109.004 178.672 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' A' ' 79' ' ' LYS . 2.6 tm-20 -56.9 -43.38 81.29 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.502 0.668 . . . . 1.7 109.559 178.549 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -64.99 -48.32 74.38 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.728 -0.607 . . . . 2.77 109.683 178.925 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.58 -42.67 97.18 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.583 -0.698 . . . . 2.35 110.187 179.789 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.03 -41.98 97.25 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.866 -0.521 . . . . 1.57 109.657 179.125 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 75' ' ' GLU . 5.0 mttp -68.07 -47.58 67.91 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.29 -0.633 . . . . 2.41 109.29 178.67 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.96 -39.13 71.3 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.425 -0.797 . . . . 2.24 109.63 178.904 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.3 ttt -77.13 -59.98 2.55 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.658 -0.651 . . . . 3.54 109.981 179.324 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.6 p -129.09 86.39 57.24 Favored Pre-proline 0 N--CA 1.499 2.011 0 O-C-N 121.238 -0.914 . . . . 2.21 109.483 179.291 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.412 ' O ' ' CB ' ' A' ' 84' ' ' ASN . 45.1 Cg_endo -68.91 -29.57 27.87 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 O-C-N 123.865 1.455 . . . . 1.75 111.822 -179.114 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.412 ' CB ' ' O ' ' A' ' 83' ' ' PRO . 5.0 t30 69.78 -51.14 0.63 Allowed 'General case' 0 N--CA 1.506 2.368 0 O-C-N 121.716 -0.615 . . . . 2.63 111.29 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.04 -92.32 0.71 Allowed Glycine 0 N--CA 1.499 2.834 0 N-CA-C 109.48 -1.448 . . . . 2.3 109.48 -179.736 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.53 ' O ' ' HB2' ' A' ' 87' ' ' GLU . 50.9 Cg_endo -79.25 -155.85 0.06 OUTLIER 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.838 1.441 . . . . 3.05 110.259 179.558 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.53 ' HB2' ' O ' ' A' ' 86' ' ' PRO . 1.2 mp0 65.71 -55.73 0.35 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.582 -0.699 . . . . 3.36 109.891 -178.812 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.457 ' N ' ' O ' ' A' ' 86' ' ' PRO . 19.7 t -95.03 -31.14 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.68 -0.638 . . . . 2.72 109.544 178.072 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 33.1 m80 49.37 46.64 23.07 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.518 -0.739 . . . . 3.51 111.735 179.534 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.843 0 CA-C-O 117.86 -1.522 . . . . 2.88 110.127 179.48 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 54.2 t . . . . . 0 N--CA 1.5 2.046 0 N-CA-C 109.02 -0.734 . . . . 2.17 109.02 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.7 t -69.89 -42.84 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.202 -0.937 . . . . 1.96 109.036 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 49.6 m -58.98 -51.36 70.39 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.771 -0.581 . . . . 1.87 109.985 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.1 m -66.95 -33.17 61.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.387 -0.821 . . . . 1.89 110.271 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.41 ' HA ' HD13 ' A' ' 18' ' ' ILE . 6.9 mm -69.64 -41.13 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 120.925 -1.109 . . . . 2.01 109.091 178.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.3 t -64.76 -45.07 96.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 108.291 -1.003 . . . . 1.74 108.291 177.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.417 HD13 ' HA ' ' A' ' 20' ' ' ILE . 23.6 mm -62.06 -46.79 95.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.85 -0.796 . . . . 1.72 108.85 178.233 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 13.1 mt -59.75 -49.67 76.81 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.849 -0.797 . . . . 1.89 108.849 178.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.0 mt -56.44 -43.1 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.575 -0.703 . . . . 2.02 109.293 178.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.68 -46.84 83.69 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.588 -0.695 . . . . 1.48 109.536 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.1 mt -58.64 -48.29 86.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.446 -0.783 . . . . 1.7 108.978 178.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.61 -45.37 94.27 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.62 -0.675 . . . . 1.53 109.937 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.4 -45.37 93.83 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 109.071 -0.714 . . . . 1.46 109.071 178.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.27 -47.1 87.55 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.014 -0.735 . . . . 1.65 109.014 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.15 -44.26 94.91 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 108.88 -1.688 . . . . 1.31 108.88 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.14 -45.73 92.14 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.409 -1.053 . . . . 1.36 109.414 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.4 mt -57.58 -41.8 81.85 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.297 -0.631 . . . . 1.61 109.297 178.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 45.6 mt -71.36 -36.04 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.302 -0.874 . . . . 1.31 110.09 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.6 tt -68.06 -45.19 74.54 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.234 -0.916 . . . . 1.67 109.825 178.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.812 0 O-C-N 121.169 -0.957 . . . . 1.26 111.469 -179.546 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 . . . . . 0 N--CA 1.495 1.79 0 N-CA-C 109.086 -0.709 . . . . 1.78 109.086 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.574 ' HA ' ' HG2' ' A' ' 70' ' ' LYS . 4.6 t80 -72.7 -35.61 67.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.781 -0.574 . . . . 1.57 109.48 178.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.0 t -61.71 -31.15 71.28 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.644 -0.66 . . . . 2.48 109.744 178.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.544 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -93.78 -50.29 5.43 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.253 -0.904 . . . . 2.27 110.868 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.574 ' HG2' ' HA ' ' A' ' 67' ' ' TYR . 5.0 pttt -70.68 -36.22 73.21 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.267 -0.896 . . . . 1.81 111.225 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.449 ' N ' ' HD2' ' A' ' 72' ' ' PRO . . . -46.6 -61.67 4.08 Favored Glycine 0 N--CA 1.498 2.83 0 N-CA-C 109.277 -1.529 . . . . 1.58 109.277 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.497 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 41.5 Cg_endo -67.23 -42.48 7.64 Favored 'Trans proline' 0 C--N 1.314 -1.242 0 O-C-N 124.039 1.547 . . . . 2.28 110.102 178.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.544 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -56.71 -44.54 81.66 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.959 -1.088 . . . . 2.73 109.815 178.876 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.404 ' HA ' ' HG2' ' A' ' 77' ' ' LYS . 25.0 t -71.05 -49.07 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.479 -0.763 . . . . 1.89 109.387 178.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 0.6 OUTLIER -55.26 -39.04 69.33 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.746 -0.596 . . . . 2.18 110.078 179.31 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.497 ' HD2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -68.37 -55.04 13.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.482 -0.761 . . . . 2.94 109.434 178.774 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.626 ' HG3' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -59.91 -31.27 69.67 Favored 'General case' 0 N--CA 1.505 2.282 0 C-N-CA 119.446 -0.902 . . . . 3.29 110.281 179.592 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.626 ' N ' ' HG3' ' A' ' 77' ' ' LYS . . . -71.13 -41.9 69.91 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.559 -0.713 . . . . 2.23 109.601 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 32.5 mttp -73.74 -34.58 64.82 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.441 -0.577 . . . . 2.74 109.441 178.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 71.6 mt . . . . . 0 N--CA 1.496 1.844 0 O-C-N 120.987 -1.071 . . . . 3.73 110.131 179.379 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 36.5 t . . . . . 0 N--CA 1.5 2.044 0 N-CA-C 109.347 -0.612 . . . . 1.31 109.347 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.7 t -62.81 -46.0 97.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.567 -0.708 . . . . 1.3 109.159 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 65.6 m -56.64 -46.66 80.9 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 121.206 0.527 . . . . 1.1 109.692 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.415 ' H ' HG23 ' A' ' 17' ' ' VAL . 2.6 t -65.25 -40.71 89.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 C-N-CA 119.695 -0.802 . . . . 0.99 109.175 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.4 mm -60.98 -40.13 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.122 -0.986 . . . . 1.24 109.039 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 49.7 t -65.58 -45.58 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.181 -1.044 . . . . 1.01 108.181 177.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 85.8 mt -61.28 -49.53 84.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.915 -0.772 . . . . 1.01 108.915 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 11.2 mt -57.71 -48.7 78.84 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.987 -0.746 . . . . 1.14 108.987 178.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.3 mt -56.95 -44.01 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 C-N-CA 119.845 -0.742 . . . . 1.17 109.195 178.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.36 -45.99 88.6 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.599 -0.688 . . . . 0.94 109.752 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.5 mt -59.2 -47.26 90.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.327 -0.858 . . . . 1.02 108.984 178.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.0 -44.95 95.64 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.591 -0.693 . . . . 0.95 109.849 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.97 -44.71 96.93 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.54 -0.725 . . . . 1.08 109.237 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.56 -45.92 90.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.44 -0.788 . . . . 1.36 108.924 178.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.47 -43.98 95.6 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 108.69 -1.764 . . . . 1.01 108.69 178.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.68 -45.13 84.03 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.611 -0.935 . . . . 1.1 109.748 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.0 mt -58.52 -41.43 85.44 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.758 -0.589 . . . . 1.57 109.426 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 40.8 mt -69.32 -48.08 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.54 -0.725 . . . . 1.4 109.478 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.83 -49.8 75.45 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.585 -0.697 . . . . 1.85 110.189 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.747 0 N-CA-C 110.452 -1.059 . . . . 1.26 110.452 -179.948 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.441 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 2.0 tt0 . . . . . 0 N--CA 1.499 1.979 0 N-CA-C 109.35 -0.611 . . . . 1.52 109.35 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.542 ' HA ' ' HG2' ' A' ' 70' ' ' LYS . 0.5 OUTLIER -68.84 -41.77 78.08 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.885 -0.783 . . . . 3.16 108.885 178.201 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 68.4 m -60.33 -37.89 82.03 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 116.19 -0.459 . . . . 1.82 110.375 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.62 -41.58 16.23 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.278 -0.889 . . . . 1.4 110.726 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.625 ' HA ' ' HB3' ' A' ' 73' ' ' CYS . 0.2 OUTLIER -65.82 -35.08 79.67 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.38 -0.825 . . . . 1.08 111.5 -179.59 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.435 ' N ' ' HD2' ' A' ' 72' ' ' PRO . . . -48.97 -61.36 5.37 Favored Glycine 0 N--CA 1.505 3.259 0 N-CA-C 109.715 -1.354 . . . . 1.19 109.715 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 71' ' ' GLY . 40.9 Cg_endo -66.97 -39.54 13.78 Favored 'Trans proline' 0 C--N 1.315 -1.225 0 O-C-N 123.755 1.397 . . . . 1.52 109.864 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.625 ' HB3' ' HA ' ' A' ' 70' ' ' LYS . 2.6 t -62.17 -48.5 79.78 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.878 -1.139 . . . . 1.31 109.609 178.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.7 ' HA ' ' HE3' ' A' ' 77' ' ' LYS . 25.4 t -57.98 -49.93 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.286 -1.005 . . . . 1.06 108.286 178.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -57.47 -40.05 77.7 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.763 -0.775 . . . . 1.58 109.318 177.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.9 ttm180 -63.78 -54.88 28.21 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.694 -0.629 . . . . 1.51 111.187 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.7 ' HE3' ' HA ' ' A' ' 74' ' ' VAL . 1.6 pttt -70.62 -33.12 70.68 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.02 -1.05 . . . . 1.75 110.605 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.405 ' N ' ' HG3' ' A' ' 77' ' ' LYS . . . -68.07 -47.77 67.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.327 -0.858 . . . . 1.51 109.636 178.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 16.4 mmtm -67.23 -44.53 79.26 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.377 -0.827 . . . . 1.79 109.805 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 tp . . . . . 0 N--CA 1.495 1.785 0 O-C-N 121.628 -0.67 . . . . 2.56 111.155 179.868 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.468 ' O ' HG23 ' A' ' 18' ' ' ILE . 37.9 t . . . . . 0 N--CA 1.498 1.964 0 N-CA-C 109.289 -0.634 . . . . 1.63 109.289 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.637 ' HA ' HG12 ' A' ' 18' ' ' ILE . 25.0 t -67.09 -37.73 79.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.326 -0.859 . . . . 1.59 109.468 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 98.4 m -64.61 -44.07 91.74 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.377 -0.827 . . . . 2.0 110.29 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.481 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 0.5 OUTLIER -71.48 -37.39 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 C-N-CA 119.133 -1.027 . . . . 1.98 110.908 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.777 ' HA ' HD23 ' A' ' 21' ' ' LEU . 8.7 pt -69.19 -33.74 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 120.299 -1.501 . . . . 1.92 109.52 178.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.501 ' N ' HG13 ' A' ' 18' ' ' ILE . 38.6 t -69.63 -44.3 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.287 -1.005 . . . . 1.57 108.287 177.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.6 mm -63.52 -46.78 94.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.401 -0.812 . . . . 1.7 109.027 178.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.777 HD23 ' HA ' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -63.28 -43.47 97.82 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.515 -0.74 . . . . 1.71 109.031 178.811 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.569 ' N ' ' HG ' ' A' ' 21' ' ' LEU . 7.5 mm -62.14 -39.07 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.029 -1.044 . . . . 1.84 109.0 178.218 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.29 -51.0 61.74 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.549 -0.719 . . . . 1.45 110.715 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.605 HG12 ' HA ' ' A' ' 21' ' ' LEU . 40.8 pt -62.36 -37.12 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.807 -1.183 . . . . 1.78 109.266 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.514 ' N ' HG13 ' A' ' 24' ' ' ILE . . . -65.15 -46.59 80.27 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.418 -0.801 . . . . 1.54 109.192 178.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.6 -43.08 99.53 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.697 -0.853 . . . . 1.52 108.697 178.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.3 tt -60.38 -48.17 82.91 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.953 -0.758 . . . . 1.68 108.953 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.72 -46.58 92.07 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 108.839 -1.705 . . . . 1.34 108.839 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.69 -42.98 99.66 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.456 -1.026 . . . . 1.54 109.558 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.4 mt -61.2 -41.3 96.58 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 109.085 -0.709 . . . . 1.83 109.085 178.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 23.5 mm -65.35 -46.14 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.519 -0.738 . . . . 1.43 109.142 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.18 -48.61 80.77 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.543 -0.723 . . . . 1.97 109.63 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.605 0 N-CA-C 110.017 -1.233 . . . . 1.42 110.017 179.221 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.422 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 6.0 tt0 . . . . . 0 N--CA 1.496 1.863 0 N-CA-C 108.758 -0.83 . . . . 2.42 108.758 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.445 ' HA ' ' HG2' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -74.44 -45.8 44.0 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 109.259 -0.645 . . . . 4.16 109.259 178.106 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 69.9 m -59.21 -37.09 76.6 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.748 -0.595 . . . . 2.42 110.488 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -84.68 -46.48 11.43 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.054 -1.028 . . . . 1.61 111.243 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.445 ' HG2' ' HA ' ' A' ' 67' ' ' TYR . 12.3 ptpt -65.17 -35.66 81.78 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.338 -0.851 . . . . 2.37 111.213 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.401 ' N ' ' HD2' ' A' ' 72' ' ' PRO . . . -49.07 -64.22 3.44 Favored Glycine 0 N--CA 1.502 3.068 0 N-CA-C 109.795 -1.322 . . . . 1.46 109.795 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.401 ' HD2' ' N ' ' A' ' 71' ' ' GLY . 40.3 Cg_endo -66.11 -37.15 26.5 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.734 1.386 . . . . 1.47 110.245 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 2.5 t -62.41 -46.04 90.39 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.039 -1.038 . . . . 1.41 109.593 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.5 t -68.66 -47.41 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.561 -0.712 . . . . 1.4 109.311 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -57.41 -40.59 78.61 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 119.799 -0.76 . . . . 1.5 109.405 178.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.421 ' HA ' ' HG2' ' A' ' 79' ' ' LYS . 3.8 ttm180 -65.11 -44.22 89.47 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.53 -0.731 . . . . 2.53 109.473 178.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.83 -38.7 89.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -0.871 . . . . 2.65 109.786 178.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.04 -50.71 53.59 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.377 0.608 . . . . 1.15 110.087 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.421 ' HG2' ' HA ' ' A' ' 76' ' ' ARG . 0.3 OUTLIER -65.64 -30.8 71.56 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.693 -0.63 . . . . 1.56 110.109 179.469 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.8 0 O-C-N 121.245 -0.909 . . . . 2.33 109.881 178.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 72.1 t . . . . . 0 N--CA 1.502 2.153 0 CA-C-O 121.417 0.627 . . . . 2.7 110.16 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.404 ' H ' HG22 ' A' ' 15' ' ' VAL . 17.2 m -71.89 -42.42 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.2 -0.938 . . . . 3.48 109.847 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 56.7 m -58.22 -50.65 72.82 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.554 -0.717 . . . . 3.42 110.175 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.4 m -66.03 -39.63 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.45 -0.781 . . . . 2.39 110.104 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.563 ' O ' HG12 ' A' ' 22' ' ' ILE . 10.9 mm -64.98 -43.52 96.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 O-C-N 120.994 -1.066 . . . . 2.31 109.445 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.518 ' HA ' HG12 ' A' ' 22' ' ' ILE . 32.2 t -61.78 -40.43 86.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 119.743 -0.783 . . . . 2.96 108.955 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 27.4 mm -69.43 -41.24 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.26 -0.9 . . . . 2.61 108.746 178.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 39.6 mt -61.99 -50.62 71.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.712 -0.617 . . . . 1.59 109.491 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.563 HG12 ' O ' ' A' ' 18' ' ' ILE . 43.5 pt -61.99 -41.16 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 120.815 -1.178 . . . . 2.53 109.409 178.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.551 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -60.27 -45.86 91.85 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.04 -0.726 . . . . 1.99 109.04 178.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 39.0 mt -59.27 -48.26 87.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.689 -0.856 . . . . 1.52 108.689 178.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.98 -42.5 94.32 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.697 -0.627 . . . . 1.28 109.878 178.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.84 -45.53 92.17 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.922 -0.769 . . . . 1.79 108.922 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.68 -45.55 93.51 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.806 -0.813 . . . . 1.53 108.806 178.025 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.84 -45.54 94.84 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 108.54 -1.824 . . . . 1.13 108.54 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.5 -44.73 95.67 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.507 -0.996 . . . . 1.63 109.36 178.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.3 mt -56.78 -42.87 80.19 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.088 -0.708 . . . . 1.98 109.088 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.8 mt -68.83 -49.18 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 109.07 -0.715 . . . . 1.25 109.07 178.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.83 -46.05 71.07 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.496 -0.753 . . . . 3.01 109.527 178.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.65 0 N-CA-C 109.925 -1.27 . . . . 1.84 109.925 179.066 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.459 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 6.5 tp-100 . . . . . 0 N--CA 1.495 1.776 0 N-CA-C 108.918 -0.771 . . . . 2.38 108.918 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -62.71 -42.45 99.66 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.518 -0.738 . . . . 2.52 109.459 178.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.2 m -56.72 -35.48 68.6 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-O 120.928 0.394 . . . . 2.5 110.703 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -91.69 -41.66 10.59 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.22 -0.925 . . . . 2.49 110.601 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 66' ' ' GLN . 1.6 mmtp -65.23 -44.3 88.69 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.528 -0.733 . . . . 2.56 110.392 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.404 ' N ' ' HD2' ' A' ' 72' ' ' PRO . . . -45.58 -63.68 2.67 Favored Glycine 0 N--CA 1.503 3.109 0 N-CA-C 110.22 -1.152 . . . . 1.86 110.22 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' A' ' 71' ' ' GLY . 42.2 Cg_endo -66.65 -39.08 16.56 Favored 'Trans proline' 0 C--N 1.316 -1.18 0 O-C-N 123.783 1.412 . . . . 2.46 110.419 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 36.7 t -60.64 -43.9 97.02 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.997 -1.064 . . . . 2.78 109.679 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.8 t -70.46 -49.42 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.682 -0.636 . . . . 1.92 109.424 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.21 -31.21 68.83 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.536 0.684 . . . . 2.39 110.3 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -75.28 -49.02 20.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.356 -0.84 . . . . 4.17 109.542 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.535 ' HG3' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -69.25 -26.95 65.04 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.364 -0.835 . . . . 3.47 109.662 179.237 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.535 ' N ' ' HG3' ' A' ' 77' ' ' LYS . . . -71.91 -52.28 18.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.451 -0.781 . . . . 2.09 108.946 178.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -68.45 -24.74 64.76 Favored 'General case' 0 N--CA 1.5 2.067 0 C-N-CA 120.48 -0.488 . . . . 2.38 110.312 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.5 tp . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.23 -0.918 . . . . 3.77 109.53 178.949 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.561 ' O ' HG12 ' A' ' 18' ' ' ILE . 28.1 t . . . . . 0 N--CA 1.497 1.883 0 N-CA-C 109.222 -0.658 . . . . 1.41 109.222 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.603 ' HA ' HG12 ' A' ' 18' ' ' ILE . 49.8 t -68.25 -41.38 83.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.261 -0.899 . . . . 1.3 109.528 178.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 52.9 m -60.51 -47.5 85.9 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.403 -0.81 . . . . 1.9 109.785 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.431 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 32.6 m -67.54 -41.65 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.465 -0.772 . . . . 1.77 111.272 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.872 ' HA ' HD23 ' A' ' 21' ' ' LEU . 4.0 pt -68.57 -33.56 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 120.292 -1.505 . . . . 1.28 109.925 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.486 ' N ' HG13 ' A' ' 18' ' ' ILE . 17.7 t -68.44 -44.39 83.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.24 -1.022 . . . . 1.38 108.24 177.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 69.5 mt -63.69 -49.23 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 108.843 -0.799 . . . . 2.03 108.843 178.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.872 HD23 ' HA ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -60.71 -42.66 97.7 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 119.926 -0.71 . . . . 1.62 109.106 178.698 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.564 ' N ' ' HG ' ' A' ' 21' ' ' LEU . 14.9 mt -61.24 -44.13 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.226 -0.921 . . . . 1.18 109.131 178.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.9 -45.74 87.94 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.514 -0.741 . . . . 1.23 109.593 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 54.6 mt -58.79 -47.77 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.437 -0.789 . . . . 2.07 108.993 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.95 -44.83 95.94 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.561 -0.712 . . . . 1.32 109.935 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.57 -45.64 93.17 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 109.149 -0.685 . . . . 0.92 109.149 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.35 -45.96 92.2 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.488 -0.758 . . . . 1.92 108.978 178.26 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.22 -45.35 94.2 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 108.617 -1.793 . . . . 1.4 108.617 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.25 -44.94 93.77 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.639 -0.918 . . . . 1.22 109.888 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.7 mt -58.82 -41.28 86.49 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.618 -0.676 . . . . 1.56 109.516 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 53.2 mt -68.22 -47.0 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.272 -0.893 . . . . 1.74 109.305 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.71 -39.37 93.81 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.358 -0.839 . . . . 2.18 110.42 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.781 0 O-C-N 120.948 -1.095 . . . . 1.26 111.142 -179.658 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.484 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.812 0 N-CA-C 108.475 -0.935 . . . . 1.27 108.475 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -62.77 -41.45 99.23 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.586 -0.696 . . . . 3.01 109.473 178.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 63.7 m -60.39 -37.56 81.2 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 122.035 -0.416 . . . . 1.5 110.308 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.499 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -81.58 -39.82 23.98 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.163 -0.961 . . . . 1.05 110.221 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 66' ' ' GLN . 2.6 mmpp? -61.57 -42.63 99.12 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.577 -0.702 . . . . 1.06 110.54 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -43.09 -66.23 1.23 Allowed Glycine 0 N--CA 1.505 3.244 0 N-CA-C 110.526 -1.03 . . . . 0.83 110.526 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.49 ' HA ' ' HB3' ' A' ' 75' ' ' GLU . 40.5 Cg_endo -66.32 -38.73 19.54 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.753 1.396 . . . . 1.03 110.235 179.248 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.499 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -58.38 -44.82 89.07 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.039 -1.038 . . . . 1.55 109.487 178.495 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 69.6 t -74.39 -41.76 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.55 -0.718 . . . . 0.74 109.233 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.49 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 1.0 OUTLIER -54.75 -46.12 74.27 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 121.529 0.681 . . . . 1.06 109.474 178.532 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -69.09 -46.35 67.99 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.719 -0.613 . . . . 1.09 110.124 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.13 -36.29 79.36 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.531 -0.73 . . . . 1.63 110.099 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.25 -46.65 73.11 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.972 -0.751 . . . . 1.08 108.972 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 35.0 mtpt -62.48 -37.37 85.69 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.206 0.527 . . . . 1.31 110.559 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.2 tp . . . . . 0 N--CA 1.496 1.862 0 O-C-N 121.607 -0.683 . . . . 1.93 112.11 -178.683 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.541 ' O ' HG23 ' A' ' 18' ' ' ILE . 33.4 t . . . . . 0 N--CA 1.496 1.871 0 N-CA-C 109.265 -0.643 . . . . 2.11 109.265 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.635 ' O ' HG22 ' A' ' 19' ' ' VAL . 33.9 t -68.21 -47.4 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.175 -0.953 . . . . 2.54 110.123 179.01 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.3 p -60.1 -37.98 81.58 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.522 -0.736 . . . . 2.35 110.987 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.0 m -76.11 -37.71 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 120.946 -1.096 . . . . 1.75 111.095 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.541 HG23 ' O ' ' A' ' 14' ' ' VAL . 45.1 pt -70.54 -38.89 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.465 -1.397 . . . . 2.46 110.234 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.635 HG22 ' O ' ' A' ' 15' ' ' VAL . 33.7 m -68.95 -39.98 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 120.887 -1.133 . . . . 2.49 108.755 178.181 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.446 HD13 ' HA ' ' A' ' 20' ' ' ILE . 14.6 mm -65.99 -47.32 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.037 -1.039 . . . . 2.26 108.669 177.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.7 mt -59.09 -48.69 80.7 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.841 -0.8 . . . . 2.1 108.841 178.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.1 mt -56.65 -43.79 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.578 -0.702 . . . . 2.64 109.273 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.57 -46.0 87.88 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.621 -0.674 . . . . 2.2 109.779 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 71.0 mt -59.62 -46.67 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.356 -0.84 . . . . 1.94 108.893 178.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.65 -43.81 97.86 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.543 -0.723 . . . . 2.18 109.869 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.67 -44.29 96.62 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.532 -0.73 . . . . 2.43 109.141 178.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.2 tt -62.23 -45.94 91.1 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.839 -0.8 . . . . 2.34 108.839 178.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.45 -46.03 93.64 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 108.694 -1.762 . . . . 2.12 108.694 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.41 -43.6 97.06 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.504 -0.998 . . . . 2.48 109.915 179.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.6 mt -59.46 -41.08 88.87 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.595 -0.691 . . . . 2.92 109.613 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 17.7 mt -70.1 -45.73 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.303 -0.873 . . . . 2.27 109.546 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -50.25 74.22 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.668 -0.645 . . . . 2.8 110.01 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.753 0 N-CA-C 109.817 -1.313 . . . . 2.6 109.817 179.522 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.469 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 5.3 tt0 . . . . . 0 N--CA 1.495 1.793 0 N-CA-C 108.834 -0.802 . . . . 3.46 108.834 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.711 ' HA ' ' HG2' ' A' ' 70' ' ' LYS . 6.9 m-85 -69.12 -40.91 78.03 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.712 -0.617 . . . . 3.92 109.877 178.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.93 -37.88 86.34 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.626 -0.671 . . . . 3.11 110.194 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.549 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -83.02 -41.99 18.03 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.289 -0.882 . . . . 2.36 109.836 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.711 ' HG2' ' HA ' ' A' ' 67' ' ' TYR . 8.1 ptpt -65.78 -35.48 80.82 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.538 -0.726 . . . . 2.72 110.652 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 70' ' ' LYS . . . -43.52 -64.21 1.9 Allowed Glycine 0 N--CA 1.501 2.996 0 N-CA-C 109.384 -1.486 . . . . 2.05 109.384 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.628 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 43.2 Cg_endo -69.44 -45.54 1.72 Allowed 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.963 1.507 . . . . 2.44 110.054 178.014 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.549 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -55.29 -42.58 73.82 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 120.942 -1.098 . . . . 2.3 110.11 179.281 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.529 ' HA ' ' HG2' ' A' ' 77' ' ' LYS . 56.0 t -73.59 -45.21 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.831 -0.803 . . . . 1.72 108.831 178.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.585 ' HG2' ' HD2' ' A' ' 79' ' ' LYS . 1.6 tt0 -51.34 -45.19 62.24 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.872 0.844 . . . . 3.28 108.902 177.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.628 ' HD2' ' O ' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -73.55 -49.32 27.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.847 -0.533 . . . . 3.72 110.868 179.447 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.529 ' HG2' ' HA ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -66.82 -19.24 65.7 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.803 -1.185 . . . . 2.73 110.89 179.757 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -86.58 -39.96 15.66 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.775 -0.824 . . . . 2.37 108.775 179.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.585 ' HD2' ' HG2' ' A' ' 75' ' ' GLU . 13.3 mttt -68.29 -37.79 81.02 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.222 -1.029 . . . . 3.64 108.222 177.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.9 tp . . . . . 0 N--CA 1.487 1.419 0 O-C-N 121.924 -0.485 . . . . 3.86 110.494 179.384 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.583 ' O ' HG12 ' A' ' 18' ' ' ILE . 26.0 t . . . . . 0 N--CA 1.496 1.843 0 N-CA-C 109.265 -0.643 . . . . 2.82 109.265 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.662 ' HA ' HG12 ' A' ' 18' ' ' ILE . 16.5 t -70.45 -41.97 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.231 -0.918 . . . . 2.25 109.116 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.49 ' O ' HG12 ' A' ' 20' ' ' ILE . 40.7 m -57.16 -49.68 75.19 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.439 -0.788 . . . . 3.15 109.642 178.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.628 ' HA ' HG12 ' A' ' 20' ' ' ILE . 35.8 m -66.82 -44.04 89.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 C-N-CA 119.814 -0.754 . . . . 2.82 111.424 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.662 HG12 ' HA ' ' A' ' 15' ' ' VAL . 5.1 pt -66.14 -30.01 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 120.236 -1.54 . . . . 1.92 109.679 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.458 ' N ' HG13 ' A' ' 18' ' ' ILE . 8.3 t -70.59 -51.82 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.233 -0.917 . . . . 2.42 108.829 178.186 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.628 HG12 ' HA ' ' A' ' 17' ' ' VAL . 30.1 pt -64.46 -36.27 76.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.028 -1.045 . . . . 2.76 109.173 178.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.486 ' N ' HG13 ' A' ' 20' ' ' ILE . 13.0 mt -66.32 -47.22 74.25 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.378 -0.826 . . . . 2.07 108.831 177.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.44 HD13 ' HA ' ' A' ' 22' ' ' ILE . 7.3 mm -60.8 -41.35 88.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 108.724 -0.843 . . . . 2.04 108.724 178.111 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.53 -46.08 84.38 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.749 -0.595 . . . . 2.42 109.454 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 43.5 mt -61.14 -45.12 99.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.344 -0.848 . . . . 2.39 108.81 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.82 -44.87 91.95 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.519 -0.738 . . . . 2.14 109.671 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.28 -41.55 98.58 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.722 -0.844 . . . . 2.62 108.722 178.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.662 HD13 ' C ' ' A' ' 27' ' ' LEU . 3.2 tm? -61.91 -52.52 63.74 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.478 -0.934 . . . . 3.05 108.478 177.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.14 -43.96 83.71 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.166 -1.574 . . . . 2.34 109.166 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.29 -41.06 90.32 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.396 -1.061 . . . . 2.82 109.808 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.3 mt -62.38 -40.07 95.27 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.981 -0.748 . . . . 3.6 108.981 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.7 mm -71.05 -49.27 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.641 -0.662 . . . . 3.05 109.292 178.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.75 -46.09 84.98 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.542 -0.724 . . . . 2.97 109.616 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.666 0 N-CA-C 109.58 -1.408 . . . . 3.5 109.58 179.221 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.579 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 9.4 mm-40 . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 108.674 -0.862 . . . . 2.7 108.674 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -63.04 -41.36 99.48 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.404 -0.961 . . . . 2.08 108.404 178.02 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.536 ' O ' ' HD2' ' A' ' 72' ' ' PRO . 29.0 t -53.5 -42.63 67.53 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.496 -0.927 . . . . 1.68 108.496 178.48 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.05 -38.63 69.46 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 119.581 -0.848 . . . . 1.98 109.246 177.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.579 ' HG2' ' O ' ' A' ' 66' ' ' GLN . 4.6 mmtm -58.18 -52.34 65.97 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.425 -0.797 . . . . 2.43 110.245 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 70' ' ' LYS . . . -34.68 -68.38 0.23 Allowed Glycine 0 N--CA 1.51 3.602 0 N-CA-C 110.911 -0.876 . . . . 1.75 110.911 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.536 ' HD2' ' O ' ' A' ' 68' ' ' SER . 39.4 Cg_endo -66.51 -38.28 19.88 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.831 1.438 . . . . 2.86 110.219 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 34.3 t -61.99 -40.98 97.49 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.995 -1.065 . . . . 3.6 109.386 178.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 55.8 t -75.53 -48.22 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.655 -0.653 . . . . 3.09 109.511 178.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.4 ' OE2' ' NZ ' ' A' ' 79' ' ' LYS . 5.2 tm-20 -57.44 -41.26 80.15 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.575 -0.898 . . . . 3.24 108.575 178.151 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.471 ' HB3' ' O ' ' A' ' 72' ' ' PRO . 0.3 OUTLIER -65.53 -46.72 78.49 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.675 -0.64 . . . . 5.36 109.736 178.465 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.0 -39.52 94.29 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.134 -0.978 . . . . 5.4 109.703 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.83 -46.74 64.97 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.947 -0.471 . . . . 4.18 110.278 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 76' ' ' ARG . 0.1 OUTLIER -69.53 -38.88 77.7 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.608 -0.683 . . . . 4.81 109.48 179.353 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.495 1.789 0 O-C-N 121.441 -0.787 . . . . 5.97 109.256 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 51.1 t . . . . . 0 N--CA 1.499 1.989 0 N-CA-C 109.569 -0.53 . . . . 2.34 109.569 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.5 t -70.59 -43.15 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.073 -1.017 . . . . 2.05 109.394 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 87.7 m -59.32 -50.81 72.55 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.735 -0.603 . . . . 1.35 110.009 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.1 m -66.78 -34.9 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.489 -0.757 . . . . 1.62 110.156 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.416 ' HA ' HD13 ' A' ' 18' ' ' ILE . 6.7 mm -68.08 -41.21 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 120.907 -1.121 . . . . 2.24 109.632 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.4 t -64.89 -44.74 96.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 108.289 -1.004 . . . . 1.78 108.289 177.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 23.2 mm -61.82 -46.92 95.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.519 -0.738 . . . . 1.42 109.056 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 11.3 mt -60.6 -49.18 78.55 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.868 -0.79 . . . . 1.94 108.868 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.2 mt -56.62 -43.83 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 C-N-CA 119.837 -0.745 . . . . 2.14 109.387 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.27 -46.08 85.28 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.615 -0.678 . . . . 1.45 110.176 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 40.6 mt -59.22 -48.15 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 108.852 -0.795 . . . . 1.51 108.852 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.59 -45.18 95.21 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.747 -0.595 . . . . 1.76 110.159 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.63 -49.78 76.16 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 109.086 -0.709 . . . . 1.69 109.086 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.19 -46.12 86.36 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.016 -0.735 . . . . 1.44 109.016 178.131 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.87 -46.18 92.72 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.073 -1.611 . . . . 1.45 109.073 178.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.13 -42.6 96.77 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.59 -0.947 . . . . 1.76 109.963 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.8 mt -61.3 -41.2 96.58 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.16 -0.682 . . . . 1.79 109.16 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 95.3 mt -67.32 -51.84 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.467 -0.771 . . . . 1.83 109.154 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.94 -45.5 78.8 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.597 -0.689 . . . . 2.17 109.921 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.671 0 N-CA-C 109.813 -1.315 . . . . 1.76 109.813 179.547 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 . . . . . 0 N--CA 1.497 1.909 0 CA-C-O 121.499 0.666 . . . . 1.86 109.231 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -67.31 -40.14 85.99 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.751 -0.593 . . . . 2.05 109.868 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 71.1 m -60.47 -32.37 71.35 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.872 -0.517 . . . . 1.75 110.686 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -94.07 -51.05 5.02 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.264 -0.897 . . . . 1.51 110.528 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -56.42 -43.93 79.88 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.44 -0.787 . . . . 1.47 110.93 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -46.64 -64.76 2.47 Favored Glycine 0 N--CA 1.503 3.108 0 N-CA-C 110.507 -1.037 . . . . 1.26 110.507 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -66.46 -40.35 14.36 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.844 1.444 . . . . 1.31 110.303 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 34.3 t -59.31 -45.3 91.68 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.058 -1.026 . . . . 1.81 109.816 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.9 t -70.61 -46.17 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.545 -0.722 . . . . 1.69 109.182 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -55.77 -40.81 73.15 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 121.637 0.732 . . . . 2.17 109.751 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.53 -47.7 59.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.85 -0.531 . . . . 1.73 110.622 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.608 ' HG3' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -67.11 -31.3 71.68 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.997 -1.064 . . . . 2.64 110.057 179.573 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.608 ' N ' ' HG3' ' A' ' 77' ' ' LYS . . . -70.61 -47.84 58.09 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.173 -0.954 . . . . 2.14 109.351 179.276 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.419 ' HG3' ' N ' ' A' ' 80' ' ' LEU . 6.9 ptpt -71.15 -34.75 71.28 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.827 -0.749 . . . . 1.94 109.764 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.419 ' N ' ' HG3' ' A' ' 79' ' ' LYS . 0.8 OUTLIER . . . . . 0 N--CA 1.497 1.897 0 O-C-N 120.986 -1.071 . . . . 2.12 109.948 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.5 m . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 120.724 0.297 . . . . 2.83 110.273 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.403 ' O ' HG23 ' A' ' 19' ' ' VAL . 7.4 t -71.44 -48.32 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 120.945 -1.097 . . . . 4.06 110.075 179.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 16.6 p -60.04 -49.29 78.23 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.365 -0.834 . . . . 4.88 109.94 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.6 m -63.79 -36.97 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 C-N-CA 119.384 -0.926 . . . . 3.53 109.855 178.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.436 HD13 ' HA ' ' A' ' 18' ' ' ILE . 6.0 mm -67.93 -38.64 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 120.792 -1.192 . . . . 2.47 109.012 178.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 15' ' ' VAL . 51.0 t -65.84 -43.07 93.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.382 -0.969 . . . . 4.53 108.382 177.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 57.7 mt -63.87 -47.3 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 108.728 -0.842 . . . . 4.55 108.728 178.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 11.6 mt -59.37 -48.8 80.26 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.987 -0.745 . . . . 2.44 108.987 178.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.0 mt -56.33 -43.05 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 121.549 -0.719 . . . . 3.53 109.39 178.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.67 -45.47 78.79 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.461 -0.775 . . . . 3.86 110.072 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 33.0 mt -60.65 -45.7 97.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.226 -0.921 . . . . 3.09 109.264 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.95 -42.95 97.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.401 -0.812 . . . . 2.23 109.528 178.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.87 -42.58 97.49 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.368 -0.832 . . . . 3.65 109.176 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.906 ' HA ' HD23 ' A' ' 30' ' ' LEU . 0.5 OUTLIER -63.02 -46.14 89.03 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.453 -0.943 . . . . 4.13 108.453 178.025 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.509 ' O ' HD13 ' A' ' 32' ' ' LEU . . . -58.92 -47.5 90.3 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 108.425 -1.87 . . . . 2.3 108.425 178.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.94 -45.08 96.15 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.506 -0.997 . . . . 3.25 110.208 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.906 HD23 ' HA ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -63.3 -37.32 86.8 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.442 -0.786 . . . . 4.5 109.697 179.238 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.513 ' N ' ' HG ' ' A' ' 30' ' ' LEU . 48.0 mt -71.2 -47.29 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.084 -1.01 . . . . 3.1 109.185 178.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.509 HD13 ' O ' ' A' ' 28' ' ' GLY . 6.8 mp -57.83 -49.86 75.25 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.79 -0.569 . . . . 3.0 109.626 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.825 0 N-CA-C 110.199 -1.16 . . . . 4.16 110.199 179.529 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.465 ' O ' ' CG ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 108.865 -0.791 . . . . 2.17 108.865 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -68.25 -47.65 67.2 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.43 -0.794 . . . . 3.68 109.864 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 69.6 m -55.19 -34.36 63.82 Favored 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 119.767 -0.773 . . . . 1.76 110.171 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -88.25 -46.44 9.23 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.202 -0.937 . . . . 1.4 110.835 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.465 ' CG ' ' O ' ' A' ' 66' ' ' GLN . 2.6 mmtp -64.56 -40.18 95.1 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.418 -0.801 . . . . 2.03 110.76 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -47.01 -64.88 2.5 Favored Glycine 0 N--CA 1.505 3.273 0 N-CA-C 110.006 -1.237 . . . . 2.17 110.006 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.59 -37.93 20.53 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 O-C-N 123.714 1.376 . . . . 1.98 110.379 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 5.0 t -62.71 -42.87 99.87 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.979 -1.076 . . . . 2.49 109.36 178.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.2 t -69.68 -44.77 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 109.048 -0.723 . . . . 3.05 109.048 178.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.48 ' HG3' ' N ' ' A' ' 76' ' ' ARG . 0.1 OUTLIER -59.15 -42.26 90.26 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.889 -0.782 . . . . 2.98 108.889 178.42 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.48 ' N ' ' HG3' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -64.0 -53.05 56.06 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.628 -0.67 . . . . 3.21 109.597 178.776 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.88 -48.28 81.95 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.674 -0.641 . . . . 3.88 109.95 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.47 -44.03 96.32 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.805 -0.56 . . . . 4.19 110.788 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.42 ' HG3' ' CD ' ' A' ' 75' ' ' GLU . 12.6 mmtp -68.75 -42.91 76.87 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.164 -0.96 . . . . 4.13 109.306 179.091 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.8 tp . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.447 0.641 . . . . 4.64 109.84 178.839 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.3 t . . . . . 0 N--CA 1.501 2.075 0 CA-C-O 121.278 0.561 . . . . 1.09 109.592 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.8 t -69.64 -43.42 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.107 -0.995 . . . . 1.25 108.981 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 49.3 m -56.69 -51.34 69.17 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.577 -0.702 . . . . 0.9 109.939 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.629 ' HA ' HG12 ' A' ' 20' ' ' ILE . 35.2 m -64.75 -39.13 84.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.526 -0.734 . . . . 0.82 110.278 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.411 HD13 ' HA ' ' A' ' 18' ' ' ILE . 6.7 mm -65.01 -36.72 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 120.819 -1.176 . . . . 1.07 109.569 178.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.1 t -66.31 -52.44 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 C-N-CA 119.689 -0.805 . . . . 1.03 109.135 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.629 HG12 ' HA ' ' A' ' 17' ' ' VAL . 27.1 pt -63.74 -36.5 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.114 -0.991 . . . . 1.0 109.38 178.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.516 ' N ' HG13 ' A' ' 20' ' ' ILE . 7.6 mt -64.27 -48.58 75.17 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.596 -0.89 . . . . 0.89 108.596 177.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.415 HD13 ' HA ' ' A' ' 22' ' ' ILE . 10.5 mm -59.04 -44.5 91.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.483 -0.76 . . . . 1.09 109.071 178.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.21 -44.9 95.53 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.625 -0.672 . . . . 0.8 109.908 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 44.5 mt -61.66 -46.51 96.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.403 -0.811 . . . . 0.82 108.825 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.93 -44.11 97.45 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.648 -0.658 . . . . 0.77 109.68 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.92 -45.41 93.82 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.423 -0.798 . . . . 0.81 109.152 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.73 ' HA ' HD23 ' A' ' 30' ' ' LEU . 0.5 OUTLIER -61.46 -46.67 89.07 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.042 -0.725 . . . . 1.0 109.042 178.269 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.45 -43.33 97.56 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 108.874 -1.69 . . . . 0.6 108.874 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.14 -43.96 93.63 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.492 -1.005 . . . . 0.79 110.009 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.73 HD23 ' HA ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -62.84 -37.6 87.45 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.56 -0.712 . . . . 0.97 109.272 178.904 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.511 ' N ' ' HG ' ' A' ' 30' ' ' LEU . 61.2 mt -71.62 -48.67 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.298 -0.876 . . . . 0.79 108.972 178.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.01 -46.32 85.44 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.656 -0.652 . . . . 1.07 109.774 178.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.659 0 N-CA-C 109.689 -1.364 . . . . 1.19 109.689 179.343 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.451 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.969 0 N-CA-C 109.346 -0.613 . . . . 1.49 109.346 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.49 ' HA ' ' HG2' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -66.64 -41.93 87.48 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.617 -0.677 . . . . 0.75 109.381 178.482 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.7 m -56.82 -38.17 72.25 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.803 -0.561 . . . . 1.08 109.744 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -82.38 -38.58 23.94 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.409 -0.807 . . . . 0.98 110.235 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.49 ' HG2' ' HA ' ' A' ' 67' ' ' TYR . 5.5 ptpt -62.59 -37.52 86.58 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.476 -0.765 . . . . 0.78 110.49 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -47.5 -63.94 3.13 Favored Glycine 0 N--CA 1.503 3.145 0 N-CA-C 110.452 -1.059 . . . . 0.82 110.452 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.31 -38.7 19.71 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 123.673 1.354 . . . . 1.15 110.099 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 7.5 t -62.15 -47.67 83.5 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.175 -0.953 . . . . 1.33 109.9 178.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 45.7 t -66.27 -44.04 91.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.547 -0.721 . . . . 0.93 109.326 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -56.8 -42.35 79.37 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 108.732 -0.84 . . . . 1.35 108.732 178.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.419 ' NH2' ' HG2' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -62.94 -55.76 23.12 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.551 0.691 . . . . 2.63 109.859 178.78 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.94 -54.59 44.93 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.362 0.601 . . . . 2.82 110.754 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -53.09 -45.35 68.15 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.836 -0.54 . . . . 1.11 111.056 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.3 mttp -72.56 -41.54 65.64 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.497 -0.752 . . . . 1.79 110.748 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.4 tp . . . . . 0 N--CA 1.497 1.887 0 O-C-N 121.245 -0.909 . . . . 2.24 111.315 -179.534 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.9 m . . . . . 0 N--CA 1.496 1.83 0 CA-C-O 120.803 0.335 . . . . 4.17 110.111 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.9 t -68.76 -41.41 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 120.997 -1.064 . . . . 3.91 109.253 178.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 52.5 m -59.98 -52.19 66.44 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.709 -0.62 . . . . 3.6 109.966 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.46 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 31.2 m -65.45 -34.6 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.536 -0.728 . . . . 3.63 110.176 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.724 ' HA ' HD23 ' A' ' 21' ' ' LEU . 21.7 mt -68.73 -41.38 82.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.093 -1.004 . . . . 3.83 109.216 178.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.5 t -64.41 -42.19 94.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.489 -0.93 . . . . 3.35 108.489 177.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 83.3 mt -64.38 -48.97 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.525 -0.734 . . . . 3.3 109.272 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.724 HD23 ' HA ' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -61.39 -43.23 99.23 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.675 -0.861 . . . . 3.43 108.675 178.788 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.595 ' N ' ' HG ' ' A' ' 21' ' ' LEU . 15.0 mt -60.33 -44.92 96.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.319 -0.863 . . . . 3.31 109.148 178.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.97 -46.03 86.48 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.724 -0.61 . . . . 2.81 109.731 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.3 mm -59.39 -45.6 93.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.41 -0.806 . . . . 2.86 109.146 178.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.78 -45.86 87.84 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.525 -0.734 . . . . 2.86 109.771 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.8 -41.89 96.51 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.732 -0.84 . . . . 2.61 108.732 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.664 ' C ' HD13 ' A' ' 27' ' ' LEU . 3.4 tm? -60.65 -53.49 56.75 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.899 -0.778 . . . . 2.46 108.899 178.101 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.62 -43.74 86.08 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 108.905 -1.678 . . . . 2.35 108.905 178.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.65 -44.65 95.73 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.414 -1.051 . . . . 2.5 109.74 178.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.4 mt -59.08 -41.17 87.37 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.649 -0.657 . . . . 2.49 109.481 178.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.7 mt -69.45 -40.93 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.544 -0.723 . . . . 2.31 109.658 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.29 -42.76 87.89 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.548 -0.72 . . . . 3.29 110.264 178.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.723 0 O-C-N 120.883 -1.135 . . . . 2.16 110.57 -179.802 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.539 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 5.2 mm-40 . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.008 -0.738 . . . . 3.68 109.008 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -65.51 -41.22 93.41 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.324 -0.621 . . . . 2.92 109.324 178.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.448 ' O ' ' CD ' ' A' ' 72' ' ' PRO . 63.5 m -55.38 -33.34 63.38 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 109.14 -0.689 . . . . 2.93 109.14 178.275 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.503 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -80.73 -40.57 25.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.646 -0.659 . . . . 3.34 109.393 178.438 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.539 ' HG2' ' O ' ' A' ' 66' ' ' GLN . 5.6 mmtm -58.97 -51.75 68.7 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.563 -0.71 . . . . 3.58 110.739 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -39.69 -64.87 0.96 Allowed Glycine 0 N--CA 1.505 3.294 0 N-CA-C 110.922 -0.871 . . . . 3.16 110.922 -179.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.572 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 39.6 Cg_endo -65.53 -39.42 21.59 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 O-C-N 123.834 1.439 . . . . 3.85 110.651 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 0.9 OUTLIER -63.44 -44.94 93.07 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.083 -1.01 . . . . 4.25 109.627 179.007 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.41 ' O ' ' HG3' ' A' ' 77' ' ' LYS . 41.4 t -67.17 -47.31 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.711 -0.848 . . . . 3.78 108.711 178.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -58.03 -39.29 78.01 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.515 0.674 . . . . 4.37 109.332 178.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.572 ' HB2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -63.69 -64.26 0.95 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.749 -0.595 . . . . 4.79 110.389 178.902 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.465 ' HG3' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -59.57 -31.82 69.79 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 120.053 -0.659 . . . . 4.67 110.864 -179.46 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.465 ' N ' ' HG3' ' A' ' 77' ' ' LYS . . . -65.26 -43.25 91.89 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.183 -0.948 . . . . 4.37 108.972 178.148 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.1 mttt -72.26 -49.91 31.34 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.173 -0.677 . . . . 4.97 109.173 178.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.815 0 CA-C-O 121.348 0.594 . . . . 6.13 110.204 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.424 ' HA ' ' CG2' ' A' ' 17' ' ' VAL . 31.2 m . . . . . 0 N--CA 1.496 1.867 0 N-CA-C 110.026 -0.361 . . . . 1.37 110.026 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.0 t -68.54 -45.83 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.126 -0.984 . . . . 1.94 109.312 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 51.7 m -57.94 -51.37 69.93 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.717 -0.614 . . . . 1.75 109.943 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.424 ' CG2' ' HA ' ' A' ' 14' ' ' VAL . 25.4 m -64.77 -35.59 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.437 -0.789 . . . . 1.27 110.138 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.413 ' HA ' HD13 ' A' ' 18' ' ' ILE . 6.6 mm -67.98 -41.2 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 121.034 -1.041 . . . . 1.82 109.19 178.489 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 37.8 t -65.1 -44.58 95.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.466 -0.939 . . . . 2.0 108.466 178.05 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.429 HD13 ' HA ' ' A' ' 20' ' ' ILE . 21.7 mm -62.41 -46.98 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 108.99 -0.745 . . . . 1.55 108.99 178.26 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 11.4 mt -59.88 -49.4 77.85 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.833 -0.803 . . . . 1.55 108.833 178.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.419 HD13 ' HA ' ' A' ' 22' ' ' ILE . 11.5 mm -57.11 -43.66 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.591 -0.693 . . . . 2.25 109.313 178.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.63 -45.82 91.08 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.57 -0.706 . . . . 1.74 109.608 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 58.6 mt -59.34 -49.25 84.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.397 -0.814 . . . . 1.53 108.855 178.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.76 -43.67 97.7 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.648 -0.658 . . . . 1.98 110.023 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.28 -43.55 98.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.376 -0.827 . . . . 2.19 109.061 178.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.411 ' HG ' HD12 ' A' ' 31' ' ' ILE . 0.8 OUTLIER -62.38 -46.83 86.87 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.613 -0.884 . . . . 1.81 108.613 178.139 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.84 -48.14 80.67 Favored Glycine 0 N--CA 1.496 2.633 0 N-CA-C 108.654 -1.778 . . . . 1.9 108.654 178.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.22 -44.03 97.93 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.427 -1.043 . . . . 2.42 109.966 178.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.5 mt -60.53 -39.23 87.1 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.627 -0.671 . . . . 2.74 109.98 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.411 HD12 ' HG ' ' A' ' 27' ' ' LEU . 3.7 mt -72.79 -47.54 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.27 -0.894 . . . . 1.94 109.162 179.046 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.66 -46.52 84.14 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.364 -0.835 . . . . 2.62 109.637 178.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.726 0 N-CA-C 109.472 -1.451 . . . . 2.73 109.472 179.279 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.498 1.952 0 N-CA-C 108.965 -0.754 . . . . 2.63 108.965 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -78.03 -46.48 20.82 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.246 -0.649 . . . . 5.54 109.246 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 75.5 m -54.79 -33.55 61.57 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 122.083 -0.386 . . . . 3.71 110.071 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.578 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -87.72 -50.71 6.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.303 -0.873 . . . . 3.16 109.871 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.1 mtmt -59.42 -51.57 69.33 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.771 -0.581 . . . . 2.07 111.712 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -40.91 -63.53 1.46 Allowed Glycine 0 N--CA 1.505 3.261 0 N-CA-C 110.352 -1.099 . . . . 2.51 110.352 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.505 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 41.9 Cg_endo -67.51 -43.15 6.11 Favored 'Trans proline' 0 C--N 1.315 -1.186 0 O-C-N 123.939 1.494 . . . . 3.55 110.275 178.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.578 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 1.2 t -56.0 -44.52 78.71 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.844 -1.16 . . . . 2.5 109.554 178.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 49.0 t -68.34 -50.61 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 108.899 -0.778 . . . . 1.82 108.899 178.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -52.01 -41.32 62.13 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.561 0.696 . . . . 4.17 109.918 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.505 ' HD2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -68.21 -56.11 9.87 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.757 -0.589 . . . . 4.68 111.587 -179.655 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.424 ' HG3' ' N ' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -64.31 -33.65 76.33 Favored 'General case' 0 N--CA 1.505 2.319 0 C-N-CA 119.075 -1.05 . . . . 2.15 110.46 -179.254 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.424 ' N ' ' HG3' ' A' ' 77' ' ' LYS . . . -67.07 -50.47 61.67 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.519 -0.738 . . . . 2.95 110.097 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.8 pttt -73.98 -32.87 63.63 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.153 -0.967 . . . . 4.68 111.216 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.5 tp . . . . . 0 N--CA 1.494 1.768 0 O-C-N 121.192 -0.942 . . . . 3.18 110.551 179.673 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 76.6 t . . . . . 0 N--CA 1.499 1.981 0 N-CA-C 108.702 -0.851 . . . . 1.86 108.702 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.7 t -64.71 -45.24 95.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.567 -0.708 . . . . 2.32 109.229 178.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 46.1 m -58.03 -46.78 84.76 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.651 -0.656 . . . . 3.03 109.283 178.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.7 t -65.82 -38.92 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 C-N-CA 119.586 -0.846 . . . . 2.39 109.242 178.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.661 ' HA ' HD23 ' A' ' 21' ' ' LEU . 10.0 mm -62.39 -41.41 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.016 -1.053 . . . . 1.55 109.077 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.9 t -66.06 -40.94 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.643 -0.873 . . . . 2.45 108.643 177.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.435 ' O ' HG23 ' A' ' 24' ' ' ILE . 92.4 mt -65.7 -50.12 73.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.522 -0.736 . . . . 2.94 109.074 178.271 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.661 HD23 ' HA ' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -61.59 -42.84 99.44 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 119.914 -0.714 . . . . 1.76 109.383 178.711 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.571 ' N ' ' HG ' ' A' ' 21' ' ' LEU . 10.4 mm -62.7 -38.54 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 120.972 -1.08 . . . . 1.79 109.106 178.291 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.97 -50.58 54.93 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.481 -0.762 . . . . 2.05 110.724 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.602 HG12 ' HA ' ' A' ' 21' ' ' LEU . 29.3 pt -62.52 -37.26 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 120.955 -1.091 . . . . 2.46 109.283 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.551 ' N ' HG13 ' A' ' 24' ' ' ILE . . . -65.75 -46.98 76.83 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.435 -0.791 . . . . 1.6 108.909 178.143 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.05 -44.06 97.96 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.008 -0.738 . . . . 1.63 109.008 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.1 tt -61.22 -45.86 92.81 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.36 -0.838 . . . . 2.52 108.93 178.017 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.3 -46.47 92.87 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.003 -1.639 . . . . 1.76 109.003 178.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.89 -41.44 95.62 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.532 -0.981 . . . . 1.83 109.89 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.6 mt -59.11 -42.12 89.78 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.821 -0.807 . . . . 2.32 108.821 178.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.402 ' HA ' HD13 ' A' ' 31' ' ' ILE . 27.7 mm -70.07 -45.93 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 109.068 -0.716 . . . . 2.13 109.068 178.149 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.1 tt -56.31 -47.34 78.9 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.727 -0.608 . . . . 3.24 109.625 178.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.51 0 N-CA-C 109.85 -1.3 . . . . 1.99 109.85 179.399 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.476 ' O ' ' CG ' ' A' ' 70' ' ' LYS . 41.0 tt0 . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 108.534 -0.913 . . . . 2.79 108.534 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -63.32 -35.43 80.34 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.359 -0.838 . . . . 2.31 109.672 178.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.75 -42.2 98.67 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.603 -0.686 . . . . 2.71 110.553 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.518 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -88.22 -41.18 13.12 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.063 -1.023 . . . . 2.72 110.938 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.476 ' CG ' ' O ' ' A' ' 66' ' ' GLN . 5.4 mmtt -66.46 -42.01 88.21 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.651 -0.656 . . . . 2.39 110.042 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -44.91 -62.64 2.89 Favored Glycine 0 N--CA 1.502 3.063 0 N-CA-C 110.142 -1.183 . . . . 1.59 110.142 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -66.75 -37.8 19.86 Favored 'Trans proline' 0 C--N 1.314 -1.255 0 O-C-N 123.627 1.33 . . . . 2.24 110.756 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.518 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 0.4 OUTLIER -66.21 -43.8 85.71 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.04 -1.038 . . . . 2.59 109.8 179.075 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.3 t -70.72 -43.73 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.792 -0.568 . . . . 1.49 109.618 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -55.49 -43.11 75.31 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.57 0.7 . . . . 2.62 109.89 178.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.425 ' HA ' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -68.92 -48.27 63.7 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.488 0.661 . . . . 2.83 109.969 179.291 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 67.4 mttt -60.08 -55.13 37.74 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.545 0.688 . . . . 2.15 109.935 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -53.37 -50.73 64.48 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 122.032 -0.417 . . . . 1.05 110.524 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.442 ' HG3' ' N ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -67.87 -25.74 65.67 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.417 -0.802 . . . . 2.63 110.714 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.442 ' N ' ' HG3' ' A' ' 79' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.064 -1.022 . . . . 2.21 110.069 179.059 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.496 1.833 0 N-CA-C 109.35 -0.611 . . . . 4.66 109.35 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.0 t -67.78 -43.26 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 120.981 -1.075 . . . . 3.28 109.135 178.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.409 ' O ' HG12 ' A' ' 20' ' ' ILE . 63.3 m -59.56 -51.87 68.0 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.613 -0.679 . . . . 2.91 109.954 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.623 ' HA ' HG12 ' A' ' 20' ' ' ILE . 31.2 m -64.42 -38.18 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 119.505 -0.878 . . . . 3.8 109.854 179.388 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.693 ' HA ' HD23 ' A' ' 21' ' ' LEU . 19.2 mt -65.21 -38.12 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 120.759 -1.213 . . . . 3.95 109.253 178.264 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.6 t -67.49 -48.05 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.237 -0.914 . . . . 2.45 109.584 178.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.623 HG12 ' HA ' ' A' ' 17' ' ' VAL . 3.3 pt -68.01 -34.87 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.886 -1.134 . . . . 3.13 109.968 179.131 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.693 HD23 ' HA ' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -70.99 -42.65 69.38 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.815 -1.178 . . . . 3.56 108.308 177.73 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.548 ' N ' ' HG ' ' A' ' 21' ' ' LEU . 13.1 mt -60.77 -43.77 96.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.111 -0.993 . . . . 3.06 108.436 177.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.75 -46.38 85.56 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.608 -0.682 . . . . 1.92 109.731 178.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.417 HD13 ' HA ' ' A' ' 24' ' ' ILE . 8.1 mm -59.49 -47.2 91.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.131 -0.981 . . . . 2.51 109.005 178.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.27 -43.91 97.74 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.456 -0.778 . . . . 2.69 109.591 178.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.18 -42.65 99.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.466 -0.771 . . . . 2.15 109.274 178.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.2 tt -63.39 -46.38 86.69 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.678 -0.86 . . . . 1.82 108.678 178.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.77 -45.04 95.44 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 108.692 -1.763 . . . . 1.93 108.692 178.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.23 -44.03 93.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.507 -0.996 . . . . 2.65 109.468 178.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.2 mt -58.73 -41.61 86.85 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.023 -0.732 . . . . 2.73 109.023 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 22.4 mm -68.93 -50.12 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.489 -0.757 . . . . 1.79 109.38 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.62 -43.07 79.83 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.567 -0.708 . . . . 3.1 109.689 178.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.508 0 N-CA-C 109.491 -1.444 . . . . 2.84 109.491 178.977 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 107.911 -1.144 . . . . 2.35 107.911 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -69.22 -43.69 73.56 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.329 0.585 . . . . 3.13 109.646 178.229 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.437 ' O ' ' CD ' ' A' ' 72' ' ' PRO . 0.4 OUTLIER -59.35 -37.93 79.09 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.957 -0.464 . . . . 2.8 110.437 179.479 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.27 -43.74 13.48 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.046 -1.034 . . . . 1.66 110.15 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 32.5 mtmt -63.81 -46.67 84.12 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.577 -0.702 . . . . 2.61 110.635 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 75' ' ' GLU . . . -41.33 -64.87 1.23 Allowed Glycine 0 N--CA 1.506 3.334 0 N-CA-C 109.947 -1.261 . . . . 2.1 109.947 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.573 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 42.5 Cg_endo -68.42 -41.31 6.74 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 O-C-N 123.956 1.503 . . . . 2.1 110.083 178.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 35.1 t -58.33 -39.54 79.73 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.839 -1.163 . . . . 2.06 109.94 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.543 ' HA ' ' HG2' ' A' ' 77' ' ' LYS . 24.1 t -74.92 -48.39 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.435 -0.791 . . . . 2.48 109.089 178.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.64 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 1.0 OUTLIER -54.63 -43.94 72.72 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.89 -0.724 . . . . 3.37 109.178 178.349 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.573 ' HD2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -64.66 -48.62 74.11 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.581 -0.7 . . . . 3.11 110.157 179.126 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.638 ' HG3' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -62.46 -32.66 73.58 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.073 -1.017 . . . . 3.31 109.397 179.02 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.638 ' N ' ' HG3' ' A' ' 77' ' ' LYS . . . -72.2 -43.26 64.75 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.546 -0.721 . . . . 3.43 109.171 178.091 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.64 ' HG2' ' O ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -68.45 -34.04 75.24 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.637 -0.665 . . . . 4.0 109.502 178.673 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.567 -0.708 . . . . 4.08 110.416 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.403 ' HA ' HG22 ' A' ' 17' ' ' VAL . 34.0 m . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 120.792 0.329 . . . . 1.98 110.171 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.1 t -70.31 -43.06 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 120.983 -1.073 . . . . 2.38 109.264 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 54.9 m -58.95 -51.69 68.95 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.848 -0.532 . . . . 1.85 109.879 179.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.454 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 27.0 m -64.66 -35.73 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.468 -0.77 . . . . 1.37 110.116 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.587 HD13 HD23 ' A' ' 21' ' ' LEU . 7.0 mm -66.79 -43.88 89.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.013 -1.054 . . . . 2.15 109.366 178.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.3 t -63.28 -42.22 95.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 108.72 -0.844 . . . . 2.28 108.72 178.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 79.1 mt -64.5 -48.56 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.506 -0.746 . . . . 1.54 109.464 178.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.587 HD23 HD13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -62.27 -43.13 99.53 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.783 -0.821 . . . . 1.86 108.783 178.818 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.553 ' N ' ' HG ' ' A' ' 21' ' ' LEU . 32.2 mt -59.49 -45.21 93.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.358 -0.839 . . . . 2.34 109.101 178.134 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.87 -46.53 84.53 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.541 -0.725 . . . . 1.68 109.836 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 55.6 mt -57.62 -46.81 86.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.511 -0.743 . . . . 1.41 109.247 178.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.21 -45.72 87.01 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.543 -0.723 . . . . 1.83 109.992 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.12 -46.04 89.35 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.44 -0.787 . . . . 1.98 108.97 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.541 ' O ' HG12 ' A' ' 31' ' ' ILE . 2.4 tt -61.69 -48.04 82.58 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.834 -0.802 . . . . 1.61 108.834 178.072 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.502 ' O ' HG13 ' A' ' 31' ' ' ILE . . . -53.76 -39.23 61.05 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 109.623 -1.391 . . . . 1.63 109.623 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.27 -41.93 47.29 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.233 -1.157 . . . . 2.0 109.517 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.6 mt -53.99 -45.88 71.57 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.148 0.499 . . . . 2.58 109.685 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.541 HG12 ' O ' ' A' ' 27' ' ' LEU . 1.3 pt -77.13 -43.95 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.416 -0.803 . . . . 1.56 111.105 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.445 ' H ' HG13 ' A' ' 31' ' ' ILE . 1.3 tt -56.96 -45.42 82.87 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.047 -1.033 . . . . 2.58 109.103 178.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.443 0 N-CA-C 109.532 -1.427 . . . . 2.1 109.532 179.247 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.501 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 1.7 tt0 . . . . . 0 N--CA 1.488 1.431 0 N-CA-C 109.534 -0.543 . . . . 2.43 109.534 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.473 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 11.1 m-85 -74.38 -49.41 22.78 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.562 -0.711 . . . . 2.56 111.006 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.439 ' O ' ' CD ' ' A' ' 72' ' ' PRO . 0.8 OUTLIER -63.07 -34.19 77.07 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.378 -0.826 . . . . 2.41 110.62 -179.923 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -79.59 -43.47 22.88 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.025 -1.047 . . . . 1.83 110.078 179.254 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.501 ' HB3' ' O ' ' A' ' 66' ' ' GLN . 12.7 ptpt -68.82 -31.73 70.92 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.428 -0.795 . . . . 2.06 110.801 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.406 ' N ' ' HD2' ' A' ' 72' ' ' PRO . . . -47.6 -63.93 3.17 Favored Glycine 0 N--CA 1.5 2.949 0 N-CA-C 109.228 -1.549 . . . . 1.53 109.228 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.531 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 41.5 Cg_endo -68.44 -41.1 6.96 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.886 1.466 . . . . 2.08 109.666 178.234 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 4.1 t -55.75 -43.81 77.0 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.013 -1.054 . . . . 2.2 109.236 178.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 37.9 t -74.5 -45.09 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.504 -0.747 . . . . 1.55 109.351 178.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -53.57 -43.21 68.31 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.708 0.766 . . . . 2.38 109.189 178.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.531 ' HD2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -71.06 -44.75 65.12 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.391 -0.596 . . . . 3.37 109.391 178.663 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.84 -40.28 79.69 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 120.223 -0.591 . . . . 2.98 110.231 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.65 -41.24 60.69 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.041 0.448 . . . . 2.21 110.322 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.2 mttp -65.52 -43.86 88.7 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 121.504 0.669 . . . . 2.68 109.325 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.687 -0.633 . . . . 3.65 109.974 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.583 ' O ' HG23 ' A' ' 18' ' ' ILE . 61.5 t . . . . . 0 N--CA 1.496 1.87 0 N-CA-C 109.529 -0.545 . . . . 2.09 109.529 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.64 ' HA ' HG12 ' A' ' 18' ' ' ILE . 43.6 t -71.11 -41.39 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.309 -0.869 . . . . 1.35 109.707 179.017 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.419 ' O ' HG12 ' A' ' 20' ' ' ILE . 50.2 m -59.81 -46.63 88.64 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.525 -0.734 . . . . 1.06 109.92 179.279 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.547 ' HA ' HG12 ' A' ' 20' ' ' ILE . 35.7 m -68.9 -42.67 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.436 -0.79 . . . . 1.6 111.312 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.64 HG12 ' HA ' ' A' ' 15' ' ' VAL . 15.6 pt -65.42 -31.64 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 120.166 -1.584 . . . . 1.79 109.608 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.459 ' N ' HG13 ' A' ' 18' ' ' ILE . 21.2 t -70.06 -48.88 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.476 -0.765 . . . . 1.14 109.342 178.363 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.547 HG12 ' HA ' ' A' ' 17' ' ' VAL . 2.5 pt -68.22 -31.35 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 120.638 -1.289 . . . . 1.43 108.847 178.214 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.473 ' N ' HG13 ' A' ' 20' ' ' ILE . 10.0 mt -66.66 -52.33 46.08 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.334 -0.854 . . . . 1.78 109.24 177.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.549 HG23 ' O ' ' A' ' 18' ' ' ILE . 30.9 pt -59.53 -42.38 87.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 C-N-CA 118.851 -1.139 . . . . 1.69 109.288 178.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.455 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -61.03 -46.8 89.24 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 120.294 -0.562 . . . . 1.1 109.707 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.413 HD13 ' HA ' ' A' ' 24' ' ' ILE . 6.1 mm -60.51 -45.53 96.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.256 -0.902 . . . . 1.18 108.952 178.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.38 -43.95 97.99 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.563 -0.711 . . . . 1.49 109.666 178.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.81 -44.31 96.51 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.116 -0.698 . . . . 1.49 109.116 178.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.05 -44.53 96.49 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.806 -0.813 . . . . 1.29 108.806 178.207 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.69 -45.9 94.93 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 108.756 -1.738 . . . . 1.07 108.756 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.99 -43.63 95.1 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.502 -0.999 . . . . 1.57 109.821 178.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.4 mt -58.27 -41.61 84.7 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.063 -0.717 . . . . 1.99 109.063 178.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 59.9 mt -70.07 -48.26 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.465 -0.772 . . . . 1.06 109.411 178.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.12 -48.83 77.69 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.429 -0.795 . . . . 2.12 110.255 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.836 0 N-CA-C 109.577 -1.409 . . . . 1.47 109.577 179.277 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.531 ' O ' ' HB2' ' A' ' 70' ' ' LYS . 1.8 mm100 . . . . . 0 N--CA 1.493 1.722 0 N-CA-C 108.245 -1.02 . . . . 1.04 108.245 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -71.37 -47.03 58.82 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.604 -0.685 . . . . 4.38 109.841 178.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.432 ' O ' ' CD ' ' A' ' 72' ' ' PRO . 65.0 m -54.56 -46.8 73.72 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.933 -0.479 . . . . 1.07 110.211 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.536 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -72.41 -57.58 4.07 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.202 -0.936 . . . . 0.84 111.308 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.539 ' HD2' ' N ' ' A' ' 70' ' ' LYS . 3.8 mptt -52.71 -60.49 3.19 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.432 -0.793 . . . . 0.96 112.914 -179.003 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 70' ' ' LYS . . . -31.74 -67.44 0.15 Allowed Glycine 0 N--CA 1.51 3.597 0 N-CA-C 111.55 -0.62 . . . . 1.15 111.55 -178.479 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.552 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 40.2 Cg_endo -66.28 -40.97 13.52 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.698 1.367 . . . . 1.17 110.649 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.536 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -58.9 -42.95 90.79 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.825 -1.172 . . . . 1.58 109.277 178.688 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 55.0 t -71.69 -45.04 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 109.327 -0.619 . . . . 1.37 109.327 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 1.2 tm-20 -57.08 -42.2 80.22 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 119.855 -0.738 . . . . 1.72 109.427 178.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.552 ' HD2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -66.99 -50.15 63.17 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.5 -0.75 . . . . 1.7 109.703 178.889 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.38 -41.62 85.24 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 120.01 -0.676 . . . . 2.24 109.595 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.96 -49.03 69.34 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.97 -0.456 . . . . 1.76 109.918 179.101 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.05 -49.26 76.69 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.206 -0.934 . . . . 1.99 109.807 179.016 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 24.3 tp . . . . . 0 N--CA 1.499 2.011 0 O-C-N 121.429 -0.795 . . . . 3.18 111.393 -179.701 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.597 ' O ' HG12 ' A' ' 18' ' ' ILE . 39.9 t . . . . . 0 N--CA 1.498 1.939 0 N-CA-C 109.109 -0.7 . . . . 1.68 109.109 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.628 ' HA ' HG12 ' A' ' 18' ' ' ILE . 34.2 t -70.73 -42.41 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.242 -0.912 . . . . 1.84 108.963 178.534 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 54.2 m -58.16 -46.78 85.1 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.487 -0.758 . . . . 1.97 109.979 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.8 m -70.16 -41.21 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.271 -0.893 . . . . 1.84 111.188 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.628 HG12 ' HA ' ' A' ' 15' ' ' VAL . 4.8 pt -67.89 -33.92 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 120.163 -1.586 . . . . 1.84 109.676 178.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.488 ' N ' HG13 ' A' ' 18' ' ' ILE . 20.8 t -67.7 -43.39 86.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 108.41 -0.959 . . . . 1.88 108.41 177.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 87.5 mt -67.4 -40.24 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.117 -1.068 . . . . 2.03 108.117 177.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.412 ' HB2' ' HA ' ' A' ' 18' ' ' ILE . 10.7 mt -60.8 -52.79 63.58 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.87 -0.519 . . . . 2.16 109.817 178.669 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.545 HG12 ' O ' ' A' ' 18' ' ' ILE . 41.4 pt -59.9 -41.69 86.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 120.943 -1.098 . . . . 1.88 109.697 179.112 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.483 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -61.83 -45.76 92.43 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 120.146 -0.622 . . . . 1.93 109.594 178.535 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.418 ' HA ' HD13 ' A' ' 24' ' ' ILE . 15.8 mm -61.97 -44.5 99.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.313 -0.867 . . . . 2.32 108.758 178.607 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.74 -44.66 96.48 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.544 -0.722 . . . . 2.03 109.645 178.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.01 -46.96 88.66 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.972 -0.751 . . . . 2.03 108.972 178.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.1 tt -59.78 -45.89 90.88 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.808 -0.812 . . . . 2.58 108.808 178.134 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.07 -45.33 94.01 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 108.937 -1.665 . . . . 2.21 108.937 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.55 -44.03 95.36 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.451 -1.029 . . . . 2.11 109.967 179.03 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.1 mt -59.67 -41.32 90.35 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.089 -0.708 . . . . 2.43 109.089 178.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 24.7 mm -68.34 -48.15 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.65 -0.656 . . . . 2.64 109.374 178.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.17 -48.1 81.35 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.447 -0.783 . . . . 2.58 110.052 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.676 0 N-CA-C 109.816 -1.314 . . . . 2.23 109.816 179.506 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.762 0 N-CA-C 108.81 -0.811 . . . . 2.41 108.81 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -62.32 -52.62 62.94 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 108.477 -0.934 . . . . 1.38 108.477 177.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.42 ' O ' ' CD ' ' A' ' 72' ' ' PRO . 2.4 m -53.72 -38.41 64.29 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-N 115.808 -0.633 . . . . 1.85 111.388 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.36 -41.56 18.05 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.012 -1.055 . . . . 1.81 110.969 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.0 mmtp -67.24 -45.78 75.71 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.419 -0.801 . . . . 2.52 111.12 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.409 ' N ' ' HD2' ' A' ' 72' ' ' PRO . . . -43.25 -62.65 2.34 Favored Glycine 0 N--CA 1.506 3.33 0 N-CA-C 110.614 -0.994 . . . . 1.52 110.614 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.556 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 40.8 Cg_endo -66.92 -43.92 6.14 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 O-C-N 123.729 1.384 . . . . 1.87 110.03 179.222 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 31.5 t -54.52 -43.05 71.54 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.935 -1.103 . . . . 2.47 109.745 178.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 37.5 t -73.62 -47.0 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.555 -0.716 . . . . 1.91 109.552 178.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -54.1 -41.4 68.23 Favored 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 121.58 0.705 . . . . 2.0 109.641 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.556 ' HD2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -69.88 -49.14 55.25 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.832 -0.543 . . . . 2.9 110.637 179.496 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.579 ' HG3' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -63.99 -29.3 70.47 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.112 -0.992 . . . . 2.4 110.075 179.292 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.579 ' N ' ' HG3' ' A' ' 77' ' ' LYS . . . -75.4 -44.41 44.8 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.283 -0.886 . . . . 2.08 109.415 179.089 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.0 mttt -68.8 -40.59 79.5 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.32 0.581 . . . . 2.25 109.494 178.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.587 -0.696 . . . . 2.98 110.021 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.1 m . . . . . 0 N--CA 1.495 1.777 0 CA-C-O 120.7 0.286 . . . . 2.12 110.261 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.6 t -71.59 -42.37 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 120.98 -1.075 . . . . 1.83 109.138 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.423 ' O ' HG12 ' A' ' 20' ' ' ILE . 53.2 m -58.97 -51.73 68.78 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.711 -0.618 . . . . 2.32 109.771 179.099 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.643 ' HA ' HG12 ' A' ' 20' ' ' ILE . 35.0 m -64.02 -40.11 87.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.512 -0.743 . . . . 2.24 109.91 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.73 HD13 HD23 ' A' ' 21' ' ' LEU . 8.9 mm -63.36 -42.73 97.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.009 -1.057 . . . . 1.77 109.393 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.606 ' O ' HG13 ' A' ' 22' ' ' ILE . 38.4 t -63.93 -43.39 97.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 C-N-CA 119.974 -0.69 . . . . 1.92 110.173 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.647 ' O ' HG23 ' A' ' 24' ' ' ILE . 22.2 pt -72.51 -34.77 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 120.52 -1.363 . . . . 2.4 109.45 178.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.73 HD23 HD13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -69.36 -45.69 68.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.23 -0.919 . . . . 1.74 109.428 178.55 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.606 HG13 ' O ' ' A' ' 19' ' ' VAL . 1.9 pp -63.73 -39.94 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 120.632 -1.293 . . . . 1.6 109.146 178.49 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.26 -50.14 72.89 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.862 -0.523 . . . . 1.93 110.768 179.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.647 HG23 ' O ' ' A' ' 20' ' ' ILE . 40.0 pt -63.99 -36.83 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 120.853 -1.155 . . . . 2.22 109.155 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.505 ' N ' HG13 ' A' ' 24' ' ' ILE . . . -65.28 -44.64 87.39 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.046 -0.724 . . . . 1.69 109.046 178.161 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.22 -44.6 94.81 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.753 -0.832 . . . . 1.81 108.753 178.375 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.26 -45.12 95.83 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.894 -0.78 . . . . 2.64 108.894 178.204 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.62 -44.7 97.54 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 108.753 -1.739 . . . . 1.91 108.753 178.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.99 -41.64 97.45 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.492 -1.005 . . . . 1.84 109.848 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.5 mt -60.68 -41.31 94.84 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.051 -0.722 . . . . 2.51 109.051 178.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 69.4 mt -69.7 -48.15 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 109.002 -0.74 . . . . 2.5 109.002 178.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.95 -43.45 91.28 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.533 -0.729 . . . . 1.98 110.103 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.779 0 N-CA-C 109.342 -1.503 . . . . 2.29 109.342 179.285 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 . . . . . 0 N--CA 1.5 2.058 0 CA-C-O 121.456 0.646 . . . . 1.96 109.264 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.491 ' HA ' ' HG2' ' A' ' 70' ' ' LYS . 2.6 m-85 -69.59 -43.64 72.4 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.579 -0.701 . . . . 2.2 109.369 178.659 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 75.4 m -59.72 -32.43 70.53 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.951 -0.468 . . . . 1.91 110.588 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.99 -44.26 11.14 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.144 -0.972 . . . . 1.73 110.4 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.491 ' HG2' ' HA ' ' A' ' 67' ' ' TYR . 10.6 ptpt -65.55 -35.8 81.91 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.466 -0.771 . . . . 1.72 111.02 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.417 ' N ' ' HD2' ' A' ' 72' ' ' PRO . . . -49.78 -62.96 4.51 Favored Glycine 0 N--CA 1.501 2.975 0 N-CA-C 109.723 -1.351 . . . . 1.69 109.723 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 71' ' ' GLY . 40.4 Cg_endo -66.49 -33.71 36.19 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 123.79 1.416 . . . . 1.94 110.348 178.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.449 ' HB3' ' HA ' ' A' ' 70' ' ' LYS . 15.1 t -67.42 -47.37 70.45 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.253 -0.904 . . . . 1.85 109.939 178.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.7 t -66.48 -46.34 86.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.663 -0.648 . . . . 1.62 109.301 178.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.473 ' OE2' ' NZ ' ' A' ' 79' ' ' LYS . 5.0 tm-20 -54.95 -42.37 72.25 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 121.367 0.603 . . . . 2.25 109.45 178.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.48 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -62.26 -54.91 33.9 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.499 0.666 . . . . 2.67 109.835 178.83 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.65 -51.51 69.63 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.2 0.524 . . . . 1.66 110.915 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.85 -47.42 80.42 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.882 -0.511 . . . . 1.96 110.68 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -70.27 -38.12 75.02 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.692 -0.803 . . . . 2.58 109.904 179.726 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 tp . . . . . 0 N--CA 1.495 1.814 0 O-C-N 121.429 -0.794 . . . . 2.41 109.396 178.454 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.495 ' HA ' ' CG2' ' A' ' 17' ' ' VAL . 27.7 m . . . . . 0 N--CA 1.492 1.657 0 N-CA-C 109.94 -0.393 . . . . 1.38 109.94 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.607 ' HA ' HG12 ' A' ' 18' ' ' ILE . 37.3 t -72.03 -40.66 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.915 -1.116 . . . . 1.2 109.15 178.068 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 42.7 m -59.04 -49.78 76.59 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.267 -0.895 . . . . 1.17 109.66 178.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.495 ' CG2' ' HA ' ' A' ' 14' ' ' VAL . 2.8 m -64.57 -43.41 96.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.604 -0.685 . . . . 1.53 111.492 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.607 HG12 ' HA ' ' A' ' 15' ' ' VAL . 2.1 pt -66.94 -32.34 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 120.153 -1.592 . . . . 1.24 110.037 179.138 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.47 ' N ' HG13 ' A' ' 18' ' ' ILE . 40.0 t -69.65 -47.63 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 108.044 -1.095 . . . . 1.05 108.044 177.615 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 69.6 mt -60.37 -46.2 95.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 N-CA-C 108.609 -0.885 . . . . 1.25 108.609 177.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.574 ' HA ' HG12 ' A' ' 24' ' ' ILE . 4.0 mt -59.36 -51.23 70.79 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.228 -0.656 . . . . 1.53 109.228 178.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.2 mt -56.46 -37.87 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.256 -0.902 . . . . 1.37 109.167 178.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.79 -52.0 42.21 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.585 -0.697 . . . . 1.08 110.797 179.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.574 HG12 ' HA ' ' A' ' 21' ' ' LEU . 39.4 pt -62.34 -37.27 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.872 -1.142 . . . . 1.43 109.201 179.311 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.496 ' N ' HG13 ' A' ' 24' ' ' ILE . . . -64.8 -45.84 84.58 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.533 -0.729 . . . . 1.13 109.118 178.122 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.03 -43.34 99.05 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.891 -0.781 . . . . 1.12 108.891 178.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.4 -47.08 87.42 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.909 -0.775 . . . . 1.45 108.909 178.146 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.0 -45.97 93.14 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 108.636 -1.786 . . . . 1.02 108.636 178.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.27 -44.83 96.59 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.595 -0.944 . . . . 0.98 109.623 178.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.6 mt -58.86 -40.1 83.3 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.787 -0.57 . . . . 1.3 109.503 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.7 mt -68.84 -46.64 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.498 -0.751 . . . . 1.37 109.323 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.05 -45.39 94.96 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.442 -0.786 . . . . 1.66 109.904 179.169 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.848 0 N-CA-C 109.494 -1.442 . . . . 0.78 109.494 179.232 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.483 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.136 0 CA-C-O 121.467 0.651 . . . . 2.12 109.332 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.533 ' HA ' ' HG2' ' A' ' 70' ' ' LYS . 9.0 m-85 -69.94 -39.04 76.31 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.556 -0.715 . . . . 1.57 109.539 178.632 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.4 t -57.82 -41.01 81.34 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.814 -0.554 . . . . 0.88 110.403 178.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.68 -47.2 8.85 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.159 -0.963 . . . . 0.73 110.964 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.551 ' HA ' ' HB2' ' A' ' 73' ' ' CYS . 6.3 ptpt -66.11 -34.88 79.06 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.396 -0.815 . . . . 1.45 111.306 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.417 ' N ' ' HD2' ' A' ' 72' ' ' PRO . . . -46.69 -63.31 3.19 Favored Glycine 0 N--CA 1.503 3.159 0 N-CA-C 109.543 -1.423 . . . . 0.78 109.543 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.545 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 40.5 Cg_endo -67.28 -47.83 2.04 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.929 1.489 . . . . 0.85 109.78 178.486 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.551 ' HB2' ' HA ' ' A' ' 70' ' ' LYS . 4.0 m -53.26 -39.95 64.25 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.15 -0.969 . . . . 0.94 110.053 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.1 t -74.32 -46.38 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 108.833 -0.803 . . . . 1.02 108.833 178.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.11 -43.23 70.25 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 121.505 0.669 . . . . 1.17 109.258 178.457 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.545 ' HD2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -63.3 -50.44 70.04 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.945 -0.761 . . . . 1.2 108.945 178.52 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.8 mttp -56.11 -44.84 79.48 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 109.167 -0.679 . . . . 1.23 109.167 178.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.6 -52.21 64.55 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.415 -0.587 . . . . 1.41 109.415 178.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 36.3 mtpt -58.88 -44.32 91.09 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.067 0.461 . . . . 1.56 109.837 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.497 1.923 0 CA-C-O 121.573 0.702 . . . . 2.58 110.692 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 55.1 t . . . . . 0 N--CA 1.498 1.935 0 CA-C-O 121.301 0.572 . . . . 1.81 109.924 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.413 ' O ' HG22 ' A' ' 19' ' ' VAL . 29.7 t -69.87 -51.67 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.102 -0.999 . . . . 2.93 110.462 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.6 p -55.67 -49.77 72.03 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.806 -0.559 . . . . 2.98 110.252 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.8 m -65.2 -35.31 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.136 -0.978 . . . . 1.97 110.081 179.12 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.428 HD13 ' HA ' ' A' ' 18' ' ' ILE . 5.6 mm -68.18 -48.69 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 120.958 -1.088 . . . . 2.25 110.431 179.303 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 15' ' ' VAL . 32.6 m -63.52 -36.8 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 C-N-CA 118.973 -1.091 . . . . 2.87 108.966 178.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 58.9 mt -66.54 -48.77 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.268 -0.895 . . . . 2.58 108.678 177.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 13.1 mt -58.95 -49.31 78.34 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.928 -0.767 . . . . 1.69 108.928 178.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 29.7 mt -56.29 -43.61 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 C-N-CA 119.992 -0.683 . . . . 2.66 109.457 178.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.34 -45.95 85.59 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.474 -0.766 . . . . 2.41 109.731 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.4 mt -59.02 -46.5 91.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.394 -0.816 . . . . 1.84 109.021 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.54 -45.35 90.96 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.556 -0.715 . . . . 1.83 109.841 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.08 -43.94 95.12 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.549 -0.719 . . . . 2.45 109.312 178.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.858 ' HA ' HD23 ' A' ' 30' ' ' LEU . 0.4 OUTLIER -63.25 -47.13 83.73 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.876 -0.787 . . . . 2.36 108.876 178.333 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.61 -41.6 95.71 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 108.636 -1.786 . . . . 1.6 108.636 178.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.05 -47.0 75.8 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.517 -0.99 . . . . 2.18 110.306 179.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.858 HD23 ' HA ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -62.27 -37.21 84.61 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.615 -0.678 . . . . 2.61 109.722 179.401 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.537 ' N ' ' HG ' ' A' ' 30' ' ' LEU . 9.7 mt -71.02 -46.95 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.304 -0.872 . . . . 1.91 109.002 178.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.4 tp -58.83 -46.86 86.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.651 -0.655 . . . . 2.27 109.704 178.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.687 0 N-CA-C 109.345 -1.502 . . . . 2.19 109.345 179.344 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.483 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 N-CA-C 108.764 -0.828 . . . . 2.72 108.764 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -62.55 -40.95 98.47 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.684 -0.635 . . . . 3.62 109.608 178.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.413 ' O ' ' CD ' ' A' ' 72' ' ' PRO . 71.2 m -59.93 -41.33 91.55 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.824 -0.547 . . . . 3.82 110.209 179.493 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -81.37 -41.79 21.46 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.206 -0.934 . . . . 2.79 110.488 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 66' ' ' GLN . 1.8 mmtp -61.38 -47.16 87.09 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.467 -0.771 . . . . 2.29 110.687 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 75' ' ' GLU . . . -41.71 -66.45 0.99 Allowed Glycine 0 N--CA 1.503 3.116 0 N-CA-C 110.544 -1.022 . . . . 2.86 110.544 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.528 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 41.3 Cg_endo -65.81 -39.84 18.83 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.788 1.415 . . . . 2.89 110.56 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 6.5 t -60.63 -43.32 97.64 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.033 -1.042 . . . . 2.15 109.325 178.62 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 69.1 t -70.94 -44.98 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 109.112 -0.699 . . . . 2.85 109.112 178.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 0.6 OUTLIER -56.48 -42.48 78.35 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.614 0.721 . . . . 3.2 109.444 178.629 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.528 ' HD2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -66.09 -50.45 64.02 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.624 -0.673 . . . . 3.03 109.731 179.05 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -41.21 80.16 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 120.208 -0.597 . . . . 2.94 109.655 179.238 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.88 -43.23 84.04 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 122.062 -0.399 . . . . 2.67 110.044 179.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.427 ' HA ' ' CE ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -68.39 -48.54 64.42 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.607 -0.683 . . . . 3.36 109.893 179.326 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.1 tp . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.486 -0.759 . . . . 2.06 109.56 179.457 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.503 ' O ' HG23 ' A' ' 18' ' ' ILE . 53.8 t . . . . . 0 N--CA 1.498 1.944 0 CA-C-O 121.159 0.504 . . . . 1.28 109.89 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.536 ' O ' HG13 ' A' ' 18' ' ' ILE . 43.2 t -72.63 -37.43 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.031 -1.043 . . . . 1.57 109.416 178.998 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.416 ' O ' HG12 ' A' ' 20' ' ' ILE . 59.5 m -62.17 -50.25 72.59 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.286 -0.884 . . . . 1.43 109.712 178.588 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.577 ' HA ' HG12 ' A' ' 20' ' ' ILE . 30.9 m -67.24 -41.86 87.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.655 -0.653 . . . . 0.99 111.643 -179.502 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.536 HG13 ' O ' ' A' ' 15' ' ' VAL . 2.1 pp -67.69 -30.42 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 120.303 -1.498 . . . . 1.27 109.764 179.138 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.6 t -68.99 -52.2 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.233 -0.917 . . . . 1.25 108.782 178.143 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.577 HG12 ' HA ' ' A' ' 17' ' ' VAL . 44.9 pt -63.96 -37.53 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.162 -0.961 . . . . 1.01 109.083 178.668 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.485 ' N ' HG13 ' A' ' 20' ' ' ILE . 9.9 mt -64.85 -48.34 74.68 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.395 -0.816 . . . . 1.02 109.0 178.028 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.45 HD13 ' HA ' ' A' ' 22' ' ' ILE . 8.0 mm -59.19 -43.57 89.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.317 -0.865 . . . . 1.21 108.873 178.481 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.85 -46.66 88.5 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.387 -0.597 . . . . 0.9 109.387 178.711 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.414 HD13 ' HA ' ' A' ' 24' ' ' ILE . 8.4 mm -59.97 -45.44 95.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.306 -0.871 . . . . 1.14 108.892 178.386 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.67 -45.4 94.18 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.579 -0.7 . . . . 0.88 109.613 178.751 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.74 -44.94 96.03 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.58 -0.7 . . . . 0.96 109.138 178.593 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.4 tt -61.96 -45.92 91.54 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.898 -0.779 . . . . 1.28 108.898 178.192 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.38 -44.09 95.39 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 108.712 -1.755 . . . . 1.11 108.712 178.651 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.28 -46.28 84.36 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.428 -1.042 . . . . 1.13 109.668 178.912 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.1 mt -56.89 -41.29 77.79 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 109.179 -0.675 . . . . 1.46 109.179 178.719 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.41 ' HA ' HD13 ' A' ' 31' ' ' ILE . 26.6 mm -70.2 -44.9 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.53 -0.731 . . . . 1.46 109.525 178.853 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.17 -48.52 80.05 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.508 -0.745 . . . . 2.28 109.891 179.285 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.838 0 N-CA-C 110.471 -1.051 . . . . 1.5 110.471 179.773 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.502 ' OE1' ' NZ ' ' A' ' 70' ' ' LYS . 2.6 mt-30 . . . . . 0 N--CA 1.499 2.025 0 N-CA-C 109.491 -0.559 . . . . 2.6 109.491 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -74.26 -41.42 61.31 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.654 0.74 . . . . 3.61 109.463 178.624 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 64.0 m -59.2 -28.54 66.74 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 122.002 -0.436 . . . . 1.15 110.938 179.77 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -95.59 -43.99 7.69 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.082 -1.011 . . . . 1.54 111.013 -179.651 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.502 ' NZ ' ' OE1' ' A' ' 66' ' ' GLN . 15.2 mtmt -70.06 -39.83 75.43 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.408 -0.808 . . . . 3.36 111.109 -179.394 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.422 ' N ' ' HD2' ' A' ' 72' ' ' PRO . . . -46.0 -61.11 4.11 Favored Glycine 0 N--CA 1.503 3.106 0 N-CA-C 109.603 -1.399 . . . . 1.07 109.603 179.821 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.591 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 42.1 Cg_endo -67.74 -43.37 5.45 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 O-C-N 123.801 1.421 . . . . 1.02 109.751 178.462 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 9.1 t -53.75 -44.77 70.23 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.906 -1.121 . . . . 2.16 110.202 179.055 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.5 t -72.68 -45.96 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.337 -0.852 . . . . 1.72 109.05 178.786 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.433 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 1.3 tm-20 -53.6 -42.59 67.83 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.6 0.714 . . . . 1.28 109.96 178.642 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.62 ' HA ' ' CD ' ' A' ' 79' ' ' LYS . 0.9 OUTLIER -72.74 -45.55 58.14 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.673 -0.642 . . . . 1.79 110.997 179.85 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.485 ' HG3' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -67.27 -28.79 68.32 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.121 -0.987 . . . . 1.82 109.984 179.594 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.485 ' N ' ' HG3' ' A' ' 77' ' ' LYS . . . -75.56 -52.36 10.79 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.426 -0.796 . . . . 1.18 109.485 179.265 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.62 ' CD ' ' HA ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -64.84 -28.95 69.9 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.622 -0.674 . . . . 1.63 111.332 179.903 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.555 ' N ' ' HG2' ' A' ' 79' ' ' LYS . 2.6 tp . . . . . 0 N--CA 1.495 1.809 0 O-C-N 121.23 -0.919 . . . . 2.11 112.166 -178.975 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 N--CA 1.499 2.003 0 N-CA-C 109.3 -0.63 . . . . 1.71 109.3 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.4 t -69.07 -42.69 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.338 -0.851 . . . . 1.32 109.037 178.434 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 53.9 m -57.31 -52.77 64.01 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.131 0.491 . . . . 1.11 110.007 179.137 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.3 m -64.29 -37.08 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.519 -0.738 . . . . 1.21 110.043 179.468 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.1 mt -66.28 -40.9 88.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.039 -1.038 . . . . 1.49 109.394 178.567 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.3 t -64.52 -45.35 95.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.533 -0.914 . . . . 1.19 108.533 178.158 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 86.2 mt -62.15 -46.32 96.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.49 -0.756 . . . . 1.2 109.016 178.312 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.8 mt -60.07 -49.59 77.07 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.908 -0.775 . . . . 1.63 108.908 178.411 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.9 mt -56.76 -43.13 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.525 -0.735 . . . . 1.39 109.394 178.52 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.21 -46.55 83.41 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.669 -0.644 . . . . 1.14 109.908 179.032 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.5 mm -59.66 -46.29 93.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.232 -0.918 . . . . 1.39 109.02 178.762 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.96 -45.0 95.57 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.607 -0.683 . . . . 1.33 109.664 178.967 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.35 -43.84 98.19 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.556 -0.715 . . . . 1.29 109.093 178.59 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.74 -48.26 81.53 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.774 -0.824 . . . . 1.35 108.774 178.133 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.35 -44.65 93.43 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 108.857 -1.697 . . . . 1.25 108.857 178.767 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.32 -43.16 95.54 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.433 -1.04 . . . . 1.42 109.866 178.963 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.9 mt -60.27 -41.36 93.12 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.244 -0.651 . . . . 1.72 109.244 178.628 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 97.0 mt -69.11 -52.91 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.558 -0.714 . . . . 1.25 109.29 179.029 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.2 -46.91 72.54 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.491 -0.756 . . . . 2.22 109.763 178.867 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.734 0 N-CA-C 109.221 -1.552 . . . . 1.54 109.221 178.964 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.719 0 N-CA-C 109.404 -0.591 . . . . 3.99 109.404 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.465 ' HA ' ' CG ' ' A' ' 70' ' ' LYS . 0.4 OUTLIER -70.48 -42.88 70.82 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.604 -0.685 . . . . 3.9 109.483 178.457 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.42 ' O ' ' CD ' ' A' ' 72' ' ' PRO . 54.2 m -60.1 -37.39 79.83 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 109.963 -0.384 . . . . 2.01 109.963 178.872 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -83.88 -43.57 15.17 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.241 -0.912 . . . . 2.09 111.338 -179.711 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.465 ' CG ' ' HA ' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -70.33 -25.65 63.39 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.084 -1.01 . . . . 1.66 110.834 -179.795 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' A' ' 75' ' ' GLU . . . -55.11 -64.68 4.15 Favored Glycine 0 N--CA 1.498 2.799 0 N-CA-C 109.063 -1.615 . . . . 1.62 109.063 178.918 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.42 ' CD ' ' O ' ' A' ' 68' ' ' SER . 39.6 Cg_endo -65.91 -37.09 28.2 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 124.085 1.571 . . . . 2.24 110.055 178.778 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 6.2 t -60.16 -46.21 90.45 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.992 -1.067 . . . . 2.2 109.656 178.725 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 39.2 t -72.24 -42.49 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.515 -0.741 . . . . 1.39 109.401 178.863 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.518 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -57.65 -41.66 81.9 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.717 0.77 . . . . 2.65 109.283 178.408 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.4 ttt85 -71.3 -45.32 63.34 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.578 -0.701 . . . . 3.65 110.371 179.36 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.25 -44.25 95.42 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.178 -0.951 . . . . 2.37 109.262 179.267 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.5 -49.06 72.83 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.526 0.679 . . . . 1.72 110.849 179.329 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.4 mttp -68.24 -46.57 70.12 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.276 -0.89 . . . . 2.98 111.502 -179.655 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.1 tp . . . . . 0 N--CA 1.495 1.801 0 O-C-N 121.226 -0.921 . . . . 2.85 112.3 -178.672 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.8 t . . . . . 0 N--CA 1.497 1.905 0 N-CA-C 109.346 -0.613 . . . . 1.85 109.346 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.6 t -69.99 -41.93 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.278 -0.889 . . . . 2.71 109.261 178.663 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 77.8 m -58.75 -51.57 69.42 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.699 -0.626 . . . . 2.7 109.928 179.155 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.3 m -65.41 -36.43 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.471 -0.768 . . . . 1.76 109.911 179.42 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.7 mt -66.58 -40.19 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 121.136 -0.977 . . . . 1.65 109.298 178.404 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 36.1 t -64.8 -43.51 96.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.036 -1.04 . . . . 2.49 108.474 177.953 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 87.7 mt -63.68 -46.73 93.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 108.919 -0.771 . . . . 2.38 108.919 178.139 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 44.7 mt -59.56 -49.15 78.87 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.705 -0.85 . . . . 1.38 108.705 178.454 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 31.4 mt -56.27 -42.44 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.557 -0.714 . . . . 1.68 109.386 178.284 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.44 -45.52 83.5 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.461 -0.774 . . . . 2.06 109.663 178.95 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.0 mt -60.09 -46.11 94.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 108.438 -0.949 . . . . 1.96 108.438 178.367 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.62 -48.12 82.31 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.753 -0.462 . . . . 1.15 109.753 178.56 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.48 -44.19 89.27 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.47 -0.769 . . . . 1.43 109.078 178.712 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.01 -46.32 89.7 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.844 -0.799 . . . . 2.85 108.844 178.116 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.98 -42.5 98.35 Favored Glycine 0 N--CA 1.497 2.717 0 N-CA-C 108.899 -1.68 . . . . 1.67 108.899 178.735 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.38 -44.15 95.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.549 -0.971 . . . . 1.14 109.315 178.72 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.4 mt -60.79 -40.84 94.11 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.003 -0.74 . . . . 2.02 109.003 178.289 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.1 mt -67.79 -48.54 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.375 -0.828 . . . . 2.93 109.208 178.445 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.99 -48.43 78.47 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.391 -0.818 . . . . 2.56 109.329 178.848 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.612 0 N-CA-C 110.908 -0.877 . . . . 1.27 110.908 179.876 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.46 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 3.0 mm-40 . . . . . 0 N--CA 1.496 1.832 0 N-CA-C 108.881 -0.785 . . . . 1.76 108.881 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -63.06 -42.06 99.6 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.355 -0.841 . . . . 3.48 109.359 178.277 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 70.4 m -56.26 -35.07 67.02 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.997 -0.44 . . . . 1.61 110.678 179.177 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -91.29 -40.94 11.22 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.166 -0.959 . . . . 1.31 110.777 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 66' ' ' GLN . 3.4 mmtp -64.59 -44.76 89.63 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.576 -0.702 . . . . 2.88 110.746 -179.851 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.41 ' N ' ' HD2' ' A' ' 72' ' ' PRO . . . -46.52 -63.56 3.02 Favored Glycine 0 N--CA 1.502 3.08 0 N-CA-C 110.455 -1.058 . . . . 1.04 110.455 -179.823 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 71' ' ' GLY . 40.2 Cg_endo -65.8 -38.15 24.87 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 O-C-N 123.736 1.387 . . . . 1.39 110.644 179.545 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 10.5 t -60.68 -43.38 97.77 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.023 -1.048 . . . . 1.54 109.496 178.841 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 54.1 t -74.26 -42.95 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.487 -0.758 . . . . 1.4 109.375 178.76 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -56.03 -44.62 78.92 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.701 -0.851 . . . . 1.5 108.701 178.318 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -66.78 -41.61 87.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.854 -0.529 . . . . 2.23 109.805 178.788 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.6 -50.12 75.13 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.432 -0.792 . . . . 3.32 110.095 179.135 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.32 -44.11 92.56 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.61 -0.681 . . . . 1.37 110.642 179.849 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -66.39 -33.63 76.15 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.522 -0.736 . . . . 1.66 110.162 179.488 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.496 1.828 0 O-C-N 121.196 -0.94 . . . . 2.8 111.119 -179.844 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.5 t . . . . . 0 N--CA 1.499 1.984 0 N-CA-C 109.465 -0.569 . . . . 3.03 109.465 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.3 t -67.45 -42.73 87.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.055 -1.028 . . . . 1.92 109.26 178.805 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 66.8 m -60.54 -52.6 64.5 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.685 -0.634 . . . . 1.63 109.812 179.08 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.463 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 23.6 m -64.32 -35.46 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 119.829 -0.748 . . . . 2.22 109.834 179.397 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.735 ' HA ' HD23 ' A' ' 21' ' ' LEU . 9.8 mt -68.71 -41.78 82.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 120.935 -1.103 . . . . 2.85 109.042 178.432 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.8 t -64.04 -42.28 95.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.391 -0.966 . . . . 1.53 108.391 178.063 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 83.3 mt -64.68 -50.09 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.483 -0.761 . . . . 1.59 109.153 178.51 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.735 HD23 ' HA ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -61.86 -41.16 97.5 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.878 -0.786 . . . . 2.52 108.878 178.827 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.572 ' N ' ' HG ' ' A' ' 21' ' ' LEU . 7.4 mm -60.97 -44.19 97.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.44 -0.948 . . . . 2.82 108.44 177.945 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.77 -44.86 88.7 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.546 -0.721 . . . . 2.04 109.689 178.817 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.9 mm -59.68 -49.59 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.421 -0.955 . . . . 2.1 108.421 178.434 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.1 -44.9 96.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.794 -0.566 . . . . 2.68 110.002 178.949 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.73 -43.44 98.84 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.571 -0.706 . . . . 2.9 109.251 178.683 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.1 tt -63.24 -46.97 84.44 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.029 -0.73 . . . . 2.73 109.029 178.24 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.38 -44.61 96.47 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 108.708 -1.757 . . . . 2.9 108.708 178.617 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.67 -40.9 96.2 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.609 -0.936 . . . . 3.52 109.573 178.691 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.5 mt -61.33 -43.13 99.4 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.105 -0.702 . . . . 3.83 109.105 178.536 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 35.4 mt -67.84 -49.26 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.451 -0.781 . . . . 3.42 109.469 179.005 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.72 -39.2 90.69 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.658 -0.652 . . . . 3.8 110.391 179.313 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.689 0 N-CA-C 110.244 -1.142 . . . . 4.46 110.244 179.86 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 . . . . . 0 N--CA 1.494 1.746 0 N-CA-C 108.911 -0.774 . . . . 4.58 108.911 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.29 -48.36 70.63 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.967 -0.753 . . . . 5.29 108.967 178.412 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.43 -30.71 60.99 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 116.31 -0.405 . . . . 1.73 111.269 179.746 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.596 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -92.87 -48.18 6.67 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.125 -0.984 . . . . 2.26 109.842 179.311 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.9 mmpp? -59.58 -51.41 69.95 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.685 -0.635 . . . . 3.75 111.511 -179.656 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.41 ' N ' ' HD2' ' A' ' 72' ' ' PRO . . . -42.87 -63.05 2.09 Favored Glycine 0 N--CA 1.504 3.231 0 N-CA-C 110.091 -1.203 . . . . 1.75 110.091 -179.631 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.524 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 41.1 Cg_endo -66.18 -40.21 16.03 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 O-C-N 123.721 1.379 . . . . 1.24 110.445 178.931 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.596 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 0.7 OUTLIER -62.28 -46.31 89.37 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.731 -1.23 . . . . 2.31 109.786 179.125 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.472 ' O ' ' HG3' ' A' ' 77' ' ' LYS . 39.0 t -64.85 -49.79 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.694 -0.854 . . . . 2.57 108.694 178.819 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.409 ' OE1' ' NZ ' ' A' ' 79' ' ' LYS . 8.6 tp10 -56.58 -40.67 75.63 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.221 0.534 . . . . 3.53 110.084 179.025 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.524 ' HB2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -63.7 -52.98 58.17 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.514 -0.741 . . . . 2.57 110.227 179.919 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.561 ' HG3' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -66.7 -31.87 72.81 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.334 -0.946 . . . . 3.21 109.778 179.552 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.561 ' N ' ' HG3' ' A' ' 77' ' ' LYS . . . -66.55 -46.69 75.26 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.202 -1.036 . . . . 2.56 108.202 177.678 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.409 ' NZ ' ' OE1' ' A' ' 75' ' ' GLU . 7.8 mmtp -66.43 -40.79 89.72 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.05 -0.722 . . . . 3.45 109.05 178.128 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.497 1.923 0 O-C-N 121.301 -0.875 . . . . 2.48 110.504 179.26 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.9 t . . . . . 0 N--CA 1.499 2.012 0 N-CA-C 109.477 -0.564 . . . . 1.5 109.477 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.2 t -68.16 -43.67 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.199 -0.938 . . . . 1.69 109.363 178.77 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 53.1 m -58.53 -50.99 71.78 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.628 -0.67 . . . . 1.91 110.164 179.436 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.5 m -66.87 -33.68 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.371 -0.831 . . . . 1.63 110.271 179.654 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.2 mm -69.25 -41.4 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 120.892 -1.13 . . . . 1.51 109.29 178.468 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.6 t -64.83 -44.15 96.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 108.413 -0.958 . . . . 1.77 108.413 177.952 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 21.8 mm -62.97 -46.91 95.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.479 -0.763 . . . . 2.1 109.059 178.29 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.8 mt -59.98 -48.82 80.13 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.912 -0.773 . . . . 1.75 108.912 178.378 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.5 mm -57.45 -44.03 83.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.533 -0.729 . . . . 1.58 109.412 178.503 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.47 -45.04 92.61 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.529 -0.732 . . . . 1.42 109.718 179.008 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 37.6 mt -60.55 -45.39 97.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.418 -0.801 . . . . 1.82 109.004 178.667 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.57 -45.57 89.87 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.48 -0.763 . . . . 1.14 109.753 178.929 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.68 -43.87 97.17 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.8 -0.815 . . . . 1.18 108.8 178.516 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.719 ' C ' HD13 ' A' ' 27' ' ' LEU . 3.0 tm? -60.04 -52.06 66.99 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.834 -0.802 . . . . 1.92 108.834 178.076 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.91 -44.66 82.21 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.033 -1.627 . . . . 1.19 109.033 178.68 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.6 -43.57 96.53 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.496 -1.002 . . . . 1.15 109.878 179.071 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.8 mt -59.76 -40.78 89.35 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.498 -0.556 . . . . 1.69 109.498 178.967 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.7 mt -71.54 -44.89 70.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.464 -0.773 . . . . 2.25 109.385 178.977 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.37 -48.44 81.64 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.301 -0.875 . . . . 2.08 109.667 179.138 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.838 0 N-CA-C 109.663 -1.375 . . . . 1.11 109.663 179.252 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 . . . . . 0 N--CA 1.493 1.71 0 N-CA-C 108.783 -0.821 . . . . 2.21 108.783 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -66.06 -43.3 87.84 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.597 -0.689 . . . . 4.31 109.46 178.28 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 69.7 m -58.45 -40.5 82.78 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.9 -0.5 . . . . 2.17 110.393 179.342 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.518 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -83.71 -44.86 14.03 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.325 -0.86 . . . . 1.47 111.05 -179.948 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.3 mmtp -61.61 -45.7 92.96 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.384 -0.823 . . . . 1.89 111.128 -179.613 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -43.02 -64.9 1.56 Allowed Glycine 0 N--CA 1.506 3.319 0 N-CA-C 110.679 -0.968 . . . . 1.38 110.679 -179.397 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.418 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 40.6 Cg_endo -65.51 -38.59 24.81 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 O-C-N 123.779 1.41 . . . . 1.44 110.45 179.41 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.518 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -62.14 -46.36 89.38 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.964 -1.085 . . . . 1.45 109.571 178.8 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.7 t -68.37 -45.4 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 109.004 -0.739 . . . . 1.41 109.004 178.672 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.416 ' O ' ' HG3' ' A' ' 79' ' ' LYS . 2.6 tm-20 -56.9 -43.38 81.29 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.502 0.668 . . . . 1.7 109.559 178.549 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.418 ' HD2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -64.99 -48.32 74.38 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.728 -0.607 . . . . 2.26 109.683 178.925 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.58 -42.67 97.18 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.583 -0.698 . . . . 1.91 110.187 179.789 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.03 -41.98 97.25 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.866 -0.521 . . . . 1.16 109.657 179.125 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 75' ' ' GLU . 5.0 mttp -68.07 -47.58 67.91 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.29 -0.633 . . . . 1.98 109.29 178.67 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.712 0 O-C-N 121.425 -0.797 . . . . 1.84 109.63 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.758 0 N-CA-C 109.956 -1.258 . . . . 6.4 109.956 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.88 141.5 37.59 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.279 -1.13 . . . . 5.84 110.57 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.569 ' O ' ' HB3' ' A' ' 4' ' ' SER . 5.7 mtt -93.88 79.97 4.16 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.443 -0.786 . . . . 7.94 109.825 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.569 ' HB3' ' O ' ' A' ' 3' ' ' MET . 11.1 t 67.88 -60.6 0.4 Allowed 'General case' 0 N--CA 1.506 2.342 0 N-CA-C 109.192 -0.67 . . . . 7.34 109.192 -178.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.521 HD12 ' C ' ' A' ' 5' ' ' ILE . 2.0 pp -82.53 -153.69 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 107.606 -1.257 . . . . 5.29 107.606 177.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.489 ' HB3' ' OG ' ' A' ' 9' ' ' SER . 8.3 mtt -124.63 63.63 1.11 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 119.623 -1.923 . . . . 4.11 112.127 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -67.22 -36.96 82.78 Favored 'General case' 0 N--CA 1.506 2.347 0 CA-C-O 121.532 0.682 . . . . 4.54 109.382 177.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -82.57 18.01 1.63 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.564 -0.71 . . . . 4.95 110.61 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.489 ' OG ' ' HB3' ' A' ' 6' ' ' MET . 9.1 p -113.3 159.39 35.24 Favored Pre-proline 0 N--CA 1.491 1.619 0 N-CA-C 108.198 -1.038 . . . . 1.85 108.198 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -74.34 43.17 0.85 Allowed 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 122.577 0.777 . . . . 2.97 111.615 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -65.15 -37.37 87.19 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.035 -1.041 . . . . 3.16 108.783 178.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.0 p -60.99 -38.32 85.59 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.25 -0.906 . . . . 2.3 108.71 177.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.493 ' O ' HG22 ' A' ' 17' ' ' VAL . . . -71.06 -51.54 17.92 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 108.69 -1.764 . . . . 1.97 108.69 178.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 54.2 t -55.79 -40.25 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.645 -0.915 . . . . 2.17 109.02 178.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.7 t -69.89 -42.84 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.202 -0.937 . . . . 1.96 109.036 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 49.6 m -58.98 -51.36 70.39 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.771 -0.581 . . . . 1.87 109.985 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 13' ' ' GLY . 29.1 m -66.95 -33.17 61.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.387 -0.821 . . . . 1.89 110.271 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.41 ' HA ' HD13 ' A' ' 18' ' ' ILE . 6.9 mm -69.64 -41.13 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 120.925 -1.109 . . . . 2.01 109.091 178.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.3 t -64.76 -45.07 96.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 108.291 -1.003 . . . . 1.74 108.291 177.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.417 HD13 ' HA ' ' A' ' 20' ' ' ILE . 23.6 mm -62.06 -46.79 95.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.85 -0.796 . . . . 1.72 108.85 178.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 13.1 mt -59.75 -49.67 76.81 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.849 -0.797 . . . . 1.89 108.849 178.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.0 mt -56.44 -43.1 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.575 -0.703 . . . . 2.02 109.293 178.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.68 -46.84 83.69 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.588 -0.695 . . . . 1.48 109.536 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.1 mt -58.64 -48.29 86.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.446 -0.783 . . . . 1.7 108.978 178.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.61 -45.37 94.27 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.62 -0.675 . . . . 1.53 109.937 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.4 -45.37 93.83 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 109.071 -0.714 . . . . 1.46 109.071 178.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.27 -47.1 87.55 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.014 -0.735 . . . . 1.65 109.014 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.15 -44.26 94.91 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 108.88 -1.688 . . . . 1.31 108.88 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.14 -45.73 92.14 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.409 -1.053 . . . . 1.36 109.414 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.494 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 6.4 mt -57.58 -41.8 81.85 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.297 -0.631 . . . . 1.61 109.297 178.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.576 HG22 ' HA ' ' A' ' 37' ' ' TYR . 45.6 mt -71.36 -36.04 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.302 -0.874 . . . . 1.31 110.09 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.475 ' HA ' ' N ' ' A' ' 37' ' ' TYR . 7.6 tt -68.06 -45.19 74.54 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.234 -0.916 . . . . 1.67 109.825 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -73.07 -40.33 51.29 Favored Glycine 0 N--CA 1.498 2.812 0 O-C-N 121.169 -0.957 . . . . 1.26 111.469 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -83.45 -33.98 25.53 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 120.854 -1.38 . . . . 1.37 112.015 -178.714 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.508 ' CD2' ' HG3' ' A' ' 39' ' ' ARG . 9.2 m0 -129.86 19.23 5.57 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.786 -1.196 . . . . 1.72 112.053 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.3 m 50.98 32.24 7.24 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.214 -0.929 . . . . 1.71 110.117 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.576 ' HA ' HG22 ' A' ' 31' ' ' ILE . 0.1 OUTLIER 54.46 25.52 6.21 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.521 -0.737 . . . . 1.6 110.67 -179.028 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 11.8 tp -128.44 -46.27 1.33 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.436 -0.79 . . . . 1.57 110.032 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.508 ' HG3' ' CD2' ' A' ' 35' ' ' TRP . 9.0 ttp-105 46.11 43.23 10.7 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.855 -0.528 . . . . 1.2 111.503 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 51.85 58.6 5.29 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.415 -0.803 . . . . 2.47 110.838 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -79.44 -14.17 59.1 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.108 -0.995 . . . . 1.43 111.077 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.29 -139.62 0.07 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.115 -0.99 . . . . 2.03 109.851 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.251 0.3 OUTLIER -62.84 -23.94 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 O-C-N 120.793 -1.192 . . . . 3.15 110.517 179.386 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.8 t 61.39 -163.02 0.27 Allowed 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.414 -0.804 . . . . 2.49 111.29 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 42.86 41.23 2.45 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.496 -0.753 . . . . 5.02 110.829 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 175.7 -42.11 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.693 -0.63 . . . . 2.78 109.816 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -63.59 148.65 48.31 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.767 -0.583 . . . . 2.23 110.669 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -102.74 -148.02 0.38 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.61 -0.681 . . . . 3.12 110.088 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.452 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 0.4 OUTLIER -73.74 122.69 22.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.949 -1.094 . . . . 2.37 109.994 179.85 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.415 ' HG2' ' HE2' ' A' ' 67' ' ' TYR . 42.0 tt0 -106.07 86.52 2.39 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.259 -0.9 . . . . 1.47 110.737 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.428 ' HB2' ' CE1' ' A' ' 37' ' ' TYR . 9.5 t -174.8 -40.72 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.411 0 O-C-N 121.322 -0.861 . . . . 1.77 110.263 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.6 mt -117.47 -58.57 3.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.658 -0.652 . . . . 2.65 109.984 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.4 p -98.46 -36.04 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 O-C-N 121.468 -0.77 . . . . 2.62 111.743 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.452 ' HA3' ' O ' ' A' ' 49' ' ' GLU . . . -71.81 -34.88 62.17 Favored Glycine 0 N--CA 1.5 2.951 0 N-CA-C 108.975 -1.65 . . . . 1.7 108.975 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -168.23 109.76 0.56 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.775 -0.838 . . . . 1.56 109.76 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 155.99 -55.92 0.4 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.062 -1.615 . . . . 2.08 109.062 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -131.37 14.0 5.05 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.825 -0.809 . . . . 3.74 111.085 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.45 -45.59 92.4 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.046 -1.034 . . . . 2.46 110.359 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.43 ' O ' ' HB2' ' A' ' 60' ' ' GLU . 49.4 tttm -147.4 124.04 11.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.32 -0.862 . . . . 3.68 111.07 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.43 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 1.3 mp0 60.22 163.28 0.1 OUTLIER Pre-proline 0 N--CA 1.506 2.356 0 N-CA-C 112.535 0.569 . . . . 4.16 112.535 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -75.49 -7.21 18.54 Favored 'Trans proline' 0 CA--C 1.547 1.172 0 O-C-N 123.372 1.196 . . . . 2.55 110.167 178.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -55.39 -51.62 66.22 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.441 -0.787 . . . . 3.43 111.153 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 36.9 mt -60.27 -30.8 69.69 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.546 -0.721 . . . . 1.67 110.687 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.2 -59.2 5.84 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.437 -0.789 . . . . 2.86 109.808 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.409 ' HA ' ' HB3' ' A' ' 68' ' ' SER . 27.1 m -66.16 -31.35 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.247 -0.908 . . . . 2.52 109.757 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -61.9 -49.31 76.7 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.477 -0.765 . . . . 1.78 109.086 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.574 ' HA ' ' HG2' ' A' ' 70' ' ' LYS . 4.6 t80 -72.7 -35.61 67.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.781 -0.574 . . . . 1.57 109.48 178.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.409 ' HB3' ' HA ' ' A' ' 65' ' ' VAL . 23.0 t -61.71 -31.15 71.28 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.644 -0.66 . . . . 2.48 109.744 178.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.544 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -93.78 -50.29 5.43 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.253 -0.904 . . . . 2.27 110.868 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.574 ' HG2' ' HA ' ' A' ' 67' ' ' TYR . 5.0 pttt -70.68 -36.22 73.21 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.267 -0.896 . . . . 1.81 111.225 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.449 ' N ' ' HD2' ' A' ' 72' ' ' PRO . . . -46.6 -61.67 4.08 Favored Glycine 0 N--CA 1.498 2.83 0 N-CA-C 109.277 -1.529 . . . . 1.58 109.277 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.497 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 41.5 Cg_endo -67.23 -42.48 7.64 Favored 'Trans proline' 0 C--N 1.314 -1.242 0 O-C-N 124.039 1.547 . . . . 2.28 110.102 178.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.544 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -56.71 -44.54 81.66 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.959 -1.088 . . . . 2.73 109.815 178.876 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.404 ' HA ' ' HG2' ' A' ' 77' ' ' LYS . 25.0 t -71.05 -49.07 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.479 -0.763 . . . . 1.89 109.387 178.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 0.6 OUTLIER -55.26 -39.04 69.33 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.746 -0.596 . . . . 2.18 110.078 179.31 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.497 ' HD2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -68.37 -55.04 13.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.482 -0.761 . . . . 2.94 109.434 178.774 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.626 ' HG3' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -59.91 -31.27 69.67 Favored 'General case' 0 N--CA 1.505 2.282 0 C-N-CA 119.446 -0.902 . . . . 3.29 110.281 179.592 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.626 ' N ' ' HG3' ' A' ' 77' ' ' LYS . . . -71.13 -41.9 69.91 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.559 -0.713 . . . . 2.23 109.601 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 32.5 mttp -73.74 -34.58 64.82 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.441 -0.577 . . . . 2.74 109.441 178.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 71.6 mt -68.62 -38.84 80.88 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.987 -1.071 . . . . 3.73 110.131 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 5.2 ttt -86.68 -43.6 12.48 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.54 -0.725 . . . . 4.4 111.23 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.1 p -116.24 160.36 36.09 Favored Pre-proline 0 N--CA 1.51 2.574 0 O-C-N 121.037 -1.039 . . . . 2.89 110.626 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.9 -33.09 65.13 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 O-C-N 123.357 1.188 . . . . 2.3 111.903 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 51.42 25.42 2.62 Favored 'General case' 0 N--CA 1.508 2.458 0 O-C-N 121.476 -0.765 . . . . 2.56 111.674 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.403 ' HA2' ' HD2' ' A' ' 86' ' ' PRO . . . -126.87 100.33 0.56 Allowed Glycine 0 N--CA 1.499 2.848 0 N-CA-C 109.159 -1.576 . . . . 2.36 109.159 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.403 ' HD2' ' HA2' ' A' ' 85' ' ' GLY . 36.4 Cg_endo -58.72 -14.74 23.0 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 O-C-N 123.772 1.406 . . . . 3.36 111.64 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -65.95 -23.46 66.61 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.132 -0.98 . . . . 3.58 108.78 177.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 8.4 p -134.64 -16.78 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.474 -0.766 . . . . 3.85 111.519 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -175.63 174.65 2.21 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 120.631 -1.293 . . . . 4.22 111.585 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.456 0 N-CA-C 109.197 -1.561 . . . . 3.95 109.197 178.43 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.649 0 N-CA-C 109.309 -1.516 . . . . 3.67 109.309 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 57.81 44.87 19.52 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 121.632 -0.922 . . . . 5.38 110.667 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -97.99 167.4 10.93 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.15 -0.969 . . . . 3.5 110.814 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.3 p -81.36 -30.86 33.61 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.169 -0.957 . . . . 3.87 110.16 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.539 HD12 ' C ' ' A' ' 5' ' ' ILE . 1.8 pp -96.07 -156.37 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.586 -0.696 . . . . 3.16 109.72 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.74 111.82 1.59 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.807 -1.183 . . . . 3.82 110.609 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -65.29 -20.42 66.4 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.532 -0.73 . . . . 2.58 110.922 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -88.3 25.64 1.6 Allowed 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.173 -0.955 . . . . 3.03 110.59 178.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.43 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 0.4 OUTLIER -123.08 104.11 35.68 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 120.931 -1.106 . . . . 1.86 110.802 -179.609 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 9' ' ' SER . 40.0 Cg_endo -67.38 -46.74 2.62 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 O-C-N 123.477 1.251 . . . . 1.64 110.993 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.4 p -68.76 -61.66 1.72 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.471 -0.768 . . . . 1.71 109.742 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.17 -36.85 63.82 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.441 -0.787 . . . . 1.5 110.362 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.74 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -65.95 -59.14 7.83 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.175 -1.57 . . . . 1.12 109.175 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 36.5 t -54.48 -40.82 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.481 -1.011 . . . . 1.31 109.347 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.7 t -62.81 -46.0 97.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.567 -0.708 . . . . 1.3 109.159 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.451 ' OG1' HG12 ' A' ' 5' ' ' ILE . 65.6 m -56.64 -46.66 80.9 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 121.206 0.527 . . . . 1.1 109.692 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 13' ' ' GLY . 2.6 t -65.25 -40.71 89.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 C-N-CA 119.695 -0.802 . . . . 0.99 109.175 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.4 mm -60.98 -40.13 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.122 -0.986 . . . . 1.24 109.039 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 49.7 t -65.58 -45.58 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.181 -1.044 . . . . 1.01 108.181 177.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 85.8 mt -61.28 -49.53 84.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.915 -0.772 . . . . 1.01 108.915 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 11.2 mt -57.71 -48.7 78.84 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.987 -0.746 . . . . 1.14 108.987 178.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.3 mt -56.95 -44.01 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 C-N-CA 119.845 -0.742 . . . . 1.17 109.195 178.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.36 -45.99 88.6 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.599 -0.688 . . . . 0.94 109.752 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.5 mt -59.2 -47.26 90.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.327 -0.858 . . . . 1.02 108.984 178.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.0 -44.95 95.64 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.591 -0.693 . . . . 0.95 109.849 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.97 -44.71 96.93 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.54 -0.725 . . . . 1.08 109.237 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.56 -45.92 90.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.44 -0.788 . . . . 1.36 108.924 178.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.47 -43.98 95.6 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 108.69 -1.764 . . . . 1.01 108.69 178.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.68 -45.13 84.03 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.611 -0.935 . . . . 1.1 109.748 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.484 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 5.0 mt -58.52 -41.43 85.44 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.758 -0.589 . . . . 1.57 109.426 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 40.8 mt -69.32 -48.08 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.54 -0.725 . . . . 1.4 109.478 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.83 -49.8 75.45 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.585 -0.697 . . . . 1.85 110.189 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.75 -46.87 92.76 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 110.452 -1.059 . . . . 1.26 110.452 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -63.5 -35.37 80.24 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.317 -1.107 . . . . 1.74 111.054 -179.687 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 5.9 m95 -82.94 -58.81 2.71 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.227 -0.921 . . . . 2.02 110.8 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 41.97 45.9 3.41 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.72 -0.612 . . . . 1.39 111.971 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -177.65 -39.44 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.387 0 O-C-N 121.437 -0.789 . . . . 1.31 110.717 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.404 ' O ' ' CB ' ' A' ' 39' ' ' ARG . 6.6 tp -127.63 -57.2 1.28 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.176 -0.952 . . . . 1.31 109.887 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.513 ' CZ ' ' HB3' ' A' ' 39' ' ' ARG . 0.0 OUTLIER 68.07 95.87 0.06 Allowed 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.604 0.716 . . . . 1.34 110.977 179.582 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.47 84.96 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.501 -0.75 . . . . 2.02 110.251 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.08 -24.65 58.2 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.326 -0.859 . . . . 2.04 111.327 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.53 -125.42 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.195 -0.94 . . . . 2.97 110.171 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.253 0.1 OUTLIER -67.59 -23.08 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 120.892 -1.13 . . . . 2.75 111.294 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 62.2 79.58 0.25 Allowed 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.429 -0.794 . . . . 1.77 110.652 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -96.37 32.08 2.08 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.298 -0.877 . . . . 2.08 110.288 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 61.96 50.26 4.23 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.642 -0.661 . . . . 1.18 109.486 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.692 ' HA ' ' SG ' ' A' ' 73' ' ' CYS . 1.0 OUTLIER -104.27 171.39 7.36 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.547 0.689 . . . . 1.46 111.887 -178.722 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.4 ' OD1' ' HB2' ' A' ' 70' ' ' LYS . 28.8 m-20 -78.2 112.52 15.26 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.359 -0.838 . . . . 1.65 110.591 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.01 175.0 10.78 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.266 -0.896 . . . . 1.38 110.973 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.64 ' HG3' HG13 ' A' ' 53' ' ' VAL . 0.4 OUTLIER 61.59 92.68 0.05 Allowed 'General case' 0 N--CA 1.502 2.139 0 CA-C-O 121.498 0.666 . . . . 1.22 110.962 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.4 p -106.01 -74.65 0.65 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.034 -1.041 . . . . 2.16 111.075 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.445 ' H ' HG23 ' A' ' 52' ' ' ILE . 16.3 pt -53.98 -39.16 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.591 -0.693 . . . . 2.0 111.723 -178.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.64 HG13 ' HG3' ' A' ' 50' ' ' GLU . 13.5 p -94.58 -27.31 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 121.087 -1.008 . . . . 1.72 111.076 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.08 77.0 0.57 Allowed Glycine 0 N--CA 1.497 2.746 0 N-CA-C 109.501 -1.44 . . . . 1.13 109.501 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.7 t70 67.07 -64.2 0.26 Allowed 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.987 -0.714 . . . . 2.02 110.872 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 121.22 -44.85 1.29 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 106.568 -2.613 . . . . 2.38 106.568 -178.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.532 ' O ' ' HB ' ' A' ' 58' ' ' THR . 2.0 pt-20 -125.06 -16.09 6.15 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 122.177 -0.602 . . . . 3.17 110.805 178.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.532 ' HB ' ' O ' ' A' ' 57' ' ' GLU . 31.8 m 72.22 124.93 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.518 0 CA-C-O 121.595 0.712 . . . . 1.75 110.515 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.405 ' HB3' ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -71.68 161.01 31.65 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.103 -0.998 . . . . 2.04 111.11 -179.097 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.626 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -48.76 -54.06 30.96 Favored Pre-proline 0 N--CA 1.504 2.23 0 O-C-N 121.546 -0.721 . . . . 2.74 111.693 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.626 ' HD3' ' HB3' ' A' ' 60' ' ' GLU . 39.8 Cg_endo -65.55 -25.31 55.18 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 O-C-N 123.29 1.153 . . . . 1.76 110.962 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.488 ' O ' ' HB2' ' A' ' 66' ' ' GLN . 2.8 m-85 -83.19 -41.69 18.14 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.036 -1.04 . . . . 2.61 110.621 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.594 HD23 ' HA ' ' A' ' 60' ' ' GLU . 0.9 OUTLIER -66.91 -30.6 70.8 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.185 -0.947 . . . . 1.91 109.957 179.28 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.438 ' N ' ' HG ' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -61.62 -53.55 54.68 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.667 -0.646 . . . . 2.7 110.385 179.349 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.0 m -72.65 -31.59 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.018 -1.051 . . . . 1.82 109.998 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.488 ' HB2' ' O ' ' A' ' 62' ' ' PHE . 2.0 tt0 -65.27 -44.84 86.75 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.434 -0.792 . . . . 1.52 109.35 178.358 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.542 ' HA ' ' HG2' ' A' ' 70' ' ' LYS . 0.5 OUTLIER -68.84 -41.77 78.08 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.885 -0.783 . . . . 3.16 108.885 178.201 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 68.4 m -60.33 -37.89 82.03 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 116.19 -0.459 . . . . 1.82 110.375 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.62 -41.58 16.23 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.278 -0.889 . . . . 1.4 110.726 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.625 ' HA ' ' HB3' ' A' ' 73' ' ' CYS . 0.2 OUTLIER -65.82 -35.08 79.67 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.38 -0.825 . . . . 1.08 111.5 -179.59 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.435 ' N ' ' HD2' ' A' ' 72' ' ' PRO . . . -48.97 -61.36 5.37 Favored Glycine 0 N--CA 1.505 3.259 0 N-CA-C 109.715 -1.354 . . . . 1.19 109.715 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 71' ' ' GLY . 40.9 Cg_endo -66.97 -39.54 13.78 Favored 'Trans proline' 0 C--N 1.315 -1.225 0 O-C-N 123.755 1.397 . . . . 1.52 109.864 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.692 ' SG ' ' HA ' ' A' ' 47' ' ' GLU . 2.6 t -62.17 -48.5 79.78 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.878 -1.139 . . . . 1.31 109.609 178.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.7 ' HA ' ' HE3' ' A' ' 77' ' ' LYS . 25.4 t -57.98 -49.93 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.286 -1.005 . . . . 1.06 108.286 178.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -57.47 -40.05 77.7 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.763 -0.775 . . . . 1.58 109.318 177.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.9 ttm180 -63.78 -54.88 28.21 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.694 -0.629 . . . . 1.51 111.187 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.7 ' HE3' ' HA ' ' A' ' 74' ' ' VAL . 1.6 pttt -70.62 -33.12 70.68 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.02 -1.05 . . . . 1.75 110.605 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.405 ' N ' ' HG3' ' A' ' 77' ' ' LYS . . . -68.07 -47.77 67.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.327 -0.858 . . . . 1.51 109.636 178.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 16.4 mmtm -67.23 -44.53 79.26 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.377 -0.827 . . . . 1.79 109.805 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 tp -61.99 -34.42 76.14 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.628 -0.67 . . . . 2.56 111.155 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.2 ttt -95.36 -60.8 1.59 Allowed 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.354 -0.841 . . . . 3.93 110.376 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.426 ' O ' HG23 ' A' ' 82' ' ' THR . 1.5 t -177.69 104.46 0.22 Allowed Pre-proline 0 N--CA 1.503 2.185 0 O-C-N 121.518 -0.739 . . . . 2.28 110.078 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -69.31 -6.15 17.66 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 O-C-N 123.822 1.433 . . . . 1.78 111.383 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 53.99 26.0 5.97 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.269 -0.894 . . . . 3.57 110.515 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -128.66 -159.08 9.86 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.93 -1.268 . . . . 2.02 109.93 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -74.09 -20.33 19.29 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 O-C-N 123.684 1.36 . . . . 2.83 112.132 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -50.59 -51.02 52.22 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.358 -0.839 . . . . 2.65 109.79 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -112.34 2.09 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.623 -0.673 . . . . 2.63 110.637 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 3.3 m80 56.35 47.33 19.26 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.367 -0.833 . . . . 3.75 110.892 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 3.015 0 CA-C-O 118.349 -1.25 . . . . 3.68 110.209 179.816 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.767 0 N-CA-C 109.963 -1.255 . . . . 1.87 109.963 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.463 ' HB3' HG13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -87.68 160.23 18.2 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.177 -1.19 . . . . 2.91 110.369 179.574 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.448 ' HG2' HG23 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -81.45 71.79 8.46 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.112 -0.993 . . . . 2.59 111.772 -179.546 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 46.37 50.22 12.53 Favored 'General case' 0 N--CA 1.509 2.52 0 O-C-N 121.559 -0.713 . . . . 2.0 112.58 178.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.617 HD12 ' C ' ' A' ' 5' ' ' ILE . 2.0 pp -99.7 -167.96 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 120.914 -1.116 . . . . 1.55 110.513 178.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.523 ' HB2' HD12 ' A' ' 5' ' ' ILE . 0.1 OUTLIER 60.1 -154.1 0.37 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.415 -0.803 . . . . 2.44 110.77 -179.57 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 55.66 27.09 10.08 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.388 -0.82 . . . . 2.13 111.214 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.471 ' ND1' ' HA ' ' A' ' 87' ' ' GLU . 2.9 t-160 -60.5 -27.88 67.94 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 121.222 -0.923 . . . . 1.35 111.467 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.603 ' O ' HG22 ' A' ' 12' ' ' THR . 12.0 t -167.14 151.54 6.65 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.319 -0.863 . . . . 1.9 110.191 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.76 -17.75 47.43 Favored 'Trans proline' 0 N--CA 1.491 1.331 0 O-C-N 123.562 1.296 . . . . 1.67 110.523 179.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.3 p -59.33 -51.6 69.26 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.476 -0.765 . . . . 1.7 109.939 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.603 HG22 ' O ' ' A' ' 9' ' ' SER . 4.9 t -61.31 -31.6 71.45 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.357 -0.84 . . . . 1.64 109.961 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.688 ' O ' HG22 ' A' ' 17' ' ' VAL . . . -70.81 -53.83 10.86 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 108.024 -2.031 . . . . 1.39 108.024 178.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.468 ' O ' HG23 ' A' ' 18' ' ' ILE . 37.9 t -55.11 -39.49 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.852 -0.793 . . . . 1.63 109.289 178.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.637 ' HA ' HG12 ' A' ' 18' ' ' ILE . 25.0 t -67.09 -37.73 79.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.326 -0.859 . . . . 1.59 109.468 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 98.4 m -64.61 -44.07 91.74 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.377 -0.827 . . . . 2.0 110.29 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.688 HG22 ' O ' ' A' ' 13' ' ' GLY . 0.5 OUTLIER -71.48 -37.39 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 C-N-CA 119.133 -1.027 . . . . 1.98 110.908 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.777 ' HA ' HD23 ' A' ' 21' ' ' LEU . 8.7 pt -69.19 -33.74 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 120.299 -1.501 . . . . 1.92 109.52 178.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.501 ' N ' HG13 ' A' ' 18' ' ' ILE . 38.6 t -69.63 -44.3 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.287 -1.005 . . . . 1.57 108.287 177.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.6 mm -63.52 -46.78 94.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.401 -0.812 . . . . 1.7 109.027 178.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.777 HD23 ' HA ' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -63.28 -43.47 97.82 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.515 -0.74 . . . . 1.71 109.031 178.811 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.569 ' N ' ' HG ' ' A' ' 21' ' ' LEU . 7.5 mm -62.14 -39.07 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.029 -1.044 . . . . 1.84 109.0 178.218 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.29 -51.0 61.74 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.549 -0.719 . . . . 1.45 110.715 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.605 HG12 ' HA ' ' A' ' 21' ' ' LEU . 40.8 pt -62.36 -37.12 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.807 -1.183 . . . . 1.78 109.266 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.514 ' N ' HG13 ' A' ' 24' ' ' ILE . . . -65.15 -46.59 80.27 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.418 -0.801 . . . . 1.54 109.192 178.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.6 -43.08 99.53 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.697 -0.853 . . . . 1.52 108.697 178.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.3 tt -60.38 -48.17 82.91 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.953 -0.758 . . . . 1.68 108.953 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.72 -46.58 92.07 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 108.839 -1.705 . . . . 1.34 108.839 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.69 -42.98 99.66 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.456 -1.026 . . . . 1.54 109.558 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 6.4 mt -61.2 -41.3 96.58 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 109.085 -0.709 . . . . 1.83 109.085 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 23.5 mm -65.35 -46.14 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.519 -0.738 . . . . 1.43 109.142 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.496 ' O ' ' HB2' ' A' ' 36' ' ' CYS . 0.2 OUTLIER -61.18 -48.61 80.77 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.543 -0.723 . . . . 1.97 109.63 178.846 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.52 -37.01 92.64 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 110.017 -1.233 . . . . 1.42 110.017 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -74.68 -42.9 57.6 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.447 -1.031 . . . . 1.24 111.049 -179.82 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.457 ' CZ2' ' HA ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -153.9 58.25 0.73 Allowed 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.364 -0.835 . . . . 1.47 112.45 -179.011 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 32' ' ' LEU . 49.6 t -61.78 -26.61 68.2 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 120.65 -1.281 . . . . 1.87 111.527 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.31 -169.0 2.29 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.107 -0.995 . . . . 3.58 109.371 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.9 tp -51.07 -36.33 39.5 Favored 'General case' 0 N--CA 1.508 2.452 0 O-C-N 120.954 -1.091 . . . . 1.98 110.67 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.418 ' HB3' ' CD1' ' A' ' 35' ' ' TRP . 0.3 OUTLIER 45.44 72.61 0.2 Allowed 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 121.587 0.708 . . . . 1.41 111.748 179.147 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.53 -34.52 50.23 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.408 -0.807 . . . . 2.24 110.977 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.44 ' HG3' ' HA ' ' A' ' 44' ' ' SER . 26.8 tt0 -71.94 55.97 0.3 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.04 -1.038 . . . . 2.15 109.741 178.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.457 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . 0.7 OUTLIER -60.32 -76.77 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.411 -0.805 . . . . 1.45 108.989 179.625 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.423 HD11 ' O ' ' A' ' 47' ' ' GLU 0.27 0.3 OUTLIER -76.88 -22.48 14.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.633 -0.667 . . . . 2.13 110.248 178.834 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.44 ' HA ' ' HG3' ' A' ' 41' ' ' GLN . 10.6 t 64.42 -67.59 0.11 Allowed 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.491 -0.755 . . . . 1.56 111.493 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.412 ' HB2' ' OE1' ' A' ' 47' ' ' GLU . 0.7 OUTLIER -99.39 -89.13 0.33 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.815 -1.178 . . . . 1.95 111.063 -179.69 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.4 m 178.46 50.29 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.375 0 O-C-N 121.016 -1.053 . . . . 2.33 110.677 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.423 ' O ' HD11 ' A' ' 43' ' ' ILE . 1.3 pm0 -111.95 -164.14 0.9 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.257 -0.902 . . . . 2.36 110.577 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.04 143.3 26.94 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.846 -1.159 . . . . 2.84 110.418 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.471 ' HG2' ' N ' ' A' ' 50' ' ' GLU . 22.7 tt0 -160.94 157.74 26.94 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.108 -0.995 . . . . 1.45 111.82 -178.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.471 ' N ' ' HG2' ' A' ' 49' ' ' GLU . 1.9 tt0 -95.09 -110.49 0.13 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.476 -0.765 . . . . 1.09 110.173 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.0 m -162.03 -39.64 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.343 0 O-C-N 120.393 -1.442 . . . . 1.3 111.838 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.5 mt -106.2 -51.07 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.348 -0.845 . . . . 1.51 110.146 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.3 m -134.01 -47.67 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 O-C-N 121.522 -0.736 . . . . 1.05 111.17 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.71 -66.02 3.39 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 109.88 -1.288 . . . . 1.19 109.88 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -100.0 158.35 15.89 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.421 -1.047 . . . . 2.79 110.523 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.43 55.34 0.4 Allowed Glycine 0 N--CA 1.497 2.764 0 N-CA-C 109.112 -1.595 . . . . 1.69 109.112 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 52.84 44.75 29.93 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.813 -0.816 . . . . 2.3 110.582 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.59 58.39 0.09 Allowed 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.348 -0.845 . . . . 1.45 110.794 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.2 105.83 5.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.154 -0.966 . . . . 2.23 109.918 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.06 122.61 10.04 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.493 -0.754 . . . . 2.46 110.868 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.517 ' O ' ' HB2' ' A' ' 62' ' ' PHE . 38.3 Cg_endo -66.46 -41.45 11.83 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.658 1.346 . . . . 2.48 110.565 178.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.517 ' HB2' ' O ' ' A' ' 61' ' ' PRO . 1.2 t80 171.28 164.08 0.09 Allowed 'General case' 0 N--CA 1.507 2.413 0 O-C-N 121.494 -0.754 . . . . 3.66 110.549 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 mt -64.08 -39.82 94.9 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.382 -0.824 . . . . 3.57 109.624 178.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.13 -42.07 97.86 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.724 -0.61 . . . . 4.03 109.519 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.433 ' HB ' ' HG2' ' A' ' 61' ' ' PRO . 11.8 t -74.52 -38.98 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.226 -0.922 . . . . 2.44 109.125 178.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.422 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 6.0 tt0 -57.7 -42.77 84.38 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.758 -0.83 . . . . 2.42 108.758 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.445 ' HA ' ' HG2' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -74.44 -45.8 44.0 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 109.259 -0.645 . . . . 4.16 109.259 178.106 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 69.9 m -59.21 -37.09 76.6 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.748 -0.595 . . . . 2.42 110.488 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -84.68 -46.48 11.43 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.054 -1.028 . . . . 1.61 111.243 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.445 ' HG2' ' HA ' ' A' ' 67' ' ' TYR . 12.3 ptpt -65.17 -35.66 81.78 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.338 -0.851 . . . . 2.37 111.213 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.401 ' N ' ' HD2' ' A' ' 72' ' ' PRO . . . -49.07 -64.22 3.44 Favored Glycine 0 N--CA 1.502 3.068 0 N-CA-C 109.795 -1.322 . . . . 1.46 109.795 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.401 ' HD2' ' N ' ' A' ' 71' ' ' GLY . 40.3 Cg_endo -66.11 -37.15 26.5 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.734 1.386 . . . . 1.47 110.245 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 2.5 t -62.41 -46.04 90.39 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.039 -1.038 . . . . 1.41 109.593 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.5 t -68.66 -47.41 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.561 -0.712 . . . . 1.4 109.311 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -57.41 -40.59 78.61 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 119.799 -0.76 . . . . 1.5 109.405 178.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.421 ' HA ' ' HG2' ' A' ' 79' ' ' LYS . 3.8 ttm180 -65.11 -44.22 89.47 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.53 -0.731 . . . . 2.53 109.473 178.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.83 -38.7 89.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -0.871 . . . . 2.65 109.786 178.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.04 -50.71 53.59 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.377 0.608 . . . . 1.15 110.087 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.421 ' HG2' ' HA ' ' A' ' 76' ' ' ARG . 0.3 OUTLIER -65.64 -30.8 71.56 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.693 -0.63 . . . . 1.56 110.109 179.469 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -76.98 -26.86 54.41 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.245 -0.909 . . . . 2.33 109.881 178.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 3.7 ttt -86.85 -40.34 14.99 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.369 -0.832 . . . . 2.91 110.756 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 14.5 t -61.15 146.63 88.0 Favored Pre-proline 0 N--CA 1.509 2.487 0 O-C-N 121.367 -0.833 . . . . 1.62 111.163 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -78.74 9.95 3.05 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 O-C-N 123.552 1.29 . . . . 1.75 112.849 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 41.51 29.45 0.1 Allowed 'General case' 0 N--CA 1.511 2.584 0 O-C-N 121.437 -0.789 . . . . 2.12 112.192 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -132.34 -93.61 0.57 Allowed Glycine 0 N--CA 1.498 2.791 0 N-CA-C 109.448 -1.461 . . . . 1.71 109.448 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.475 ' O ' ' N ' ' A' ' 88' ' ' VAL . 53.6 Cg_endo -80.72 -108.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.28 0 O-C-N 123.848 1.446 . . . . 1.94 110.106 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.471 ' HA ' ' ND1' ' A' ' 8' ' ' HIS . 0.5 OUTLIER 65.14 -57.76 0.28 Allowed 'General case' 0 N--CA 1.507 2.38 0 O-C-N 120.979 -1.076 . . . . 1.41 110.86 -179.526 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.475 ' N ' ' O ' ' A' ' 86' ' ' PRO . 11.5 p -110.54 -20.84 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.748 -0.595 . . . . 2.25 110.121 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -119.5 157.45 28.29 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.265 -0.897 . . . . 3.3 109.653 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.657 0 CA-C-O 117.848 -1.529 . . . . 2.84 109.707 179.18 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.519 ' HA2' ' OE2' ' A' ' 57' ' ' GLU . . . . . . . . 0 N--CA 1.496 2.692 0 N-CA-C 111.485 -0.646 . . . . 3.15 111.485 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 m -78.3 47.64 0.7 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.194 -1.18 . . . . 4.02 110.617 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -75.87 -20.62 57.94 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 121.219 -0.926 . . . . 6.07 111.306 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 80.4 p -129.47 -65.55 0.84 Allowed 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.598 -0.89 . . . . 6.08 108.598 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.564 HD12 ' C ' ' A' ' 5' ' ' ILE . 2.0 pp -98.05 -174.73 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-O 121.25 0.547 . . . . 5.79 110.107 178.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.2 71.05 1.22 Allowed 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 122.067 0.937 . . . . 5.89 110.492 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.407 ' HB3' ' CD1' ' A' ' 5' ' ' ILE . 3.6 p-10 -65.74 -18.51 65.38 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.524 -0.735 . . . . 3.05 109.767 178.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 1.021 ' HA ' HG22 ' A' ' 14' ' ' VAL . 5.5 m80 -79.05 -5.31 53.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.64 -0.662 . . . . 2.99 110.867 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.448 ' CB ' ' CD ' ' A' ' 10' ' ' PRO . 0.5 OUTLIER -61.49 -57.73 23.17 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.168 -0.957 . . . . 3.57 110.652 179.706 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.499 ' O ' HG23 ' A' ' 14' ' ' VAL . 49.6 Cg_endo -73.82 109.51 2.88 Favored 'Trans proline' 0 N--CA 1.488 1.203 0 O-C-N 123.54 1.284 . . . . 3.37 110.679 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.749 ' O ' HG22 ' A' ' 15' ' ' VAL . 5.3 p -57.2 -46.68 82.66 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.393 -0.817 . . . . 4.2 110.412 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 p -59.03 -33.12 70.39 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.417 -0.802 . . . . 4.44 109.235 178.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.535 ' O ' HG22 ' A' ' 17' ' ' VAL . . . -75.32 -50.13 8.66 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 108.342 -1.903 . . . . 3.31 108.342 178.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 1.021 HG22 ' HA ' ' A' ' 8' ' ' HIS . 72.1 t -49.99 -45.68 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 121.964 -0.727 . . . . 2.7 110.16 178.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.749 HG22 ' O ' ' A' ' 11' ' ' THR . 17.2 m -71.89 -42.42 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.2 -0.938 . . . . 3.48 109.847 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 56.7 m -58.22 -50.65 72.82 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.554 -0.717 . . . . 3.42 110.175 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.535 HG22 ' O ' ' A' ' 13' ' ' GLY . 27.4 m -66.03 -39.63 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.45 -0.781 . . . . 2.39 110.104 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.563 ' O ' HG12 ' A' ' 22' ' ' ILE . 10.9 mm -64.98 -43.52 96.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 O-C-N 120.994 -1.066 . . . . 2.31 109.445 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.518 ' HA ' HG12 ' A' ' 22' ' ' ILE . 32.2 t -61.78 -40.43 86.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 119.743 -0.783 . . . . 2.96 108.955 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 27.4 mm -69.43 -41.24 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.26 -0.9 . . . . 2.61 108.746 178.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 39.6 mt -61.99 -50.62 71.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.712 -0.617 . . . . 1.59 109.491 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.563 HG12 ' O ' ' A' ' 18' ' ' ILE . 43.5 pt -61.99 -41.16 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 120.815 -1.178 . . . . 2.53 109.409 178.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.551 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -60.27 -45.86 91.85 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.04 -0.726 . . . . 1.99 109.04 178.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 39.0 mt -59.27 -48.26 87.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.689 -0.856 . . . . 1.52 108.689 178.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.98 -42.5 94.32 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.697 -0.627 . . . . 1.28 109.878 178.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.84 -45.53 92.17 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.922 -0.769 . . . . 1.79 108.922 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.68 -45.55 93.51 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.806 -0.813 . . . . 1.53 108.806 178.025 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.469 ' HA3' ' HG2' ' A' ' 60' ' ' GLU . . . -58.84 -45.54 94.84 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 108.54 -1.824 . . . . 1.13 108.54 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.5 -44.73 95.67 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.507 -0.996 . . . . 1.63 109.36 178.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 5.3 mt -56.78 -42.87 80.19 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.088 -0.708 . . . . 1.98 109.088 178.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.8 mt -68.83 -49.18 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 109.07 -0.715 . . . . 1.25 109.07 178.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.83 -46.05 71.07 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.496 -0.753 . . . . 3.01 109.527 178.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.3 -40.21 70.26 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.925 -1.27 . . . . 1.84 109.925 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 6.9 t -62.7 -44.88 95.09 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.339 -1.095 . . . . 1.64 110.955 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.457 ' O ' ' N ' ' A' ' 37' ' ' TYR . 2.0 t-105 -165.23 40.08 0.07 Allowed 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.024 -1.048 . . . . 2.73 112.334 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.518 ' SG ' ' CD1' ' A' ' 63' ' ' LEU . 38.1 t 62.38 -64.46 0.09 Allowed 'General case' 0 N--CA 1.51 2.545 0 O-C-N 121.232 -0.918 . . . . 2.66 112.234 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.548 ' HB3' ' HG2' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -153.64 -66.92 0.15 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.82 -1.175 . . . . 6.05 110.363 -178.971 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -136.65 -62.54 0.65 Allowed 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.413 -0.958 . . . . 2.44 108.413 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.8 mtm-85 171.73 54.42 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.072 0.463 . . . . 2.17 110.239 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.616 HD22 ' HB2' ' A' ' 46' ' ' SER . 0.2 OUTLIER -124.58 20.57 8.63 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.95 -1.094 . . . . 2.74 111.95 -179.47 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -96.89 38.31 1.24 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.862 -1.149 . . . . 2.37 110.476 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? -112.01 -64.38 1.3 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.184 -0.947 . . . . 3.17 111.158 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.507 HG13 ' H ' ' A' ' 44' ' ' SER . 3.0 pt -94.51 -39.08 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 CA-C-O 121.802 0.811 . . . . 3.26 110.468 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.507 ' H ' HG13 ' A' ' 43' ' ' ILE . 1.1 m -168.99 125.39 0.93 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.522 -0.548 . . . . 3.36 109.522 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -66.64 162.06 21.94 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.583 0.706 . . . . 2.97 110.924 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.616 ' HB2' HD22 ' A' ' 40' ' ' LEU . 3.1 m -170.67 45.72 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.408 -0.807 . . . . 2.74 109.664 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.548 ' HG2' ' HB3' ' A' ' 37' ' ' TYR . 1.9 mp0 -111.04 166.01 11.41 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.634 -0.666 . . . . 2.43 110.42 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.19 80.19 1.29 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.445 -0.784 . . . . 3.96 110.449 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -98.06 82.16 2.93 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.437 -0.579 . . . . 2.22 109.437 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.86 -175.28 3.13 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 122.253 1.025 . . . . 3.28 111.07 -179.08 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.5 t -137.86 -37.22 0.6 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.793 -0.567 . . . . 2.67 110.514 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 38.2 mt -76.98 -48.42 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.115 -0.991 . . . . 2.75 109.647 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.63 HG12 ' N ' ' A' ' 54' ' ' GLY . 1.0 OUTLIER -55.21 -56.91 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-O 121.391 0.615 . . . . 2.74 109.669 178.894 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.63 ' N ' HG12 ' A' ' 53' ' ' VAL . . . -73.63 73.99 1.14 Allowed Glycine 0 N--CA 1.497 2.759 0 N-CA-C 109.818 -1.313 . . . . 2.18 109.818 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -115.98 -162.79 0.86 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.514 -0.992 . . . . 2.38 110.417 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' A' ' 57' ' ' GLU . . . 111.26 48.32 0.71 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 108.117 -1.993 . . . . 2.27 108.117 -178.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.519 ' OE2' ' HA2' ' A' ' 1' ' ' GLY . 0.9 OUTLIER 62.02 14.91 6.84 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.927 -0.749 . . . . 2.37 111.035 -178.586 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.6 t -154.32 144.63 22.1 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.974 -1.079 . . . . 2.3 110.296 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -137.39 121.01 17.28 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.437 -0.79 . . . . 2.31 110.021 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.469 ' HG2' ' HA3' ' A' ' 28' ' ' GLY . 0.3 OUTLIER -64.37 144.67 98.5 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.426 -0.796 . . . . 2.21 110.339 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -69.85 58.02 1.56 Allowed 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.719 1.379 . . . . 1.91 110.429 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.453 ' CE2' ' HB2' ' A' ' 60' ' ' GLU . 55.2 m-85 -55.29 155.22 5.21 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.639 -0.663 . . . . 2.59 110.371 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.518 ' CD1' ' SG ' ' A' ' 36' ' ' CYS . 0.5 OUTLIER -59.97 -36.72 77.74 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.861 -1.149 . . . . 2.07 110.668 179.592 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.91 -58.07 10.25 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.368 -0.833 . . . . 2.46 110.049 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.451 ' HA ' ' HB2' ' A' ' 68' ' ' SER . 33.5 m -68.99 -31.57 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.224 -0.923 . . . . 2.55 109.821 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.459 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 6.5 tp-100 -63.05 -55.25 27.15 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.363 -0.836 . . . . 2.38 108.918 178.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -62.71 -42.45 99.66 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.518 -0.738 . . . . 2.52 109.459 178.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.451 ' HB2' ' HA ' ' A' ' 65' ' ' VAL . 1.2 m -56.72 -35.48 68.6 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-O 120.928 0.394 . . . . 2.5 110.703 179.311 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -91.69 -41.66 10.59 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.22 -0.925 . . . . 2.49 110.601 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 66' ' ' GLN . 1.6 mmtp -65.23 -44.3 88.69 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.528 -0.733 . . . . 2.56 110.392 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.404 ' N ' ' HD2' ' A' ' 72' ' ' PRO . . . -45.58 -63.68 2.67 Favored Glycine 0 N--CA 1.503 3.109 0 N-CA-C 110.22 -1.152 . . . . 1.86 110.22 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' A' ' 71' ' ' GLY . 42.2 Cg_endo -66.65 -39.08 16.56 Favored 'Trans proline' 0 C--N 1.316 -1.18 0 O-C-N 123.783 1.412 . . . . 2.46 110.419 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 36.7 t -60.64 -43.9 97.02 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.997 -1.064 . . . . 2.78 109.679 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.8 t -70.46 -49.42 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.682 -0.636 . . . . 1.92 109.424 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.21 -31.21 68.83 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.536 0.684 . . . . 2.39 110.3 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -75.28 -49.02 20.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.356 -0.84 . . . . 4.17 109.542 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.535 ' HG3' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -69.25 -26.95 65.04 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.364 -0.835 . . . . 3.47 109.662 179.237 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.821 ' O ' HG22 ' A' ' 82' ' ' THR . . . -71.91 -52.28 18.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.451 -0.781 . . . . 2.09 108.946 178.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -68.45 -24.74 64.76 Favored 'General case' 0 N--CA 1.5 2.067 0 C-N-CA 120.48 -0.488 . . . . 2.38 110.312 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.5 tp -78.02 -39.91 40.61 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.23 -0.918 . . . . 3.77 109.53 178.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 12.0 ttt -78.37 -50.34 11.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.623 -0.673 . . . . 4.28 109.909 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.821 HG22 ' O ' ' A' ' 78' ' ' ALA . 5.1 t -79.92 144.58 59.86 Favored Pre-proline 0 N--CA 1.492 1.633 0 C-N-CA 119.612 -0.835 . . . . 2.58 109.186 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.451 ' HG3' ' HB3' ' A' ' 89' ' ' HIS . 44.5 Cg_endo -73.16 -3.54 13.85 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 123.521 1.274 . . . . 3.56 110.531 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.23 19.37 10.91 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.32 -0.862 . . . . 4.01 109.64 -178.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -151.89 101.44 0.21 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 107.979 -2.048 . . . . 4.29 107.979 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.586 ' HA ' ' O ' ' A' ' 89' ' ' HIS . 39.0 Cg_endo -62.51 -10.22 18.39 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 O-C-N 123.573 1.301 . . . . 5.57 111.775 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -60.84 -26.3 67.26 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.235 -0.915 . . . . 6.73 110.733 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.7 p -113.84 -23.94 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 O-C-N 121.126 -0.984 . . . . 6.0 111.373 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.586 ' O ' ' HA ' ' A' ' 86' ' ' PRO . 58.1 t-80 -149.47 141.52 23.91 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.902 -1.123 . . . . 4.74 111.017 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.617 0 N-CA-C 109.998 -1.241 . . . . 4.24 109.998 178.985 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.685 0 N-CA-C 109.555 -1.418 . . . . 2.91 109.555 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.414 ' HA ' ' CG2' ' A' ' 11' ' ' THR . 0.6 OUTLIER -176.95 62.18 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.478 -1.013 . . . . 2.55 110.823 179.5 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.0 mtt -100.1 -96.54 0.25 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.114 -0.991 . . . . 3.94 109.95 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 81.2 p -129.63 -50.45 1.16 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.04 -1.037 . . . . 2.65 110.257 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.551 HD12 ' C ' ' A' ' 5' ' ' ILE . 1.6 pp -71.88 -165.26 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 CA-C-O 121.267 0.555 . . . . 3.05 110.529 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 2.0 mtt -72.05 84.0 0.99 Allowed 'General case' 0 N--CA 1.503 2.19 0 O-C-N 120.66 -1.275 . . . . 3.58 111.419 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.549 ' HB2' HG21 ' A' ' 11' ' ' THR . 0.8 OUTLIER -95.07 33.43 1.52 Allowed 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.278 -0.889 . . . . 2.67 110.434 179.274 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 62.02 34.06 16.84 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.288 -0.883 . . . . 2.74 109.662 -178.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -161.57 170.54 8.02 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.677 -0.639 . . . . 1.6 109.296 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -74.33 56.18 3.78 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 O-C-N 123.537 1.283 . . . . 1.73 110.914 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.549 HG21 ' HB2' ' A' ' 7' ' ' ASP . 21.6 p -64.43 -51.45 63.09 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.425 -0.797 . . . . 1.35 110.759 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.3 p -56.1 -36.99 68.79 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.446 -0.784 . . . . 1.99 110.438 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.33 -52.79 11.82 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 109.133 -1.587 . . . . 1.3 109.133 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.561 ' O ' HG12 ' A' ' 18' ' ' ILE . 28.1 t -56.53 -40.43 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.701 -0.882 . . . . 1.41 109.222 178.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.603 ' HA ' HG12 ' A' ' 18' ' ' ILE . 49.8 t -68.25 -41.38 83.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.261 -0.899 . . . . 1.3 109.528 178.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 52.9 m -60.51 -47.5 85.9 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.403 -0.81 . . . . 1.9 109.785 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.431 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 32.6 m -67.54 -41.65 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.465 -0.772 . . . . 1.77 111.272 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.872 ' HA ' HD23 ' A' ' 21' ' ' LEU . 4.0 pt -68.57 -33.56 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 120.292 -1.505 . . . . 1.28 109.925 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.486 ' N ' HG13 ' A' ' 18' ' ' ILE . 17.7 t -68.44 -44.39 83.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.24 -1.022 . . . . 1.38 108.24 177.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 69.5 mt -63.69 -49.23 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 108.843 -0.799 . . . . 2.03 108.843 178.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.872 HD23 ' HA ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -60.71 -42.66 97.7 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 119.926 -0.71 . . . . 1.62 109.106 178.698 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.564 ' N ' ' HG ' ' A' ' 21' ' ' LEU . 14.9 mt -61.24 -44.13 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.226 -0.921 . . . . 1.18 109.131 178.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.9 -45.74 87.94 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.514 -0.741 . . . . 1.23 109.593 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 54.6 mt -58.79 -47.77 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.437 -0.789 . . . . 2.07 108.993 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.95 -44.83 95.94 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.561 -0.712 . . . . 1.32 109.935 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.57 -45.64 93.17 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 109.149 -0.685 . . . . 0.92 109.149 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.35 -45.96 92.2 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.488 -0.758 . . . . 1.92 108.978 178.26 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.22 -45.35 94.2 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 108.617 -1.793 . . . . 1.4 108.617 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.25 -44.94 93.77 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.639 -0.918 . . . . 1.22 109.888 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.479 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 6.7 mt -58.82 -41.28 86.49 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.618 -0.676 . . . . 1.56 109.516 178.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 53.2 mt -68.22 -47.0 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.272 -0.893 . . . . 1.74 109.305 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.472 ' O ' ' HA ' ' A' ' 36' ' ' CYS . 0.3 OUTLIER -62.71 -39.37 93.81 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.358 -0.839 . . . . 2.18 110.42 179.043 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -75.49 -37.8 39.95 Favored Glycine 0 N--CA 1.498 2.781 0 O-C-N 120.948 -1.095 . . . . 1.26 111.142 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.544 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 0.1 OUTLIER -84.19 -32.63 24.45 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.942 -1.328 . . . . 1.56 111.859 -179.033 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.544 ' CE3' ' HB3' ' A' ' 34' ' ' CYS . 7.0 m-90 -125.51 1.02 7.62 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 120.979 -1.076 . . . . 1.9 112.393 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER 64.68 -69.49 0.09 Allowed 'General case' 0 N--CA 1.511 2.576 0 O-C-N 121.059 -1.025 . . . . 2.31 112.044 179.435 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.729 ' HB3' HD23 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -131.05 96.55 4.07 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.326 -0.859 . . . . 5.08 109.957 -179.256 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.412 ' HB3' ' O ' ' A' ' 37' ' ' TYR . 34.1 tp 62.94 -66.87 0.09 Allowed 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.561 -0.712 . . . . 3.93 111.117 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.474 ' N ' ' O ' ' A' ' 37' ' ' TYR . 2.1 mmt180 -140.32 -48.51 0.44 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.662 -0.649 . . . . 2.96 110.49 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.729 HD23 ' HB3' ' A' ' 37' ' ' TYR . 0.2 OUTLIER 46.4 52.06 11.06 Favored 'General case' 0 N--CA 1.504 2.231 0 CA-C-O 121.64 0.734 . . . . 1.91 111.271 -179.977 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.8 pm0 -96.16 19.65 11.45 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.66 -0.65 . . . . 4.1 111.562 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.486 ' HG3' HG12 ' A' ' 43' ' ' ILE . 0.6 OUTLIER -100.62 -147.51 0.35 Allowed 'General case' 0 N--CA 1.485 1.313 0 O-C-N 120.739 -1.226 . . . . 2.92 108.645 178.998 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.486 HG12 ' HG3' ' A' ' 42' ' ' ARG . 16.7 pt -48.8 -33.66 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.36 -0.838 . . . . 2.36 110.175 178.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.543 ' HA ' HD12 ' A' ' 40' ' ' LEU . 0.4 OUTLIER 71.44 117.59 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.263 0 CA-C-O 121.382 0.61 . . . . 1.64 110.849 179.798 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.18 -1.59 21.73 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.1 -1.0 . . . . 1.74 110.952 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.505 ' HB2' HD13 ' A' ' 80' ' ' LEU . 0.1 OUTLIER 59.56 39.23 21.78 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.176 -0.953 . . . . 1.97 110.369 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.407 ' O ' ' HG2' ' A' ' 47' ' ' GLU . 5.7 pm0 -83.26 146.89 28.3 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.189 -0.944 . . . . 1.66 111.493 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -160.8 -57.05 0.05 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.906 -0.496 . . . . 1.52 110.07 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.529 ' HB2' ' NH2' ' A' ' 76' ' ' ARG . 1.4 tt0 -69.3 124.93 25.16 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.432 -0.792 . . . . 1.91 110.272 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.453 ' HB3' ' HA2' ' A' ' 54' ' ' GLY . 0.2 OUTLIER 70.65 165.99 0.29 Allowed 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.76 0.791 . . . . 2.27 110.301 -179.236 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.0 p -141.66 -28.7 0.64 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.421 -0.799 . . . . 2.28 111.59 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 67.9 mt -74.31 -51.52 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.186 -0.946 . . . . 2.82 110.447 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 55' ' ' ASP . 13.9 p -134.96 -33.96 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.294 -0.879 . . . . 2.67 112.164 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.453 ' HA2' ' HB3' ' A' ' 50' ' ' GLU . . . 66.53 -65.24 0.17 Allowed Glycine 0 N--CA 1.505 3.245 0 O-C-N 120.918 -1.114 . . . . 1.92 110.761 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.545 ' O ' HG22 ' A' ' 53' ' ' VAL . 16.8 t70 -88.39 149.4 23.74 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.386 -1.067 . . . . 2.52 110.182 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 175.41 -62.12 0.11 Allowed Glycine 0 N--CA 1.496 2.672 0 N-CA-C 108.883 -1.687 . . . . 2.33 108.883 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -112.17 25.84 11.16 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.585 -0.95 . . . . 2.76 110.187 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.12 62.78 0.32 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.32 -0.862 . . . . 2.05 110.195 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.4 mttt -113.44 152.62 29.85 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.302 -0.874 . . . . 2.22 110.246 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.673 ' HG2' ' HA ' ' A' ' 66' ' ' GLN . 1.7 mp0 -113.5 73.77 2.08 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.367 -0.833 . . . . 1.65 110.302 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.406 ' HD2' HG11 ' A' ' 65' ' ' VAL . 42.7 Cg_endo -69.62 -33.4 17.19 Favored 'Trans proline' 0 N--CA 1.491 1.334 0 O-C-N 123.602 1.317 . . . . 2.12 111.356 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -127.35 163.3 24.31 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.985 -1.072 . . . . 2.82 110.367 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 pp -56.96 -33.21 66.83 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.254 -0.904 . . . . 2.16 110.462 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.17 -49.1 71.1 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.574 -0.704 . . . . 2.45 109.422 178.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.497 ' HA ' ' HB2' ' A' ' 68' ' ' SER . 4.1 t -70.67 -32.71 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.158 -0.964 . . . . 1.74 109.124 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.673 ' HA ' ' HG2' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -57.17 -55.74 30.8 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.475 -0.935 . . . . 1.27 108.475 178.559 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -62.77 -41.45 99.23 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.586 -0.696 . . . . 3.01 109.473 178.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.497 ' HB2' ' HA ' ' A' ' 65' ' ' VAL . 63.7 m -60.39 -37.56 81.2 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 122.035 -0.416 . . . . 1.5 110.308 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.499 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -81.58 -39.82 23.98 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.163 -0.961 . . . . 1.05 110.221 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 66' ' ' GLN . 2.6 mmpp? -61.57 -42.63 99.12 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.577 -0.702 . . . . 1.06 110.54 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -43.09 -66.23 1.23 Allowed Glycine 0 N--CA 1.505 3.244 0 N-CA-C 110.526 -1.03 . . . . 0.83 110.526 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.49 ' HA ' ' HB3' ' A' ' 75' ' ' GLU . 40.5 Cg_endo -66.32 -38.73 19.54 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.753 1.396 . . . . 1.03 110.235 179.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.499 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -58.38 -44.82 89.07 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.039 -1.038 . . . . 1.55 109.487 178.495 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 69.6 t -74.39 -41.76 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.55 -0.718 . . . . 0.74 109.233 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.49 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 1.0 OUTLIER -54.75 -46.12 74.27 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 121.529 0.681 . . . . 1.06 109.474 178.532 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.529 ' NH2' ' HB2' ' A' ' 49' ' ' GLU . 6.7 mpt_? -69.09 -46.35 67.99 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.719 -0.613 . . . . 1.09 110.124 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.13 -36.29 79.36 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.531 -0.73 . . . . 1.63 110.099 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.721 ' HA ' ' HA ' ' A' ' 82' ' ' THR . . . -67.25 -46.65 73.11 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.972 -0.751 . . . . 1.08 108.972 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 35.0 mtpt -62.48 -37.37 85.69 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.206 0.527 . . . . 1.31 110.559 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.521 HD11 ' O ' ' A' ' 44' ' ' SER . 9.2 tp -79.5 -50.05 11.33 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.607 -0.683 . . . . 1.93 112.11 -178.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.8 ttm -131.78 -7.2 3.59 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.177 -0.952 . . . . 3.92 112.785 -178.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.721 ' HA ' ' HA ' ' A' ' 78' ' ' ALA . 10.4 m 49.41 84.51 0.2 Allowed Pre-proline 0 N--CA 1.51 2.552 0 O-C-N 121.014 -1.054 . . . . 1.29 111.503 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 78' ' ' ALA . 51.8 Cg_endo -73.59 17.85 0.44 Allowed 'Trans proline' 0 N--CA 1.494 1.51 0 O-C-N 123.394 1.207 . . . . 1.33 112.541 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -71.71 53.42 0.23 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.681 -1.262 . . . . 2.04 109.948 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 169.45 -82.89 0.09 OUTLIER Glycine 0 N--CA 1.498 2.781 0 N-CA-C 110.101 -1.2 . . . . 1.91 110.101 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.409 ' O ' ' N ' ' A' ' 88' ' ' VAL . 56.0 Cg_endo -81.85 -174.48 2.16 Favored 'Trans proline' 0 C--N 1.316 -1.17 0 O-C-N 123.526 1.277 . . . . 2.02 111.114 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 67.97 -55.27 0.5 Allowed 'General case' 0 N--CA 1.506 2.372 0 CA-C-O 121.707 0.765 . . . . 2.45 110.045 -178.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.409 ' N ' ' O ' ' A' ' 86' ' ' PRO . 7.7 p -105.89 -9.75 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.921 -0.487 . . . . 2.32 110.249 178.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 62.24 51.15 3.57 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.388 -0.82 . . . . 4.52 110.443 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.691 0 CA-C-O 118.053 -1.415 . . . . 2.72 109.777 179.668 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 7' ' ' ASP . . . . . . . . 0 N--CA 1.498 2.804 0 N-CA-C 109.772 -1.331 . . . . 4.32 109.772 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.581 ' CB ' ' HA ' ' A' ' 7' ' ' ASP . 9.6 t -150.19 177.38 9.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.362 -1.081 . . . . 4.99 110.39 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.4 ptt? -97.38 -18.21 19.25 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.659 -0.651 . . . . 6.69 110.857 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 98.9 p -146.77 -83.75 0.12 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.048 -1.033 . . . . 5.12 110.634 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.674 HD12 ' HB2' ' A' ' 6' ' ' MET . 2.4 pp -103.78 -174.44 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.21 -0.932 . . . . 4.1 110.929 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.674 ' HB2' HD12 ' A' ' 5' ' ' ILE . 0.8 OUTLIER 67.46 -82.26 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.774 -0.579 . . . . 3.93 111.383 179.813 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.581 ' HA ' ' CB ' ' A' ' 2' ' ' SER . 24.0 t70 65.43 -56.08 0.32 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.774 -0.579 . . . . 3.57 111.078 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.44 ' N ' ' O ' ' A' ' 6' ' ' MET . 9.5 m80 -131.41 23.59 4.78 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.523 -0.736 . . . . 3.24 109.329 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 46.73 64.51 8.25 Favored Pre-proline 0 N--CA 1.501 2.114 0 O-C-N 121.681 -0.637 . . . . 2.94 111.112 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -70.84 98.17 0.77 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.552 1.29 . . . . 1.96 110.861 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 19.8 p -57.24 -50.93 71.33 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.4 -0.812 . . . . 2.36 109.727 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.2 p -58.43 -48.21 81.44 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.609 -0.682 . . . . 2.5 109.704 178.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.451 ' O ' HG22 ' A' ' 17' ' ' VAL . . . -59.65 -53.86 42.51 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 109.234 -1.546 . . . . 1.9 109.234 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.541 ' O ' HG23 ' A' ' 18' ' ' ILE . 33.4 t -54.96 -38.79 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.501 -1.0 . . . . 2.11 109.265 178.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.635 ' O ' HG22 ' A' ' 19' ' ' VAL . 33.9 t -68.21 -47.4 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.175 -0.953 . . . . 2.54 110.123 179.01 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.3 p -60.1 -37.98 81.58 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.522 -0.736 . . . . 2.35 110.987 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.451 HG22 ' O ' ' A' ' 13' ' ' GLY . 33.0 m -76.11 -37.71 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 120.946 -1.096 . . . . 1.75 111.095 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.541 HG23 ' O ' ' A' ' 14' ' ' VAL . 45.1 pt -70.54 -38.89 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.465 -1.397 . . . . 2.46 110.234 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.635 HG22 ' O ' ' A' ' 15' ' ' VAL . 33.7 m -68.95 -39.98 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 120.887 -1.133 . . . . 2.49 108.755 178.181 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.446 HD13 ' HA ' ' A' ' 20' ' ' ILE . 14.6 mm -65.99 -47.32 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.037 -1.039 . . . . 2.26 108.669 177.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.7 mt -59.09 -48.69 80.7 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.841 -0.8 . . . . 2.1 108.841 178.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.1 mt -56.65 -43.79 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.578 -0.702 . . . . 2.64 109.273 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.57 -46.0 87.88 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.621 -0.674 . . . . 2.2 109.779 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 71.0 mt -59.62 -46.67 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.356 -0.84 . . . . 1.94 108.893 178.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.65 -43.81 97.86 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.543 -0.723 . . . . 2.18 109.869 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.67 -44.29 96.62 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.532 -0.73 . . . . 2.43 109.141 178.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.2 tt -62.23 -45.94 91.1 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.839 -0.8 . . . . 2.34 108.839 178.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.45 -46.03 93.64 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 108.694 -1.762 . . . . 2.12 108.694 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.41 -43.6 97.06 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.504 -0.998 . . . . 2.48 109.915 179.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.6 mt -59.46 -41.08 88.87 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.595 -0.691 . . . . 2.92 109.613 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 17.7 mt -70.1 -45.73 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.303 -0.873 . . . . 2.27 109.546 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.453 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -60.75 -50.25 74.22 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.668 -0.645 . . . . 2.8 110.01 179.232 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.8 -42.24 99.72 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 109.817 -1.313 . . . . 2.6 109.817 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 46.8 t -56.25 -47.56 78.29 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.456 -1.026 . . . . 2.68 109.984 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.605 ' HB3' ' CG ' ' A' ' 39' ' ' ARG . 1.0 OUTLIER -178.68 65.61 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.503 -0.748 . . . . 3.15 110.982 179.453 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 3.1 m 50.92 -95.94 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.916 -0.49 . . . . 2.53 111.458 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -153.39 -62.2 0.14 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.597 -1.314 . . . . 3.07 112.229 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.403 HD11 HD12 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -91.68 -5.37 53.86 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 120.968 -1.082 . . . . 2.1 112.201 -179.059 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.605 ' CG ' ' HB3' ' A' ' 35' ' ' TRP . 0.0 OUTLIER 52.0 68.23 0.84 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.194 -0.941 . . . . 2.7 111.593 179.224 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.494 ' HB3' ' CG1' ' A' ' 43' ' ' ILE . 0.3 OUTLIER -65.53 112.95 3.84 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.413 -0.804 . . . . 2.31 109.377 178.798 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.5 -14.54 8.17 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.24 -0.912 . . . . 3.47 111.656 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.592 ' HG3' ' N ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -78.43 -63.28 1.44 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.093 -1.004 . . . . 3.17 109.264 179.285 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.796 HG22 ' HB2' ' A' ' 47' ' ' GLU . 1.5 pp -64.36 -37.86 81.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 109.145 -0.687 . . . . 2.7 109.145 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.405 ' H ' HG13 ' A' ' 43' ' ' ILE . 38.3 t 48.93 -84.34 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.288 0 CA-C-N 116.226 -0.443 . . . . 3.11 110.947 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.478 ' N ' ' O ' ' A' ' 43' ' ' ILE . 1.2 pm0 -135.27 -8.28 2.27 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.385 -0.822 . . . . 4.18 112.153 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 p -84.95 -50.29 7.62 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.646 -1.283 . . . . 3.73 110.705 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.796 ' HB2' HG22 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -95.88 156.81 16.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.484 -0.76 . . . . 3.22 109.816 179.824 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.42 148.25 30.64 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.296 -0.877 . . . . 2.92 111.294 -179.156 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -77.79 102.04 7.0 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.1 -1.0 . . . . 2.23 109.92 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.521 ' OE1' HG22 ' A' ' 52' ' ' ILE . 0.0 OUTLIER 66.43 -176.55 0.19 Allowed 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 122.428 1.109 . . . . 2.15 110.367 -179.264 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.3 m -173.13 -48.22 0.02 OUTLIER 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.599 -0.728 . . . . 3.77 109.843 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.521 HG22 ' OE1' ' A' ' 50' ' ' GLU . 2.1 tp -53.31 -36.35 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.758 -0.589 . . . . 4.39 110.875 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.6 p -60.52 -29.22 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.319 -0.863 . . . . 3.74 110.405 178.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -98.78 11.0 62.65 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.502 -1.439 . . . . 4.75 109.502 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.491 ' OD1' ' HB ' ' A' ' 58' ' ' THR . 4.4 t70 -86.21 -147.82 0.12 Allowed 'General case' 0 N--CA 1.483 1.208 0 O-C-N 121.437 -1.037 . . . . 5.08 109.717 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.8 -34.83 2.23 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 108.465 -1.854 . . . . 6.38 108.465 -179.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -135.11 7.64 3.42 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.738 -0.86 . . . . 7.61 112.771 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.491 ' HB ' ' OD1' ' A' ' 55' ' ' ASP . 2.4 m -59.95 116.84 4.42 Favored 'General case' 0 N--CA 1.507 2.398 0 O-C-N 120.4 -1.438 . . . . 5.8 110.367 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.69 159.42 41.32 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.44 -0.788 . . . . 6.48 110.795 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 1.1 tt0 46.07 56.15 15.86 Favored Pre-proline 0 N--CA 1.499 2.014 0 O-C-N 121.876 -0.515 . . . . 5.31 111.203 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.45 143.91 89.35 Favored 'Trans proline' 0 N--CA 1.49 1.283 0 O-C-N 123.264 1.139 . . . . 5.12 109.871 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.503 ' O ' ' HB2' ' A' ' 66' ' ' GLN . 18.9 t80 69.44 -52.87 0.6 Allowed 'General case' 0 N--CA 1.506 2.343 0 O-C-N 121.745 -0.597 . . . . 4.09 109.5 -177.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.7 mt -61.95 -41.83 98.42 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.596 -0.69 . . . . 4.75 111.091 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.444 ' HB2' ' O ' ' A' ' 60' ' ' GLU . 0.4 OUTLIER -57.64 -57.19 13.8 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.297 -0.877 . . . . 4.74 110.155 179.759 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 31.4 m -64.77 -34.6 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.118 -0.989 . . . . 3.29 109.904 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.503 ' HB2' ' O ' ' A' ' 62' ' ' PHE . 5.3 tt0 -61.11 -48.39 81.88 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.834 -0.802 . . . . 3.46 108.834 178.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.711 ' HA ' ' HG2' ' A' ' 70' ' ' LYS . 6.9 m-85 -69.12 -40.91 78.03 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.712 -0.617 . . . . 3.92 109.877 178.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.427 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -61.93 -37.88 86.34 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.626 -0.671 . . . . 3.11 110.194 179.049 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.549 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -83.02 -41.99 18.03 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.289 -0.882 . . . . 2.36 109.836 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.711 ' HG2' ' HA ' ' A' ' 67' ' ' TYR . 8.1 ptpt -65.78 -35.48 80.82 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.538 -0.726 . . . . 2.72 110.652 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 70' ' ' LYS . . . -43.52 -64.21 1.9 Allowed Glycine 0 N--CA 1.501 2.996 0 N-CA-C 109.384 -1.486 . . . . 2.05 109.384 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.628 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 43.2 Cg_endo -69.44 -45.54 1.72 Allowed 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.963 1.507 . . . . 2.44 110.054 178.014 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.549 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -55.29 -42.58 73.82 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 120.942 -1.098 . . . . 2.3 110.11 179.281 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.529 ' HA ' ' HG2' ' A' ' 77' ' ' LYS . 56.0 t -73.59 -45.21 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.831 -0.803 . . . . 1.72 108.831 178.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.585 ' HG2' ' HD2' ' A' ' 79' ' ' LYS . 1.6 tt0 -51.34 -45.19 62.24 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.872 0.844 . . . . 3.28 108.902 177.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.628 ' HD2' ' O ' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -73.55 -49.32 27.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.847 -0.533 . . . . 3.72 110.868 179.447 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.591 ' HE3' ' HD3' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -66.82 -19.24 65.7 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.803 -1.185 . . . . 2.73 110.89 179.757 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.687 ' HA ' ' HA ' ' A' ' 82' ' ' THR . . . -86.58 -39.96 15.66 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.775 -0.824 . . . . 2.37 108.775 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.585 ' HD2' ' HG2' ' A' ' 75' ' ' GLU . 13.3 mttt -68.29 -37.79 81.02 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.222 -1.029 . . . . 3.64 108.222 177.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.9 tp -81.23 -38.01 27.65 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.924 -0.485 . . . . 3.86 110.494 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.58 63.79 0.8 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.422 -0.799 . . . . 4.94 110.802 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.687 ' HA ' ' HA ' ' A' ' 78' ' ' ALA . 1.7 m -37.06 121.73 0.84 Allowed Pre-proline 0 N--CA 1.513 2.702 0 O-C-N 121.694 -0.628 . . . . 2.97 111.855 -179.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.591 ' HD3' ' HE3' ' A' ' 77' ' ' LYS . 52.0 Cg_endo -74.9 -3.24 13.61 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 O-C-N 123.893 1.47 . . . . 3.16 112.026 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.438 ' CB ' ' O ' ' A' ' 83' ' ' PRO . 0.5 OUTLIER 71.25 -5.91 1.46 Allowed 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.259 -0.901 . . . . 3.67 111.594 -179.237 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.48 ' O ' HG12 ' A' ' 88' ' ' VAL . . . -173.14 71.0 0.1 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 108.712 -1.755 . . . . 2.95 108.712 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -61.84 -19.47 65.73 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 O-C-N 123.907 1.477 . . . . 2.53 111.277 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -57.66 -30.59 65.55 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.396 -0.815 . . . . 3.34 110.106 178.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 85' ' ' GLY . 9.6 p -108.67 -5.22 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.384 -0.823 . . . . 4.17 111.06 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -142.05 74.88 1.47 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.853 -1.154 . . . . 3.93 110.263 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.472 0 CA-C-O 118.102 -1.388 . . . . 2.49 109.784 -179.906 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 4' ' ' SER . . . . . . . . 0 N--CA 1.492 2.427 0 N-CA-C 109.572 -1.411 . . . . 5.25 109.572 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.8 t -55.46 124.65 17.91 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.558 -0.966 . . . . 6.12 109.379 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.6 mtt 49.05 26.47 1.4 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.776 -0.578 . . . . 6.6 110.731 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 1' ' ' GLY . 4.1 p -151.36 83.7 1.31 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.328 -0.857 . . . . 5.62 109.518 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.564 HD12 ' C ' ' A' ' 5' ' ' ILE . 1.5 pp -57.46 179.6 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.364 -0.835 . . . . 5.41 110.982 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.522 ' O ' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER 63.87 -68.16 0.09 Allowed 'General case' 0 N--CA 1.506 2.341 0 O-C-N 121.634 -0.666 . . . . 6.0 110.971 -179.467 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.441 ' N ' ' O ' ' A' ' 5' ' ' ILE . 8.5 t70 62.65 -57.86 0.14 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.832 -0.543 . . . . 5.36 110.949 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.522 ' N ' ' O ' ' A' ' 6' ' ' MET . 11.3 m80 -129.48 -0.05 5.01 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.481 -0.762 . . . . 6.17 110.522 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.487 ' HB2' ' SD ' ' A' ' 6' ' ' MET . 21.6 t 46.35 69.72 2.47 Favored Pre-proline 0 N--CA 1.502 2.16 0 O-C-N 121.266 -0.897 . . . . 4.19 110.41 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -68.62 63.78 1.21 Allowed 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 123.776 1.408 . . . . 3.7 111.3 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.412 HG23 ' N ' ' A' ' 12' ' ' THR . 8.9 t -57.42 -39.52 76.36 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.398 -0.814 . . . . 3.12 109.737 179.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.412 ' N ' HG23 ' A' ' 11' ' ' THR . 2.1 p -63.74 -42.01 97.93 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.991 -1.068 . . . . 3.61 109.448 178.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.487 ' O ' HG22 ' A' ' 17' ' ' VAL . . . -71.23 -51.18 18.75 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 108.929 -1.668 . . . . 3.16 108.929 178.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.583 ' O ' HG12 ' A' ' 18' ' ' ILE . 26.0 t -56.8 -40.58 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.644 -0.915 . . . . 2.82 109.265 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.662 ' HA ' HG12 ' A' ' 18' ' ' ILE . 16.5 t -70.45 -41.97 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.231 -0.918 . . . . 2.25 109.116 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.49 ' O ' HG12 ' A' ' 20' ' ' ILE . 40.7 m -57.16 -49.68 75.19 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.439 -0.788 . . . . 3.15 109.642 178.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.628 ' HA ' HG12 ' A' ' 20' ' ' ILE . 35.8 m -66.82 -44.04 89.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 C-N-CA 119.814 -0.754 . . . . 2.82 111.424 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.662 HG12 ' HA ' ' A' ' 15' ' ' VAL . 5.1 pt -66.14 -30.01 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 120.236 -1.54 . . . . 1.92 109.679 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.458 ' N ' HG13 ' A' ' 18' ' ' ILE . 8.3 t -70.59 -51.82 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.233 -0.917 . . . . 2.42 108.829 178.186 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.628 HG12 ' HA ' ' A' ' 17' ' ' VAL . 30.1 pt -64.46 -36.27 76.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.028 -1.045 . . . . 2.76 109.173 178.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.486 ' N ' HG13 ' A' ' 20' ' ' ILE . 13.0 mt -66.32 -47.22 74.25 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.378 -0.826 . . . . 2.07 108.831 177.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.44 HD13 ' HA ' ' A' ' 22' ' ' ILE . 7.3 mm -60.8 -41.35 88.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 108.724 -0.843 . . . . 2.04 108.724 178.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.53 -46.08 84.38 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.749 -0.595 . . . . 2.42 109.454 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 43.5 mt -61.14 -45.12 99.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.344 -0.848 . . . . 2.39 108.81 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.82 -44.87 91.95 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.519 -0.738 . . . . 2.14 109.671 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.28 -41.55 98.58 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.722 -0.844 . . . . 2.62 108.722 178.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.662 HD13 ' C ' ' A' ' 27' ' ' LEU . 3.2 tm? -61.91 -52.52 63.74 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.478 -0.934 . . . . 3.05 108.478 177.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.14 -43.96 83.71 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.166 -1.574 . . . . 2.34 109.166 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.29 -41.06 90.32 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.396 -1.061 . . . . 2.82 109.808 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.504 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 10.3 mt -62.38 -40.07 95.27 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.981 -0.748 . . . . 3.6 108.981 178.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.7 mm -71.05 -49.27 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.641 -0.662 . . . . 3.05 109.292 178.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.75 -46.09 84.98 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.542 -0.724 . . . . 2.97 109.616 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.16 -48.14 82.24 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 109.58 -1.408 . . . . 3.5 109.58 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -58.49 -46.23 87.08 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.523 -0.986 . . . . 3.96 109.887 179.343 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.409 ' O ' ' N ' ' A' ' 37' ' ' TYR . 5.2 t-105 -65.66 -55.4 17.73 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.554 -0.716 . . . . 3.13 109.843 179.116 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 64.48 -57.9 0.24 Allowed 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.984 -0.448 . . . . 3.81 111.776 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.409 ' N ' ' O ' ' A' ' 35' ' ' TRP . 12.3 t80 -151.33 -55.19 0.14 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.99 -1.069 . . . . 3.23 111.347 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.596 ' CD2' ' HG3' ' A' ' 49' ' ' GLU . 5.6 mt -97.53 -55.43 2.83 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.079 -1.013 . . . . 3.76 110.712 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.408 ' O ' ' HA ' ' A' ' 35' ' ' TRP . 2.2 mtm180 179.62 -50.92 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 121.021 0.438 . . . . 3.36 111.102 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.596 ' HB3' HG12 ' A' ' 43' ' ' ILE . 1.5 mt -124.94 70.05 1.14 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.469 -0.77 . . . . 4.32 110.384 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -58.06 -15.46 9.42 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.185 -0.947 . . . . 4.36 111.351 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.492 ' HG3' ' N ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -64.92 -62.49 1.53 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.148 -0.97 . . . . 6.5 108.948 178.7 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.596 HG12 ' HB3' ' A' ' 40' ' ' LEU . 3.4 pt -71.7 -30.81 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-O 121.865 0.84 . . . . 5.04 108.892 178.194 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.468 ' N ' HG13 ' A' ' 43' ' ' ILE . 0.9 OUTLIER 76.93 96.17 0.07 Allowed 'General case' 0 N--CA 1.503 2.206 0 CA-C-N 115.337 -0.847 . . . . 5.0 111.1 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.548 ' O ' HD13 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -103.83 146.87 28.0 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.745 -0.597 . . . . 4.26 110.122 179.349 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 77.4 p -92.5 -74.78 0.51 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.006 -1.059 . . . . 4.67 110.208 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 63.54 -176.17 0.16 Allowed 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.902 -0.499 . . . . 3.93 110.726 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -82.22 -43.89 17.07 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.068 -1.02 . . . . 3.5 110.247 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.596 ' HG3' ' CD2' ' A' ' 38' ' ' LEU . 0.5 OUTLIER 67.33 138.52 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.438 0 CA-C-O 121.518 0.675 . . . . 4.15 111.728 179.296 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -85.31 72.03 10.76 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.926 -1.109 . . . . 3.35 110.617 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 59.8 p -152.65 -56.88 0.13 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.439 -0.788 . . . . 3.4 110.022 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.44 ' H ' HG23 ' A' ' 52' ' ' ILE . 13.9 pt -51.47 -34.72 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 CA-C-O 121.263 0.554 . . . . 3.52 110.398 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.9 p -54.58 -29.56 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 121.689 -0.632 . . . . 3.37 110.993 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.12 -35.93 3.09 Favored Glycine 0 N--CA 1.499 2.862 0 N-CA-C 110.023 -1.231 . . . . 3.53 110.023 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.418 ' CB ' HD11 ' A' ' 63' ' ' LEU . 15.2 t0 -81.26 154.76 26.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.425 -1.044 . . . . 3.49 110.764 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.96 -58.49 0.05 OUTLIER Glycine 0 N--CA 1.496 2.66 0 N-CA-C 108.947 -1.661 . . . . 3.43 108.947 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -117.84 1.66 12.13 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.551 -0.97 . . . . 5.55 111.694 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.484 ' O ' ' HD3' ' A' ' 61' ' ' PRO . 4.1 m -50.68 140.19 15.0 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.054 -1.028 . . . . 3.25 110.691 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 12.7 ttpp -63.47 134.04 54.96 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.236 -0.915 . . . . 3.11 109.76 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 46.25 61.48 12.86 Favored Pre-proline 0 N--CA 1.502 2.155 0 O-C-N 121.544 -0.723 . . . . 2.82 110.586 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.491 ' O ' ' N ' ' A' ' 63' ' ' LEU . 40.6 Cg_endo -70.24 -34.29 13.26 Favored 'Trans proline' 0 N--CA 1.488 1.164 0 O-C-N 123.51 1.268 . . . . 2.01 111.327 -179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 12.3 t80 62.17 -66.11 0.08 Allowed 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.462 -0.774 . . . . 2.63 111.132 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.491 ' N ' ' O ' ' A' ' 61' ' ' PRO . 2.6 pp -60.25 -32.79 71.49 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.38 -0.825 . . . . 2.74 110.204 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.9 tp -65.78 -48.81 70.52 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.372 -0.83 . . . . 2.78 109.243 178.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.529 ' HA ' ' HB3' ' A' ' 68' ' ' SER . 9.1 t -67.05 -33.63 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 108.324 -0.991 . . . . 1.45 108.324 178.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.579 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 9.4 mm-40 -60.76 -58.35 8.81 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.674 -0.862 . . . . 2.7 108.674 178.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -63.04 -41.36 99.48 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.404 -0.961 . . . . 2.08 108.404 178.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.536 ' O ' ' HD2' ' A' ' 72' ' ' PRO . 29.0 t -53.5 -42.63 67.53 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.496 -0.927 . . . . 1.68 108.496 178.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.05 -38.63 69.46 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 119.581 -0.848 . . . . 1.98 109.246 177.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.579 ' HG2' ' O ' ' A' ' 66' ' ' GLN . 4.6 mmtm -58.18 -52.34 65.97 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.425 -0.797 . . . . 2.43 110.245 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 70' ' ' LYS . . . -34.68 -68.38 0.23 Allowed Glycine 0 N--CA 1.51 3.602 0 N-CA-C 110.911 -0.876 . . . . 1.75 110.911 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.536 ' HD2' ' O ' ' A' ' 68' ' ' SER . 39.4 Cg_endo -66.51 -38.28 19.88 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.831 1.438 . . . . 2.86 110.219 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 34.3 t -61.99 -40.98 97.49 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.995 -1.065 . . . . 3.6 109.386 178.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 55.8 t -75.53 -48.22 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.655 -0.653 . . . . 3.09 109.511 178.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.4 ' OE2' ' NZ ' ' A' ' 79' ' ' LYS . 5.2 tm-20 -57.44 -41.26 80.15 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.575 -0.898 . . . . 3.24 108.575 178.151 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.471 ' HB3' ' O ' ' A' ' 72' ' ' PRO . 0.3 OUTLIER -65.53 -46.72 78.49 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.675 -0.64 . . . . 5.36 109.736 178.465 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.0 -39.52 94.29 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.134 -0.978 . . . . 5.4 109.703 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.83 -46.74 64.97 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.947 -0.471 . . . . 4.18 110.278 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 76' ' ' ARG . 0.1 OUTLIER -69.53 -38.88 77.7 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.608 -0.683 . . . . 4.81 109.48 179.353 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.71 -39.67 94.05 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.441 -0.787 . . . . 5.97 109.256 178.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 13.8 ttt -77.16 -38.84 50.95 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.55 -0.719 . . . . 6.25 109.796 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 82' ' ' THR . 8.0 m 56.75 91.29 0.08 OUTLIER Pre-proline 0 N--CA 1.507 2.389 0 O-C-N 121.837 -0.539 . . . . 5.44 110.75 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -74.75 15.28 0.71 Allowed 'Trans proline' 0 N--CA 1.492 1.393 0 O-C-N 123.261 1.137 . . . . 5.31 112.405 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -72.6 48.51 0.2 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.696 -1.252 . . . . 5.64 109.584 178.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 56.34 57.24 20.25 Favored Glycine 0 N--CA 1.499 2.862 0 N-CA-C 110.4 -1.08 . . . . 6.66 110.4 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.12 -24.44 66.24 Favored 'Trans proline' 0 N--CA 1.488 1.174 0 O-C-N 123.353 1.186 . . . . 7.72 110.935 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -65.99 -28.0 68.56 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.368 -0.975 . . . . 8.73 108.368 177.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 60.1 t -100.68 -34.01 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.892 -0.505 . . . . 7.96 109.741 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 -81.63 -52.34 7.29 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.428 -0.795 . . . . 7.95 110.748 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.672 0 CA-C-O 117.912 -1.493 . . . . 8.29 109.581 -179.146 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.777 0 N-CA-C 110.57 -1.012 . . . . 3.74 110.57 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.1 t -64.33 121.34 14.07 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.223 -1.163 . . . . 3.35 111.594 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -81.43 66.09 6.84 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.092 -1.005 . . . . 4.41 108.72 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.411 ' OG ' ' N ' ' A' ' 5' ' ' ILE . 87.6 p -151.46 -68.31 0.18 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.521 -0.737 . . . . 2.89 110.191 -178.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.545 HD12 ' C ' ' A' ' 5' ' ' ILE . 1.8 pp -98.85 -169.49 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.579 -0.701 . . . . 3.34 110.66 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.42 59.81 5.86 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.064 -1.022 . . . . 3.39 111.272 -179.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.474 ' HB3' ' CD1' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -73.39 -26.71 61.11 Favored 'General case' 0 N--CA 1.508 2.43 0 O-C-N 121.032 -1.042 . . . . 3.04 109.768 178.676 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.445 ' O ' ' CB ' ' A' ' 9' ' ' SER . 0.2 OUTLIER -136.09 70.19 1.42 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.598 -0.689 . . . . 3.51 109.732 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER 72.79 176.77 0.06 OUTLIER Pre-proline 0 N--CA 1.517 2.919 0 O-C-N 121.42 -0.8 . . . . 1.95 110.439 -179.308 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.54 -9.86 26.73 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 O-C-N 123.068 1.036 . . . . 2.39 111.074 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.7 p -59.67 -43.34 94.0 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.248 -0.908 . . . . 2.42 111.201 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.409 HG21 ' OD1' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -57.08 -37.31 71.69 Favored 'General case' 0 N--CA 1.507 2.421 0 O-C-N 121.345 -0.847 . . . . 2.03 110.14 179.753 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.535 ' O ' HG22 ' A' ' 17' ' ' VAL . . . -71.59 -51.89 14.55 Favored Glycine 0 N--CA 1.498 2.769 0 N-CA-C 108.81 -1.716 . . . . 1.41 108.81 178.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 51.1 t -54.87 -39.63 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.692 -0.887 . . . . 2.34 109.569 178.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.5 t -70.59 -43.15 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.073 -1.017 . . . . 2.05 109.394 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 87.7 m -59.32 -50.81 72.55 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.735 -0.603 . . . . 1.35 110.009 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.535 HG22 ' O ' ' A' ' 13' ' ' GLY . 33.1 m -66.78 -34.9 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.489 -0.757 . . . . 1.62 110.156 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.416 ' HA ' HD13 ' A' ' 18' ' ' ILE . 6.7 mm -68.08 -41.21 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 120.907 -1.121 . . . . 2.24 109.632 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.4 t -64.89 -44.74 96.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 108.289 -1.004 . . . . 1.78 108.289 177.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 23.2 mm -61.82 -46.92 95.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.519 -0.738 . . . . 1.42 109.056 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 11.3 mt -60.6 -49.18 78.55 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.868 -0.79 . . . . 1.94 108.868 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.2 mt -56.62 -43.83 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 C-N-CA 119.837 -0.745 . . . . 2.14 109.387 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.27 -46.08 85.28 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.615 -0.678 . . . . 1.45 110.176 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 40.6 mt -59.22 -48.15 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 108.852 -0.795 . . . . 1.51 108.852 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.59 -45.18 95.21 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.747 -0.595 . . . . 1.76 110.159 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.63 -49.78 76.16 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 109.086 -0.709 . . . . 1.69 109.086 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.19 -46.12 86.36 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.016 -0.735 . . . . 1.44 109.016 178.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.87 -46.18 92.72 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.073 -1.611 . . . . 1.45 109.073 178.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.13 -42.6 96.77 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.59 -0.947 . . . . 1.76 109.963 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.498 ' CD1' HG21 ' A' ' 53' ' ' VAL . 8.8 mt -61.3 -41.2 96.58 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.16 -0.682 . . . . 1.79 109.16 178.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 95.3 mt -67.32 -51.84 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.467 -0.771 . . . . 1.83 109.154 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.94 -45.5 78.8 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.597 -0.689 . . . . 2.17 109.921 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.5 -53.86 35.93 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.813 -1.315 . . . . 1.76 109.813 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -56.28 -39.6 72.91 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.4 -1.059 . . . . 1.71 109.972 179.531 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.578 ' HA ' ' CE3' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -72.55 -65.65 0.76 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.255 -0.903 . . . . 1.68 110.666 179.584 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 36.7 t 52.05 -76.6 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.396 0 O-C-N 121.892 -0.505 . . . . 2.12 112.189 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.504 ' N ' ' O ' ' A' ' 35' ' ' TRP . 0.2 OUTLIER -98.92 -24.18 15.05 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.937 -1.102 . . . . 3.88 110.747 179.832 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.886 HD11 ' HB3' ' A' ' 42' ' ' ARG . 52.9 tp -80.21 -46.53 16.14 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.151 -0.968 . . . . 1.56 110.479 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.451 ' HG2' ' O ' ' A' ' 38' ' ' LEU . 0.2 OUTLIER 26.26 63.2 0.08 Allowed 'General case' 0 N--CA 1.512 2.653 0 N-CA-C 113.344 0.868 . . . . 2.61 113.344 179.852 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.648 ' HG ' ' HA ' ' A' ' 44' ' ' SER . 0.1 OUTLIER 58.87 14.57 3.35 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 121.538 -0.726 . . . . 1.79 112.903 178.644 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.426 ' OE1' ' NH2' ' A' ' 42' ' ' ARG . 3.4 tt0 -81.07 3.58 22.79 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 120.453 -1.405 . . . . 2.82 110.936 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.886 ' HB3' HD11 ' A' ' 38' ' ' LEU . 0.1 OUTLIER -134.86 -86.07 0.4 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.677 -1.264 . . . . 3.64 110.535 179.564 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.436 ' O ' ' HB2' ' A' ' 46' ' ' SER . 0.9 OUTLIER -54.95 -34.29 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.304 -0.872 . . . . 2.74 110.109 179.208 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.648 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 29.4 t 61.74 -106.5 0.23 Allowed 'General case' 0 N--CA 1.507 2.412 0 CA-C-N 115.986 -0.552 . . . . 2.21 110.772 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -101.92 19.98 17.33 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 120.789 -1.195 . . . . 2.9 111.042 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 0.5 OUTLIER -84.15 49.65 1.69 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.982 -1.074 . . . . 2.66 111.369 -179.482 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.637 ' HG3' ' HB1' ' A' ' 69' ' ' ALA . 0.0 OUTLIER 54.09 -160.31 0.15 Allowed 'General case' 0 N--CA 1.506 2.374 0 O-C-N 121.424 -0.798 . . . . 3.14 111.413 179.589 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 58.09 24.47 11.26 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.671 -0.643 . . . . 1.86 111.581 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.51 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . 0.9 OUTLIER -76.12 -39.41 55.23 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.057 -1.027 . . . . 1.5 108.968 178.149 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -139.58 153.11 47.33 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.353 -0.98 . . . . 1.53 108.353 178.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.5 m -166.49 24.52 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.254 0 O-C-N 120.957 -1.09 . . . . 1.13 110.494 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.4 mt -119.11 -42.71 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 108.472 -0.936 . . . . 1.5 108.472 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.498 HG21 ' CD1' ' A' ' 30' ' ' LEU . 94.5 t -104.21 -76.04 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.917 -0.49 . . . . 1.49 110.317 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.81 -62.15 1.62 Allowed Glycine 0 N--CA 1.5 2.964 0 N-CA-C 110.12 -1.192 . . . . 1.65 110.12 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.38 -176.05 3.9 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.6 -0.941 . . . . 1.79 110.521 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -160.9 -47.41 0.02 OUTLIER Glycine 0 N--CA 1.495 2.573 0 N-CA-C 107.511 -2.235 . . . . 1.84 107.511 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.568 ' O ' ' HB ' ' A' ' 58' ' ' THR . 2.8 pm0 -89.62 -7.41 54.8 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.871 -0.782 . . . . 1.99 110.265 178.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.568 ' HB ' ' O ' ' A' ' 57' ' ' GLU . 87.2 m 70.81 82.96 0.15 Allowed 'General case' 0 N--CA 1.508 2.461 0 O-C-N 121.642 -0.661 . . . . 2.05 109.823 -179.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.7 ptpp? -119.7 158.42 26.5 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.547 -0.721 . . . . 2.04 111.597 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.569 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 1.5 tt0 -63.05 -50.63 75.52 Favored Pre-proline 0 N--CA 1.502 2.151 0 O-C-N 121.554 -0.716 . . . . 2.0 111.583 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.569 ' HD3' ' HB3' ' A' ' 60' ' ' GLU . 43.6 Cg_endo -68.39 162.94 38.46 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 O-C-N 123.163 1.086 . . . . 1.68 111.113 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.41 ' CB ' ' O ' ' A' ' 61' ' ' PRO . 0.1 OUTLIER 70.13 -60.66 0.48 Allowed 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.563 -0.71 . . . . 2.47 110.822 -179.626 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.9 mt -62.45 -44.39 96.52 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.393 -0.817 . . . . 1.59 110.586 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.432 ' HB2' ' O ' ' A' ' 60' ' ' GLU . 0.2 OUTLIER -55.28 -56.18 23.0 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.75 -0.594 . . . . 2.24 110.633 -179.844 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.5 m -67.22 -34.24 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.046 -1.034 . . . . 1.93 110.633 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -61.07 -51.36 69.47 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.329 -0.857 . . . . 1.86 109.231 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -67.31 -40.14 85.99 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.751 -0.593 . . . . 2.05 109.868 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 71.1 m -60.47 -32.37 71.35 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.872 -0.517 . . . . 1.75 110.686 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.637 ' HB1' ' HG3' ' A' ' 47' ' ' GLU . . . -94.07 -51.05 5.02 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.264 -0.897 . . . . 1.51 110.528 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.438 ' HG2' ' OE2' ' A' ' 47' ' ' GLU . 3.0 mmpt? -56.42 -43.93 79.88 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.44 -0.787 . . . . 1.47 110.93 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -46.64 -64.76 2.47 Favored Glycine 0 N--CA 1.503 3.108 0 N-CA-C 110.507 -1.037 . . . . 1.26 110.507 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -66.46 -40.35 14.36 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.844 1.444 . . . . 1.31 110.303 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 34.3 t -59.31 -45.3 91.68 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.058 -1.026 . . . . 1.81 109.816 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.9 t -70.61 -46.17 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.545 -0.722 . . . . 1.69 109.182 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -55.77 -40.81 73.15 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 121.637 0.732 . . . . 2.17 109.751 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.53 -47.7 59.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.85 -0.531 . . . . 1.73 110.622 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.608 ' HG3' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -67.11 -31.3 71.68 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.997 -1.064 . . . . 2.64 110.057 179.573 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.608 ' N ' ' HG3' ' A' ' 77' ' ' LYS . . . -70.61 -47.84 58.09 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.173 -0.954 . . . . 2.14 109.351 179.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.475 ' HG3' ' CA ' ' A' ' 90' ' ' GLY . 6.9 ptpt -71.15 -34.75 71.28 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.827 -0.749 . . . . 1.94 109.764 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.419 ' N ' ' HG3' ' A' ' 79' ' ' LYS . 0.8 OUTLIER -64.08 -45.89 86.71 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.986 -1.071 . . . . 2.12 109.948 179.097 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 19.7 ttt -74.44 -41.28 61.1 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.405 -0.809 . . . . 3.45 110.319 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -123.73 67.14 39.48 Favored Pre-proline 0 N--CA 1.502 2.146 0 O-C-N 121.293 -0.88 . . . . 2.88 110.686 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.418 ' O ' ' CB ' ' A' ' 84' ' ' ASN . 52.1 Cg_endo -78.0 -9.94 16.69 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 O-C-N 123.588 1.309 . . . . 2.61 112.13 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' A' ' 83' ' ' PRO . 2.7 t-20 70.2 -51.76 0.65 Allowed 'General case' 0 N--CA 1.507 2.386 0 O-C-N 121.339 -0.85 . . . . 3.61 109.854 -178.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -126.4 132.11 7.64 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.111 -1.596 . . . . 2.71 109.111 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -66.09 -16.85 53.73 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 O-C-N 123.323 1.17 . . . . 2.99 111.096 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.423 ' HG2' ' H ' ' A' ' 88' ' ' VAL . 1.9 pm0 -49.37 -42.69 42.87 Favored 'General case' 0 N--CA 1.508 2.442 0 O-C-N 121.463 -0.773 . . . . 4.11 110.693 178.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.452 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 6.4 p -90.69 -22.98 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.783 -0.573 . . . . 3.23 110.743 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.452 ' HB2' ' O ' ' A' ' 88' ' ' VAL . 0.3 OUTLIER 66.92 -57.3 0.41 Allowed 'General case' 0 N--CA 1.508 2.458 0 O-C-N 121.61 -0.681 . . . . 3.32 110.548 -179.56 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.475 ' CA ' ' HG3' ' A' ' 79' ' ' LYS . . . . . . . . 0 N--CA 1.497 2.702 0 O-C-N 121.232 -0.917 . . . . 1.78 110.892 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.922 0 N-CA-C 109.762 -1.335 . . . . 5.58 109.762 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.0 p -76.54 -48.2 20.12 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.393 -1.063 . . . . 4.68 110.783 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.1 -176.88 4.4 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.577 -0.702 . . . . 5.49 110.439 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.642 ' C ' HG23 ' A' ' 11' ' ' THR . 0.3 OUTLIER 52.3 40.56 29.4 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.598 -0.689 . . . . 3.86 110.589 -179.297 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.429 ' O ' ' CB ' ' A' ' 6' ' ' MET . 0.0 OUTLIER -97.39 -115.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.428 -0.795 . . . . 3.29 109.458 179.595 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.429 ' CB ' ' O ' ' A' ' 5' ' ' ILE . 2.4 ttp 71.48 164.93 0.28 Allowed 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.321 -0.862 . . . . 3.8 110.583 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.556 ' CB ' HG11 ' A' ' 14' ' ' VAL . 4.3 m-20 43.41 33.8 0.67 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.61 -0.681 . . . . 3.34 111.439 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 48.02 45.03 19.26 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-O 121.674 0.75 . . . . 6.01 111.541 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.516 ' HB3' HG13 ' A' ' 14' ' ' VAL . 0.4 OUTLIER -179.58 -177.85 0.23 Allowed Pre-proline 0 N--CA 1.492 1.659 0 N-CA-C 108.927 -0.768 . . . . 3.89 108.927 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -75.21 146.04 31.44 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 N-CA-C 109.442 -1.022 . . . . 4.11 109.442 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.642 HG23 ' C ' ' A' ' 4' ' ' SER . 25.3 p -49.41 -46.88 48.09 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 121.611 0.72 . . . . 3.7 109.479 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.3 t -64.69 -35.29 80.55 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.698 -0.626 . . . . 5.17 110.275 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.564 ' O ' HG22 ' A' ' 17' ' ' VAL . . . -67.79 -56.22 11.82 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.832 -1.307 . . . . 3.79 109.832 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.556 HG11 ' CB ' ' A' ' 7' ' ' ASP . 14.5 m -63.71 -33.08 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.245 -1.15 . . . . 2.83 110.273 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.403 ' O ' HG23 ' A' ' 19' ' ' VAL . 7.4 t -71.44 -48.32 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 120.945 -1.097 . . . . 4.06 110.075 179.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 16.6 p -60.04 -49.29 78.23 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.365 -0.834 . . . . 4.88 109.94 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.564 HG22 ' O ' ' A' ' 13' ' ' GLY . 21.6 m -63.79 -36.97 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 C-N-CA 119.384 -0.926 . . . . 3.53 109.855 178.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.436 HD13 ' HA ' ' A' ' 18' ' ' ILE . 6.0 mm -67.93 -38.64 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 120.792 -1.192 . . . . 2.47 109.012 178.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 15' ' ' VAL . 51.0 t -65.84 -43.07 93.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.382 -0.969 . . . . 4.53 108.382 177.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 57.7 mt -63.87 -47.3 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 108.728 -0.842 . . . . 4.55 108.728 178.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 11.6 mt -59.37 -48.8 80.26 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.987 -0.745 . . . . 2.44 108.987 178.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.0 mt -56.33 -43.05 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 121.549 -0.719 . . . . 3.53 109.39 178.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.67 -45.47 78.79 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.461 -0.775 . . . . 3.86 110.072 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 33.0 mt -60.65 -45.7 97.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.226 -0.921 . . . . 3.09 109.264 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.95 -42.95 97.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.401 -0.812 . . . . 2.23 109.528 178.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.87 -42.58 97.49 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.368 -0.832 . . . . 3.65 109.176 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.906 ' HA ' HD23 ' A' ' 30' ' ' LEU . 0.5 OUTLIER -63.02 -46.14 89.03 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.453 -0.943 . . . . 4.13 108.453 178.025 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.509 ' O ' HD13 ' A' ' 32' ' ' LEU . . . -58.92 -47.5 90.3 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 108.425 -1.87 . . . . 2.3 108.425 178.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.94 -45.08 96.15 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.506 -0.997 . . . . 3.25 110.208 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.906 HD23 ' HA ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -63.3 -37.32 86.8 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.442 -0.786 . . . . 4.5 109.697 179.238 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.513 ' N ' ' HG ' ' A' ' 30' ' ' LEU . 48.0 mt -71.2 -47.29 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.084 -1.01 . . . . 3.1 109.185 178.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.804 ' HG ' ' HA ' ' A' ' 38' ' ' LEU . 6.8 mp -57.83 -49.86 75.25 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.79 -0.569 . . . . 3.0 109.626 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.48 -45.59 76.89 Favored Glycine 0 N--CA 1.498 2.825 0 N-CA-C 110.199 -1.16 . . . . 4.16 110.199 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 50.4 t -55.34 -40.44 71.21 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.479 -1.012 . . . . 4.57 110.309 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.486 ' HA ' ' CE3' ' A' ' 35' ' ' TRP . 1.5 m95 -72.48 -55.58 6.76 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.178 -0.951 . . . . 3.32 109.778 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.441 ' CB ' ' O ' ' A' ' 35' ' ' TRP . 0.0 OUTLIER 168.59 -39.71 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.539 0 CA-C-O 121.43 0.633 . . . . 4.25 109.733 179.698 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -161.22 -61.46 0.05 Allowed 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.806 -0.812 . . . . 6.12 108.806 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.804 ' HA ' ' HG ' ' A' ' 32' ' ' LEU . 6.6 tp -115.94 -65.5 1.18 Allowed 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.543 -0.91 . . . . 3.55 108.543 177.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.459 ' NH2' ' HB2' ' A' ' 41' ' ' GLN . 0.1 OUTLIER -155.02 -55.75 0.1 Allowed 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.645 -0.872 . . . . 2.55 108.645 178.553 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 48.76 -149.06 0.2 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.748 -0.595 . . . . 3.13 111.306 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.459 ' HB2' ' NH2' ' A' ' 39' ' ' ARG . 3.2 tt0 50.93 26.57 2.74 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.379 -0.826 . . . . 3.34 110.403 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.412 ' NH1' ' OH ' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -73.34 -51.04 18.88 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.59 0.71 . . . . 3.26 109.223 179.618 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.275 0.1 OUTLIER -86.41 -20.16 7.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 109.29 -0.633 . . . . 3.91 109.29 178.789 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 47.45 61.2 3.03 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 121.765 0.793 . . . . 3.46 110.112 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 51.65 -108.22 0.36 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.966 -0.459 . . . . 4.02 111.11 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.621 ' O ' HD11 ' A' ' 63' ' ' LEU . 0.3 OUTLIER 51.86 30.9 7.6 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 120.909 -1.12 . . . . 3.06 109.606 -178.457 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -57.53 150.09 19.75 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.671 -0.643 . . . . 3.31 111.709 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.458 ' OD2' HG23 ' A' ' 52' ' ' ILE . 7.5 t70 66.6 -63.99 0.24 Allowed 'General case' 0 N--CA 1.504 2.232 0 O-C-N 122.001 -0.437 . . . . 2.49 110.859 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 65.16 -65.16 0.16 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.988 -0.445 . . . . 2.55 110.1 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 48' ' ' ASP . 10.6 tt0 -149.22 71.81 1.14 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.352 -0.843 . . . . 2.5 110.207 178.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.42 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 14.3 t -129.71 -71.67 0.61 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.375 -0.828 . . . . 2.62 109.735 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.458 HG23 ' OD2' ' A' ' 48' ' ' ASP . 27.2 pt -62.54 -37.58 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.351 -0.843 . . . . 3.39 109.898 179.083 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.423 ' N ' HG13 ' A' ' 52' ' ' ILE . 14.5 p -74.32 -31.14 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 121.625 -0.672 . . . . 3.35 110.607 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -95.06 64.27 1.41 Allowed Glycine 0 N--CA 1.498 2.815 0 N-CA-C 109.021 -1.632 . . . . 3.18 109.021 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -49.65 135.68 18.39 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.798 -0.825 . . . . 5.45 111.91 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 142.05 58.49 0.03 OUTLIER Glycine 0 N--CA 1.497 2.704 0 N-CA-C 109.29 -1.524 . . . . 3.89 109.29 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 58.42 30.34 19.52 Favored 'General case' 0 N--CA 1.507 2.418 0 O-C-N 121.637 -0.919 . . . . 4.6 110.429 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.42 ' HB ' ' HA ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -79.39 62.13 3.64 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.198 -0.939 . . . . 2.8 110.654 -179.539 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 19.7 ttpp -63.6 149.49 46.29 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.332 -0.855 . . . . 3.25 110.772 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 62.04 171.3 0.08 OUTLIER Pre-proline 0 N--CA 1.502 2.135 0 O-C-N 121.949 -0.47 . . . . 3.01 111.333 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -74.07 146.35 36.7 Favored 'Trans proline' 0 C--N 1.313 -1.311 0 O-C-N 123.619 1.326 . . . . 2.16 109.719 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -67.42 -17.93 64.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.389 -0.819 . . . . 1.71 110.229 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.621 HD11 ' O ' ' A' ' 46' ' ' SER . 6.3 mt -44.8 -38.61 4.63 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.727 -0.608 . . . . 2.98 112.289 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.409 ' O ' ' OG ' ' A' ' 68' ' ' SER . 0.2 OUTLIER -56.6 -49.21 75.6 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.292 -0.88 . . . . 2.83 109.758 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.408 ' H ' HG23 ' A' ' 65' ' ' VAL . 1.4 t -81.44 -39.89 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 121.436 -0.79 . . . . 1.88 109.468 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.465 ' O ' ' CG ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -55.21 -51.87 65.19 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.865 -0.791 . . . . 2.17 108.865 178.881 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.412 ' OH ' ' NH1' ' A' ' 42' ' ' ARG . 6.4 t80 -68.25 -47.65 67.2 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.43 -0.794 . . . . 3.68 109.864 178.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.409 ' OG ' ' O ' ' A' ' 64' ' ' LEU . 69.6 m -55.19 -34.36 63.82 Favored 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 119.767 -0.773 . . . . 1.76 110.171 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -88.25 -46.44 9.23 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.202 -0.937 . . . . 1.4 110.835 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.465 ' CG ' ' O ' ' A' ' 66' ' ' GLN . 2.6 mmtp -64.56 -40.18 95.1 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.418 -0.801 . . . . 2.03 110.76 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -47.01 -64.88 2.5 Favored Glycine 0 N--CA 1.505 3.273 0 N-CA-C 110.006 -1.237 . . . . 2.17 110.006 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.59 -37.93 20.53 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 O-C-N 123.714 1.376 . . . . 1.98 110.379 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 5.0 t -62.71 -42.87 99.87 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.979 -1.076 . . . . 2.49 109.36 178.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.2 t -69.68 -44.77 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 109.048 -0.723 . . . . 3.05 109.048 178.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.48 ' HG3' ' N ' ' A' ' 76' ' ' ARG . 0.1 OUTLIER -59.15 -42.26 90.26 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.889 -0.782 . . . . 2.98 108.889 178.42 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.48 ' N ' ' HG3' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -64.0 -53.05 56.06 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.628 -0.67 . . . . 3.21 109.597 178.776 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.88 -48.28 81.95 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.674 -0.641 . . . . 3.88 109.95 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.47 -44.03 96.32 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.805 -0.56 . . . . 4.19 110.788 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.42 ' HG3' ' CD ' ' A' ' 75' ' ' GLU . 12.6 mmtp -68.75 -42.91 76.87 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.164 -0.96 . . . . 4.13 109.306 179.091 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.421 HD21 ' HB2' ' A' ' 89' ' ' HIS . 1.8 tp -64.7 -35.24 80.42 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.447 0.641 . . . . 4.64 109.84 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 8.6 ttt -84.56 -22.85 29.95 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.66 -0.65 . . . . 5.89 111.12 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.541 ' N ' ' HD2' ' A' ' 83' ' ' PRO . 8.9 m -46.19 -51.41 33.42 Favored Pre-proline 0 N--CA 1.51 2.565 0 O-C-N 121.376 -0.828 . . . . 5.53 111.974 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 82' ' ' THR . 45.1 Cg_endo -67.83 -8.26 21.99 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 O-C-N 123.422 1.222 . . . . 5.89 110.591 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 55.0 24.21 5.75 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.577 -0.702 . . . . 7.52 111.341 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -111.96 75.78 0.22 Allowed Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.943 -1.263 . . . . 5.9 109.943 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.442 ' HA ' ' O ' ' A' ' 89' ' ' HIS . 43.6 Cg_endo -67.85 -15.05 43.23 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 O-C-N 123.722 1.38 . . . . 6.26 111.02 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -54.13 -34.14 59.61 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.364 -0.835 . . . . 6.95 109.939 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.6 t -92.53 -36.53 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.737 -0.602 . . . . 5.72 109.533 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.442 ' O ' ' HA ' ' A' ' 86' ' ' PRO . 2.5 p80 -161.35 124.74 3.24 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.328 -0.858 . . . . 4.94 110.718 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.405 ' O ' HD23 ' A' ' 80' ' ' LEU . . . . . . . . 0 N--CA 1.499 2.876 0 CA-C-O 117.893 -1.504 . . . . 4.38 110.075 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.706 0 N-CA-C 109.394 -1.482 . . . . 1.06 109.394 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.5 p -78.03 -83.68 0.08 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.962 -1.316 . . . . 1.17 109.768 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.1 58.69 0.37 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.373 -0.829 . . . . 2.66 109.791 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.542 ' HB2' ' HB2' ' A' ' 7' ' ' ASP . 53.3 p -148.45 87.45 1.58 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.064 -1.023 . . . . 1.4 109.82 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -38.73 -54.92 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.294 0 O-C-N 121.786 -0.572 . . . . 2.38 112.041 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.507 ' O ' ' HB3' ' A' ' 7' ' ' ASP . 0.3 OUTLIER -99.41 -80.3 0.47 Allowed 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.503 -0.748 . . . . 3.35 110.309 179.405 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.542 ' HB2' ' HB2' ' A' ' 4' ' ' SER . 32.7 t70 63.6 -52.97 0.22 Allowed 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.638 -0.664 . . . . 1.94 111.433 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.472 ' N ' ' O ' ' A' ' 6' ' ' MET . 8.2 m80 -139.15 -42.51 0.46 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.194 -0.941 . . . . 2.22 111.089 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -176.01 172.52 0.98 Allowed Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.536 -0.728 . . . . 2.02 110.676 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.04 64.46 1.38 Allowed 'Trans proline' 0 N--CA 1.49 1.297 0 O-C-N 123.861 1.453 . . . . 1.84 110.806 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.0 t -155.63 -38.81 0.08 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.609 -0.682 . . . . 1.35 111.009 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.3 t -52.93 -34.41 55.28 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 121.0 -1.063 . . . . 1.1 110.602 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.413 ' O ' HG22 ' A' ' 17' ' ' VAL . . . -74.15 -52.46 7.77 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.02 -1.632 . . . . 0.95 109.02 178.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.3 t -56.48 -38.66 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 121.76 -0.847 . . . . 1.09 109.592 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.8 t -69.64 -43.42 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.107 -0.995 . . . . 1.25 108.981 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 49.3 m -56.69 -51.34 69.17 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.577 -0.702 . . . . 0.9 109.939 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.629 ' HA ' HG12 ' A' ' 20' ' ' ILE . 35.2 m -64.75 -39.13 84.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.526 -0.734 . . . . 0.82 110.278 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.411 HD13 ' HA ' ' A' ' 18' ' ' ILE . 6.7 mm -65.01 -36.72 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 120.819 -1.176 . . . . 1.07 109.569 178.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.1 t -66.31 -52.44 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 C-N-CA 119.689 -0.805 . . . . 1.03 109.135 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.629 HG12 ' HA ' ' A' ' 17' ' ' VAL . 27.1 pt -63.74 -36.5 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.114 -0.991 . . . . 1.0 109.38 178.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.516 ' N ' HG13 ' A' ' 20' ' ' ILE . 7.6 mt -64.27 -48.58 75.17 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.596 -0.89 . . . . 0.89 108.596 177.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.415 HD13 ' HA ' ' A' ' 22' ' ' ILE . 10.5 mm -59.04 -44.5 91.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.483 -0.76 . . . . 1.09 109.071 178.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.21 -44.9 95.53 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.625 -0.672 . . . . 0.8 109.908 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 44.5 mt -61.66 -46.51 96.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.403 -0.811 . . . . 0.82 108.825 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.93 -44.11 97.45 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.648 -0.658 . . . . 0.77 109.68 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.92 -45.41 93.82 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.423 -0.798 . . . . 0.81 109.152 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.73 ' HA ' HD23 ' A' ' 30' ' ' LEU . 0.5 OUTLIER -61.46 -46.67 89.07 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.042 -0.725 . . . . 1.0 109.042 178.269 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.45 -43.33 97.56 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 108.874 -1.69 . . . . 0.6 108.874 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.14 -43.96 93.63 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.492 -1.005 . . . . 0.79 110.009 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.73 HD23 ' HA ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -62.84 -37.6 87.45 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.56 -0.712 . . . . 0.97 109.272 178.904 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.511 ' N ' ' HG ' ' A' ' 30' ' ' LEU . 61.2 mt -71.62 -48.67 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.298 -0.876 . . . . 0.79 108.972 178.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.492 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 0.6 OUTLIER -58.01 -46.32 85.44 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.656 -0.652 . . . . 1.07 109.774 178.991 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.96 -44.7 95.6 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 109.689 -1.364 . . . . 1.19 109.689 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.9 t -58.37 -48.92 79.04 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.499 -1.001 . . . . 1.31 110.593 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.427 ' O ' ' N ' ' A' ' 37' ' ' TYR . 1.4 t-105 -172.9 44.0 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.115 -0.991 . . . . 2.17 111.327 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER 65.26 -60.6 0.25 Allowed 'General case' 0 N--CA 1.509 2.484 0 O-C-N 121.528 -0.732 . . . . 1.33 111.264 179.746 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.464 ' CE2' ' HG2' ' A' ' 47' ' ' GLU . 0.1 OUTLIER -167.4 -61.12 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.269 -0.894 . . . . 1.6 110.219 179.791 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.8 tp -122.74 -67.9 0.92 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.362 -0.837 . . . . 2.66 109.944 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -145.35 29.43 1.16 Allowed 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.635 -0.666 . . . . 2.4 111.093 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.461 HD12 ' HB2' ' A' ' 36' ' ' CYS . 0.0 OUTLIER 49.56 41.86 22.01 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.4 -0.812 . . . . 2.04 111.108 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -121.91 29.41 7.11 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.364 -0.835 . . . . 2.79 110.778 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.88 -148.04 0.25 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.865 -1.147 . . . . 3.19 109.972 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.617 HD12 ' CB ' ' A' ' 46' ' ' SER . 14.8 pt -42.66 -36.12 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 O-C-N 121.448 -0.783 . . . . 2.19 111.621 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.524 ' HB3' ' O ' ' A' ' 43' ' ' ILE . 6.2 t 63.97 -73.11 0.05 Allowed 'General case' 0 N--CA 1.506 2.356 0 O-C-N 122.116 -0.365 . . . . 1.93 111.197 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -85.53 95.25 9.25 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.993 -1.067 . . . . 1.97 110.487 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.617 ' CB ' HD12 ' A' ' 43' ' ' ILE . 3.1 m -166.06 44.1 0.07 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.272 -0.893 . . . . 1.42 110.216 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.464 ' HG2' ' CE2' ' A' ' 37' ' ' TYR . 2.4 mm-40 -141.11 -159.46 0.96 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.377 -0.827 . . . . 1.55 110.763 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 59.67 44.22 14.59 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.414 0.625 . . . . 1.23 110.988 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 50.73 48.97 21.88 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.531 -0.731 . . . . 0.78 111.635 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.614 ' OE1' HG12 ' A' ' 53' ' ' VAL . 0.7 OUTLIER -83.74 134.89 34.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.683 -1.261 . . . . 1.69 110.38 179.52 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.445 ' OG ' ' NZ ' ' A' ' 70' ' ' LYS . 75.4 m -158.46 21.4 0.23 Allowed 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.537 -0.727 . . . . 0.95 110.847 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.853 ' O ' HG22 ' A' ' 53' ' ' VAL . 3.0 mt -122.9 -44.6 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 107.569 -1.271 . . . . 1.26 107.569 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.853 HG22 ' O ' ' A' ' 52' ' ' ILE . 1.3 m 57.03 -34.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.717 0 N-CA-C 113.147 0.795 . . . . 1.65 113.147 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 52' ' ' ILE . . . -127.51 51.05 0.86 Allowed Glycine 0 N--CA 1.497 2.716 0 N-CA-C 109.596 -1.402 . . . . 1.56 109.596 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -59.12 147.48 34.87 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.634 -0.921 . . . . 1.82 110.961 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -120.98 -54.17 0.23 Allowed Glycine 0 N--CA 1.495 2.58 0 N-CA-C 107.729 -2.148 . . . . 2.0 107.729 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.477 ' OE2' ' NZ ' ' A' ' 59' ' ' LYS . 15.2 pt-20 -141.52 34.96 1.64 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.766 -0.843 . . . . 2.71 109.744 178.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.4 m 48.24 33.61 3.85 Favored 'General case' 0 N--CA 1.505 2.283 0 CA-C-O 121.421 0.629 . . . . 1.9 111.149 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.477 ' NZ ' ' OE2' ' A' ' 57' ' ' GLU . 7.6 ttpp -156.64 72.58 0.74 Allowed 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.316 -0.865 . . . . 1.86 108.883 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -134.29 160.58 67.95 Favored Pre-proline 0 N--CA 1.497 1.89 0 CA-C-N 116.045 -0.525 . . . . 1.68 110.608 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.416 ' O ' HG22 ' A' ' 65' ' ' VAL . 41.7 Cg_endo -68.75 -30.98 26.54 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 O-C-N 123.838 1.441 . . . . 1.34 111.063 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.472 ' O ' ' HB2' ' A' ' 66' ' ' GLN . 0.5 OUTLIER -52.31 -64.15 0.91 Allowed 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.589 -0.694 . . . . 2.4 111.063 179.879 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.539 ' HB3' HG12 ' A' ' 52' ' ' ILE . 3.2 pp -64.43 -27.23 68.85 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.242 -0.911 . . . . 1.26 110.424 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.3 -51.05 69.23 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.535 -0.728 . . . . 1.8 109.55 178.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 61' ' ' PRO . 32.7 m -74.45 -35.18 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.235 -0.916 . . . . 1.16 109.645 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.472 ' HB2' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -61.04 -49.9 75.52 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.577 -0.702 . . . . 1.49 109.346 178.672 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.509 ' HB2' ' O ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -66.64 -41.93 87.48 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.617 -0.677 . . . . 0.75 109.381 178.482 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.7 m -56.82 -38.17 72.25 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.803 -0.561 . . . . 1.08 109.744 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -82.38 -38.58 23.94 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.409 -0.807 . . . . 0.98 110.235 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.49 ' HG2' ' HA ' ' A' ' 67' ' ' TYR . 5.5 ptpt -62.59 -37.52 86.58 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.476 -0.765 . . . . 0.78 110.49 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -47.5 -63.94 3.13 Favored Glycine 0 N--CA 1.503 3.145 0 N-CA-C 110.452 -1.059 . . . . 0.82 110.452 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.31 -38.7 19.71 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 123.673 1.354 . . . . 1.15 110.099 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 7.5 t -62.15 -47.67 83.5 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.175 -0.953 . . . . 1.33 109.9 178.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 45.7 t -66.27 -44.04 91.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.547 -0.721 . . . . 0.93 109.326 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -56.8 -42.35 79.37 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 108.732 -0.84 . . . . 1.35 108.732 178.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.419 ' NH2' ' HG2' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -62.94 -55.76 23.12 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.551 0.691 . . . . 2.63 109.859 178.78 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.94 -54.59 44.93 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.362 0.601 . . . . 2.82 110.754 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -53.09 -45.35 68.15 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.836 -0.54 . . . . 1.11 111.056 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.3 mttp -72.56 -41.54 65.64 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.497 -0.752 . . . . 1.79 110.748 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.4 tp -68.82 -41.37 78.71 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.245 -0.909 . . . . 2.24 111.315 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 3.1 ttt -88.98 -24.37 22.41 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.326 -0.859 . . . . 2.69 111.301 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 14.6 m 53.54 60.77 11.44 Favored Pre-proline 0 N--CA 1.505 2.281 0 O-C-N 121.419 -0.8 . . . . 1.42 110.478 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -79.56 19.65 0.95 Allowed 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.731 1.385 . . . . 1.49 111.099 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.594 ' HA ' ' CD ' ' A' ' 87' ' ' GLU . 26.7 m120 -73.9 45.91 0.21 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.952 -1.092 . . . . 1.63 110.635 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.445 ' N ' ' HD2' ' A' ' 86' ' ' PRO . . . -67.95 -61.19 5.09 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.875 -1.29 . . . . 2.07 109.875 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 85' ' ' GLY . 42.2 Cg_endo -67.08 -29.75 39.58 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.776 1.408 . . . . 2.76 111.016 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.594 ' CD ' ' HA ' ' A' ' 84' ' ' ASN . 1.5 mp0 -57.85 -34.74 70.06 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.412 -0.805 . . . . 2.95 110.176 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.5 p -108.57 -15.05 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.489 -0.757 . . . . 3.57 111.117 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.417 ' O ' ' HA ' ' A' ' 86' ' ' PRO . 0.1 OUTLIER -154.12 102.8 2.5 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.987 -1.071 . . . . 4.52 110.003 -179.959 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.879 0 CA-C-O 118.016 -1.435 . . . . 4.72 109.827 -179.541 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.726 0 N-CA-C 108.892 -1.683 . . . . 7.88 108.892 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.04 -42.05 72.17 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 122.344 1.068 . . . . 7.08 108.123 177.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.6 ptt? -112.54 -179.52 3.69 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.473 -1.306 . . . . 5.53 107.473 177.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.8 t -173.76 -40.86 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.214 -0.929 . . . . 4.87 110.657 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.58 HD12 ' N ' ' A' ' 7' ' ' ASP . 2.7 pp -117.55 -147.43 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 N-CA-C 109.477 -0.564 . . . . 3.76 109.477 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.476 ' N ' HD12 ' A' ' 5' ' ' ILE . 4.2 tpt -78.21 42.37 0.41 Allowed 'General case' 0 C--N 1.296 -1.722 0 O-C-N 120.832 -1.168 . . . . 4.91 110.945 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.58 ' N ' HD12 ' A' ' 5' ' ' ILE . 15.8 m-20 -51.58 -38.41 54.31 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.939 0.876 . . . . 6.6 109.147 178.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -63.21 -49.4 74.35 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.614 0.721 . . . . 10.02 111.89 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.468 ' O ' ' HG2' ' A' ' 6' ' ' MET . 0.3 OUTLIER -136.48 65.25 55.03 Favored Pre-proline 0 C--N 1.302 -1.473 0 O-C-N 121.649 -0.657 . . . . 6.48 111.574 -178.108 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.504 ' O ' HG22 ' A' ' 14' ' ' VAL . 47.4 Cg_endo -72.05 171.82 15.96 Favored 'Trans proline' 0 C--N 1.301 -1.971 0 N-CA-C 108.259 -1.477 . . . . 5.86 108.259 178.313 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.0 p -49.63 -44.41 47.45 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.995 -1.066 . . . . 4.51 109.05 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.8 p -64.9 -39.3 93.32 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.634 -0.666 . . . . 4.17 110.558 177.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.77 -60.35 7.03 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 110.011 -1.235 . . . . 3.91 110.011 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.504 HG22 ' O ' ' A' ' 10' ' ' PRO . 34.9 m -58.04 -36.56 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.402 -1.058 . . . . 4.17 110.111 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.9 t -68.76 -41.41 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 120.997 -1.064 . . . . 3.91 109.253 178.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 52.5 m -59.98 -52.19 66.44 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.709 -0.62 . . . . 3.6 109.966 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.46 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 31.2 m -65.45 -34.6 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.536 -0.728 . . . . 3.63 110.176 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.724 ' HA ' HD23 ' A' ' 21' ' ' LEU . 21.7 mt -68.73 -41.38 82.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.093 -1.004 . . . . 3.83 109.216 178.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.5 t -64.41 -42.19 94.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.489 -0.93 . . . . 3.35 108.489 177.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 83.3 mt -64.38 -48.97 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.525 -0.734 . . . . 3.3 109.272 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.724 HD23 ' HA ' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -61.39 -43.23 99.23 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.675 -0.861 . . . . 3.43 108.675 178.788 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.595 ' N ' ' HG ' ' A' ' 21' ' ' LEU . 15.0 mt -60.33 -44.92 96.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.319 -0.863 . . . . 3.31 109.148 178.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.97 -46.03 86.48 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.724 -0.61 . . . . 2.81 109.731 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.3 mm -59.39 -45.6 93.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.41 -0.806 . . . . 2.86 109.146 178.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.78 -45.86 87.84 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.525 -0.734 . . . . 2.86 109.771 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.8 -41.89 96.51 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.732 -0.84 . . . . 2.61 108.732 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.664 HD13 ' C ' ' A' ' 27' ' ' LEU . 3.4 tm? -60.65 -53.49 56.75 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.899 -0.778 . . . . 2.46 108.899 178.101 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.62 -43.74 86.08 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 108.905 -1.678 . . . . 2.35 108.905 178.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.65 -44.65 95.73 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.414 -1.051 . . . . 2.5 109.74 178.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.511 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 7.4 mt -59.08 -41.17 87.37 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.649 -0.657 . . . . 2.49 109.481 178.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.7 mt -69.45 -40.93 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.544 -0.723 . . . . 2.31 109.658 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.29 -42.76 87.89 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.548 -0.72 . . . . 3.29 110.264 178.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -71.2 -38.97 63.01 Favored Glycine 0 N--CA 1.497 2.723 0 O-C-N 120.883 -1.135 . . . . 2.16 110.57 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -82.98 -33.14 26.69 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.125 -1.22 . . . . 2.36 112.015 -179.041 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.675 ' CG ' ' HA ' ' A' ' 39' ' ' ARG . 5.0 m0 -123.31 13.82 9.6 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.816 -1.178 . . . . 2.3 112.509 -178.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 64.18 -61.78 0.18 Allowed 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.362 -0.836 . . . . 2.49 111.806 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.457 ' N ' ' O ' ' A' ' 35' ' ' TRP . 0.7 OUTLIER -119.44 -75.48 0.58 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.295 -0.878 . . . . 5.18 110.384 -179.699 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.28 -55.69 2.21 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.694 -0.854 . . . . 1.82 108.694 179.117 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.675 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -150.36 34.79 0.64 Allowed 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.209 0.528 . . . . 1.85 111.092 179.256 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.876 HD23 ' HA ' ' A' ' 44' ' ' SER . 3.6 mp -80.27 86.75 5.62 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.019 -1.051 . . . . 1.67 109.106 179.124 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -101.1 12.39 37.72 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.3 -0.875 . . . . 2.84 111.981 -178.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.13 -129.17 0.25 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.904 -1.123 . . . . 2.58 109.877 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.42 HG13 ' N ' ' A' ' 44' ' ' SER . 20.1 pt -53.59 -34.37 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.092 -1.005 . . . . 2.31 110.746 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.876 ' HA ' HD23 ' A' ' 40' ' ' LEU . 0.9 OUTLIER 69.95 48.93 0.52 Allowed 'General case' 0 N--CA 1.502 2.15 0 CA-C-O 122.044 0.926 . . . . 1.93 109.379 -179.138 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.446 ' HG2' ' C ' ' A' ' 44' ' ' SER . 5.5 mm100 -136.21 -34.22 0.8 Allowed 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 115.943 -0.572 . . . . 2.29 110.697 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 56.8 m -147.36 54.21 1.07 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.553 -0.717 . . . . 1.26 110.967 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.573 ' HB2' ' HG ' ' A' ' 40' ' ' LEU . 1.4 mp0 -122.03 144.37 48.94 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.928 -1.108 . . . . 1.37 111.257 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 50' ' ' GLU . 0.5 OUTLIER 51.93 -148.67 0.38 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 122.026 -0.421 . . . . 1.55 111.073 179.457 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 66.37 -61.63 0.29 Allowed 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.471 -0.768 . . . . 2.25 111.345 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' A' ' 48' ' ' ASP . 0.1 OUTLIER -111.01 -163.01 0.82 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.199 -0.938 . . . . 2.11 110.548 -179.915 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.86 -39.25 0.87 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.291 -0.88 . . . . 2.8 110.859 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 24.2 mt -87.34 -53.96 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.421 -0.8 . . . . 2.91 109.81 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.812 HG12 ' HB2' ' A' ' 55' ' ' ASP . 47.1 t -89.91 -68.66 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.744 -0.598 . . . . 2.4 109.606 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.75 -6.92 82.73 Favored Glycine 0 N--CA 1.501 3.001 0 N-CA-C 109.632 -1.387 . . . . 1.21 109.632 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.812 ' HB2' HG12 ' A' ' 53' ' ' VAL . 0.4 OUTLIER -67.24 157.1 34.67 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.732 -0.863 . . . . 1.98 110.642 -179.948 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 62' ' ' PHE . . . -157.66 -52.57 0.01 OUTLIER Glycine 0 N--CA 1.487 2.055 0 N-CA-C 108.898 -1.681 . . . . 1.82 108.898 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -126.11 -5.18 6.75 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.634 -0.921 . . . . 2.5 112.431 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.9 m -58.95 -50.93 72.21 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 120.615 -1.303 . . . . 1.48 110.879 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.0 pttp -133.91 27.73 3.9 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.168 -0.958 . . . . 2.32 110.732 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -133.31 131.52 21.63 Favored Pre-proline 0 C--N 1.297 -1.696 0 O-C-N 121.86 -0.525 . . . . 3.24 110.075 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.02 53.56 2.92 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.637 1.335 . . . . 2.34 109.75 178.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.474 ' HB2' ' O ' ' A' ' 56' ' ' GLY . 34.8 t80 -63.01 -50.75 69.5 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.477 -0.765 . . . . 3.5 110.293 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.5 mt -62.23 -33.92 75.5 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.45 -0.782 . . . . 2.96 109.365 178.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.87 -57.27 12.43 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.615 -0.513 . . . . 2.73 109.615 178.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.472 ' HA ' ' HB2' ' A' ' 68' ' ' SER . 32.8 m -69.18 -32.17 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.292 -0.88 . . . . 2.66 109.807 179.137 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.539 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 5.2 mm-40 -61.24 -54.71 40.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.44 -0.787 . . . . 3.68 109.008 178.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -65.51 -41.22 93.41 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.324 -0.621 . . . . 2.92 109.324 178.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.472 ' HB2' ' HA ' ' A' ' 65' ' ' VAL . 63.5 m -55.38 -33.34 63.38 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 109.14 -0.689 . . . . 2.93 109.14 178.275 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.503 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -80.73 -40.57 25.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.646 -0.659 . . . . 3.34 109.393 178.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.539 ' HG2' ' O ' ' A' ' 66' ' ' GLN . 5.6 mmtm -58.97 -51.75 68.7 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.563 -0.71 . . . . 3.58 110.739 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -39.69 -64.87 0.96 Allowed Glycine 0 N--CA 1.505 3.294 0 N-CA-C 110.922 -0.871 . . . . 3.16 110.922 -179.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.572 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 39.6 Cg_endo -65.53 -39.42 21.59 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 O-C-N 123.834 1.439 . . . . 3.85 110.651 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 0.9 OUTLIER -63.44 -44.94 93.07 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.083 -1.01 . . . . 4.25 109.627 179.007 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.41 ' O ' ' HG3' ' A' ' 77' ' ' LYS . 41.4 t -67.17 -47.31 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.711 -0.848 . . . . 3.78 108.711 178.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -58.03 -39.29 78.01 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.515 0.674 . . . . 4.37 109.332 178.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.572 ' HB2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -63.69 -64.26 0.95 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.749 -0.595 . . . . 4.79 110.389 178.902 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.571 ' O ' ' HB2' ' A' ' 81' ' ' MET . 0.0 OUTLIER -59.57 -31.82 69.79 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 120.053 -0.659 . . . . 4.67 110.864 -179.46 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.465 ' N ' ' HG3' ' A' ' 77' ' ' LYS . . . -65.26 -43.25 91.89 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.183 -0.948 . . . . 4.37 108.972 178.148 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.1 mttt -72.26 -49.91 31.34 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.173 -0.677 . . . . 4.97 109.173 178.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.87 -40.21 66.37 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.348 0.594 . . . . 6.13 110.204 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.571 ' HB2' ' O ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -80.71 -46.23 15.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.572 -0.705 . . . . 5.82 109.173 178.893 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.625 HG22 ' CD ' ' A' ' 83' ' ' PRO . 0.1 OUTLIER 54.46 -173.67 0.02 OUTLIER Pre-proline 0 N--CA 1.498 1.948 0 N-CA-C 109.853 -0.425 . . . . 5.14 109.853 179.342 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.625 ' CD ' HG22 ' A' ' 82' ' ' THR . 53.2 Cg_endo -80.68 14.08 2.13 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 O-C-N 122.71 0.847 . . . . 5.3 110.604 179.448 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.428 ' CB ' ' O ' ' A' ' 83' ' ' PRO . 0.4 OUTLIER 73.26 -27.86 0.19 Allowed 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.512 -0.743 . . . . 6.5 111.825 -179.392 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -75.22 140.18 26.05 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.18 -1.568 . . . . 5.87 109.18 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 89' ' ' HIS . 39.6 Cg_endo -63.79 -17.66 60.8 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 O-C-N 123.712 1.375 . . . . 6.65 111.467 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -57.07 -34.87 68.7 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.205 -0.935 . . . . 6.37 109.21 178.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.0 t -110.12 -30.09 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.757 -0.589 . . . . 5.61 110.081 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.448 ' O ' ' HA ' ' A' ' 86' ' ' PRO . 12.0 t60 -104.81 95.76 6.1 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.177 -0.952 . . . . 6.64 110.149 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.579 0 CA-C-O 118.116 -1.38 . . . . 6.61 110.084 -179.823 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 7' ' ' ASP . . . . . . . . 0 N--CA 1.495 2.6 0 N-CA-C 109.307 -1.517 . . . . 3.68 109.307 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.458 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 3.4 t 73.86 87.8 0.1 Allowed 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.918 -0.754 . . . . 4.88 110.24 -179.132 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.89 86.54 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.149 0 CA-C-O 121.673 0.749 . . . . 4.08 110.265 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 65.6 p -150.75 -78.67 0.13 Allowed 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.182 -0.673 . . . . 4.08 109.182 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -94.71 -125.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 108.129 -1.063 . . . . 4.13 108.129 178.263 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.552 ' O ' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -52.14 -52.83 49.28 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.87 -1.144 . . . . 3.7 111.035 178.829 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.517 ' HB3' ' O ' ' A' ' 6' ' ' MET . 2.5 t70 63.39 -52.6 0.21 Allowed 'General case' 0 N--CA 1.501 2.123 0 CA-C-N 118.084 0.402 . . . . 2.8 110.198 -178.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.552 ' N ' ' O ' ' A' ' 6' ' ' MET . 0.9 OUTLIER 48.96 32.01 3.59 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.447 -0.783 . . . . 2.73 112.377 179.227 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.506 ' N ' ' HD2' ' A' ' 10' ' ' PRO . 0.4 OUTLIER -74.5 -55.33 2.76 Favored Pre-proline 0 N--CA 1.5 2.044 0 O-C-N 120.639 -1.288 . . . . 2.51 111.258 179.782 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 9' ' ' SER . 41.0 Cg_endo -66.2 -38.35 21.59 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 O-C-N 123.434 1.228 . . . . 1.69 111.335 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -65.91 -50.71 63.48 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.527 -0.733 . . . . 1.84 109.736 179.156 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.1 m -59.36 -34.12 72.0 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.107 -0.996 . . . . 2.14 109.973 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.48 -60.96 5.41 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.686 -1.365 . . . . 1.51 109.686 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 10' ' ' PRO . 31.2 m -57.37 -35.45 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.472 -1.016 . . . . 1.37 110.026 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.0 t -68.54 -45.83 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.126 -0.984 . . . . 1.94 109.312 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 51.7 m -57.94 -51.37 69.93 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.717 -0.614 . . . . 1.75 109.943 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.424 ' CG2' ' HA ' ' A' ' 14' ' ' VAL . 25.4 m -64.77 -35.59 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.437 -0.789 . . . . 1.27 110.138 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.413 ' HA ' HD13 ' A' ' 18' ' ' ILE . 6.6 mm -67.98 -41.2 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 121.034 -1.041 . . . . 1.82 109.19 178.489 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 37.8 t -65.1 -44.58 95.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.466 -0.939 . . . . 2.0 108.466 178.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.429 HD13 ' HA ' ' A' ' 20' ' ' ILE . 21.7 mm -62.41 -46.98 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 108.99 -0.745 . . . . 1.55 108.99 178.26 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 11.4 mt -59.88 -49.4 77.85 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.833 -0.803 . . . . 1.55 108.833 178.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.419 HD13 ' HA ' ' A' ' 22' ' ' ILE . 11.5 mm -57.11 -43.66 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.591 -0.693 . . . . 2.25 109.313 178.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.63 -45.82 91.08 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.57 -0.706 . . . . 1.74 109.608 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 58.6 mt -59.34 -49.25 84.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.397 -0.814 . . . . 1.53 108.855 178.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.76 -43.67 97.7 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.648 -0.658 . . . . 1.98 110.023 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.28 -43.55 98.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.376 -0.827 . . . . 2.19 109.061 178.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.411 ' HG ' HD12 ' A' ' 31' ' ' ILE . 0.8 OUTLIER -62.38 -46.83 86.87 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.613 -0.884 . . . . 1.81 108.613 178.139 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.84 -48.14 80.67 Favored Glycine 0 N--CA 1.496 2.633 0 N-CA-C 108.654 -1.778 . . . . 1.9 108.654 178.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.22 -44.03 97.93 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.427 -1.043 . . . . 2.42 109.966 178.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.5 mt -60.53 -39.23 87.1 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.627 -0.671 . . . . 2.74 109.98 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.687 HD13 HG22 ' A' ' 52' ' ' ILE . 3.7 mt -72.79 -47.54 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.27 -0.894 . . . . 1.94 109.162 179.046 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.559 HD13 ' HB3' ' A' ' 55' ' ' ASP . 1.0 OUTLIER -57.66 -46.52 84.14 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.364 -0.835 . . . . 2.62 109.637 178.796 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.26 -55.3 28.51 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.472 -1.451 . . . . 2.73 109.472 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.6 t -55.56 -39.91 71.26 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.427 -1.043 . . . . 2.66 109.531 179.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.5 ' O ' ' N ' ' A' ' 37' ' ' TYR . 56.3 t90 -64.29 -62.05 1.85 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.707 -0.621 . . . . 2.42 109.352 178.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 60.75 -61.85 0.07 Allowed 'General case' 0 N--CA 1.508 2.459 0 O-C-N 121.745 -0.597 . . . . 3.31 111.736 178.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.5 ' N ' ' O ' ' A' ' 35' ' ' TRP . 0.2 OUTLIER -114.83 169.5 9.03 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.313 -0.867 . . . . 4.91 109.372 179.517 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.88 39.85 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.543 0 O-C-N 120.938 -1.102 . . . . 3.03 112.144 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.489 ' HG3' ' N ' ' A' ' 40' ' ' LEU . 8.1 ptt180 -90.73 -32.16 16.26 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.622 -1.299 . . . . 2.84 111.196 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.489 ' N ' ' HG3' ' A' ' 39' ' ' ARG . 0.2 OUTLIER -120.88 59.29 0.93 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.426 -0.797 . . . . 2.23 109.949 -179.891 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.556 ' O ' ' N ' ' A' ' 43' ' ' ILE . 7.1 tp60 -67.13 -5.95 15.61 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.567 -0.708 . . . . 2.71 111.745 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.655 ' HB3' HG11 ' A' ' 53' ' ' VAL . 0.0 OUTLIER 61.16 -62.4 0.08 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.555 -0.715 . . . . 3.19 110.744 179.837 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.556 ' N ' ' O ' ' A' ' 41' ' ' GLN 0.268 0.0 OUTLIER -68.2 -17.35 22.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 O-C-N 121.475 -0.766 . . . . 3.0 109.149 177.941 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.498 ' HB3' ' O ' ' A' ' 43' ' ' ILE . 24.5 t 66.69 -159.52 0.25 Allowed 'General case' 0 N--CA 1.501 2.111 0 CA-C-O 121.354 0.597 . . . . 2.52 111.705 179.058 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 50.25 -115.45 0.83 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 122.01 -0.431 . . . . 3.76 110.388 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -150.95 37.52 0.64 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.603 -1.31 . . . . 3.24 110.41 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -120.68 145.98 46.9 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.349 -0.844 . . . . 2.98 110.84 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.408 ' HB3' ' CE ' ' A' ' 59' ' ' LYS . 11.1 t70 -138.94 21.51 2.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.486 -0.759 . . . . 2.24 110.465 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.48 60.93 2.17 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.225 -0.922 . . . . 2.7 110.233 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.501 ' HB3' HG22 ' A' ' 53' ' ' VAL . 1.5 tt0 -122.01 -129.68 0.27 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.517 -0.74 . . . . 1.76 109.746 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.26 -44.31 0.08 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.653 -1.28 . . . . 1.9 110.906 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.687 HG22 HD13 ' A' ' 31' ' ' ILE . 38.8 mt -74.3 -47.85 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.595 -0.691 . . . . 1.27 109.569 179.279 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.655 HG11 ' HB3' ' A' ' 42' ' ' ARG . 19.6 m -75.69 -30.39 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.609 -0.682 . . . . 1.73 110.386 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -103.91 57.97 0.53 Allowed Glycine 0 N--CA 1.498 2.771 0 N-CA-C 109.632 -1.387 . . . . 1.77 109.632 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.559 ' HB3' HD13 ' A' ' 32' ' ' LEU . 25.4 t70 -69.5 137.65 52.72 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.63 -0.923 . . . . 2.15 110.548 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.63 55.55 0.52 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 108.328 -1.909 . . . . 2.62 108.328 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.556 ' O ' ' HB ' ' A' ' 58' ' ' THR . 3.1 mm-40 61.82 46.86 6.54 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 122.193 -0.592 . . . . 4.21 110.759 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.556 ' HB ' ' O ' ' A' ' 57' ' ' GLU . 24.7 m 66.47 -57.85 0.37 Allowed 'General case' 0 N--CA 1.509 2.494 0 O-C-N 121.661 -0.649 . . . . 2.66 110.528 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.533 ' O ' ' HD3' ' A' ' 61' ' ' PRO . 0.7 OUTLIER -172.48 178.55 2.72 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.05 -0.722 . . . . 3.14 109.05 179.294 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.659 ' HB3' HD12 ' A' ' 63' ' ' LEU . 0.5 OUTLIER -75.17 109.13 6.77 Favored Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 121.224 -0.923 . . . . 3.98 111.328 -178.952 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.533 ' HD3' ' O ' ' A' ' 59' ' ' LYS . 47.8 Cg_endo -73.01 -31.44 9.8 Favored 'Trans proline' 0 C--N 1.316 -1.179 0 O-C-N 123.698 1.367 . . . . 4.57 110.968 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -65.91 -29.18 69.56 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.924 -1.11 . . . . 5.03 109.931 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.659 HD12 ' HB3' ' A' ' 60' ' ' GLU . 2.2 mt -55.51 -37.11 67.45 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.501 -0.75 . . . . 2.72 109.596 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.431 ' HB2' ' O ' ' A' ' 61' ' ' PRO . 0.1 OUTLIER -55.67 -47.02 77.41 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.359 -0.608 . . . . 3.9 109.359 179.055 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.492 ' HA ' ' HB2' ' A' ' 68' ' ' SER . 3.8 t -77.81 -40.76 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 121.512 -0.743 . . . . 4.23 109.428 178.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -52.68 -41.7 64.09 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.965 -0.754 . . . . 2.63 108.965 178.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -78.03 -46.48 20.82 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.246 -0.649 . . . . 5.54 109.246 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.492 ' HB2' ' HA ' ' A' ' 65' ' ' VAL . 75.5 m -54.79 -33.55 61.57 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 122.083 -0.386 . . . . 3.71 110.071 179.066 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.578 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -87.72 -50.71 6.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.303 -0.873 . . . . 3.16 109.871 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.1 mtmt -59.42 -51.57 69.33 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.771 -0.581 . . . . 2.07 111.712 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -40.91 -63.53 1.46 Allowed Glycine 0 N--CA 1.505 3.261 0 N-CA-C 110.352 -1.099 . . . . 2.51 110.352 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.505 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 41.9 Cg_endo -67.51 -43.15 6.11 Favored 'Trans proline' 0 C--N 1.315 -1.186 0 O-C-N 123.939 1.494 . . . . 3.55 110.275 178.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.578 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 1.2 t -56.0 -44.52 78.71 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.844 -1.16 . . . . 2.5 109.554 178.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 49.0 t -68.34 -50.61 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 108.899 -0.778 . . . . 1.82 108.899 178.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -52.01 -41.32 62.13 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.561 0.696 . . . . 4.17 109.918 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.505 ' HD2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -68.21 -56.11 9.87 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.757 -0.589 . . . . 4.68 111.587 -179.655 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.46 ' NZ ' ' OE2' ' A' ' 87' ' ' GLU . 0.1 OUTLIER -64.31 -33.65 76.33 Favored 'General case' 0 N--CA 1.505 2.319 0 C-N-CA 119.075 -1.05 . . . . 2.15 110.46 -179.254 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.545 ' O ' ' HD2' ' A' ' 83' ' ' PRO . . . -67.07 -50.47 61.67 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.519 -0.738 . . . . 2.95 110.097 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.8 pttt -73.98 -32.87 63.63 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.153 -0.967 . . . . 4.68 111.216 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.5 tp -72.24 -55.1 7.77 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.192 -0.942 . . . . 3.18 110.551 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.1 mtt -80.49 -15.74 55.99 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.674 -0.641 . . . . 2.96 110.813 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.466 ' N ' ' HD3' ' A' ' 83' ' ' PRO . 47.1 p 47.61 53.37 13.92 Favored Pre-proline 0 N--CA 1.504 2.254 0 O-C-N 121.587 -0.695 . . . . 3.98 111.538 -179.034 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.637 ' HB2' ' HD3' ' A' ' 86' ' ' PRO . 54.3 Cg_endo -78.61 16.91 1.19 Allowed 'Trans proline' 0 N--CA 1.488 1.147 0 O-C-N 123.432 1.227 . . . . 4.68 111.162 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.3 t30 66.44 -52.84 0.43 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.197 -0.939 . . . . 7.05 111.053 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 83' ' ' PRO . . . 166.49 70.41 0.03 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.32 -1.512 . . . . 5.7 109.32 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.637 ' HD3' ' HB2' ' A' ' 83' ' ' PRO . 39.4 Cg_endo -65.53 -17.38 57.13 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 O-C-N 123.701 1.369 . . . . 6.22 109.458 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.46 ' OE2' ' NZ ' ' A' ' 77' ' ' LYS . 14.5 mp0 -69.91 -31.18 68.82 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.583 -0.895 . . . . 7.01 108.583 177.212 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.44 HG12 ' O ' ' A' ' 85' ' ' GLY . 1.5 p -108.99 -19.88 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.685 -0.634 . . . . 7.92 110.845 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.605 ' O ' ' HA ' ' A' ' 86' ' ' PRO . 44.8 t-80 -150.67 119.49 6.61 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.958 -1.089 . . . . 8.96 110.737 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.775 0 CA-C-O 117.642 -1.643 . . . . 7.28 110.037 179.38 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.711 0 N-CA-C 109.221 -1.552 . . . . 6.07 109.221 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.5 t -165.8 -161.16 0.49 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.366 -1.079 . . . . 6.27 110.295 179.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.3 ptt? -123.49 155.33 37.73 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.157 -0.964 . . . . 6.49 111.005 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -115.38 51.73 0.91 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.38 -0.825 . . . . 6.16 111.088 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -52.61 -44.71 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.273 -0.892 . . . . 4.6 109.968 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.8 mtp 52.41 28.84 6.21 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-N 115.897 -0.592 . . . . 5.26 110.99 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -68.28 -20.01 64.74 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.146 -0.971 . . . . 2.76 110.653 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 57.27 33.81 23.84 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.591 -0.693 . . . . 2.64 109.961 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.19 173.88 5.24 Favored Pre-proline 0 N--CA 1.483 1.195 0 O-C-N 121.471 -0.768 . . . . 2.03 110.177 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -76.07 57.53 5.25 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.414 1.218 . . . . 2.6 110.907 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.2 t -53.83 -37.77 63.94 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.4 -0.812 . . . . 2.28 110.43 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.7 t -55.01 -30.03 58.64 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.462 -0.774 . . . . 3.3 110.213 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.797 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -72.67 -55.43 6.63 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 108.544 -1.822 . . . . 2.49 108.544 178.36 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 76.6 t -54.92 -42.17 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.721 -0.87 . . . . 1.86 108.702 178.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.7 t -64.71 -45.24 95.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.567 -0.708 . . . . 2.32 109.229 178.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 46.1 m -58.03 -46.78 84.76 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.651 -0.656 . . . . 3.03 109.283 178.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.797 HG23 ' O ' ' A' ' 13' ' ' GLY . 3.7 t -65.82 -38.92 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 C-N-CA 119.586 -0.846 . . . . 2.39 109.242 178.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.661 ' HA ' HD23 ' A' ' 21' ' ' LEU . 10.0 mm -62.39 -41.41 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.016 -1.053 . . . . 1.55 109.077 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.9 t -66.06 -40.94 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.643 -0.873 . . . . 2.45 108.643 177.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.435 ' O ' HG23 ' A' ' 24' ' ' ILE . 92.4 mt -65.7 -50.12 73.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.522 -0.736 . . . . 2.94 109.074 178.271 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.661 HD23 ' HA ' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -61.59 -42.84 99.44 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 119.914 -0.714 . . . . 1.76 109.383 178.711 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.571 ' N ' ' HG ' ' A' ' 21' ' ' LEU . 10.4 mm -62.7 -38.54 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 120.972 -1.08 . . . . 1.79 109.106 178.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.97 -50.58 54.93 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.481 -0.762 . . . . 2.05 110.724 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.602 HG12 ' HA ' ' A' ' 21' ' ' LEU . 29.3 pt -62.52 -37.26 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 120.955 -1.091 . . . . 2.46 109.283 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.551 ' N ' HG13 ' A' ' 24' ' ' ILE . . . -65.75 -46.98 76.83 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.435 -0.791 . . . . 1.6 108.909 178.143 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.05 -44.06 97.96 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.008 -0.738 . . . . 1.63 109.008 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.1 tt -61.22 -45.86 92.81 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.36 -0.838 . . . . 2.52 108.93 178.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.3 -46.47 92.87 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.003 -1.639 . . . . 1.76 109.003 178.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.89 -41.44 95.62 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.532 -0.981 . . . . 1.83 109.89 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.504 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 6.6 mt -59.11 -42.12 89.78 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.821 -0.807 . . . . 2.32 108.821 178.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.402 ' HA ' HD13 ' A' ' 31' ' ' ILE . 27.7 mm -70.07 -45.93 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 109.068 -0.716 . . . . 2.13 109.068 178.149 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.614 ' HG ' ' HB2' ' A' ' 36' ' ' CYS . 1.1 tt -56.31 -47.34 78.9 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.727 -0.608 . . . . 3.24 109.625 178.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.73 -43.13 76.92 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.85 -1.3 . . . . 1.99 109.85 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 2.5 t -56.45 -51.49 68.23 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.485 -1.009 . . . . 2.16 110.19 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.424 ' CH2' ' HA ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -168.72 57.62 0.05 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.379 -0.826 . . . . 2.38 111.838 179.665 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.614 ' HB2' ' HG ' ' A' ' 32' ' ' LEU . 47.7 t -56.13 -35.43 67.09 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.077 -1.014 . . . . 2.95 109.906 178.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -123.6 164.4 19.11 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.726 -0.608 . . . . 4.3 109.366 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.424 ' HA ' ' CH2' ' A' ' 35' ' ' TRP . 0.8 OUTLIER -68.49 1.46 3.06 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.975 -1.078 . . . . 2.94 111.834 179.931 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.13 9.25 12.6 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.747 -1.221 . . . . 2.3 111.074 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -77.06 157.18 31.25 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.851 -1.156 . . . . 2.05 110.786 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 60.88 13.96 4.86 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 121.725 -0.609 . . . . 1.9 111.515 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.41 ' HD3' ' HA ' ' A' ' 88' ' ' VAL . 1.7 tpm_? -145.19 -74.81 0.23 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.038 -1.039 . . . . 1.64 109.562 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.632 ' HA ' ' HA ' ' A' ' 47' ' ' GLU 0.271 0.1 OUTLIER -89.24 -39.61 12.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 109.63 -0.508 . . . . 1.59 109.63 179.873 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.402 ' N ' HG22 ' A' ' 43' ' ' ILE . 1.7 m 42.77 -97.24 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.222 0 O-C-N 122.016 -0.428 . . . . 2.14 111.322 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.446 ' HG2' ' N ' ' A' ' 46' ' ' SER . 1.8 pt20 -120.7 -31.68 4.2 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.853 -1.154 . . . . 2.16 111.226 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.446 ' N ' ' HG2' ' A' ' 45' ' ' GLN . 0.9 OUTLIER -145.61 46.75 1.28 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.284 -0.885 . . . . 1.08 109.193 179.171 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.632 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 2.1 mm-40 64.8 -160.03 0.29 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.694 -0.629 . . . . 1.27 110.187 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.418 ' CB ' HD13 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -39.94 -46.58 2.07 Favored 'General case' 0 N--CA 1.51 2.552 0 O-C-N 121.378 -0.827 . . . . 1.43 111.442 -179.086 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 51.2 -96.65 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.46 -0.775 . . . . 1.8 111.872 178.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -67.56 75.39 0.17 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.267 -0.895 . . . . 2.92 110.88 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.1 t 177.72 -65.27 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.822 0.82 . . . . 2.12 109.077 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.542 HD12 ' N ' ' A' ' 78' ' ' ALA . 5.6 pt -81.18 -37.83 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.648 -0.657 . . . . 1.92 110.477 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.593 ' HB ' HG22 ' A' ' 74' ' ' VAL . 9.5 p -45.95 -36.28 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.683 -0.636 . . . . 2.2 111.404 -179.001 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.64 -62.08 1.2 Allowed Glycine 0 N--CA 1.498 2.792 0 N-CA-C 109.231 -1.547 . . . . 2.8 109.231 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -73.23 103.67 4.02 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.745 -0.856 . . . . 2.91 109.767 179.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.88 37.42 0.14 Allowed Glycine 0 N--CA 1.497 2.746 0 N-CA-C 108.125 -1.99 . . . . 2.82 108.125 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.4 -37.91 0.08 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 122.188 -0.595 . . . . 3.7 110.698 -179.062 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.62 HG23 ' HD3' ' A' ' 59' ' ' LYS . 7.4 t -81.3 -148.06 0.06 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.192 -0.943 . . . . 3.8 110.735 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.62 ' HD3' HG23 ' A' ' 58' ' ' THR . 0.0 OUTLIER -53.14 137.33 34.12 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.103 -0.998 . . . . 3.46 110.337 179.894 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -144.26 137.82 14.3 Favored Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 121.169 -0.957 . . . . 3.15 111.002 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.536 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 55.6 Cg_endo -82.74 -178.81 4.11 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 O-C-N 123.982 1.517 . . . . 3.04 110.407 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -55.41 155.45 5.25 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.136 -0.978 . . . . 4.72 110.232 179.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.7 pp -51.88 -31.02 26.36 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 121.16 -0.963 . . . . 3.13 111.203 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.527 ' O ' ' HB2' ' A' ' 68' ' ' SER . 0.0 OUTLIER -61.89 -58.53 7.6 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.304 -0.873 . . . . 3.5 109.402 178.563 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.536 ' HB ' ' HB2' ' A' ' 61' ' ' PRO . 16.1 t -66.43 -33.11 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 108.96 -0.755 . . . . 3.32 108.96 178.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.476 ' O ' ' CG ' ' A' ' 70' ' ' LYS . 41.0 tt0 -57.77 -59.71 4.8 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.534 -0.913 . . . . 2.79 108.534 178.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -63.32 -35.43 80.34 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.359 -0.838 . . . . 2.31 109.672 178.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.527 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 0.4 OUTLIER -61.75 -42.2 98.67 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.603 -0.686 . . . . 2.71 110.553 179.256 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.518 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -88.22 -41.18 13.12 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.063 -1.023 . . . . 2.72 110.938 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.476 ' CG ' ' O ' ' A' ' 66' ' ' GLN . 5.4 mmtt -66.46 -42.01 88.21 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.651 -0.656 . . . . 2.39 110.042 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -44.91 -62.64 2.89 Favored Glycine 0 N--CA 1.502 3.063 0 N-CA-C 110.142 -1.183 . . . . 1.59 110.142 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -66.75 -37.8 19.86 Favored 'Trans proline' 0 C--N 1.314 -1.255 0 O-C-N 123.627 1.33 . . . . 2.24 110.756 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.518 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 0.4 OUTLIER -66.21 -43.8 85.71 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.04 -1.038 . . . . 2.59 109.8 179.075 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.593 HG22 ' HB ' ' A' ' 53' ' ' VAL . 47.3 t -70.72 -43.73 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.792 -0.568 . . . . 1.49 109.618 179.166 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -55.49 -43.11 75.31 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.57 0.7 . . . . 2.62 109.89 178.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.425 ' HA ' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -68.92 -48.27 63.7 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.488 0.661 . . . . 2.83 109.969 179.291 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.466 ' HD3' ' O ' ' A' ' 52' ' ' ILE . 67.4 mttt -60.08 -55.13 37.74 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.545 0.688 . . . . 2.15 109.935 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.542 ' N ' HD12 ' A' ' 52' ' ' ILE . . . -53.37 -50.73 64.48 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 122.032 -0.417 . . . . 1.05 110.524 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.461 ' HB2' ' OD1' ' A' ' 84' ' ' ASN . 0.0 OUTLIER -67.87 -25.74 65.67 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.417 -0.802 . . . . 2.63 110.714 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.442 ' N ' ' HG3' ' A' ' 79' ' ' LYS . 0.6 OUTLIER -80.54 -30.76 37.1 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.064 -1.022 . . . . 2.21 110.069 179.059 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.87 -47.26 8.0 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.529 -0.732 . . . . 2.62 110.006 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.549 ' HB ' ' HD2' ' A' ' 83' ' ' PRO . 29.0 p -82.6 169.12 19.1 Favored Pre-proline 0 N--CA 1.499 2.024 0 O-C-N 121.525 -0.734 . . . . 1.48 109.503 179.013 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.549 ' HD2' ' HB ' ' A' ' 82' ' ' THR . 50.3 Cg_endo -76.25 6.01 4.21 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.42 1.221 . . . . 1.8 113.147 -178.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.461 ' OD1' ' HB2' ' A' ' 79' ' ' LYS . 0.1 OUTLIER 55.51 21.64 4.54 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 121.08 -1.013 . . . . 2.62 111.287 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -158.09 -82.69 0.04 OUTLIER Glycine 0 N--CA 1.502 3.1 0 N-CA-C 109.09 -1.604 . . . . 2.18 109.09 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.525 ' HD2' ' HB2' ' A' ' 83' ' ' PRO . 50.2 Cg_endo -72.72 -177.09 2.62 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 O-C-N 123.845 1.445 . . . . 2.55 108.818 178.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.429 ' HB3' ' O ' ' A' ' 86' ' ' PRO . 0.5 OUTLIER 67.6 -60.0 0.4 Allowed 'General case' 0 N--CA 1.507 2.381 0 N-CA-C 108.266 -1.013 . . . . 2.31 108.266 -177.986 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.497 ' N ' ' O ' ' A' ' 86' ' ' PRO . 87.4 t -82.83 -29.33 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 108.781 -0.822 . . . . 2.08 108.781 177.083 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 69.8 m80 54.26 56.85 6.45 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.337 0.589 . . . . 3.15 110.985 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.666 0 CA-C-O 118.059 -1.412 . . . . 2.33 110.044 179.698 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 4' ' ' SER . . . . . . . . 0 N--CA 1.5 2.927 0 N-CA-C 110.198 -1.161 . . . . 3.55 110.198 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.456 ' HB3' ' O ' ' A' ' 1' ' ' GLY . 40.8 t 58.15 -148.57 0.48 Allowed 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.386 -1.067 . . . . 4.3 110.164 -179.555 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.527 ' O ' HD13 ' A' ' 5' ' ' ILE . 10.8 ptt? -54.01 -34.06 58.88 Favored 'General case' 0 N--CA 1.505 2.319 0 N-CA-C 108.231 -1.025 . . . . 3.51 108.231 178.582 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.705 ' HB2' HG21 ' A' ' 12' ' ' THR . 7.5 t -82.49 53.42 2.32 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.196 -1.038 . . . . 3.09 108.196 177.089 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.527 HD13 ' O ' ' A' ' 3' ' ' MET . 0.0 OUTLIER -25.95 -68.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.383 0 CA-C-O 121.366 0.603 . . . . 3.21 110.728 -178.47 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.615 ' HB3' ' HB3' ' A' ' 9' ' ' SER . 0.0 OUTLIER -102.16 98.54 8.69 Favored 'General case' 0 C--N 1.287 -2.133 0 C-N-CA 120.016 -0.673 . . . . 5.08 109.207 178.195 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -58.43 -24.6 60.61 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.502 -0.925 . . . . 4.81 108.502 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -86.02 34.85 0.62 Allowed 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.953 -0.758 . . . . 6.1 108.953 176.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.615 ' HB3' ' HB3' ' A' ' 6' ' ' MET . 21.5 p -145.75 157.56 51.09 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 120.894 -1.129 . . . . 5.08 110.547 -179.222 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.401 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 57.6 Cg_endo -80.82 15.91 1.72 Allowed 'Trans proline' 0 C--N 1.313 -1.29 0 O-C-N 123.528 1.278 . . . . 5.9 111.144 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.8 p -62.59 -63.53 1.2 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.908 -1.12 . . . . 4.28 109.869 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.705 HG21 ' HB2' ' A' ' 4' ' ' SER . 0.1 OUTLIER -62.42 -33.08 74.09 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.499 -0.751 . . . . 3.36 110.281 179.317 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.63 -53.16 21.7 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 108.829 -1.708 . . . . 3.68 108.829 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.401 ' HB ' ' O ' ' A' ' 10' ' ' PRO . 23.0 t -62.29 -36.79 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.684 -0.892 . . . . 4.66 109.35 178.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.0 t -67.78 -43.26 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 120.981 -1.075 . . . . 3.28 109.135 178.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.409 ' O ' HG12 ' A' ' 20' ' ' ILE . 63.3 m -59.56 -51.87 68.0 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.613 -0.679 . . . . 2.91 109.954 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.623 ' HA ' HG12 ' A' ' 20' ' ' ILE . 31.2 m -64.42 -38.18 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 119.505 -0.878 . . . . 3.8 109.854 179.388 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.693 ' HA ' HD23 ' A' ' 21' ' ' LEU . 19.2 mt -65.21 -38.12 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 120.759 -1.213 . . . . 3.95 109.253 178.264 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.6 t -67.49 -48.05 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.237 -0.914 . . . . 2.45 109.584 178.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.623 HG12 ' HA ' ' A' ' 17' ' ' VAL . 3.3 pt -68.01 -34.87 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.886 -1.134 . . . . 3.13 109.968 179.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.693 HD23 ' HA ' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -70.99 -42.65 69.38 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.815 -1.178 . . . . 3.56 108.308 177.73 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.548 ' N ' ' HG ' ' A' ' 21' ' ' LEU . 13.1 mt -60.77 -43.77 96.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.111 -0.993 . . . . 3.06 108.436 177.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.75 -46.38 85.56 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.608 -0.682 . . . . 1.92 109.731 178.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.417 HD13 ' HA ' ' A' ' 24' ' ' ILE . 8.1 mm -59.49 -47.2 91.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.131 -0.981 . . . . 2.51 109.005 178.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.27 -43.91 97.74 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.456 -0.778 . . . . 2.69 109.591 178.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.18 -42.65 99.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.466 -0.771 . . . . 2.15 109.274 178.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.2 tt -63.39 -46.38 86.69 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.678 -0.86 . . . . 1.82 108.678 178.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.77 -45.04 95.44 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 108.692 -1.763 . . . . 1.93 108.692 178.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.23 -44.03 93.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.507 -0.996 . . . . 2.65 109.468 178.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.2 mt -58.73 -41.61 86.85 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.023 -0.732 . . . . 2.73 109.023 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 22.4 mm -68.93 -50.12 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.489 -0.757 . . . . 1.79 109.38 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.62 -43.07 79.83 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.567 -0.708 . . . . 3.1 109.689 178.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.9 -39.18 75.51 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.491 -1.444 . . . . 2.84 109.491 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 40.1 t -61.19 -47.8 84.48 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.389 -1.065 . . . . 2.47 110.389 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.453 ' CG ' ' HB3' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -168.88 45.76 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.39 -0.819 . . . . 2.23 111.178 179.792 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.708 ' HB2' ' HG3' ' A' ' 49' ' ' GLU . 0.0 OUTLIER 57.74 -81.71 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.672 -0.643 . . . . 2.61 111.772 179.53 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -153.06 -64.88 0.15 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.763 -1.211 . . . . 4.16 111.587 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.476 ' HG ' ' OE2' ' A' ' 49' ' ' GLU . 0.7 OUTLIER -108.52 17.45 22.02 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.821 -1.175 . . . . 1.56 111.368 -179.83 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.469 ' HG2' ' C ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER 29.93 50.93 0.08 Allowed 'General case' 0 N--CA 1.508 2.447 0 CA-C-O 121.45 0.643 . . . . 2.62 112.5 179.799 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.434 HD13 ' H ' ' A' ' 45' ' ' GLN . 7.6 mt 42.57 48.36 4.64 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.251 0.548 . . . . 1.99 111.525 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -72.38 42.91 0.1 Allowed 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.149 -0.969 . . . . 2.41 111.325 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.668 ' HG3' HG23 ' A' ' 43' ' ' ILE . 0.5 OUTLIER -141.88 -66.06 0.41 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.909 -1.119 . . . . 3.5 110.306 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.668 HG23 ' HG3' ' A' ' 42' ' ' ARG . 20.2 pt -101.44 -38.83 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.719 -0.613 . . . . 2.93 109.847 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.486 ' N ' HG13 ' A' ' 43' ' ' ILE . 1.4 t 75.45 110.02 0.07 Allowed 'General case' 0 N--CA 1.506 2.366 0 CA-C-O 121.537 0.684 . . . . 2.87 111.081 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.434 ' H ' HD13 ' A' ' 40' ' ' LEU . 12.9 mt-30 -120.77 177.05 5.23 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.483 -0.76 . . . . 2.88 110.195 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.73 -52.66 9.97 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.445 -0.784 . . . . 3.67 110.711 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.447 ' O ' ' HB3' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -117.13 -175.6 2.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 3.01 110.976 -179.655 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.507 ' HA ' ' HG3' ' A' ' 61' ' ' PRO . 20.2 t0 60.92 173.76 0.1 Allowed 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 121.954 0.883 . . . . 2.16 111.547 179.56 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.708 ' HG3' ' HB2' ' A' ' 36' ' ' CYS . 0.7 OUTLIER -148.75 -60.18 0.23 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.344 -0.847 . . . . 1.69 109.511 179.697 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -110.7 113.01 25.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.424 -0.797 . . . . 2.93 110.221 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 78.6 p -158.9 -71.25 0.09 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.498 -0.751 . . . . 1.99 110.709 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.5 mt -50.16 -56.94 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 O-C-N 121.746 -0.596 . . . . 2.63 110.903 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.2 p -85.6 -33.03 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 O-C-N 121.406 -0.809 . . . . 2.59 111.094 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -109.23 65.32 0.25 Allowed Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.911 -1.276 . . . . 2.06 109.911 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -92.08 -156.11 0.45 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.329 -1.101 . . . . 2.39 110.267 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 137.76 -41.13 1.41 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 107.957 -2.057 . . . . 2.69 107.957 -179.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.448 ' C ' HG22 ' A' ' 58' ' ' THR . 9.8 mt-10 -139.0 37.46 2.14 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 122.039 -0.683 . . . . 3.57 109.645 178.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.448 HG22 ' C ' ' A' ' 57' ' ' GLU . 5.1 t 36.54 54.94 1.11 Allowed 'General case' 0 N--CA 1.511 2.597 0 CA-C-O 121.387 0.613 . . . . 2.07 111.139 -178.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.437 ' O ' ' NZ ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -63.36 88.64 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.481 -0.762 . . . . 1.85 110.607 -179.865 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.513 ' HB3' HD12 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -99.53 105.49 33.88 Favored Pre-proline 0 N--CA 1.494 1.737 0 CA-C-N 116.254 -0.43 . . . . 2.06 110.212 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.507 ' HG3' ' HA ' ' A' ' 48' ' ' ASP . 44.6 Cg_endo -71.53 -34.48 9.33 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 O-C-N 123.773 1.407 . . . . 2.65 110.949 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -61.7 -38.84 89.33 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.307 -0.871 . . . . 3.18 110.646 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.513 HD12 ' HB3' ' A' ' 60' ' ' GLU . 3.6 mt -52.2 -37.59 55.33 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.479 -0.763 . . . . 2.2 110.302 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.512 ' O ' ' HB2' ' A' ' 68' ' ' SER . 0.0 OUTLIER -61.33 -53.49 55.97 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.475 -0.565 . . . . 3.48 109.475 178.912 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.0 t -67.72 -31.59 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.461 -0.774 . . . . 2.44 109.321 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.03 -51.54 69.63 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.911 -1.144 . . . . 2.35 107.911 178.237 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -69.22 -43.69 73.56 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.329 0.585 . . . . 3.13 109.646 178.229 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.512 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 0.4 OUTLIER -59.35 -37.93 79.09 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.957 -0.464 . . . . 2.8 110.437 179.479 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.27 -43.74 13.48 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.046 -1.034 . . . . 1.66 110.15 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 32.5 mtmt -63.81 -46.67 84.12 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.577 -0.702 . . . . 2.61 110.635 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 75' ' ' GLU . . . -41.33 -64.87 1.23 Allowed Glycine 0 N--CA 1.506 3.334 0 N-CA-C 109.947 -1.261 . . . . 2.1 109.947 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.573 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 42.5 Cg_endo -68.42 -41.31 6.74 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 O-C-N 123.956 1.503 . . . . 2.1 110.083 178.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 35.1 t -58.33 -39.54 79.73 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.839 -1.163 . . . . 2.06 109.94 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.543 ' HA ' ' HG2' ' A' ' 77' ' ' LYS . 24.1 t -74.92 -48.39 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.435 -0.791 . . . . 2.48 109.089 178.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.64 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 1.0 OUTLIER -54.63 -43.94 72.72 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.89 -0.724 . . . . 3.37 109.178 178.349 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.573 ' HD2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -64.66 -48.62 74.11 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.581 -0.7 . . . . 3.11 110.157 179.126 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.638 ' HG3' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -62.46 -32.66 73.58 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.073 -1.017 . . . . 3.31 109.397 179.02 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.638 ' N ' ' HG3' ' A' ' 77' ' ' LYS . . . -72.2 -43.26 64.75 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.546 -0.721 . . . . 3.43 109.171 178.091 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.935 ' HG3' HG11 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -68.45 -34.04 75.24 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.637 -0.665 . . . . 4.0 109.502 178.673 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.72 -32.62 62.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.567 -0.708 . . . . 4.08 110.416 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 15.0 ttt -84.47 -44.18 13.89 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.429 -0.794 . . . . 4.86 110.4 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.57 ' HB ' ' HD2' ' A' ' 83' ' ' PRO . 48.3 p -86.34 170.3 12.95 Favored Pre-proline 0 N--CA 1.503 2.224 0 O-C-N 121.468 -0.77 . . . . 4.24 109.827 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.57 ' HD2' ' HB ' ' A' ' 82' ' ' THR . 46.5 Cg_endo -75.85 2.2 7.3 Favored 'Trans proline' 0 C--N 1.316 -1.148 0 O-C-N 123.251 1.132 . . . . 5.0 111.371 178.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.607 ' HB3' ' HD3' ' A' ' 79' ' ' LYS . 3.3 t-20 -73.26 39.13 0.09 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.199 -0.938 . . . . 4.65 110.069 179.189 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 83' ' ' PRO . . . -70.9 -60.91 4.29 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.461 -1.056 . . . . 4.54 110.461 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -71.31 -34.22 10.13 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 O-C-N 123.731 1.385 . . . . 5.57 111.535 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.455 ' CD ' ' HA ' ' A' ' 84' ' ' ASN . 1.5 mp0 -51.42 -40.35 59.17 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.408 -0.808 . . . . 5.5 109.48 179.159 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.935 HG11 ' HG3' ' A' ' 79' ' ' LYS . 4.2 p -103.14 -20.53 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.932 -0.48 . . . . 4.77 110.505 178.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 60.21 54.83 3.86 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.523 -0.736 . . . . 6.46 111.26 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.534 0 CA-C-O 118.323 -1.265 . . . . 4.11 110.205 178.966 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.641 0 N-CA-C 109.332 -1.507 . . . . 3.73 109.332 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.0 p -131.07 -41.55 1.12 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.571 -0.958 . . . . 3.3 111.419 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.49 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 2.0 mmt -104.81 90.53 3.51 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.305 -0.872 . . . . 4.34 110.561 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.8 p -51.57 -30.45 20.91 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.582 -0.699 . . . . 4.46 110.944 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.489 HD11 ' SD ' ' A' ' 3' ' ' MET . 0.6 OUTLIER -58.5 -40.1 77.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 CA-C-O 121.653 0.739 . . . . 4.32 110.528 179.446 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.425 ' O ' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -140.98 -74.85 0.32 Allowed 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 116.258 -0.428 . . . . 2.7 110.812 179.833 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.49 ' HB2' ' O ' ' A' ' 3' ' ' MET . 3.7 t70 65.72 -48.0 0.39 Allowed 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.489 -0.757 . . . . 2.86 110.854 -179.096 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.514 ' O ' ' HB3' ' A' ' 9' ' ' SER . 0.1 OUTLIER -145.18 27.06 1.29 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.117 -0.989 . . . . 3.47 110.058 179.393 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.514 ' HB3' ' O ' ' A' ' 8' ' ' HIS . 43.5 t 66.92 149.29 0.12 Allowed Pre-proline 0 N--CA 1.505 2.322 0 O-C-N 121.749 -0.594 . . . . 2.08 111.076 -179.313 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.438 ' O ' HG22 ' A' ' 14' ' ' VAL . 42.9 Cg_endo -68.32 -24.41 37.36 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.679 1.357 . . . . 1.69 110.12 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.1 p -61.12 -54.45 44.45 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.741 -0.599 . . . . 2.57 109.898 179.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -59.44 -30.16 68.3 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.325 -0.859 . . . . 2.51 110.339 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -70.37 -57.46 6.72 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.532 -1.427 . . . . 1.61 109.532 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 10' ' ' PRO . 34.0 m -61.47 -32.6 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.418 -1.048 . . . . 1.98 110.171 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.1 t -70.31 -43.06 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 120.983 -1.073 . . . . 2.38 109.264 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 54.9 m -58.95 -51.69 68.95 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.848 -0.532 . . . . 1.85 109.879 179.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.454 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 27.0 m -64.66 -35.73 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.468 -0.77 . . . . 1.37 110.116 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.587 HD13 HD23 ' A' ' 21' ' ' LEU . 7.0 mm -66.79 -43.88 89.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.013 -1.054 . . . . 2.15 109.366 178.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.3 t -63.28 -42.22 95.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 108.72 -0.844 . . . . 2.28 108.72 178.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 79.1 mt -64.5 -48.56 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.506 -0.746 . . . . 1.54 109.464 178.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.587 HD23 HD13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -62.27 -43.13 99.53 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.783 -0.821 . . . . 1.86 108.783 178.818 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.553 ' N ' ' HG ' ' A' ' 21' ' ' LEU . 32.2 mt -59.49 -45.21 93.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.358 -0.839 . . . . 2.34 109.101 178.134 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.87 -46.53 84.53 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.541 -0.725 . . . . 1.68 109.836 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 55.6 mt -57.62 -46.81 86.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.511 -0.743 . . . . 1.41 109.247 178.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.21 -45.72 87.01 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.543 -0.723 . . . . 1.83 109.992 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.12 -46.04 89.35 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.44 -0.787 . . . . 1.98 108.97 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.541 ' O ' HG12 ' A' ' 31' ' ' ILE . 2.4 tt -61.69 -48.04 82.58 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.834 -0.802 . . . . 1.61 108.834 178.072 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.502 ' O ' HG13 ' A' ' 31' ' ' ILE . . . -53.76 -39.23 61.05 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 109.623 -1.391 . . . . 1.63 109.623 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.27 -41.93 47.29 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.233 -1.157 . . . . 2.0 109.517 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.417 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 1.6 mt -53.99 -45.88 71.57 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.148 0.499 . . . . 2.58 109.685 178.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.772 HD11 HG21 ' A' ' 52' ' ' ILE . 1.3 pt -77.13 -43.95 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.416 -0.803 . . . . 1.56 111.105 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.445 ' H ' HG13 ' A' ' 31' ' ' ILE . 1.3 tt -56.96 -45.42 82.87 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.047 -1.033 . . . . 2.58 109.103 178.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.78 -55.65 21.22 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.532 -1.427 . . . . 2.1 109.532 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.787 ' HB3' HD13 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -56.51 -36.76 69.55 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.272 -1.134 . . . . 2.19 111.001 179.955 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.644 ' CH2' ' HG3' ' A' ' 41' ' ' GLN . 1.9 t90 -77.4 -50.97 11.6 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.333 -0.855 . . . . 1.69 111.371 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 18.2 t -74.59 -25.96 59.61 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.481 -0.762 . . . . 2.43 112.074 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -92.0 -50.39 5.72 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.902 -1.124 . . . . 3.3 110.144 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.466 ' O ' ' CB ' ' A' ' 39' ' ' ARG . 7.0 tp -98.2 -70.24 0.73 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.312 -0.868 . . . . 2.15 109.945 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.466 ' CB ' ' O ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER 167.81 -57.49 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.53 -0.544 . . . . 1.82 109.53 -179.773 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.787 HD13 ' HB3' ' A' ' 34' ' ' CYS . 6.8 tp 65.13 170.04 0.2 Allowed 'General case' 0 N--CA 1.505 2.294 0 CA-C-O 121.501 0.667 . . . . 1.92 111.065 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.644 ' HG3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER 53.39 35.27 20.01 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.212 -0.93 . . . . 2.22 110.75 -179.17 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.46 -48.78 7.36 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.347 -0.845 . . . . 1.98 109.679 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.279 0.4 OUTLIER -67.09 -16.13 20.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 CA-C-O 121.497 0.665 . . . . 2.76 110.2 179.393 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.432 ' OG ' ' N ' ' A' ' 45' ' ' GLN . 17.7 t -99.82 -163.44 1.03 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.684 -0.635 . . . . 2.11 110.573 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.432 ' N ' ' OG ' ' A' ' 44' ' ' SER . 52.9 mm-40 -118.7 178.04 4.62 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.204 -0.935 . . . . 3.18 110.888 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.6 t 59.09 59.15 2.86 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.472 -0.768 . . . . 2.97 110.902 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -74.46 153.96 38.93 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.423 -0.798 . . . . 2.49 110.962 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -157.36 173.24 17.23 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.749 -0.595 . . . . 3.05 110.415 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -65.35 -31.94 73.32 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.137 0.494 . . . . 3.02 110.48 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -154.52 -165.36 2.05 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.565 -0.709 . . . . 2.61 109.911 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.594 ' HB3' ' CZ3' ' A' ' 35' ' ' TRP . 21.0 p -145.29 -53.92 0.29 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.223 -0.923 . . . . 3.38 110.14 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.772 HG21 HD11 ' A' ' 31' ' ' ILE . 17.2 pt -79.09 -36.32 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.647 -0.658 . . . . 2.12 109.937 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.56 HG12 ' N ' ' A' ' 54' ' ' GLY . 0.9 OUTLIER -68.12 -55.08 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.528 -0.733 . . . . 3.09 109.453 179.228 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.56 ' N ' HG12 ' A' ' 53' ' ' VAL . . . 85.52 -57.65 4.9 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.339 -1.504 . . . . 2.61 109.339 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.525 ' HB3' ' O ' ' A' ' 54' ' ' GLY . 19.1 t70 65.13 162.66 0.14 Allowed 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 122.193 0.997 . . . . 3.15 111.557 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 57' ' ' GLU . . . -133.59 45.7 1.1 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 106.557 -2.617 . . . . 3.63 106.557 178.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.43 ' HB2' ' O ' ' A' ' 56' ' ' GLY . 10.3 mm-40 63.76 36.54 10.49 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.787 0.803 . . . . 3.87 109.875 -177.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.65 47.4 1.18 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.439 -0.788 . . . . 4.68 109.857 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.484 ' HG2' ' HD3' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -150.0 -174.6 4.76 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.033 -1.042 . . . . 3.39 110.872 -179.436 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.736 ' HB3' HG22 ' A' ' 65' ' ' VAL . 5.4 mt-10 -123.99 74.57 57.41 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.335 -0.853 . . . . 3.39 110.563 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.484 ' HD3' ' HG2' ' A' ' 59' ' ' LYS . 43.1 Cg_endo -75.14 -46.44 0.23 Allowed 'Trans proline' 0 N--CA 1.486 1.074 0 O-C-N 123.773 1.407 . . . . 2.61 111.941 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -165.51 -67.35 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.864 -1.148 . . . . 3.17 111.485 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.5 mt -58.36 -47.18 84.65 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.438 -0.789 . . . . 2.71 110.293 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.452 ' O ' ' HB3' ' A' ' 68' ' ' SER . 0.2 OUTLIER -59.22 -39.24 82.06 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.403 -0.592 . . . . 3.3 109.403 178.838 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.736 HG22 ' HB3' ' A' ' 60' ' ' GLU . 5.4 t -67.76 -43.91 86.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 N-CA-C 108.646 -0.872 . . . . 2.35 108.646 177.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.501 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 1.7 tt0 -55.9 -44.81 78.57 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.735 -0.603 . . . . 2.43 109.534 179.329 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.473 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 11.1 m-85 -74.38 -49.41 22.78 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.562 -0.711 . . . . 2.56 111.006 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.452 ' HB3' ' O ' ' A' ' 64' ' ' LEU . 0.8 OUTLIER -63.07 -34.19 77.07 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.378 -0.826 . . . . 2.41 110.62 -179.923 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -79.59 -43.47 22.88 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.025 -1.047 . . . . 1.83 110.078 179.254 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.501 ' HB3' ' O ' ' A' ' 66' ' ' GLN . 12.7 ptpt -68.82 -31.73 70.92 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.428 -0.795 . . . . 2.06 110.801 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.406 ' N ' ' HD2' ' A' ' 72' ' ' PRO . . . -47.6 -63.93 3.17 Favored Glycine 0 N--CA 1.5 2.949 0 N-CA-C 109.228 -1.549 . . . . 1.53 109.228 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.531 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 41.5 Cg_endo -68.44 -41.1 6.96 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.886 1.466 . . . . 2.08 109.666 178.234 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 4.1 t -55.75 -43.81 77.0 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.013 -1.054 . . . . 2.2 109.236 178.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 37.9 t -74.5 -45.09 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.504 -0.747 . . . . 1.55 109.351 178.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -53.57 -43.21 68.31 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.708 0.766 . . . . 2.38 109.189 178.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.531 ' HD2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -71.06 -44.75 65.12 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.391 -0.596 . . . . 3.37 109.391 178.663 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.84 -40.28 79.69 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 120.223 -0.591 . . . . 2.98 110.231 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.65 -41.24 60.69 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.041 0.448 . . . . 2.21 110.322 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.496 ' HD3' HG23 ' A' ' 88' ' ' VAL . 4.2 mttp -65.52 -43.86 88.7 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 121.504 0.669 . . . . 2.68 109.325 179.049 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.87 -42.31 85.82 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.687 -0.633 . . . . 3.65 109.974 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 8.1 ttt -69.5 -44.99 69.96 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.439 0.637 . . . . 4.34 110.093 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.62 103.37 40.92 Favored Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.652 -0.655 . . . . 2.98 109.375 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.17 15.87 0.47 Allowed 'Trans proline' 0 N--CA 1.492 1.418 0 O-C-N 123.706 1.372 . . . . 3.34 112.685 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -73.68 50.16 0.33 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.552 -1.343 . . . . 3.01 110.023 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -162.37 160.44 32.65 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.76 -1.336 . . . . 2.96 109.76 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.449 ' O ' ' CB ' ' A' ' 87' ' ' GLU . 49.5 Cg_endo -72.01 -172.29 0.82 Allowed 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.69 1.363 . . . . 3.35 111.165 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.449 ' CB ' ' O ' ' A' ' 86' ' ' PRO . 3.7 tt0 72.78 -58.73 0.59 Allowed 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 108.605 -0.887 . . . . 4.0 108.605 -178.187 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.503 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 92.4 t -85.51 -35.94 10.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 108.739 -0.838 . . . . 4.11 108.739 177.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.503 ' HB2' ' O ' ' A' ' 88' ' ' VAL . 67.6 m80 64.16 -59.75 0.2 Allowed 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.895 -0.503 . . . . 4.46 111.808 178.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 88' ' ' VAL . . . . . . . . 0 N--CA 1.493 2.459 0 CA-C-O 117.895 -1.503 . . . . 4.94 109.786 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.705 0 N-CA-C 109.904 -1.278 . . . . 2.85 109.904 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 56.26 56.69 5.56 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.589 -0.947 . . . . 3.98 109.936 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.612 ' SD ' ' HB3' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -141.54 170.09 16.37 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.31 -0.869 . . . . 2.55 111.137 -179.155 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.2 p -88.31 -28.51 21.0 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.525 -0.734 . . . . 2.57 110.617 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -85.19 -144.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.326 -0.859 . . . . 1.9 110.96 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.537 ' O ' ' HB3' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -87.77 -73.34 0.49 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.19 -0.944 . . . . 2.43 111.101 -179.626 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.612 ' HB3' ' SD ' ' A' ' 3' ' ' MET . 1.2 t70 65.0 -52.88 0.33 Allowed 'General case' 0 N--CA 1.51 2.556 0 O-C-N 121.625 -0.672 . . . . 1.77 110.203 -179.02 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.468 ' N ' ' O ' ' A' ' 6' ' ' MET . 0.8 OUTLIER -91.09 46.05 1.29 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.191 -0.943 . . . . 1.95 110.039 179.201 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.6 t -159.83 143.89 10.77 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.203 -0.935 . . . . 1.43 110.254 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.24 -17.56 50.08 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 O-C-N 124.029 1.541 . . . . 2.13 111.502 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.9 t -66.25 -29.94 70.28 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.145 -0.972 . . . . 1.76 109.954 179.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.9 m -51.26 -35.31 36.6 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.586 -0.696 . . . . 1.12 110.36 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.448 ' O ' HG22 ' A' ' 17' ' ' VAL . . . -72.34 -53.3 9.02 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 108.952 -1.659 . . . . 1.37 108.952 179.217 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.583 ' O ' HG23 ' A' ' 18' ' ' ILE . 61.5 t -55.81 -39.17 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.868 -0.784 . . . . 2.09 109.529 178.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.64 ' HA ' HG12 ' A' ' 18' ' ' ILE . 43.6 t -71.11 -41.39 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.309 -0.869 . . . . 1.35 109.707 179.017 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.419 ' O ' HG12 ' A' ' 20' ' ' ILE . 50.2 m -59.81 -46.63 88.64 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.525 -0.734 . . . . 1.06 109.92 179.279 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.547 ' HA ' HG12 ' A' ' 20' ' ' ILE . 35.7 m -68.9 -42.67 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.436 -0.79 . . . . 1.6 111.312 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.64 HG12 ' HA ' ' A' ' 15' ' ' VAL . 15.6 pt -65.42 -31.64 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 120.166 -1.584 . . . . 1.79 109.608 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.459 ' N ' HG13 ' A' ' 18' ' ' ILE . 21.2 t -70.06 -48.88 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.476 -0.765 . . . . 1.14 109.342 178.363 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.547 HG12 ' HA ' ' A' ' 17' ' ' VAL . 2.5 pt -68.22 -31.35 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 120.638 -1.289 . . . . 1.43 108.847 178.214 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.473 ' N ' HG13 ' A' ' 20' ' ' ILE . 10.0 mt -66.66 -52.33 46.08 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.334 -0.854 . . . . 1.78 109.24 177.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.549 HG23 ' O ' ' A' ' 18' ' ' ILE . 30.9 pt -59.53 -42.38 87.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 C-N-CA 118.851 -1.139 . . . . 1.69 109.288 178.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.455 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -61.03 -46.8 89.24 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 120.294 -0.562 . . . . 1.1 109.707 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.413 HD13 ' HA ' ' A' ' 24' ' ' ILE . 6.1 mm -60.51 -45.53 96.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.256 -0.902 . . . . 1.18 108.952 178.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.38 -43.95 97.99 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.563 -0.711 . . . . 1.49 109.666 178.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.81 -44.31 96.51 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.116 -0.698 . . . . 1.49 109.116 178.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.05 -44.53 96.49 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.806 -0.813 . . . . 1.29 108.806 178.207 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.69 -45.9 94.93 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 108.756 -1.738 . . . . 1.07 108.756 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.99 -43.63 95.1 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.502 -0.999 . . . . 1.57 109.821 178.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.457 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 7.4 mt -58.27 -41.61 84.7 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.063 -0.717 . . . . 1.99 109.063 178.556 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 59.9 mt -70.07 -48.26 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.465 -0.772 . . . . 1.06 109.411 178.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.12 -48.83 77.69 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.429 -0.795 . . . . 2.12 110.255 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.01 -46.8 93.32 Favored Glycine 0 N--CA 1.499 2.836 0 N-CA-C 109.577 -1.409 . . . . 1.47 109.577 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.873 ' HB3' HD12 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -63.81 -31.63 72.87 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.329 -1.101 . . . . 2.06 110.588 179.564 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.487 ' HZ3' HG23 ' A' ' 53' ' ' VAL . 6.7 m0 -81.58 -59.7 2.52 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.105 -0.997 . . . . 1.19 110.059 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.46 ' HB3' ' H ' ' A' ' 37' ' ' TYR . 0.1 OUTLIER 36.75 -95.36 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.415 0 N-CA-C 112.212 0.449 . . . . 1.49 112.212 179.833 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.46 ' H ' ' HB3' ' A' ' 36' ' ' CYS . 0.2 OUTLIER -117.54 -1.6 11.65 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.582 -1.324 . . . . 3.39 111.102 179.833 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -111.87 -11.8 13.87 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.948 -1.095 . . . . 1.33 111.159 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.499 ' HD2' ' CE1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER 49.55 44.78 24.36 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.095 -1.003 . . . . 1.19 109.981 -179.479 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.873 HD12 ' HB3' ' A' ' 34' ' ' CYS . 0.1 OUTLIER 44.75 39.37 3.41 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.801 -0.562 . . . . 1.75 111.298 -179.619 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.428 ' O ' ' NZ ' ' A' ' 70' ' ' LYS . 9.7 pt20 -81.49 37.51 0.46 Allowed 'General case' 0 N--CA 1.502 2.163 0 O-C-N 120.927 -1.108 . . . . 1.33 111.627 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.57 -63.44 1.25 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.693 -1.254 . . . . 2.73 109.138 178.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.476 HG13 ' N ' ' A' ' 44' ' ' SER . 9.3 pt -59.3 -35.33 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-O 121.556 0.693 . . . . 1.68 110.286 178.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.476 ' N ' HG13 ' A' ' 43' ' ' ILE . 1.8 t 68.18 64.38 0.36 Allowed 'General case' 0 N--CA 1.504 2.26 0 CA-C-O 121.527 0.68 . . . . 1.25 110.76 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.406 ' HG2' ' N ' ' A' ' 46' ' ' SER . 11.1 pm0 -68.69 -19.93 64.4 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.515 -0.741 . . . . 1.6 111.279 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.406 ' N ' ' HG2' ' A' ' 45' ' ' GLN . 0.3 OUTLIER 54.08 52.26 13.09 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.251 -0.906 . . . . 2.12 110.928 179.843 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.18 169.63 17.19 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.469 -0.769 . . . . 1.92 110.996 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.9 -42.58 3.55 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.215 -0.928 . . . . 2.72 110.879 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.01 161.76 29.17 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.008 -1.057 . . . . 4.16 111.224 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.406 ' HG2' ' CZ ' ' A' ' 62' ' ' PHE . 1.6 tm-20 -153.8 147.36 25.08 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.539 -0.726 . . . . 2.37 109.354 179.142 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.1 m -162.12 21.36 0.1 Allowed 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.108 -0.995 . . . . 2.74 111.302 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.2 mt -121.04 -43.71 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.568 -0.901 . . . . 2.63 108.568 179.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.487 HG23 ' HZ3' ' A' ' 35' ' ' TRP . 38.0 t -86.69 -63.45 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-O 121.427 0.632 . . . . 1.92 109.389 178.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.65 -52.89 3.37 Favored Glycine 0 N--CA 1.499 2.834 0 N-CA-C 109.713 -1.355 . . . . 1.66 109.713 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.0 t70 62.53 -155.59 0.34 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 122.05 -0.677 . . . . 1.6 111.016 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.87 -42.52 0.59 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 108.348 -1.901 . . . . 1.55 108.348 -179.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -112.48 -39.46 4.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.58 -0.953 . . . . 2.44 111.311 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.556 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 0.2 OUTLIER -57.55 -40.68 79.42 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 120.832 -1.168 . . . . 1.61 109.825 179.602 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.556 ' HB2' ' O ' ' A' ' 58' ' ' THR . 2.2 mttt 68.19 120.66 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 CA-C-O 121.602 0.715 . . . . 1.78 111.048 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.546 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 1.1 mp0 46.59 57.8 16.85 Favored Pre-proline 0 N--CA 1.499 1.995 0 O-C-N 121.587 -0.696 . . . . 1.5 111.433 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.54 ' O ' HG12 ' A' ' 65' ' ' VAL . 41.2 Cg_endo -65.85 -29.63 49.93 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 O-C-N 123.524 1.276 . . . . 1.01 111.578 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.499 ' CE1' ' HD2' ' A' ' 39' ' ' ARG . 3.3 m-30 -60.88 -66.41 0.54 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.459 -0.775 . . . . 1.2 110.965 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.591 ' HA ' ' HB2' ' A' ' 66' ' ' GLN . 2.5 pp -65.49 -28.16 69.0 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.493 -0.754 . . . . 1.24 111.0 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.546 ' HB2' ' O ' ' A' ' 60' ' ' GLU . 0.5 OUTLIER -58.08 -57.13 14.2 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.332 -0.855 . . . . 1.58 109.692 179.321 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.54 HG12 ' O ' ' A' ' 61' ' ' PRO . 9.0 p -73.51 -29.52 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 C-N-CA 119.387 -0.925 . . . . 0.79 109.877 178.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.591 ' HB2' ' HA ' ' A' ' 63' ' ' LEU . 1.8 mm100 -59.36 -49.8 76.41 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.245 -1.02 . . . . 1.04 108.245 177.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -71.37 -47.03 58.82 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.604 -0.685 . . . . 4.38 109.841 178.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.528 ' HB2' ' HA ' ' A' ' 65' ' ' VAL . 65.0 m -54.56 -46.8 73.72 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.933 -0.479 . . . . 1.07 110.211 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.536 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -72.41 -57.58 4.07 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.202 -0.936 . . . . 0.84 111.308 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.539 ' HD2' ' N ' ' A' ' 70' ' ' LYS . 3.8 mptt -52.71 -60.49 3.19 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.432 -0.793 . . . . 0.96 112.914 -179.003 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 70' ' ' LYS . . . -31.74 -67.44 0.15 Allowed Glycine 0 N--CA 1.51 3.597 0 N-CA-C 111.55 -0.62 . . . . 1.15 111.55 -178.479 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.552 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 40.2 Cg_endo -66.28 -40.97 13.52 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.698 1.367 . . . . 1.17 110.649 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.536 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -58.9 -42.95 90.79 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.825 -1.172 . . . . 1.58 109.277 178.688 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 55.0 t -71.69 -45.04 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 109.327 -0.619 . . . . 1.37 109.327 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 1.2 tm-20 -57.08 -42.2 80.22 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 119.855 -0.738 . . . . 1.72 109.427 178.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.552 ' HD2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -66.99 -50.15 63.17 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.5 -0.75 . . . . 1.7 109.703 178.889 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.38 -41.62 85.24 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 120.01 -0.676 . . . . 2.24 109.595 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.449 ' O ' ' HD3' ' A' ' 83' ' ' PRO . . . -65.96 -49.03 69.34 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.97 -0.456 . . . . 1.76 109.918 179.101 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.05 -49.26 76.69 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.206 -0.934 . . . . 1.99 109.807 179.016 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 24.3 tp -59.27 -41.86 89.88 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.429 -0.795 . . . . 3.18 111.393 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 5.4 ttt -81.6 -28.2 33.86 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.137 -0.977 . . . . 3.83 110.227 179.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 90.4 m 57.49 79.55 0.32 Allowed Pre-proline 0 N--CA 1.502 2.144 0 O-C-N 121.786 -0.571 . . . . 2.07 109.922 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 78' ' ' ALA . 43.4 Cg_endo -68.45 -1.34 7.21 Favored 'Trans proline' 0 N--CA 1.491 1.352 0 O-C-N 123.791 1.416 . . . . 2.5 111.871 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 57.45 23.3 8.91 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.32 -0.863 . . . . 3.61 110.985 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.409 ' O ' ' ND1' ' A' ' 89' ' ' HIS . . . -92.59 -91.02 1.5 Allowed Glycine 0 N--CA 1.498 2.793 0 N-CA-C 109.255 -1.538 . . . . 2.34 109.255 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.11 -25.52 19.12 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 O-C-N 123.954 1.502 . . . . 2.55 110.659 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.0 mp0 -54.87 -38.53 67.61 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.71 -0.619 . . . . 3.08 110.293 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.5 p -105.23 -15.98 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.271 -0.893 . . . . 4.06 111.083 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.409 ' ND1' ' O ' ' A' ' 85' ' ' GLY . 41.4 m80 -94.2 -35.59 12.42 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.757 -1.214 . . . . 4.44 110.931 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.417 0 CA-C-O 118.024 -1.431 . . . . 5.22 109.848 -179.97 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.987 0 N-CA-C 110.067 -1.213 . . . . 4.91 110.067 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.461 ' O ' HG13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -71.07 -172.73 0.73 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.477 -1.013 . . . . 3.83 111.2 -179.752 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.448 ' N ' ' OG ' ' A' ' 2' ' ' SER . 3.7 ptt? -84.63 -27.02 27.46 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 120.963 -1.086 . . . . 3.94 110.79 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.459 ' OG ' ' OG1' ' A' ' 11' ' ' THR . 0.3 OUTLIER -107.97 52.58 0.71 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.86 -1.15 . . . . 2.58 109.964 178.982 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.527 HD11 ' CE1' ' A' ' 8' ' ' HIS . 1.5 pp -101.19 -164.93 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.619 -0.675 . . . . 3.27 110.388 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.481 ' HG3' ' C ' ' A' ' 5' ' ' ILE . 24.1 mtp -139.51 4.76 2.19 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.102 -0.999 . . . . 4.74 111.467 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -65.06 -25.43 67.81 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.825 -1.172 . . . . 3.57 110.855 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.527 ' CE1' HD11 ' A' ' 5' ' ' ILE . 27.6 p-80 -146.47 -9.05 0.49 Allowed 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.271 -0.893 . . . . 3.43 112.758 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.3 123.25 6.41 Favored Pre-proline 0 N--CA 1.487 1.402 0 O-C-N 120.802 -1.186 . . . . 3.44 109.66 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.85 82.0 1.81 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.754 1.397 . . . . 2.37 110.295 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.459 ' OG1' ' OG ' ' A' ' 4' ' ' SER . 4.7 t -54.33 -39.12 66.77 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.055 -1.028 . . . . 2.07 109.765 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 p -60.61 -40.8 93.21 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.151 -0.968 . . . . 2.5 109.367 177.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.518 ' O ' HG22 ' A' ' 17' ' ' VAL . . . -70.41 -50.82 24.58 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 108.902 -1.679 . . . . 1.68 108.902 178.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.597 ' O ' HG12 ' A' ' 18' ' ' ILE . 39.9 t -56.48 -40.21 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.663 -0.904 . . . . 1.68 109.109 178.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.628 ' HA ' HG12 ' A' ' 18' ' ' ILE . 34.2 t -70.73 -42.41 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.242 -0.912 . . . . 1.84 108.963 178.534 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 54.2 m -58.16 -46.78 85.1 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.487 -0.758 . . . . 1.97 109.979 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.518 HG22 ' O ' ' A' ' 13' ' ' GLY . 35.8 m -70.16 -41.21 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.271 -0.893 . . . . 1.84 111.188 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.628 HG12 ' HA ' ' A' ' 15' ' ' VAL . 4.8 pt -67.89 -33.92 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 120.163 -1.586 . . . . 1.84 109.676 178.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.488 ' N ' HG13 ' A' ' 18' ' ' ILE . 20.8 t -67.7 -43.39 86.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 108.41 -0.959 . . . . 1.88 108.41 177.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 87.5 mt -67.4 -40.24 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.117 -1.068 . . . . 2.03 108.117 177.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.412 ' HB2' ' HA ' ' A' ' 18' ' ' ILE . 10.7 mt -60.8 -52.79 63.58 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.87 -0.519 . . . . 2.16 109.817 178.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.545 HG12 ' O ' ' A' ' 18' ' ' ILE . 41.4 pt -59.9 -41.69 86.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 120.943 -1.098 . . . . 1.88 109.697 179.112 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.483 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -61.83 -45.76 92.43 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 120.146 -0.622 . . . . 1.93 109.594 178.535 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.418 ' HA ' HD13 ' A' ' 24' ' ' ILE . 15.8 mm -61.97 -44.5 99.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.313 -0.867 . . . . 2.32 108.758 178.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.74 -44.66 96.48 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.544 -0.722 . . . . 2.03 109.645 178.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.01 -46.96 88.66 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.972 -0.751 . . . . 2.03 108.972 178.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.1 tt -59.78 -45.89 90.88 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.808 -0.812 . . . . 2.58 108.808 178.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.07 -45.33 94.01 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 108.937 -1.665 . . . . 2.21 108.937 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.55 -44.03 95.36 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.451 -1.029 . . . . 2.11 109.967 179.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.1 mt -59.67 -41.32 90.35 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.089 -0.708 . . . . 2.43 109.089 178.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 24.7 mm -68.34 -48.15 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.65 -0.656 . . . . 2.64 109.374 178.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.17 -48.1 81.35 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.447 -0.783 . . . . 2.58 110.052 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.07 -47.5 90.88 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 109.816 -1.314 . . . . 2.23 109.816 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 17.9 t -61.99 -43.38 98.96 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.633 -0.922 . . . . 2.69 109.994 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -66.48 -47.0 74.43 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.398 -0.814 . . . . 3.02 109.63 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.5 t -149.01 108.02 3.89 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.418 -0.801 . . . . 2.55 108.935 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.524 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -47.2 121.56 3.88 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.448 -0.782 . . . . 3.06 110.921 -178.772 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.572 HD21 ' HA ' ' A' ' 44' ' ' SER . 0.3 OUTLIER 42.0 28.41 0.1 Allowed 'General case' 0 N--CA 1.503 2.219 0 CA-C-O 121.245 0.545 . . . . 2.58 111.393 -178.794 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.89 28.58 12.73 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.52 -0.738 . . . . 4.22 111.44 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.419 ' HG ' ' OG ' ' A' ' 44' ' ' SER . 0.1 OUTLIER 48.15 46.1 19.69 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.366 -0.834 . . . . 2.98 110.564 -179.815 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -104.05 10.78 35.89 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.225 -0.922 . . . . 3.74 111.886 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.84 -142.35 0.1 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.635 -1.29 . . . . 4.33 109.649 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.417 ' O ' ' HB3' ' A' ' 44' ' ' SER . 0.8 OUTLIER -47.49 -36.62 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 121.089 -1.007 . . . . 3.01 110.904 179.399 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.572 ' HA ' HD21 ' A' ' 38' ' ' LEU . 8.6 t 66.31 -57.35 0.37 Allowed 'General case' 0 N--CA 1.504 2.235 0 O-C-N 122.111 -0.368 . . . . 1.95 111.281 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.676 ' HA ' ' CZ ' ' A' ' 67' ' ' TYR . 74.3 mt-30 -70.37 96.84 1.18 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.126 -0.984 . . . . 2.19 110.221 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 45.9 t -108.14 -79.6 0.58 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.44 -0.787 . . . . 2.38 108.955 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.889 ' HB2' HD13 ' A' ' 63' ' ' LEU . 1.2 mp0 -83.21 162.09 21.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.092 -1.005 . . . . 2.3 109.155 178.366 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.681 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 5.0 m-20 65.29 130.46 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.324 0 CA-C-O 121.65 0.738 . . . . 1.95 109.909 -179.026 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -113.75 129.23 56.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.943 -1.098 . . . . 2.52 111.336 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.705 ' HB3' ' HG ' ' A' ' 64' ' ' LEU . 1.0 OUTLIER -133.88 28.21 3.88 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.31 -0.869 . . . . 2.25 111.104 179.357 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.9 p -133.13 -49.12 0.86 Allowed 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.997 -1.064 . . . . 3.1 111.518 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.7 mm -83.96 -53.68 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.583 -0.698 . . . . 3.47 110.436 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 55' ' ' ASP . 8.6 p -112.69 -35.91 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.294 -0.879 . . . . 2.84 111.087 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.694 ' HA2' ' HA ' ' A' ' 50' ' ' GLU . . . 73.09 -71.41 1.18 Allowed Glycine 0 N--CA 1.498 2.827 0 N-CA-C 109.923 -1.271 . . . . 2.36 109.923 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.556 ' O ' HG22 ' A' ' 53' ' ' VAL . 3.1 t0 -120.43 -174.22 2.75 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.271 -1.135 . . . . 2.8 110.637 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 131.41 -65.72 0.59 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 107.157 -2.377 . . . . 2.65 107.157 -179.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.455 ' HA ' ' NZ ' ' A' ' 59' ' ' LYS . 2.9 mm-40 -128.12 -1.36 5.8 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.937 -0.743 . . . . 3.07 110.835 177.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.459 ' O ' ' HD3' ' A' ' 61' ' ' PRO . 0.1 OUTLIER -76.43 59.96 1.52 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.909 -1.119 . . . . 2.12 109.722 179.204 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.455 ' NZ ' ' HA ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -66.91 135.33 53.68 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.277 -0.889 . . . . 3.11 109.81 179.99 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 45.86 58.64 15.7 Favored Pre-proline 0 N--CA 1.502 2.17 0 O-C-N 121.557 -0.714 . . . . 4.05 110.557 -179.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 58' ' ' THR . 43.8 Cg_endo -74.17 159.55 43.9 Favored 'Trans proline' 0 N--CA 1.49 1.268 0 O-C-N 123.765 1.403 . . . . 2.18 111.508 -179.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -127.35 -56.27 1.32 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.515 -0.741 . . . . 3.81 109.931 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.889 HD13 ' HB2' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -61.49 -31.57 71.56 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.316 -0.865 . . . . 1.68 108.882 178.297 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.705 ' HG ' ' HB3' ' A' ' 50' ' ' GLU . 5.6 tt -54.89 -54.72 38.9 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.125 -0.694 . . . . 2.0 109.125 178.027 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.2 t -65.3 -32.92 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.316 -0.865 . . . . 2.04 108.763 178.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.448 ' HB2' ' HA ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -59.58 -49.4 77.91 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.81 -0.811 . . . . 2.41 108.81 178.609 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.676 ' CZ ' ' HA ' ' A' ' 45' ' ' GLN . 10.8 m-85 -62.32 -52.62 62.94 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 108.477 -0.934 . . . . 1.38 108.477 177.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.42 ' O ' ' CD ' ' A' ' 72' ' ' PRO . 2.4 m -53.72 -38.41 64.29 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-N 115.808 -0.633 . . . . 1.85 111.388 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.36 -41.56 18.05 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.012 -1.055 . . . . 1.81 110.969 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.0 mmtp -67.24 -45.78 75.71 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.419 -0.801 . . . . 2.52 111.12 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.409 ' N ' ' HD2' ' A' ' 72' ' ' PRO . . . -43.25 -62.65 2.34 Favored Glycine 0 N--CA 1.506 3.33 0 N-CA-C 110.614 -0.994 . . . . 1.52 110.614 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.556 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 40.8 Cg_endo -66.92 -43.92 6.14 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 O-C-N 123.729 1.384 . . . . 1.87 110.03 179.222 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 31.5 t -54.52 -43.05 71.54 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.935 -1.103 . . . . 2.47 109.745 178.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 37.5 t -73.62 -47.0 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.555 -0.716 . . . . 1.91 109.552 178.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -54.1 -41.4 68.23 Favored 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 121.58 0.705 . . . . 2.0 109.641 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.556 ' HD2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -69.88 -49.14 55.25 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.832 -0.543 . . . . 2.9 110.637 179.496 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.579 ' HG3' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -63.99 -29.3 70.47 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.112 -0.992 . . . . 2.4 110.075 179.292 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.579 ' N ' ' HG3' ' A' ' 77' ' ' LYS . . . -75.4 -44.41 44.8 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.283 -0.886 . . . . 2.08 109.415 179.089 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.0 mttt -68.8 -40.59 79.5 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.32 0.581 . . . . 2.25 109.494 178.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.13 -47.6 79.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.587 -0.696 . . . . 2.98 110.021 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 12.5 ttt -69.65 -49.87 49.53 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.444 -0.785 . . . . 4.11 110.363 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.6 85.59 38.62 Favored Pre-proline 0 N--CA 1.499 1.981 0 O-C-N 121.485 -0.76 . . . . 2.71 109.334 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.661 ' CB ' HG11 ' A' ' 88' ' ' VAL . 45.3 Cg_endo -69.84 -30.91 21.16 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 O-C-N 123.865 1.455 . . . . 2.52 112.605 -178.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.5 t30 68.44 -51.98 0.55 Allowed 'General case' 0 N--CA 1.507 2.394 0 O-C-N 121.679 -0.638 . . . . 3.06 110.813 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 174.09 -113.75 0.48 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.594 -1.402 . . . . 2.55 109.594 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.89 -17.33 25.5 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.847 1.446 . . . . 3.32 111.638 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -54.05 -32.28 54.06 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.326 -0.859 . . . . 3.21 111.175 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.661 HG11 ' CB ' ' A' ' 83' ' ' PRO . 7.5 p -98.97 -26.93 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.707 -0.621 . . . . 3.15 111.427 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -94.31 60.28 2.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.308 -0.87 . . . . 4.23 110.402 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.502 3.091 0 N-CA-C 109.511 -1.435 . . . . 7.02 109.511 -179.871 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.821 0 N-CA-C 109.063 -1.615 . . . . 4.96 109.063 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.5 m 53.62 48.27 21.98 Favored 'General case' 0 N--CA 1.508 2.475 0 O-C-N 121.083 -1.245 . . . . 4.01 111.12 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.446 ' O ' ' CB ' ' A' ' 4' ' ' SER . 24.0 mtp -121.11 176.76 5.43 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.06 -1.025 . . . . 3.66 110.25 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.446 ' CB ' ' O ' ' A' ' 3' ' ' MET . 0.2 OUTLIER 71.77 -51.02 0.7 Allowed 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 121.181 0.515 . . . . 3.12 110.538 -179.504 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -49.14 -43.93 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 CA-C-O 121.516 0.674 . . . . 2.4 110.919 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.564 ' HG3' ' HG3' ' A' ' 81' ' ' MET . 0.0 OUTLIER -125.04 35.08 4.84 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.667 0.746 . . . . 2.64 110.092 178.845 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -121.07 10.33 10.72 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.434 -0.791 . . . . 1.83 110.004 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -103.1 52.77 0.78 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.584 -0.698 . . . . 3.96 110.519 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.42 ' HB3' HG13 ' A' ' 14' ' ' VAL . 0.4 OUTLIER -64.26 133.86 95.78 Favored Pre-proline 0 N--CA 1.5 2.043 0 O-C-N 121.098 -1.001 . . . . 2.15 111.019 -179.707 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.96 157.68 57.42 Favored 'Trans proline' 0 C--N 1.316 -1.18 0 O-C-N 123.927 1.488 . . . . 2.5 110.758 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.418 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 11.4 t -53.23 -36.68 61.31 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.451 -0.78 . . . . 2.21 110.309 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 p -64.68 -35.16 80.15 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.068 -1.02 . . . . 2.35 110.112 178.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.432 ' O ' HG22 ' A' ' 17' ' ' VAL . . . -69.78 -57.2 7.37 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.655 -1.378 . . . . 2.14 109.655 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.42 HG13 ' HB3' ' A' ' 9' ' ' SER . 31.1 m -59.95 -34.11 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.501 -1.0 . . . . 2.12 110.261 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.6 t -71.59 -42.37 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 120.98 -1.075 . . . . 1.83 109.138 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.423 ' O ' HG12 ' A' ' 20' ' ' ILE . 53.2 m -58.97 -51.73 68.78 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.711 -0.618 . . . . 2.32 109.771 179.099 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.643 ' HA ' HG12 ' A' ' 20' ' ' ILE . 35.0 m -64.02 -40.11 87.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.512 -0.743 . . . . 2.24 109.91 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.73 HD13 HD23 ' A' ' 21' ' ' LEU . 8.9 mm -63.36 -42.73 97.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.009 -1.057 . . . . 1.77 109.393 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.606 ' O ' HG13 ' A' ' 22' ' ' ILE . 38.4 t -63.93 -43.39 97.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 C-N-CA 119.974 -0.69 . . . . 1.92 110.173 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.647 ' O ' HG23 ' A' ' 24' ' ' ILE . 22.2 pt -72.51 -34.77 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 120.52 -1.363 . . . . 2.4 109.45 178.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.73 HD23 HD13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -69.36 -45.69 68.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.23 -0.919 . . . . 1.74 109.428 178.55 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.606 HG13 ' O ' ' A' ' 19' ' ' VAL . 1.9 pp -63.73 -39.94 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 120.632 -1.293 . . . . 1.6 109.146 178.49 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.26 -50.14 72.89 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.862 -0.523 . . . . 1.93 110.768 179.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.647 HG23 ' O ' ' A' ' 20' ' ' ILE . 40.0 pt -63.99 -36.83 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 120.853 -1.155 . . . . 2.22 109.155 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.505 ' N ' HG13 ' A' ' 24' ' ' ILE . . . -65.28 -44.64 87.39 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.046 -0.724 . . . . 1.69 109.046 178.161 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.22 -44.6 94.81 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.753 -0.832 . . . . 1.81 108.753 178.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.26 -45.12 95.83 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.894 -0.78 . . . . 2.64 108.894 178.204 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.62 -44.7 97.54 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 108.753 -1.739 . . . . 1.91 108.753 178.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.99 -41.64 97.45 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.492 -1.005 . . . . 1.84 109.848 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.5 mt -60.68 -41.31 94.84 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.051 -0.722 . . . . 2.51 109.051 178.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 69.4 mt -69.7 -48.15 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 109.002 -0.74 . . . . 2.5 109.002 178.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.95 -43.45 91.28 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.533 -0.729 . . . . 1.98 110.103 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.42 -50.56 49.12 Favored Glycine 0 N--CA 1.498 2.779 0 N-CA-C 109.342 -1.503 . . . . 2.29 109.342 179.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 18.4 t -60.53 -40.37 91.24 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.545 -0.974 . . . . 3.04 110.145 179.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.42 ' CD1' ' HA ' ' A' ' 39' ' ' ARG . 0.6 OUTLIER -71.89 -42.67 66.51 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.202 -0.936 . . . . 3.6 109.548 179.28 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 45.6 t 53.7 -94.55 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.893 -0.505 . . . . 2.47 111.209 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -111.54 -24.53 10.07 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.836 -1.165 . . . . 2.58 112.235 -179.302 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pp -73.91 7.43 2.6 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.042 -1.036 . . . . 2.86 112.106 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.42 ' HA ' ' CD1' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -56.9 -30.15 63.68 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.119 -0.988 . . . . 2.78 112.097 -179.7 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.464 ' O ' ' N ' ' A' ' 42' ' ' ARG . 1.4 mm? 50.79 -100.82 0.09 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.457 -0.777 . . . . 3.12 110.433 -179.254 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.87 -50.33 0.33 Allowed 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.199 -0.938 . . . . 3.63 111.09 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.464 ' N ' ' O ' ' A' ' 40' ' ' LEU . 3.1 ttm180 -155.44 -119.59 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.981 -1.075 . . . . 4.92 108.691 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -65.42 -37.26 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.702 -1.249 . . . . 3.0 109.775 178.478 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.41 ' O ' ' NH2' ' A' ' 39' ' ' ARG . 5.5 t 69.79 -65.94 0.29 Allowed 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 109.764 -0.458 . . . . 2.62 109.764 -179.263 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.65 100.33 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.389 -0.819 . . . . 3.05 110.055 179.105 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 6.6 p -148.12 -73.13 0.2 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.522 -0.736 . . . . 1.92 109.694 -178.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 46' ' ' SER . 2.8 mp0 57.7 -167.98 0.13 Allowed 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.329 0.585 . . . . 2.31 111.715 178.297 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.12 84.64 1.83 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.248 -0.907 . . . . 3.13 110.154 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -127.96 173.26 10.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.988 -1.07 . . . . 2.12 111.091 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.73 ' HG3' HG23 ' A' ' 58' ' ' THR . 21.9 tt0 -131.01 74.42 1.6 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.406 -0.809 . . . . 2.7 110.528 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.414 ' OG ' HG13 ' A' ' 52' ' ' ILE . 4.9 p -169.99 -46.25 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.821 -1.174 . . . . 3.37 111.565 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.414 HG13 ' OG ' ' A' ' 51' ' ' SER . 46.0 mt -104.48 -57.96 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.566 -0.708 . . . . 3.12 110.418 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.4 p -95.27 -33.5 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.406 -0.808 . . . . 2.57 109.89 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.691 ' HA3' HG22 ' A' ' 58' ' ' THR . . . -77.21 63.31 3.29 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.264 -1.534 . . . . 2.52 109.264 179.005 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -85.81 126.74 34.25 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.426 -1.043 . . . . 4.46 110.806 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.57 36.34 2.65 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 108.386 -1.885 . . . . 3.43 108.386 -179.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.431 ' O ' ' NZ ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER 58.16 24.99 11.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.842 -0.799 . . . . 3.67 109.877 -178.613 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.73 HG23 ' HG3' ' A' ' 50' ' ' GLU . 15.7 p 40.39 -112.57 0.14 Allowed 'General case' 0 N--CA 1.51 2.559 0 O-C-N 121.678 -0.639 . . . . 2.63 111.026 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.474 ' N ' ' OG1' ' A' ' 58' ' ' THR . 0.0 OUTLIER 51.53 -166.24 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.335 -0.853 . . . . 3.43 111.452 179.324 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.408 ' HA ' ' HD2' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -105.25 97.95 15.05 Favored Pre-proline 0 N--CA 1.487 1.397 0 O-C-N 121.28 -0.888 . . . . 3.06 109.259 179.388 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.761 ' HB2' ' HB2' ' A' ' 64' ' ' LEU . 40.2 Cg_endo -66.68 -26.81 45.61 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 124.102 1.58 . . . . 2.63 111.49 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.455 ' O ' ' HB2' ' A' ' 66' ' ' GLN . 58.6 t80 59.29 -73.04 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.64 -0.663 . . . . 3.36 111.652 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.485 ' N ' ' O ' ' A' ' 61' ' ' PRO . 2.7 pp -63.13 -32.5 73.9 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.062 -1.024 . . . . 2.53 111.26 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.761 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -63.28 -52.17 63.11 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.108 -0.995 . . . . 2.36 109.584 179.333 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.7 m -71.44 -36.08 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.392 -0.817 . . . . 1.96 109.383 178.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.455 ' HB2' ' O ' ' A' ' 62' ' ' PHE . 5.2 tt0 -59.37 -48.39 81.83 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.419 -0.801 . . . . 1.96 109.264 178.451 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.491 ' HA ' ' HG2' ' A' ' 70' ' ' LYS . 2.6 m-85 -69.59 -43.64 72.4 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.579 -0.701 . . . . 2.2 109.369 178.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 75.4 m -59.72 -32.43 70.53 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.951 -0.468 . . . . 1.91 110.588 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.99 -44.26 11.14 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.144 -0.972 . . . . 1.73 110.4 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.491 ' HG2' ' HA ' ' A' ' 67' ' ' TYR . 10.6 ptpt -65.55 -35.8 81.91 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.466 -0.771 . . . . 1.72 111.02 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.417 ' N ' ' HD2' ' A' ' 72' ' ' PRO . . . -49.78 -62.96 4.51 Favored Glycine 0 N--CA 1.501 2.975 0 N-CA-C 109.723 -1.351 . . . . 1.69 109.723 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 71' ' ' GLY . 40.4 Cg_endo -66.49 -33.71 36.19 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 123.79 1.416 . . . . 1.94 110.348 178.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.449 ' HB3' ' HA ' ' A' ' 70' ' ' LYS . 15.1 t -67.42 -47.37 70.45 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.253 -0.904 . . . . 1.85 109.939 178.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.7 t -66.48 -46.34 86.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.663 -0.648 . . . . 1.62 109.301 178.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.473 ' OE2' ' NZ ' ' A' ' 79' ' ' LYS . 5.0 tm-20 -54.95 -42.37 72.25 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 121.367 0.603 . . . . 2.25 109.45 178.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.48 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -62.26 -54.91 33.9 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.499 0.666 . . . . 2.67 109.835 178.83 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.65 -51.51 69.63 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.2 0.524 . . . . 1.66 110.915 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.85 -47.42 80.42 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.882 -0.511 . . . . 1.96 110.68 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -70.27 -38.12 75.02 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.692 -0.803 . . . . 2.58 109.904 179.726 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 tp -62.41 -39.65 93.97 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.429 -0.794 . . . . 2.41 109.396 178.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.564 ' HG3' ' HG3' ' A' ' 6' ' ' MET . 3.1 ttt -74.17 -36.11 64.06 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.749 -0.834 . . . . 2.57 108.749 178.28 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.441 ' HA ' ' CD ' ' A' ' 87' ' ' GLU . 4.4 m 58.52 71.35 1.02 Allowed Pre-proline 0 N--CA 1.498 1.949 0 O-C-N 121.86 -0.525 . . . . 2.88 111.834 179.037 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.598 ' HG2' ' HD2' ' A' ' 86' ' ' PRO . 49.3 Cg_endo -75.33 12.49 1.29 Allowed 'Trans proline' 0 C--N 1.315 -1.2 0 O-C-N 123.388 1.204 . . . . 2.96 111.13 178.001 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 60.49 21.53 11.24 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.205 -0.935 . . . . 3.99 110.506 -179.242 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -111.51 -76.8 0.84 Allowed Glycine 0 N--CA 1.497 2.718 0 N-CA-C 110.088 -1.205 . . . . 4.03 110.088 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.598 ' HD2' ' HG2' ' A' ' 83' ' ' PRO . 46.9 Cg_endo -80.55 -84.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.223 0 O-C-N 123.842 1.443 . . . . 3.95 111.124 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 86' ' ' PRO . 0.4 OUTLIER 64.34 -56.95 0.24 Allowed 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 121.518 0.675 . . . . 3.94 109.86 -179.05 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.524 ' N ' ' O ' ' A' ' 86' ' ' PRO . 8.1 p -102.32 -19.6 5.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 O-C-N 122.021 -0.424 . . . . 5.08 110.009 178.007 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.535 ' CE1' ' HB2' ' A' ' 86' ' ' PRO . 22.7 m80 54.17 47.92 22.08 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.37 -0.831 . . . . 5.56 111.061 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.731 0 CA-C-O 118.018 -1.434 . . . . 6.57 109.636 179.699 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.901 0 N-CA-C 109.576 -1.41 . . . . 2.44 109.576 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.2 p -51.94 -52.47 49.93 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 121.39 -1.065 . . . . 3.9 108.789 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.7 mtt -96.78 127.56 42.88 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.06 -1.089 . . . . 4.28 108.06 177.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 64.9 94.8 0.06 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.407 -0.808 . . . . 2.16 109.294 -178.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.492 HD12 ' C ' ' A' ' 5' ' ' ILE . 1.3 pp -80.12 -165.45 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.394 -0.816 . . . . 2.03 110.275 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 59.4 45.52 13.67 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.284 -0.885 . . . . 2.88 110.689 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.444 ' O ' HG23 ' A' ' 12' ' ' THR . 4.6 m-20 -53.66 -24.32 13.96 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.431 -0.793 . . . . 1.65 111.245 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -93.74 57.47 2.52 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.16 -0.963 . . . . 3.44 109.847 179.093 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.452 ' H ' ' HD2' ' A' ' 10' ' ' PRO . 2.4 m -160.39 -59.5 0.02 OUTLIER Pre-proline 0 N--CA 1.499 1.976 0 O-C-N 121.066 -1.021 . . . . 1.75 112.075 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.576 ' HG2' HG22 ' A' ' 12' ' ' THR . 47.8 Cg_endo -72.26 -155.06 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.615 0 O-C-N 123.318 1.168 . . . . 1.27 111.7 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.7 p -55.11 -51.53 66.13 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.247 -0.908 . . . . 1.67 110.303 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.576 HG22 ' HG2' ' A' ' 10' ' ' PRO . 10.7 t -57.46 -28.46 63.39 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.383 -0.823 . . . . 1.38 110.075 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.725 ' O ' HG22 ' A' ' 17' ' ' VAL . . . -75.14 -58.71 3.88 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.501 -1.44 . . . . 0.99 109.501 179.063 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.495 ' HA ' ' CG2' ' A' ' 17' ' ' VAL . 27.7 m -57.79 -33.06 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.612 -0.934 . . . . 1.38 109.94 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.607 ' HA ' HG12 ' A' ' 18' ' ' ILE . 37.3 t -72.03 -40.66 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.915 -1.116 . . . . 1.2 109.15 178.068 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 42.7 m -59.04 -49.78 76.59 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.267 -0.895 . . . . 1.17 109.66 178.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.725 HG22 ' O ' ' A' ' 13' ' ' GLY . 2.8 m -64.57 -43.41 96.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.604 -0.685 . . . . 1.53 111.492 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.607 HG12 ' HA ' ' A' ' 15' ' ' VAL . 2.1 pt -66.94 -32.34 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 120.153 -1.592 . . . . 1.24 110.037 179.138 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.47 ' N ' HG13 ' A' ' 18' ' ' ILE . 40.0 t -69.65 -47.63 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 108.044 -1.095 . . . . 1.05 108.044 177.615 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 69.6 mt -60.37 -46.2 95.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 N-CA-C 108.609 -0.885 . . . . 1.25 108.609 177.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.574 ' HA ' HG12 ' A' ' 24' ' ' ILE . 4.0 mt -59.36 -51.23 70.79 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.228 -0.656 . . . . 1.53 109.228 178.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.2 mt -56.46 -37.87 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.256 -0.902 . . . . 1.37 109.167 178.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.79 -52.0 42.21 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.585 -0.697 . . . . 1.08 110.797 179.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.574 HG12 ' HA ' ' A' ' 21' ' ' LEU . 39.4 pt -62.34 -37.27 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.872 -1.142 . . . . 1.43 109.201 179.311 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.496 ' N ' HG13 ' A' ' 24' ' ' ILE . . . -64.8 -45.84 84.58 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.533 -0.729 . . . . 1.13 109.118 178.122 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.03 -43.34 99.05 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.891 -0.781 . . . . 1.12 108.891 178.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.4 -47.08 87.42 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.909 -0.775 . . . . 1.45 108.909 178.146 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.0 -45.97 93.14 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 108.636 -1.786 . . . . 1.02 108.636 178.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.27 -44.83 96.59 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.595 -0.944 . . . . 0.98 109.623 178.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.6 mt -58.86 -40.1 83.3 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.787 -0.57 . . . . 1.3 109.503 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.7 mt -68.84 -46.64 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.498 -0.751 . . . . 1.37 109.323 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.05 -45.39 94.96 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.442 -0.786 . . . . 1.66 109.904 179.169 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.7 -49.13 75.87 Favored Glycine 0 N--CA 1.499 2.848 0 N-CA-C 109.494 -1.442 . . . . 0.78 109.494 179.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.7 t -60.82 -40.45 92.82 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.526 -0.985 . . . . 1.55 109.531 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.497 ' HA ' HD23 ' A' ' 38' ' ' LEU . 61.1 t90 -66.21 -51.34 58.61 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.391 -0.818 . . . . 1.17 109.86 179.169 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 62.57 -67.35 0.08 Allowed 'General case' 0 N--CA 1.506 2.358 0 O-C-N 121.991 -0.443 . . . . 1.26 111.079 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.466 ' N ' ' O ' ' A' ' 35' ' ' TRP . 0.2 OUTLIER 179.66 38.85 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.712 -0.618 . . . . 2.04 110.206 179.577 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.497 HD23 ' HA ' ' A' ' 35' ' ' TRP . 0.9 OUTLIER -85.42 -10.69 55.86 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.996 -1.065 . . . . 1.61 111.487 -179.709 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.468 ' HG2' HD12 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -143.43 -104.16 0.12 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.947 -1.095 . . . . 2.82 110.51 179.277 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -156.79 22.6 0.33 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.784 -1.197 . . . . 2.01 112.032 -179.322 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -80.02 43.39 0.6 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.854 -1.154 . . . . 1.94 111.041 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.481 ' NH2' ' OG ' ' A' ' 68' ' ' SER . 2.2 tpm_? -84.63 -65.92 0.95 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.036 -1.04 . . . . 1.15 109.358 179.257 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.436 HG13 ' H ' ' A' ' 44' ' ' SER . 1.2 pt -65.92 -33.62 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 122.115 0.96 . . . . 1.57 109.552 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.436 ' H ' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -73.62 72.39 1.44 Allowed 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 115.589 -0.732 . . . . 1.25 110.622 -179.958 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -76.2 -23.43 54.65 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.45 -0.781 . . . . 1.17 110.423 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 50.23 39.04 18.89 Favored 'General case' 0 N--CA 1.506 2.361 0 O-C-N 121.365 -0.834 . . . . 1.37 111.922 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.431 ' HG2' ' NH2' ' A' ' 76' ' ' ARG . 1.4 pm0 -81.74 -177.66 6.65 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.253 -0.904 . . . . 1.13 110.229 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -68.79 -179.88 1.57 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.999 -1.063 . . . . 2.3 110.381 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.564 ' HA ' ' HG2' ' A' ' 76' ' ' ARG . 43.6 mm-40 -74.51 100.84 3.98 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.951 -1.093 . . . . 1.46 109.808 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.537 ' CD ' HG22 ' A' ' 53' ' ' VAL . 2.5 tm-20 -116.44 155.01 29.3 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 122.134 0.969 . . . . 1.89 111.231 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -174.25 -10.49 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.417 0 N-CA-C 112.842 0.682 . . . . 1.23 112.842 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 39.6 mm -82.62 -42.21 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.566 -1.333 . . . . 1.94 110.211 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.537 HG22 ' CD ' ' A' ' 50' ' ' GLU . 12.4 m -95.97 -40.93 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.228 -0.92 . . . . 1.87 111.151 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.584 ' HA3' ' SG ' ' A' ' 73' ' ' CYS . . . -50.88 -44.53 49.55 Favored Glycine 0 N--CA 1.5 2.951 0 N-CA-C 110.414 -1.074 . . . . 1.08 110.414 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -105.9 27.72 8.27 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.355 -1.085 . . . . 0.93 110.159 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -133.43 -34.01 0.33 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.799 -1.72 . . . . 0.91 108.799 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.47 -36.25 68.87 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.43 -1.041 . . . . 2.49 110.179 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.0 m 52.36 44.48 29.81 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.414 -0.804 . . . . 1.47 110.299 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.53 179.29 4.5 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.543 -0.723 . . . . 1.85 110.082 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 53.12 79.25 0.35 Allowed Pre-proline 0 N--CA 1.503 2.19 0 O-C-N 121.589 -0.695 . . . . 1.66 111.202 179.257 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -74.58 11.47 1.32 Allowed 'Trans proline' 0 N--CA 1.493 1.45 0 O-C-N 123.502 1.264 . . . . 1.81 112.866 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.486 ' HB2' HG22 ' A' ' 65' ' ' VAL . 45.2 m-85 -88.77 144.2 26.4 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.467 -1.395 . . . . 2.54 110.441 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.1 mt -58.16 -37.62 75.04 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.165 -0.959 . . . . 1.59 110.963 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.491 ' O ' ' HB2' ' A' ' 68' ' ' SER . 0.1 OUTLIER -53.97 -59.01 5.2 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.826 -0.546 . . . . 1.62 109.977 179.363 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.486 HG22 ' HB2' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -69.12 -36.49 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.549 -0.719 . . . . 1.62 110.225 179.606 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.483 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -56.33 -52.88 62.93 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.463 -0.773 . . . . 2.12 109.332 178.793 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.533 ' HA ' ' HG2' ' A' ' 70' ' ' LYS . 9.0 m-85 -69.94 -39.04 76.31 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.556 -0.715 . . . . 1.57 109.539 178.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.491 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 8.4 t -57.82 -41.01 81.34 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.814 -0.554 . . . . 0.88 110.403 178.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.68 -47.2 8.85 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.159 -0.963 . . . . 0.73 110.964 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.551 ' HA ' ' HB2' ' A' ' 73' ' ' CYS . 6.3 ptpt -66.11 -34.88 79.06 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.396 -0.815 . . . . 1.45 111.306 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.417 ' N ' ' HD2' ' A' ' 72' ' ' PRO . . . -46.69 -63.31 3.19 Favored Glycine 0 N--CA 1.503 3.159 0 N-CA-C 109.543 -1.423 . . . . 0.78 109.543 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.545 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 40.5 Cg_endo -67.28 -47.83 2.04 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.929 1.489 . . . . 0.85 109.78 178.486 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.584 ' SG ' ' HA3' ' A' ' 54' ' ' GLY . 4.0 m -53.26 -39.95 64.25 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.15 -0.969 . . . . 0.94 110.053 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 1.069 HG11 HG11 ' A' ' 88' ' ' VAL . 24.1 t -74.32 -46.38 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 108.833 -0.803 . . . . 1.02 108.833 178.429 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.11 -43.23 70.25 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 121.505 0.669 . . . . 1.17 109.258 178.457 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.564 ' HG2' ' HA ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -63.3 -50.44 70.04 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.945 -0.761 . . . . 1.2 108.945 178.52 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.8 mttp -56.11 -44.84 79.48 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 109.167 -0.679 . . . . 1.23 109.167 178.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.486 ' HA ' ' CA ' ' A' ' 82' ' ' THR . . . -55.6 -52.21 64.55 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.415 -0.587 . . . . 1.41 109.415 178.296 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 36.3 mtpt -58.88 -44.32 91.09 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.067 0.461 . . . . 1.56 109.837 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.87 -62.88 1.29 Allowed 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.573 0.702 . . . . 2.58 110.692 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.443 ' O ' ' OG1' ' A' ' 82' ' ' THR . 1.5 ttt -158.63 60.41 0.43 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.527 -0.733 . . . . 3.01 109.829 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.486 ' CA ' ' HA ' ' A' ' 78' ' ' ALA . 3.5 p 67.83 147.14 0.11 Allowed Pre-proline 0 N--CA 1.517 2.908 0 O-C-N 121.928 -0.482 . . . . 1.58 110.765 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.482 ' CB ' HG13 ' A' ' 74' ' ' VAL . 50.6 Cg_endo -76.2 -22.24 12.96 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.742 1.391 . . . . 1.52 111.17 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 53.87 28.67 8.71 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.677 -0.64 . . . . 1.86 110.374 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -138.51 99.03 0.26 Allowed Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.048 -1.221 . . . . 1.35 110.048 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.05 -18.13 56.25 Favored 'Trans proline' 0 N--CA 1.491 1.366 0 O-C-N 123.754 1.397 . . . . 1.59 111.224 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -53.85 -34.8 60.43 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.226 -0.921 . . . . 1.55 109.999 178.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 1.069 HG11 HG11 ' A' ' 74' ' ' VAL . 7.2 p -114.45 -25.53 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.871 -0.518 . . . . 2.2 110.64 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -162.94 -72.09 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.966 -1.084 . . . . 3.65 110.603 179.462 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.705 0 CA-C-O 117.865 -1.52 . . . . 1.94 109.929 -179.762 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.935 0 N-CA-C 109.311 -1.516 . . . . 7.78 109.311 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.3 m -86.78 149.12 25.07 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.881 -1.364 . . . . 5.91 110.571 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.501 ' SD ' HD11 ' A' ' 5' ' ' ILE . 1.9 mmt -104.7 118.71 37.26 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.077 -1.014 . . . . 8.53 113.401 -177.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.6 m -111.39 6.19 20.18 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.303 -1.369 . . . . 4.17 107.303 175.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.501 HD11 ' SD ' ' A' ' 3' ' ' MET . 0.6 OUTLIER -77.63 -153.41 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.578 -0.701 . . . . 3.67 109.87 179.843 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 50.12 25.48 1.75 Allowed 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.85 -0.796 . . . . 4.83 108.85 -179.198 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.574 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 0.8 OUTLIER -58.22 -29.23 65.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.72 -0.613 . . . . 2.92 110.377 -178.812 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.511 ' CB ' ' O ' ' A' ' 7' ' ' ASP . 6.9 t-80 77.69 4.23 2.99 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 122.076 -0.39 . . . . 2.83 110.754 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.546 ' N ' ' HD3' ' A' ' 10' ' ' PRO . 3.3 t 47.99 48.22 5.63 Favored Pre-proline 0 N--CA 1.497 1.921 0 O-C-N 121.52 -0.737 . . . . 2.57 112.324 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.574 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 52.0 Cg_endo -81.09 -46.65 0.08 OUTLIER 'Trans proline' 0 C--N 1.32 -0.972 0 O-C-N 123.379 1.2 . . . . 2.85 109.756 179.103 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.477 HG23 ' N ' ' A' ' 12' ' ' THR . 3.9 t -147.69 -44.76 0.17 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.978 -0.451 . . . . 2.79 109.818 179.349 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.477 ' N ' HG23 ' A' ' 11' ' ' THR . 0.0 OUTLIER -56.68 -45.74 81.56 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.318 -0.864 . . . . 3.38 110.349 179.285 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.611 ' O ' HG22 ' A' ' 17' ' ' VAL . . . -62.16 -48.68 81.22 Favored Glycine 0 N--CA 1.499 2.863 0 N-CA-C 109.249 -1.541 . . . . 2.33 109.249 179.004 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 55.1 t -62.33 -37.14 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.513 -0.993 . . . . 1.81 109.924 179.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.413 ' O ' HG22 ' A' ' 19' ' ' VAL . 29.7 t -69.87 -51.67 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.102 -0.999 . . . . 2.93 110.462 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.6 p -55.67 -49.77 72.03 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.806 -0.559 . . . . 2.98 110.252 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.611 HG22 ' O ' ' A' ' 13' ' ' GLY . 28.8 m -65.2 -35.31 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.136 -0.978 . . . . 1.97 110.081 179.12 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.428 HD13 ' HA ' ' A' ' 18' ' ' ILE . 5.6 mm -68.18 -48.69 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 120.958 -1.088 . . . . 2.25 110.431 179.303 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 15' ' ' VAL . 32.6 m -63.52 -36.8 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 C-N-CA 118.973 -1.091 . . . . 2.87 108.966 178.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 58.9 mt -66.54 -48.77 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.268 -0.895 . . . . 2.58 108.678 177.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 13.1 mt -58.95 -49.31 78.34 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.928 -0.767 . . . . 1.69 108.928 178.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 29.7 mt -56.29 -43.61 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 C-N-CA 119.992 -0.683 . . . . 2.66 109.457 178.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.34 -45.95 85.59 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.474 -0.766 . . . . 2.41 109.731 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.4 mt -59.02 -46.5 91.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.394 -0.816 . . . . 1.84 109.021 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.54 -45.35 90.96 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.556 -0.715 . . . . 1.83 109.841 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.08 -43.94 95.12 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.549 -0.719 . . . . 2.45 109.312 178.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.858 ' HA ' HD23 ' A' ' 30' ' ' LEU . 0.4 OUTLIER -63.25 -47.13 83.73 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.876 -0.787 . . . . 2.36 108.876 178.333 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.61 -41.6 95.71 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 108.636 -1.786 . . . . 1.6 108.636 178.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.05 -47.0 75.8 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.517 -0.99 . . . . 2.18 110.306 179.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.858 HD23 ' HA ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -62.27 -37.21 84.61 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.615 -0.678 . . . . 2.61 109.722 179.401 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.537 ' N ' ' HG ' ' A' ' 30' ' ' LEU . 9.7 mt -71.02 -46.95 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.304 -0.872 . . . . 1.91 109.002 178.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.871 ' CD1' HD11 ' A' ' 52' ' ' ILE . 1.4 tp -58.83 -46.86 86.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.651 -0.655 . . . . 2.27 109.704 178.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -60.49 -57.9 16.66 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 109.345 -1.502 . . . . 2.19 109.345 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.515 ' SG ' HD12 ' A' ' 38' ' ' LEU . 0.5 OUTLIER -53.59 -42.33 67.52 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.406 -1.055 . . . . 3.03 110.273 179.314 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.535 ' HA ' ' HA ' ' A' ' 39' ' ' ARG . 57.3 t90 -67.27 -56.24 10.65 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.493 -0.755 . . . . 1.75 111.115 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -63.35 -24.09 67.7 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.307 -0.871 . . . . 2.38 111.937 -179.388 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.443 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 0.3 OUTLIER -98.47 -48.04 5.17 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.958 -1.089 . . . . 4.4 111.374 -179.345 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.515 HD12 ' SG ' ' A' ' 34' ' ' CYS . 2.5 mt -109.67 -37.72 5.6 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.113 -0.992 . . . . 2.84 110.715 -179.381 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.535 ' HA ' ' HA ' ' A' ' 35' ' ' TRP . 0.0 OUTLIER 52.79 47.35 24.87 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.772 -0.58 . . . . 1.94 110.622 -179.513 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 42' ' ' ARG . 0.5 OUTLIER -80.24 -63.91 1.3 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.015 -1.053 . . . . 3.12 111.887 -179.409 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.415 ' CB ' ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER 68.84 -49.27 0.58 Allowed 'General case' 0 N--CA 1.506 2.368 0 O-C-N 121.342 -0.849 . . . . 2.69 109.584 -177.708 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.439 ' N ' ' O ' ' A' ' 40' ' ' LEU . 2.4 ttm105 -149.03 -146.95 0.21 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.436 -0.95 . . . . 3.24 108.436 178.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.259 0.3 OUTLIER -62.39 -24.02 33.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 O-C-N 120.77 -1.206 . . . . 3.63 110.1 178.805 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.41 ' OG ' ' N ' ' A' ' 45' ' ' GLN . 88.8 p -172.9 -64.86 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.776 -0.577 . . . . 2.65 109.621 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.41 ' N ' ' OG ' ' A' ' 44' ' ' SER . 0.0 OUTLIER 46.63 58.57 4.53 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.77 -0.581 . . . . 2.61 111.386 179.469 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.02 35.86 0.54 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.83 -1.169 . . . . 2.73 110.976 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -94.9 -177.36 4.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.003 -1.061 . . . . 2.92 110.809 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.76 98.79 0.07 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.43 -0.794 . . . . 2.9 109.989 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -145.12 146.78 31.94 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.275 -0.891 . . . . 1.97 110.576 -179.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.519 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -134.79 -175.34 3.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.291 -0.881 . . . . 2.14 110.891 -179.57 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.2 t -133.95 -34.3 1.0 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.6 -0.688 . . . . 1.9 111.087 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.871 HD11 ' CD1' ' A' ' 32' ' ' LEU . 37.1 mm -88.76 -53.66 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.252 -0.905 . . . . 2.37 110.19 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.47 HG12 ' O ' ' A' ' 55' ' ' ASP . 96.0 t -92.31 -66.77 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.507 -0.746 . . . . 2.12 109.401 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.31 -62.25 2.65 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 108.589 -1.805 . . . . 1.75 108.589 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.47 ' O ' HG12 ' A' ' 53' ' ' VAL . 1.1 t0 -79.83 -163.72 0.57 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.761 -0.847 . . . . 2.28 109.705 178.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 140.89 -58.8 0.57 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 108.874 -1.69 . . . . 1.76 108.874 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -124.81 20.66 8.43 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.68 -0.894 . . . . 2.53 110.505 179.109 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.8 m -70.42 56.02 0.16 Allowed 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.122 -0.986 . . . . 2.03 110.288 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.97 -162.15 1.1 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.405 -0.961 . . . . 3.27 108.405 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 60.96 105.76 0.03 OUTLIER Pre-proline 0 N--CA 1.502 2.142 0 O-C-N 121.37 -0.832 . . . . 4.47 111.171 178.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -68.23 55.66 0.79 Allowed 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 120.83 1.02 . . . . 3.07 110.512 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.465 ' O ' ' HB2' ' A' ' 66' ' ' GLN . 1.1 m-85 -74.24 163.49 27.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.315 -0.865 . . . . 4.86 109.553 179.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.2 mt -54.89 -40.45 69.79 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.914 -1.117 . . . . 3.35 110.554 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.21 -52.63 64.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.707 -0.621 . . . . 4.71 110.025 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.41 ' HA ' ' HB2' ' A' ' 68' ' ' SER . 14.8 t -68.64 -33.67 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.259 -0.9 . . . . 3.55 109.392 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.483 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -59.25 -57.84 11.26 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.764 -0.828 . . . . 2.72 108.764 179.107 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -62.55 -40.95 98.47 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.684 -0.635 . . . . 3.62 109.608 178.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.413 ' O ' ' CD ' ' A' ' 72' ' ' PRO . 71.2 m -59.93 -41.33 91.55 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.824 -0.547 . . . . 3.82 110.209 179.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -81.37 -41.79 21.46 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.206 -0.934 . . . . 2.79 110.488 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 66' ' ' GLN . 1.8 mmtp -61.38 -47.16 87.09 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.467 -0.771 . . . . 2.29 110.687 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 75' ' ' GLU . . . -41.71 -66.45 0.99 Allowed Glycine 0 N--CA 1.503 3.116 0 N-CA-C 110.544 -1.022 . . . . 2.86 110.544 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.528 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 41.3 Cg_endo -65.81 -39.84 18.83 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.788 1.415 . . . . 2.89 110.56 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 6.5 t -60.63 -43.32 97.64 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.033 -1.042 . . . . 2.15 109.325 178.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 69.1 t -70.94 -44.98 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 109.112 -0.699 . . . . 2.85 109.112 178.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 0.6 OUTLIER -56.48 -42.48 78.35 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.614 0.721 . . . . 3.2 109.444 178.629 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.528 ' HD2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -66.09 -50.45 64.02 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.624 -0.673 . . . . 3.03 109.731 179.05 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -41.21 80.16 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 120.208 -0.597 . . . . 2.94 109.655 179.238 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.88 -43.23 84.04 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 122.062 -0.399 . . . . 2.67 110.044 179.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.427 ' HA ' ' CE ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -68.39 -48.54 64.42 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.607 -0.683 . . . . 3.36 109.893 179.326 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.1 tp -57.17 -47.1 82.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.486 -0.759 . . . . 2.06 109.56 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -68.63 -55.02 12.9 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.591 0.71 . . . . 3.75 109.514 178.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.75 98.54 27.84 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.775 -0.578 . . . . 4.46 109.453 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.404 ' O ' ' CB ' ' A' ' 84' ' ' ASN . 43.7 Cg_endo -67.95 -10.11 27.81 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.465 1.245 . . . . 3.66 110.413 178.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.567 ' HB3' ' HB2' ' A' ' 87' ' ' GLU . 2.0 t-20 71.22 -45.83 0.62 Allowed 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.686 -0.634 . . . . 4.98 110.656 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.73 -85.42 0.39 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 108.719 -1.753 . . . . 5.0 108.719 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.44 ' HA ' ' H ' ' A' ' 90' ' ' GLY . 51.0 Cg_endo -76.76 -21.05 12.99 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.734 1.386 . . . . 6.06 111.39 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.567 ' HB2' ' HB3' ' A' ' 84' ' ' ASN . 1.1 tt0 -58.58 -44.99 89.97 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.862 -1.149 . . . . 4.99 110.36 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.5 m -92.7 -9.89 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.499 -0.751 . . . . 5.62 110.687 178.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -111.23 -61.24 1.72 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.214 -0.929 . . . . 7.69 110.706 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.44 ' H ' ' HA ' ' A' ' 86' ' ' PRO . . . . . . . . 0 N--CA 1.493 2.474 0 N-CA-C 109.08 -1.608 . . . . 6.79 109.08 -179.141 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.5 ' N ' ' OG1' ' A' ' 16' ' ' THR . . . . . . . . 0 N--CA 1.494 2.53 0 N-CA-C 110.402 -1.079 . . . . 2.42 110.402 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.9 p -104.61 5.44 33.73 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.186 -1.185 . . . . 3.84 111.826 -179.431 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.1 mtt -106.46 161.49 14.54 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.947 -1.096 . . . . 3.98 110.09 179.835 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.71 29.16 0.92 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.072 -1.017 . . . . 2.61 111.233 -179.877 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -53.1 -43.14 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.509 -0.744 . . . . 2.15 111.112 179.367 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.4 mmt 53.2 59.73 4.22 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.379 0.609 . . . . 3.14 110.663 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.476 ' HB3' ' CG ' ' A' ' 10' ' ' PRO . 8.1 m-20 -57.22 -33.06 67.14 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.394 -0.817 . . . . 2.85 110.18 179.643 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 28.0 t-80 50.31 46.97 24.51 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.745 -0.597 . . . . 2.62 111.593 179.391 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.497 ' CB ' ' CD ' ' A' ' 10' ' ' PRO . 0.9 OUTLIER -177.0 -63.03 0.0 OUTLIER Pre-proline 0 N--CA 1.499 2.002 0 O-C-N 121.325 -0.859 . . . . 2.16 110.806 179.275 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 9' ' ' SER . 47.7 Cg_endo -73.28 170.44 19.87 Favored 'Trans proline' 0 N--CA 1.487 1.146 0 O-C-N 123.33 1.173 . . . . 1.96 110.899 179.771 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.9 t -59.86 -30.13 68.76 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.247 -0.908 . . . . 2.02 110.867 179.8 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.6 p -60.1 -35.65 75.69 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.93 -1.107 . . . . 2.12 109.751 178.705 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.584 ' O ' HG22 ' A' ' 17' ' ' VAL . . . -73.84 -51.91 8.7 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 108.743 -1.743 . . . . 1.51 108.743 178.891 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.503 ' O ' HG23 ' A' ' 18' ' ' ILE . 53.8 t -57.18 -37.99 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.705 -0.88 . . . . 1.28 109.89 178.939 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.536 ' O ' HG13 ' A' ' 18' ' ' ILE . 43.2 t -72.63 -37.43 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.031 -1.043 . . . . 1.57 109.416 178.998 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.5 ' OG1' ' N ' ' A' ' 1' ' ' GLY . 59.5 m -62.17 -50.25 72.59 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.286 -0.884 . . . . 1.43 109.712 178.588 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.584 HG22 ' O ' ' A' ' 13' ' ' GLY . 30.9 m -67.24 -41.86 87.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.655 -0.653 . . . . 0.99 111.643 -179.502 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.536 HG13 ' O ' ' A' ' 15' ' ' VAL . 2.1 pp -67.69 -30.42 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 120.303 -1.498 . . . . 1.27 109.764 179.138 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.6 t -68.99 -52.2 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.233 -0.917 . . . . 1.25 108.782 178.143 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.577 HG12 ' HA ' ' A' ' 17' ' ' VAL . 44.9 pt -63.96 -37.53 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.162 -0.961 . . . . 1.01 109.083 178.668 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.485 ' N ' HG13 ' A' ' 20' ' ' ILE . 9.9 mt -64.85 -48.34 74.68 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.395 -0.816 . . . . 1.02 109.0 178.028 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.45 HD13 ' HA ' ' A' ' 22' ' ' ILE . 8.0 mm -59.19 -43.57 89.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.317 -0.865 . . . . 1.21 108.873 178.481 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.85 -46.66 88.5 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.387 -0.597 . . . . 0.9 109.387 178.711 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.414 HD13 ' HA ' ' A' ' 24' ' ' ILE . 8.4 mm -59.97 -45.44 95.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.306 -0.871 . . . . 1.14 108.892 178.386 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.67 -45.4 94.18 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.579 -0.7 . . . . 0.88 109.613 178.751 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.74 -44.94 96.03 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.58 -0.7 . . . . 0.96 109.138 178.593 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.4 tt -61.96 -45.92 91.54 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.898 -0.779 . . . . 1.28 108.898 178.192 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.38 -44.09 95.39 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 108.712 -1.755 . . . . 1.11 108.712 178.651 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.28 -46.28 84.36 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.428 -1.042 . . . . 1.13 109.668 178.912 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.1 mt -56.89 -41.29 77.79 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 109.179 -0.675 . . . . 1.46 109.179 178.719 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.41 HD13 ' HA ' ' A' ' 31' ' ' ILE . 26.6 mm -70.2 -44.9 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.53 -0.731 . . . . 1.46 109.525 178.853 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.496 ' HA ' ' HD1' ' A' ' 35' ' ' TRP . 0.2 OUTLIER -58.17 -48.52 80.05 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.508 -0.745 . . . . 2.28 109.891 179.285 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.403 ' HA2' ' CG ' ' A' ' 39' ' ' ARG . . . -68.03 -41.68 86.78 Favored Glycine 0 N--CA 1.499 2.838 0 N-CA-C 110.471 -1.051 . . . . 1.5 110.471 179.773 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 9.8 t -64.38 -41.41 96.7 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.395 -1.062 . . . . 1.95 111.011 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.496 ' HD1' ' HA ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -84.53 -34.43 23.3 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.094 -1.004 . . . . 2.71 110.764 -179.808 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.421 ' HB2' ' CE2' ' A' ' 35' ' ' TRP . 2.5 t -128.27 101.72 6.36 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.006 -1.059 . . . . 2.25 109.995 179.414 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -52.78 -43.15 65.65 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.308 -0.87 . . . . 4.17 110.826 -179.784 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.48 -10.69 59.81 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.933 -1.104 . . . . 2.49 111.074 179.499 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.403 ' CG ' ' HA2' ' A' ' 33' ' ' GLY . 10.2 mtm105 43.64 41.18 3.36 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.621 -0.674 . . . . 2.08 111.254 179.235 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 46.75 46.83 15.17 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.649 -0.657 . . . . 2.73 110.921 -179.673 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -69.33 -1.07 7.28 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.035 -1.041 . . . . 2.7 112.118 -179.533 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.725 ' HG3' HG23 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -80.58 -60.03 2.47 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.627 -1.296 . . . . 4.11 108.723 178.549 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.725 HG23 ' HG3' ' A' ' 42' ' ' ARG . 13.7 pt -103.32 -38.46 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.534 -0.729 . . . . 3.1 110.141 178.782 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.489 ' N ' HG13 ' A' ' 43' ' ' ILE . 5.1 t 61.84 -76.6 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.498 0 O-C-N 122.154 -0.342 . . . . 2.61 110.923 -179.474 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -165.72 -176.3 3.83 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.149 -0.97 . . . . 2.43 110.241 179.655 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.5 m -155.3 35.5 0.38 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.852 -1.155 . . . . 3.47 110.606 179.736 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -98.92 162.38 13.12 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.313 -0.867 . . . . 2.76 109.63 179.573 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.454 ' O ' ' N ' ' A' ' 50' ' ' GLU . 21.6 t70 -65.05 -57.29 9.02 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.233 -0.917 . . . . 2.28 109.646 179.389 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 62.39 -64.68 0.09 Allowed 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.896 -0.502 . . . . 2.68 111.897 179.161 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.454 ' N ' ' O ' ' A' ' 48' ' ' ASP . 3.8 tp10 -136.8 120.79 17.65 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.006 -1.059 . . . . 2.36 110.706 179.958 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 96.0 p -155.22 -57.52 0.1 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.351 -0.843 . . . . 2.06 111.56 -179.406 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.7 mt -78.09 -59.7 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.655 -0.653 . . . . 2.21 111.081 -178.673 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.1 p -66.91 -46.81 84.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.496 -0.752 . . . . 1.88 110.985 -179.244 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 63.48 30.12 76.64 Favored Glycine 0 N--CA 1.496 2.664 0 N-CA-C 109.519 -1.433 . . . . 1.4 109.519 -179.499 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.408 ' HB3' ' CB ' ' A' ' 62' ' ' PHE . 21.5 m-20 54.42 84.55 0.07 Allowed 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 121.953 0.882 . . . . 2.06 110.698 -179.551 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -165.25 -48.33 0.02 OUTLIER Glycine 0 N--CA 1.496 2.653 0 N-CA-C 108.227 -1.949 . . . . 1.23 108.227 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -96.45 -48.8 5.42 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.776 -0.837 . . . . 2.17 109.249 178.529 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -119.58 179.12 4.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.627 -0.671 . . . . 1.33 109.228 178.699 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.11 -156.57 0.34 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.522 -0.736 . . . . 1.86 109.581 -179.356 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.497 ' HG2' ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -63.36 144.35 97.58 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 121.005 -1.059 . . . . 1.62 110.398 -179.742 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.497 ' HD2' ' HG2' ' A' ' 60' ' ' GLU . 38.1 Cg_endo -63.62 -33.12 68.24 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 O-C-N 123.424 1.223 . . . . 1.12 110.444 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.408 ' CB ' ' HB3' ' A' ' 55' ' ' ASP . 24.6 t80 32.55 -90.85 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.346 0 N-CA-C 112.334 0.494 . . . . 2.5 112.334 178.933 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.455 ' HA ' ' HB2' ' A' ' 66' ' ' GLN . 1.6 mt -57.36 -33.21 67.55 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.997 -1.065 . . . . 2.02 111.099 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.432 ' HB3' ' HB2' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -60.1 -56.52 20.65 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.445 -0.784 . . . . 1.48 109.844 179.347 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.423 ' HA ' ' HB2' ' A' ' 68' ' ' SER . 33.7 m -71.52 -32.0 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.041 -1.037 . . . . 1.27 110.034 179.137 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.502 ' OE1' ' NZ ' ' A' ' 70' ' ' LYS . 2.6 mt-30 -60.66 -45.48 93.97 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.362 -0.836 . . . . 2.6 109.491 178.465 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -74.26 -41.42 61.31 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.654 0.74 . . . . 3.61 109.463 178.624 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.423 ' HB2' ' HA ' ' A' ' 65' ' ' VAL . 64.0 m -59.2 -28.54 66.74 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 122.002 -0.436 . . . . 1.15 110.938 179.77 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -95.59 -43.99 7.69 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.082 -1.011 . . . . 1.54 111.013 -179.651 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.502 ' NZ ' ' OE1' ' A' ' 66' ' ' GLN . 15.2 mtmt -70.06 -39.83 75.43 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.408 -0.808 . . . . 3.36 111.109 -179.394 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.422 ' N ' ' HD2' ' A' ' 72' ' ' PRO . . . -46.0 -61.11 4.11 Favored Glycine 0 N--CA 1.503 3.106 0 N-CA-C 109.603 -1.399 . . . . 1.07 109.603 179.821 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.591 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 42.1 Cg_endo -67.74 -43.37 5.45 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 O-C-N 123.801 1.421 . . . . 1.02 109.751 178.462 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 9.1 t -53.75 -44.77 70.23 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.906 -1.121 . . . . 2.16 110.202 179.055 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.5 t -72.68 -45.96 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.337 -0.852 . . . . 1.72 109.05 178.786 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.433 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 1.3 tm-20 -53.6 -42.59 67.83 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.6 0.714 . . . . 1.28 109.96 178.642 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.62 ' HA ' ' CD ' ' A' ' 79' ' ' LYS . 0.9 OUTLIER -72.74 -45.55 58.14 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.673 -0.642 . . . . 1.79 110.997 179.85 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.485 ' HG3' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -67.27 -28.79 68.32 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.121 -0.987 . . . . 1.82 109.984 179.594 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.485 ' N ' ' HG3' ' A' ' 77' ' ' LYS . . . -75.56 -52.36 10.79 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.426 -0.796 . . . . 1.18 109.485 179.265 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.62 ' CD ' ' HA ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -64.84 -28.95 69.9 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.622 -0.674 . . . . 1.63 111.332 179.903 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.555 ' N ' ' HG2' ' A' ' 79' ' ' LYS . 2.6 tp -87.93 -36.58 17.04 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.23 -0.919 . . . . 2.11 112.166 -178.975 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -110.88 -38.76 5.02 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.91 -1.119 . . . . 3.5 112.425 -178.659 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 37.0 p -132.27 68.02 79.42 Favored Pre-proline 0 N--CA 1.506 2.352 0 O-C-N 120.533 -1.354 . . . . 1.89 111.687 -179.303 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.444 ' O ' ' N ' ' A' ' 85' ' ' GLY . 39.0 Cg_endo -64.48 -23.9 64.28 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 O-C-N 123.505 1.266 . . . . 2.1 111.086 179.397 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.5 t30 66.05 -53.52 0.39 Allowed 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.774 -0.579 . . . . 3.2 110.46 -179.822 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 83' ' ' PRO . . . -138.6 86.28 0.22 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.104 -1.598 . . . . 2.79 109.104 179.237 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -61.15 -17.45 52.45 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 O-C-N 123.676 1.356 . . . . 3.33 110.575 179.361 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -55.77 -37.52 68.67 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.53 -0.732 . . . . 4.51 109.474 178.253 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -98.11 -24.6 4.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.739 -0.601 . . . . 4.57 110.107 179.891 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 57.64 -161.39 0.23 Allowed 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.556 -0.715 . . . . 3.4 110.14 -179.797 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.413 ' OXT' ' NZ ' ' A' ' 79' ' ' LYS . . . . . . . . 0 N--CA 1.489 2.207 0 N-CA-C 109.471 -1.452 . . . . 2.38 109.471 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 3.279 0 N-CA-C 110.464 -1.055 . . . . 4.81 110.464 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.492 ' OG ' ' N ' ' A' ' 3' ' ' MET . 15.9 t 50.82 -144.88 0.52 Allowed 'General case' 0 N--CA 1.506 2.332 0 O-C-N 121.442 -1.034 . . . . 5.55 109.795 -179.403 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.492 ' N ' ' OG ' ' A' ' 2' ' ' SER . 0.1 OUTLIER -77.71 46.24 0.54 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.824 -1.172 . . . . 5.5 109.581 178.74 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.6 m -155.08 86.18 1.1 Allowed 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.102 -0.703 . . . . 3.25 109.102 -179.759 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.447 ' O ' ' N ' ' A' ' 7' ' ' ASP . 0.6 OUTLIER -77.71 -143.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.767 -0.827 . . . . 3.34 108.767 179.761 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.402 ' O ' ' N ' ' A' ' 8' ' ' HIS . 0.1 OUTLIER 64.5 -60.7 0.21 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.372 -0.83 . . . . 3.52 111.95 179.142 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.447 ' N ' ' O ' ' A' ' 5' ' ' ILE . 0.2 OUTLIER 66.26 -45.45 0.42 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.768 -0.583 . . . . 3.44 110.376 -178.684 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.402 ' N ' ' O ' ' A' ' 6' ' ' MET . 0.3 OUTLIER -66.64 -28.64 68.64 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.918 -1.114 . . . . 4.69 110.408 178.276 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.99 64.78 3.46 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.76 -0.587 . . . . 2.38 110.794 -179.655 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -72.18 88.4 0.84 Allowed 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.331 1.174 . . . . 1.9 110.428 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.433 HG23 ' N ' ' A' ' 12' ' ' THR . 9.0 t -54.63 -40.69 69.2 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.316 -0.865 . . . . 1.67 110.254 179.921 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.433 ' N ' HG23 ' A' ' 11' ' ' THR . 1.7 p -61.61 -38.97 89.55 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.311 -0.868 . . . . 1.46 109.615 178.46 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -70.56 -51.33 21.33 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 108.69 -1.764 . . . . 1.09 108.69 178.606 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.7 t -55.4 -40.3 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.838 -0.801 . . . . 1.71 109.3 178.649 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.4 t -69.07 -42.69 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.338 -0.851 . . . . 1.32 109.037 178.434 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 53.9 m -57.31 -52.77 64.01 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.131 0.491 . . . . 1.11 110.007 179.137 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.3 m -64.29 -37.08 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.519 -0.738 . . . . 1.21 110.043 179.468 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.1 mt -66.28 -40.9 88.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.039 -1.038 . . . . 1.49 109.394 178.567 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.3 t -64.52 -45.35 95.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.533 -0.914 . . . . 1.19 108.533 178.158 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 86.2 mt -62.15 -46.32 96.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.49 -0.756 . . . . 1.2 109.016 178.312 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.8 mt -60.07 -49.59 77.07 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.908 -0.775 . . . . 1.63 108.908 178.411 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.9 mt -56.76 -43.13 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.525 -0.735 . . . . 1.39 109.394 178.52 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.21 -46.55 83.41 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.669 -0.644 . . . . 1.14 109.908 179.032 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.5 mm -59.66 -46.29 93.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.232 -0.918 . . . . 1.39 109.02 178.762 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.96 -45.0 95.57 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.607 -0.683 . . . . 1.33 109.664 178.967 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.35 -43.84 98.19 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.556 -0.715 . . . . 1.29 109.093 178.59 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.74 -48.26 81.53 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.774 -0.824 . . . . 1.35 108.774 178.133 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.35 -44.65 93.43 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 108.857 -1.697 . . . . 1.25 108.857 178.767 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.32 -43.16 95.54 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.433 -1.04 . . . . 1.42 109.866 178.963 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 6.9 mt -60.27 -41.36 93.12 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.244 -0.651 . . . . 1.72 109.244 178.628 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.942 HG22 ' HB2' ' A' ' 49' ' ' GLU . 97.0 mt -69.11 -52.91 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.558 -0.714 . . . . 1.25 109.29 179.029 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.2 -46.91 72.54 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.491 -0.756 . . . . 2.22 109.763 178.867 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.63 -47.53 89.94 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 109.221 -1.552 . . . . 1.54 109.221 178.964 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -57.86 -41.71 83.0 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.557 -0.967 . . . . 2.0 109.618 178.876 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.483 ' O ' ' N ' ' A' ' 37' ' ' TYR . 1.2 m-90 -68.29 -42.1 79.99 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.289 -0.882 . . . . 1.38 109.728 178.868 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.458 ' O ' ' NH1' ' A' ' 39' ' ' ARG . 4.0 t 55.41 -75.58 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.904 -0.498 . . . . 1.99 111.739 179.082 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.483 ' N ' ' O ' ' A' ' 35' ' ' TRP . 0.2 OUTLIER -146.73 14.22 1.2 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.915 -1.116 . . . . 3.18 111.946 179.912 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.659 ' O ' HD12 ' A' ' 38' ' ' LEU . 2.6 pp -91.77 22.55 4.1 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.83 -1.169 . . . . 1.69 110.886 179.457 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.458 ' NH1' ' O ' ' A' ' 36' ' ' CYS . 68.9 mtt85 -50.3 -48.69 55.01 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.296 -0.878 . . . . 1.44 111.206 179.669 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.74 54.19 0.35 Allowed 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.328 -0.857 . . . . 2.74 110.92 -179.788 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -90.74 -16.84 27.73 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.173 -0.954 . . . . 2.44 110.943 179.931 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.2 tpp180 -159.04 -134.64 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.16 -0.963 . . . . 2.85 109.88 -179.731 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.467 HG13 ' N ' ' A' ' 44' ' ' SER . 5.2 pt -53.34 -33.31 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 O-C-N 121.095 -1.003 . . . . 2.33 110.813 179.24 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.467 ' N ' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -53.1 102.1 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 121.259 0.552 . . . . 1.59 111.107 -179.943 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -84.51 -25.01 29.13 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.484 -0.76 . . . . 2.91 111.142 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 23.1 t -116.06 -68.98 0.88 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.968 -1.083 . . . . 1.7 110.217 179.68 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -115.67 169.26 9.33 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.248 -0.907 . . . . 1.95 110.808 179.545 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.454 ' HB3' ' CD1' ' A' ' 35' ' ' TRP . 24.2 t70 -139.02 -33.64 0.63 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.778 -0.576 . . . . 1.07 110.738 -179.916 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.942 ' HB2' HG22 ' A' ' 31' ' ' ILE . 0.9 OUTLIER -73.83 -135.88 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.224 -0.922 . . . . 1.16 111.621 -179.852 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.56 80.05 1.97 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.494 -1.379 . . . . 2.65 112.285 -178.567 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 42.5 t -161.11 -69.88 0.06 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.391 -0.818 . . . . 1.85 109.655 178.343 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.562 ' O ' ' HB2' ' A' ' 55' ' ' ASP . 1.1 pp -68.15 -27.77 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.388 -0.82 . . . . 2.13 109.771 178.832 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.441 ' N ' HG13 ' A' ' 52' ' ' ILE . 33.1 m -57.7 -33.41 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.376 -0.828 . . . . 2.35 109.033 178.162 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -103.72 42.12 1.97 Allowed Glycine 0 N--CA 1.498 2.805 0 N-CA-C 108.668 -1.773 . . . . 2.14 108.668 178.364 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.562 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 2.5 t0 -101.62 95.31 6.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.6 -0.941 . . . . 2.75 110.381 -179.283 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -157.04 -53.98 0.01 OUTLIER Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.828 -1.709 . . . . 2.65 108.828 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -95.95 -23.46 16.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.801 -0.823 . . . . 2.84 110.343 178.82 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.456 ' O ' ' NZ ' ' A' ' 59' ' ' LYS . 9.4 p -69.44 60.7 0.14 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.517 -0.739 . . . . 2.83 110.908 179.908 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.456 ' NZ ' ' O ' ' A' ' 58' ' ' THR . 3.1 mmtt -124.43 -156.28 0.71 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.105 -0.997 . . . . 2.84 110.64 -179.581 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.506 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 0.8 OUTLIER -80.05 114.88 50.2 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.641 -0.662 . . . . 3.42 109.512 179.264 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.605 ' O ' HG23 ' A' ' 65' ' ' VAL . 39.0 Cg_endo -65.03 -38.13 29.89 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.751 1.395 . . . . 3.03 111.758 -178.795 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.502 ' HB3' ' OE1' ' A' ' 60' ' ' GLU . 59.1 t80 -62.84 -55.29 27.59 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.941 -1.099 . . . . 3.76 109.776 179.493 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.488 ' HB2' ' HB3' ' A' ' 60' ' ' GLU . 4.3 mt -59.86 -37.78 80.28 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.473 -0.767 . . . . 3.17 109.948 178.848 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.506 ' HB2' ' O ' ' A' ' 60' ' ' GLU . 0.3 OUTLIER -58.83 -49.25 78.41 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.713 -0.617 . . . . 2.64 109.933 179.356 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 61' ' ' PRO . 17.5 t -73.07 -36.54 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.138 -0.976 . . . . 2.46 109.186 178.821 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.85 -46.73 84.36 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 120.138 -0.625 . . . . 3.99 109.404 179.463 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.465 ' HA ' ' CG ' ' A' ' 70' ' ' LYS . 0.4 OUTLIER -70.48 -42.88 70.82 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.604 -0.685 . . . . 3.9 109.483 178.457 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.42 ' O ' ' CD ' ' A' ' 72' ' ' PRO . 54.2 m -60.1 -37.39 79.83 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 109.963 -0.384 . . . . 2.01 109.963 178.872 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -83.88 -43.57 15.17 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.241 -0.912 . . . . 2.09 111.338 -179.711 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.465 ' CG ' ' HA ' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -70.33 -25.65 63.39 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.084 -1.01 . . . . 1.66 110.834 -179.795 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' A' ' 75' ' ' GLU . . . -55.11 -64.68 4.15 Favored Glycine 0 N--CA 1.498 2.799 0 N-CA-C 109.063 -1.615 . . . . 1.62 109.063 178.918 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.42 ' CD ' ' O ' ' A' ' 68' ' ' SER . 39.6 Cg_endo -65.91 -37.09 28.2 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 124.085 1.571 . . . . 2.24 110.055 178.778 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 6.2 t -60.16 -46.21 90.45 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.992 -1.067 . . . . 2.2 109.656 178.725 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 39.2 t -72.24 -42.49 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.515 -0.741 . . . . 1.39 109.401 178.863 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.518 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -57.65 -41.66 81.9 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.717 0.77 . . . . 2.65 109.283 178.408 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.4 ttt85 -71.3 -45.32 63.34 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.578 -0.701 . . . . 3.65 110.371 179.36 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.25 -44.25 95.42 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.178 -0.951 . . . . 2.37 109.262 179.267 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.62 ' HA ' ' CD ' ' A' ' 83' ' ' PRO . . . -64.5 -49.06 72.83 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.526 0.679 . . . . 1.72 110.849 179.329 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.4 mttp -68.24 -46.57 70.12 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.276 -0.89 . . . . 2.98 111.502 -179.655 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.1 tp -70.69 -53.06 17.14 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.226 -0.921 . . . . 2.85 112.3 -178.672 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.434 ' CG ' ' HG3' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -100.2 -24.66 14.5 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.214 -0.929 . . . . 3.19 112.174 -178.596 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.426 ' HA ' ' O ' ' A' ' 78' ' ' ALA . 86.8 m 53.62 81.47 0.26 Allowed Pre-proline 0 N--CA 1.504 2.255 0 O-C-N 121.223 -0.923 . . . . 2.9 111.509 179.567 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.62 ' CD ' ' HA ' ' A' ' 78' ' ' ALA . 50.1 Cg_endo -73.14 17.97 0.39 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.842 1.443 . . . . 2.72 112.505 179.428 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -71.54 53.22 0.21 Allowed 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.458 -1.401 . . . . 3.96 108.875 178.487 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 83' ' ' PRO . . . 140.19 -75.16 0.36 Allowed Glycine 0 N--CA 1.494 2.538 0 N-CA-C 108.34 -1.904 . . . . 3.27 108.34 -178.617 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -79.23 -173.53 1.91 Allowed 'Trans proline' 0 C--N 1.315 -1.217 0 O-C-N 123.645 1.34 . . . . 2.44 110.321 178.91 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.434 ' HG3' ' CG ' ' A' ' 81' ' ' MET . 0.1 OUTLIER 67.63 -50.39 0.51 Allowed 'General case' 0 N--CA 1.51 2.532 0 O-C-N 121.375 -0.828 . . . . 3.25 110.229 -178.31 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.0 p -109.97 -6.08 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.706 -0.622 . . . . 4.32 110.932 179.057 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 60.75 51.26 4.94 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.158 -0.964 . . . . 4.84 110.197 -179.565 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.877 0 CA-C-O 118.105 -1.386 . . . . 5.11 110.02 179.85 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.419 ' N ' ' OE2' ' A' ' 57' ' ' GLU . . . . . . . . 0 N--CA 1.496 2.652 0 N-CA-C 109.575 -1.41 . . . . 1.74 109.575 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.431 ' OG ' ' N ' ' A' ' 3' ' ' MET . 90.1 p -161.37 -81.98 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.386 -1.067 . . . . 2.91 110.493 179.26 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.431 ' N ' ' OG ' ' A' ' 2' ' ' SER . 22.3 mtt -130.16 73.7 1.55 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.548 -0.72 . . . . 3.37 110.534 -179.47 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.4 m -121.05 29.22 7.46 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.351 -0.843 . . . . 2.2 110.553 179.852 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.58 -124.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.156 -0.965 . . . . 1.29 110.136 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.414 ' HG3' HG11 ' A' ' 17' ' ' VAL . 5.4 mmt -97.02 39.03 1.19 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.309 -1.494 . . . . 2.71 110.521 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -60.55 -30.26 69.66 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.519 -0.738 . . . . 1.43 110.924 179.827 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -102.42 35.08 2.54 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.083 -1.011 . . . . 3.28 110.54 179.795 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.6 t -95.05 142.2 24.29 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.151 -0.968 . . . . 1.73 110.37 179.722 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.58 170.94 16.36 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 123.633 1.333 . . . . 2.37 110.554 179.729 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.7 t -52.47 -38.77 60.12 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.199 -0.938 . . . . 3.12 110.126 179.831 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 p -65.72 -42.03 91.55 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.27 -0.894 . . . . 3.43 109.397 178.289 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.42 ' O ' HG22 ' A' ' 17' ' ' VAL . . . -70.31 -51.02 24.1 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.13 -1.588 . . . . 2.34 109.13 178.988 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.8 t -53.97 -41.52 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.714 -0.874 . . . . 1.85 109.346 178.747 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.6 t -69.99 -41.93 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.278 -0.889 . . . . 2.71 109.261 178.663 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 77.8 m -58.75 -51.57 69.42 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.699 -0.626 . . . . 2.7 109.928 179.155 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 13' ' ' GLY . 23.3 m -65.41 -36.43 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.471 -0.768 . . . . 1.76 109.911 179.42 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.7 mt -66.58 -40.19 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 121.136 -0.977 . . . . 1.65 109.298 178.404 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 36.1 t -64.8 -43.51 96.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.036 -1.04 . . . . 2.49 108.474 177.953 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 87.7 mt -63.68 -46.73 93.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 108.919 -0.771 . . . . 2.38 108.919 178.139 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.674 HD22 ' O ' ' A' ' 50' ' ' GLU . 44.7 mt -59.56 -49.15 78.87 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.705 -0.85 . . . . 1.38 108.705 178.454 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 31.4 mt -56.27 -42.44 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.557 -0.714 . . . . 1.68 109.386 178.284 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.44 -45.52 83.5 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.461 -0.774 . . . . 2.06 109.663 178.95 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.0 mt -60.09 -46.11 94.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 108.438 -0.949 . . . . 1.96 108.438 178.367 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.633 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . . . -61.62 -48.12 82.31 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.753 -0.462 . . . . 1.15 109.753 178.56 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.48 -44.19 89.27 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.47 -0.769 . . . . 1.43 109.078 178.712 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.01 -46.32 89.7 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.844 -0.799 . . . . 2.85 108.844 178.116 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.98 -42.5 98.35 Favored Glycine 0 N--CA 1.497 2.717 0 N-CA-C 108.899 -1.68 . . . . 1.67 108.899 178.735 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.38 -44.15 95.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.549 -0.971 . . . . 1.14 109.315 178.72 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.507 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 6.4 mt -60.79 -40.84 94.11 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.003 -0.74 . . . . 2.02 109.003 178.289 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.1 mt -67.79 -48.54 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.375 -0.828 . . . . 2.93 109.208 178.445 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.637 ' HA ' ' HD1' ' A' ' 35' ' ' TRP . 0.2 OUTLIER -56.99 -48.43 78.47 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.391 -0.818 . . . . 2.56 109.329 178.848 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.505 ' HA2' ' CZ ' ' A' ' 39' ' ' ARG . . . -64.35 -35.79 92.39 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 110.908 -0.877 . . . . 1.27 110.908 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -79.44 -29.58 41.87 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.983 -1.304 . . . . 2.4 111.319 -179.515 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.637 ' HD1' ' HA ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -89.24 -31.09 18.06 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.902 -1.124 . . . . 3.88 111.29 -179.694 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.542 ' HB2' ' NE1' ' A' ' 35' ' ' TRP . 6.5 t -127.58 150.37 49.74 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.785 -1.197 . . . . 2.71 110.931 -179.541 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -80.23 -38.19 31.55 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.481 -0.762 . . . . 3.56 109.657 179.229 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.474 ' O ' ' C ' ' A' ' 39' ' ' ARG . 6.5 mt -85.03 -61.27 1.81 Allowed 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.309 -0.87 . . . . 3.27 110.688 179.821 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.528 ' HD2' ' O ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER 28.77 71.2 0.06 Allowed 'General case' 0 N--CA 1.511 2.621 0 CA-C-O 122.005 0.907 . . . . 2.16 110.878 -179.203 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.9 85.48 6.75 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.412 -0.805 . . . . 3.79 111.136 -178.968 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -54.17 -19.99 6.01 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.453 -0.78 . . . . 3.0 110.373 178.673 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.506 ' CZ ' ' HA ' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -157.39 -145.4 0.14 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.345 -0.847 . . . . 3.62 109.616 179.373 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.258 0.4 OUTLIER -54.88 -26.92 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 O-C-N 120.909 -1.12 . . . . 5.34 110.941 179.316 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.6 m -178.86 78.77 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.46 -0.775 . . . . 4.47 109.354 179.734 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 43.41 58.71 3.31 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.606 -0.684 . . . . 2.35 110.908 -179.602 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 36.6 m -142.22 77.9 1.6 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.066 -1.021 . . . . 3.78 111.841 -179.274 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.506 ' HA ' ' CZ ' ' A' ' 42' ' ' ARG . 1.7 pm0 -96.39 154.49 17.24 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.366 -0.834 . . . . 2.02 109.833 178.633 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.21 -54.4 3.08 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.145 -0.972 . . . . 1.92 110.613 -179.597 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.81 163.01 40.1 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.175 -0.953 . . . . 1.64 110.974 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.674 ' O ' HD22 ' A' ' 21' ' ' LEU . 2.6 tp10 -94.71 91.35 6.47 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.435 -0.79 . . . . 2.01 110.304 179.432 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.42 ' OG ' ' N ' ' A' ' 52' ' ' ILE . 96.4 p -145.82 -79.54 0.17 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.048 -1.032 . . . . 1.97 110.498 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.42 ' N ' ' OG ' ' A' ' 51' ' ' SER . 15.2 pt -70.71 -34.5 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.379 -0.826 . . . . 2.45 110.472 -179.781 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.2 m -75.87 -33.21 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 O-C-N 121.361 -0.837 . . . . 1.98 110.405 179.544 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -86.32 -24.95 38.13 Favored Glycine 0 N--CA 1.498 2.794 0 N-CA-C 110.031 -1.228 . . . . 1.57 110.031 179.855 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.8 t70 62.44 -165.53 0.23 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.66 -0.906 . . . . 2.16 111.245 179.891 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.64 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 149.43 -54.53 0.5 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 108.326 -1.91 . . . . 1.14 108.326 -179.308 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.419 ' OE2' ' N ' ' A' ' 1' ' ' GLY . 1.0 OUTLIER -117.79 -33.64 4.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.834 -0.804 . . . . 1.5 111.381 179.346 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.498 ' O ' ' NZ ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -52.88 97.61 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.19 -0.944 . . . . 1.71 110.433 179.945 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.498 ' NZ ' ' O ' ' A' ' 58' ' ' THR . 0.0 OUTLIER 68.88 -176.56 0.21 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.24 -0.652 . . . . 1.73 109.24 -178.535 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.472 ' N ' ' CG ' ' A' ' 59' ' ' LYS . 0.4 OUTLIER -99.08 102.49 15.71 Favored Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 120.785 -1.197 . . . . 1.54 110.546 -179.552 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.638 ' HG2' ' HB3' ' A' ' 64' ' ' LEU . 48.4 Cg_endo -73.17 142.9 34.81 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 O-C-N 123.616 1.324 . . . . 1.11 111.048 -179.958 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -77.67 -48.1 17.59 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.543 -0.723 . . . . 2.67 111.172 -179.751 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 81.3 mt -62.82 -35.25 79.28 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.467 -0.77 . . . . 2.38 110.812 -179.657 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.64 HD13 ' HA2' ' A' ' 56' ' ' GLY . 0.5 OUTLIER -60.9 -55.63 30.73 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.19 -0.944 . . . . 2.46 109.975 179.394 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.4 m -68.93 -32.96 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.113 -0.992 . . . . 1.28 110.119 179.813 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.46 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 3.0 mm-40 -61.92 -53.52 54.58 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.239 -0.913 . . . . 1.76 108.881 178.257 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -63.06 -42.06 99.6 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.355 -0.841 . . . . 3.48 109.359 178.277 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 70.4 m -56.26 -35.07 67.02 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.997 -0.44 . . . . 1.61 110.678 179.177 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -91.29 -40.94 11.22 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.166 -0.959 . . . . 1.31 110.777 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 66' ' ' GLN . 3.4 mmtp -64.59 -44.76 89.63 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.576 -0.702 . . . . 2.88 110.746 -179.851 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.41 ' N ' ' HD2' ' A' ' 72' ' ' PRO . . . -46.52 -63.56 3.02 Favored Glycine 0 N--CA 1.502 3.08 0 N-CA-C 110.455 -1.058 . . . . 1.04 110.455 -179.823 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 71' ' ' GLY . 40.2 Cg_endo -65.8 -38.15 24.87 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 O-C-N 123.736 1.387 . . . . 1.39 110.644 179.545 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 10.5 t -60.68 -43.38 97.77 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.023 -1.048 . . . . 1.54 109.496 178.841 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 54.1 t -74.26 -42.95 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.487 -0.758 . . . . 1.4 109.375 178.76 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -56.03 -44.62 78.92 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.701 -0.851 . . . . 1.5 108.701 178.318 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -66.78 -41.61 87.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.854 -0.529 . . . . 2.23 109.805 178.788 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.6 -50.12 75.13 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.432 -0.792 . . . . 3.32 110.095 179.135 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.32 -44.11 92.56 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.61 -0.681 . . . . 1.37 110.642 179.849 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.656 ' HD2' ' HB3' ' A' ' 84' ' ' ASN . 3.0 mmmm -66.39 -33.63 76.15 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.522 -0.736 . . . . 1.66 110.162 179.488 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.37 -34.24 58.9 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.196 -0.94 . . . . 2.8 111.119 -179.844 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.93 -39.62 25.9 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.368 -0.832 . . . . 3.14 110.372 179.793 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.64 ' HB ' ' HD2' ' A' ' 83' ' ' PRO . 46.1 p -91.09 174.23 4.68 Favored Pre-proline 0 N--CA 1.502 2.174 0 O-C-N 121.339 -0.85 . . . . 1.58 109.977 179.571 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.64 ' HD2' ' HB ' ' A' ' 82' ' ' THR . 46.8 Cg_endo -77.43 8.96 3.05 Favored 'Trans proline' 0 C--N 1.316 -1.139 0 O-C-N 123.225 1.118 . . . . 1.59 111.651 179.049 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.656 ' HB3' ' HD2' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -76.37 51.03 0.68 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.902 -1.124 . . . . 2.01 109.116 179.178 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -80.71 -150.46 6.93 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 110.716 -0.954 . . . . 2.06 110.716 -179.083 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.1 -16.53 40.41 Favored 'Trans proline' 0 N--CA 1.49 1.279 0 O-C-N 123.912 1.48 . . . . 2.96 111.225 -179.916 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -63.92 -32.23 73.68 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.229 -0.919 . . . . 4.56 108.627 178.512 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 48.8 t -102.92 -32.03 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.612 -0.68 . . . . 2.82 109.813 178.284 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -169.87 -58.03 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.096 -1.003 . . . . 3.11 111.467 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.793 0 N-CA-C 110.202 -1.159 . . . . 2.36 110.202 -179.113 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.815 0 N-CA-C 110.492 -1.043 . . . . 6.75 110.492 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.484 ' OG ' ' N ' ' A' ' 3' ' ' MET . 30.0 t 52.5 -143.0 0.73 Allowed 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.911 -0.758 . . . . 5.97 111.023 -179.966 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.484 ' N ' ' OG ' ' A' ' 2' ' ' SER . 0.6 OUTLIER -68.71 66.71 0.13 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.34 -0.85 . . . . 4.41 110.446 179.876 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.5 m -79.39 11.56 2.91 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.181 -0.95 . . . . 5.78 110.465 179.217 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.589 HD12 ' C ' ' A' ' 5' ' ' ILE . 1.4 pp -82.91 -170.07 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 O-C-N 121.616 -0.677 . . . . 4.91 109.41 178.643 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.586 ' O ' ' HB3' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -109.69 -172.38 2.03 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.272 -0.892 . . . . 5.51 110.648 179.906 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.586 ' HB3' ' O ' ' A' ' 6' ' ' MET . 1.3 t70 66.58 -43.34 0.41 Allowed 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.899 -0.5 . . . . 3.83 111.002 -178.789 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -97.02 -34.19 11.27 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.704 -1.247 . . . . 3.12 111.469 -179.754 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.51 ' OG ' ' HD3' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -59.71 -52.86 70.93 Favored Pre-proline 0 N--CA 1.503 2.196 0 O-C-N 121.05 -1.031 . . . . 3.6 112.094 -179.609 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.51 ' HD3' ' OG ' ' A' ' 9' ' ' SER . 44.7 Cg_endo -70.4 -38.18 6.73 Favored 'Trans proline' 0 N--CA 1.49 1.292 0 O-C-N 123.039 1.021 . . . . 3.5 111.367 -179.418 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.0 p -69.6 -57.89 4.63 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.372 -0.83 . . . . 2.83 110.198 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.3 p -59.52 -37.44 78.35 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.156 -0.965 . . . . 2.25 109.626 179.46 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.412 ' O ' HG22 ' A' ' 17' ' ' VAL . . . -65.44 -57.3 11.72 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.285 -1.526 . . . . 2.23 109.285 179.176 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.5 t -56.3 -39.71 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.685 -0.891 . . . . 3.03 109.465 179.042 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.3 t -67.45 -42.73 87.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.055 -1.028 . . . . 1.92 109.26 178.805 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 66.8 m -60.54 -52.6 64.5 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.685 -0.634 . . . . 1.63 109.812 179.08 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.463 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 23.6 m -64.32 -35.46 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 119.829 -0.748 . . . . 2.22 109.834 179.397 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.735 ' HA ' HD23 ' A' ' 21' ' ' LEU . 9.8 mt -68.71 -41.78 82.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 120.935 -1.103 . . . . 2.85 109.042 178.432 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.8 t -64.04 -42.28 95.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.391 -0.966 . . . . 1.53 108.391 178.063 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 83.3 mt -64.68 -50.09 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.483 -0.761 . . . . 1.59 109.153 178.51 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.735 HD23 ' HA ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -61.86 -41.16 97.5 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.878 -0.786 . . . . 2.52 108.878 178.827 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.572 ' N ' ' HG ' ' A' ' 21' ' ' LEU . 7.4 mm -60.97 -44.19 97.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.44 -0.948 . . . . 2.82 108.44 177.945 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.77 -44.86 88.7 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.546 -0.721 . . . . 2.04 109.689 178.817 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.9 mm -59.68 -49.59 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.421 -0.955 . . . . 2.1 108.421 178.434 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.1 -44.9 96.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.794 -0.566 . . . . 2.68 110.002 178.949 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.73 -43.44 98.84 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.571 -0.706 . . . . 2.9 109.251 178.683 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.1 tt -63.24 -46.97 84.44 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.029 -0.73 . . . . 2.73 109.029 178.24 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.38 -44.61 96.47 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 108.708 -1.757 . . . . 2.9 108.708 178.617 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.67 -40.9 96.2 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.609 -0.936 . . . . 3.52 109.573 178.691 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.485 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 6.5 mt -61.33 -43.13 99.4 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.105 -0.702 . . . . 3.83 109.105 178.536 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 35.4 mt -67.84 -49.26 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.451 -0.781 . . . . 3.42 109.469 179.005 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.72 -39.2 90.69 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.658 -0.652 . . . . 3.8 110.391 179.313 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.91 -42.19 31.05 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 110.244 -1.142 . . . . 4.46 110.244 179.86 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 1.9 t -70.92 -40.97 71.79 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.054 -1.262 . . . . 4.64 110.734 -179.858 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.421 ' CD1' ' HG3' ' A' ' 39' ' ' ARG . 0.3 OUTLIER -94.22 -10.91 31.49 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.285 -0.884 . . . . 3.88 111.815 -179.491 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.416 ' O ' ' NH2' ' A' ' 39' ' ' ARG . 0.8 OUTLIER 62.62 172.68 0.14 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 122.192 0.996 . . . . 4.29 111.435 -179.89 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -82.85 -30.03 28.95 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 121.334 -0.854 . . . . 3.89 110.888 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.94 11.27 20.65 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.264 -0.898 . . . . 3.11 112.005 -179.479 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.421 ' HG3' ' CD1' ' A' ' 35' ' ' TRP . 0.0 OUTLIER 53.08 24.63 3.64 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 121.025 -1.047 . . . . 3.19 112.02 179.238 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.15 168.13 20.47 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.232 -0.918 . . . . 3.13 110.268 179.613 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 57.32 33.41 23.26 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.506 -0.746 . . . . 2.7 109.451 -178.749 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -146.01 -58.21 0.31 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.395 -0.816 . . . . 3.9 111.321 -178.801 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.472 HG13 ' OE2' ' A' ' 47' ' ' GLU . 23.2 pt -55.06 -31.45 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 CA-C-O 121.655 0.741 . . . . 3.8 110.537 -179.781 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 71.56 49.87 0.28 Allowed 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 121.816 0.817 . . . . 2.98 109.446 -179.179 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -125.65 -63.11 1.15 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.872 -0.518 . . . . 4.09 109.723 -179.611 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.7 p -79.59 -23.9 42.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.506 -0.746 . . . . 2.45 110.102 179.253 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.472 ' OE2' HG13 ' A' ' 43' ' ' ILE . 0.8 OUTLIER -100.01 172.04 7.46 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-O 121.682 0.753 . . . . 3.16 110.618 179.593 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.719 ' HB3' HD23 ' A' ' 64' ' ' LEU . 4.7 m-20 -86.39 -37.74 18.1 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.659 -0.651 . . . . 1.97 111.258 -178.567 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -144.45 174.9 10.53 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.376 -0.828 . . . . 2.09 111.363 -178.792 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.78 -67.17 0.8 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.539 -0.725 . . . . 3.4 110.556 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.444 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 0.6 OUTLIER -173.39 81.44 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.563 -0.711 . . . . 3.23 110.062 -179.984 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.677 HG23 ' HA ' ' A' ' 60' ' ' GLU . 27.8 mm 65.41 -44.93 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.703 -0.623 . . . . 3.3 112.106 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.421 ' N ' ' O ' ' A' ' 51' ' ' SER . 33.7 m -50.37 -33.05 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.304 0 O-C-N 121.324 -0.86 . . . . 3.17 111.596 -179.669 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -66.83 61.37 0.2 Allowed Glycine 0 N--CA 1.5 2.918 0 N-CA-C 110.88 -0.888 . . . . 2.06 110.88 -179.265 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 53' ' ' VAL . 31.3 m-20 -86.13 146.42 26.6 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.427 -1.043 . . . . 3.44 110.226 179.425 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 179.11 -49.74 0.09 OUTLIER Glycine 0 N--CA 1.5 2.954 0 N-CA-C 108.019 -2.033 . . . . 2.47 108.019 -179.835 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.67 -50.63 3.37 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 122.046 -0.679 . . . . 4.25 109.299 178.554 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.7 m -122.93 124.28 42.85 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.427 -0.796 . . . . 4.08 109.477 179.136 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -69.13 129.17 39.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.263 -0.898 . . . . 4.21 109.005 179.096 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.677 ' HA ' HG23 ' A' ' 52' ' ' ILE . 0.4 OUTLIER 64.04 63.9 1.33 Allowed Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.89 -0.506 . . . . 4.78 110.209 -179.068 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.538 ' HB2' ' HB2' ' A' ' 64' ' ' LEU . 43.2 Cg_endo -68.27 55.9 0.82 Allowed 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 121.236 1.29 . . . . 3.19 110.878 179.589 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -56.68 -46.01 81.39 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.287 -0.883 . . . . 5.33 111.229 -179.544 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.458 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 2.2 mt -62.89 -37.33 86.51 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.588 -0.695 . . . . 4.89 110.204 179.836 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.719 HD23 ' HB3' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -58.82 -59.29 5.68 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.31 -0.626 . . . . 2.93 109.31 178.871 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.1 m -66.14 -34.65 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.397 -0.814 . . . . 3.03 110.154 179.137 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -61.62 -48.11 82.36 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.142 -0.974 . . . . 4.58 108.911 178.439 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.458 ' HB2' ' O ' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -66.29 -48.36 70.63 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.967 -0.753 . . . . 5.29 108.967 178.412 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.514 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -55.43 -30.71 60.99 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 116.31 -0.405 . . . . 1.73 111.269 179.746 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.596 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -92.87 -48.18 6.67 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.125 -0.984 . . . . 2.26 109.842 179.311 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.9 mmpp? -59.58 -51.41 69.95 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.685 -0.635 . . . . 3.75 111.511 -179.656 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.41 ' N ' ' HD2' ' A' ' 72' ' ' PRO . . . -42.87 -63.05 2.09 Favored Glycine 0 N--CA 1.504 3.231 0 N-CA-C 110.091 -1.203 . . . . 1.75 110.091 -179.631 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.524 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 41.1 Cg_endo -66.18 -40.21 16.03 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 O-C-N 123.721 1.379 . . . . 1.24 110.445 178.931 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.596 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 0.7 OUTLIER -62.28 -46.31 89.37 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.731 -1.23 . . . . 2.31 109.786 179.125 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.472 ' O ' ' HG3' ' A' ' 77' ' ' LYS . 39.0 t -64.85 -49.79 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.694 -0.854 . . . . 2.57 108.694 178.819 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.409 ' OE1' ' NZ ' ' A' ' 79' ' ' LYS . 8.6 tp10 -56.58 -40.67 75.63 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.221 0.534 . . . . 3.53 110.084 179.025 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.524 ' HB2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -63.7 -52.98 58.17 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.514 -0.741 . . . . 2.57 110.227 179.919 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.561 ' HG3' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -66.7 -31.87 72.81 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.334 -0.946 . . . . 3.21 109.778 179.552 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.561 ' N ' ' HG3' ' A' ' 77' ' ' LYS . . . -66.55 -46.69 75.26 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.202 -1.036 . . . . 2.56 108.202 177.678 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.564 ' HE2' ' O ' ' A' ' 84' ' ' ASN . 7.8 mmtp -66.43 -40.79 89.72 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.05 -0.722 . . . . 3.45 109.05 178.128 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.51 -49.36 78.07 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.301 -0.875 . . . . 2.48 110.504 179.26 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.47 -52.46 10.63 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.45 0.643 . . . . 3.9 110.496 -179.725 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.43 122.75 46.95 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.486 -0.759 . . . . 3.97 110.081 -179.649 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -71.1 19.97 0.23 Allowed 'Trans proline' 0 N--CA 1.495 1.604 0 O-C-N 123.581 1.306 . . . . 4.56 112.046 178.958 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.564 ' O ' ' HE2' ' A' ' 79' ' ' LYS . 0.5 OUTLIER -70.84 45.49 0.09 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 120.973 -1.079 . . . . 5.1 110.535 179.201 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 154.64 96.07 0.12 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 108.916 -1.674 . . . . 4.42 108.916 -179.361 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.473 ' O ' ' HB3' ' A' ' 87' ' ' GLU . 46.0 Cg_endo -68.18 -166.39 0.14 Allowed 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 124.156 1.608 . . . . 5.36 109.873 -179.747 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.473 ' HB3' ' O ' ' A' ' 86' ' ' PRO . 3.4 tt0 69.46 -53.77 0.6 Allowed 'General case' 0 N--CA 1.509 2.522 0 O-C-N 121.143 -0.973 . . . . 5.95 109.685 -178.384 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.52 ' CG2' ' HD2' ' A' ' 79' ' ' LYS . 17.4 m -103.83 -1.84 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.689 -0.632 . . . . 3.94 110.817 178.919 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 50.3 t60 -84.37 -43.87 14.29 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.844 -1.16 . . . . 3.91 108.988 178.757 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.261 0 N-CA-C 108.749 -1.74 . . . . 3.96 108.749 178.828 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.578 0 N-CA-C 110.41 -1.076 . . . . 1.89 110.41 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.537 ' HB3' ' O ' ' A' ' 5' ' ' ILE . 41.0 t -98.17 -166.65 1.4 Allowed 'General case' 0 N--CA 1.483 1.216 0 O-C-N 121.034 -1.274 . . . . 2.59 109.935 179.435 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.8 mmt -77.91 -38.17 46.23 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.509 -0.744 . . . . 3.88 110.429 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 75.4 p -120.62 -76.28 0.58 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.263 -0.898 . . . . 3.25 110.659 -179.739 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.537 ' O ' ' HB3' ' A' ' 2' ' ' SER . 0.2 OUTLIER -95.94 -143.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.814 -0.554 . . . . 3.6 110.518 -179.328 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.8 mtt 51.49 65.22 1.55 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.289 -0.882 . . . . 4.18 110.988 179.776 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.482 ' HB2' ' HD2' ' A' ' 10' ' ' PRO . 2.7 p30 -55.81 -35.01 65.87 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.229 -0.92 . . . . 1.64 109.301 179.201 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 55.72 31.81 18.18 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.125 0.488 . . . . 3.28 111.132 179.32 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.594 ' HB3' ' CD ' ' A' ' 10' ' ' PRO . 8.2 t -154.67 -68.22 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.413 -0.804 . . . . 1.9 110.227 179.453 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.594 ' CD ' ' HB3' ' A' ' 9' ' ' SER . 39.4 Cg_endo -65.07 -48.64 3.43 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 O-C-N 123.076 1.04 . . . . 1.53 111.599 179.38 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.1 m -64.53 -50.88 65.61 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.013 -1.055 . . . . 1.89 110.229 179.792 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -60.32 -37.31 80.2 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.342 -0.849 . . . . 2.1 109.84 179.032 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.436 ' O ' HG22 ' A' ' 17' ' ' VAL . . . -69.13 -52.66 22.0 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 108.947 -1.661 . . . . 1.25 108.947 178.849 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.9 t -56.0 -40.25 62.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.785 -0.833 . . . . 1.5 109.477 178.95 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.2 t -68.16 -43.67 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.199 -0.938 . . . . 1.69 109.363 178.77 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 53.1 m -58.53 -50.99 71.78 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.628 -0.67 . . . . 1.91 110.164 179.436 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 13' ' ' GLY . 31.5 m -66.87 -33.68 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.371 -0.831 . . . . 1.63 110.271 179.654 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.2 mm -69.25 -41.4 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 120.892 -1.13 . . . . 1.51 109.29 178.468 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.6 t -64.83 -44.15 96.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 108.413 -0.958 . . . . 1.77 108.413 177.952 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 21.8 mm -62.97 -46.91 95.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.479 -0.763 . . . . 2.1 109.059 178.29 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.8 mt -59.98 -48.82 80.13 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.912 -0.773 . . . . 1.75 108.912 178.378 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.5 mm -57.45 -44.03 83.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.533 -0.729 . . . . 1.58 109.412 178.503 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.47 -45.04 92.61 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.529 -0.732 . . . . 1.42 109.718 179.008 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 37.6 mt -60.55 -45.39 97.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.418 -0.801 . . . . 1.82 109.004 178.667 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.57 -45.57 89.87 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.48 -0.763 . . . . 1.14 109.753 178.929 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.68 -43.87 97.17 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.8 -0.815 . . . . 1.18 108.8 178.516 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.719 HD13 ' C ' ' A' ' 27' ' ' LEU . 3.0 tm? -60.04 -52.06 66.99 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.834 -0.802 . . . . 1.92 108.834 178.076 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.91 -44.66 82.21 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.033 -1.627 . . . . 1.19 109.033 178.68 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.6 -43.57 96.53 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.496 -1.002 . . . . 1.15 109.878 179.071 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.8 mt -59.76 -40.78 89.35 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.498 -0.556 . . . . 1.69 109.498 178.967 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.7 mt -71.54 -44.89 70.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.464 -0.773 . . . . 2.25 109.385 178.977 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.451 ' O ' ' HB2' ' A' ' 36' ' ' CYS . 0.4 OUTLIER -59.37 -48.44 81.64 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.301 -0.875 . . . . 2.08 109.667 179.138 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.32 -55.63 28.13 Favored Glycine 0 N--CA 1.499 2.838 0 N-CA-C 109.663 -1.375 . . . . 1.11 109.663 179.252 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 44.4 t -51.25 -49.19 61.64 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.493 -1.004 . . . . 1.15 109.976 179.195 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 40.4 t90 -63.03 -49.24 75.37 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.294 -0.879 . . . . 3.18 110.056 179.224 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -58.33 -33.64 69.75 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.239 -0.913 . . . . 2.04 110.585 179.475 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -79.09 -42.57 26.02 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.36 -0.837 . . . . 2.58 110.62 179.864 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.521 HD21 ' HA ' ' A' ' 44' ' ' SER . 6.5 tp -85.25 -44.46 12.87 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.712 -0.617 . . . . 1.22 111.974 -179.261 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.534 ' HB2' ' CZ ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER 66.57 -52.4 0.44 Allowed 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.648 -0.658 . . . . 1.85 111.2 -179.244 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 38' ' ' LEU . 1.8 mt -76.56 70.3 3.08 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.282 -0.886 . . . . 2.4 111.123 -179.722 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -67.82 -12.24 60.2 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.085 -1.009 . . . . 2.87 111.313 179.509 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.467 ' HG3' ' N ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -69.01 -61.61 1.72 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.115 -0.991 . . . . 3.8 109.1 179.744 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.467 ' N ' ' HG3' ' A' ' 42' ' ' ARG . 7.6 pt -81.24 -32.18 12.06 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-O 121.842 0.829 . . . . 1.98 108.982 178.277 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.521 ' HA ' HD21 ' A' ' 38' ' ' LEU . 0.1 OUTLIER 61.21 40.87 14.13 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 115.857 -0.61 . . . . 1.8 109.657 -179.462 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.507 ' HG3' ' CD1' ' A' ' 38' ' ' LEU . 3.7 mt-30 59.41 -82.54 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 122.185 -0.322 . . . . 2.27 110.487 -179.425 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.4 m 45.76 34.99 2.0 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.443 -0.786 . . . . 2.44 111.679 179.291 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -79.78 165.44 22.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.162 -0.961 . . . . 2.87 110.684 -179.658 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.93 86.43 6.53 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.388 -0.82 . . . . 4.47 110.482 -179.746 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.75 169.32 10.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.109 -0.994 . . . . 4.7 110.208 179.813 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.699 ' HB3' HG22 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -77.81 -64.41 1.16 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.22 -0.925 . . . . 4.65 110.181 -179.988 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 m -179.76 -44.74 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.746 -0.596 . . . . 4.82 110.491 -179.941 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.554 HD13 ' N ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -125.44 -30.16 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.588 -0.695 . . . . 3.43 110.817 -179.589 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.699 HG22 ' HB3' ' A' ' 50' ' ' GLU . 21.7 m -58.75 -34.72 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.405 0 O-C-N 120.653 -1.279 . . . . 3.59 110.889 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -90.75 33.87 4.45 Favored Glycine 0 N--CA 1.499 2.839 0 N-CA-C 110.243 -1.143 . . . . 2.19 110.243 179.763 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.425 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 22.7 t70 -76.32 164.96 25.52 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.319 -1.106 . . . . 2.05 111.133 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 153.25 -50.9 0.49 Allowed Glycine 0 N--CA 1.495 2.593 0 N-CA-C 108.192 -1.963 . . . . 1.77 108.192 -179.84 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -126.17 31.27 5.46 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.886 -0.773 . . . . 2.44 109.76 178.652 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.0 62.38 2.77 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.219 -0.925 . . . . 2.02 110.577 -179.718 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.43 151.22 25.83 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.162 -0.961 . . . . 2.6 110.19 179.768 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.537 ' OE1' HG23 ' A' ' 65' ' ' VAL . 1.1 tm-20 -85.76 115.56 62.14 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.23 -0.919 . . . . 2.49 110.145 179.87 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -80.69 31.48 0.5 Allowed 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.534 1.281 . . . . 3.65 111.581 -179.941 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.7 t80 70.55 -30.17 0.2 Allowed 'General case' 0 N--CA 1.508 2.44 0 O-C-N 121.181 -0.949 . . . . 2.59 112.73 -179.851 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.0 mt -56.07 -41.03 74.48 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.959 -1.088 . . . . 2.84 111.721 -179.384 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.37 -47.46 84.06 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.686 -0.806 . . . . 3.11 110.031 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.537 HG23 ' OE1' ' A' ' 60' ' ' GLU . 21.6 t -70.46 -34.38 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.097 -1.002 . . . . 1.93 109.161 178.637 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -58.86 -52.28 66.39 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.783 -0.821 . . . . 2.21 108.783 178.963 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -66.06 -43.3 87.84 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.597 -0.689 . . . . 4.31 109.46 178.28 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.418 ' HB2' ' HA ' ' A' ' 65' ' ' VAL . 69.7 m -58.45 -40.5 82.78 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.9 -0.5 . . . . 2.17 110.393 179.342 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.518 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -83.71 -44.86 14.03 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.325 -0.86 . . . . 1.47 111.05 -179.948 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.3 mmtp -61.61 -45.7 92.96 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.384 -0.823 . . . . 1.89 111.128 -179.613 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -43.02 -64.9 1.56 Allowed Glycine 0 N--CA 1.506 3.319 0 N-CA-C 110.679 -0.968 . . . . 1.38 110.679 -179.397 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.418 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 40.6 Cg_endo -65.51 -38.59 24.81 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 O-C-N 123.779 1.41 . . . . 1.44 110.45 179.41 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.518 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -62.14 -46.36 89.38 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.964 -1.085 . . . . 1.45 109.571 178.8 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.7 t -68.37 -45.4 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 109.004 -0.739 . . . . 1.41 109.004 178.672 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.416 ' O ' ' HG3' ' A' ' 79' ' ' LYS . 2.6 tm-20 -56.9 -43.38 81.29 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.502 0.668 . . . . 1.7 109.559 178.549 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.418 ' HD2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -64.99 -48.32 74.38 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.728 -0.607 . . . . 2.26 109.683 178.925 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.58 -42.67 97.18 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.583 -0.698 . . . . 1.91 110.187 179.789 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.03 -41.98 97.25 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.866 -0.521 . . . . 1.16 109.657 179.125 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 75' ' ' GLU . 5.0 mttp -68.07 -47.58 67.91 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.29 -0.633 . . . . 1.98 109.29 178.67 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.96 -39.13 71.3 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.425 -0.797 . . . . 1.84 109.63 178.904 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.3 ttt -77.13 -59.98 2.55 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.658 -0.651 . . . . 3.14 109.981 179.324 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.6 p -129.09 86.39 57.24 Favored Pre-proline 0 N--CA 1.499 2.011 0 O-C-N 121.238 -0.914 . . . . 1.9 109.483 179.291 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.412 ' O ' ' CB ' ' A' ' 84' ' ' ASN . 45.1 Cg_endo -68.91 -29.57 27.87 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 O-C-N 123.865 1.455 . . . . 1.6 111.822 -179.114 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.412 ' CB ' ' O ' ' A' ' 83' ' ' PRO . 5.0 t30 69.78 -51.14 0.63 Allowed 'General case' 0 N--CA 1.506 2.368 0 O-C-N 121.716 -0.615 . . . . 2.4 111.29 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.04 -92.32 0.71 Allowed Glycine 0 N--CA 1.499 2.834 0 N-CA-C 109.48 -1.448 . . . . 2.1 109.48 -179.736 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.539 ' O ' ' HB2' ' A' ' 87' ' ' GLU . 50.9 Cg_endo -79.25 -155.85 0.06 OUTLIER 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.838 1.441 . . . . 2.8 110.259 179.558 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.539 ' HB2' ' O ' ' A' ' 86' ' ' PRO . 1.2 mp0 65.71 -55.73 0.35 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.582 -0.699 . . . . 3.36 109.891 -178.812 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.477 ' N ' ' O ' ' A' ' 86' ' ' PRO . 19.7 t -95.03 -31.14 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.68 -0.638 . . . . 2.38 109.544 178.072 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 33.1 m80 49.37 46.64 23.07 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.518 -0.739 . . . . 2.87 111.735 179.534 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.843 0 CA-C-O 117.86 -1.522 . . . . 2.54 110.127 179.48 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 54.2 t . . . . . 0 N--CA 1.5 2.046 0 N-CA-C 109.02 -0.734 . . . . 2.1699999999999999 109.02 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.7 t -69.89 -42.84 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.202 -0.937 . . . . 1.96 109.036 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 49.6 m -58.98 -51.36 70.39 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.771 -0.581 . . . . 1.8700000000000001 109.985 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.1 m -66.95 -33.17 61.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.387 -0.821 . . . . 1.8899999999999999 110.271 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.41 ' HA ' HD13 ' A' ' 18' ' ' ILE . 6.9 mm -69.64 -41.13 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 120.925 -1.109 . . . . 2.0099999999999998 109.091 178.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.3 t -64.76 -45.07 96.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 108.291 -1.003 . . . . 1.74 108.291 177.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.417 HD13 ' HA ' ' A' ' 20' ' ' ILE . 23.6 mm -62.06 -46.79 95.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.85 -0.796 . . . . 1.72 108.85 178.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 13.1 mt -59.75 -49.67 76.81 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.849 -0.797 . . . . 1.8899999999999999 108.849 178.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.0 mt -56.44 -43.1 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.575 -0.703 . . . . 2.02 109.293 178.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.68 -46.84 83.69 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.588 -0.695 . . . . 1.48 109.536 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.1 mt -58.64 -48.29 86.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.446 -0.783 . . . . 1.7 108.978 178.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.61 -45.37 94.27 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.62 -0.675 . . . . 1.53 109.937 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.4 -45.37 93.83 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 109.071 -0.714 . . . . 1.46 109.071 178.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.27 -47.1 87.55 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.014 -0.735 . . . . 1.6499999999999999 109.014 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.15 -44.26 94.91 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 108.88 -1.688 . . . . 1.3100000000000001 108.88 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.14 -45.73 92.14 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.409 -1.053 . . . . 1.3600000000000001 109.414 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.4 mt -57.58 -41.8 81.85 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.297 -0.631 . . . . 1.6100000000000001 109.297 178.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 45.6 mt -71.36 -36.04 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.302 -0.874 . . . . 1.3100000000000001 110.09 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.6 tt -68.06 -45.19 74.54 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.234 -0.916 . . . . 1.6699999999999999 109.825 178.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.812 0 O-C-N 121.169 -0.957 . . . . 1.26 111.469 -179.546 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 . . . . . 0 N--CA 1.495 1.79 0 N-CA-C 109.086 -0.709 . . . . 1.78 109.086 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.574 ' HA ' ' HG2' ' A' ' 70' ' ' LYS . 4.6 t80 -72.7 -35.61 67.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.781 -0.574 . . . . 1.5700000000000001 109.48 178.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 23.0 t -61.71 -31.15 71.28 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.644 -0.66 . . . . 2.48 109.744 178.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.544 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -93.78 -50.29 5.43 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.253 -0.904 . . . . 2.27 110.868 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.574 ' HG2' ' HA ' ' A' ' 67' ' ' TYR . 5.0 pttt -70.68 -36.22 73.21 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.267 -0.896 . . . . 1.8100000000000001 111.225 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.449 ' N ' ' HD2' ' A' ' 72' ' ' PRO . . . -46.6 -61.67 4.08 Favored Glycine 0 N--CA 1.498 2.83 0 N-CA-C 109.277 -1.529 . . . . 1.5800000000000001 109.277 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.497 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 41.5 Cg_endo -67.23 -42.48 7.64 Favored 'Trans proline' 0 C--N 1.314 -1.242 0 O-C-N 124.039 1.547 . . . . 2.2799999999999998 110.102 178.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.544 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -56.71 -44.54 81.66 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.959 -1.088 . . . . 2.73 109.815 178.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.404 ' HA ' ' HG2' ' A' ' 77' ' ' LYS . 25.0 t -71.05 -49.07 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.479 -0.763 . . . . 1.8899999999999999 109.387 178.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 0.6 OUTLIER -55.26 -39.04 69.33 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.746 -0.596 . . . . 2.1800000000000002 110.078 179.31 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.497 ' HD2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -68.37 -55.04 13.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.482 -0.761 . . . . 2.9399999999999999 109.434 178.774 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.626 ' HG3' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -59.91 -31.27 69.67 Favored 'General case' 0 N--CA 1.505 2.282 0 C-N-CA 119.446 -0.902 . . . . 3.29 110.281 179.592 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.626 ' N ' ' HG3' ' A' ' 77' ' ' LYS . . . -71.13 -41.9 69.91 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.559 -0.713 . . . . 2.23 109.601 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 32.5 mttp -73.74 -34.58 64.82 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.441 -0.577 . . . . 2.7400000000000002 109.441 178.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 71.6 mt . . . . . 0 N--CA 1.496 1.844 0 O-C-N 120.987 -1.071 . . . . 3.73 110.131 179.379 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 36.5 t . . . . . 0 N--CA 1.5 2.044 0 N-CA-C 109.347 -0.612 . . . . 1.3100000000000001 109.347 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.7 t -62.81 -46.0 97.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.567 -0.708 . . . . 1.3 109.159 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 65.6 m -56.64 -46.66 80.9 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 121.206 0.527 . . . . 1.1000000000000001 109.692 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.415 ' H ' HG23 ' A' ' 17' ' ' VAL . 2.6 t -65.25 -40.71 89.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 C-N-CA 119.695 -0.802 . . . . 0.98999999999999999 109.175 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.4 mm -60.98 -40.13 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.122 -0.986 . . . . 1.24 109.039 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 49.7 t -65.58 -45.58 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.181 -1.044 . . . . 1.01 108.181 177.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 85.8 mt -61.28 -49.53 84.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.915 -0.772 . . . . 1.01 108.915 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 11.2 mt -57.71 -48.7 78.84 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.987 -0.746 . . . . 1.1399999999999999 108.987 178.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.3 mt -56.95 -44.01 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 C-N-CA 119.845 -0.742 . . . . 1.1699999999999999 109.195 178.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.36 -45.99 88.6 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.599 -0.688 . . . . 0.93999999999999995 109.752 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.5 mt -59.2 -47.26 90.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.327 -0.858 . . . . 1.02 108.984 178.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.0 -44.95 95.64 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.591 -0.693 . . . . 0.94999999999999996 109.849 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.97 -44.71 96.93 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.54 -0.725 . . . . 1.0800000000000001 109.237 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.56 -45.92 90.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.44 -0.788 . . . . 1.3600000000000001 108.924 178.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.47 -43.98 95.6 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 108.69 -1.764 . . . . 1.01 108.69 178.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.68 -45.13 84.03 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.611 -0.935 . . . . 1.1000000000000001 109.748 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.0 mt -58.52 -41.43 85.44 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.758 -0.589 . . . . 1.5700000000000001 109.426 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 40.8 mt -69.32 -48.08 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.54 -0.725 . . . . 1.3999999999999999 109.478 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.83 -49.8 75.45 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.585 -0.697 . . . . 1.8500000000000001 110.189 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.747 0 N-CA-C 110.452 -1.059 . . . . 1.26 110.452 -179.948 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.441 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 2.0 tt0 . . . . . 0 N--CA 1.499 1.979 0 N-CA-C 109.35 -0.611 . . . . 1.52 109.35 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.542 ' HA ' ' HG2' ' A' ' 70' ' ' LYS . 0.5 OUTLIER -68.84 -41.77 78.08 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.885 -0.783 . . . . 3.1600000000000001 108.885 178.201 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 68.4 m -60.33 -37.89 82.03 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 116.19 -0.459 . . . . 1.8200000000000001 110.375 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.62 -41.58 16.23 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.278 -0.889 . . . . 1.3999999999999999 110.726 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.625 ' HA ' ' HB3' ' A' ' 73' ' ' CYS . 0.2 OUTLIER -65.82 -35.08 79.67 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.38 -0.825 . . . . 1.0800000000000001 111.5 -179.59 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.435 ' N ' ' HD2' ' A' ' 72' ' ' PRO . . . -48.97 -61.36 5.37 Favored Glycine 0 N--CA 1.505 3.259 0 N-CA-C 109.715 -1.354 . . . . 1.1899999999999999 109.715 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 71' ' ' GLY . 40.9 Cg_endo -66.97 -39.54 13.78 Favored 'Trans proline' 0 C--N 1.315 -1.225 0 O-C-N 123.755 1.397 . . . . 1.52 109.864 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.625 ' HB3' ' HA ' ' A' ' 70' ' ' LYS . 2.6 t -62.17 -48.5 79.78 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.878 -1.139 . . . . 1.3100000000000001 109.609 178.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.7 ' HA ' ' HE3' ' A' ' 77' ' ' LYS . 25.4 t -57.98 -49.93 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.286 -1.005 . . . . 1.0600000000000001 108.286 178.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -57.47 -40.05 77.7 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.763 -0.775 . . . . 1.5800000000000001 109.318 177.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.9 ttm180 -63.78 -54.88 28.21 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.694 -0.629 . . . . 1.51 111.187 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.7 ' HE3' ' HA ' ' A' ' 74' ' ' VAL . 1.6 pttt -70.62 -33.12 70.68 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.02 -1.05 . . . . 1.75 110.605 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.405 ' N ' ' HG3' ' A' ' 77' ' ' LYS . . . -68.07 -47.77 67.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.327 -0.858 . . . . 1.51 109.636 178.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 16.4 mmtm -67.23 -44.53 79.26 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.377 -0.827 . . . . 1.79 109.805 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 tp . . . . . 0 N--CA 1.495 1.785 0 O-C-N 121.628 -0.67 . . . . 2.5600000000000001 111.155 179.868 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.468 ' O ' HG23 ' A' ' 18' ' ' ILE . 37.9 t . . . . . 0 N--CA 1.498 1.964 0 N-CA-C 109.289 -0.634 . . . . 1.6299999999999999 109.289 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.637 ' HA ' HG12 ' A' ' 18' ' ' ILE . 25.0 t -67.09 -37.73 79.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.326 -0.859 . . . . 1.5900000000000001 109.468 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 98.4 m -64.61 -44.07 91.74 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.377 -0.827 . . . . 2.0 110.29 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.481 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 0.5 OUTLIER -71.48 -37.39 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 C-N-CA 119.133 -1.027 . . . . 1.98 110.908 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.777 ' HA ' HD23 ' A' ' 21' ' ' LEU . 8.7 pt -69.19 -33.74 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 120.299 -1.501 . . . . 1.9199999999999999 109.52 178.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.501 ' N ' HG13 ' A' ' 18' ' ' ILE . 38.6 t -69.63 -44.3 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.287 -1.005 . . . . 1.5700000000000001 108.287 177.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.6 mm -63.52 -46.78 94.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.401 -0.812 . . . . 1.7 109.027 178.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.777 HD23 ' HA ' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -63.28 -43.47 97.82 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.515 -0.74 . . . . 1.71 109.031 178.811 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.569 ' N ' ' HG ' ' A' ' 21' ' ' LEU . 7.5 mm -62.14 -39.07 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.029 -1.044 . . . . 1.8400000000000001 109.0 178.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.29 -51.0 61.74 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.549 -0.719 . . . . 1.45 110.715 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.605 HG12 ' HA ' ' A' ' 21' ' ' LEU . 40.8 pt -62.36 -37.12 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.807 -1.183 . . . . 1.78 109.266 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.514 ' N ' HG13 ' A' ' 24' ' ' ILE . . . -65.15 -46.59 80.27 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.418 -0.801 . . . . 1.54 109.192 178.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.6 -43.08 99.53 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.697 -0.853 . . . . 1.52 108.697 178.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.3 tt -60.38 -48.17 82.91 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.953 -0.758 . . . . 1.6799999999999999 108.953 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.72 -46.58 92.07 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 108.839 -1.705 . . . . 1.3400000000000001 108.839 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.69 -42.98 99.66 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.456 -1.026 . . . . 1.54 109.558 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.4 mt -61.2 -41.3 96.58 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 109.085 -0.709 . . . . 1.8300000000000001 109.085 178.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 23.5 mm -65.35 -46.14 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.519 -0.738 . . . . 1.4299999999999999 109.142 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.18 -48.61 80.77 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.543 -0.723 . . . . 1.97 109.63 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.605 0 N-CA-C 110.017 -1.233 . . . . 1.4199999999999999 110.017 179.221 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.422 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 6.0 tt0 . . . . . 0 N--CA 1.496 1.863 0 N-CA-C 108.758 -0.83 . . . . 2.4199999999999999 108.758 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.445 ' HA ' ' HG2' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -74.44 -45.8 44.0 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 109.259 -0.645 . . . . 4.1600000000000001 109.259 178.106 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 69.9 m -59.21 -37.09 76.6 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.748 -0.595 . . . . 2.4199999999999999 110.488 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -84.68 -46.48 11.43 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.054 -1.028 . . . . 1.6100000000000001 111.243 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.445 ' HG2' ' HA ' ' A' ' 67' ' ' TYR . 12.3 ptpt -65.17 -35.66 81.78 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.338 -0.851 . . . . 2.3700000000000001 111.213 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.401 ' N ' ' HD2' ' A' ' 72' ' ' PRO . . . -49.07 -64.22 3.44 Favored Glycine 0 N--CA 1.502 3.068 0 N-CA-C 109.795 -1.322 . . . . 1.46 109.795 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.401 ' HD2' ' N ' ' A' ' 71' ' ' GLY . 40.3 Cg_endo -66.11 -37.15 26.5 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.734 1.386 . . . . 1.47 110.245 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 2.5 t -62.41 -46.04 90.39 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.039 -1.038 . . . . 1.4099999999999999 109.593 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.5 t -68.66 -47.41 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.561 -0.712 . . . . 1.3999999999999999 109.311 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -57.41 -40.59 78.61 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 119.799 -0.76 . . . . 1.5 109.405 178.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.421 ' HA ' ' HG2' ' A' ' 79' ' ' LYS . 3.8 ttm180 -65.11 -44.22 89.47 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.53 -0.731 . . . . 2.5299999999999998 109.473 178.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.83 -38.7 89.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -0.871 . . . . 2.6499999999999999 109.786 178.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.04 -50.71 53.59 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.377 0.608 . . . . 1.1499999999999999 110.087 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.421 ' HG2' ' HA ' ' A' ' 76' ' ' ARG . 0.3 OUTLIER -65.64 -30.8 71.56 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.693 -0.63 . . . . 1.5600000000000001 110.109 179.469 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.8 0 O-C-N 121.245 -0.909 . . . . 2.3300000000000001 109.881 178.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 72.1 t . . . . . 0 N--CA 1.502 2.153 0 CA-C-O 121.417 0.627 . . . . 2.7000000000000002 110.16 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.404 ' H ' HG22 ' A' ' 15' ' ' VAL . 17.2 m -71.89 -42.42 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.2 -0.938 . . . . 3.48 109.847 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 56.7 m -58.22 -50.65 72.82 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.554 -0.717 . . . . 3.4199999999999999 110.175 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.4 m -66.03 -39.63 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.45 -0.781 . . . . 2.3900000000000001 110.104 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.563 ' O ' HG12 ' A' ' 22' ' ' ILE . 10.9 mm -64.98 -43.52 96.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 O-C-N 120.994 -1.066 . . . . 2.3100000000000001 109.445 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.518 ' HA ' HG12 ' A' ' 22' ' ' ILE . 32.2 t -61.78 -40.43 86.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 119.743 -0.783 . . . . 2.96 108.955 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 27.4 mm -69.43 -41.24 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.26 -0.9 . . . . 2.6099999999999999 108.746 178.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 39.6 mt -61.99 -50.62 71.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.712 -0.617 . . . . 1.5900000000000001 109.491 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.563 HG12 ' O ' ' A' ' 18' ' ' ILE . 43.5 pt -61.99 -41.16 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 120.815 -1.178 . . . . 2.5299999999999998 109.409 178.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.551 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -60.27 -45.86 91.85 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.04 -0.726 . . . . 1.99 109.04 178.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 39.0 mt -59.27 -48.26 87.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.689 -0.856 . . . . 1.52 108.689 178.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.98 -42.5 94.32 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.697 -0.627 . . . . 1.28 109.878 178.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.84 -45.53 92.17 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.922 -0.769 . . . . 1.79 108.922 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.68 -45.55 93.51 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.806 -0.813 . . . . 1.53 108.806 178.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.84 -45.54 94.84 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 108.54 -1.824 . . . . 1.1299999999999999 108.54 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.5 -44.73 95.67 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.507 -0.996 . . . . 1.6299999999999999 109.36 178.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.3 mt -56.78 -42.87 80.19 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.088 -0.708 . . . . 1.98 109.088 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.8 mt -68.83 -49.18 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 109.07 -0.715 . . . . 1.25 109.07 178.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.83 -46.05 71.07 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.496 -0.753 . . . . 3.0099999999999998 109.527 178.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.65 0 N-CA-C 109.925 -1.27 . . . . 1.8400000000000001 109.925 179.066 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.459 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 6.5 tp-100 . . . . . 0 N--CA 1.495 1.776 0 N-CA-C 108.918 -0.771 . . . . 2.3799999999999999 108.918 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -62.71 -42.45 99.66 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.518 -0.738 . . . . 2.52 109.459 178.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.2 m -56.72 -35.48 68.6 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-O 120.928 0.394 . . . . 2.5 110.703 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -91.69 -41.66 10.59 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.22 -0.925 . . . . 2.4900000000000002 110.601 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 66' ' ' GLN . 1.6 mmtp -65.23 -44.3 88.69 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.528 -0.733 . . . . 2.5600000000000001 110.392 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.404 ' N ' ' HD2' ' A' ' 72' ' ' PRO . . . -45.58 -63.68 2.67 Favored Glycine 0 N--CA 1.503 3.109 0 N-CA-C 110.22 -1.152 . . . . 1.8600000000000001 110.22 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' A' ' 71' ' ' GLY . 42.2 Cg_endo -66.65 -39.08 16.56 Favored 'Trans proline' 0 C--N 1.316 -1.18 0 O-C-N 123.783 1.412 . . . . 2.46 110.419 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 36.7 t -60.64 -43.9 97.02 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.997 -1.064 . . . . 2.7799999999999998 109.679 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.8 t -70.46 -49.42 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.682 -0.636 . . . . 1.9199999999999999 109.424 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.21 -31.21 68.83 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.536 0.684 . . . . 2.3900000000000001 110.3 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -75.28 -49.02 20.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.356 -0.84 . . . . 4.1699999999999999 109.542 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.535 ' HG3' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -69.25 -26.95 65.04 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.364 -0.835 . . . . 3.4700000000000002 109.662 179.237 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.535 ' N ' ' HG3' ' A' ' 77' ' ' LYS . . . -71.91 -52.28 18.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.451 -0.781 . . . . 2.0899999999999999 108.946 178.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -68.45 -24.74 64.76 Favored 'General case' 0 N--CA 1.5 2.067 0 C-N-CA 120.48 -0.488 . . . . 2.3799999999999999 110.312 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.5 tp . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.23 -0.918 . . . . 3.77 109.53 178.949 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.561 ' O ' HG12 ' A' ' 18' ' ' ILE . 28.1 t . . . . . 0 N--CA 1.497 1.883 0 N-CA-C 109.222 -0.658 . . . . 1.4099999999999999 109.222 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.603 ' HA ' HG12 ' A' ' 18' ' ' ILE . 49.8 t -68.25 -41.38 83.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.261 -0.899 . . . . 1.3 109.528 178.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 52.9 m -60.51 -47.5 85.9 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.403 -0.81 . . . . 1.8999999999999999 109.785 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.431 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 32.6 m -67.54 -41.65 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.465 -0.772 . . . . 1.77 111.272 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.872 ' HA ' HD23 ' A' ' 21' ' ' LEU . 4.0 pt -68.57 -33.56 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 120.292 -1.505 . . . . 1.28 109.925 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.486 ' N ' HG13 ' A' ' 18' ' ' ILE . 17.7 t -68.44 -44.39 83.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.24 -1.022 . . . . 1.3799999999999999 108.24 177.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 69.5 mt -63.69 -49.23 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 108.843 -0.799 . . . . 2.0299999999999998 108.843 178.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.872 HD23 ' HA ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -60.71 -42.66 97.7 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 119.926 -0.71 . . . . 1.6200000000000001 109.106 178.698 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.564 ' N ' ' HG ' ' A' ' 21' ' ' LEU . 14.9 mt -61.24 -44.13 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.226 -0.921 . . . . 1.1799999999999999 109.131 178.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.9 -45.74 87.94 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.514 -0.741 . . . . 1.23 109.593 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 54.6 mt -58.79 -47.77 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.437 -0.789 . . . . 2.0699999999999998 108.993 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.95 -44.83 95.94 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.561 -0.712 . . . . 1.3200000000000001 109.935 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.57 -45.64 93.17 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 109.149 -0.685 . . . . 0.92000000000000004 109.149 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.35 -45.96 92.2 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.488 -0.758 . . . . 1.9199999999999999 108.978 178.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.22 -45.35 94.2 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 108.617 -1.793 . . . . 1.3999999999999999 108.617 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.25 -44.94 93.77 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.639 -0.918 . . . . 1.22 109.888 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.7 mt -58.82 -41.28 86.49 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.618 -0.676 . . . . 1.5600000000000001 109.516 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 53.2 mt -68.22 -47.0 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.272 -0.893 . . . . 1.74 109.305 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.71 -39.37 93.81 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.358 -0.839 . . . . 2.1800000000000002 110.42 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.781 0 O-C-N 120.948 -1.095 . . . . 1.26 111.142 -179.658 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.484 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.812 0 N-CA-C 108.475 -0.935 . . . . 1.27 108.475 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -62.77 -41.45 99.23 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.586 -0.696 . . . . 3.0099999999999998 109.473 178.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 63.7 m -60.39 -37.56 81.2 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 122.035 -0.416 . . . . 1.5 110.308 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.499 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -81.58 -39.82 23.98 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.163 -0.961 . . . . 1.05 110.221 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 66' ' ' GLN . 2.6 mmpp? -61.57 -42.63 99.12 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.577 -0.702 . . . . 1.0600000000000001 110.54 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -43.09 -66.23 1.23 Allowed Glycine 0 N--CA 1.505 3.244 0 N-CA-C 110.526 -1.03 . . . . 0.82999999999999996 110.526 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.49 ' HA ' ' HB3' ' A' ' 75' ' ' GLU . 40.5 Cg_endo -66.32 -38.73 19.54 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.753 1.396 . . . . 1.03 110.235 179.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.499 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -58.38 -44.82 89.07 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.039 -1.038 . . . . 1.55 109.487 178.495 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 69.6 t -74.39 -41.76 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.55 -0.718 . . . . 0.73999999999999999 109.233 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.49 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 1.0 OUTLIER -54.75 -46.12 74.27 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 121.529 0.681 . . . . 1.0600000000000001 109.474 178.532 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -69.09 -46.35 67.99 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.719 -0.613 . . . . 1.0900000000000001 110.124 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.13 -36.29 79.36 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.531 -0.73 . . . . 1.6299999999999999 110.099 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.25 -46.65 73.11 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.972 -0.751 . . . . 1.0800000000000001 108.972 178.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 35.0 mtpt -62.48 -37.37 85.69 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.206 0.527 . . . . 1.3100000000000001 110.559 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.2 tp . . . . . 0 N--CA 1.496 1.862 0 O-C-N 121.607 -0.683 . . . . 1.9299999999999999 112.11 -178.683 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.541 ' O ' HG23 ' A' ' 18' ' ' ILE . 33.4 t . . . . . 0 N--CA 1.496 1.871 0 N-CA-C 109.265 -0.643 . . . . 2.1099999999999999 109.265 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.635 ' O ' HG22 ' A' ' 19' ' ' VAL . 33.9 t -68.21 -47.4 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.175 -0.953 . . . . 2.54 110.123 179.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.3 p -60.1 -37.98 81.58 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.522 -0.736 . . . . 2.3500000000000001 110.987 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.0 m -76.11 -37.71 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 120.946 -1.096 . . . . 1.75 111.095 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.541 HG23 ' O ' ' A' ' 14' ' ' VAL . 45.1 pt -70.54 -38.89 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.465 -1.397 . . . . 2.46 110.234 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.635 HG22 ' O ' ' A' ' 15' ' ' VAL . 33.7 m -68.95 -39.98 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 120.887 -1.133 . . . . 2.4900000000000002 108.755 178.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.446 ' HA ' HD13 ' A' ' 20' ' ' ILE . 14.6 mm -65.99 -47.32 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.037 -1.039 . . . . 2.2599999999999998 108.669 177.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.7 mt -59.09 -48.69 80.7 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.841 -0.8 . . . . 2.1000000000000001 108.841 178.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.1 mt -56.65 -43.79 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.578 -0.702 . . . . 2.6400000000000001 109.273 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.57 -46.0 87.88 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.621 -0.674 . . . . 2.2000000000000002 109.779 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 71.0 mt -59.62 -46.67 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.356 -0.84 . . . . 1.9399999999999999 108.893 178.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.65 -43.81 97.86 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.543 -0.723 . . . . 2.1800000000000002 109.869 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.67 -44.29 96.62 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.532 -0.73 . . . . 2.4300000000000002 109.141 178.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.2 tt -62.23 -45.94 91.1 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.839 -0.8 . . . . 2.3399999999999999 108.839 178.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.45 -46.03 93.64 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 108.694 -1.762 . . . . 2.1200000000000001 108.694 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.41 -43.6 97.06 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.504 -0.998 . . . . 2.48 109.915 179.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.6 mt -59.46 -41.08 88.87 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.595 -0.691 . . . . 2.9199999999999999 109.613 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 17.7 mt -70.1 -45.73 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.303 -0.873 . . . . 2.27 109.546 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -50.25 74.22 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.668 -0.645 . . . . 2.7999999999999998 110.01 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.753 0 N-CA-C 109.817 -1.313 . . . . 2.6000000000000001 109.817 179.522 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.469 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 5.3 tt0 . . . . . 0 N--CA 1.495 1.793 0 N-CA-C 108.834 -0.802 . . . . 3.46 108.834 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.711 ' HA ' ' HG2' ' A' ' 70' ' ' LYS . 6.9 m-85 -69.12 -40.91 78.03 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.712 -0.617 . . . . 3.9199999999999999 109.877 178.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -61.93 -37.88 86.34 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.626 -0.671 . . . . 3.1099999999999999 110.194 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.549 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -83.02 -41.99 18.03 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.289 -0.882 . . . . 2.3599999999999999 109.836 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.711 ' HG2' ' HA ' ' A' ' 67' ' ' TYR . 8.1 ptpt -65.78 -35.48 80.82 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.538 -0.726 . . . . 2.7200000000000002 110.652 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 70' ' ' LYS . . . -43.52 -64.21 1.9 Allowed Glycine 0 N--CA 1.501 2.996 0 N-CA-C 109.384 -1.486 . . . . 2.0499999999999998 109.384 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.628 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 43.2 Cg_endo -69.44 -45.54 1.72 Allowed 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.963 1.507 . . . . 2.4399999999999999 110.054 178.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.549 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -55.29 -42.58 73.82 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 120.942 -1.098 . . . . 2.2999999999999998 110.11 179.281 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.529 ' HA ' ' HG2' ' A' ' 77' ' ' LYS . 56.0 t -73.59 -45.21 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.831 -0.803 . . . . 1.72 108.831 178.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.585 ' HG2' ' HD2' ' A' ' 79' ' ' LYS . 1.6 tt0 -51.34 -45.19 62.24 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.872 0.844 . . . . 3.2799999999999998 108.902 177.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.628 ' HD2' ' O ' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -73.55 -49.32 27.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.847 -0.533 . . . . 3.7200000000000002 110.868 179.447 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.529 ' HG2' ' HA ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -66.82 -19.24 65.7 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.803 -1.185 . . . . 2.73 110.89 179.757 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -86.58 -39.96 15.66 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.775 -0.824 . . . . 2.3700000000000001 108.775 179.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.585 ' HD2' ' HG2' ' A' ' 75' ' ' GLU . 13.3 mttt -68.29 -37.79 81.02 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.222 -1.029 . . . . 3.6400000000000001 108.222 177.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.9 tp . . . . . 0 N--CA 1.487 1.419 0 O-C-N 121.924 -0.485 . . . . 3.8599999999999999 110.494 179.384 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.583 ' O ' HG12 ' A' ' 18' ' ' ILE . 26.0 t . . . . . 0 N--CA 1.496 1.843 0 N-CA-C 109.265 -0.643 . . . . 2.8199999999999998 109.265 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.662 ' HA ' HG12 ' A' ' 18' ' ' ILE . 16.5 t -70.45 -41.97 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.231 -0.918 . . . . 2.25 109.116 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.49 ' O ' HG12 ' A' ' 20' ' ' ILE . 40.7 m -57.16 -49.68 75.19 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.439 -0.788 . . . . 3.1499999999999999 109.642 178.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.628 ' HA ' HG12 ' A' ' 20' ' ' ILE . 35.8 m -66.82 -44.04 89.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 C-N-CA 119.814 -0.754 . . . . 2.8199999999999998 111.424 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.662 HG12 ' HA ' ' A' ' 15' ' ' VAL . 5.1 pt -66.14 -30.01 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 120.236 -1.54 . . . . 1.9199999999999999 109.679 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.458 ' N ' HG13 ' A' ' 18' ' ' ILE . 8.3 t -70.59 -51.82 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.233 -0.917 . . . . 2.4199999999999999 108.829 178.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.628 HG12 ' HA ' ' A' ' 17' ' ' VAL . 30.1 pt -64.46 -36.27 76.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.028 -1.045 . . . . 2.7599999999999998 109.173 178.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.486 ' N ' HG13 ' A' ' 20' ' ' ILE . 13.0 mt -66.32 -47.22 74.25 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.378 -0.826 . . . . 2.0699999999999998 108.831 177.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.44 HD13 ' HA ' ' A' ' 22' ' ' ILE . 7.3 mm -60.8 -41.35 88.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 108.724 -0.843 . . . . 2.04 108.724 178.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.53 -46.08 84.38 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.749 -0.595 . . . . 2.4199999999999999 109.454 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 43.5 mt -61.14 -45.12 99.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.344 -0.848 . . . . 2.3900000000000001 108.81 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.82 -44.87 91.95 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.519 -0.738 . . . . 2.1400000000000001 109.671 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.28 -41.55 98.58 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.722 -0.844 . . . . 2.6200000000000001 108.722 178.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.662 HD13 ' C ' ' A' ' 27' ' ' LEU . 3.2 tm? -61.91 -52.52 63.74 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.478 -0.934 . . . . 3.0499999999999998 108.478 177.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.14 -43.96 83.71 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.166 -1.574 . . . . 2.3399999999999999 109.166 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.29 -41.06 90.32 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.396 -1.061 . . . . 2.8199999999999998 109.808 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.3 mt -62.38 -40.07 95.27 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.981 -0.748 . . . . 3.6000000000000001 108.981 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.7 mm -71.05 -49.27 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.641 -0.662 . . . . 3.0499999999999998 109.292 178.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.75 -46.09 84.98 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.542 -0.724 . . . . 2.9700000000000002 109.616 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.666 0 N-CA-C 109.58 -1.408 . . . . 3.5 109.58 179.221 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.579 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 9.4 mm-40 . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 108.674 -0.862 . . . . 2.7000000000000002 108.674 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -63.04 -41.36 99.48 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.404 -0.961 . . . . 2.0800000000000001 108.404 178.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.536 ' O ' ' HD2' ' A' ' 72' ' ' PRO . 29.0 t -53.5 -42.63 67.53 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.496 -0.927 . . . . 1.6799999999999999 108.496 178.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.05 -38.63 69.46 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 119.581 -0.848 . . . . 1.98 109.246 177.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.579 ' HG2' ' O ' ' A' ' 66' ' ' GLN . 4.6 mmtm -58.18 -52.34 65.97 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.425 -0.797 . . . . 2.4300000000000002 110.245 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 70' ' ' LYS . . . -34.68 -68.38 0.23 Allowed Glycine 0 N--CA 1.51 3.602 0 N-CA-C 110.911 -0.876 . . . . 1.75 110.911 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.536 ' HD2' ' O ' ' A' ' 68' ' ' SER . 39.4 Cg_endo -66.51 -38.28 19.88 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.831 1.438 . . . . 2.8599999999999999 110.219 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 34.3 t -61.99 -40.98 97.49 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.995 -1.065 . . . . 3.6000000000000001 109.386 178.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 55.8 t -75.53 -48.22 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.655 -0.653 . . . . 3.0899999999999999 109.511 178.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.4 ' OE2' ' NZ ' ' A' ' 79' ' ' LYS . 5.2 tm-20 -57.44 -41.26 80.15 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.575 -0.898 . . . . 3.2400000000000002 108.575 178.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.471 ' HB3' ' O ' ' A' ' 72' ' ' PRO . 0.3 OUTLIER -65.53 -46.72 78.49 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.675 -0.64 . . . . 5.3600000000000003 109.736 178.465 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.0 -39.52 94.29 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.134 -0.978 . . . . 5.4000000000000004 109.703 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.83 -46.74 64.97 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.947 -0.471 . . . . 4.1799999999999997 110.278 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 76' ' ' ARG . 0.1 OUTLIER -69.53 -38.88 77.7 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.608 -0.683 . . . . 4.8099999999999996 109.48 179.353 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.495 1.789 0 O-C-N 121.441 -0.787 . . . . 5.9699999999999998 109.256 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 51.1 t . . . . . 0 N--CA 1.499 1.989 0 N-CA-C 109.569 -0.53 . . . . 2.3399999999999999 109.569 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.5 t -70.59 -43.15 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.073 -1.017 . . . . 2.0499999999999998 109.394 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 87.7 m -59.32 -50.81 72.55 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.735 -0.603 . . . . 1.3500000000000001 110.009 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.1 m -66.78 -34.9 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.489 -0.757 . . . . 1.6200000000000001 110.156 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.416 HD13 ' HA ' ' A' ' 18' ' ' ILE . 6.7 mm -68.08 -41.21 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 120.907 -1.121 . . . . 2.2400000000000002 109.632 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.4 t -64.89 -44.74 96.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 108.289 -1.004 . . . . 1.78 108.289 177.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 23.2 mm -61.82 -46.92 95.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.519 -0.738 . . . . 1.4199999999999999 109.056 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 11.3 mt -60.6 -49.18 78.55 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.868 -0.79 . . . . 1.9399999999999999 108.868 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.2 mt -56.62 -43.83 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 C-N-CA 119.837 -0.745 . . . . 2.1400000000000001 109.387 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.27 -46.08 85.28 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.615 -0.678 . . . . 1.45 110.176 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 40.6 mt -59.22 -48.15 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 108.852 -0.795 . . . . 1.51 108.852 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.59 -45.18 95.21 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.747 -0.595 . . . . 1.76 110.159 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.63 -49.78 76.16 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 109.086 -0.709 . . . . 1.6899999999999999 109.086 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.19 -46.12 86.36 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.016 -0.735 . . . . 1.4399999999999999 109.016 178.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.87 -46.18 92.72 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.073 -1.611 . . . . 1.45 109.073 178.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.13 -42.6 96.77 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.59 -0.947 . . . . 1.76 109.963 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.8 mt -61.3 -41.2 96.58 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.16 -0.682 . . . . 1.79 109.16 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 95.3 mt -67.32 -51.84 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.467 -0.771 . . . . 1.8300000000000001 109.154 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.94 -45.5 78.8 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.597 -0.689 . . . . 2.1699999999999999 109.921 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.671 0 N-CA-C 109.813 -1.315 . . . . 1.76 109.813 179.547 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 . . . . . 0 N--CA 1.497 1.909 0 CA-C-O 121.499 0.666 . . . . 1.8600000000000001 109.231 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -67.31 -40.14 85.99 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.751 -0.593 . . . . 2.0499999999999998 109.868 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 71.1 m -60.47 -32.37 71.35 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.872 -0.517 . . . . 1.75 110.686 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -94.07 -51.05 5.02 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.264 -0.897 . . . . 1.51 110.528 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -56.42 -43.93 79.88 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.44 -0.787 . . . . 1.47 110.93 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -46.64 -64.76 2.47 Favored Glycine 0 N--CA 1.503 3.108 0 N-CA-C 110.507 -1.037 . . . . 1.26 110.507 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -66.46 -40.35 14.36 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.844 1.444 . . . . 1.3100000000000001 110.303 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 34.3 t -59.31 -45.3 91.68 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.058 -1.026 . . . . 1.8100000000000001 109.816 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.9 t -70.61 -46.17 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.545 -0.722 . . . . 1.6899999999999999 109.182 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -55.77 -40.81 73.15 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 121.637 0.732 . . . . 2.1699999999999999 109.751 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.53 -47.7 59.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.85 -0.531 . . . . 1.73 110.622 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.608 ' HG3' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -67.11 -31.3 71.68 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.997 -1.064 . . . . 2.6400000000000001 110.057 179.573 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.608 ' N ' ' HG3' ' A' ' 77' ' ' LYS . . . -70.61 -47.84 58.09 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.173 -0.954 . . . . 2.1400000000000001 109.351 179.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.419 ' HG3' ' N ' ' A' ' 80' ' ' LEU . 6.9 ptpt -71.15 -34.75 71.28 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.827 -0.749 . . . . 1.9399999999999999 109.764 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.419 ' N ' ' HG3' ' A' ' 79' ' ' LYS . 0.8 OUTLIER . . . . . 0 N--CA 1.497 1.897 0 O-C-N 120.986 -1.071 . . . . 2.1200000000000001 109.948 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.5 m . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 120.724 0.297 . . . . 2.8300000000000001 110.273 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.403 ' O ' HG23 ' A' ' 19' ' ' VAL . 7.4 t -71.44 -48.32 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 120.945 -1.097 . . . . 4.0599999999999996 110.075 179.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 16.6 p -60.04 -49.29 78.23 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.365 -0.834 . . . . 4.8799999999999999 109.94 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.6 m -63.79 -36.97 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 C-N-CA 119.384 -0.926 . . . . 3.5299999999999998 109.855 178.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.436 HD13 ' HA ' ' A' ' 18' ' ' ILE . 6.0 mm -67.93 -38.64 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 120.792 -1.192 . . . . 2.4700000000000002 109.012 178.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 15' ' ' VAL . 51.0 t -65.84 -43.07 93.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.382 -0.969 . . . . 4.5300000000000002 108.382 177.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 57.7 mt -63.87 -47.3 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 108.728 -0.842 . . . . 4.5499999999999998 108.728 178.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 11.6 mt -59.37 -48.8 80.26 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.987 -0.745 . . . . 2.4399999999999999 108.987 178.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.0 mt -56.33 -43.05 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 121.549 -0.719 . . . . 3.5299999999999998 109.39 178.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.67 -45.47 78.79 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.461 -0.775 . . . . 3.8599999999999999 110.072 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 33.0 mt -60.65 -45.7 97.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.226 -0.921 . . . . 3.0899999999999999 109.264 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.95 -42.95 97.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.401 -0.812 . . . . 2.23 109.528 178.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.87 -42.58 97.49 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.368 -0.832 . . . . 3.6499999999999999 109.176 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.906 ' HA ' HD23 ' A' ' 30' ' ' LEU . 0.5 OUTLIER -63.02 -46.14 89.03 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.453 -0.943 . . . . 4.1299999999999999 108.453 178.025 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.509 ' O ' HD13 ' A' ' 32' ' ' LEU . . . -58.92 -47.5 90.3 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 108.425 -1.87 . . . . 2.2999999999999998 108.425 178.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.94 -45.08 96.15 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.506 -0.997 . . . . 3.25 110.208 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.906 HD23 ' HA ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -63.3 -37.32 86.8 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.442 -0.786 . . . . 4.5 109.697 179.238 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.513 ' N ' ' HG ' ' A' ' 30' ' ' LEU . 48.0 mt -71.2 -47.29 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.084 -1.01 . . . . 3.1000000000000001 109.185 178.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.509 HD13 ' O ' ' A' ' 28' ' ' GLY . 6.8 mp -57.83 -49.86 75.25 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.79 -0.569 . . . . 3.0 109.626 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.825 0 N-CA-C 110.199 -1.16 . . . . 4.1600000000000001 110.199 179.529 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.465 ' O ' ' CG ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 108.865 -0.791 . . . . 2.1699999999999999 108.865 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -68.25 -47.65 67.2 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.43 -0.794 . . . . 3.6800000000000002 109.864 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 69.6 m -55.19 -34.36 63.82 Favored 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 119.767 -0.773 . . . . 1.76 110.171 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -88.25 -46.44 9.23 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.202 -0.937 . . . . 1.3999999999999999 110.835 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.465 ' CG ' ' O ' ' A' ' 66' ' ' GLN . 2.6 mmtp -64.56 -40.18 95.1 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.418 -0.801 . . . . 2.0299999999999998 110.76 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -47.01 -64.88 2.5 Favored Glycine 0 N--CA 1.505 3.273 0 N-CA-C 110.006 -1.237 . . . . 2.1699999999999999 110.006 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.59 -37.93 20.53 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 O-C-N 123.714 1.376 . . . . 1.98 110.379 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 5.0 t -62.71 -42.87 99.87 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.979 -1.076 . . . . 2.4900000000000002 109.36 178.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.2 t -69.68 -44.77 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 109.048 -0.723 . . . . 3.0499999999999998 109.048 178.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.48 ' HG3' ' N ' ' A' ' 76' ' ' ARG . 0.1 OUTLIER -59.15 -42.26 90.26 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.889 -0.782 . . . . 2.98 108.889 178.42 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.48 ' N ' ' HG3' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -64.0 -53.05 56.06 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.628 -0.67 . . . . 3.21 109.597 178.776 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.88 -48.28 81.95 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.674 -0.641 . . . . 3.8799999999999999 109.95 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.47 -44.03 96.32 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.805 -0.56 . . . . 4.1900000000000004 110.788 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.42 ' HG3' ' CD ' ' A' ' 75' ' ' GLU . 12.6 mmtp -68.75 -42.91 76.87 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.164 -0.96 . . . . 4.1299999999999999 109.306 179.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.8 tp . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.447 0.641 . . . . 4.6399999999999997 109.84 178.839 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.3 t . . . . . 0 N--CA 1.501 2.075 0 CA-C-O 121.278 0.561 . . . . 1.0900000000000001 109.592 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.8 t -69.64 -43.42 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.107 -0.995 . . . . 1.25 108.981 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 49.3 m -56.69 -51.34 69.17 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.577 -0.702 . . . . 0.90000000000000002 109.939 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.629 ' HA ' HG12 ' A' ' 20' ' ' ILE . 35.2 m -64.75 -39.13 84.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.526 -0.734 . . . . 0.81999999999999995 110.278 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.411 HD13 ' HA ' ' A' ' 18' ' ' ILE . 6.7 mm -65.01 -36.72 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 120.819 -1.176 . . . . 1.0700000000000001 109.569 178.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.1 t -66.31 -52.44 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 C-N-CA 119.689 -0.805 . . . . 1.03 109.135 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.629 HG12 ' HA ' ' A' ' 17' ' ' VAL . 27.1 pt -63.74 -36.5 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.114 -0.991 . . . . 1.0 109.38 178.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.516 ' N ' HG13 ' A' ' 20' ' ' ILE . 7.6 mt -64.27 -48.58 75.17 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.596 -0.89 . . . . 0.89000000000000001 108.596 177.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.415 HD13 ' HA ' ' A' ' 22' ' ' ILE . 10.5 mm -59.04 -44.5 91.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.483 -0.76 . . . . 1.0900000000000001 109.071 178.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.21 -44.9 95.53 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.625 -0.672 . . . . 0.80000000000000004 109.908 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 44.5 mt -61.66 -46.51 96.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.403 -0.811 . . . . 0.81999999999999995 108.825 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.93 -44.11 97.45 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.648 -0.658 . . . . 0.77000000000000002 109.68 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.92 -45.41 93.82 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.423 -0.798 . . . . 0.81000000000000005 109.152 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.73 ' HA ' HD23 ' A' ' 30' ' ' LEU . 0.5 OUTLIER -61.46 -46.67 89.07 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.042 -0.725 . . . . 1.0 109.042 178.269 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.45 -43.33 97.56 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 108.874 -1.69 . . . . 0.59999999999999998 108.874 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.14 -43.96 93.63 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.492 -1.005 . . . . 0.79000000000000004 110.009 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.73 HD23 ' HA ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -62.84 -37.6 87.45 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.56 -0.712 . . . . 0.96999999999999997 109.272 178.904 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.511 ' N ' ' HG ' ' A' ' 30' ' ' LEU . 61.2 mt -71.62 -48.67 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.298 -0.876 . . . . 0.79000000000000004 108.972 178.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.01 -46.32 85.44 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.656 -0.652 . . . . 1.0700000000000001 109.774 178.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.659 0 N-CA-C 109.689 -1.364 . . . . 1.1899999999999999 109.689 179.343 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.451 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.969 0 N-CA-C 109.346 -0.613 . . . . 1.49 109.346 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.49 ' HA ' ' HG2' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -66.64 -41.93 87.48 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.617 -0.677 . . . . 0.75 109.381 178.482 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.7 m -56.82 -38.17 72.25 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.803 -0.561 . . . . 1.0800000000000001 109.744 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -82.38 -38.58 23.94 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.409 -0.807 . . . . 0.97999999999999998 110.235 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.49 ' HG2' ' HA ' ' A' ' 67' ' ' TYR . 5.5 ptpt -62.59 -37.52 86.58 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.476 -0.765 . . . . 0.78000000000000003 110.49 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -47.5 -63.94 3.13 Favored Glycine 0 N--CA 1.503 3.145 0 N-CA-C 110.452 -1.059 . . . . 0.81999999999999995 110.452 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.31 -38.7 19.71 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 123.673 1.354 . . . . 1.1499999999999999 110.099 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 7.5 t -62.15 -47.67 83.5 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.175 -0.953 . . . . 1.3300000000000001 109.9 178.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 45.7 t -66.27 -44.04 91.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.547 -0.721 . . . . 0.93000000000000005 109.326 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -56.8 -42.35 79.37 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 108.732 -0.84 . . . . 1.3500000000000001 108.732 178.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.419 ' NH2' ' HG2' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -62.94 -55.76 23.12 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.551 0.691 . . . . 2.6299999999999999 109.859 178.78 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.94 -54.59 44.93 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.362 0.601 . . . . 2.8199999999999998 110.754 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -53.09 -45.35 68.15 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.836 -0.54 . . . . 1.1100000000000001 111.056 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.3 mttp -72.56 -41.54 65.64 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.497 -0.752 . . . . 1.79 110.748 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.4 tp . . . . . 0 N--CA 1.497 1.887 0 O-C-N 121.245 -0.909 . . . . 2.2400000000000002 111.315 -179.534 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.9 m . . . . . 0 N--CA 1.496 1.83 0 CA-C-O 120.803 0.335 . . . . 4.1699999999999999 110.111 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.9 t -68.76 -41.41 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 120.997 -1.064 . . . . 3.9100000000000001 109.253 178.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 52.5 m -59.98 -52.19 66.44 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.709 -0.62 . . . . 3.6000000000000001 109.966 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.46 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 31.2 m -65.45 -34.6 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.536 -0.728 . . . . 3.6299999999999999 110.176 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.724 ' HA ' HD23 ' A' ' 21' ' ' LEU . 21.7 mt -68.73 -41.38 82.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.093 -1.004 . . . . 3.8300000000000001 109.216 178.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.5 t -64.41 -42.19 94.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.489 -0.93 . . . . 3.3500000000000001 108.489 177.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 83.3 mt -64.38 -48.97 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.525 -0.734 . . . . 3.2999999999999998 109.272 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.724 HD23 ' HA ' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -61.39 -43.23 99.23 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.675 -0.861 . . . . 3.4300000000000002 108.675 178.788 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.595 ' N ' ' HG ' ' A' ' 21' ' ' LEU . 15.0 mt -60.33 -44.92 96.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.319 -0.863 . . . . 3.3100000000000001 109.148 178.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.97 -46.03 86.48 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.724 -0.61 . . . . 2.8100000000000001 109.731 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.3 mm -59.39 -45.6 93.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.41 -0.806 . . . . 2.8599999999999999 109.146 178.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.78 -45.86 87.84 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.525 -0.734 . . . . 2.8599999999999999 109.771 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.8 -41.89 96.51 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.732 -0.84 . . . . 2.6099999999999999 108.732 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.664 ' C ' HD13 ' A' ' 27' ' ' LEU . 3.4 tm? -60.65 -53.49 56.75 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.899 -0.778 . . . . 2.46 108.899 178.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.62 -43.74 86.08 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 108.905 -1.678 . . . . 2.3500000000000001 108.905 178.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.65 -44.65 95.73 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.414 -1.051 . . . . 2.5 109.74 178.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.4 mt -59.08 -41.17 87.37 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.649 -0.657 . . . . 2.4900000000000002 109.481 178.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.7 mt -69.45 -40.93 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.544 -0.723 . . . . 2.3100000000000001 109.658 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.29 -42.76 87.89 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.548 -0.72 . . . . 3.29 110.264 178.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.723 0 O-C-N 120.883 -1.135 . . . . 2.1600000000000001 110.57 -179.802 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.539 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 5.2 mm-40 . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.008 -0.738 . . . . 3.6800000000000002 109.008 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -65.51 -41.22 93.41 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.324 -0.621 . . . . 2.9199999999999999 109.324 178.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.448 ' O ' ' CD ' ' A' ' 72' ' ' PRO . 63.5 m -55.38 -33.34 63.38 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 109.14 -0.689 . . . . 2.9300000000000002 109.14 178.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.503 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -80.73 -40.57 25.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.646 -0.659 . . . . 3.3399999999999999 109.393 178.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.539 ' HG2' ' O ' ' A' ' 66' ' ' GLN . 5.6 mmtm -58.97 -51.75 68.7 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.563 -0.71 . . . . 3.5800000000000001 110.739 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -39.69 -64.87 0.96 Allowed Glycine 0 N--CA 1.505 3.294 0 N-CA-C 110.922 -0.871 . . . . 3.1600000000000001 110.922 -179.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.572 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 39.6 Cg_endo -65.53 -39.42 21.59 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 O-C-N 123.834 1.439 . . . . 3.8500000000000001 110.651 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 0.9 OUTLIER -63.44 -44.94 93.07 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.083 -1.01 . . . . 4.25 109.627 179.007 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.41 ' O ' ' HG3' ' A' ' 77' ' ' LYS . 41.4 t -67.17 -47.31 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.711 -0.848 . . . . 3.7799999999999998 108.711 178.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -58.03 -39.29 78.01 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.515 0.674 . . . . 4.3700000000000001 109.332 178.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.572 ' HB2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -63.69 -64.26 0.95 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.749 -0.595 . . . . 4.79 110.389 178.902 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.465 ' HG3' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -59.57 -31.82 69.79 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 120.053 -0.659 . . . . 4.6699999999999999 110.864 -179.46 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.465 ' N ' ' HG3' ' A' ' 77' ' ' LYS . . . -65.26 -43.25 91.89 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.183 -0.948 . . . . 4.3700000000000001 108.972 178.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.1 mttt -72.26 -49.91 31.34 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.173 -0.677 . . . . 4.9699999999999998 109.173 178.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.815 0 CA-C-O 121.348 0.594 . . . . 6.1299999999999999 110.204 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.424 ' HA ' ' CG2' ' A' ' 17' ' ' VAL . 31.2 m . . . . . 0 N--CA 1.496 1.867 0 N-CA-C 110.026 -0.361 . . . . 1.3700000000000001 110.026 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.0 t -68.54 -45.83 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.126 -0.984 . . . . 1.9399999999999999 109.312 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 51.7 m -57.94 -51.37 69.93 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.717 -0.614 . . . . 1.75 109.943 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.424 ' CG2' ' HA ' ' A' ' 14' ' ' VAL . 25.4 m -64.77 -35.59 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.437 -0.789 . . . . 1.27 110.138 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.413 HD13 ' HA ' ' A' ' 18' ' ' ILE . 6.6 mm -67.98 -41.2 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 121.034 -1.041 . . . . 1.8200000000000001 109.19 178.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 37.8 t -65.1 -44.58 95.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.466 -0.939 . . . . 2.0 108.466 178.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.429 ' HA ' HD13 ' A' ' 20' ' ' ILE . 21.7 mm -62.41 -46.98 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 108.99 -0.745 . . . . 1.55 108.99 178.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 11.4 mt -59.88 -49.4 77.85 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.833 -0.803 . . . . 1.55 108.833 178.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.419 HD13 ' HA ' ' A' ' 22' ' ' ILE . 11.5 mm -57.11 -43.66 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.591 -0.693 . . . . 2.25 109.313 178.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.63 -45.82 91.08 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.57 -0.706 . . . . 1.74 109.608 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 58.6 mt -59.34 -49.25 84.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.397 -0.814 . . . . 1.53 108.855 178.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.76 -43.67 97.7 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.648 -0.658 . . . . 1.98 110.023 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.28 -43.55 98.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.376 -0.827 . . . . 2.1899999999999999 109.061 178.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.411 ' HG ' HD12 ' A' ' 31' ' ' ILE . 0.8 OUTLIER -62.38 -46.83 86.87 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.613 -0.884 . . . . 1.8100000000000001 108.613 178.139 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.84 -48.14 80.67 Favored Glycine 0 N--CA 1.496 2.633 0 N-CA-C 108.654 -1.778 . . . . 1.8999999999999999 108.654 178.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.22 -44.03 97.93 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.427 -1.043 . . . . 2.4199999999999999 109.966 178.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.5 mt -60.53 -39.23 87.1 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.627 -0.671 . . . . 2.7400000000000002 109.98 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.411 HD12 ' HG ' ' A' ' 27' ' ' LEU . 3.7 mt -72.79 -47.54 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.27 -0.894 . . . . 1.9399999999999999 109.162 179.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.66 -46.52 84.14 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.364 -0.835 . . . . 2.6200000000000001 109.637 178.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.726 0 N-CA-C 109.472 -1.451 . . . . 2.73 109.472 179.279 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.498 1.952 0 N-CA-C 108.965 -0.754 . . . . 2.6299999999999999 108.965 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -78.03 -46.48 20.82 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.246 -0.649 . . . . 5.54 109.246 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 75.5 m -54.79 -33.55 61.57 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 122.083 -0.386 . . . . 3.71 110.071 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.578 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -87.72 -50.71 6.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.303 -0.873 . . . . 3.1600000000000001 109.871 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.1 mtmt -59.42 -51.57 69.33 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.771 -0.581 . . . . 2.0699999999999998 111.712 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -40.91 -63.53 1.46 Allowed Glycine 0 N--CA 1.505 3.261 0 N-CA-C 110.352 -1.099 . . . . 2.5099999999999998 110.352 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.505 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 41.9 Cg_endo -67.51 -43.15 6.11 Favored 'Trans proline' 0 C--N 1.315 -1.186 0 O-C-N 123.939 1.494 . . . . 3.5499999999999998 110.275 178.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.578 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 1.2 t -56.0 -44.52 78.71 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.844 -1.16 . . . . 2.5 109.554 178.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 49.0 t -68.34 -50.61 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 108.899 -0.778 . . . . 1.8200000000000001 108.899 178.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -52.01 -41.32 62.13 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.561 0.696 . . . . 4.1699999999999999 109.918 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.505 ' HD2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -68.21 -56.11 9.87 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.757 -0.589 . . . . 4.6799999999999997 111.587 -179.655 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.424 ' HG3' ' N ' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -64.31 -33.65 76.33 Favored 'General case' 0 N--CA 1.505 2.319 0 C-N-CA 119.075 -1.05 . . . . 2.1499999999999999 110.46 -179.254 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.424 ' N ' ' HG3' ' A' ' 77' ' ' LYS . . . -67.07 -50.47 61.67 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.519 -0.738 . . . . 2.9500000000000002 110.097 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.8 pttt -73.98 -32.87 63.63 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.153 -0.967 . . . . 4.6799999999999997 111.216 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.5 tp . . . . . 0 N--CA 1.494 1.768 0 O-C-N 121.192 -0.942 . . . . 3.1800000000000002 110.551 179.673 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 76.6 t . . . . . 0 N--CA 1.499 1.981 0 N-CA-C 108.702 -0.851 . . . . 1.8600000000000001 108.702 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.7 t -64.71 -45.24 95.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.567 -0.708 . . . . 2.3199999999999998 109.229 178.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 46.1 m -58.03 -46.78 84.76 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.651 -0.656 . . . . 3.0299999999999998 109.283 178.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.7 t -65.82 -38.92 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 C-N-CA 119.586 -0.846 . . . . 2.3900000000000001 109.242 178.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.661 ' HA ' HD23 ' A' ' 21' ' ' LEU . 10.0 mm -62.39 -41.41 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.016 -1.053 . . . . 1.55 109.077 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.9 t -66.06 -40.94 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.643 -0.873 . . . . 2.4500000000000002 108.643 177.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.435 ' O ' HG23 ' A' ' 24' ' ' ILE . 92.4 mt -65.7 -50.12 73.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.522 -0.736 . . . . 2.9399999999999999 109.074 178.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.661 HD23 ' HA ' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -61.59 -42.84 99.44 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 119.914 -0.714 . . . . 1.76 109.383 178.711 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.571 ' N ' ' HG ' ' A' ' 21' ' ' LEU . 10.4 mm -62.7 -38.54 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 120.972 -1.08 . . . . 1.79 109.106 178.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.97 -50.58 54.93 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.481 -0.762 . . . . 2.0499999999999998 110.724 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.602 HG12 ' HA ' ' A' ' 21' ' ' LEU . 29.3 pt -62.52 -37.26 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 120.955 -1.091 . . . . 2.46 109.283 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.551 ' N ' HG13 ' A' ' 24' ' ' ILE . . . -65.75 -46.98 76.83 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.435 -0.791 . . . . 1.6000000000000001 108.909 178.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.05 -44.06 97.96 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.008 -0.738 . . . . 1.6299999999999999 109.008 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.1 tt -61.22 -45.86 92.81 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.36 -0.838 . . . . 2.52 108.93 178.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.3 -46.47 92.87 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.003 -1.639 . . . . 1.76 109.003 178.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.89 -41.44 95.62 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.532 -0.981 . . . . 1.8300000000000001 109.89 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.6 mt -59.11 -42.12 89.78 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.821 -0.807 . . . . 2.3199999999999998 108.821 178.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.402 ' HA ' HD13 ' A' ' 31' ' ' ILE . 27.7 mm -70.07 -45.93 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 109.068 -0.716 . . . . 2.1299999999999999 109.068 178.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.1 tt -56.31 -47.34 78.9 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.727 -0.608 . . . . 3.2400000000000002 109.625 178.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.51 0 N-CA-C 109.85 -1.3 . . . . 1.99 109.85 179.399 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.476 ' O ' ' CG ' ' A' ' 70' ' ' LYS . 41.0 tt0 . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 108.534 -0.913 . . . . 2.79 108.534 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -63.32 -35.43 80.34 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.359 -0.838 . . . . 2.3100000000000001 109.672 178.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.75 -42.2 98.67 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.603 -0.686 . . . . 2.71 110.553 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.518 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -88.22 -41.18 13.12 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.063 -1.023 . . . . 2.7200000000000002 110.938 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.476 ' CG ' ' O ' ' A' ' 66' ' ' GLN . 5.4 mmtt -66.46 -42.01 88.21 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.651 -0.656 . . . . 2.3900000000000001 110.042 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -44.91 -62.64 2.89 Favored Glycine 0 N--CA 1.502 3.063 0 N-CA-C 110.142 -1.183 . . . . 1.5900000000000001 110.142 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -66.75 -37.8 19.86 Favored 'Trans proline' 0 C--N 1.314 -1.255 0 O-C-N 123.627 1.33 . . . . 2.2400000000000002 110.756 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.518 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 0.4 OUTLIER -66.21 -43.8 85.71 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.04 -1.038 . . . . 2.5899999999999999 109.8 179.075 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.3 t -70.72 -43.73 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.792 -0.568 . . . . 1.49 109.618 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -55.49 -43.11 75.31 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.57 0.7 . . . . 2.6200000000000001 109.89 178.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.425 ' HA ' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -68.92 -48.27 63.7 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.488 0.661 . . . . 2.8300000000000001 109.969 179.291 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 67.4 mttt -60.08 -55.13 37.74 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.545 0.688 . . . . 2.1499999999999999 109.935 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -53.37 -50.73 64.48 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 122.032 -0.417 . . . . 1.05 110.524 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.442 ' HG3' ' N ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -67.87 -25.74 65.67 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.417 -0.802 . . . . 2.6299999999999999 110.714 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.442 ' N ' ' HG3' ' A' ' 79' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.064 -1.022 . . . . 2.21 110.069 179.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.496 1.833 0 N-CA-C 109.35 -0.611 . . . . 4.6600000000000001 109.35 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.0 t -67.78 -43.26 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 120.981 -1.075 . . . . 3.2799999999999998 109.135 178.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.409 ' O ' HG12 ' A' ' 20' ' ' ILE . 63.3 m -59.56 -51.87 68.0 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.613 -0.679 . . . . 2.9100000000000001 109.954 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.623 ' HA ' HG12 ' A' ' 20' ' ' ILE . 31.2 m -64.42 -38.18 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 119.505 -0.878 . . . . 3.7999999999999998 109.854 179.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.693 ' HA ' HD23 ' A' ' 21' ' ' LEU . 19.2 mt -65.21 -38.12 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 120.759 -1.213 . . . . 3.9500000000000002 109.253 178.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.6 t -67.49 -48.05 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.237 -0.914 . . . . 2.4500000000000002 109.584 178.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.623 HG12 ' HA ' ' A' ' 17' ' ' VAL . 3.3 pt -68.01 -34.87 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.886 -1.134 . . . . 3.1299999999999999 109.968 179.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.693 HD23 ' HA ' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -70.99 -42.65 69.38 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.815 -1.178 . . . . 3.5600000000000001 108.308 177.73 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.548 ' N ' ' HG ' ' A' ' 21' ' ' LEU . 13.1 mt -60.77 -43.77 96.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.111 -0.993 . . . . 3.0600000000000001 108.436 177.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.75 -46.38 85.56 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.608 -0.682 . . . . 1.9199999999999999 109.731 178.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.417 HD13 ' HA ' ' A' ' 24' ' ' ILE . 8.1 mm -59.49 -47.2 91.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.131 -0.981 . . . . 2.5099999999999998 109.005 178.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.27 -43.91 97.74 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.456 -0.778 . . . . 2.6899999999999999 109.591 178.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.18 -42.65 99.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.466 -0.771 . . . . 2.1499999999999999 109.274 178.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.2 tt -63.39 -46.38 86.69 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.678 -0.86 . . . . 1.8200000000000001 108.678 178.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.77 -45.04 95.44 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 108.692 -1.763 . . . . 1.9299999999999999 108.692 178.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.23 -44.03 93.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.507 -0.996 . . . . 2.6499999999999999 109.468 178.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.2 mt -58.73 -41.61 86.85 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.023 -0.732 . . . . 2.73 109.023 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 22.4 mm -68.93 -50.12 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.489 -0.757 . . . . 1.79 109.38 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.62 -43.07 79.83 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.567 -0.708 . . . . 3.1000000000000001 109.689 178.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.508 0 N-CA-C 109.491 -1.444 . . . . 2.8399999999999999 109.491 178.977 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 107.911 -1.144 . . . . 2.3500000000000001 107.911 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -69.22 -43.69 73.56 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.329 0.585 . . . . 3.1299999999999999 109.646 178.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.437 ' O ' ' CD ' ' A' ' 72' ' ' PRO . 0.4 OUTLIER -59.35 -37.93 79.09 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.957 -0.464 . . . . 2.7999999999999998 110.437 179.479 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.27 -43.74 13.48 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.046 -1.034 . . . . 1.6599999999999999 110.15 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 32.5 mtmt -63.81 -46.67 84.12 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.577 -0.702 . . . . 2.6099999999999999 110.635 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 75' ' ' GLU . . . -41.33 -64.87 1.23 Allowed Glycine 0 N--CA 1.506 3.334 0 N-CA-C 109.947 -1.261 . . . . 2.1000000000000001 109.947 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.573 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 42.5 Cg_endo -68.42 -41.31 6.74 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 O-C-N 123.956 1.503 . . . . 2.1000000000000001 110.083 178.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 35.1 t -58.33 -39.54 79.73 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.839 -1.163 . . . . 2.0600000000000001 109.94 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.543 ' HA ' ' HG2' ' A' ' 77' ' ' LYS . 24.1 t -74.92 -48.39 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.435 -0.791 . . . . 2.48 109.089 178.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.64 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 1.0 OUTLIER -54.63 -43.94 72.72 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.89 -0.724 . . . . 3.3700000000000001 109.178 178.349 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.573 ' HD2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -64.66 -48.62 74.11 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.581 -0.7 . . . . 3.1099999999999999 110.157 179.126 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.638 ' HG3' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -62.46 -32.66 73.58 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.073 -1.017 . . . . 3.3100000000000001 109.397 179.02 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.638 ' N ' ' HG3' ' A' ' 77' ' ' LYS . . . -72.2 -43.26 64.75 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.546 -0.721 . . . . 3.4300000000000002 109.171 178.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.64 ' HG2' ' O ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -68.45 -34.04 75.24 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.637 -0.665 . . . . 4.0 109.502 178.673 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.567 -0.708 . . . . 4.0800000000000001 110.416 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.403 ' HA ' HG22 ' A' ' 17' ' ' VAL . 34.0 m . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 120.792 0.329 . . . . 1.98 110.171 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.1 t -70.31 -43.06 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 120.983 -1.073 . . . . 2.3799999999999999 109.264 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 54.9 m -58.95 -51.69 68.95 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.848 -0.532 . . . . 1.8500000000000001 109.879 179.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.454 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 27.0 m -64.66 -35.73 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.468 -0.77 . . . . 1.3700000000000001 110.116 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.587 HD13 HD23 ' A' ' 21' ' ' LEU . 7.0 mm -66.79 -43.88 89.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.013 -1.054 . . . . 2.1499999999999999 109.366 178.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.3 t -63.28 -42.22 95.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 108.72 -0.844 . . . . 2.2799999999999998 108.72 178.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 79.1 mt -64.5 -48.56 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.506 -0.746 . . . . 1.54 109.464 178.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.587 HD23 HD13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -62.27 -43.13 99.53 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.783 -0.821 . . . . 1.8600000000000001 108.783 178.818 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.553 ' N ' ' HG ' ' A' ' 21' ' ' LEU . 32.2 mt -59.49 -45.21 93.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.358 -0.839 . . . . 2.3399999999999999 109.101 178.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.87 -46.53 84.53 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.541 -0.725 . . . . 1.6799999999999999 109.836 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 55.6 mt -57.62 -46.81 86.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.511 -0.743 . . . . 1.4099999999999999 109.247 178.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.21 -45.72 87.01 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.543 -0.723 . . . . 1.8300000000000001 109.992 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.12 -46.04 89.35 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.44 -0.787 . . . . 1.98 108.97 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.541 ' O ' HG12 ' A' ' 31' ' ' ILE . 2.4 tt -61.69 -48.04 82.58 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.834 -0.802 . . . . 1.6100000000000001 108.834 178.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.502 ' O ' HG13 ' A' ' 31' ' ' ILE . . . -53.76 -39.23 61.05 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 109.623 -1.391 . . . . 1.6299999999999999 109.623 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.27 -41.93 47.29 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.233 -1.157 . . . . 2.0 109.517 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.6 mt -53.99 -45.88 71.57 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.148 0.499 . . . . 2.5800000000000001 109.685 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.541 HG12 ' O ' ' A' ' 27' ' ' LEU . 1.3 pt -77.13 -43.95 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.416 -0.803 . . . . 1.5600000000000001 111.105 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.445 ' H ' HG13 ' A' ' 31' ' ' ILE . 1.3 tt -56.96 -45.42 82.87 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.047 -1.033 . . . . 2.5800000000000001 109.103 178.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.443 0 N-CA-C 109.532 -1.427 . . . . 2.1000000000000001 109.532 179.247 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.501 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 1.7 tt0 . . . . . 0 N--CA 1.488 1.431 0 N-CA-C 109.534 -0.543 . . . . 2.4300000000000002 109.534 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.473 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 11.1 m-85 -74.38 -49.41 22.78 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.562 -0.711 . . . . 2.5600000000000001 111.006 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.439 ' O ' ' CD ' ' A' ' 72' ' ' PRO . 0.8 OUTLIER -63.07 -34.19 77.07 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.378 -0.826 . . . . 2.4100000000000001 110.62 -179.923 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -79.59 -43.47 22.88 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.025 -1.047 . . . . 1.8300000000000001 110.078 179.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.501 ' HB3' ' O ' ' A' ' 66' ' ' GLN . 12.7 ptpt -68.82 -31.73 70.92 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.428 -0.795 . . . . 2.0600000000000001 110.801 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.406 ' N ' ' HD2' ' A' ' 72' ' ' PRO . . . -47.6 -63.93 3.17 Favored Glycine 0 N--CA 1.5 2.949 0 N-CA-C 109.228 -1.549 . . . . 1.53 109.228 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.531 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 41.5 Cg_endo -68.44 -41.1 6.96 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.886 1.466 . . . . 2.0800000000000001 109.666 178.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 4.1 t -55.75 -43.81 77.0 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.013 -1.054 . . . . 2.2000000000000002 109.236 178.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 37.9 t -74.5 -45.09 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.504 -0.747 . . . . 1.55 109.351 178.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -53.57 -43.21 68.31 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.708 0.766 . . . . 2.3799999999999999 109.189 178.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.531 ' HD2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -71.06 -44.75 65.12 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.391 -0.596 . . . . 3.3700000000000001 109.391 178.663 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.84 -40.28 79.69 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 120.223 -0.591 . . . . 2.98 110.231 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.65 -41.24 60.69 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.041 0.448 . . . . 2.21 110.322 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.2 mttp -65.52 -43.86 88.7 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 121.504 0.669 . . . . 2.6800000000000002 109.325 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.687 -0.633 . . . . 3.6499999999999999 109.974 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.583 ' O ' HG23 ' A' ' 18' ' ' ILE . 61.5 t . . . . . 0 N--CA 1.496 1.87 0 N-CA-C 109.529 -0.545 . . . . 2.0899999999999999 109.529 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.64 ' HA ' HG12 ' A' ' 18' ' ' ILE . 43.6 t -71.11 -41.39 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.309 -0.869 . . . . 1.3500000000000001 109.707 179.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.419 ' O ' HG12 ' A' ' 20' ' ' ILE . 50.2 m -59.81 -46.63 88.64 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.525 -0.734 . . . . 1.0600000000000001 109.92 179.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.547 ' HA ' HG12 ' A' ' 20' ' ' ILE . 35.7 m -68.9 -42.67 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.436 -0.79 . . . . 1.6000000000000001 111.312 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.64 HG12 ' HA ' ' A' ' 15' ' ' VAL . 15.6 pt -65.42 -31.64 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 120.166 -1.584 . . . . 1.79 109.608 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.459 ' N ' HG13 ' A' ' 18' ' ' ILE . 21.2 t -70.06 -48.88 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.476 -0.765 . . . . 1.1399999999999999 109.342 178.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.547 HG12 ' HA ' ' A' ' 17' ' ' VAL . 2.5 pt -68.22 -31.35 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 120.638 -1.289 . . . . 1.4299999999999999 108.847 178.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.473 ' N ' HG13 ' A' ' 20' ' ' ILE . 10.0 mt -66.66 -52.33 46.08 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.334 -0.854 . . . . 1.78 109.24 177.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.549 HG23 ' O ' ' A' ' 18' ' ' ILE . 30.9 pt -59.53 -42.38 87.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 C-N-CA 118.851 -1.139 . . . . 1.6899999999999999 109.288 178.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.455 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -61.03 -46.8 89.24 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 120.294 -0.562 . . . . 1.1000000000000001 109.707 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.413 HD13 ' HA ' ' A' ' 24' ' ' ILE . 6.1 mm -60.51 -45.53 96.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.256 -0.902 . . . . 1.1799999999999999 108.952 178.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.38 -43.95 97.99 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.563 -0.711 . . . . 1.49 109.666 178.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.81 -44.31 96.51 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.116 -0.698 . . . . 1.49 109.116 178.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.05 -44.53 96.49 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.806 -0.813 . . . . 1.29 108.806 178.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.69 -45.9 94.93 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 108.756 -1.738 . . . . 1.0700000000000001 108.756 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.99 -43.63 95.1 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.502 -0.999 . . . . 1.5700000000000001 109.821 178.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.4 mt -58.27 -41.61 84.7 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.063 -0.717 . . . . 1.99 109.063 178.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 59.9 mt -70.07 -48.26 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.465 -0.772 . . . . 1.0600000000000001 109.411 178.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.12 -48.83 77.69 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.429 -0.795 . . . . 2.1200000000000001 110.255 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.836 0 N-CA-C 109.577 -1.409 . . . . 1.47 109.577 179.277 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.531 ' O ' ' HB2' ' A' ' 70' ' ' LYS . 1.8 mm100 . . . . . 0 N--CA 1.493 1.722 0 N-CA-C 108.245 -1.02 . . . . 1.04 108.245 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -71.37 -47.03 58.82 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.604 -0.685 . . . . 4.3799999999999999 109.841 178.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.432 ' O ' ' CD ' ' A' ' 72' ' ' PRO . 65.0 m -54.56 -46.8 73.72 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.933 -0.479 . . . . 1.0700000000000001 110.211 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.536 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -72.41 -57.58 4.07 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.202 -0.936 . . . . 0.83999999999999997 111.308 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.539 ' HD2' ' N ' ' A' ' 70' ' ' LYS . 3.8 mptt -52.71 -60.49 3.19 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.432 -0.793 . . . . 0.95999999999999996 112.914 -179.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 70' ' ' LYS . . . -31.74 -67.44 0.15 Allowed Glycine 0 N--CA 1.51 3.597 0 N-CA-C 111.55 -0.62 . . . . 1.1499999999999999 111.55 -178.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.552 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 40.2 Cg_endo -66.28 -40.97 13.52 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.698 1.367 . . . . 1.1699999999999999 110.649 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.536 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -58.9 -42.95 90.79 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.825 -1.172 . . . . 1.5800000000000001 109.277 178.688 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 55.0 t -71.69 -45.04 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 109.327 -0.619 . . . . 1.3700000000000001 109.327 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 1.2 tm-20 -57.08 -42.2 80.22 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 119.855 -0.738 . . . . 1.72 109.427 178.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.552 ' HD2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -66.99 -50.15 63.17 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.5 -0.75 . . . . 1.7 109.703 178.889 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.38 -41.62 85.24 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 120.01 -0.676 . . . . 2.2400000000000002 109.595 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.96 -49.03 69.34 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.97 -0.456 . . . . 1.76 109.918 179.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.05 -49.26 76.69 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.206 -0.934 . . . . 1.99 109.807 179.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 24.3 tp . . . . . 0 N--CA 1.499 2.011 0 O-C-N 121.429 -0.795 . . . . 3.1800000000000002 111.393 -179.701 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.597 ' O ' HG12 ' A' ' 18' ' ' ILE . 39.9 t . . . . . 0 N--CA 1.498 1.939 0 N-CA-C 109.109 -0.7 . . . . 1.6799999999999999 109.109 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.628 ' HA ' HG12 ' A' ' 18' ' ' ILE . 34.2 t -70.73 -42.41 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.242 -0.912 . . . . 1.8400000000000001 108.963 178.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 54.2 m -58.16 -46.78 85.1 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.487 -0.758 . . . . 1.97 109.979 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.8 m -70.16 -41.21 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.271 -0.893 . . . . 1.8400000000000001 111.188 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.628 HG12 ' HA ' ' A' ' 15' ' ' VAL . 4.8 pt -67.89 -33.92 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 120.163 -1.586 . . . . 1.8400000000000001 109.676 178.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.488 ' N ' HG13 ' A' ' 18' ' ' ILE . 20.8 t -67.7 -43.39 86.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 108.41 -0.959 . . . . 1.8799999999999999 108.41 177.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 87.5 mt -67.4 -40.24 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.117 -1.068 . . . . 2.0299999999999998 108.117 177.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.412 ' HB2' ' HA ' ' A' ' 18' ' ' ILE . 10.7 mt -60.8 -52.79 63.58 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.87 -0.519 . . . . 2.1600000000000001 109.817 178.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.545 HG12 ' O ' ' A' ' 18' ' ' ILE . 41.4 pt -59.9 -41.69 86.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 120.943 -1.098 . . . . 1.8799999999999999 109.697 179.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.483 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -61.83 -45.76 92.43 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 120.146 -0.622 . . . . 1.9299999999999999 109.594 178.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.418 ' HA ' HD13 ' A' ' 24' ' ' ILE . 15.8 mm -61.97 -44.5 99.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.313 -0.867 . . . . 2.3199999999999998 108.758 178.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.74 -44.66 96.48 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.544 -0.722 . . . . 2.0299999999999998 109.645 178.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.01 -46.96 88.66 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.972 -0.751 . . . . 2.0299999999999998 108.972 178.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.1 tt -59.78 -45.89 90.88 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.808 -0.812 . . . . 2.5800000000000001 108.808 178.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.07 -45.33 94.01 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 108.937 -1.665 . . . . 2.21 108.937 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.55 -44.03 95.36 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.451 -1.029 . . . . 2.1099999999999999 109.967 179.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.1 mt -59.67 -41.32 90.35 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.089 -0.708 . . . . 2.4300000000000002 109.089 178.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 24.7 mm -68.34 -48.15 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.65 -0.656 . . . . 2.6400000000000001 109.374 178.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.17 -48.1 81.35 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.447 -0.783 . . . . 2.5800000000000001 110.052 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.676 0 N-CA-C 109.816 -1.314 . . . . 2.23 109.816 179.506 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.762 0 N-CA-C 108.81 -0.811 . . . . 2.4100000000000001 108.81 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -62.32 -52.62 62.94 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 108.477 -0.934 . . . . 1.3799999999999999 108.477 177.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.42 ' O ' ' CD ' ' A' ' 72' ' ' PRO . 2.4 m -53.72 -38.41 64.29 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-N 115.808 -0.633 . . . . 1.8500000000000001 111.388 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.36 -41.56 18.05 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.012 -1.055 . . . . 1.8100000000000001 110.969 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.0 mmtp -67.24 -45.78 75.71 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.419 -0.801 . . . . 2.52 111.12 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.409 ' N ' ' HD2' ' A' ' 72' ' ' PRO . . . -43.25 -62.65 2.34 Favored Glycine 0 N--CA 1.506 3.33 0 N-CA-C 110.614 -0.994 . . . . 1.52 110.614 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.556 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 40.8 Cg_endo -66.92 -43.92 6.14 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 O-C-N 123.729 1.384 . . . . 1.8700000000000001 110.03 179.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 31.5 t -54.52 -43.05 71.54 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.935 -1.103 . . . . 2.4700000000000002 109.745 178.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 37.5 t -73.62 -47.0 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.555 -0.716 . . . . 1.9099999999999999 109.552 178.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -54.1 -41.4 68.23 Favored 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 121.58 0.705 . . . . 2.0 109.641 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.556 ' HD2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -69.88 -49.14 55.25 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.832 -0.543 . . . . 2.8999999999999999 110.637 179.496 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.579 ' HG3' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -63.99 -29.3 70.47 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.112 -0.992 . . . . 2.3999999999999999 110.075 179.292 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.579 ' N ' ' HG3' ' A' ' 77' ' ' LYS . . . -75.4 -44.41 44.8 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.283 -0.886 . . . . 2.0800000000000001 109.415 179.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.0 mttt -68.8 -40.59 79.5 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.32 0.581 . . . . 2.25 109.494 178.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.587 -0.696 . . . . 2.98 110.021 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.1 m . . . . . 0 N--CA 1.495 1.777 0 CA-C-O 120.7 0.286 . . . . 2.1200000000000001 110.261 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.6 t -71.59 -42.37 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 120.98 -1.075 . . . . 1.8300000000000001 109.138 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.423 ' O ' HG12 ' A' ' 20' ' ' ILE . 53.2 m -58.97 -51.73 68.78 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.711 -0.618 . . . . 2.3199999999999998 109.771 179.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.643 ' HA ' HG12 ' A' ' 20' ' ' ILE . 35.0 m -64.02 -40.11 87.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.512 -0.743 . . . . 2.2400000000000002 109.91 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.73 HD13 HD23 ' A' ' 21' ' ' LEU . 8.9 mm -63.36 -42.73 97.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.009 -1.057 . . . . 1.77 109.393 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.606 ' O ' HG13 ' A' ' 22' ' ' ILE . 38.4 t -63.93 -43.39 97.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 C-N-CA 119.974 -0.69 . . . . 1.9199999999999999 110.173 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.647 ' O ' HG23 ' A' ' 24' ' ' ILE . 22.2 pt -72.51 -34.77 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 120.52 -1.363 . . . . 2.3999999999999999 109.45 178.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.73 HD23 HD13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -69.36 -45.69 68.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.23 -0.919 . . . . 1.74 109.428 178.55 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.606 HG13 ' O ' ' A' ' 19' ' ' VAL . 1.9 pp -63.73 -39.94 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 120.632 -1.293 . . . . 1.6000000000000001 109.146 178.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.26 -50.14 72.89 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.862 -0.523 . . . . 1.9299999999999999 110.768 179.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.647 HG23 ' O ' ' A' ' 20' ' ' ILE . 40.0 pt -63.99 -36.83 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 120.853 -1.155 . . . . 2.2200000000000002 109.155 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.505 ' N ' HG13 ' A' ' 24' ' ' ILE . . . -65.28 -44.64 87.39 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.046 -0.724 . . . . 1.6899999999999999 109.046 178.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.22 -44.6 94.81 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.753 -0.832 . . . . 1.8100000000000001 108.753 178.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.26 -45.12 95.83 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.894 -0.78 . . . . 2.6400000000000001 108.894 178.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.62 -44.7 97.54 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 108.753 -1.739 . . . . 1.9099999999999999 108.753 178.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.99 -41.64 97.45 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.492 -1.005 . . . . 1.8400000000000001 109.848 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.5 mt -60.68 -41.31 94.84 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.051 -0.722 . . . . 2.5099999999999998 109.051 178.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 69.4 mt -69.7 -48.15 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 109.002 -0.74 . . . . 2.5 109.002 178.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.95 -43.45 91.28 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.533 -0.729 . . . . 1.98 110.103 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.779 0 N-CA-C 109.342 -1.503 . . . . 2.29 109.342 179.285 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 . . . . . 0 N--CA 1.5 2.058 0 CA-C-O 121.456 0.646 . . . . 1.96 109.264 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.491 ' HA ' ' HG2' ' A' ' 70' ' ' LYS . 2.6 m-85 -69.59 -43.64 72.4 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.579 -0.701 . . . . 2.2000000000000002 109.369 178.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 75.4 m -59.72 -32.43 70.53 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.951 -0.468 . . . . 1.9099999999999999 110.588 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.99 -44.26 11.14 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.144 -0.972 . . . . 1.73 110.4 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.491 ' HG2' ' HA ' ' A' ' 67' ' ' TYR . 10.6 ptpt -65.55 -35.8 81.91 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.466 -0.771 . . . . 1.72 111.02 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.417 ' N ' ' HD2' ' A' ' 72' ' ' PRO . . . -49.78 -62.96 4.51 Favored Glycine 0 N--CA 1.501 2.975 0 N-CA-C 109.723 -1.351 . . . . 1.6899999999999999 109.723 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 71' ' ' GLY . 40.4 Cg_endo -66.49 -33.71 36.19 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 123.79 1.416 . . . . 1.9399999999999999 110.348 178.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.449 ' HB3' ' HA ' ' A' ' 70' ' ' LYS . 15.1 t -67.42 -47.37 70.45 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.253 -0.904 . . . . 1.8500000000000001 109.939 178.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.7 t -66.48 -46.34 86.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.663 -0.648 . . . . 1.6200000000000001 109.301 178.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.473 ' OE2' ' NZ ' ' A' ' 79' ' ' LYS . 5.0 tm-20 -54.95 -42.37 72.25 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 121.367 0.603 . . . . 2.25 109.45 178.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.48 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -62.26 -54.91 33.9 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.499 0.666 . . . . 2.6699999999999999 109.835 178.83 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.65 -51.51 69.63 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.2 0.524 . . . . 1.6599999999999999 110.915 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.85 -47.42 80.42 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.882 -0.511 . . . . 1.96 110.68 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -70.27 -38.12 75.02 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.692 -0.803 . . . . 2.5800000000000001 109.904 179.726 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 tp . . . . . 0 N--CA 1.495 1.814 0 O-C-N 121.429 -0.794 . . . . 2.4100000000000001 109.396 178.454 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.495 ' HA ' ' CG2' ' A' ' 17' ' ' VAL . 27.7 m . . . . . 0 N--CA 1.492 1.657 0 N-CA-C 109.94 -0.393 . . . . 1.3799999999999999 109.94 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.607 ' HA ' HG12 ' A' ' 18' ' ' ILE . 37.3 t -72.03 -40.66 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.915 -1.116 . . . . 1.2 109.15 178.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 42.7 m -59.04 -49.78 76.59 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.267 -0.895 . . . . 1.1699999999999999 109.66 178.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.495 ' CG2' ' HA ' ' A' ' 14' ' ' VAL . 2.8 m -64.57 -43.41 96.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.604 -0.685 . . . . 1.53 111.492 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.607 HG12 ' HA ' ' A' ' 15' ' ' VAL . 2.1 pt -66.94 -32.34 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 120.153 -1.592 . . . . 1.24 110.037 179.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.47 ' N ' HG13 ' A' ' 18' ' ' ILE . 40.0 t -69.65 -47.63 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 108.044 -1.095 . . . . 1.05 108.044 177.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 69.6 mt -60.37 -46.2 95.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 N-CA-C 108.609 -0.885 . . . . 1.25 108.609 177.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.574 ' HA ' HG12 ' A' ' 24' ' ' ILE . 4.0 mt -59.36 -51.23 70.79 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.228 -0.656 . . . . 1.53 109.228 178.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.2 mt -56.46 -37.87 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.256 -0.902 . . . . 1.3700000000000001 109.167 178.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.79 -52.0 42.21 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.585 -0.697 . . . . 1.0800000000000001 110.797 179.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.574 HG12 ' HA ' ' A' ' 21' ' ' LEU . 39.4 pt -62.34 -37.27 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.872 -1.142 . . . . 1.4299999999999999 109.201 179.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.496 ' N ' HG13 ' A' ' 24' ' ' ILE . . . -64.8 -45.84 84.58 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.533 -0.729 . . . . 1.1299999999999999 109.118 178.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.03 -43.34 99.05 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.891 -0.781 . . . . 1.1200000000000001 108.891 178.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.4 -47.08 87.42 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.909 -0.775 . . . . 1.45 108.909 178.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.0 -45.97 93.14 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 108.636 -1.786 . . . . 1.02 108.636 178.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.27 -44.83 96.59 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.595 -0.944 . . . . 0.97999999999999998 109.623 178.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.6 mt -58.86 -40.1 83.3 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.787 -0.57 . . . . 1.3 109.503 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.7 mt -68.84 -46.64 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.498 -0.751 . . . . 1.3700000000000001 109.323 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.05 -45.39 94.96 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.442 -0.786 . . . . 1.6599999999999999 109.904 179.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.848 0 N-CA-C 109.494 -1.442 . . . . 0.78000000000000003 109.494 179.232 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.483 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.136 0 CA-C-O 121.467 0.651 . . . . 2.1200000000000001 109.332 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.533 ' HA ' ' HG2' ' A' ' 70' ' ' LYS . 9.0 m-85 -69.94 -39.04 76.31 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.556 -0.715 . . . . 1.5700000000000001 109.539 178.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.4 t -57.82 -41.01 81.34 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.814 -0.554 . . . . 0.88 110.403 178.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.68 -47.2 8.85 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.159 -0.963 . . . . 0.72999999999999998 110.964 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.551 ' HA ' ' HB2' ' A' ' 73' ' ' CYS . 6.3 ptpt -66.11 -34.88 79.06 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.396 -0.815 . . . . 1.45 111.306 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.417 ' N ' ' HD2' ' A' ' 72' ' ' PRO . . . -46.69 -63.31 3.19 Favored Glycine 0 N--CA 1.503 3.159 0 N-CA-C 109.543 -1.423 . . . . 0.78000000000000003 109.543 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.545 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 40.5 Cg_endo -67.28 -47.83 2.04 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.929 1.489 . . . . 0.84999999999999998 109.78 178.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.551 ' HB2' ' HA ' ' A' ' 70' ' ' LYS . 4.0 m -53.26 -39.95 64.25 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.15 -0.969 . . . . 0.93999999999999995 110.053 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.1 t -74.32 -46.38 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 108.833 -0.803 . . . . 1.02 108.833 178.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.11 -43.23 70.25 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 121.505 0.669 . . . . 1.1699999999999999 109.258 178.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.545 ' HD2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -63.3 -50.44 70.04 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.945 -0.761 . . . . 1.2 108.945 178.52 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.8 mttp -56.11 -44.84 79.48 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 109.167 -0.679 . . . . 1.23 109.167 178.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.6 -52.21 64.55 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.415 -0.587 . . . . 1.4099999999999999 109.415 178.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 36.3 mtpt -58.88 -44.32 91.09 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.067 0.461 . . . . 1.5600000000000001 109.837 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.497 1.923 0 CA-C-O 121.573 0.702 . . . . 2.5800000000000001 110.692 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 55.1 t . . . . . 0 N--CA 1.498 1.935 0 CA-C-O 121.301 0.572 . . . . 1.8100000000000001 109.924 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.413 ' O ' HG22 ' A' ' 19' ' ' VAL . 29.7 t -69.87 -51.67 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.102 -0.999 . . . . 2.9300000000000002 110.462 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.6 p -55.67 -49.77 72.03 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.806 -0.559 . . . . 2.98 110.252 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.8 m -65.2 -35.31 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.136 -0.978 . . . . 1.97 110.081 179.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.428 HD13 ' HA ' ' A' ' 18' ' ' ILE . 5.6 mm -68.18 -48.69 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 120.958 -1.088 . . . . 2.25 110.431 179.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 15' ' ' VAL . 32.6 m -63.52 -36.8 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 C-N-CA 118.973 -1.091 . . . . 2.8700000000000001 108.966 178.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 58.9 mt -66.54 -48.77 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.268 -0.895 . . . . 2.5800000000000001 108.678 177.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 13.1 mt -58.95 -49.31 78.34 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.928 -0.767 . . . . 1.6899999999999999 108.928 178.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 29.7 mt -56.29 -43.61 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 C-N-CA 119.992 -0.683 . . . . 2.6600000000000001 109.457 178.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.34 -45.95 85.59 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.474 -0.766 . . . . 2.4100000000000001 109.731 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.4 mt -59.02 -46.5 91.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.394 -0.816 . . . . 1.8400000000000001 109.021 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.54 -45.35 90.96 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.556 -0.715 . . . . 1.8300000000000001 109.841 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.08 -43.94 95.12 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.549 -0.719 . . . . 2.4500000000000002 109.312 178.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.858 ' HA ' HD23 ' A' ' 30' ' ' LEU . 0.4 OUTLIER -63.25 -47.13 83.73 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.876 -0.787 . . . . 2.3599999999999999 108.876 178.333 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.61 -41.6 95.71 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 108.636 -1.786 . . . . 1.6000000000000001 108.636 178.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.05 -47.0 75.8 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.517 -0.99 . . . . 2.1800000000000002 110.306 179.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.858 HD23 ' HA ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -62.27 -37.21 84.61 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.615 -0.678 . . . . 2.6099999999999999 109.722 179.401 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.537 ' N ' ' HG ' ' A' ' 30' ' ' LEU . 9.7 mt -71.02 -46.95 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.304 -0.872 . . . . 1.9099999999999999 109.002 178.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.4 tp -58.83 -46.86 86.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.651 -0.655 . . . . 2.27 109.704 178.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.687 0 N-CA-C 109.345 -1.502 . . . . 2.1899999999999999 109.345 179.344 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.483 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 N-CA-C 108.764 -0.828 . . . . 2.7200000000000002 108.764 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -62.55 -40.95 98.47 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.684 -0.635 . . . . 3.6200000000000001 109.608 178.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.413 ' O ' ' CD ' ' A' ' 72' ' ' PRO . 71.2 m -59.93 -41.33 91.55 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.824 -0.547 . . . . 3.8199999999999998 110.209 179.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -81.37 -41.79 21.46 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.206 -0.934 . . . . 2.79 110.488 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 66' ' ' GLN . 1.8 mmtp -61.38 -47.16 87.09 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.467 -0.771 . . . . 2.29 110.687 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 75' ' ' GLU . . . -41.71 -66.45 0.99 Allowed Glycine 0 N--CA 1.503 3.116 0 N-CA-C 110.544 -1.022 . . . . 2.8599999999999999 110.544 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.528 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 41.3 Cg_endo -65.81 -39.84 18.83 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.788 1.415 . . . . 2.8900000000000001 110.56 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 6.5 t -60.63 -43.32 97.64 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.033 -1.042 . . . . 2.1499999999999999 109.325 178.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 69.1 t -70.94 -44.98 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 109.112 -0.699 . . . . 2.8500000000000001 109.112 178.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 0.6 OUTLIER -56.48 -42.48 78.35 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.614 0.721 . . . . 3.2000000000000002 109.444 178.629 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.528 ' HD2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -66.09 -50.45 64.02 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.624 -0.673 . . . . 3.0299999999999998 109.731 179.05 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -41.21 80.16 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 120.208 -0.597 . . . . 2.9399999999999999 109.655 179.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.88 -43.23 84.04 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 122.062 -0.399 . . . . 2.6699999999999999 110.044 179.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.427 ' HA ' ' CE ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -68.39 -48.54 64.42 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.607 -0.683 . . . . 3.3599999999999999 109.893 179.326 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.1 tp . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.486 -0.759 . . . . 2.0600000000000001 109.56 179.457 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.503 ' O ' HG23 ' A' ' 18' ' ' ILE . 53.8 t . . . . . 0 N--CA 1.498 1.944 0 CA-C-O 121.159 0.504 . . . . 1.28 109.89 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.536 ' O ' HG13 ' A' ' 18' ' ' ILE . 43.2 t -72.63 -37.43 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.031 -1.043 . . . . 1.5700000000000001 109.416 178.998 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.416 ' O ' HG12 ' A' ' 20' ' ' ILE . 59.5 m -62.17 -50.25 72.59 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.286 -0.884 . . . . 1.4299999999999999 109.712 178.588 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.577 ' HA ' HG12 ' A' ' 20' ' ' ILE . 30.9 m -67.24 -41.86 87.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.655 -0.653 . . . . 0.98999999999999999 111.643 -179.502 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.536 HG13 ' O ' ' A' ' 15' ' ' VAL . 2.1 pp -67.69 -30.42 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 120.303 -1.498 . . . . 1.27 109.764 179.138 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.6 t -68.99 -52.2 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.233 -0.917 . . . . 1.25 108.782 178.143 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.577 HG12 ' HA ' ' A' ' 17' ' ' VAL . 44.9 pt -63.96 -37.53 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.162 -0.961 . . . . 1.01 109.083 178.668 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.485 ' N ' HG13 ' A' ' 20' ' ' ILE . 9.9 mt -64.85 -48.34 74.68 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.395 -0.816 . . . . 1.02 109.0 178.028 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.45 HD13 ' HA ' ' A' ' 22' ' ' ILE . 8.0 mm -59.19 -43.57 89.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.317 -0.865 . . . . 1.21 108.873 178.481 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.85 -46.66 88.5 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.387 -0.597 . . . . 0.90000000000000002 109.387 178.711 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.414 HD13 ' HA ' ' A' ' 24' ' ' ILE . 8.4 mm -59.97 -45.44 95.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.306 -0.871 . . . . 1.1399999999999999 108.892 178.386 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.67 -45.4 94.18 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.579 -0.7 . . . . 0.88 109.613 178.751 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.74 -44.94 96.03 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.58 -0.7 . . . . 0.95999999999999996 109.138 178.593 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.4 tt -61.96 -45.92 91.54 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.898 -0.779 . . . . 1.28 108.898 178.192 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.38 -44.09 95.39 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 108.712 -1.755 . . . . 1.1100000000000001 108.712 178.651 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.28 -46.28 84.36 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.428 -1.042 . . . . 1.1299999999999999 109.668 178.912 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.1 mt -56.89 -41.29 77.79 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 109.179 -0.675 . . . . 1.46 109.179 178.719 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.41 ' HA ' HD13 ' A' ' 31' ' ' ILE . 26.6 mm -70.2 -44.9 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.53 -0.731 . . . . 1.46 109.525 178.853 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.17 -48.52 80.05 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.508 -0.745 . . . . 2.2799999999999998 109.891 179.285 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.838 0 N-CA-C 110.471 -1.051 . . . . 1.5 110.471 179.773 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.502 ' OE1' ' NZ ' ' A' ' 70' ' ' LYS . 2.6 mt-30 . . . . . 0 N--CA 1.499 2.025 0 N-CA-C 109.491 -0.559 . . . . 2.6000000000000001 109.491 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -74.26 -41.42 61.31 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.654 0.74 . . . . 3.6099999999999999 109.463 178.624 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 64.0 m -59.2 -28.54 66.74 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 122.002 -0.436 . . . . 1.1499999999999999 110.938 179.77 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -95.59 -43.99 7.69 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.082 -1.011 . . . . 1.54 111.013 -179.651 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.502 ' NZ ' ' OE1' ' A' ' 66' ' ' GLN . 15.2 mtmt -70.06 -39.83 75.43 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.408 -0.808 . . . . 3.3599999999999999 111.109 -179.394 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.422 ' N ' ' HD2' ' A' ' 72' ' ' PRO . . . -46.0 -61.11 4.11 Favored Glycine 0 N--CA 1.503 3.106 0 N-CA-C 109.603 -1.399 . . . . 1.0700000000000001 109.603 179.821 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.591 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 42.1 Cg_endo -67.74 -43.37 5.45 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 O-C-N 123.801 1.421 . . . . 1.02 109.751 178.462 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 9.1 t -53.75 -44.77 70.23 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.906 -1.121 . . . . 2.1600000000000001 110.202 179.055 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.5 t -72.68 -45.96 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.337 -0.852 . . . . 1.72 109.05 178.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.433 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 1.3 tm-20 -53.6 -42.59 67.83 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.6 0.714 . . . . 1.28 109.96 178.642 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.62 ' HA ' ' CD ' ' A' ' 79' ' ' LYS . 0.9 OUTLIER -72.74 -45.55 58.14 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.673 -0.642 . . . . 1.79 110.997 179.85 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.485 ' HG3' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -67.27 -28.79 68.32 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.121 -0.987 . . . . 1.8200000000000001 109.984 179.594 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.485 ' N ' ' HG3' ' A' ' 77' ' ' LYS . . . -75.56 -52.36 10.79 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.426 -0.796 . . . . 1.1799999999999999 109.485 179.265 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.62 ' CD ' ' HA ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -64.84 -28.95 69.9 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.622 -0.674 . . . . 1.6299999999999999 111.332 179.903 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.555 ' N ' ' HG2' ' A' ' 79' ' ' LYS . 2.6 tp . . . . . 0 N--CA 1.495 1.809 0 O-C-N 121.23 -0.919 . . . . 2.1099999999999999 112.166 -178.975 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 N--CA 1.499 2.003 0 N-CA-C 109.3 -0.63 . . . . 1.71 109.3 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.4 t -69.07 -42.69 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.338 -0.851 . . . . 1.3200000000000001 109.037 178.434 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 53.9 m -57.31 -52.77 64.01 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.131 0.491 . . . . 1.1100000000000001 110.007 179.137 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.3 m -64.29 -37.08 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.519 -0.738 . . . . 1.21 110.043 179.468 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.1 mt -66.28 -40.9 88.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.039 -1.038 . . . . 1.49 109.394 178.567 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.3 t -64.52 -45.35 95.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.533 -0.914 . . . . 1.1899999999999999 108.533 178.158 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 86.2 mt -62.15 -46.32 96.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.49 -0.756 . . . . 1.2 109.016 178.312 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.8 mt -60.07 -49.59 77.07 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.908 -0.775 . . . . 1.6299999999999999 108.908 178.411 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.9 mt -56.76 -43.13 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.525 -0.735 . . . . 1.3899999999999999 109.394 178.52 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.21 -46.55 83.41 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.669 -0.644 . . . . 1.1399999999999999 109.908 179.032 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.5 mm -59.66 -46.29 93.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.232 -0.918 . . . . 1.3899999999999999 109.02 178.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.96 -45.0 95.57 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.607 -0.683 . . . . 1.3300000000000001 109.664 178.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.35 -43.84 98.19 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.556 -0.715 . . . . 1.29 109.093 178.59 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.74 -48.26 81.53 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.774 -0.824 . . . . 1.3500000000000001 108.774 178.133 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.35 -44.65 93.43 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 108.857 -1.697 . . . . 1.25 108.857 178.767 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.32 -43.16 95.54 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.433 -1.04 . . . . 1.4199999999999999 109.866 178.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.9 mt -60.27 -41.36 93.12 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.244 -0.651 . . . . 1.72 109.244 178.628 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 97.0 mt -69.11 -52.91 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.558 -0.714 . . . . 1.25 109.29 179.029 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.2 -46.91 72.54 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.491 -0.756 . . . . 2.2200000000000002 109.763 178.867 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.734 0 N-CA-C 109.221 -1.552 . . . . 1.54 109.221 178.964 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.719 0 N-CA-C 109.404 -0.591 . . . . 3.9900000000000002 109.404 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.465 ' HA ' ' CG ' ' A' ' 70' ' ' LYS . 0.4 OUTLIER -70.48 -42.88 70.82 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.604 -0.685 . . . . 3.8999999999999999 109.483 178.457 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.42 ' O ' ' CD ' ' A' ' 72' ' ' PRO . 54.2 m -60.1 -37.39 79.83 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 109.963 -0.384 . . . . 2.0099999999999998 109.963 178.872 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -83.88 -43.57 15.17 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.241 -0.912 . . . . 2.0899999999999999 111.338 -179.711 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.465 ' CG ' ' HA ' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -70.33 -25.65 63.39 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.084 -1.01 . . . . 1.6599999999999999 110.834 -179.795 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' A' ' 75' ' ' GLU . . . -55.11 -64.68 4.15 Favored Glycine 0 N--CA 1.498 2.799 0 N-CA-C 109.063 -1.615 . . . . 1.6200000000000001 109.063 178.918 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.42 ' CD ' ' O ' ' A' ' 68' ' ' SER . 39.6 Cg_endo -65.91 -37.09 28.2 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 124.085 1.571 . . . . 2.2400000000000002 110.055 178.778 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 6.2 t -60.16 -46.21 90.45 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.992 -1.067 . . . . 2.2000000000000002 109.656 178.725 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 39.2 t -72.24 -42.49 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.515 -0.741 . . . . 1.3899999999999999 109.401 178.863 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.518 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -57.65 -41.66 81.9 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.717 0.77 . . . . 2.6499999999999999 109.283 178.408 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.4 ttt85 -71.3 -45.32 63.34 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.578 -0.701 . . . . 3.6499999999999999 110.371 179.36 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.25 -44.25 95.42 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.178 -0.951 . . . . 2.3700000000000001 109.262 179.267 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.5 -49.06 72.83 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.526 0.679 . . . . 1.72 110.849 179.329 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.4 mttp -68.24 -46.57 70.12 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.276 -0.89 . . . . 2.98 111.502 -179.655 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.1 tp . . . . . 0 N--CA 1.495 1.801 0 O-C-N 121.226 -0.921 . . . . 2.8500000000000001 112.3 -178.672 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.8 t . . . . . 0 N--CA 1.497 1.905 0 N-CA-C 109.346 -0.613 . . . . 1.8500000000000001 109.346 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.6 t -69.99 -41.93 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.278 -0.889 . . . . 2.71 109.261 178.663 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 77.8 m -58.75 -51.57 69.42 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.699 -0.626 . . . . 2.7000000000000002 109.928 179.155 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.3 m -65.41 -36.43 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.471 -0.768 . . . . 1.76 109.911 179.42 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.7 mt -66.58 -40.19 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 121.136 -0.977 . . . . 1.6499999999999999 109.298 178.404 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 36.1 t -64.8 -43.51 96.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.036 -1.04 . . . . 2.4900000000000002 108.474 177.953 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 87.7 mt -63.68 -46.73 93.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 108.919 -0.771 . . . . 2.3799999999999999 108.919 178.139 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 44.7 mt -59.56 -49.15 78.87 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.705 -0.85 . . . . 1.3799999999999999 108.705 178.454 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 31.4 mt -56.27 -42.44 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.557 -0.714 . . . . 1.6799999999999999 109.386 178.284 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.44 -45.52 83.5 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.461 -0.774 . . . . 2.0600000000000001 109.663 178.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.0 mt -60.09 -46.11 94.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 108.438 -0.949 . . . . 1.96 108.438 178.367 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.62 -48.12 82.31 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.753 -0.462 . . . . 1.1499999999999999 109.753 178.56 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.48 -44.19 89.27 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.47 -0.769 . . . . 1.4299999999999999 109.078 178.712 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.01 -46.32 89.7 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.844 -0.799 . . . . 2.8500000000000001 108.844 178.116 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.98 -42.5 98.35 Favored Glycine 0 N--CA 1.497 2.717 0 N-CA-C 108.899 -1.68 . . . . 1.6699999999999999 108.899 178.735 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.38 -44.15 95.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.549 -0.971 . . . . 1.1399999999999999 109.315 178.72 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.4 mt -60.79 -40.84 94.11 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.003 -0.74 . . . . 2.02 109.003 178.289 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.1 mt -67.79 -48.54 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.375 -0.828 . . . . 2.9300000000000002 109.208 178.445 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.99 -48.43 78.47 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.391 -0.818 . . . . 2.5600000000000001 109.329 178.848 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.612 0 N-CA-C 110.908 -0.877 . . . . 1.27 110.908 179.876 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.46 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 3.0 mm-40 . . . . . 0 N--CA 1.496 1.832 0 N-CA-C 108.881 -0.785 . . . . 1.76 108.881 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -63.06 -42.06 99.6 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.355 -0.841 . . . . 3.48 109.359 178.277 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 70.4 m -56.26 -35.07 67.02 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.997 -0.44 . . . . 1.6100000000000001 110.678 179.177 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -91.29 -40.94 11.22 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.166 -0.959 . . . . 1.3100000000000001 110.777 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 66' ' ' GLN . 3.4 mmtp -64.59 -44.76 89.63 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.576 -0.702 . . . . 2.8799999999999999 110.746 -179.851 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.41 ' N ' ' HD2' ' A' ' 72' ' ' PRO . . . -46.52 -63.56 3.02 Favored Glycine 0 N--CA 1.502 3.08 0 N-CA-C 110.455 -1.058 . . . . 1.04 110.455 -179.823 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 71' ' ' GLY . 40.2 Cg_endo -65.8 -38.15 24.87 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 O-C-N 123.736 1.387 . . . . 1.3899999999999999 110.644 179.545 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 10.5 t -60.68 -43.38 97.77 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.023 -1.048 . . . . 1.54 109.496 178.841 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 54.1 t -74.26 -42.95 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.487 -0.758 . . . . 1.3999999999999999 109.375 178.76 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -56.03 -44.62 78.92 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.701 -0.851 . . . . 1.5 108.701 178.318 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -66.78 -41.61 87.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.854 -0.529 . . . . 2.23 109.805 178.788 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.6 -50.12 75.13 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.432 -0.792 . . . . 3.3199999999999998 110.095 179.135 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.32 -44.11 92.56 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.61 -0.681 . . . . 1.3700000000000001 110.642 179.849 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -66.39 -33.63 76.15 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.522 -0.736 . . . . 1.6599999999999999 110.162 179.488 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.496 1.828 0 O-C-N 121.196 -0.94 . . . . 2.7999999999999998 111.119 -179.844 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.5 t . . . . . 0 N--CA 1.499 1.984 0 N-CA-C 109.465 -0.569 . . . . 3.0299999999999998 109.465 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.3 t -67.45 -42.73 87.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.055 -1.028 . . . . 1.9199999999999999 109.26 178.805 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 66.8 m -60.54 -52.6 64.5 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.685 -0.634 . . . . 1.6299999999999999 109.812 179.08 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.463 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 23.6 m -64.32 -35.46 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 119.829 -0.748 . . . . 2.2200000000000002 109.834 179.397 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.735 ' HA ' HD23 ' A' ' 21' ' ' LEU . 9.8 mt -68.71 -41.78 82.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 120.935 -1.103 . . . . 2.8500000000000001 109.042 178.432 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.8 t -64.04 -42.28 95.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.391 -0.966 . . . . 1.53 108.391 178.063 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 83.3 mt -64.68 -50.09 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.483 -0.761 . . . . 1.5900000000000001 109.153 178.51 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.735 HD23 ' HA ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -61.86 -41.16 97.5 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.878 -0.786 . . . . 2.52 108.878 178.827 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.572 ' N ' ' HG ' ' A' ' 21' ' ' LEU . 7.4 mm -60.97 -44.19 97.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.44 -0.948 . . . . 2.8199999999999998 108.44 177.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.77 -44.86 88.7 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.546 -0.721 . . . . 2.04 109.689 178.817 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.9 mm -59.68 -49.59 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.421 -0.955 . . . . 2.1000000000000001 108.421 178.434 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.1 -44.9 96.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.794 -0.566 . . . . 2.6800000000000002 110.002 178.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.73 -43.44 98.84 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.571 -0.706 . . . . 2.8999999999999999 109.251 178.683 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.1 tt -63.24 -46.97 84.44 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.029 -0.73 . . . . 2.73 109.029 178.24 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.38 -44.61 96.47 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 108.708 -1.757 . . . . 2.8999999999999999 108.708 178.617 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.67 -40.9 96.2 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.609 -0.936 . . . . 3.52 109.573 178.691 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.5 mt -61.33 -43.13 99.4 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.105 -0.702 . . . . 3.8300000000000001 109.105 178.536 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 35.4 mt -67.84 -49.26 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.451 -0.781 . . . . 3.4199999999999999 109.469 179.005 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.72 -39.2 90.69 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.658 -0.652 . . . . 3.7999999999999998 110.391 179.313 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.689 0 N-CA-C 110.244 -1.142 . . . . 4.46 110.244 179.86 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 . . . . . 0 N--CA 1.494 1.746 0 N-CA-C 108.911 -0.774 . . . . 4.5800000000000001 108.911 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.29 -48.36 70.63 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.967 -0.753 . . . . 5.29 108.967 178.412 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.43 -30.71 60.99 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 116.31 -0.405 . . . . 1.73 111.269 179.746 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.596 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -92.87 -48.18 6.67 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.125 -0.984 . . . . 2.2599999999999998 109.842 179.311 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.9 mmpp? -59.58 -51.41 69.95 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.685 -0.635 . . . . 3.75 111.511 -179.656 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.41 ' N ' ' HD2' ' A' ' 72' ' ' PRO . . . -42.87 -63.05 2.09 Favored Glycine 0 N--CA 1.504 3.231 0 N-CA-C 110.091 -1.203 . . . . 1.75 110.091 -179.631 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.524 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 41.1 Cg_endo -66.18 -40.21 16.03 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 O-C-N 123.721 1.379 . . . . 1.24 110.445 178.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.596 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 0.7 OUTLIER -62.28 -46.31 89.37 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.731 -1.23 . . . . 2.3100000000000001 109.786 179.125 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.472 ' O ' ' HG3' ' A' ' 77' ' ' LYS . 39.0 t -64.85 -49.79 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.694 -0.854 . . . . 2.5699999999999998 108.694 178.819 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.409 ' OE1' ' NZ ' ' A' ' 79' ' ' LYS . 8.6 tp10 -56.58 -40.67 75.63 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.221 0.534 . . . . 3.5299999999999998 110.084 179.025 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.524 ' HB2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -63.7 -52.98 58.17 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.514 -0.741 . . . . 2.5699999999999998 110.227 179.919 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.561 ' HG3' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -66.7 -31.87 72.81 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.334 -0.946 . . . . 3.21 109.778 179.552 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.561 ' N ' ' HG3' ' A' ' 77' ' ' LYS . . . -66.55 -46.69 75.26 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.202 -1.036 . . . . 2.5600000000000001 108.202 177.678 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.409 ' NZ ' ' OE1' ' A' ' 75' ' ' GLU . 7.8 mmtp -66.43 -40.79 89.72 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.05 -0.722 . . . . 3.4500000000000002 109.05 178.128 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.497 1.923 0 O-C-N 121.301 -0.875 . . . . 2.48 110.504 179.26 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.9 t . . . . . 0 N--CA 1.499 2.012 0 N-CA-C 109.477 -0.564 . . . . 1.5 109.477 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.2 t -68.16 -43.67 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.199 -0.938 . . . . 1.6899999999999999 109.363 178.77 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 53.1 m -58.53 -50.99 71.78 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.628 -0.67 . . . . 1.9099999999999999 110.164 179.436 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.5 m -66.87 -33.68 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.371 -0.831 . . . . 1.6299999999999999 110.271 179.654 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.2 mm -69.25 -41.4 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 120.892 -1.13 . . . . 1.51 109.29 178.468 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.6 t -64.83 -44.15 96.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 108.413 -0.958 . . . . 1.77 108.413 177.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 21.8 mm -62.97 -46.91 95.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.479 -0.763 . . . . 2.1000000000000001 109.059 178.29 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.8 mt -59.98 -48.82 80.13 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.912 -0.773 . . . . 1.75 108.912 178.378 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.5 mm -57.45 -44.03 83.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.533 -0.729 . . . . 1.5800000000000001 109.412 178.503 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.47 -45.04 92.61 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.529 -0.732 . . . . 1.4199999999999999 109.718 179.008 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 37.6 mt -60.55 -45.39 97.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.418 -0.801 . . . . 1.8200000000000001 109.004 178.667 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.57 -45.57 89.87 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.48 -0.763 . . . . 1.1399999999999999 109.753 178.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.68 -43.87 97.17 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.8 -0.815 . . . . 1.1799999999999999 108.8 178.516 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.719 ' C ' HD13 ' A' ' 27' ' ' LEU . 3.0 tm? -60.04 -52.06 66.99 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.834 -0.802 . . . . 1.9199999999999999 108.834 178.076 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.91 -44.66 82.21 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.033 -1.627 . . . . 1.1899999999999999 109.033 178.68 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.6 -43.57 96.53 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.496 -1.002 . . . . 1.1499999999999999 109.878 179.071 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.8 mt -59.76 -40.78 89.35 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.498 -0.556 . . . . 1.6899999999999999 109.498 178.967 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.7 mt -71.54 -44.89 70.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.464 -0.773 . . . . 2.25 109.385 178.977 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.37 -48.44 81.64 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.301 -0.875 . . . . 2.0800000000000001 109.667 179.138 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.838 0 N-CA-C 109.663 -1.375 . . . . 1.1100000000000001 109.663 179.252 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 . . . . . 0 N--CA 1.493 1.71 0 N-CA-C 108.783 -0.821 . . . . 2.21 108.783 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -66.06 -43.3 87.84 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.597 -0.689 . . . . 4.3099999999999996 109.46 178.28 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 69.7 m -58.45 -40.5 82.78 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.9 -0.5 . . . . 2.1699999999999999 110.393 179.342 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.518 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -83.71 -44.86 14.03 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.325 -0.86 . . . . 1.47 111.05 -179.948 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.3 mmtp -61.61 -45.7 92.96 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.384 -0.823 . . . . 1.8899999999999999 111.128 -179.613 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -43.02 -64.9 1.56 Allowed Glycine 0 N--CA 1.506 3.319 0 N-CA-C 110.679 -0.968 . . . . 1.3799999999999999 110.679 -179.397 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.418 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 40.6 Cg_endo -65.51 -38.59 24.81 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 O-C-N 123.779 1.41 . . . . 1.4399999999999999 110.45 179.41 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.518 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -62.14 -46.36 89.38 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.964 -1.085 . . . . 1.45 109.571 178.8 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.7 t -68.37 -45.4 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 109.004 -0.739 . . . . 1.4099999999999999 109.004 178.672 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.416 ' O ' ' HG3' ' A' ' 79' ' ' LYS . 2.6 tm-20 -56.9 -43.38 81.29 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.502 0.668 . . . . 1.7 109.559 178.549 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.418 ' HD2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -64.99 -48.32 74.38 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.728 -0.607 . . . . 2.2599999999999998 109.683 178.925 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.58 -42.67 97.18 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.583 -0.698 . . . . 1.9099999999999999 110.187 179.789 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.03 -41.98 97.25 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.866 -0.521 . . . . 1.1599999999999999 109.657 179.125 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 75' ' ' GLU . 5.0 mttp -68.07 -47.58 67.91 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.29 -0.633 . . . . 1.98 109.29 178.67 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.712 0 O-C-N 121.425 -0.797 . . . . 1.8400000000000001 109.63 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.758 0 N-CA-C 109.956 -1.258 . . . . 6.4000000000000004 109.956 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.88 141.5 37.59 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.279 -1.13 . . . . 5.8399999999999999 110.57 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.569 ' O ' ' HB3' ' A' ' 4' ' ' SER . 5.7 mtt -93.88 79.97 4.16 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.443 -0.786 . . . . 7.9400000000000004 109.825 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.569 ' HB3' ' O ' ' A' ' 3' ' ' MET . 11.1 t 67.88 -60.6 0.4 Allowed 'General case' 0 N--CA 1.506 2.342 0 N-CA-C 109.192 -0.67 . . . . 7.3399999999999999 109.192 -178.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.521 ' C ' HD12 ' A' ' 5' ' ' ILE . 2.0 pp -82.53 -153.69 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 107.606 -1.257 . . . . 5.29 107.606 177.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.489 ' HB3' ' OG ' ' A' ' 9' ' ' SER . 8.3 mtt -124.63 63.63 1.11 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 119.623 -1.923 . . . . 4.1100000000000003 112.127 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -67.22 -36.96 82.78 Favored 'General case' 0 N--CA 1.506 2.347 0 CA-C-O 121.532 0.682 . . . . 4.54 109.382 177.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -82.57 18.01 1.63 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.564 -0.71 . . . . 4.9500000000000002 110.61 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.489 ' OG ' ' HB3' ' A' ' 6' ' ' MET . 9.1 p -113.3 159.39 35.24 Favored Pre-proline 0 N--CA 1.491 1.619 0 N-CA-C 108.198 -1.038 . . . . 1.8500000000000001 108.198 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -74.34 43.17 0.85 Allowed 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 122.577 0.777 . . . . 2.9700000000000002 111.615 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -65.15 -37.37 87.19 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.035 -1.041 . . . . 3.1600000000000001 108.783 178.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.0 p -60.99 -38.32 85.59 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.25 -0.906 . . . . 2.2999999999999998 108.71 177.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.493 ' O ' HG22 ' A' ' 17' ' ' VAL . . . -71.06 -51.54 17.92 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 108.69 -1.764 . . . . 1.97 108.69 178.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 54.2 t -55.79 -40.25 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.645 -0.915 . . . . 2.1699999999999999 109.02 178.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.7 t -69.89 -42.84 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.202 -0.937 . . . . 1.96 109.036 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 49.6 m -58.98 -51.36 70.39 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.771 -0.581 . . . . 1.8700000000000001 109.985 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.493 HG22 ' O ' ' A' ' 13' ' ' GLY . 29.1 m -66.95 -33.17 61.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.387 -0.821 . . . . 1.8899999999999999 110.271 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.41 ' HA ' HD13 ' A' ' 18' ' ' ILE . 6.9 mm -69.64 -41.13 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 O-C-N 120.925 -1.109 . . . . 2.0099999999999998 109.091 178.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.3 t -64.76 -45.07 96.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 108.291 -1.003 . . . . 1.74 108.291 177.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.417 HD13 ' HA ' ' A' ' 20' ' ' ILE . 23.6 mm -62.06 -46.79 95.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.85 -0.796 . . . . 1.72 108.85 178.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 13.1 mt -59.75 -49.67 76.81 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.849 -0.797 . . . . 1.8899999999999999 108.849 178.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.0 mt -56.44 -43.1 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.575 -0.703 . . . . 2.02 109.293 178.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.68 -46.84 83.69 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.588 -0.695 . . . . 1.48 109.536 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.1 mt -58.64 -48.29 86.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.446 -0.783 . . . . 1.7 108.978 178.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.61 -45.37 94.27 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.62 -0.675 . . . . 1.53 109.937 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.4 -45.37 93.83 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 109.071 -0.714 . . . . 1.46 109.071 178.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.27 -47.1 87.55 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.014 -0.735 . . . . 1.6499999999999999 109.014 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.15 -44.26 94.91 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 108.88 -1.688 . . . . 1.3100000000000001 108.88 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.14 -45.73 92.14 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.409 -1.053 . . . . 1.3600000000000001 109.414 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.494 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 6.4 mt -57.58 -41.8 81.85 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.297 -0.631 . . . . 1.6100000000000001 109.297 178.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.576 HG22 ' HA ' ' A' ' 37' ' ' TYR . 45.6 mt -71.36 -36.04 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.302 -0.874 . . . . 1.3100000000000001 110.09 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.475 ' HA ' ' N ' ' A' ' 37' ' ' TYR . 7.6 tt -68.06 -45.19 74.54 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.234 -0.916 . . . . 1.6699999999999999 109.825 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -73.07 -40.33 51.29 Favored Glycine 0 N--CA 1.498 2.812 0 O-C-N 121.169 -0.957 . . . . 1.26 111.469 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -83.45 -33.98 25.53 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 120.854 -1.38 . . . . 1.3700000000000001 112.015 -178.714 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.508 ' CD2' ' HG3' ' A' ' 39' ' ' ARG . 9.2 m0 -129.86 19.23 5.57 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.786 -1.196 . . . . 1.72 112.053 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.3 m 50.98 32.24 7.24 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.214 -0.929 . . . . 1.71 110.117 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.576 ' HA ' HG22 ' A' ' 31' ' ' ILE . 0.1 OUTLIER 54.46 25.52 6.21 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.521 -0.737 . . . . 1.6000000000000001 110.67 -179.028 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 11.8 tp -128.44 -46.27 1.33 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.436 -0.79 . . . . 1.5700000000000001 110.032 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.508 ' HG3' ' CD2' ' A' ' 35' ' ' TRP . 9.0 ttp-105 46.11 43.23 10.7 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.855 -0.528 . . . . 1.2 111.503 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 51.85 58.6 5.29 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.415 -0.803 . . . . 2.4700000000000002 110.838 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -79.44 -14.17 59.1 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.108 -0.995 . . . . 1.4299999999999999 111.077 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.29 -139.62 0.07 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.115 -0.99 . . . . 2.0299999999999998 109.851 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.251 0.3 OUTLIER -62.84 -23.94 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 O-C-N 120.793 -1.192 . . . . 3.1499999999999999 110.517 179.386 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.8 t 61.39 -163.02 0.27 Allowed 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.414 -0.804 . . . . 2.4900000000000002 111.29 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 42.86 41.23 2.45 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.496 -0.753 . . . . 5.0199999999999996 110.829 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 175.7 -42.11 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.693 -0.63 . . . . 2.7799999999999998 109.816 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -63.59 148.65 48.31 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.767 -0.583 . . . . 2.23 110.669 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -102.74 -148.02 0.38 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.61 -0.681 . . . . 3.1200000000000001 110.088 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.452 ' O ' ' HA3' ' A' ' 54' ' ' GLY . 0.4 OUTLIER -73.74 122.69 22.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.949 -1.094 . . . . 2.3700000000000001 109.994 179.85 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.415 ' HG2' ' HE2' ' A' ' 67' ' ' TYR . 42.0 tt0 -106.07 86.52 2.39 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.259 -0.9 . . . . 1.47 110.737 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.428 ' HB2' ' CE1' ' A' ' 37' ' ' TYR . 9.5 t -174.8 -40.72 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.411 0 O-C-N 121.322 -0.861 . . . . 1.77 110.263 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.6 mt -117.47 -58.57 3.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.658 -0.652 . . . . 2.6499999999999999 109.984 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.4 p -98.46 -36.04 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 O-C-N 121.468 -0.77 . . . . 2.6200000000000001 111.743 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.452 ' HA3' ' O ' ' A' ' 49' ' ' GLU . . . -71.81 -34.88 62.17 Favored Glycine 0 N--CA 1.5 2.951 0 N-CA-C 108.975 -1.65 . . . . 1.7 108.975 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -168.23 109.76 0.56 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.775 -0.838 . . . . 1.5600000000000001 109.76 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 155.99 -55.92 0.4 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.062 -1.615 . . . . 2.0800000000000001 109.062 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -131.37 14.0 5.05 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.825 -0.809 . . . . 3.7400000000000002 111.085 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.45 -45.59 92.4 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.046 -1.034 . . . . 2.46 110.359 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.43 ' O ' ' HB2' ' A' ' 60' ' ' GLU . 49.4 tttm -147.4 124.04 11.13 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.32 -0.862 . . . . 3.6800000000000002 111.07 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.43 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 1.3 mp0 60.22 163.28 0.1 OUTLIER Pre-proline 0 N--CA 1.506 2.356 0 N-CA-C 112.535 0.569 . . . . 4.1600000000000001 112.535 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -75.49 -7.21 18.54 Favored 'Trans proline' 0 CA--C 1.547 1.172 0 O-C-N 123.372 1.196 . . . . 2.5499999999999998 110.167 178.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -55.39 -51.62 66.22 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.441 -0.787 . . . . 3.4300000000000002 111.153 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 36.9 mt -60.27 -30.8 69.69 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.546 -0.721 . . . . 1.6699999999999999 110.687 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.2 -59.2 5.84 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.437 -0.789 . . . . 2.8599999999999999 109.808 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.409 ' HA ' ' HB3' ' A' ' 68' ' ' SER . 27.1 m -66.16 -31.35 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.247 -0.908 . . . . 2.52 109.757 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -61.9 -49.31 76.7 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.477 -0.765 . . . . 1.78 109.086 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.574 ' HA ' ' HG2' ' A' ' 70' ' ' LYS . 4.6 t80 -72.7 -35.61 67.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.781 -0.574 . . . . 1.5700000000000001 109.48 178.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.409 ' HB3' ' HA ' ' A' ' 65' ' ' VAL . 23.0 t -61.71 -31.15 71.28 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.644 -0.66 . . . . 2.48 109.744 178.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.544 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -93.78 -50.29 5.43 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.253 -0.904 . . . . 2.27 110.868 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.574 ' HG2' ' HA ' ' A' ' 67' ' ' TYR . 5.0 pttt -70.68 -36.22 73.21 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.267 -0.896 . . . . 1.8100000000000001 111.225 -179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.449 ' N ' ' HD2' ' A' ' 72' ' ' PRO . . . -46.6 -61.67 4.08 Favored Glycine 0 N--CA 1.498 2.83 0 N-CA-C 109.277 -1.529 . . . . 1.5800000000000001 109.277 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.497 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 41.5 Cg_endo -67.23 -42.48 7.64 Favored 'Trans proline' 0 C--N 1.314 -1.242 0 O-C-N 124.039 1.547 . . . . 2.2799999999999998 110.102 178.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.544 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -56.71 -44.54 81.66 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.959 -1.088 . . . . 2.73 109.815 178.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.404 ' HA ' ' HG2' ' A' ' 77' ' ' LYS . 25.0 t -71.05 -49.07 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.479 -0.763 . . . . 1.8899999999999999 109.387 178.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 0.6 OUTLIER -55.26 -39.04 69.33 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.746 -0.596 . . . . 2.1800000000000002 110.078 179.31 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.497 ' HD2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -68.37 -55.04 13.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.482 -0.761 . . . . 2.9399999999999999 109.434 178.774 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.626 ' HG3' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -59.91 -31.27 69.67 Favored 'General case' 0 N--CA 1.505 2.282 0 C-N-CA 119.446 -0.902 . . . . 3.29 110.281 179.592 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.626 ' N ' ' HG3' ' A' ' 77' ' ' LYS . . . -71.13 -41.9 69.91 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.559 -0.713 . . . . 2.23 109.601 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 32.5 mttp -73.74 -34.58 64.82 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.441 -0.577 . . . . 2.7400000000000002 109.441 178.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 71.6 mt -68.62 -38.84 80.88 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.987 -1.071 . . . . 3.73 110.131 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 5.2 ttt -86.68 -43.6 12.48 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.54 -0.725 . . . . 4.4000000000000004 111.23 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.1 p -116.24 160.36 36.09 Favored Pre-proline 0 N--CA 1.51 2.574 0 O-C-N 121.037 -1.039 . . . . 2.8900000000000001 110.626 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.9 -33.09 65.13 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 O-C-N 123.357 1.188 . . . . 2.2999999999999998 111.903 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 51.42 25.42 2.62 Favored 'General case' 0 N--CA 1.508 2.458 0 O-C-N 121.476 -0.765 . . . . 2.5600000000000001 111.674 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.403 ' HA2' ' HD2' ' A' ' 86' ' ' PRO . . . -126.87 100.33 0.56 Allowed Glycine 0 N--CA 1.499 2.848 0 N-CA-C 109.159 -1.576 . . . . 2.3599999999999999 109.159 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.403 ' HD2' ' HA2' ' A' ' 85' ' ' GLY . 36.4 Cg_endo -58.72 -14.74 23.0 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 O-C-N 123.772 1.406 . . . . 3.3599999999999999 111.64 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -65.95 -23.46 66.61 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.132 -0.98 . . . . 3.5800000000000001 108.78 177.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 8.4 p -134.64 -16.78 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.474 -0.766 . . . . 3.8500000000000001 111.519 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -175.63 174.65 2.21 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 120.631 -1.293 . . . . 4.2199999999999998 111.585 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.456 0 N-CA-C 109.197 -1.561 . . . . 3.9500000000000002 109.197 178.43 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.649 0 N-CA-C 109.309 -1.516 . . . . 3.6699999999999999 109.309 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 57.81 44.87 19.52 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 121.632 -0.922 . . . . 5.3799999999999999 110.667 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -97.99 167.4 10.93 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.15 -0.969 . . . . 3.5 110.814 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.3 p -81.36 -30.86 33.61 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.169 -0.957 . . . . 3.8700000000000001 110.16 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.539 ' C ' HD12 ' A' ' 5' ' ' ILE . 1.8 pp -96.07 -156.37 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.586 -0.696 . . . . 3.1600000000000001 109.72 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.74 111.82 1.59 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.807 -1.183 . . . . 3.8199999999999998 110.609 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -65.29 -20.42 66.4 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.532 -0.73 . . . . 2.5800000000000001 110.922 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -88.3 25.64 1.6 Allowed 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.173 -0.955 . . . . 3.0299999999999998 110.59 178.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.43 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 0.4 OUTLIER -123.08 104.11 35.68 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 120.931 -1.106 . . . . 1.8600000000000001 110.802 -179.609 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 9' ' ' SER . 40.0 Cg_endo -67.38 -46.74 2.62 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 O-C-N 123.477 1.251 . . . . 1.6399999999999999 110.993 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.4 p -68.76 -61.66 1.72 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.471 -0.768 . . . . 1.71 109.742 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.17 -36.85 63.82 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.441 -0.787 . . . . 1.5 110.362 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.74 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -65.95 -59.14 7.83 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.175 -1.57 . . . . 1.1200000000000001 109.175 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 36.5 t -54.48 -40.82 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.481 -1.011 . . . . 1.3100000000000001 109.347 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.7 t -62.81 -46.0 97.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.567 -0.708 . . . . 1.3 109.159 178.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.451 ' OG1' HG12 ' A' ' 5' ' ' ILE . 65.6 m -56.64 -46.66 80.9 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 121.206 0.527 . . . . 1.1000000000000001 109.692 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 13' ' ' GLY . 2.6 t -65.25 -40.71 89.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 C-N-CA 119.695 -0.802 . . . . 0.98999999999999999 109.175 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.4 mm -60.98 -40.13 84.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.122 -0.986 . . . . 1.24 109.039 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 49.7 t -65.58 -45.58 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.181 -1.044 . . . . 1.01 108.181 177.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 85.8 mt -61.28 -49.53 84.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.915 -0.772 . . . . 1.01 108.915 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 11.2 mt -57.71 -48.7 78.84 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.987 -0.746 . . . . 1.1399999999999999 108.987 178.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.3 mt -56.95 -44.01 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 C-N-CA 119.845 -0.742 . . . . 1.1699999999999999 109.195 178.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.36 -45.99 88.6 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.599 -0.688 . . . . 0.93999999999999995 109.752 179.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.5 mt -59.2 -47.26 90.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.327 -0.858 . . . . 1.02 108.984 178.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.0 -44.95 95.64 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.591 -0.693 . . . . 0.94999999999999996 109.849 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.97 -44.71 96.93 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.54 -0.725 . . . . 1.0800000000000001 109.237 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.56 -45.92 90.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.44 -0.788 . . . . 1.3600000000000001 108.924 178.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.47 -43.98 95.6 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 108.69 -1.764 . . . . 1.01 108.69 178.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.68 -45.13 84.03 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.611 -0.935 . . . . 1.1000000000000001 109.748 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.484 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 5.0 mt -58.52 -41.43 85.44 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.758 -0.589 . . . . 1.5700000000000001 109.426 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 40.8 mt -69.32 -48.08 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.54 -0.725 . . . . 1.3999999999999999 109.478 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.83 -49.8 75.45 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.585 -0.697 . . . . 1.8500000000000001 110.189 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.75 -46.87 92.76 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 110.452 -1.059 . . . . 1.26 110.452 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -63.5 -35.37 80.24 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.317 -1.107 . . . . 1.74 111.054 -179.687 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 5.9 m95 -82.94 -58.81 2.71 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.227 -0.921 . . . . 2.02 110.8 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 41.97 45.9 3.41 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.72 -0.612 . . . . 1.3899999999999999 111.971 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -177.65 -39.44 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.387 0 O-C-N 121.437 -0.789 . . . . 1.3100000000000001 110.717 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.404 ' O ' ' CB ' ' A' ' 39' ' ' ARG . 6.6 tp -127.63 -57.2 1.28 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.176 -0.952 . . . . 1.3100000000000001 109.887 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.513 ' CZ ' ' HB3' ' A' ' 39' ' ' ARG . 0.0 OUTLIER 68.07 95.87 0.06 Allowed 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.604 0.716 . . . . 1.3400000000000001 110.977 179.582 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.47 84.96 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.501 -0.75 . . . . 2.02 110.251 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.08 -24.65 58.2 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.326 -0.859 . . . . 2.04 111.327 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.53 -125.42 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.195 -0.94 . . . . 2.9700000000000002 110.171 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.253 0.1 OUTLIER -67.59 -23.08 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 120.892 -1.13 . . . . 2.75 111.294 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 62.2 79.58 0.25 Allowed 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.429 -0.794 . . . . 1.77 110.652 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -96.37 32.08 2.08 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.298 -0.877 . . . . 2.0800000000000001 110.288 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 61.96 50.26 4.23 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.642 -0.661 . . . . 1.1799999999999999 109.486 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.692 ' HA ' ' SG ' ' A' ' 73' ' ' CYS . 1.0 OUTLIER -104.27 171.39 7.36 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.547 0.689 . . . . 1.46 111.887 -178.722 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.4 ' OD1' ' HB2' ' A' ' 70' ' ' LYS . 28.8 m-20 -78.2 112.52 15.26 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.359 -0.838 . . . . 1.6499999999999999 110.591 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.01 175.0 10.78 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.266 -0.896 . . . . 1.3799999999999999 110.973 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.64 ' HG3' HG13 ' A' ' 53' ' ' VAL . 0.4 OUTLIER 61.59 92.68 0.05 Allowed 'General case' 0 N--CA 1.502 2.139 0 CA-C-O 121.498 0.666 . . . . 1.22 110.962 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.4 p -106.01 -74.65 0.65 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.034 -1.041 . . . . 2.1600000000000001 111.075 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.445 ' H ' HG23 ' A' ' 52' ' ' ILE . 16.3 pt -53.98 -39.16 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.591 -0.693 . . . . 2.0 111.723 -178.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.64 HG13 ' HG3' ' A' ' 50' ' ' GLU . 13.5 p -94.58 -27.31 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 121.087 -1.008 . . . . 1.72 111.076 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.08 77.0 0.57 Allowed Glycine 0 N--CA 1.497 2.746 0 N-CA-C 109.501 -1.44 . . . . 1.1299999999999999 109.501 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.7 t70 67.07 -64.2 0.26 Allowed 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.987 -0.714 . . . . 2.02 110.872 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 121.22 -44.85 1.29 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 106.568 -2.613 . . . . 2.3799999999999999 106.568 -178.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.532 ' O ' ' HB ' ' A' ' 58' ' ' THR . 2.0 pt-20 -125.06 -16.09 6.15 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 122.177 -0.602 . . . . 3.1699999999999999 110.805 178.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.532 ' HB ' ' O ' ' A' ' 57' ' ' GLU . 31.8 m 72.22 124.93 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.518 0 CA-C-O 121.595 0.712 . . . . 1.75 110.515 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.405 ' HB3' ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -71.68 161.01 31.65 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.103 -0.998 . . . . 2.04 111.11 -179.097 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.626 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -48.76 -54.06 30.96 Favored Pre-proline 0 N--CA 1.504 2.23 0 O-C-N 121.546 -0.721 . . . . 2.7400000000000002 111.693 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.626 ' HD3' ' HB3' ' A' ' 60' ' ' GLU . 39.8 Cg_endo -65.55 -25.31 55.18 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 O-C-N 123.29 1.153 . . . . 1.76 110.962 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.488 ' O ' ' HB2' ' A' ' 66' ' ' GLN . 2.8 m-85 -83.19 -41.69 18.14 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.036 -1.04 . . . . 2.6099999999999999 110.621 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.594 HD23 ' HA ' ' A' ' 60' ' ' GLU . 0.9 OUTLIER -66.91 -30.6 70.8 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.185 -0.947 . . . . 1.9099999999999999 109.957 179.28 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.438 ' N ' ' HG ' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -61.62 -53.55 54.68 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.667 -0.646 . . . . 2.7000000000000002 110.385 179.349 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.0 m -72.65 -31.59 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.018 -1.051 . . . . 1.8200000000000001 109.998 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.488 ' HB2' ' O ' ' A' ' 62' ' ' PHE . 2.0 tt0 -65.27 -44.84 86.75 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.434 -0.792 . . . . 1.52 109.35 178.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.542 ' HA ' ' HG2' ' A' ' 70' ' ' LYS . 0.5 OUTLIER -68.84 -41.77 78.08 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.885 -0.783 . . . . 3.1600000000000001 108.885 178.201 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 68.4 m -60.33 -37.89 82.03 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 116.19 -0.459 . . . . 1.8200000000000001 110.375 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.62 -41.58 16.23 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.278 -0.889 . . . . 1.3999999999999999 110.726 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.625 ' HA ' ' HB3' ' A' ' 73' ' ' CYS . 0.2 OUTLIER -65.82 -35.08 79.67 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.38 -0.825 . . . . 1.0800000000000001 111.5 -179.59 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.435 ' N ' ' HD2' ' A' ' 72' ' ' PRO . . . -48.97 -61.36 5.37 Favored Glycine 0 N--CA 1.505 3.259 0 N-CA-C 109.715 -1.354 . . . . 1.1899999999999999 109.715 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 71' ' ' GLY . 40.9 Cg_endo -66.97 -39.54 13.78 Favored 'Trans proline' 0 C--N 1.315 -1.225 0 O-C-N 123.755 1.397 . . . . 1.52 109.864 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.692 ' SG ' ' HA ' ' A' ' 47' ' ' GLU . 2.6 t -62.17 -48.5 79.78 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.878 -1.139 . . . . 1.3100000000000001 109.609 178.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.7 ' HA ' ' HE3' ' A' ' 77' ' ' LYS . 25.4 t -57.98 -49.93 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.286 -1.005 . . . . 1.0600000000000001 108.286 178.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -57.47 -40.05 77.7 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.763 -0.775 . . . . 1.5800000000000001 109.318 177.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.9 ttm180 -63.78 -54.88 28.21 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.694 -0.629 . . . . 1.51 111.187 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.7 ' HE3' ' HA ' ' A' ' 74' ' ' VAL . 1.6 pttt -70.62 -33.12 70.68 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.02 -1.05 . . . . 1.75 110.605 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.405 ' N ' ' HG3' ' A' ' 77' ' ' LYS . . . -68.07 -47.77 67.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.327 -0.858 . . . . 1.51 109.636 178.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 16.4 mmtm -67.23 -44.53 79.26 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.377 -0.827 . . . . 1.79 109.805 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 tp -61.99 -34.42 76.14 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.628 -0.67 . . . . 2.5600000000000001 111.155 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.2 ttt -95.36 -60.8 1.59 Allowed 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.354 -0.841 . . . . 3.9300000000000002 110.376 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.426 HG23 ' O ' ' A' ' 82' ' ' THR . 1.5 t -177.69 104.46 0.22 Allowed Pre-proline 0 N--CA 1.503 2.185 0 O-C-N 121.518 -0.739 . . . . 2.2799999999999998 110.078 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -69.31 -6.15 17.66 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 O-C-N 123.822 1.433 . . . . 1.78 111.383 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 53.99 26.0 5.97 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.269 -0.894 . . . . 3.5699999999999998 110.515 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -128.66 -159.08 9.86 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.93 -1.268 . . . . 2.02 109.93 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -74.09 -20.33 19.29 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 O-C-N 123.684 1.36 . . . . 2.8300000000000001 112.132 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -50.59 -51.02 52.22 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.358 -0.839 . . . . 2.6499999999999999 109.79 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -112.34 2.09 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.623 -0.673 . . . . 2.6299999999999999 110.637 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 3.3 m80 56.35 47.33 19.26 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.367 -0.833 . . . . 3.75 110.892 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 3.015 0 CA-C-O 118.349 -1.25 . . . . 3.6800000000000002 110.209 179.816 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.767 0 N-CA-C 109.963 -1.255 . . . . 1.8700000000000001 109.963 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.463 ' HB3' HG13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -87.68 160.23 18.2 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.177 -1.19 . . . . 2.9100000000000001 110.369 179.574 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.448 ' HG2' HG23 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -81.45 71.79 8.46 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.112 -0.993 . . . . 2.5899999999999999 111.772 -179.546 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 46.37 50.22 12.53 Favored 'General case' 0 N--CA 1.509 2.52 0 O-C-N 121.559 -0.713 . . . . 2.0 112.58 178.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.617 ' C ' HD12 ' A' ' 5' ' ' ILE . 2.0 pp -99.7 -167.96 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 120.914 -1.116 . . . . 1.55 110.513 178.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.523 ' HB2' HD12 ' A' ' 5' ' ' ILE . 0.1 OUTLIER 60.1 -154.1 0.37 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.415 -0.803 . . . . 2.4399999999999999 110.77 -179.57 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 55.66 27.09 10.08 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.388 -0.82 . . . . 2.1299999999999999 111.214 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.471 ' ND1' ' HA ' ' A' ' 87' ' ' GLU . 2.9 t-160 -60.5 -27.88 67.94 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 121.222 -0.923 . . . . 1.3500000000000001 111.467 179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.603 ' O ' HG22 ' A' ' 12' ' ' THR . 12.0 t -167.14 151.54 6.65 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.319 -0.863 . . . . 1.8999999999999999 110.191 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.76 -17.75 47.43 Favored 'Trans proline' 0 N--CA 1.491 1.331 0 O-C-N 123.562 1.296 . . . . 1.6699999999999999 110.523 179.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.3 p -59.33 -51.6 69.26 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.476 -0.765 . . . . 1.7 109.939 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.603 HG22 ' O ' ' A' ' 9' ' ' SER . 4.9 t -61.31 -31.6 71.45 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.357 -0.84 . . . . 1.6399999999999999 109.961 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.688 ' O ' HG22 ' A' ' 17' ' ' VAL . . . -70.81 -53.83 10.86 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 108.024 -2.031 . . . . 1.3899999999999999 108.024 178.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.468 ' O ' HG23 ' A' ' 18' ' ' ILE . 37.9 t -55.11 -39.49 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.852 -0.793 . . . . 1.6299999999999999 109.289 178.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.637 ' HA ' HG12 ' A' ' 18' ' ' ILE . 25.0 t -67.09 -37.73 79.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.326 -0.859 . . . . 1.5900000000000001 109.468 178.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 98.4 m -64.61 -44.07 91.74 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.377 -0.827 . . . . 2.0 110.29 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.688 HG22 ' O ' ' A' ' 13' ' ' GLY . 0.5 OUTLIER -71.48 -37.39 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 C-N-CA 119.133 -1.027 . . . . 1.98 110.908 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.777 ' HA ' HD23 ' A' ' 21' ' ' LEU . 8.7 pt -69.19 -33.74 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 120.299 -1.501 . . . . 1.9199999999999999 109.52 178.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.501 ' N ' HG13 ' A' ' 18' ' ' ILE . 38.6 t -69.63 -44.3 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.287 -1.005 . . . . 1.5700000000000001 108.287 177.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.6 mm -63.52 -46.78 94.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.401 -0.812 . . . . 1.7 109.027 178.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.777 HD23 ' HA ' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -63.28 -43.47 97.82 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.515 -0.74 . . . . 1.71 109.031 178.811 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.569 ' N ' ' HG ' ' A' ' 21' ' ' LEU . 7.5 mm -62.14 -39.07 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.029 -1.044 . . . . 1.8400000000000001 109.0 178.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.29 -51.0 61.74 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.549 -0.719 . . . . 1.45 110.715 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.605 HG12 ' HA ' ' A' ' 21' ' ' LEU . 40.8 pt -62.36 -37.12 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.807 -1.183 . . . . 1.78 109.266 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.514 ' N ' HG13 ' A' ' 24' ' ' ILE . . . -65.15 -46.59 80.27 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.418 -0.801 . . . . 1.54 109.192 178.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.6 -43.08 99.53 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.697 -0.853 . . . . 1.52 108.697 178.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.3 tt -60.38 -48.17 82.91 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.953 -0.758 . . . . 1.6799999999999999 108.953 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.72 -46.58 92.07 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 108.839 -1.705 . . . . 1.3400000000000001 108.839 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.69 -42.98 99.66 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.456 -1.026 . . . . 1.54 109.558 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 6.4 mt -61.2 -41.3 96.58 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 109.085 -0.709 . . . . 1.8300000000000001 109.085 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 23.5 mm -65.35 -46.14 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.519 -0.738 . . . . 1.4299999999999999 109.142 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.496 ' O ' ' HB2' ' A' ' 36' ' ' CYS . 0.2 OUTLIER -61.18 -48.61 80.77 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.543 -0.723 . . . . 1.97 109.63 178.846 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.52 -37.01 92.64 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 110.017 -1.233 . . . . 1.4199999999999999 110.017 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -74.68 -42.9 57.6 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.447 -1.031 . . . . 1.24 111.049 -179.82 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.457 ' CZ2' ' HA ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -153.9 58.25 0.73 Allowed 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.364 -0.835 . . . . 1.47 112.45 -179.011 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 32' ' ' LEU . 49.6 t -61.78 -26.61 68.2 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 120.65 -1.281 . . . . 1.8700000000000001 111.527 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.31 -169.0 2.29 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.107 -0.995 . . . . 3.5800000000000001 109.371 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.9 tp -51.07 -36.33 39.5 Favored 'General case' 0 N--CA 1.508 2.452 0 O-C-N 120.954 -1.091 . . . . 1.98 110.67 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.418 ' HB3' ' CD1' ' A' ' 35' ' ' TRP . 0.3 OUTLIER 45.44 72.61 0.2 Allowed 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 121.587 0.708 . . . . 1.4099999999999999 111.748 179.147 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.53 -34.52 50.23 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.408 -0.807 . . . . 2.2400000000000002 110.977 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.44 ' HG3' ' HA ' ' A' ' 44' ' ' SER . 26.8 tt0 -71.94 55.97 0.3 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.04 -1.038 . . . . 2.1499999999999999 109.741 178.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.457 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . 0.7 OUTLIER -60.32 -76.77 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.411 -0.805 . . . . 1.45 108.989 179.625 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.423 HD11 ' O ' ' A' ' 47' ' ' GLU 0.27 0.3 OUTLIER -76.88 -22.48 14.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.633 -0.667 . . . . 2.1299999999999999 110.248 178.834 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.44 ' HA ' ' HG3' ' A' ' 41' ' ' GLN . 10.6 t 64.42 -67.59 0.11 Allowed 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.491 -0.755 . . . . 1.5600000000000001 111.493 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.412 ' HB2' ' OE1' ' A' ' 47' ' ' GLU . 0.7 OUTLIER -99.39 -89.13 0.33 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.815 -1.178 . . . . 1.95 111.063 -179.69 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.4 m 178.46 50.29 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.375 0 O-C-N 121.016 -1.053 . . . . 2.3300000000000001 110.677 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.423 ' O ' HD11 ' A' ' 43' ' ' ILE . 1.3 pm0 -111.95 -164.14 0.9 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.257 -0.902 . . . . 2.3599999999999999 110.577 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.04 143.3 26.94 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.846 -1.159 . . . . 2.8399999999999999 110.418 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.471 ' HG2' ' N ' ' A' ' 50' ' ' GLU . 22.7 tt0 -160.94 157.74 26.94 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.108 -0.995 . . . . 1.45 111.82 -178.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.471 ' N ' ' HG2' ' A' ' 49' ' ' GLU . 1.9 tt0 -95.09 -110.49 0.13 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.476 -0.765 . . . . 1.0900000000000001 110.173 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.0 m -162.03 -39.64 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.343 0 O-C-N 120.393 -1.442 . . . . 1.3 111.838 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.5 mt -106.2 -51.07 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.348 -0.845 . . . . 1.51 110.146 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.3 m -134.01 -47.67 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.295 0 O-C-N 121.522 -0.736 . . . . 1.05 111.17 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.71 -66.02 3.39 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 109.88 -1.288 . . . . 1.1899999999999999 109.88 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -100.0 158.35 15.89 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.421 -1.047 . . . . 2.79 110.523 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.43 55.34 0.4 Allowed Glycine 0 N--CA 1.497 2.764 0 N-CA-C 109.112 -1.595 . . . . 1.6899999999999999 109.112 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 52.84 44.75 29.93 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.813 -0.816 . . . . 2.2999999999999998 110.582 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.59 58.39 0.09 Allowed 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.348 -0.845 . . . . 1.45 110.794 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.2 105.83 5.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.154 -0.966 . . . . 2.23 109.918 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.06 122.61 10.04 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.493 -0.754 . . . . 2.46 110.868 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.517 ' O ' ' HB2' ' A' ' 62' ' ' PHE . 38.3 Cg_endo -66.46 -41.45 11.83 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.658 1.346 . . . . 2.48 110.565 178.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.517 ' HB2' ' O ' ' A' ' 61' ' ' PRO . 1.2 t80 171.28 164.08 0.09 Allowed 'General case' 0 N--CA 1.507 2.413 0 O-C-N 121.494 -0.754 . . . . 3.6600000000000001 110.549 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 mt -64.08 -39.82 94.9 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.382 -0.824 . . . . 3.5699999999999998 109.624 178.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.13 -42.07 97.86 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.724 -0.61 . . . . 4.0300000000000002 109.519 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.433 ' HB ' ' HG2' ' A' ' 61' ' ' PRO . 11.8 t -74.52 -38.98 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.226 -0.922 . . . . 2.4399999999999999 109.125 178.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.422 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 6.0 tt0 -57.7 -42.77 84.38 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.758 -0.83 . . . . 2.4199999999999999 108.758 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.445 ' HA ' ' HG2' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -74.44 -45.8 44.0 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 109.259 -0.645 . . . . 4.1600000000000001 109.259 178.106 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 69.9 m -59.21 -37.09 76.6 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.748 -0.595 . . . . 2.4199999999999999 110.488 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -84.68 -46.48 11.43 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.054 -1.028 . . . . 1.6100000000000001 111.243 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.445 ' HG2' ' HA ' ' A' ' 67' ' ' TYR . 12.3 ptpt -65.17 -35.66 81.78 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.338 -0.851 . . . . 2.3700000000000001 111.213 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.401 ' N ' ' HD2' ' A' ' 72' ' ' PRO . . . -49.07 -64.22 3.44 Favored Glycine 0 N--CA 1.502 3.068 0 N-CA-C 109.795 -1.322 . . . . 1.46 109.795 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.401 ' HD2' ' N ' ' A' ' 71' ' ' GLY . 40.3 Cg_endo -66.11 -37.15 26.5 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.734 1.386 . . . . 1.47 110.245 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 2.5 t -62.41 -46.04 90.39 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.039 -1.038 . . . . 1.4099999999999999 109.593 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.5 t -68.66 -47.41 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.561 -0.712 . . . . 1.3999999999999999 109.311 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -57.41 -40.59 78.61 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 119.799 -0.76 . . . . 1.5 109.405 178.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.421 ' HA ' ' HG2' ' A' ' 79' ' ' LYS . 3.8 ttm180 -65.11 -44.22 89.47 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.53 -0.731 . . . . 2.5299999999999998 109.473 178.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.83 -38.7 89.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -0.871 . . . . 2.6499999999999999 109.786 178.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.04 -50.71 53.59 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.377 0.608 . . . . 1.1499999999999999 110.087 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.421 ' HG2' ' HA ' ' A' ' 76' ' ' ARG . 0.3 OUTLIER -65.64 -30.8 71.56 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.693 -0.63 . . . . 1.5600000000000001 110.109 179.469 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -76.98 -26.86 54.41 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.245 -0.909 . . . . 2.3300000000000001 109.881 178.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 3.7 ttt -86.85 -40.34 14.99 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.369 -0.832 . . . . 2.9100000000000001 110.756 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 14.5 t -61.15 146.63 88.0 Favored Pre-proline 0 N--CA 1.509 2.487 0 O-C-N 121.367 -0.833 . . . . 1.6200000000000001 111.163 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -78.74 9.95 3.05 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 O-C-N 123.552 1.29 . . . . 1.75 112.849 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 41.51 29.45 0.1 Allowed 'General case' 0 N--CA 1.511 2.584 0 O-C-N 121.437 -0.789 . . . . 2.1200000000000001 112.192 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -132.34 -93.61 0.57 Allowed Glycine 0 N--CA 1.498 2.791 0 N-CA-C 109.448 -1.461 . . . . 1.71 109.448 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.475 ' O ' ' N ' ' A' ' 88' ' ' VAL . 53.6 Cg_endo -80.72 -108.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.28 0 O-C-N 123.848 1.446 . . . . 1.9399999999999999 110.106 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.471 ' HA ' ' ND1' ' A' ' 8' ' ' HIS . 0.5 OUTLIER 65.14 -57.76 0.28 Allowed 'General case' 0 N--CA 1.507 2.38 0 O-C-N 120.979 -1.076 . . . . 1.4099999999999999 110.86 -179.526 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.475 ' N ' ' O ' ' A' ' 86' ' ' PRO . 11.5 p -110.54 -20.84 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.748 -0.595 . . . . 2.25 110.121 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -119.5 157.45 28.29 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.265 -0.897 . . . . 3.2999999999999998 109.653 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.657 0 CA-C-O 117.848 -1.529 . . . . 2.8399999999999999 109.707 179.18 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.519 ' HA2' ' OE2' ' A' ' 57' ' ' GLU . . . . . . . . 0 N--CA 1.496 2.692 0 N-CA-C 111.485 -0.646 . . . . 3.1499999999999999 111.485 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 m -78.3 47.64 0.7 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.194 -1.18 . . . . 4.0199999999999996 110.617 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -75.87 -20.62 57.94 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 121.219 -0.926 . . . . 6.0700000000000003 111.306 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 80.4 p -129.47 -65.55 0.84 Allowed 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.598 -0.89 . . . . 6.0800000000000001 108.598 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.564 ' C ' HD12 ' A' ' 5' ' ' ILE . 2.0 pp -98.05 -174.73 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-O 121.25 0.547 . . . . 5.79 110.107 178.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.2 71.05 1.22 Allowed 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 122.067 0.937 . . . . 5.8899999999999997 110.492 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.407 ' HB3' ' CD1' ' A' ' 5' ' ' ILE . 3.6 p-10 -65.74 -18.51 65.38 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.524 -0.735 . . . . 3.0499999999999998 109.767 178.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 1.021 ' HA ' HG22 ' A' ' 14' ' ' VAL . 5.5 m80 -79.05 -5.31 53.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.64 -0.662 . . . . 2.9900000000000002 110.867 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.448 ' CB ' ' CD ' ' A' ' 10' ' ' PRO . 0.5 OUTLIER -61.49 -57.73 23.17 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.168 -0.957 . . . . 3.5699999999999998 110.652 179.706 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.499 ' O ' HG23 ' A' ' 14' ' ' VAL . 49.6 Cg_endo -73.82 109.51 2.88 Favored 'Trans proline' 0 N--CA 1.488 1.203 0 O-C-N 123.54 1.284 . . . . 3.3700000000000001 110.679 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.749 ' O ' HG22 ' A' ' 15' ' ' VAL . 5.3 p -57.2 -46.68 82.66 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.393 -0.817 . . . . 4.2000000000000002 110.412 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 p -59.03 -33.12 70.39 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.417 -0.802 . . . . 4.4400000000000004 109.235 178.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.535 ' O ' HG22 ' A' ' 17' ' ' VAL . . . -75.32 -50.13 8.66 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 108.342 -1.903 . . . . 3.3100000000000001 108.342 178.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 1.021 HG22 ' HA ' ' A' ' 8' ' ' HIS . 72.1 t -49.99 -45.68 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 121.964 -0.727 . . . . 2.7000000000000002 110.16 178.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.749 HG22 ' O ' ' A' ' 11' ' ' THR . 17.2 m -71.89 -42.42 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.2 -0.938 . . . . 3.48 109.847 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 56.7 m -58.22 -50.65 72.82 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.554 -0.717 . . . . 3.4199999999999999 110.175 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.535 HG22 ' O ' ' A' ' 13' ' ' GLY . 27.4 m -66.03 -39.63 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.45 -0.781 . . . . 2.3900000000000001 110.104 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.563 ' O ' HG12 ' A' ' 22' ' ' ILE . 10.9 mm -64.98 -43.52 96.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 O-C-N 120.994 -1.066 . . . . 2.3100000000000001 109.445 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.518 ' HA ' HG12 ' A' ' 22' ' ' ILE . 32.2 t -61.78 -40.43 86.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 119.743 -0.783 . . . . 2.96 108.955 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 27.4 mm -69.43 -41.24 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.26 -0.9 . . . . 2.6099999999999999 108.746 178.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 39.6 mt -61.99 -50.62 71.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.712 -0.617 . . . . 1.5900000000000001 109.491 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.563 HG12 ' O ' ' A' ' 18' ' ' ILE . 43.5 pt -61.99 -41.16 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 120.815 -1.178 . . . . 2.5299999999999998 109.409 178.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.551 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -60.27 -45.86 91.85 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 109.04 -0.726 . . . . 1.99 109.04 178.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 39.0 mt -59.27 -48.26 87.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.689 -0.856 . . . . 1.52 108.689 178.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.98 -42.5 94.32 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.697 -0.627 . . . . 1.28 109.878 178.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.84 -45.53 92.17 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.922 -0.769 . . . . 1.79 108.922 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.68 -45.55 93.51 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.806 -0.813 . . . . 1.53 108.806 178.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.469 ' HA3' ' HG2' ' A' ' 60' ' ' GLU . . . -58.84 -45.54 94.84 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 108.54 -1.824 . . . . 1.1299999999999999 108.54 178.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.5 -44.73 95.67 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.507 -0.996 . . . . 1.6299999999999999 109.36 178.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 5.3 mt -56.78 -42.87 80.19 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 109.088 -0.708 . . . . 1.98 109.088 178.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 39.8 mt -68.83 -49.18 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 109.07 -0.715 . . . . 1.25 109.07 178.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.83 -46.05 71.07 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.496 -0.753 . . . . 3.0099999999999998 109.527 178.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.3 -40.21 70.26 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.925 -1.27 . . . . 1.8400000000000001 109.925 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 6.9 t -62.7 -44.88 95.09 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.339 -1.095 . . . . 1.6399999999999999 110.955 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.457 ' O ' ' N ' ' A' ' 37' ' ' TYR . 2.0 t-105 -165.23 40.08 0.07 Allowed 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.024 -1.048 . . . . 2.73 112.334 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.518 ' SG ' ' CD1' ' A' ' 63' ' ' LEU . 38.1 t 62.38 -64.46 0.09 Allowed 'General case' 0 N--CA 1.51 2.545 0 O-C-N 121.232 -0.918 . . . . 2.6600000000000001 112.234 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.548 ' HB3' ' HG2' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -153.64 -66.92 0.15 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.82 -1.175 . . . . 6.0499999999999998 110.363 -178.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -136.65 -62.54 0.65 Allowed 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.413 -0.958 . . . . 2.4399999999999999 108.413 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.8 mtm-85 171.73 54.42 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.072 0.463 . . . . 2.1699999999999999 110.239 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.616 HD22 ' HB2' ' A' ' 46' ' ' SER . 0.2 OUTLIER -124.58 20.57 8.63 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.95 -1.094 . . . . 2.7400000000000002 111.95 -179.47 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -96.89 38.31 1.24 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.862 -1.149 . . . . 2.3700000000000001 110.476 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? -112.01 -64.38 1.3 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.184 -0.947 . . . . 3.1699999999999999 111.158 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.507 HG13 ' H ' ' A' ' 44' ' ' SER . 3.0 pt -94.51 -39.08 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 CA-C-O 121.802 0.811 . . . . 3.2599999999999998 110.468 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.507 ' H ' HG13 ' A' ' 43' ' ' ILE . 1.1 m -168.99 125.39 0.93 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.522 -0.548 . . . . 3.3599999999999999 109.522 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -66.64 162.06 21.94 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.583 0.706 . . . . 2.9700000000000002 110.924 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.616 ' HB2' HD22 ' A' ' 40' ' ' LEU . 3.1 m -170.67 45.72 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.408 -0.807 . . . . 2.7400000000000002 109.664 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.548 ' HG2' ' HB3' ' A' ' 37' ' ' TYR . 1.9 mp0 -111.04 166.01 11.41 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.634 -0.666 . . . . 2.4300000000000002 110.42 -179.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.19 80.19 1.29 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.445 -0.784 . . . . 3.96 110.449 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -98.06 82.16 2.93 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.437 -0.579 . . . . 2.2200000000000002 109.437 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.86 -175.28 3.13 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 122.253 1.025 . . . . 3.2799999999999998 111.07 -179.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.5 t -137.86 -37.22 0.6 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.793 -0.567 . . . . 2.6699999999999999 110.514 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 38.2 mt -76.98 -48.42 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.115 -0.991 . . . . 2.75 109.647 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.63 HG12 ' N ' ' A' ' 54' ' ' GLY . 1.0 OUTLIER -55.21 -56.91 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-O 121.391 0.615 . . . . 2.7400000000000002 109.669 178.894 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.63 ' N ' HG12 ' A' ' 53' ' ' VAL . . . -73.63 73.99 1.14 Allowed Glycine 0 N--CA 1.497 2.759 0 N-CA-C 109.818 -1.313 . . . . 2.1800000000000002 109.818 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -115.98 -162.79 0.86 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.514 -0.992 . . . . 2.3799999999999999 110.417 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' A' ' 57' ' ' GLU . . . 111.26 48.32 0.71 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 108.117 -1.993 . . . . 2.27 108.117 -178.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.519 ' OE2' ' HA2' ' A' ' 1' ' ' GLY . 0.9 OUTLIER 62.02 14.91 6.84 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.927 -0.749 . . . . 2.3700000000000001 111.035 -178.586 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.6 t -154.32 144.63 22.1 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.974 -1.079 . . . . 2.2999999999999998 110.296 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -137.39 121.01 17.28 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.437 -0.79 . . . . 2.3100000000000001 110.021 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.469 ' HG2' ' HA3' ' A' ' 28' ' ' GLY . 0.3 OUTLIER -64.37 144.67 98.5 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.426 -0.796 . . . . 2.21 110.339 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -69.85 58.02 1.56 Allowed 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.719 1.379 . . . . 1.9099999999999999 110.429 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.453 ' CE2' ' HB2' ' A' ' 60' ' ' GLU . 55.2 m-85 -55.29 155.22 5.21 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.639 -0.663 . . . . 2.5899999999999999 110.371 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.518 ' CD1' ' SG ' ' A' ' 36' ' ' CYS . 0.5 OUTLIER -59.97 -36.72 77.74 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.861 -1.149 . . . . 2.0699999999999998 110.668 179.592 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.91 -58.07 10.25 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.368 -0.833 . . . . 2.46 110.049 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.451 ' HA ' ' HB2' ' A' ' 68' ' ' SER . 33.5 m -68.99 -31.57 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.224 -0.923 . . . . 2.5499999999999998 109.821 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.459 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 6.5 tp-100 -63.05 -55.25 27.15 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.363 -0.836 . . . . 2.3799999999999999 108.918 178.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -62.71 -42.45 99.66 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.518 -0.738 . . . . 2.52 109.459 178.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.451 ' HB2' ' HA ' ' A' ' 65' ' ' VAL . 1.2 m -56.72 -35.48 68.6 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-O 120.928 0.394 . . . . 2.5 110.703 179.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -91.69 -41.66 10.59 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.22 -0.925 . . . . 2.4900000000000002 110.601 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 66' ' ' GLN . 1.6 mmtp -65.23 -44.3 88.69 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.528 -0.733 . . . . 2.5600000000000001 110.392 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.404 ' N ' ' HD2' ' A' ' 72' ' ' PRO . . . -45.58 -63.68 2.67 Favored Glycine 0 N--CA 1.503 3.109 0 N-CA-C 110.22 -1.152 . . . . 1.8600000000000001 110.22 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' A' ' 71' ' ' GLY . 42.2 Cg_endo -66.65 -39.08 16.56 Favored 'Trans proline' 0 C--N 1.316 -1.18 0 O-C-N 123.783 1.412 . . . . 2.46 110.419 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 36.7 t -60.64 -43.9 97.02 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.997 -1.064 . . . . 2.7799999999999998 109.679 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.8 t -70.46 -49.42 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.682 -0.636 . . . . 1.9199999999999999 109.424 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.21 -31.21 68.83 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.536 0.684 . . . . 2.3900000000000001 110.3 179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -75.28 -49.02 20.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.356 -0.84 . . . . 4.1699999999999999 109.542 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.535 ' HG3' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -69.25 -26.95 65.04 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.364 -0.835 . . . . 3.4700000000000002 109.662 179.237 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.821 ' O ' HG22 ' A' ' 82' ' ' THR . . . -71.91 -52.28 18.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.451 -0.781 . . . . 2.0899999999999999 108.946 178.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -68.45 -24.74 64.76 Favored 'General case' 0 N--CA 1.5 2.067 0 C-N-CA 120.48 -0.488 . . . . 2.3799999999999999 110.312 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.5 tp -78.02 -39.91 40.61 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.23 -0.918 . . . . 3.77 109.53 178.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 12.0 ttt -78.37 -50.34 11.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.623 -0.673 . . . . 4.2800000000000002 109.909 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.821 HG22 ' O ' ' A' ' 78' ' ' ALA . 5.1 t -79.92 144.58 59.86 Favored Pre-proline 0 N--CA 1.492 1.633 0 C-N-CA 119.612 -0.835 . . . . 2.5800000000000001 109.186 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.451 ' HG3' ' HB3' ' A' ' 89' ' ' HIS . 44.5 Cg_endo -73.16 -3.54 13.85 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 123.521 1.274 . . . . 3.5600000000000001 110.531 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.23 19.37 10.91 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.32 -0.862 . . . . 4.0099999999999998 109.64 -178.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -151.89 101.44 0.21 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 107.979 -2.048 . . . . 4.29 107.979 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.586 ' HA ' ' O ' ' A' ' 89' ' ' HIS . 39.0 Cg_endo -62.51 -10.22 18.39 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 O-C-N 123.573 1.301 . . . . 5.5700000000000003 111.775 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -60.84 -26.3 67.26 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.235 -0.915 . . . . 6.7300000000000004 110.733 178.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.7 p -113.84 -23.94 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 O-C-N 121.126 -0.984 . . . . 6.0 111.373 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.586 ' O ' ' HA ' ' A' ' 86' ' ' PRO . 58.1 t-80 -149.47 141.52 23.91 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.902 -1.123 . . . . 4.7400000000000002 111.017 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.617 0 N-CA-C 109.998 -1.241 . . . . 4.2400000000000002 109.998 178.985 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.685 0 N-CA-C 109.555 -1.418 . . . . 2.9100000000000001 109.555 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.414 ' HA ' ' CG2' ' A' ' 11' ' ' THR . 0.6 OUTLIER -176.95 62.18 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.478 -1.013 . . . . 2.5499999999999998 110.823 179.5 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.0 mtt -100.1 -96.54 0.25 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.114 -0.991 . . . . 3.9399999999999999 109.95 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 81.2 p -129.63 -50.45 1.16 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.04 -1.037 . . . . 2.6499999999999999 110.257 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.551 ' C ' HD12 ' A' ' 5' ' ' ILE . 1.6 pp -71.88 -165.26 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 CA-C-O 121.267 0.555 . . . . 3.0499999999999998 110.529 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 2.0 mtt -72.05 84.0 0.99 Allowed 'General case' 0 N--CA 1.503 2.19 0 O-C-N 120.66 -1.275 . . . . 3.5800000000000001 111.419 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.549 ' HB2' HG21 ' A' ' 11' ' ' THR . 0.8 OUTLIER -95.07 33.43 1.52 Allowed 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.278 -0.889 . . . . 2.6699999999999999 110.434 179.274 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 62.02 34.06 16.84 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.288 -0.883 . . . . 2.7400000000000002 109.662 -178.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -161.57 170.54 8.02 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.677 -0.639 . . . . 1.6000000000000001 109.296 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -74.33 56.18 3.78 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 O-C-N 123.537 1.283 . . . . 1.73 110.914 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.549 HG21 ' HB2' ' A' ' 7' ' ' ASP . 21.6 p -64.43 -51.45 63.09 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.425 -0.797 . . . . 1.3500000000000001 110.759 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.3 p -56.1 -36.99 68.79 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.446 -0.784 . . . . 1.99 110.438 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -71.33 -52.79 11.82 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 109.133 -1.587 . . . . 1.3 109.133 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.561 ' O ' HG12 ' A' ' 18' ' ' ILE . 28.1 t -56.53 -40.43 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.701 -0.882 . . . . 1.4099999999999999 109.222 178.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.603 ' HA ' HG12 ' A' ' 18' ' ' ILE . 49.8 t -68.25 -41.38 83.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.261 -0.899 . . . . 1.3 109.528 178.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 52.9 m -60.51 -47.5 85.9 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.403 -0.81 . . . . 1.8999999999999999 109.785 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.431 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 32.6 m -67.54 -41.65 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.465 -0.772 . . . . 1.77 111.272 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.872 ' HA ' HD23 ' A' ' 21' ' ' LEU . 4.0 pt -68.57 -33.56 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 120.292 -1.505 . . . . 1.28 109.925 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.486 ' N ' HG13 ' A' ' 18' ' ' ILE . 17.7 t -68.44 -44.39 83.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.24 -1.022 . . . . 1.3799999999999999 108.24 177.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 69.5 mt -63.69 -49.23 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 108.843 -0.799 . . . . 2.0299999999999998 108.843 178.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.872 HD23 ' HA ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -60.71 -42.66 97.7 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 119.926 -0.71 . . . . 1.6200000000000001 109.106 178.698 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.564 ' N ' ' HG ' ' A' ' 21' ' ' LEU . 14.9 mt -61.24 -44.13 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.226 -0.921 . . . . 1.1799999999999999 109.131 178.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.9 -45.74 87.94 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.514 -0.741 . . . . 1.23 109.593 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 54.6 mt -58.79 -47.77 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.437 -0.789 . . . . 2.0699999999999998 108.993 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.95 -44.83 95.94 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.561 -0.712 . . . . 1.3200000000000001 109.935 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.57 -45.64 93.17 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 109.149 -0.685 . . . . 0.92000000000000004 109.149 178.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.35 -45.96 92.2 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.488 -0.758 . . . . 1.9199999999999999 108.978 178.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.22 -45.35 94.2 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 108.617 -1.793 . . . . 1.3999999999999999 108.617 178.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.25 -44.94 93.77 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.639 -0.918 . . . . 1.22 109.888 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.479 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 6.7 mt -58.82 -41.28 86.49 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.618 -0.676 . . . . 1.5600000000000001 109.516 178.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 53.2 mt -68.22 -47.0 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.272 -0.893 . . . . 1.74 109.305 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.472 ' O ' ' HA ' ' A' ' 36' ' ' CYS . 0.3 OUTLIER -62.71 -39.37 93.81 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.358 -0.839 . . . . 2.1800000000000002 110.42 179.043 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -75.49 -37.8 39.95 Favored Glycine 0 N--CA 1.498 2.781 0 O-C-N 120.948 -1.095 . . . . 1.26 111.142 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.544 ' HB3' ' CE3' ' A' ' 35' ' ' TRP . 0.1 OUTLIER -84.19 -32.63 24.45 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.942 -1.328 . . . . 1.5600000000000001 111.859 -179.033 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.544 ' CE3' ' HB3' ' A' ' 34' ' ' CYS . 7.0 m-90 -125.51 1.02 7.62 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 120.979 -1.076 . . . . 1.8999999999999999 112.393 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER 64.68 -69.49 0.09 Allowed 'General case' 0 N--CA 1.511 2.576 0 O-C-N 121.059 -1.025 . . . . 2.3100000000000001 112.044 179.435 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.729 ' HB3' HD23 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -131.05 96.55 4.07 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.326 -0.859 . . . . 5.0800000000000001 109.957 -179.256 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.412 ' HB3' ' O ' ' A' ' 37' ' ' TYR . 34.1 tp 62.94 -66.87 0.09 Allowed 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.561 -0.712 . . . . 3.9300000000000002 111.117 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.474 ' N ' ' O ' ' A' ' 37' ' ' TYR . 2.1 mmt180 -140.32 -48.51 0.44 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.662 -0.649 . . . . 2.96 110.49 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.729 HD23 ' HB3' ' A' ' 37' ' ' TYR . 0.2 OUTLIER 46.4 52.06 11.06 Favored 'General case' 0 N--CA 1.504 2.231 0 CA-C-O 121.64 0.734 . . . . 1.9099999999999999 111.271 -179.977 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.8 pm0 -96.16 19.65 11.45 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.66 -0.65 . . . . 4.0999999999999996 111.562 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.486 ' HG3' HG12 ' A' ' 43' ' ' ILE . 0.6 OUTLIER -100.62 -147.51 0.35 Allowed 'General case' 0 N--CA 1.485 1.313 0 O-C-N 120.739 -1.226 . . . . 2.9199999999999999 108.645 178.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.486 HG12 ' HG3' ' A' ' 42' ' ' ARG . 16.7 pt -48.8 -33.66 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.36 -0.838 . . . . 2.3599999999999999 110.175 178.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.543 ' HA ' HD12 ' A' ' 40' ' ' LEU . 0.4 OUTLIER 71.44 117.59 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.263 0 CA-C-O 121.382 0.61 . . . . 1.6399999999999999 110.849 179.798 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.18 -1.59 21.73 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.1 -1.0 . . . . 1.74 110.952 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.505 ' HB2' HD13 ' A' ' 80' ' ' LEU . 0.1 OUTLIER 59.56 39.23 21.78 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.176 -0.953 . . . . 1.97 110.369 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.407 ' O ' ' HG2' ' A' ' 47' ' ' GLU . 5.7 pm0 -83.26 146.89 28.3 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.189 -0.944 . . . . 1.6599999999999999 111.493 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -160.8 -57.05 0.05 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.906 -0.496 . . . . 1.52 110.07 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.529 ' HB2' ' NH2' ' A' ' 76' ' ' ARG . 1.4 tt0 -69.3 124.93 25.16 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.432 -0.792 . . . . 1.9099999999999999 110.272 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.453 ' HB3' ' HA2' ' A' ' 54' ' ' GLY . 0.2 OUTLIER 70.65 165.99 0.29 Allowed 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.76 0.791 . . . . 2.27 110.301 -179.236 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.0 p -141.66 -28.7 0.64 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.421 -0.799 . . . . 2.2799999999999998 111.59 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 67.9 mt -74.31 -51.52 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.186 -0.946 . . . . 2.8199999999999998 110.447 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 55' ' ' ASP . 13.9 p -134.96 -33.96 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.294 -0.879 . . . . 2.6699999999999999 112.164 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.453 ' HA2' ' HB3' ' A' ' 50' ' ' GLU . . . 66.53 -65.24 0.17 Allowed Glycine 0 N--CA 1.505 3.245 0 O-C-N 120.918 -1.114 . . . . 1.9199999999999999 110.761 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.545 ' O ' HG22 ' A' ' 53' ' ' VAL . 16.8 t70 -88.39 149.4 23.74 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.386 -1.067 . . . . 2.52 110.182 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 175.41 -62.12 0.11 Allowed Glycine 0 N--CA 1.496 2.672 0 N-CA-C 108.883 -1.687 . . . . 2.3300000000000001 108.883 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -112.17 25.84 11.16 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.585 -0.95 . . . . 2.7599999999999998 110.187 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.12 62.78 0.32 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.32 -0.862 . . . . 2.0499999999999998 110.195 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 5.4 mttt -113.44 152.62 29.85 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.302 -0.874 . . . . 2.2200000000000002 110.246 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.673 ' HG2' ' HA ' ' A' ' 66' ' ' GLN . 1.7 mp0 -113.5 73.77 2.08 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.367 -0.833 . . . . 1.6499999999999999 110.302 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.406 ' HD2' HG11 ' A' ' 65' ' ' VAL . 42.7 Cg_endo -69.62 -33.4 17.19 Favored 'Trans proline' 0 N--CA 1.491 1.334 0 O-C-N 123.602 1.317 . . . . 2.1200000000000001 111.356 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -127.35 163.3 24.31 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.985 -1.072 . . . . 2.8199999999999998 110.367 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 pp -56.96 -33.21 66.83 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.254 -0.904 . . . . 2.1600000000000001 110.462 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.17 -49.1 71.1 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.574 -0.704 . . . . 2.4500000000000002 109.422 178.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.497 ' HA ' ' HB2' ' A' ' 68' ' ' SER . 4.1 t -70.67 -32.71 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.158 -0.964 . . . . 1.74 109.124 178.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.673 ' HA ' ' HG2' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -57.17 -55.74 30.8 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.475 -0.935 . . . . 1.27 108.475 178.559 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -62.77 -41.45 99.23 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.586 -0.696 . . . . 3.0099999999999998 109.473 178.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.497 ' HB2' ' HA ' ' A' ' 65' ' ' VAL . 63.7 m -60.39 -37.56 81.2 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 122.035 -0.416 . . . . 1.5 110.308 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.499 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -81.58 -39.82 23.98 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.163 -0.961 . . . . 1.05 110.221 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 66' ' ' GLN . 2.6 mmpp? -61.57 -42.63 99.12 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.577 -0.702 . . . . 1.0600000000000001 110.54 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -43.09 -66.23 1.23 Allowed Glycine 0 N--CA 1.505 3.244 0 N-CA-C 110.526 -1.03 . . . . 0.82999999999999996 110.526 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.49 ' HA ' ' HB3' ' A' ' 75' ' ' GLU . 40.5 Cg_endo -66.32 -38.73 19.54 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.753 1.396 . . . . 1.03 110.235 179.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.499 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -58.38 -44.82 89.07 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.039 -1.038 . . . . 1.55 109.487 178.495 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 69.6 t -74.39 -41.76 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.55 -0.718 . . . . 0.73999999999999999 109.233 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.49 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 1.0 OUTLIER -54.75 -46.12 74.27 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 121.529 0.681 . . . . 1.0600000000000001 109.474 178.532 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.529 ' NH2' ' HB2' ' A' ' 49' ' ' GLU . 6.7 mpt_? -69.09 -46.35 67.99 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.719 -0.613 . . . . 1.0900000000000001 110.124 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.13 -36.29 79.36 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.531 -0.73 . . . . 1.6299999999999999 110.099 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.721 ' HA ' ' HA ' ' A' ' 82' ' ' THR . . . -67.25 -46.65 73.11 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.972 -0.751 . . . . 1.0800000000000001 108.972 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 35.0 mtpt -62.48 -37.37 85.69 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.206 0.527 . . . . 1.3100000000000001 110.559 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.521 HD11 ' O ' ' A' ' 44' ' ' SER . 9.2 tp -79.5 -50.05 11.33 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.607 -0.683 . . . . 1.9299999999999999 112.11 -178.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.8 ttm -131.78 -7.2 3.59 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.177 -0.952 . . . . 3.9199999999999999 112.785 -178.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.721 ' HA ' ' HA ' ' A' ' 78' ' ' ALA . 10.4 m 49.41 84.51 0.2 Allowed Pre-proline 0 N--CA 1.51 2.552 0 O-C-N 121.014 -1.054 . . . . 1.29 111.503 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 78' ' ' ALA . 51.8 Cg_endo -73.59 17.85 0.44 Allowed 'Trans proline' 0 N--CA 1.494 1.51 0 O-C-N 123.394 1.207 . . . . 1.3300000000000001 112.541 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -71.71 53.42 0.23 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.681 -1.262 . . . . 2.04 109.948 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 169.45 -82.89 0.09 OUTLIER Glycine 0 N--CA 1.498 2.781 0 N-CA-C 110.101 -1.2 . . . . 1.9099999999999999 110.101 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.409 ' O ' ' N ' ' A' ' 88' ' ' VAL . 56.0 Cg_endo -81.85 -174.48 2.16 Favored 'Trans proline' 0 C--N 1.316 -1.17 0 O-C-N 123.526 1.277 . . . . 2.02 111.114 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 67.97 -55.27 0.5 Allowed 'General case' 0 N--CA 1.506 2.372 0 CA-C-O 121.707 0.765 . . . . 2.4500000000000002 110.045 -178.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.409 ' N ' ' O ' ' A' ' 86' ' ' PRO . 7.7 p -105.89 -9.75 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.921 -0.487 . . . . 2.3199999999999998 110.249 178.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 62.24 51.15 3.57 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.388 -0.82 . . . . 4.5199999999999996 110.443 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.691 0 CA-C-O 118.053 -1.415 . . . . 2.7200000000000002 109.777 179.668 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 7' ' ' ASP . . . . . . . . 0 N--CA 1.498 2.804 0 N-CA-C 109.772 -1.331 . . . . 4.3200000000000003 109.772 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.581 ' CB ' ' HA ' ' A' ' 7' ' ' ASP . 9.6 t -150.19 177.38 9.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.362 -1.081 . . . . 4.9900000000000002 110.39 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.4 ptt? -97.38 -18.21 19.25 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.659 -0.651 . . . . 6.6900000000000004 110.857 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 98.9 p -146.77 -83.75 0.12 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.048 -1.033 . . . . 5.1200000000000001 110.634 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.674 HD12 ' HB2' ' A' ' 6' ' ' MET . 2.4 pp -103.78 -174.44 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.21 -0.932 . . . . 4.0999999999999996 110.929 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.674 ' HB2' HD12 ' A' ' 5' ' ' ILE . 0.8 OUTLIER 67.46 -82.26 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.774 -0.579 . . . . 3.9300000000000002 111.383 179.813 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.581 ' HA ' ' CB ' ' A' ' 2' ' ' SER . 24.0 t70 65.43 -56.08 0.32 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.774 -0.579 . . . . 3.5699999999999998 111.078 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.44 ' N ' ' O ' ' A' ' 6' ' ' MET . 9.5 m80 -131.41 23.59 4.78 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.523 -0.736 . . . . 3.2400000000000002 109.329 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 46.73 64.51 8.25 Favored Pre-proline 0 N--CA 1.501 2.114 0 O-C-N 121.681 -0.637 . . . . 2.9399999999999999 111.112 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -70.84 98.17 0.77 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.552 1.29 . . . . 1.96 110.861 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 19.8 p -57.24 -50.93 71.33 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.4 -0.812 . . . . 2.3599999999999999 109.727 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.2 p -58.43 -48.21 81.44 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.609 -0.682 . . . . 2.5 109.704 178.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.451 ' O ' HG22 ' A' ' 17' ' ' VAL . . . -59.65 -53.86 42.51 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 109.234 -1.546 . . . . 1.8999999999999999 109.234 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.541 ' O ' HG23 ' A' ' 18' ' ' ILE . 33.4 t -54.96 -38.79 46.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.501 -1.0 . . . . 2.1099999999999999 109.265 178.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.635 ' O ' HG22 ' A' ' 19' ' ' VAL . 33.9 t -68.21 -47.4 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.175 -0.953 . . . . 2.54 110.123 179.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.3 p -60.1 -37.98 81.58 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.522 -0.736 . . . . 2.3500000000000001 110.987 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.451 HG22 ' O ' ' A' ' 13' ' ' GLY . 33.0 m -76.11 -37.71 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 120.946 -1.096 . . . . 1.75 111.095 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.541 HG23 ' O ' ' A' ' 14' ' ' VAL . 45.1 pt -70.54 -38.89 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.465 -1.397 . . . . 2.46 110.234 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.635 HG22 ' O ' ' A' ' 15' ' ' VAL . 33.7 m -68.95 -39.98 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 120.887 -1.133 . . . . 2.4900000000000002 108.755 178.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.446 HD13 ' HA ' ' A' ' 20' ' ' ILE . 14.6 mm -65.99 -47.32 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.037 -1.039 . . . . 2.2599999999999998 108.669 177.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.7 mt -59.09 -48.69 80.7 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.841 -0.8 . . . . 2.1000000000000001 108.841 178.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.1 mt -56.65 -43.79 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.578 -0.702 . . . . 2.6400000000000001 109.273 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.57 -46.0 87.88 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.621 -0.674 . . . . 2.2000000000000002 109.779 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 71.0 mt -59.62 -46.67 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.356 -0.84 . . . . 1.9399999999999999 108.893 178.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.65 -43.81 97.86 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.543 -0.723 . . . . 2.1800000000000002 109.869 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.67 -44.29 96.62 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.532 -0.73 . . . . 2.4300000000000002 109.141 178.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.2 tt -62.23 -45.94 91.1 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.839 -0.8 . . . . 2.3399999999999999 108.839 178.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.45 -46.03 93.64 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 108.694 -1.762 . . . . 2.1200000000000001 108.694 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.41 -43.6 97.06 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.504 -0.998 . . . . 2.48 109.915 179.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.6 mt -59.46 -41.08 88.87 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.595 -0.691 . . . . 2.9199999999999999 109.613 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 17.7 mt -70.1 -45.73 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.303 -0.873 . . . . 2.27 109.546 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.453 ' HA ' ' O ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -60.75 -50.25 74.22 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.668 -0.645 . . . . 2.7999999999999998 110.01 179.232 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.8 -42.24 99.72 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 109.817 -1.313 . . . . 2.6000000000000001 109.817 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 46.8 t -56.25 -47.56 78.29 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.456 -1.026 . . . . 2.6800000000000002 109.984 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.605 ' HB3' ' CG ' ' A' ' 39' ' ' ARG . 1.0 OUTLIER -178.68 65.61 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.503 -0.748 . . . . 3.1499999999999999 110.982 179.453 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 32' ' ' LEU . 3.1 m 50.92 -95.94 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.916 -0.49 . . . . 2.5299999999999998 111.458 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -153.39 -62.2 0.14 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.597 -1.314 . . . . 3.0699999999999998 112.229 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.403 HD11 HD12 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -91.68 -5.37 53.86 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 120.968 -1.082 . . . . 2.1000000000000001 112.201 -179.059 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.605 ' CG ' ' HB3' ' A' ' 35' ' ' TRP . 0.0 OUTLIER 52.0 68.23 0.84 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.194 -0.941 . . . . 2.7000000000000002 111.593 179.224 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.494 ' HB3' ' CG1' ' A' ' 43' ' ' ILE . 0.3 OUTLIER -65.53 112.95 3.84 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.413 -0.804 . . . . 2.3100000000000001 109.377 178.798 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.5 -14.54 8.17 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.24 -0.912 . . . . 3.4700000000000002 111.656 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.592 ' HG3' ' N ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -78.43 -63.28 1.44 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.093 -1.004 . . . . 3.1699999999999999 109.264 179.285 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.796 HG22 ' HB2' ' A' ' 47' ' ' GLU . 1.5 pp -64.36 -37.86 81.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 109.145 -0.687 . . . . 2.7000000000000002 109.145 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.405 ' H ' HG13 ' A' ' 43' ' ' ILE . 38.3 t 48.93 -84.34 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.288 0 CA-C-N 116.226 -0.443 . . . . 3.1099999999999999 110.947 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.478 ' N ' ' O ' ' A' ' 43' ' ' ILE . 1.2 pm0 -135.27 -8.28 2.27 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.385 -0.822 . . . . 4.1799999999999997 112.153 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 p -84.95 -50.29 7.62 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.646 -1.283 . . . . 3.73 110.705 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.796 ' HB2' HG22 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -95.88 156.81 16.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.484 -0.76 . . . . 3.2200000000000002 109.816 179.824 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.42 148.25 30.64 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.296 -0.877 . . . . 2.9199999999999999 111.294 -179.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -77.79 102.04 7.0 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.1 -1.0 . . . . 2.23 109.92 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.521 ' OE1' HG22 ' A' ' 52' ' ' ILE . 0.0 OUTLIER 66.43 -176.55 0.19 Allowed 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 122.428 1.109 . . . . 2.1499999999999999 110.367 -179.264 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.3 m -173.13 -48.22 0.02 OUTLIER 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.599 -0.728 . . . . 3.77 109.843 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.521 HG22 ' OE1' ' A' ' 50' ' ' GLU . 2.1 tp -53.31 -36.35 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.758 -0.589 . . . . 4.3899999999999997 110.875 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.6 p -60.52 -29.22 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.319 -0.863 . . . . 3.7400000000000002 110.405 178.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -98.78 11.0 62.65 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.502 -1.439 . . . . 4.75 109.502 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.491 ' OD1' ' HB ' ' A' ' 58' ' ' THR . 4.4 t70 -86.21 -147.82 0.12 Allowed 'General case' 0 N--CA 1.483 1.208 0 O-C-N 121.437 -1.037 . . . . 5.0800000000000001 109.717 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 135.8 -34.83 2.23 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 108.465 -1.854 . . . . 6.3799999999999999 108.465 -179.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -135.11 7.64 3.42 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.738 -0.86 . . . . 7.6100000000000003 112.771 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.491 ' HB ' ' OD1' ' A' ' 55' ' ' ASP . 2.4 m -59.95 116.84 4.42 Favored 'General case' 0 N--CA 1.507 2.398 0 O-C-N 120.4 -1.438 . . . . 5.7999999999999998 110.367 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.69 159.42 41.32 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.44 -0.788 . . . . 6.4800000000000004 110.795 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 1.1 tt0 46.07 56.15 15.86 Favored Pre-proline 0 N--CA 1.499 2.014 0 O-C-N 121.876 -0.515 . . . . 5.3099999999999996 111.203 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.45 143.91 89.35 Favored 'Trans proline' 0 N--CA 1.49 1.283 0 O-C-N 123.264 1.139 . . . . 5.1200000000000001 109.871 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.503 ' O ' ' HB2' ' A' ' 66' ' ' GLN . 18.9 t80 69.44 -52.87 0.6 Allowed 'General case' 0 N--CA 1.506 2.343 0 O-C-N 121.745 -0.597 . . . . 4.0899999999999999 109.5 -177.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.7 mt -61.95 -41.83 98.42 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.596 -0.69 . . . . 4.75 111.091 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.444 ' HB2' ' O ' ' A' ' 60' ' ' GLU . 0.4 OUTLIER -57.64 -57.19 13.8 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.297 -0.877 . . . . 4.7400000000000002 110.155 179.759 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 31.4 m -64.77 -34.6 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.118 -0.989 . . . . 3.29 109.904 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.503 ' HB2' ' O ' ' A' ' 62' ' ' PHE . 5.3 tt0 -61.11 -48.39 81.88 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.834 -0.802 . . . . 3.46 108.834 178.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.711 ' HA ' ' HG2' ' A' ' 70' ' ' LYS . 6.9 m-85 -69.12 -40.91 78.03 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.712 -0.617 . . . . 3.9199999999999999 109.877 178.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.427 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -61.93 -37.88 86.34 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.626 -0.671 . . . . 3.1099999999999999 110.194 179.049 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.549 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -83.02 -41.99 18.03 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.289 -0.882 . . . . 2.3599999999999999 109.836 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.711 ' HG2' ' HA ' ' A' ' 67' ' ' TYR . 8.1 ptpt -65.78 -35.48 80.82 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.538 -0.726 . . . . 2.7200000000000002 110.652 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 70' ' ' LYS . . . -43.52 -64.21 1.9 Allowed Glycine 0 N--CA 1.501 2.996 0 N-CA-C 109.384 -1.486 . . . . 2.0499999999999998 109.384 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.628 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 43.2 Cg_endo -69.44 -45.54 1.72 Allowed 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.963 1.507 . . . . 2.4399999999999999 110.054 178.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.549 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -55.29 -42.58 73.82 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 120.942 -1.098 . . . . 2.2999999999999998 110.11 179.281 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.529 ' HA ' ' HG2' ' A' ' 77' ' ' LYS . 56.0 t -73.59 -45.21 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.831 -0.803 . . . . 1.72 108.831 178.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.585 ' HG2' ' HD2' ' A' ' 79' ' ' LYS . 1.6 tt0 -51.34 -45.19 62.24 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.872 0.844 . . . . 3.2799999999999998 108.902 177.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.628 ' HD2' ' O ' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -73.55 -49.32 27.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.847 -0.533 . . . . 3.7200000000000002 110.868 179.447 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.591 ' HE3' ' HD3' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -66.82 -19.24 65.7 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.803 -1.185 . . . . 2.73 110.89 179.757 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.687 ' HA ' ' HA ' ' A' ' 82' ' ' THR . . . -86.58 -39.96 15.66 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.775 -0.824 . . . . 2.3700000000000001 108.775 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.585 ' HD2' ' HG2' ' A' ' 75' ' ' GLU . 13.3 mttt -68.29 -37.79 81.02 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.222 -1.029 . . . . 3.6400000000000001 108.222 177.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.9 tp -81.23 -38.01 27.65 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.924 -0.485 . . . . 3.8599999999999999 110.494 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.58 63.79 0.8 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.422 -0.799 . . . . 4.9400000000000004 110.802 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.687 ' HA ' ' HA ' ' A' ' 78' ' ' ALA . 1.7 m -37.06 121.73 0.84 Allowed Pre-proline 0 N--CA 1.513 2.702 0 O-C-N 121.694 -0.628 . . . . 2.9700000000000002 111.855 -179.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.591 ' HD3' ' HE3' ' A' ' 77' ' ' LYS . 52.0 Cg_endo -74.9 -3.24 13.61 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 O-C-N 123.893 1.47 . . . . 3.1600000000000001 112.026 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.438 ' CB ' ' O ' ' A' ' 83' ' ' PRO . 0.5 OUTLIER 71.25 -5.91 1.46 Allowed 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.259 -0.901 . . . . 3.6699999999999999 111.594 -179.237 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.48 ' O ' HG12 ' A' ' 88' ' ' VAL . . . -173.14 71.0 0.1 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 108.712 -1.755 . . . . 2.9500000000000002 108.712 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -61.84 -19.47 65.73 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 O-C-N 123.907 1.477 . . . . 2.5299999999999998 111.277 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -57.66 -30.59 65.55 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.396 -0.815 . . . . 3.3399999999999999 110.106 178.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 85' ' ' GLY . 9.6 p -108.67 -5.22 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.384 -0.823 . . . . 4.1699999999999999 111.06 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -142.05 74.88 1.47 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.853 -1.154 . . . . 3.9300000000000002 110.263 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.472 0 CA-C-O 118.102 -1.388 . . . . 2.4900000000000002 109.784 -179.906 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 4' ' ' SER . . . . . . . . 0 N--CA 1.492 2.427 0 N-CA-C 109.572 -1.411 . . . . 5.25 109.572 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.8 t -55.46 124.65 17.91 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.558 -0.966 . . . . 6.1200000000000001 109.379 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.6 mtt 49.05 26.47 1.4 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.776 -0.578 . . . . 6.5999999999999996 110.731 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 1' ' ' GLY . 4.1 p -151.36 83.7 1.31 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.328 -0.857 . . . . 5.6200000000000001 109.518 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.564 ' C ' HD12 ' A' ' 5' ' ' ILE . 1.5 pp -57.46 179.6 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.364 -0.835 . . . . 5.4100000000000001 110.982 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.522 ' O ' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER 63.87 -68.16 0.09 Allowed 'General case' 0 N--CA 1.506 2.341 0 O-C-N 121.634 -0.666 . . . . 6.0 110.971 -179.467 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.441 ' N ' ' O ' ' A' ' 5' ' ' ILE . 8.5 t70 62.65 -57.86 0.14 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.832 -0.543 . . . . 5.3600000000000003 110.949 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.522 ' N ' ' O ' ' A' ' 6' ' ' MET . 11.3 m80 -129.48 -0.05 5.01 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.481 -0.762 . . . . 6.1699999999999999 110.522 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.487 ' HB2' ' SD ' ' A' ' 6' ' ' MET . 21.6 t 46.35 69.72 2.47 Favored Pre-proline 0 N--CA 1.502 2.16 0 O-C-N 121.266 -0.897 . . . . 4.1900000000000004 110.41 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -68.62 63.78 1.21 Allowed 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 123.776 1.408 . . . . 3.7000000000000002 111.3 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.412 HG23 ' N ' ' A' ' 12' ' ' THR . 8.9 t -57.42 -39.52 76.36 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.398 -0.814 . . . . 3.1200000000000001 109.737 179.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.412 ' N ' HG23 ' A' ' 11' ' ' THR . 2.1 p -63.74 -42.01 97.93 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.991 -1.068 . . . . 3.6099999999999999 109.448 178.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.487 ' O ' HG22 ' A' ' 17' ' ' VAL . . . -71.23 -51.18 18.75 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 108.929 -1.668 . . . . 3.1600000000000001 108.929 178.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.583 ' O ' HG12 ' A' ' 18' ' ' ILE . 26.0 t -56.8 -40.58 71.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.644 -0.915 . . . . 2.8199999999999998 109.265 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.662 ' HA ' HG12 ' A' ' 18' ' ' ILE . 16.5 t -70.45 -41.97 78.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.231 -0.918 . . . . 2.25 109.116 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.49 ' O ' HG12 ' A' ' 20' ' ' ILE . 40.7 m -57.16 -49.68 75.19 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.439 -0.788 . . . . 3.1499999999999999 109.642 178.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.628 ' HA ' HG12 ' A' ' 20' ' ' ILE . 35.8 m -66.82 -44.04 89.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 C-N-CA 119.814 -0.754 . . . . 2.8199999999999998 111.424 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.662 HG12 ' HA ' ' A' ' 15' ' ' VAL . 5.1 pt -66.14 -30.01 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 120.236 -1.54 . . . . 1.9199999999999999 109.679 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.458 ' N ' HG13 ' A' ' 18' ' ' ILE . 8.3 t -70.59 -51.82 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.233 -0.917 . . . . 2.4199999999999999 108.829 178.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.628 HG12 ' HA ' ' A' ' 17' ' ' VAL . 30.1 pt -64.46 -36.27 76.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.028 -1.045 . . . . 2.7599999999999998 109.173 178.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.486 ' N ' HG13 ' A' ' 20' ' ' ILE . 13.0 mt -66.32 -47.22 74.25 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.378 -0.826 . . . . 2.0699999999999998 108.831 177.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.44 HD13 ' HA ' ' A' ' 22' ' ' ILE . 7.3 mm -60.8 -41.35 88.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 108.724 -0.843 . . . . 2.04 108.724 178.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.53 -46.08 84.38 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.749 -0.595 . . . . 2.4199999999999999 109.454 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 43.5 mt -61.14 -45.12 99.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.344 -0.848 . . . . 2.3900000000000001 108.81 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.82 -44.87 91.95 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.519 -0.738 . . . . 2.1400000000000001 109.671 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.28 -41.55 98.58 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.722 -0.844 . . . . 2.6200000000000001 108.722 178.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.662 HD13 ' C ' ' A' ' 27' ' ' LEU . 3.2 tm? -61.91 -52.52 63.74 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.478 -0.934 . . . . 3.0499999999999998 108.478 177.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.14 -43.96 83.71 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.166 -1.574 . . . . 2.3399999999999999 109.166 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.29 -41.06 90.32 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.396 -1.061 . . . . 2.8199999999999998 109.808 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.504 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 10.3 mt -62.38 -40.07 95.27 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.981 -0.748 . . . . 3.6000000000000001 108.981 178.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 27.7 mm -71.05 -49.27 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.641 -0.662 . . . . 3.0499999999999998 109.292 178.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.75 -46.09 84.98 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.542 -0.724 . . . . 2.9700000000000002 109.616 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.16 -48.14 82.24 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 109.58 -1.408 . . . . 3.5 109.58 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -58.49 -46.23 87.08 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.523 -0.986 . . . . 3.96 109.887 179.343 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.409 ' O ' ' N ' ' A' ' 37' ' ' TYR . 5.2 t-105 -65.66 -55.4 17.73 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.554 -0.716 . . . . 3.1299999999999999 109.843 179.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 64.48 -57.9 0.24 Allowed 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.984 -0.448 . . . . 3.8100000000000001 111.776 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.409 ' N ' ' O ' ' A' ' 35' ' ' TRP . 12.3 t80 -151.33 -55.19 0.14 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.99 -1.069 . . . . 3.23 111.347 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.596 ' CD2' ' HG3' ' A' ' 49' ' ' GLU . 5.6 mt -97.53 -55.43 2.83 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.079 -1.013 . . . . 3.7599999999999998 110.712 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.408 ' O ' ' HA ' ' A' ' 35' ' ' TRP . 2.2 mtm180 179.62 -50.92 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 121.021 0.438 . . . . 3.3599999999999999 111.102 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.596 ' HB3' HG12 ' A' ' 43' ' ' ILE . 1.5 mt -124.94 70.05 1.14 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.469 -0.77 . . . . 4.3200000000000003 110.384 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -58.06 -15.46 9.42 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.185 -0.947 . . . . 4.3600000000000003 111.351 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.492 ' HG3' ' N ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -64.92 -62.49 1.53 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.148 -0.97 . . . . 6.5 108.948 178.7 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.596 HG12 ' HB3' ' A' ' 40' ' ' LEU . 3.4 pt -71.7 -30.81 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-O 121.865 0.84 . . . . 5.04 108.892 178.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.468 ' N ' HG13 ' A' ' 43' ' ' ILE . 0.9 OUTLIER 76.93 96.17 0.07 Allowed 'General case' 0 N--CA 1.503 2.206 0 CA-C-N 115.337 -0.847 . . . . 5.0 111.1 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.548 ' O ' HD13 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -103.83 146.87 28.0 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.745 -0.597 . . . . 4.2599999999999998 110.122 179.349 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 77.4 p -92.5 -74.78 0.51 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.006 -1.059 . . . . 4.6699999999999999 110.208 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 63.54 -176.17 0.16 Allowed 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.902 -0.499 . . . . 3.9300000000000002 110.726 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -82.22 -43.89 17.07 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.068 -1.02 . . . . 3.5 110.247 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.596 ' HG3' ' CD2' ' A' ' 38' ' ' LEU . 0.5 OUTLIER 67.33 138.52 0.03 OUTLIER 'General case' 0 N--CA 1.508 2.438 0 CA-C-O 121.518 0.675 . . . . 4.1500000000000004 111.728 179.296 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -85.31 72.03 10.76 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.926 -1.109 . . . . 3.3500000000000001 110.617 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 59.8 p -152.65 -56.88 0.13 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.439 -0.788 . . . . 3.3999999999999999 110.022 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.44 HG23 ' H ' ' A' ' 52' ' ' ILE . 13.9 pt -51.47 -34.72 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 CA-C-O 121.263 0.554 . . . . 3.52 110.398 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.9 p -54.58 -29.56 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 121.689 -0.632 . . . . 3.3700000000000001 110.993 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.12 -35.93 3.09 Favored Glycine 0 N--CA 1.499 2.862 0 N-CA-C 110.023 -1.231 . . . . 3.5299999999999998 110.023 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.418 ' CB ' HD11 ' A' ' 63' ' ' LEU . 15.2 t0 -81.26 154.76 26.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.425 -1.044 . . . . 3.4900000000000002 110.764 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -173.96 -58.49 0.05 OUTLIER Glycine 0 N--CA 1.496 2.66 0 N-CA-C 108.947 -1.661 . . . . 3.4300000000000002 108.947 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -117.84 1.66 12.13 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.551 -0.97 . . . . 5.5499999999999998 111.694 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.484 ' O ' ' HD3' ' A' ' 61' ' ' PRO . 4.1 m -50.68 140.19 15.0 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.054 -1.028 . . . . 3.25 110.691 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 12.7 ttpp -63.47 134.04 54.96 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.236 -0.915 . . . . 3.1099999999999999 109.76 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 46.25 61.48 12.86 Favored Pre-proline 0 N--CA 1.502 2.155 0 O-C-N 121.544 -0.723 . . . . 2.8199999999999998 110.586 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.491 ' O ' ' N ' ' A' ' 63' ' ' LEU . 40.6 Cg_endo -70.24 -34.29 13.26 Favored 'Trans proline' 0 N--CA 1.488 1.164 0 O-C-N 123.51 1.268 . . . . 2.0099999999999998 111.327 -179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 12.3 t80 62.17 -66.11 0.08 Allowed 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.462 -0.774 . . . . 2.6299999999999999 111.132 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.491 ' N ' ' O ' ' A' ' 61' ' ' PRO . 2.6 pp -60.25 -32.79 71.49 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.38 -0.825 . . . . 2.7400000000000002 110.204 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.9 tp -65.78 -48.81 70.52 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.372 -0.83 . . . . 2.7799999999999998 109.243 178.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.529 ' HA ' ' HB3' ' A' ' 68' ' ' SER . 9.1 t -67.05 -33.63 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 108.324 -0.991 . . . . 1.45 108.324 178.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.579 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 9.4 mm-40 -60.76 -58.35 8.81 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.674 -0.862 . . . . 2.7000000000000002 108.674 178.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -63.04 -41.36 99.48 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 108.404 -0.961 . . . . 2.0800000000000001 108.404 178.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.536 ' O ' ' HD2' ' A' ' 72' ' ' PRO . 29.0 t -53.5 -42.63 67.53 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.496 -0.927 . . . . 1.6799999999999999 108.496 178.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.05 -38.63 69.46 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 119.581 -0.848 . . . . 1.98 109.246 177.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.579 ' HG2' ' O ' ' A' ' 66' ' ' GLN . 4.6 mmtm -58.18 -52.34 65.97 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.425 -0.797 . . . . 2.4300000000000002 110.245 179.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 70' ' ' LYS . . . -34.68 -68.38 0.23 Allowed Glycine 0 N--CA 1.51 3.602 0 N-CA-C 110.911 -0.876 . . . . 1.75 110.911 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.536 ' HD2' ' O ' ' A' ' 68' ' ' SER . 39.4 Cg_endo -66.51 -38.28 19.88 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.831 1.438 . . . . 2.8599999999999999 110.219 179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 34.3 t -61.99 -40.98 97.49 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.995 -1.065 . . . . 3.6000000000000001 109.386 178.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 55.8 t -75.53 -48.22 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.655 -0.653 . . . . 3.0899999999999999 109.511 178.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.4 ' OE2' ' NZ ' ' A' ' 79' ' ' LYS . 5.2 tm-20 -57.44 -41.26 80.15 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.575 -0.898 . . . . 3.2400000000000002 108.575 178.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.471 ' HB3' ' O ' ' A' ' 72' ' ' PRO . 0.3 OUTLIER -65.53 -46.72 78.49 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.675 -0.64 . . . . 5.3600000000000003 109.736 178.465 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.0 -39.52 94.29 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.134 -0.978 . . . . 5.4000000000000004 109.703 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.83 -46.74 64.97 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.947 -0.471 . . . . 4.1799999999999997 110.278 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 76' ' ' ARG . 0.1 OUTLIER -69.53 -38.88 77.7 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.608 -0.683 . . . . 4.8099999999999996 109.48 179.353 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.71 -39.67 94.05 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.441 -0.787 . . . . 5.9699999999999998 109.256 178.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 13.8 ttt -77.16 -38.84 50.95 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.55 -0.719 . . . . 6.25 109.796 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 82' ' ' THR . 8.0 m 56.75 91.29 0.08 OUTLIER Pre-proline 0 N--CA 1.507 2.389 0 O-C-N 121.837 -0.539 . . . . 5.4400000000000004 110.75 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -74.75 15.28 0.71 Allowed 'Trans proline' 0 N--CA 1.492 1.393 0 O-C-N 123.261 1.137 . . . . 5.3099999999999996 112.405 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -72.6 48.51 0.2 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.696 -1.252 . . . . 5.6399999999999997 109.584 178.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 56.34 57.24 20.25 Favored Glycine 0 N--CA 1.499 2.862 0 N-CA-C 110.4 -1.08 . . . . 6.6600000000000001 110.4 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.12 -24.44 66.24 Favored 'Trans proline' 0 N--CA 1.488 1.174 0 O-C-N 123.353 1.186 . . . . 7.7199999999999998 110.935 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -65.99 -28.0 68.56 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.368 -0.975 . . . . 8.7300000000000004 108.368 177.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 60.1 t -100.68 -34.01 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.892 -0.505 . . . . 7.96 109.741 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 -81.63 -52.34 7.29 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.428 -0.795 . . . . 7.9500000000000002 110.748 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.672 0 CA-C-O 117.912 -1.493 . . . . 8.2899999999999991 109.581 -179.146 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.777 0 N-CA-C 110.57 -1.012 . . . . 3.7400000000000002 110.57 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.1 t -64.33 121.34 14.07 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.223 -1.163 . . . . 3.3500000000000001 111.594 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -81.43 66.09 6.84 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.092 -1.005 . . . . 4.4100000000000001 108.72 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.411 ' OG ' ' N ' ' A' ' 5' ' ' ILE . 87.6 p -151.46 -68.31 0.18 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.521 -0.737 . . . . 2.8900000000000001 110.191 -178.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.545 ' C ' HD12 ' A' ' 5' ' ' ILE . 1.8 pp -98.85 -169.49 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.579 -0.701 . . . . 3.3399999999999999 110.66 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.42 59.81 5.86 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.064 -1.022 . . . . 3.3900000000000001 111.272 -179.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.474 ' HB3' ' CD1' ' A' ' 5' ' ' ILE . 0.0 OUTLIER -73.39 -26.71 61.11 Favored 'General case' 0 N--CA 1.508 2.43 0 O-C-N 121.032 -1.042 . . . . 3.04 109.768 178.676 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.445 ' O ' ' CB ' ' A' ' 9' ' ' SER . 0.2 OUTLIER -136.09 70.19 1.42 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.598 -0.689 . . . . 3.5099999999999998 109.732 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER 72.79 176.77 0.06 OUTLIER Pre-proline 0 N--CA 1.517 2.919 0 O-C-N 121.42 -0.8 . . . . 1.95 110.439 -179.308 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.54 -9.86 26.73 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 O-C-N 123.068 1.036 . . . . 2.3900000000000001 111.074 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.7 p -59.67 -43.34 94.0 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.248 -0.908 . . . . 2.4199999999999999 111.201 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.409 HG21 ' OD1' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -57.08 -37.31 71.69 Favored 'General case' 0 N--CA 1.507 2.421 0 O-C-N 121.345 -0.847 . . . . 2.0299999999999998 110.14 179.753 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.535 ' O ' HG22 ' A' ' 17' ' ' VAL . . . -71.59 -51.89 14.55 Favored Glycine 0 N--CA 1.498 2.769 0 N-CA-C 108.81 -1.716 . . . . 1.4099999999999999 108.81 178.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 51.1 t -54.87 -39.63 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.692 -0.887 . . . . 2.3399999999999999 109.569 178.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.5 t -70.59 -43.15 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.073 -1.017 . . . . 2.0499999999999998 109.394 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 87.7 m -59.32 -50.81 72.55 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.735 -0.603 . . . . 1.3500000000000001 110.009 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.535 HG22 ' O ' ' A' ' 13' ' ' GLY . 33.1 m -66.78 -34.9 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.489 -0.757 . . . . 1.6200000000000001 110.156 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.416 HD13 ' HA ' ' A' ' 18' ' ' ILE . 6.7 mm -68.08 -41.21 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 120.907 -1.121 . . . . 2.2400000000000002 109.632 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.4 t -64.89 -44.74 96.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 108.289 -1.004 . . . . 1.78 108.289 177.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 23.2 mm -61.82 -46.92 95.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.519 -0.738 . . . . 1.4199999999999999 109.056 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 11.3 mt -60.6 -49.18 78.55 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.868 -0.79 . . . . 1.9399999999999999 108.868 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.2 mt -56.62 -43.83 79.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 C-N-CA 119.837 -0.745 . . . . 2.1400000000000001 109.387 178.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.27 -46.08 85.28 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.615 -0.678 . . . . 1.45 110.176 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 40.6 mt -59.22 -48.15 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 108.852 -0.795 . . . . 1.51 108.852 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.59 -45.18 95.21 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.747 -0.595 . . . . 1.76 110.159 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.63 -49.78 76.16 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 109.086 -0.709 . . . . 1.6899999999999999 109.086 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.19 -46.12 86.36 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.016 -0.735 . . . . 1.4399999999999999 109.016 178.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.87 -46.18 92.72 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.073 -1.611 . . . . 1.45 109.073 178.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.13 -42.6 96.77 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.59 -0.947 . . . . 1.76 109.963 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.498 ' CD1' HG21 ' A' ' 53' ' ' VAL . 8.8 mt -61.3 -41.2 96.58 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.16 -0.682 . . . . 1.79 109.16 178.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 95.3 mt -67.32 -51.84 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.467 -0.771 . . . . 1.8300000000000001 109.154 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.94 -45.5 78.8 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.597 -0.689 . . . . 2.1699999999999999 109.921 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.5 -53.86 35.93 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.813 -1.315 . . . . 1.76 109.813 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -56.28 -39.6 72.91 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.4 -1.059 . . . . 1.71 109.972 179.531 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.578 ' HA ' ' CE3' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -72.55 -65.65 0.76 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.255 -0.903 . . . . 1.6799999999999999 110.666 179.584 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 36.7 t 52.05 -76.6 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.396 0 O-C-N 121.892 -0.505 . . . . 2.1200000000000001 112.189 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.504 ' N ' ' O ' ' A' ' 35' ' ' TRP . 0.2 OUTLIER -98.92 -24.18 15.05 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.937 -1.102 . . . . 3.8799999999999999 110.747 179.832 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.886 HD11 ' HB3' ' A' ' 42' ' ' ARG . 52.9 tp -80.21 -46.53 16.14 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.151 -0.968 . . . . 1.5600000000000001 110.479 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.451 ' HG2' ' O ' ' A' ' 38' ' ' LEU . 0.2 OUTLIER 26.26 63.2 0.08 Allowed 'General case' 0 N--CA 1.512 2.653 0 N-CA-C 113.344 0.868 . . . . 2.6099999999999999 113.344 179.852 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.648 ' HG ' ' HA ' ' A' ' 44' ' ' SER . 0.1 OUTLIER 58.87 14.57 3.35 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 121.538 -0.726 . . . . 1.79 112.903 178.644 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.426 ' OE1' ' NH2' ' A' ' 42' ' ' ARG . 3.4 tt0 -81.07 3.58 22.79 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 120.453 -1.405 . . . . 2.8199999999999998 110.936 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.886 ' HB3' HD11 ' A' ' 38' ' ' LEU . 0.1 OUTLIER -134.86 -86.07 0.4 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.677 -1.264 . . . . 3.6400000000000001 110.535 179.564 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.436 ' O ' ' HB2' ' A' ' 46' ' ' SER . 0.9 OUTLIER -54.95 -34.29 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.304 -0.872 . . . . 2.7400000000000002 110.109 179.208 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.648 ' HA ' ' HG ' ' A' ' 40' ' ' LEU . 29.4 t 61.74 -106.5 0.23 Allowed 'General case' 0 N--CA 1.507 2.412 0 CA-C-N 115.986 -0.552 . . . . 2.21 110.772 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -101.92 19.98 17.33 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 120.789 -1.195 . . . . 2.8999999999999999 111.042 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' A' ' 43' ' ' ILE . 0.5 OUTLIER -84.15 49.65 1.69 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.982 -1.074 . . . . 2.6600000000000001 111.369 -179.482 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.637 ' HG3' ' HB1' ' A' ' 69' ' ' ALA . 0.0 OUTLIER 54.09 -160.31 0.15 Allowed 'General case' 0 N--CA 1.506 2.374 0 O-C-N 121.424 -0.798 . . . . 3.1400000000000001 111.413 179.589 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 58.09 24.47 11.26 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.671 -0.643 . . . . 1.8600000000000001 111.581 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.51 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . 0.9 OUTLIER -76.12 -39.41 55.23 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.057 -1.027 . . . . 1.5 108.968 178.149 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -139.58 153.11 47.33 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.353 -0.98 . . . . 1.53 108.353 178.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.5 m -166.49 24.52 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.254 0 O-C-N 120.957 -1.09 . . . . 1.1299999999999999 110.494 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.4 mt -119.11 -42.71 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 108.472 -0.936 . . . . 1.5 108.472 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.498 HG21 ' CD1' ' A' ' 30' ' ' LEU . 94.5 t -104.21 -76.04 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.917 -0.49 . . . . 1.49 110.317 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.81 -62.15 1.62 Allowed Glycine 0 N--CA 1.5 2.964 0 N-CA-C 110.12 -1.192 . . . . 1.6499999999999999 110.12 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.38 -176.05 3.9 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.6 -0.941 . . . . 1.79 110.521 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -160.9 -47.41 0.02 OUTLIER Glycine 0 N--CA 1.495 2.573 0 N-CA-C 107.511 -2.235 . . . . 1.8400000000000001 107.511 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.568 ' O ' ' HB ' ' A' ' 58' ' ' THR . 2.8 pm0 -89.62 -7.41 54.8 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.871 -0.782 . . . . 1.99 110.265 178.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.568 ' HB ' ' O ' ' A' ' 57' ' ' GLU . 87.2 m 70.81 82.96 0.15 Allowed 'General case' 0 N--CA 1.508 2.461 0 O-C-N 121.642 -0.661 . . . . 2.0499999999999998 109.823 -179.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.7 ptpp? -119.7 158.42 26.5 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.547 -0.721 . . . . 2.04 111.597 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.569 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 1.5 tt0 -63.05 -50.63 75.52 Favored Pre-proline 0 N--CA 1.502 2.151 0 O-C-N 121.554 -0.716 . . . . 2.0 111.583 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.569 ' HD3' ' HB3' ' A' ' 60' ' ' GLU . 43.6 Cg_endo -68.39 162.94 38.46 Favored 'Trans proline' 0 N--CA 1.489 1.236 0 O-C-N 123.163 1.086 . . . . 1.6799999999999999 111.113 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.41 ' CB ' ' O ' ' A' ' 61' ' ' PRO . 0.1 OUTLIER 70.13 -60.66 0.48 Allowed 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.563 -0.71 . . . . 2.4700000000000002 110.822 -179.626 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.9 mt -62.45 -44.39 96.52 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.393 -0.817 . . . . 1.5900000000000001 110.586 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.432 ' HB2' ' O ' ' A' ' 60' ' ' GLU . 0.2 OUTLIER -55.28 -56.18 23.0 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.75 -0.594 . . . . 2.2400000000000002 110.633 -179.844 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.5 m -67.22 -34.24 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.046 -1.034 . . . . 1.9299999999999999 110.633 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -61.07 -51.36 69.47 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.329 -0.857 . . . . 1.8600000000000001 109.231 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -67.31 -40.14 85.99 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.751 -0.593 . . . . 2.0499999999999998 109.868 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 71.1 m -60.47 -32.37 71.35 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.872 -0.517 . . . . 1.75 110.686 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.637 ' HB1' ' HG3' ' A' ' 47' ' ' GLU . . . -94.07 -51.05 5.02 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.264 -0.897 . . . . 1.51 110.528 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.438 ' HG2' ' OE2' ' A' ' 47' ' ' GLU . 3.0 mmpt? -56.42 -43.93 79.88 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.44 -0.787 . . . . 1.47 110.93 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -46.64 -64.76 2.47 Favored Glycine 0 N--CA 1.503 3.108 0 N-CA-C 110.507 -1.037 . . . . 1.26 110.507 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -66.46 -40.35 14.36 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.844 1.444 . . . . 1.3100000000000001 110.303 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 34.3 t -59.31 -45.3 91.68 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.058 -1.026 . . . . 1.8100000000000001 109.816 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.9 t -70.61 -46.17 70.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.545 -0.722 . . . . 1.6899999999999999 109.182 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -55.77 -40.81 73.15 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 121.637 0.732 . . . . 2.1699999999999999 109.751 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.53 -47.7 59.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.85 -0.531 . . . . 1.73 110.622 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.608 ' HG3' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -67.11 -31.3 71.68 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.997 -1.064 . . . . 2.6400000000000001 110.057 179.573 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.608 ' N ' ' HG3' ' A' ' 77' ' ' LYS . . . -70.61 -47.84 58.09 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.173 -0.954 . . . . 2.1400000000000001 109.351 179.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.475 ' HG3' ' CA ' ' A' ' 90' ' ' GLY . 6.9 ptpt -71.15 -34.75 71.28 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.827 -0.749 . . . . 1.9399999999999999 109.764 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.419 ' N ' ' HG3' ' A' ' 79' ' ' LYS . 0.8 OUTLIER -64.08 -45.89 86.71 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.986 -1.071 . . . . 2.1200000000000001 109.948 179.097 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 19.7 ttt -74.44 -41.28 61.1 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.405 -0.809 . . . . 3.4500000000000002 110.319 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -123.73 67.14 39.48 Favored Pre-proline 0 N--CA 1.502 2.146 0 O-C-N 121.293 -0.88 . . . . 2.8799999999999999 110.686 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.418 ' O ' ' CB ' ' A' ' 84' ' ' ASN . 52.1 Cg_endo -78.0 -9.94 16.69 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 O-C-N 123.588 1.309 . . . . 2.6099999999999999 112.13 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' A' ' 83' ' ' PRO . 2.7 t-20 70.2 -51.76 0.65 Allowed 'General case' 0 N--CA 1.507 2.386 0 O-C-N 121.339 -0.85 . . . . 3.6099999999999999 109.854 -178.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -126.4 132.11 7.64 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.111 -1.596 . . . . 2.71 109.111 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -66.09 -16.85 53.73 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 O-C-N 123.323 1.17 . . . . 2.9900000000000002 111.096 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.423 ' HG2' ' H ' ' A' ' 88' ' ' VAL . 1.9 pm0 -49.37 -42.69 42.87 Favored 'General case' 0 N--CA 1.508 2.442 0 O-C-N 121.463 -0.773 . . . . 4.1100000000000003 110.693 178.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.452 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 6.4 p -90.69 -22.98 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.783 -0.573 . . . . 3.23 110.743 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.452 ' HB2' ' O ' ' A' ' 88' ' ' VAL . 0.3 OUTLIER 66.92 -57.3 0.41 Allowed 'General case' 0 N--CA 1.508 2.458 0 O-C-N 121.61 -0.681 . . . . 3.3199999999999998 110.548 -179.56 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.475 ' CA ' ' HG3' ' A' ' 79' ' ' LYS . . . . . . . . 0 N--CA 1.497 2.702 0 O-C-N 121.232 -0.917 . . . . 1.78 110.892 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.922 0 N-CA-C 109.762 -1.335 . . . . 5.5800000000000001 109.762 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.0 p -76.54 -48.2 20.12 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.393 -1.063 . . . . 4.6799999999999997 110.783 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.1 -176.88 4.4 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.577 -0.702 . . . . 5.4900000000000002 110.439 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.642 ' C ' HG23 ' A' ' 11' ' ' THR . 0.3 OUTLIER 52.3 40.56 29.4 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.598 -0.689 . . . . 3.8599999999999999 110.589 -179.297 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.429 ' O ' ' CB ' ' A' ' 6' ' ' MET . 0.0 OUTLIER -97.39 -115.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.428 -0.795 . . . . 3.29 109.458 179.595 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.429 ' CB ' ' O ' ' A' ' 5' ' ' ILE . 2.4 ttp 71.48 164.93 0.28 Allowed 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.321 -0.862 . . . . 3.7999999999999998 110.583 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.556 ' CB ' HG11 ' A' ' 14' ' ' VAL . 4.3 m-20 43.41 33.8 0.67 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.61 -0.681 . . . . 3.3399999999999999 111.439 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 48.02 45.03 19.26 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-O 121.674 0.75 . . . . 6.0099999999999998 111.541 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.516 ' HB3' HG13 ' A' ' 14' ' ' VAL . 0.4 OUTLIER -179.58 -177.85 0.23 Allowed Pre-proline 0 N--CA 1.492 1.659 0 N-CA-C 108.927 -0.768 . . . . 3.8900000000000001 108.927 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -75.21 146.04 31.44 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 N-CA-C 109.442 -1.022 . . . . 4.1100000000000003 109.442 178.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.642 HG23 ' C ' ' A' ' 4' ' ' SER . 25.3 p -49.41 -46.88 48.09 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 121.611 0.72 . . . . 3.7000000000000002 109.479 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.3 t -64.69 -35.29 80.55 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.698 -0.626 . . . . 5.1699999999999999 110.275 179.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.564 ' O ' HG22 ' A' ' 17' ' ' VAL . . . -67.79 -56.22 11.82 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.832 -1.307 . . . . 3.79 109.832 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.556 HG11 ' CB ' ' A' ' 7' ' ' ASP . 14.5 m -63.71 -33.08 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.245 -1.15 . . . . 2.8300000000000001 110.273 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.403 ' O ' HG23 ' A' ' 19' ' ' VAL . 7.4 t -71.44 -48.32 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 120.945 -1.097 . . . . 4.0599999999999996 110.075 179.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 16.6 p -60.04 -49.29 78.23 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.365 -0.834 . . . . 4.8799999999999999 109.94 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.564 HG22 ' O ' ' A' ' 13' ' ' GLY . 21.6 m -63.79 -36.97 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 C-N-CA 119.384 -0.926 . . . . 3.5299999999999998 109.855 178.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.436 HD13 ' HA ' ' A' ' 18' ' ' ILE . 6.0 mm -67.93 -38.64 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 120.792 -1.192 . . . . 2.4700000000000002 109.012 178.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 15' ' ' VAL . 51.0 t -65.84 -43.07 93.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.382 -0.969 . . . . 4.5300000000000002 108.382 177.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 57.7 mt -63.87 -47.3 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 108.728 -0.842 . . . . 4.5499999999999998 108.728 178.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 11.6 mt -59.37 -48.8 80.26 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.987 -0.745 . . . . 2.4399999999999999 108.987 178.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.0 mt -56.33 -43.05 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 121.549 -0.719 . . . . 3.5299999999999998 109.39 178.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.67 -45.47 78.79 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.461 -0.775 . . . . 3.8599999999999999 110.072 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 33.0 mt -60.65 -45.7 97.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.226 -0.921 . . . . 3.0899999999999999 109.264 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.95 -42.95 97.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.401 -0.812 . . . . 2.23 109.528 178.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.87 -42.58 97.49 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.368 -0.832 . . . . 3.6499999999999999 109.176 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.906 ' HA ' HD23 ' A' ' 30' ' ' LEU . 0.5 OUTLIER -63.02 -46.14 89.03 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.453 -0.943 . . . . 4.1299999999999999 108.453 178.025 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.509 ' O ' HD13 ' A' ' 32' ' ' LEU . . . -58.92 -47.5 90.3 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 108.425 -1.87 . . . . 2.2999999999999998 108.425 178.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.94 -45.08 96.15 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.506 -0.997 . . . . 3.25 110.208 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.906 HD23 ' HA ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -63.3 -37.32 86.8 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.442 -0.786 . . . . 4.5 109.697 179.238 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.513 ' N ' ' HG ' ' A' ' 30' ' ' LEU . 48.0 mt -71.2 -47.29 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.084 -1.01 . . . . 3.1000000000000001 109.185 178.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.804 ' HG ' ' HA ' ' A' ' 38' ' ' LEU . 6.8 mp -57.83 -49.86 75.25 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.79 -0.569 . . . . 3.0 109.626 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.48 -45.59 76.89 Favored Glycine 0 N--CA 1.498 2.825 0 N-CA-C 110.199 -1.16 . . . . 4.1600000000000001 110.199 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 50.4 t -55.34 -40.44 71.21 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.479 -1.012 . . . . 4.5700000000000003 110.309 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.486 ' HA ' ' CE3' ' A' ' 35' ' ' TRP . 1.5 m95 -72.48 -55.58 6.76 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.178 -0.951 . . . . 3.3199999999999998 109.778 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.441 ' CB ' ' O ' ' A' ' 35' ' ' TRP . 0.0 OUTLIER 168.59 -39.71 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.539 0 CA-C-O 121.43 0.633 . . . . 4.25 109.733 179.698 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -161.22 -61.46 0.05 Allowed 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.806 -0.812 . . . . 6.1200000000000001 108.806 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.804 ' HA ' ' HG ' ' A' ' 32' ' ' LEU . 6.6 tp -115.94 -65.5 1.18 Allowed 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.543 -0.91 . . . . 3.5499999999999998 108.543 177.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.459 ' NH2' ' HB2' ' A' ' 41' ' ' GLN . 0.1 OUTLIER -155.02 -55.75 0.1 Allowed 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.645 -0.872 . . . . 2.5499999999999998 108.645 178.553 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 48.76 -149.06 0.2 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.748 -0.595 . . . . 3.1299999999999999 111.306 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.459 ' HB2' ' NH2' ' A' ' 39' ' ' ARG . 3.2 tt0 50.93 26.57 2.74 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.379 -0.826 . . . . 3.3399999999999999 110.403 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.412 ' NH1' ' OH ' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -73.34 -51.04 18.88 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.59 0.71 . . . . 3.2599999999999998 109.223 179.618 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.275 0.1 OUTLIER -86.41 -20.16 7.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 109.29 -0.633 . . . . 3.9100000000000001 109.29 178.789 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 47.45 61.2 3.03 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 121.765 0.793 . . . . 3.46 110.112 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 51.65 -108.22 0.36 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.966 -0.459 . . . . 4.0199999999999996 111.11 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.621 ' O ' HD11 ' A' ' 63' ' ' LEU . 0.3 OUTLIER 51.86 30.9 7.6 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 120.909 -1.12 . . . . 3.0600000000000001 109.606 -178.457 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -57.53 150.09 19.75 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.671 -0.643 . . . . 3.3100000000000001 111.709 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.458 ' OD2' HG23 ' A' ' 52' ' ' ILE . 7.5 t70 66.6 -63.99 0.24 Allowed 'General case' 0 N--CA 1.504 2.232 0 O-C-N 122.001 -0.437 . . . . 2.4900000000000002 110.859 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 65.16 -65.16 0.16 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.988 -0.445 . . . . 2.5499999999999998 110.1 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 48' ' ' ASP . 10.6 tt0 -149.22 71.81 1.14 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.352 -0.843 . . . . 2.5 110.207 178.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.42 ' HA ' ' HB ' ' A' ' 58' ' ' THR . 14.3 t -129.71 -71.67 0.61 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.375 -0.828 . . . . 2.6200000000000001 109.735 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.458 HG23 ' OD2' ' A' ' 48' ' ' ASP . 27.2 pt -62.54 -37.58 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.351 -0.843 . . . . 3.3900000000000001 109.898 179.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.423 ' N ' HG13 ' A' ' 52' ' ' ILE . 14.5 p -74.32 -31.14 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 121.625 -0.672 . . . . 3.3500000000000001 110.607 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -95.06 64.27 1.41 Allowed Glycine 0 N--CA 1.498 2.815 0 N-CA-C 109.021 -1.632 . . . . 3.1800000000000002 109.021 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -49.65 135.68 18.39 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.798 -0.825 . . . . 5.4500000000000002 111.91 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 142.05 58.49 0.03 OUTLIER Glycine 0 N--CA 1.497 2.704 0 N-CA-C 109.29 -1.524 . . . . 3.8900000000000001 109.29 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 58.42 30.34 19.52 Favored 'General case' 0 N--CA 1.507 2.418 0 O-C-N 121.637 -0.919 . . . . 4.5999999999999996 110.429 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.42 ' HB ' ' HA ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -79.39 62.13 3.64 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.198 -0.939 . . . . 2.7999999999999998 110.654 -179.539 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 19.7 ttpp -63.6 149.49 46.29 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.332 -0.855 . . . . 3.25 110.772 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 62.04 171.3 0.08 OUTLIER Pre-proline 0 N--CA 1.502 2.135 0 O-C-N 121.949 -0.47 . . . . 3.0099999999999998 111.333 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -74.07 146.35 36.7 Favored 'Trans proline' 0 C--N 1.313 -1.311 0 O-C-N 123.619 1.326 . . . . 2.1600000000000001 109.719 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -67.42 -17.93 64.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.389 -0.819 . . . . 1.71 110.229 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.621 HD11 ' O ' ' A' ' 46' ' ' SER . 6.3 mt -44.8 -38.61 4.63 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.727 -0.608 . . . . 2.98 112.289 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.409 ' O ' ' OG ' ' A' ' 68' ' ' SER . 0.2 OUTLIER -56.6 -49.21 75.6 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.292 -0.88 . . . . 2.8300000000000001 109.758 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.408 ' H ' HG23 ' A' ' 65' ' ' VAL . 1.4 t -81.44 -39.89 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 O-C-N 121.436 -0.79 . . . . 1.8799999999999999 109.468 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.465 ' O ' ' CG ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -55.21 -51.87 65.19 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.865 -0.791 . . . . 2.1699999999999999 108.865 178.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.412 ' OH ' ' NH1' ' A' ' 42' ' ' ARG . 6.4 t80 -68.25 -47.65 67.2 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.43 -0.794 . . . . 3.6800000000000002 109.864 178.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.409 ' OG ' ' O ' ' A' ' 64' ' ' LEU . 69.6 m -55.19 -34.36 63.82 Favored 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 119.767 -0.773 . . . . 1.76 110.171 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -88.25 -46.44 9.23 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.202 -0.937 . . . . 1.3999999999999999 110.835 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.465 ' CG ' ' O ' ' A' ' 66' ' ' GLN . 2.6 mmtp -64.56 -40.18 95.1 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.418 -0.801 . . . . 2.0299999999999998 110.76 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -47.01 -64.88 2.5 Favored Glycine 0 N--CA 1.505 3.273 0 N-CA-C 110.006 -1.237 . . . . 2.1699999999999999 110.006 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -66.59 -37.93 20.53 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 O-C-N 123.714 1.376 . . . . 1.98 110.379 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 5.0 t -62.71 -42.87 99.87 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.979 -1.076 . . . . 2.4900000000000002 109.36 178.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.2 t -69.68 -44.77 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 109.048 -0.723 . . . . 3.0499999999999998 109.048 178.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.48 ' HG3' ' N ' ' A' ' 76' ' ' ARG . 0.1 OUTLIER -59.15 -42.26 90.26 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.889 -0.782 . . . . 2.98 108.889 178.42 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.48 ' N ' ' HG3' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -64.0 -53.05 56.06 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.628 -0.67 . . . . 3.21 109.597 178.776 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.88 -48.28 81.95 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.674 -0.641 . . . . 3.8799999999999999 109.95 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.47 -44.03 96.32 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.805 -0.56 . . . . 4.1900000000000004 110.788 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.42 ' HG3' ' CD ' ' A' ' 75' ' ' GLU . 12.6 mmtp -68.75 -42.91 76.87 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.164 -0.96 . . . . 4.1299999999999999 109.306 179.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.511 ' HG ' ' CD2' ' A' ' 89' ' ' HIS . 1.8 tp -64.7 -35.24 80.42 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.447 0.641 . . . . 4.6399999999999997 109.84 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 8.6 ttt -84.56 -22.85 29.95 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.66 -0.65 . . . . 5.8899999999999997 111.12 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.541 ' N ' ' HD2' ' A' ' 83' ' ' PRO . 8.9 m -46.19 -51.41 33.42 Favored Pre-proline 0 N--CA 1.51 2.565 0 O-C-N 121.376 -0.828 . . . . 5.5300000000000002 111.974 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 82' ' ' THR . 45.1 Cg_endo -67.83 -8.26 21.99 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 O-C-N 123.422 1.222 . . . . 5.8899999999999997 110.591 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 55.0 24.21 5.75 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.577 -0.702 . . . . 7.5199999999999996 111.341 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -111.96 75.78 0.22 Allowed Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.943 -1.263 . . . . 5.9000000000000004 109.943 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.442 ' HA ' ' O ' ' A' ' 89' ' ' HIS . 43.6 Cg_endo -67.85 -15.05 43.23 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 O-C-N 123.722 1.38 . . . . 6.2599999999999998 111.02 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -54.13 -34.14 59.61 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.364 -0.835 . . . . 6.9500000000000002 109.939 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.6 t -92.53 -36.53 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.737 -0.602 . . . . 5.7199999999999998 109.533 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.511 ' CD2' ' HG ' ' A' ' 80' ' ' LEU . 0.9 OUTLIER -161.35 124.74 3.24 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.328 -0.858 . . . . 4.9400000000000004 110.718 179.44 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.405 ' O ' HD23 ' A' ' 80' ' ' LEU . . . . . . . . 0 N--CA 1.499 2.876 0 CA-C-O 117.893 -1.504 . . . . 4.3799999999999999 110.075 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.706 0 N-CA-C 109.394 -1.482 . . . . 1.0600000000000001 109.394 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.5 p -78.03 -83.68 0.08 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.962 -1.316 . . . . 1.1699999999999999 109.768 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.1 58.69 0.37 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.373 -0.829 . . . . 2.6600000000000001 109.791 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.542 ' HB2' ' HB2' ' A' ' 7' ' ' ASP . 53.3 p -148.45 87.45 1.58 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.064 -1.023 . . . . 1.3999999999999999 109.82 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -38.73 -54.92 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.294 0 O-C-N 121.786 -0.572 . . . . 2.3799999999999999 112.041 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.507 ' O ' ' HB3' ' A' ' 7' ' ' ASP . 0.3 OUTLIER -99.41 -80.3 0.47 Allowed 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.503 -0.748 . . . . 3.3500000000000001 110.309 179.405 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.542 ' HB2' ' HB2' ' A' ' 4' ' ' SER . 32.7 t70 63.6 -52.97 0.22 Allowed 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.638 -0.664 . . . . 1.9399999999999999 111.433 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.472 ' N ' ' O ' ' A' ' 6' ' ' MET . 8.2 m80 -139.15 -42.51 0.46 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.194 -0.941 . . . . 2.2200000000000002 111.089 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -176.01 172.52 0.98 Allowed Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.536 -0.728 . . . . 2.02 110.676 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.04 64.46 1.38 Allowed 'Trans proline' 0 N--CA 1.49 1.297 0 O-C-N 123.861 1.453 . . . . 1.8400000000000001 110.806 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.0 t -155.63 -38.81 0.08 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.609 -0.682 . . . . 1.3500000000000001 111.009 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.3 t -52.93 -34.41 55.28 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 121.0 -1.063 . . . . 1.1000000000000001 110.602 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.413 ' O ' HG22 ' A' ' 17' ' ' VAL . . . -74.15 -52.46 7.77 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.02 -1.632 . . . . 0.94999999999999996 109.02 178.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.3 t -56.48 -38.66 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 121.76 -0.847 . . . . 1.0900000000000001 109.592 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.8 t -69.64 -43.42 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.107 -0.995 . . . . 1.25 108.981 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 49.3 m -56.69 -51.34 69.17 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.577 -0.702 . . . . 0.90000000000000002 109.939 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.629 ' HA ' HG12 ' A' ' 20' ' ' ILE . 35.2 m -64.75 -39.13 84.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.526 -0.734 . . . . 0.81999999999999995 110.278 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.411 HD13 ' HA ' ' A' ' 18' ' ' ILE . 6.7 mm -65.01 -36.72 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 120.819 -1.176 . . . . 1.0700000000000001 109.569 178.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.1 t -66.31 -52.44 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 C-N-CA 119.689 -0.805 . . . . 1.03 109.135 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.629 HG12 ' HA ' ' A' ' 17' ' ' VAL . 27.1 pt -63.74 -36.5 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.114 -0.991 . . . . 1.0 109.38 178.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.516 ' N ' HG13 ' A' ' 20' ' ' ILE . 7.6 mt -64.27 -48.58 75.17 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.596 -0.89 . . . . 0.89000000000000001 108.596 177.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.415 HD13 ' HA ' ' A' ' 22' ' ' ILE . 10.5 mm -59.04 -44.5 91.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.483 -0.76 . . . . 1.0900000000000001 109.071 178.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.21 -44.9 95.53 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.625 -0.672 . . . . 0.80000000000000004 109.908 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 44.5 mt -61.66 -46.51 96.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.403 -0.811 . . . . 0.81999999999999995 108.825 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.93 -44.11 97.45 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.648 -0.658 . . . . 0.77000000000000002 109.68 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.92 -45.41 93.82 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.423 -0.798 . . . . 0.81000000000000005 109.152 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.73 ' HA ' HD23 ' A' ' 30' ' ' LEU . 0.5 OUTLIER -61.46 -46.67 89.07 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.042 -0.725 . . . . 1.0 109.042 178.269 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.45 -43.33 97.56 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 108.874 -1.69 . . . . 0.59999999999999998 108.874 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.14 -43.96 93.63 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.492 -1.005 . . . . 0.79000000000000004 110.009 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.73 HD23 ' HA ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -62.84 -37.6 87.45 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.56 -0.712 . . . . 0.96999999999999997 109.272 178.904 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.511 ' N ' ' HG ' ' A' ' 30' ' ' LEU . 61.2 mt -71.62 -48.67 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.298 -0.876 . . . . 0.79000000000000004 108.972 178.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.492 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . 0.6 OUTLIER -58.01 -46.32 85.44 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.656 -0.652 . . . . 1.0700000000000001 109.774 178.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.96 -44.7 95.6 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 109.689 -1.364 . . . . 1.1899999999999999 109.689 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.9 t -58.37 -48.92 79.04 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.499 -1.001 . . . . 1.3100000000000001 110.593 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.427 ' O ' ' N ' ' A' ' 37' ' ' TYR . 1.4 t-105 -172.9 44.0 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.115 -0.991 . . . . 2.1699999999999999 111.327 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER 65.26 -60.6 0.25 Allowed 'General case' 0 N--CA 1.509 2.484 0 O-C-N 121.528 -0.732 . . . . 1.3300000000000001 111.264 179.746 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.464 ' CE2' ' HG2' ' A' ' 47' ' ' GLU . 0.1 OUTLIER -167.4 -61.12 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.269 -0.894 . . . . 1.6000000000000001 110.219 179.791 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.8 tp -122.74 -67.9 0.92 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.362 -0.837 . . . . 2.6600000000000001 109.944 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -145.35 29.43 1.16 Allowed 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.635 -0.666 . . . . 2.3999999999999999 111.093 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.461 HD12 ' HB2' ' A' ' 36' ' ' CYS . 0.0 OUTLIER 49.56 41.86 22.01 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.4 -0.812 . . . . 2.04 111.108 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -121.91 29.41 7.11 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.364 -0.835 . . . . 2.79 110.778 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.88 -148.04 0.25 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.865 -1.147 . . . . 3.1899999999999999 109.972 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.617 HD12 ' CB ' ' A' ' 46' ' ' SER . 14.8 pt -42.66 -36.12 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.246 0 O-C-N 121.448 -0.783 . . . . 2.1899999999999999 111.621 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.524 ' HB3' ' O ' ' A' ' 43' ' ' ILE . 6.2 t 63.97 -73.11 0.05 Allowed 'General case' 0 N--CA 1.506 2.356 0 O-C-N 122.116 -0.365 . . . . 1.9299999999999999 111.197 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -85.53 95.25 9.25 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.993 -1.067 . . . . 1.97 110.487 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.617 ' CB ' HD12 ' A' ' 43' ' ' ILE . 3.1 m -166.06 44.1 0.07 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.272 -0.893 . . . . 1.4199999999999999 110.216 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.464 ' HG2' ' CE2' ' A' ' 37' ' ' TYR . 2.4 mm-40 -141.11 -159.46 0.96 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.377 -0.827 . . . . 1.55 110.763 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 59.67 44.22 14.59 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.414 0.625 . . . . 1.23 110.988 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 50.73 48.97 21.88 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.531 -0.731 . . . . 0.78000000000000003 111.635 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.614 ' OE1' HG12 ' A' ' 53' ' ' VAL . 0.7 OUTLIER -83.74 134.89 34.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.683 -1.261 . . . . 1.6899999999999999 110.38 179.52 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.445 ' OG ' ' NZ ' ' A' ' 70' ' ' LYS . 75.4 m -158.46 21.4 0.23 Allowed 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.537 -0.727 . . . . 0.94999999999999996 110.847 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.853 ' O ' HG22 ' A' ' 53' ' ' VAL . 3.0 mt -122.9 -44.6 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 107.569 -1.271 . . . . 1.26 107.569 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.853 HG22 ' O ' ' A' ' 52' ' ' ILE . 1.3 m 57.03 -34.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.717 0 N-CA-C 113.147 0.795 . . . . 1.6499999999999999 113.147 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 52' ' ' ILE . . . -127.51 51.05 0.86 Allowed Glycine 0 N--CA 1.497 2.716 0 N-CA-C 109.596 -1.402 . . . . 1.5600000000000001 109.596 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -59.12 147.48 34.87 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.634 -0.921 . . . . 1.8200000000000001 110.961 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -120.98 -54.17 0.23 Allowed Glycine 0 N--CA 1.495 2.58 0 N-CA-C 107.729 -2.148 . . . . 2.0 107.729 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.477 ' OE2' ' NZ ' ' A' ' 59' ' ' LYS . 15.2 pt-20 -141.52 34.96 1.64 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.766 -0.843 . . . . 2.71 109.744 178.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.4 m 48.24 33.61 3.85 Favored 'General case' 0 N--CA 1.505 2.283 0 CA-C-O 121.421 0.629 . . . . 1.8999999999999999 111.149 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.477 ' NZ ' ' OE2' ' A' ' 57' ' ' GLU . 7.6 ttpp -156.64 72.58 0.74 Allowed 'General case' 0 C--N 1.307 -1.244 0 O-C-N 121.316 -0.865 . . . . 1.8600000000000001 108.883 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -134.29 160.58 67.95 Favored Pre-proline 0 N--CA 1.497 1.89 0 CA-C-N 116.045 -0.525 . . . . 1.6799999999999999 110.608 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.416 ' O ' HG22 ' A' ' 65' ' ' VAL . 41.7 Cg_endo -68.75 -30.98 26.54 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 O-C-N 123.838 1.441 . . . . 1.3400000000000001 111.063 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.472 ' O ' ' HB2' ' A' ' 66' ' ' GLN . 0.5 OUTLIER -52.31 -64.15 0.91 Allowed 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.589 -0.694 . . . . 2.3999999999999999 111.063 179.879 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.539 ' HB3' HG12 ' A' ' 52' ' ' ILE . 3.2 pp -64.43 -27.23 68.85 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.242 -0.911 . . . . 1.26 110.424 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.3 -51.05 69.23 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.535 -0.728 . . . . 1.8 109.55 178.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 61' ' ' PRO . 32.7 m -74.45 -35.18 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.235 -0.916 . . . . 1.1599999999999999 109.645 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.472 ' HB2' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -61.04 -49.9 75.52 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.577 -0.702 . . . . 1.49 109.346 178.672 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.509 ' HB2' ' O ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -66.64 -41.93 87.48 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.617 -0.677 . . . . 0.75 109.381 178.482 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.7 m -56.82 -38.17 72.25 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.803 -0.561 . . . . 1.0800000000000001 109.744 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -82.38 -38.58 23.94 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.409 -0.807 . . . . 0.97999999999999998 110.235 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.49 ' HG2' ' HA ' ' A' ' 67' ' ' TYR . 5.5 ptpt -62.59 -37.52 86.58 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.476 -0.765 . . . . 0.78000000000000003 110.49 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -47.5 -63.94 3.13 Favored Glycine 0 N--CA 1.503 3.145 0 N-CA-C 110.452 -1.059 . . . . 0.81999999999999995 110.452 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.31 -38.7 19.71 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 123.673 1.354 . . . . 1.1499999999999999 110.099 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 7.5 t -62.15 -47.67 83.5 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.175 -0.953 . . . . 1.3300000000000001 109.9 178.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 45.7 t -66.27 -44.04 91.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.547 -0.721 . . . . 0.93000000000000005 109.326 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -56.8 -42.35 79.37 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 108.732 -0.84 . . . . 1.3500000000000001 108.732 178.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.419 ' NH2' ' HG2' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -62.94 -55.76 23.12 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.551 0.691 . . . . 2.6299999999999999 109.859 178.78 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.94 -54.59 44.93 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.362 0.601 . . . . 2.8199999999999998 110.754 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -53.09 -45.35 68.15 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.836 -0.54 . . . . 1.1100000000000001 111.056 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.3 mttp -72.56 -41.54 65.64 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.497 -0.752 . . . . 1.79 110.748 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.4 tp -68.82 -41.37 78.71 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.245 -0.909 . . . . 2.2400000000000002 111.315 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 3.1 ttt -88.98 -24.37 22.41 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.326 -0.859 . . . . 2.6899999999999999 111.301 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 14.6 m 53.54 60.77 11.44 Favored Pre-proline 0 N--CA 1.505 2.281 0 O-C-N 121.419 -0.8 . . . . 1.4199999999999999 110.478 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -79.56 19.65 0.95 Allowed 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.731 1.385 . . . . 1.49 111.099 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.594 ' HA ' ' CD ' ' A' ' 87' ' ' GLU . 26.7 m120 -73.9 45.91 0.21 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.952 -1.092 . . . . 1.6299999999999999 110.635 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.445 ' N ' ' HD2' ' A' ' 86' ' ' PRO . . . -67.95 -61.19 5.09 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.875 -1.29 . . . . 2.0699999999999998 109.875 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 85' ' ' GLY . 42.2 Cg_endo -67.08 -29.75 39.58 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.776 1.408 . . . . 2.7599999999999998 111.016 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.594 ' CD ' ' HA ' ' A' ' 84' ' ' ASN . 1.5 mp0 -57.85 -34.74 70.06 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.412 -0.805 . . . . 2.9500000000000002 110.176 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.5 p -108.57 -15.05 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.489 -0.757 . . . . 3.5699999999999998 111.117 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.417 ' O ' ' HA ' ' A' ' 86' ' ' PRO . 0.1 OUTLIER -154.12 102.8 2.5 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.987 -1.071 . . . . 4.5199999999999996 110.003 -179.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.879 0 CA-C-O 118.016 -1.435 . . . . 4.7199999999999998 109.827 -179.541 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.726 0 N-CA-C 108.892 -1.683 . . . . 7.8799999999999999 108.892 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.04 -42.05 72.17 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 122.344 1.068 . . . . 7.0800000000000001 108.123 177.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.6 ptt? -112.54 -179.52 3.69 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.473 -1.306 . . . . 5.5300000000000002 107.473 177.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.8 t -173.76 -40.86 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.214 -0.929 . . . . 4.8700000000000001 110.657 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.58 HD12 ' N ' ' A' ' 7' ' ' ASP . 2.7 pp -117.55 -147.43 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 N-CA-C 109.477 -0.564 . . . . 3.7599999999999998 109.477 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.476 ' N ' HD12 ' A' ' 5' ' ' ILE . 4.2 tpt -78.21 42.37 0.41 Allowed 'General case' 0 C--N 1.296 -1.722 0 O-C-N 120.832 -1.168 . . . . 4.9100000000000001 110.945 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.58 ' N ' HD12 ' A' ' 5' ' ' ILE . 15.8 m-20 -51.58 -38.41 54.31 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.939 0.876 . . . . 6.5999999999999996 109.147 178.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -63.21 -49.4 74.35 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.614 0.721 . . . . 10.02 111.89 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.468 ' O ' ' HG2' ' A' ' 6' ' ' MET . 0.3 OUTLIER -136.48 65.25 55.03 Favored Pre-proline 0 C--N 1.302 -1.473 0 O-C-N 121.649 -0.657 . . . . 6.4800000000000004 111.574 -178.108 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.504 ' O ' HG22 ' A' ' 14' ' ' VAL . 47.4 Cg_endo -72.05 171.82 15.96 Favored 'Trans proline' 0 C--N 1.301 -1.971 0 N-CA-C 108.259 -1.477 . . . . 5.8600000000000003 108.259 178.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.0 p -49.63 -44.41 47.45 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.995 -1.066 . . . . 4.5099999999999998 109.05 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.8 p -64.9 -39.3 93.32 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.634 -0.666 . . . . 4.1699999999999999 110.558 177.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.77 -60.35 7.03 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 110.011 -1.235 . . . . 3.9100000000000001 110.011 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.504 HG22 ' O ' ' A' ' 10' ' ' PRO . 34.9 m -58.04 -36.56 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.402 -1.058 . . . . 4.1699999999999999 110.111 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.9 t -68.76 -41.41 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 120.997 -1.064 . . . . 3.9100000000000001 109.253 178.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 52.5 m -59.98 -52.19 66.44 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.709 -0.62 . . . . 3.6000000000000001 109.966 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.46 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 31.2 m -65.45 -34.6 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.536 -0.728 . . . . 3.6299999999999999 110.176 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.724 ' HA ' HD23 ' A' ' 21' ' ' LEU . 21.7 mt -68.73 -41.38 82.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.093 -1.004 . . . . 3.8300000000000001 109.216 178.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 18.5 t -64.41 -42.19 94.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 108.489 -0.93 . . . . 3.3500000000000001 108.489 177.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 83.3 mt -64.38 -48.97 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.525 -0.734 . . . . 3.2999999999999998 109.272 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.724 HD23 ' HA ' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -61.39 -43.23 99.23 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.675 -0.861 . . . . 3.4300000000000002 108.675 178.788 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.595 ' N ' ' HG ' ' A' ' 21' ' ' LEU . 15.0 mt -60.33 -44.92 96.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.319 -0.863 . . . . 3.3100000000000001 109.148 178.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.97 -46.03 86.48 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.724 -0.61 . . . . 2.8100000000000001 109.731 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.3 mm -59.39 -45.6 93.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.41 -0.806 . . . . 2.8599999999999999 109.146 178.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.78 -45.86 87.84 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.525 -0.734 . . . . 2.8599999999999999 109.771 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.8 -41.89 96.51 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.732 -0.84 . . . . 2.6099999999999999 108.732 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.664 HD13 ' C ' ' A' ' 27' ' ' LEU . 3.4 tm? -60.65 -53.49 56.75 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.899 -0.778 . . . . 2.46 108.899 178.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.62 -43.74 86.08 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 108.905 -1.678 . . . . 2.3500000000000001 108.905 178.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.65 -44.65 95.73 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.414 -1.051 . . . . 2.5 109.74 178.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.511 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 7.4 mt -59.08 -41.17 87.37 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.649 -0.657 . . . . 2.4900000000000002 109.481 178.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.7 mt -69.45 -40.93 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.544 -0.723 . . . . 2.3100000000000001 109.658 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.29 -42.76 87.89 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.548 -0.72 . . . . 3.29 110.264 178.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -71.2 -38.97 63.01 Favored Glycine 0 N--CA 1.497 2.723 0 O-C-N 120.883 -1.135 . . . . 2.1600000000000001 110.57 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -82.98 -33.14 26.69 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.125 -1.22 . . . . 2.3599999999999999 112.015 -179.041 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.675 ' CG ' ' HA ' ' A' ' 39' ' ' ARG . 5.0 m0 -123.31 13.82 9.6 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.816 -1.178 . . . . 2.2999999999999998 112.509 -178.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 64.18 -61.78 0.18 Allowed 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.362 -0.836 . . . . 2.4900000000000002 111.806 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.457 ' N ' ' O ' ' A' ' 35' ' ' TRP . 0.7 OUTLIER -119.44 -75.48 0.58 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.295 -0.878 . . . . 5.1799999999999997 110.384 -179.699 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.28 -55.69 2.21 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.694 -0.854 . . . . 1.8200000000000001 108.694 179.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.675 ' HA ' ' CG ' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -150.36 34.79 0.64 Allowed 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.209 0.528 . . . . 1.8500000000000001 111.092 179.256 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.876 HD23 ' HA ' ' A' ' 44' ' ' SER . 3.6 mp -80.27 86.75 5.62 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.019 -1.051 . . . . 1.6699999999999999 109.106 179.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -101.1 12.39 37.72 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.3 -0.875 . . . . 2.8399999999999999 111.981 -178.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.13 -129.17 0.25 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.904 -1.123 . . . . 2.5800000000000001 109.877 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.42 HG13 ' N ' ' A' ' 44' ' ' SER . 20.1 pt -53.59 -34.37 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.092 -1.005 . . . . 2.3100000000000001 110.746 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.876 ' HA ' HD23 ' A' ' 40' ' ' LEU . 0.9 OUTLIER 69.95 48.93 0.52 Allowed 'General case' 0 N--CA 1.502 2.15 0 CA-C-O 122.044 0.926 . . . . 1.9299999999999999 109.379 -179.138 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.446 ' HG2' ' C ' ' A' ' 44' ' ' SER . 4.2 mm-40 -136.21 -34.22 0.8 Allowed 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 115.943 -0.572 . . . . 2.29 110.697 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 56.8 m -147.36 54.21 1.07 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.553 -0.717 . . . . 1.26 110.967 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.573 ' HB2' ' HG ' ' A' ' 40' ' ' LEU . 1.4 mp0 -122.03 144.37 48.94 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.928 -1.108 . . . . 1.3700000000000001 111.257 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 50' ' ' GLU . 0.5 OUTLIER 51.93 -148.67 0.38 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 122.026 -0.421 . . . . 1.55 111.073 179.457 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 66.37 -61.63 0.29 Allowed 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.471 -0.768 . . . . 2.25 111.345 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' A' ' 48' ' ' ASP . 0.1 OUTLIER -111.01 -163.01 0.82 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.199 -0.938 . . . . 2.1099999999999999 110.548 -179.915 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.86 -39.25 0.87 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.291 -0.88 . . . . 2.7999999999999998 110.859 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 24.2 mt -87.34 -53.96 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.421 -0.8 . . . . 2.9100000000000001 109.81 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.812 HG12 ' HB2' ' A' ' 55' ' ' ASP . 47.1 t -89.91 -68.66 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.744 -0.598 . . . . 2.3999999999999999 109.606 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.75 -6.92 82.73 Favored Glycine 0 N--CA 1.501 3.001 0 N-CA-C 109.632 -1.387 . . . . 1.21 109.632 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.812 ' HB2' HG12 ' A' ' 53' ' ' VAL . 0.4 OUTLIER -67.24 157.1 34.67 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.732 -0.863 . . . . 1.98 110.642 -179.948 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 62' ' ' PHE . . . -157.66 -52.57 0.01 OUTLIER Glycine 0 N--CA 1.487 2.055 0 N-CA-C 108.898 -1.681 . . . . 1.8200000000000001 108.898 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.408 ' HB3' ' NE2' ' A' ' 45' ' ' GLN . 3.6 tp10 -126.11 -5.18 6.75 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.634 -0.921 . . . . 2.5 112.431 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.9 m -58.95 -50.93 72.21 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 120.615 -1.303 . . . . 1.48 110.879 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.0 pttp -133.91 27.73 3.9 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.168 -0.958 . . . . 2.3199999999999998 110.732 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -133.31 131.52 21.63 Favored Pre-proline 0 C--N 1.297 -1.696 0 O-C-N 121.86 -0.525 . . . . 3.2400000000000002 110.075 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.02 53.56 2.92 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.637 1.335 . . . . 2.3399999999999999 109.75 178.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.474 ' HB2' ' O ' ' A' ' 56' ' ' GLY . 34.8 t80 -63.01 -50.75 69.5 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.477 -0.765 . . . . 3.5 110.293 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.5 mt -62.23 -33.92 75.5 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.45 -0.782 . . . . 2.96 109.365 178.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.87 -57.27 12.43 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.615 -0.513 . . . . 2.73 109.615 178.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.472 ' HA ' ' HB2' ' A' ' 68' ' ' SER . 32.8 m -69.18 -32.17 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.292 -0.88 . . . . 2.6600000000000001 109.807 179.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.539 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 5.2 mm-40 -61.24 -54.71 40.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.44 -0.787 . . . . 3.6800000000000002 109.008 178.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -65.51 -41.22 93.41 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.324 -0.621 . . . . 2.9199999999999999 109.324 178.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.472 ' HB2' ' HA ' ' A' ' 65' ' ' VAL . 63.5 m -55.38 -33.34 63.38 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 109.14 -0.689 . . . . 2.9300000000000002 109.14 178.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.503 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -80.73 -40.57 25.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.646 -0.659 . . . . 3.3399999999999999 109.393 178.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.539 ' HG2' ' O ' ' A' ' 66' ' ' GLN . 5.6 mmtm -58.97 -51.75 68.7 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.563 -0.71 . . . . 3.5800000000000001 110.739 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -39.69 -64.87 0.96 Allowed Glycine 0 N--CA 1.505 3.294 0 N-CA-C 110.922 -0.871 . . . . 3.1600000000000001 110.922 -179.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.572 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 39.6 Cg_endo -65.53 -39.42 21.59 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 O-C-N 123.834 1.439 . . . . 3.8500000000000001 110.651 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 0.9 OUTLIER -63.44 -44.94 93.07 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.083 -1.01 . . . . 4.25 109.627 179.007 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.41 ' O ' ' HG3' ' A' ' 77' ' ' LYS . 41.4 t -67.17 -47.31 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.711 -0.848 . . . . 3.7799999999999998 108.711 178.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -58.03 -39.29 78.01 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.515 0.674 . . . . 4.3700000000000001 109.332 178.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.572 ' HB2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -63.69 -64.26 0.95 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.749 -0.595 . . . . 4.79 110.389 178.902 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.571 ' O ' ' HB2' ' A' ' 81' ' ' MET . 0.0 OUTLIER -59.57 -31.82 69.79 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 120.053 -0.659 . . . . 4.6699999999999999 110.864 -179.46 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.465 ' N ' ' HG3' ' A' ' 77' ' ' LYS . . . -65.26 -43.25 91.89 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.183 -0.948 . . . . 4.3700000000000001 108.972 178.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.1 mttt -72.26 -49.91 31.34 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.173 -0.677 . . . . 4.9699999999999998 109.173 178.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.87 -40.21 66.37 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.348 0.594 . . . . 6.1299999999999999 110.204 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.571 ' HB2' ' O ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -80.71 -46.23 15.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.572 -0.705 . . . . 5.8200000000000003 109.173 178.893 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.625 HG22 ' CD ' ' A' ' 83' ' ' PRO . 0.1 OUTLIER 54.46 -173.67 0.02 OUTLIER Pre-proline 0 N--CA 1.498 1.948 0 N-CA-C 109.853 -0.425 . . . . 5.1399999999999997 109.853 179.342 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.625 ' CD ' HG22 ' A' ' 82' ' ' THR . 53.2 Cg_endo -80.68 14.08 2.13 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 O-C-N 122.71 0.847 . . . . 5.2999999999999998 110.604 179.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.428 ' CB ' ' O ' ' A' ' 83' ' ' PRO . 0.4 OUTLIER 73.26 -27.86 0.19 Allowed 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.512 -0.743 . . . . 6.5 111.825 -179.392 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -75.22 140.18 26.05 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.18 -1.568 . . . . 5.8700000000000001 109.18 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 89' ' ' HIS . 39.6 Cg_endo -63.79 -17.66 60.8 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 O-C-N 123.712 1.375 . . . . 6.6500000000000004 111.467 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -57.07 -34.87 68.7 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.205 -0.935 . . . . 6.3700000000000001 109.21 178.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.0 t -110.12 -30.09 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.757 -0.589 . . . . 5.6100000000000003 110.081 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.448 ' O ' ' HA ' ' A' ' 86' ' ' PRO . 12.0 t60 -104.81 95.76 6.1 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.177 -0.952 . . . . 6.6399999999999997 110.149 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.579 0 CA-C-O 118.116 -1.38 . . . . 6.6100000000000003 110.084 -179.823 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 7' ' ' ASP . . . . . . . . 0 N--CA 1.495 2.6 0 N-CA-C 109.307 -1.517 . . . . 3.6800000000000002 109.307 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.458 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 3.4 t 73.86 87.8 0.1 Allowed 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.918 -0.754 . . . . 4.8799999999999999 110.24 -179.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.89 86.54 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.149 0 CA-C-O 121.673 0.749 . . . . 4.0800000000000001 110.265 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 65.6 p -150.75 -78.67 0.13 Allowed 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.182 -0.673 . . . . 4.0800000000000001 109.182 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -94.71 -125.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 108.129 -1.063 . . . . 4.1299999999999999 108.129 178.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.552 ' O ' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -52.14 -52.83 49.28 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.87 -1.144 . . . . 3.7000000000000002 111.035 178.829 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.517 ' HB3' ' O ' ' A' ' 6' ' ' MET . 2.5 t70 63.39 -52.6 0.21 Allowed 'General case' 0 N--CA 1.501 2.123 0 CA-C-N 118.084 0.402 . . . . 2.7999999999999998 110.198 -178.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.552 ' N ' ' O ' ' A' ' 6' ' ' MET . 0.9 OUTLIER 48.96 32.01 3.59 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.447 -0.783 . . . . 2.73 112.377 179.227 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.506 ' N ' ' HD2' ' A' ' 10' ' ' PRO . 0.4 OUTLIER -74.5 -55.33 2.76 Favored Pre-proline 0 N--CA 1.5 2.044 0 O-C-N 120.639 -1.288 . . . . 2.5099999999999998 111.258 179.782 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 9' ' ' SER . 41.0 Cg_endo -66.2 -38.35 21.59 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 O-C-N 123.434 1.228 . . . . 1.6899999999999999 111.335 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -65.91 -50.71 63.48 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.527 -0.733 . . . . 1.8400000000000001 109.736 179.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.1 m -59.36 -34.12 72.0 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.107 -0.996 . . . . 2.1400000000000001 109.973 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.48 -60.96 5.41 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.686 -1.365 . . . . 1.51 109.686 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 10' ' ' PRO . 31.2 m -57.37 -35.45 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.472 -1.016 . . . . 1.3700000000000001 110.026 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.0 t -68.54 -45.83 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.126 -0.984 . . . . 1.9399999999999999 109.312 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 51.7 m -57.94 -51.37 69.93 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.717 -0.614 . . . . 1.75 109.943 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.424 ' CG2' ' HA ' ' A' ' 14' ' ' VAL . 25.4 m -64.77 -35.59 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.437 -0.789 . . . . 1.27 110.138 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.413 HD13 ' HA ' ' A' ' 18' ' ' ILE . 6.6 mm -67.98 -41.2 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 121.034 -1.041 . . . . 1.8200000000000001 109.19 178.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 37.8 t -65.1 -44.58 95.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.466 -0.939 . . . . 2.0 108.466 178.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.429 HD13 ' HA ' ' A' ' 20' ' ' ILE . 21.7 mm -62.41 -46.98 95.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 108.99 -0.745 . . . . 1.55 108.99 178.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 11.4 mt -59.88 -49.4 77.85 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.833 -0.803 . . . . 1.55 108.833 178.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.419 HD13 ' HA ' ' A' ' 22' ' ' ILE . 11.5 mm -57.11 -43.66 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.591 -0.693 . . . . 2.25 109.313 178.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.63 -45.82 91.08 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.57 -0.706 . . . . 1.74 109.608 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 58.6 mt -59.34 -49.25 84.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.397 -0.814 . . . . 1.53 108.855 178.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.76 -43.67 97.7 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.648 -0.658 . . . . 1.98 110.023 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.28 -43.55 98.57 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.376 -0.827 . . . . 2.1899999999999999 109.061 178.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.411 ' HG ' HD12 ' A' ' 31' ' ' ILE . 0.8 OUTLIER -62.38 -46.83 86.87 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.613 -0.884 . . . . 1.8100000000000001 108.613 178.139 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.84 -48.14 80.67 Favored Glycine 0 N--CA 1.496 2.633 0 N-CA-C 108.654 -1.778 . . . . 1.8999999999999999 108.654 178.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.22 -44.03 97.93 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.427 -1.043 . . . . 2.4199999999999999 109.966 178.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.5 mt -60.53 -39.23 87.1 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.627 -0.671 . . . . 2.7400000000000002 109.98 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.687 HD13 HG22 ' A' ' 52' ' ' ILE . 3.7 mt -72.79 -47.54 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.27 -0.894 . . . . 1.9399999999999999 109.162 179.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.559 HD13 ' HB3' ' A' ' 55' ' ' ASP . 1.0 OUTLIER -57.66 -46.52 84.14 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.364 -0.835 . . . . 2.6200000000000001 109.637 178.796 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.26 -55.3 28.51 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.472 -1.451 . . . . 2.73 109.472 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.6 t -55.56 -39.91 71.26 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.427 -1.043 . . . . 2.6600000000000001 109.531 179.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.5 ' O ' ' N ' ' A' ' 37' ' ' TYR . 56.3 t90 -64.29 -62.05 1.85 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.707 -0.621 . . . . 2.4199999999999999 109.352 178.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 60.75 -61.85 0.07 Allowed 'General case' 0 N--CA 1.508 2.459 0 O-C-N 121.745 -0.597 . . . . 3.3100000000000001 111.736 178.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.5 ' N ' ' O ' ' A' ' 35' ' ' TRP . 0.2 OUTLIER -114.83 169.5 9.03 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.313 -0.867 . . . . 4.9100000000000001 109.372 179.517 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.88 39.85 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.543 0 O-C-N 120.938 -1.102 . . . . 3.0299999999999998 112.144 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.489 ' HG3' ' N ' ' A' ' 40' ' ' LEU . 8.1 ptt180 -90.73 -32.16 16.26 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.622 -1.299 . . . . 2.8399999999999999 111.196 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.489 ' N ' ' HG3' ' A' ' 39' ' ' ARG . 0.2 OUTLIER -120.88 59.29 0.93 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.426 -0.797 . . . . 2.23 109.949 -179.891 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.556 ' O ' ' N ' ' A' ' 43' ' ' ILE . 7.1 tp60 -67.13 -5.95 15.61 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.567 -0.708 . . . . 2.71 111.745 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.655 ' HB3' HG11 ' A' ' 53' ' ' VAL . 0.0 OUTLIER 61.16 -62.4 0.08 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.555 -0.715 . . . . 3.1899999999999999 110.744 179.837 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.556 ' N ' ' O ' ' A' ' 41' ' ' GLN 0.268 0.0 OUTLIER -68.2 -17.35 22.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 O-C-N 121.475 -0.766 . . . . 3.0 109.149 177.941 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.498 ' HB3' ' O ' ' A' ' 43' ' ' ILE . 24.5 t 66.69 -159.52 0.25 Allowed 'General case' 0 N--CA 1.501 2.111 0 CA-C-O 121.354 0.597 . . . . 2.52 111.705 179.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 50.25 -115.45 0.83 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 122.01 -0.431 . . . . 3.7599999999999998 110.388 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -150.95 37.52 0.64 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.603 -1.31 . . . . 3.2400000000000002 110.41 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -120.68 145.98 46.9 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.349 -0.844 . . . . 2.98 110.84 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.408 ' HB3' ' CE ' ' A' ' 59' ' ' LYS . 11.1 t70 -138.94 21.51 2.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.486 -0.759 . . . . 2.2400000000000002 110.465 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.48 60.93 2.17 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.225 -0.922 . . . . 2.7000000000000002 110.233 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.501 ' HB3' HG22 ' A' ' 53' ' ' VAL . 1.5 tt0 -122.01 -129.68 0.27 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.517 -0.74 . . . . 1.76 109.746 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.26 -44.31 0.08 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.653 -1.28 . . . . 1.8999999999999999 110.906 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.687 HG22 HD13 ' A' ' 31' ' ' ILE . 38.8 mt -74.3 -47.85 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.595 -0.691 . . . . 1.27 109.569 179.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.655 HG11 ' HB3' ' A' ' 42' ' ' ARG . 19.6 m -75.69 -30.39 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.609 -0.682 . . . . 1.73 110.386 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -103.91 57.97 0.53 Allowed Glycine 0 N--CA 1.498 2.771 0 N-CA-C 109.632 -1.387 . . . . 1.77 109.632 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.559 ' HB3' HD13 ' A' ' 32' ' ' LEU . 25.4 t70 -69.5 137.65 52.72 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.63 -0.923 . . . . 2.1499999999999999 110.548 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.63 55.55 0.52 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 108.328 -1.909 . . . . 2.6200000000000001 108.328 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.556 ' O ' ' HB ' ' A' ' 58' ' ' THR . 3.1 mm-40 61.82 46.86 6.54 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 122.193 -0.592 . . . . 4.21 110.759 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.556 ' HB ' ' O ' ' A' ' 57' ' ' GLU . 24.7 m 66.47 -57.85 0.37 Allowed 'General case' 0 N--CA 1.509 2.494 0 O-C-N 121.661 -0.649 . . . . 2.6600000000000001 110.528 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.533 ' O ' ' HD3' ' A' ' 61' ' ' PRO . 0.7 OUTLIER -172.48 178.55 2.72 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.05 -0.722 . . . . 3.1400000000000001 109.05 179.294 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.659 ' HB3' HD12 ' A' ' 63' ' ' LEU . 0.5 OUTLIER -75.17 109.13 6.77 Favored Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 121.224 -0.923 . . . . 3.98 111.328 -178.952 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.533 ' HD3' ' O ' ' A' ' 59' ' ' LYS . 47.8 Cg_endo -73.01 -31.44 9.8 Favored 'Trans proline' 0 C--N 1.316 -1.179 0 O-C-N 123.698 1.367 . . . . 4.5700000000000003 110.968 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -65.91 -29.18 69.56 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.924 -1.11 . . . . 5.0300000000000002 109.931 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.659 HD12 ' HB3' ' A' ' 60' ' ' GLU . 2.2 mt -55.51 -37.11 67.45 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.501 -0.75 . . . . 2.7200000000000002 109.596 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.431 ' HB2' ' O ' ' A' ' 61' ' ' PRO . 0.1 OUTLIER -55.67 -47.02 77.41 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.359 -0.608 . . . . 3.8999999999999999 109.359 179.055 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.492 ' HA ' ' HB2' ' A' ' 68' ' ' SER . 3.8 t -77.81 -40.76 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 121.512 -0.743 . . . . 4.2300000000000004 109.428 178.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -52.68 -41.7 64.09 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.965 -0.754 . . . . 2.6299999999999999 108.965 178.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -78.03 -46.48 20.82 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.246 -0.649 . . . . 5.54 109.246 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.492 ' HB2' ' HA ' ' A' ' 65' ' ' VAL . 75.5 m -54.79 -33.55 61.57 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 122.083 -0.386 . . . . 3.71 110.071 179.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.578 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -87.72 -50.71 6.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.303 -0.873 . . . . 3.1600000000000001 109.871 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.1 mtmt -59.42 -51.57 69.33 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.771 -0.581 . . . . 2.0699999999999998 111.712 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -40.91 -63.53 1.46 Allowed Glycine 0 N--CA 1.505 3.261 0 N-CA-C 110.352 -1.099 . . . . 2.5099999999999998 110.352 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.505 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 41.9 Cg_endo -67.51 -43.15 6.11 Favored 'Trans proline' 0 C--N 1.315 -1.186 0 O-C-N 123.939 1.494 . . . . 3.5499999999999998 110.275 178.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.578 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 1.2 t -56.0 -44.52 78.71 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.844 -1.16 . . . . 2.5 109.554 178.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 49.0 t -68.34 -50.61 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 108.899 -0.778 . . . . 1.8200000000000001 108.899 178.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -52.01 -41.32 62.13 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.561 0.696 . . . . 4.1699999999999999 109.918 178.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.505 ' HD2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -68.21 -56.11 9.87 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.757 -0.589 . . . . 4.6799999999999997 111.587 -179.655 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.46 ' NZ ' ' OE2' ' A' ' 87' ' ' GLU . 0.1 OUTLIER -64.31 -33.65 76.33 Favored 'General case' 0 N--CA 1.505 2.319 0 C-N-CA 119.075 -1.05 . . . . 2.1499999999999999 110.46 -179.254 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.545 ' O ' ' HD2' ' A' ' 83' ' ' PRO . . . -67.07 -50.47 61.67 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.519 -0.738 . . . . 2.9500000000000002 110.097 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.8 pttt -73.98 -32.87 63.63 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.153 -0.967 . . . . 4.6799999999999997 111.216 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.5 tp -72.24 -55.1 7.77 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.192 -0.942 . . . . 3.1800000000000002 110.551 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.1 mtt -80.49 -15.74 55.99 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.674 -0.641 . . . . 2.96 110.813 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.466 ' N ' ' HD3' ' A' ' 83' ' ' PRO . 47.1 p 47.61 53.37 13.92 Favored Pre-proline 0 N--CA 1.504 2.254 0 O-C-N 121.587 -0.695 . . . . 3.98 111.538 -179.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.637 ' HB2' ' HD3' ' A' ' 86' ' ' PRO . 54.3 Cg_endo -78.61 16.91 1.19 Allowed 'Trans proline' 0 N--CA 1.488 1.147 0 O-C-N 123.432 1.227 . . . . 4.6799999999999997 111.162 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 7.3 t30 66.44 -52.84 0.43 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.197 -0.939 . . . . 7.0499999999999998 111.053 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 83' ' ' PRO . . . 166.49 70.41 0.03 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.32 -1.512 . . . . 5.7000000000000002 109.32 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.637 ' HD3' ' HB2' ' A' ' 83' ' ' PRO . 39.4 Cg_endo -65.53 -17.38 57.13 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 O-C-N 123.701 1.369 . . . . 6.2199999999999998 109.458 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.46 ' OE2' ' NZ ' ' A' ' 77' ' ' LYS . 14.5 mp0 -69.91 -31.18 68.82 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.583 -0.895 . . . . 7.0099999999999998 108.583 177.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.44 HG12 ' O ' ' A' ' 85' ' ' GLY . 1.5 p -108.99 -19.88 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.685 -0.634 . . . . 7.9199999999999999 110.845 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.605 ' O ' ' HA ' ' A' ' 86' ' ' PRO . 44.8 t-80 -150.67 119.49 6.61 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.958 -1.089 . . . . 8.9600000000000009 110.737 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.775 0 CA-C-O 117.642 -1.643 . . . . 7.2800000000000002 110.037 179.38 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.711 0 N-CA-C 109.221 -1.552 . . . . 6.0700000000000003 109.221 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.5 t -165.8 -161.16 0.49 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.366 -1.079 . . . . 6.2699999999999996 110.295 179.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.3 ptt? -123.49 155.33 37.73 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.157 -0.964 . . . . 6.4900000000000002 111.005 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -115.38 51.73 0.91 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.38 -0.825 . . . . 6.1600000000000001 111.088 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -52.61 -44.71 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.273 -0.892 . . . . 4.5999999999999996 109.968 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.8 mtp 52.41 28.84 6.21 Favored 'General case' 0 N--CA 1.499 1.999 0 CA-C-N 115.897 -0.592 . . . . 5.2599999999999998 110.99 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -68.28 -20.01 64.74 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.146 -0.971 . . . . 2.7599999999999998 110.653 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 57.27 33.81 23.84 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.591 -0.693 . . . . 2.6400000000000001 109.961 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.19 173.88 5.24 Favored Pre-proline 0 N--CA 1.483 1.195 0 O-C-N 121.471 -0.768 . . . . 2.0299999999999998 110.177 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -76.07 57.53 5.25 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.414 1.218 . . . . 2.6000000000000001 110.907 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.2 t -53.83 -37.77 63.94 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.4 -0.812 . . . . 2.2799999999999998 110.43 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.7 t -55.01 -30.03 58.64 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.462 -0.774 . . . . 3.2999999999999998 110.213 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.797 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -72.67 -55.43 6.63 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 108.544 -1.822 . . . . 2.4900000000000002 108.544 178.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 76.6 t -54.92 -42.17 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.721 -0.87 . . . . 1.8600000000000001 108.702 178.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 44.7 t -64.71 -45.24 95.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.567 -0.708 . . . . 2.3199999999999998 109.229 178.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 46.1 m -58.03 -46.78 84.76 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.651 -0.656 . . . . 3.0299999999999998 109.283 178.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.797 HG23 ' O ' ' A' ' 13' ' ' GLY . 3.7 t -65.82 -38.92 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 C-N-CA 119.586 -0.846 . . . . 2.3900000000000001 109.242 178.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.661 ' HA ' HD23 ' A' ' 21' ' ' LEU . 10.0 mm -62.39 -41.41 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.016 -1.053 . . . . 1.55 109.077 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.9 t -66.06 -40.94 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 N-CA-C 108.643 -0.873 . . . . 2.4500000000000002 108.643 177.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.435 ' O ' HG23 ' A' ' 24' ' ' ILE . 92.4 mt -65.7 -50.12 73.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.522 -0.736 . . . . 2.9399999999999999 109.074 178.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.661 HD23 ' HA ' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -61.59 -42.84 99.44 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 119.914 -0.714 . . . . 1.76 109.383 178.711 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.571 ' N ' ' HG ' ' A' ' 21' ' ' LEU . 10.4 mm -62.7 -38.54 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 120.972 -1.08 . . . . 1.79 109.106 178.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.97 -50.58 54.93 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.481 -0.762 . . . . 2.0499999999999998 110.724 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.602 HG12 ' HA ' ' A' ' 21' ' ' LEU . 29.3 pt -62.52 -37.26 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 120.955 -1.091 . . . . 2.46 109.283 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.551 ' N ' HG13 ' A' ' 24' ' ' ILE . . . -65.75 -46.98 76.83 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.435 -0.791 . . . . 1.6000000000000001 108.909 178.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.05 -44.06 97.96 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.008 -0.738 . . . . 1.6299999999999999 109.008 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.1 tt -61.22 -45.86 92.81 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.36 -0.838 . . . . 2.52 108.93 178.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.3 -46.47 92.87 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.003 -1.639 . . . . 1.76 109.003 178.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.89 -41.44 95.62 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.532 -0.981 . . . . 1.8300000000000001 109.89 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.504 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 6.6 mt -59.11 -42.12 89.78 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.821 -0.807 . . . . 2.3199999999999998 108.821 178.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.402 ' HA ' HD13 ' A' ' 31' ' ' ILE . 27.7 mm -70.07 -45.93 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 109.068 -0.716 . . . . 2.1299999999999999 109.068 178.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.614 ' HG ' ' HB2' ' A' ' 36' ' ' CYS . 1.1 tt -56.31 -47.34 78.9 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.727 -0.608 . . . . 3.2400000000000002 109.625 178.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -68.73 -43.13 76.92 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.85 -1.3 . . . . 1.99 109.85 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 2.5 t -56.45 -51.49 68.23 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.485 -1.009 . . . . 2.1600000000000001 110.19 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.424 ' CH2' ' HA ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER -168.72 57.62 0.05 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.379 -0.826 . . . . 2.3799999999999999 111.838 179.665 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.614 ' HB2' ' HG ' ' A' ' 32' ' ' LEU . 47.7 t -56.13 -35.43 67.09 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.077 -1.014 . . . . 2.9500000000000002 109.906 178.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -123.6 164.4 19.11 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.726 -0.608 . . . . 4.2999999999999998 109.366 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.424 ' HA ' ' CH2' ' A' ' 35' ' ' TRP . 0.8 OUTLIER -68.49 1.46 3.06 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.975 -1.078 . . . . 2.9399999999999999 111.834 179.931 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.13 9.25 12.6 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.747 -1.221 . . . . 2.2999999999999998 111.074 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -77.06 157.18 31.25 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.851 -1.156 . . . . 2.0499999999999998 110.786 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 60.88 13.96 4.86 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 121.725 -0.609 . . . . 1.8999999999999999 111.515 -179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.41 ' HD3' ' HA ' ' A' ' 88' ' ' VAL . 1.7 tpm_? -145.19 -74.81 0.23 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.038 -1.039 . . . . 1.6399999999999999 109.562 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.632 ' HA ' ' HA ' ' A' ' 47' ' ' GLU 0.271 0.1 OUTLIER -89.24 -39.61 12.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 109.63 -0.508 . . . . 1.5900000000000001 109.63 179.873 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.402 ' N ' HG22 ' A' ' 43' ' ' ILE . 1.7 m 42.77 -97.24 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.222 0 O-C-N 122.016 -0.428 . . . . 2.1400000000000001 111.322 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.446 ' HG2' ' N ' ' A' ' 46' ' ' SER . 1.8 pt20 -120.7 -31.68 4.2 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.853 -1.154 . . . . 2.1600000000000001 111.226 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.446 ' N ' ' HG2' ' A' ' 45' ' ' GLN . 0.9 OUTLIER -145.61 46.75 1.28 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.284 -0.885 . . . . 1.0800000000000001 109.193 179.171 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.632 ' HA ' ' HA ' ' A' ' 43' ' ' ILE . 2.1 mm-40 64.8 -160.03 0.29 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.694 -0.629 . . . . 1.27 110.187 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.418 ' CB ' HD13 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -39.94 -46.58 2.07 Favored 'General case' 0 N--CA 1.51 2.552 0 O-C-N 121.378 -0.827 . . . . 1.4299999999999999 111.442 -179.086 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 51.2 -96.65 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.46 -0.775 . . . . 1.8 111.872 178.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -67.56 75.39 0.17 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.267 -0.895 . . . . 2.9199999999999999 110.88 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.1 t 177.72 -65.27 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.822 0.82 . . . . 2.1200000000000001 109.077 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.542 HD12 ' N ' ' A' ' 78' ' ' ALA . 5.6 pt -81.18 -37.83 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.648 -0.657 . . . . 1.9199999999999999 110.477 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.593 ' HB ' HG22 ' A' ' 74' ' ' VAL . 9.5 p -45.95 -36.28 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.683 -0.636 . . . . 2.2000000000000002 111.404 -179.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.64 -62.08 1.2 Allowed Glycine 0 N--CA 1.498 2.792 0 N-CA-C 109.231 -1.547 . . . . 2.7999999999999998 109.231 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -73.23 103.67 4.02 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.745 -0.856 . . . . 2.9100000000000001 109.767 179.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -172.88 37.42 0.14 Allowed Glycine 0 N--CA 1.497 2.746 0 N-CA-C 108.125 -1.99 . . . . 2.8199999999999998 108.125 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.4 -37.91 0.08 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 122.188 -0.595 . . . . 3.7000000000000002 110.698 -179.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.62 HG23 ' HD3' ' A' ' 59' ' ' LYS . 7.4 t -81.3 -148.06 0.06 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.192 -0.943 . . . . 3.7999999999999998 110.735 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.62 ' HD3' HG23 ' A' ' 58' ' ' THR . 0.0 OUTLIER -53.14 137.33 34.12 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.103 -0.998 . . . . 3.46 110.337 179.894 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -144.26 137.82 14.3 Favored Pre-proline 0 N--CA 1.499 2.017 0 O-C-N 121.169 -0.957 . . . . 3.1499999999999999 111.002 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.536 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 55.6 Cg_endo -82.74 -178.81 4.11 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 O-C-N 123.982 1.517 . . . . 3.04 110.407 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -55.41 155.45 5.25 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.136 -0.978 . . . . 4.7199999999999998 110.232 179.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.7 pp -51.88 -31.02 26.36 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 121.16 -0.963 . . . . 3.1299999999999999 111.203 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.527 ' O ' ' HB2' ' A' ' 68' ' ' SER . 0.0 OUTLIER -61.89 -58.53 7.6 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.304 -0.873 . . . . 3.5 109.402 178.563 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.536 ' HB ' ' HB2' ' A' ' 61' ' ' PRO . 16.1 t -66.43 -33.11 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 108.96 -0.755 . . . . 3.3199999999999998 108.96 178.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.476 ' O ' ' CG ' ' A' ' 70' ' ' LYS . 41.0 tt0 -57.77 -59.71 4.8 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.534 -0.913 . . . . 2.79 108.534 178.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -63.32 -35.43 80.34 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.359 -0.838 . . . . 2.3100000000000001 109.672 178.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.527 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 0.4 OUTLIER -61.75 -42.2 98.67 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.603 -0.686 . . . . 2.71 110.553 179.256 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.518 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -88.22 -41.18 13.12 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.063 -1.023 . . . . 2.7200000000000002 110.938 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.476 ' CG ' ' O ' ' A' ' 66' ' ' GLN . 5.4 mmtt -66.46 -42.01 88.21 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.651 -0.656 . . . . 2.3900000000000001 110.042 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -44.91 -62.64 2.89 Favored Glycine 0 N--CA 1.502 3.063 0 N-CA-C 110.142 -1.183 . . . . 1.5900000000000001 110.142 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -66.75 -37.8 19.86 Favored 'Trans proline' 0 C--N 1.314 -1.255 0 O-C-N 123.627 1.33 . . . . 2.2400000000000002 110.756 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.518 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 0.4 OUTLIER -66.21 -43.8 85.71 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.04 -1.038 . . . . 2.5899999999999999 109.8 179.075 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.593 HG22 ' HB ' ' A' ' 53' ' ' VAL . 47.3 t -70.72 -43.73 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.792 -0.568 . . . . 1.49 109.618 179.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -55.49 -43.11 75.31 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.57 0.7 . . . . 2.6200000000000001 109.89 178.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.425 ' HA ' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -68.92 -48.27 63.7 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.488 0.661 . . . . 2.8300000000000001 109.969 179.291 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.466 ' HD3' ' O ' ' A' ' 52' ' ' ILE . 67.4 mttt -60.08 -55.13 37.74 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.545 0.688 . . . . 2.1499999999999999 109.935 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.542 ' N ' HD12 ' A' ' 52' ' ' ILE . . . -53.37 -50.73 64.48 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 122.032 -0.417 . . . . 1.05 110.524 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.461 ' HB2' ' OD1' ' A' ' 84' ' ' ASN . 0.0 OUTLIER -67.87 -25.74 65.67 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.417 -0.802 . . . . 2.6299999999999999 110.714 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.442 ' N ' ' HG3' ' A' ' 79' ' ' LYS . 0.6 OUTLIER -80.54 -30.76 37.1 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.064 -1.022 . . . . 2.21 110.069 179.059 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.87 -47.26 8.0 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.529 -0.732 . . . . 2.6200000000000001 110.006 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.549 ' HB ' ' HD2' ' A' ' 83' ' ' PRO . 29.0 p -82.6 169.12 19.1 Favored Pre-proline 0 N--CA 1.499 2.024 0 O-C-N 121.525 -0.734 . . . . 1.48 109.503 179.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.549 ' HD2' ' HB ' ' A' ' 82' ' ' THR . 50.3 Cg_endo -76.25 6.01 4.21 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.42 1.221 . . . . 1.8 113.147 -178.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.461 ' OD1' ' HB2' ' A' ' 79' ' ' LYS . 0.1 OUTLIER 55.51 21.64 4.54 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 121.08 -1.013 . . . . 2.6200000000000001 111.287 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -158.09 -82.69 0.04 OUTLIER Glycine 0 N--CA 1.502 3.1 0 N-CA-C 109.09 -1.604 . . . . 2.1800000000000002 109.09 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.525 ' HD2' ' HB2' ' A' ' 83' ' ' PRO . 50.2 Cg_endo -72.72 -177.09 2.62 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 O-C-N 123.845 1.445 . . . . 2.5499999999999998 108.818 178.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.429 ' HB3' ' O ' ' A' ' 86' ' ' PRO . 0.5 OUTLIER 67.6 -60.0 0.4 Allowed 'General case' 0 N--CA 1.507 2.381 0 N-CA-C 108.266 -1.013 . . . . 2.3100000000000001 108.266 -177.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.497 ' N ' ' O ' ' A' ' 86' ' ' PRO . 87.4 t -82.83 -29.33 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 108.781 -0.822 . . . . 2.0800000000000001 108.781 177.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 69.8 m80 54.26 56.85 6.45 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.337 0.589 . . . . 3.1499999999999999 110.985 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.666 0 CA-C-O 118.059 -1.412 . . . . 2.3300000000000001 110.044 179.698 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 4' ' ' SER . . . . . . . . 0 N--CA 1.5 2.927 0 N-CA-C 110.198 -1.161 . . . . 3.5499999999999998 110.198 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.456 ' HB3' ' O ' ' A' ' 1' ' ' GLY . 40.8 t 58.15 -148.57 0.48 Allowed 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.386 -1.067 . . . . 4.2999999999999998 110.164 -179.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.527 ' O ' HD13 ' A' ' 5' ' ' ILE . 10.8 ptt? -54.01 -34.06 58.88 Favored 'General case' 0 N--CA 1.505 2.319 0 N-CA-C 108.231 -1.025 . . . . 3.5099999999999998 108.231 178.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.705 ' HB2' HG21 ' A' ' 12' ' ' THR . 7.5 t -82.49 53.42 2.32 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.196 -1.038 . . . . 3.0899999999999999 108.196 177.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.527 HD13 ' O ' ' A' ' 3' ' ' MET . 0.0 OUTLIER -25.95 -68.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.383 0 CA-C-O 121.366 0.603 . . . . 3.21 110.728 -178.47 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.615 ' HB3' ' HB3' ' A' ' 9' ' ' SER . 0.0 OUTLIER -102.16 98.54 8.69 Favored 'General case' 0 C--N 1.287 -2.133 0 C-N-CA 120.016 -0.673 . . . . 5.0800000000000001 109.207 178.195 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -58.43 -24.6 60.61 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.502 -0.925 . . . . 4.8099999999999996 108.502 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -86.02 34.85 0.62 Allowed 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.953 -0.758 . . . . 6.0999999999999996 108.953 176.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.615 ' HB3' ' HB3' ' A' ' 6' ' ' MET . 21.5 p -145.75 157.56 51.09 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 120.894 -1.129 . . . . 5.0800000000000001 110.547 -179.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.401 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 57.6 Cg_endo -80.82 15.91 1.72 Allowed 'Trans proline' 0 C--N 1.313 -1.29 0 O-C-N 123.528 1.278 . . . . 5.9000000000000004 111.144 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 15.8 p -62.59 -63.53 1.2 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.908 -1.12 . . . . 4.2800000000000002 109.869 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.705 HG21 ' HB2' ' A' ' 4' ' ' SER . 0.1 OUTLIER -62.42 -33.08 74.09 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.499 -0.751 . . . . 3.3599999999999999 110.281 179.317 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.63 -53.16 21.7 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 108.829 -1.708 . . . . 3.6800000000000002 108.829 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.401 ' HB ' ' O ' ' A' ' 10' ' ' PRO . 23.0 t -62.29 -36.79 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.684 -0.892 . . . . 4.6600000000000001 109.35 178.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.0 t -67.78 -43.26 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 120.981 -1.075 . . . . 3.2799999999999998 109.135 178.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.409 ' O ' HG12 ' A' ' 20' ' ' ILE . 63.3 m -59.56 -51.87 68.0 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.613 -0.679 . . . . 2.9100000000000001 109.954 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.623 ' HA ' HG12 ' A' ' 20' ' ' ILE . 31.2 m -64.42 -38.18 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 C-N-CA 119.505 -0.878 . . . . 3.7999999999999998 109.854 179.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.693 ' HA ' HD23 ' A' ' 21' ' ' LEU . 19.2 mt -65.21 -38.12 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 120.759 -1.213 . . . . 3.9500000000000002 109.253 178.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.6 t -67.49 -48.05 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.237 -0.914 . . . . 2.4500000000000002 109.584 178.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.623 HG12 ' HA ' ' A' ' 17' ' ' VAL . 3.3 pt -68.01 -34.87 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.886 -1.134 . . . . 3.1299999999999999 109.968 179.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.693 HD23 ' HA ' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -70.99 -42.65 69.38 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.815 -1.178 . . . . 3.5600000000000001 108.308 177.73 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.548 ' N ' ' HG ' ' A' ' 21' ' ' LEU . 13.1 mt -60.77 -43.77 96.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.111 -0.993 . . . . 3.0600000000000001 108.436 177.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.75 -46.38 85.56 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.608 -0.682 . . . . 1.9199999999999999 109.731 178.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.417 HD13 ' HA ' ' A' ' 24' ' ' ILE . 8.1 mm -59.49 -47.2 91.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.131 -0.981 . . . . 2.5099999999999998 109.005 178.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.27 -43.91 97.74 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.456 -0.778 . . . . 2.6899999999999999 109.591 178.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.18 -42.65 99.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.466 -0.771 . . . . 2.1499999999999999 109.274 178.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.2 tt -63.39 -46.38 86.69 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.678 -0.86 . . . . 1.8200000000000001 108.678 178.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.77 -45.04 95.44 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 108.692 -1.763 . . . . 1.9299999999999999 108.692 178.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.23 -44.03 93.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.507 -0.996 . . . . 2.6499999999999999 109.468 178.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.2 mt -58.73 -41.61 86.85 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.023 -0.732 . . . . 2.73 109.023 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 22.4 mm -68.93 -50.12 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.489 -0.757 . . . . 1.79 109.38 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.62 -43.07 79.83 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.567 -0.708 . . . . 3.1000000000000001 109.689 178.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -69.9 -39.18 75.51 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.491 -1.444 . . . . 2.8399999999999999 109.491 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 40.1 t -61.19 -47.8 84.48 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.389 -1.065 . . . . 2.4700000000000002 110.389 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.453 ' CG ' ' HB3' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -168.88 45.76 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.39 -0.819 . . . . 2.23 111.178 179.792 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.708 ' HB2' ' HG3' ' A' ' 49' ' ' GLU . 0.0 OUTLIER 57.74 -81.71 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.672 -0.643 . . . . 2.6099999999999999 111.772 179.53 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -153.06 -64.88 0.15 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.763 -1.211 . . . . 4.1600000000000001 111.587 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.476 ' HG ' ' OE2' ' A' ' 49' ' ' GLU . 0.7 OUTLIER -108.52 17.45 22.02 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.821 -1.175 . . . . 1.5600000000000001 111.368 -179.83 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.469 ' HG2' ' C ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER 29.93 50.93 0.08 Allowed 'General case' 0 N--CA 1.508 2.447 0 CA-C-O 121.45 0.643 . . . . 2.6200000000000001 112.5 179.799 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.434 HD13 ' H ' ' A' ' 45' ' ' GLN . 7.6 mt 42.57 48.36 4.64 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.251 0.548 . . . . 1.99 111.525 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -72.38 42.91 0.1 Allowed 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.149 -0.969 . . . . 2.4100000000000001 111.325 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.668 ' HG3' HG23 ' A' ' 43' ' ' ILE . 0.5 OUTLIER -141.88 -66.06 0.41 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.909 -1.119 . . . . 3.5 110.306 179.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.668 HG23 ' HG3' ' A' ' 42' ' ' ARG . 20.2 pt -101.44 -38.83 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.719 -0.613 . . . . 2.9300000000000002 109.847 179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.486 ' N ' HG13 ' A' ' 43' ' ' ILE . 1.4 t 75.45 110.02 0.07 Allowed 'General case' 0 N--CA 1.506 2.366 0 CA-C-O 121.537 0.684 . . . . 2.8700000000000001 111.081 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.434 ' H ' HD13 ' A' ' 40' ' ' LEU . 12.9 mt-30 -120.77 177.05 5.23 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.483 -0.76 . . . . 2.8799999999999999 110.195 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.73 -52.66 9.97 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.445 -0.784 . . . . 3.6699999999999999 110.711 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.447 ' O ' ' HB3' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -117.13 -175.6 2.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 3.0099999999999998 110.976 -179.655 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.507 ' HA ' ' HG3' ' A' ' 61' ' ' PRO . 20.2 t0 60.92 173.76 0.1 Allowed 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 121.954 0.883 . . . . 2.1600000000000001 111.547 179.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.708 ' HG3' ' HB2' ' A' ' 36' ' ' CYS . 0.7 OUTLIER -148.75 -60.18 0.23 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.344 -0.847 . . . . 1.6899999999999999 109.511 179.697 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -110.7 113.01 25.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.424 -0.797 . . . . 2.9300000000000002 110.221 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 78.6 p -158.9 -71.25 0.09 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.498 -0.751 . . . . 1.99 110.709 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.5 mt -50.16 -56.94 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 O-C-N 121.746 -0.596 . . . . 2.6299999999999999 110.903 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.2 p -85.6 -33.03 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 O-C-N 121.406 -0.809 . . . . 2.5899999999999999 111.094 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -109.23 65.32 0.25 Allowed Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.911 -1.276 . . . . 2.0600000000000001 109.911 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -92.08 -156.11 0.45 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.329 -1.101 . . . . 2.3900000000000001 110.267 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 137.76 -41.13 1.41 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 107.957 -2.057 . . . . 2.6899999999999999 107.957 -179.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.448 ' C ' HG22 ' A' ' 58' ' ' THR . 9.8 mt-10 -139.0 37.46 2.14 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 122.039 -0.683 . . . . 3.5699999999999998 109.645 178.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.448 HG22 ' C ' ' A' ' 57' ' ' GLU . 5.1 t 36.54 54.94 1.11 Allowed 'General case' 0 N--CA 1.511 2.597 0 CA-C-O 121.387 0.613 . . . . 2.0699999999999998 111.139 -178.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.437 ' O ' ' NZ ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -63.36 88.64 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.481 -0.762 . . . . 1.8500000000000001 110.607 -179.865 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.513 ' HB3' HD12 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -99.53 105.49 33.88 Favored Pre-proline 0 N--CA 1.494 1.737 0 CA-C-N 116.254 -0.43 . . . . 2.0600000000000001 110.212 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.507 ' HG3' ' HA ' ' A' ' 48' ' ' ASP . 44.6 Cg_endo -71.53 -34.48 9.33 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 O-C-N 123.773 1.407 . . . . 2.6499999999999999 110.949 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -61.7 -38.84 89.33 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.307 -0.871 . . . . 3.1800000000000002 110.646 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.513 HD12 ' HB3' ' A' ' 60' ' ' GLU . 3.6 mt -52.2 -37.59 55.33 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.479 -0.763 . . . . 2.2000000000000002 110.302 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.512 ' O ' ' HB2' ' A' ' 68' ' ' SER . 0.0 OUTLIER -61.33 -53.49 55.97 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.475 -0.565 . . . . 3.48 109.475 178.912 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.0 t -67.72 -31.59 53.04 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.461 -0.774 . . . . 2.4399999999999999 109.321 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.03 -51.54 69.63 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.911 -1.144 . . . . 2.3500000000000001 107.911 178.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -69.22 -43.69 73.56 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.329 0.585 . . . . 3.1299999999999999 109.646 178.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.512 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 0.4 OUTLIER -59.35 -37.93 79.09 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.957 -0.464 . . . . 2.7999999999999998 110.437 179.479 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.27 -43.74 13.48 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.046 -1.034 . . . . 1.6599999999999999 110.15 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 32.5 mtmt -63.81 -46.67 84.12 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.577 -0.702 . . . . 2.6099999999999999 110.635 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 75' ' ' GLU . . . -41.33 -64.87 1.23 Allowed Glycine 0 N--CA 1.506 3.334 0 N-CA-C 109.947 -1.261 . . . . 2.1000000000000001 109.947 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.573 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 42.5 Cg_endo -68.42 -41.31 6.74 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 O-C-N 123.956 1.503 . . . . 2.1000000000000001 110.083 178.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 35.1 t -58.33 -39.54 79.73 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.839 -1.163 . . . . 2.0600000000000001 109.94 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.543 ' HA ' ' HG2' ' A' ' 77' ' ' LYS . 24.1 t -74.92 -48.39 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.435 -0.791 . . . . 2.48 109.089 178.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.64 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 1.0 OUTLIER -54.63 -43.94 72.72 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.89 -0.724 . . . . 3.3700000000000001 109.178 178.349 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.573 ' HD2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -64.66 -48.62 74.11 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.581 -0.7 . . . . 3.1099999999999999 110.157 179.126 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.638 ' HG3' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -62.46 -32.66 73.58 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.073 -1.017 . . . . 3.3100000000000001 109.397 179.02 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.638 ' N ' ' HG3' ' A' ' 77' ' ' LYS . . . -72.2 -43.26 64.75 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.546 -0.721 . . . . 3.4300000000000002 109.171 178.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.935 ' HG3' HG11 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -68.45 -34.04 75.24 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.637 -0.665 . . . . 4.0 109.502 178.673 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.72 -32.62 62.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.567 -0.708 . . . . 4.0800000000000001 110.416 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 15.0 ttt -84.47 -44.18 13.89 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.429 -0.794 . . . . 4.8600000000000003 110.4 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.57 ' HB ' ' HD2' ' A' ' 83' ' ' PRO . 48.3 p -86.34 170.3 12.95 Favored Pre-proline 0 N--CA 1.503 2.224 0 O-C-N 121.468 -0.77 . . . . 4.2400000000000002 109.827 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.57 ' HD2' ' HB ' ' A' ' 82' ' ' THR . 46.5 Cg_endo -75.85 2.2 7.3 Favored 'Trans proline' 0 C--N 1.316 -1.148 0 O-C-N 123.251 1.132 . . . . 5.0 111.371 178.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.607 ' HB3' ' HD3' ' A' ' 79' ' ' LYS . 3.3 t-20 -73.26 39.13 0.09 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.199 -0.938 . . . . 4.6500000000000004 110.069 179.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 83' ' ' PRO . . . -70.9 -60.91 4.29 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.461 -1.056 . . . . 4.54 110.461 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -71.31 -34.22 10.13 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 O-C-N 123.731 1.385 . . . . 5.5700000000000003 111.535 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.455 ' CD ' ' HA ' ' A' ' 84' ' ' ASN . 1.5 mp0 -51.42 -40.35 59.17 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.408 -0.808 . . . . 5.5 109.48 179.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.935 HG11 ' HG3' ' A' ' 79' ' ' LYS . 4.2 p -103.14 -20.53 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.932 -0.48 . . . . 4.7699999999999996 110.505 178.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 60.21 54.83 3.86 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.523 -0.736 . . . . 6.46 111.26 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.534 0 CA-C-O 118.323 -1.265 . . . . 4.1100000000000003 110.205 178.966 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.641 0 N-CA-C 109.332 -1.507 . . . . 3.73 109.332 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.0 p -131.07 -41.55 1.12 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.571 -0.958 . . . . 3.2999999999999998 111.419 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.49 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 2.0 mmt -104.81 90.53 3.51 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.305 -0.872 . . . . 4.3399999999999999 110.561 -179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.8 p -51.57 -30.45 20.91 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.582 -0.699 . . . . 4.46 110.944 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.489 HD11 ' SD ' ' A' ' 3' ' ' MET . 0.6 OUTLIER -58.5 -40.1 77.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 CA-C-O 121.653 0.739 . . . . 4.3200000000000003 110.528 179.446 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.425 ' O ' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -140.98 -74.85 0.32 Allowed 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 116.258 -0.428 . . . . 2.7000000000000002 110.812 179.833 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.49 ' HB2' ' O ' ' A' ' 3' ' ' MET . 3.7 t70 65.72 -48.0 0.39 Allowed 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.489 -0.757 . . . . 2.8599999999999999 110.854 -179.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.514 ' O ' ' HB3' ' A' ' 9' ' ' SER . 0.1 OUTLIER -145.18 27.06 1.29 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.117 -0.989 . . . . 3.4700000000000002 110.058 179.393 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.514 ' HB3' ' O ' ' A' ' 8' ' ' HIS . 43.5 t 66.92 149.29 0.12 Allowed Pre-proline 0 N--CA 1.505 2.322 0 O-C-N 121.749 -0.594 . . . . 2.0800000000000001 111.076 -179.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.438 ' O ' HG22 ' A' ' 14' ' ' VAL . 42.9 Cg_endo -68.32 -24.41 37.36 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.679 1.357 . . . . 1.6899999999999999 110.12 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.1 p -61.12 -54.45 44.45 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.741 -0.599 . . . . 2.5699999999999998 109.898 179.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -59.44 -30.16 68.3 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.325 -0.859 . . . . 2.5099999999999998 110.339 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -70.37 -57.46 6.72 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.532 -1.427 . . . . 1.6100000000000001 109.532 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 10' ' ' PRO . 34.0 m -61.47 -32.6 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.418 -1.048 . . . . 1.98 110.171 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.1 t -70.31 -43.06 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 120.983 -1.073 . . . . 2.3799999999999999 109.264 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 54.9 m -58.95 -51.69 68.95 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.848 -0.532 . . . . 1.8500000000000001 109.879 179.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.454 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 27.0 m -64.66 -35.73 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.468 -0.77 . . . . 1.3700000000000001 110.116 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.587 HD13 HD23 ' A' ' 21' ' ' LEU . 7.0 mm -66.79 -43.88 89.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.013 -1.054 . . . . 2.1499999999999999 109.366 178.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.3 t -63.28 -42.22 95.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 108.72 -0.844 . . . . 2.2799999999999998 108.72 178.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 79.1 mt -64.5 -48.56 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.506 -0.746 . . . . 1.54 109.464 178.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.587 HD23 HD13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -62.27 -43.13 99.53 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.783 -0.821 . . . . 1.8600000000000001 108.783 178.818 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.553 ' N ' ' HG ' ' A' ' 21' ' ' LEU . 32.2 mt -59.49 -45.21 93.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.358 -0.839 . . . . 2.3399999999999999 109.101 178.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.87 -46.53 84.53 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.541 -0.725 . . . . 1.6799999999999999 109.836 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 55.6 mt -57.62 -46.81 86.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.511 -0.743 . . . . 1.4099999999999999 109.247 178.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.21 -45.72 87.01 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.543 -0.723 . . . . 1.8300000000000001 109.992 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.12 -46.04 89.35 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.44 -0.787 . . . . 1.98 108.97 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.541 ' O ' HG12 ' A' ' 31' ' ' ILE . 2.4 tt -61.69 -48.04 82.58 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.834 -0.802 . . . . 1.6100000000000001 108.834 178.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.502 ' O ' HG13 ' A' ' 31' ' ' ILE . . . -53.76 -39.23 61.05 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 109.623 -1.391 . . . . 1.6299999999999999 109.623 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.27 -41.93 47.29 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.233 -1.157 . . . . 2.0 109.517 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.417 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 1.6 mt -53.99 -45.88 71.57 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.148 0.499 . . . . 2.5800000000000001 109.685 178.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.772 HD11 HG21 ' A' ' 52' ' ' ILE . 1.3 pt -77.13 -43.95 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.416 -0.803 . . . . 1.5600000000000001 111.105 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.445 ' H ' HG13 ' A' ' 31' ' ' ILE . 1.3 tt -56.96 -45.42 82.87 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.047 -1.033 . . . . 2.5800000000000001 109.103 178.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.78 -55.65 21.22 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.532 -1.427 . . . . 2.1000000000000001 109.532 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.787 ' HB3' HD13 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -56.51 -36.76 69.55 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.272 -1.134 . . . . 2.1899999999999999 111.001 179.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.644 ' CH2' ' HG3' ' A' ' 41' ' ' GLN . 1.9 t90 -77.4 -50.97 11.6 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.333 -0.855 . . . . 1.6899999999999999 111.371 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 18.2 t -74.59 -25.96 59.61 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.481 -0.762 . . . . 2.4300000000000002 112.074 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -92.0 -50.39 5.72 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.902 -1.124 . . . . 3.2999999999999998 110.144 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.466 ' O ' ' CB ' ' A' ' 39' ' ' ARG . 7.0 tp -98.2 -70.24 0.73 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.312 -0.868 . . . . 2.1499999999999999 109.945 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.466 ' CB ' ' O ' ' A' ' 38' ' ' LEU . 0.0 OUTLIER 167.81 -57.49 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.53 -0.544 . . . . 1.8200000000000001 109.53 -179.773 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.787 HD13 ' HB3' ' A' ' 34' ' ' CYS . 6.8 tp 65.13 170.04 0.2 Allowed 'General case' 0 N--CA 1.505 2.294 0 CA-C-O 121.501 0.667 . . . . 1.9199999999999999 111.065 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.644 ' HG3' ' CH2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER 53.39 35.27 20.01 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.212 -0.93 . . . . 2.2200000000000002 110.75 -179.17 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.46 -48.78 7.36 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.347 -0.845 . . . . 1.98 109.679 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.279 0.4 OUTLIER -67.09 -16.13 20.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 CA-C-O 121.497 0.665 . . . . 2.7599999999999998 110.2 179.393 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.432 ' OG ' ' N ' ' A' ' 45' ' ' GLN . 17.7 t -99.82 -163.44 1.03 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.684 -0.635 . . . . 2.1099999999999999 110.573 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.432 ' N ' ' OG ' ' A' ' 44' ' ' SER . 52.9 mm-40 -118.7 178.04 4.62 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.204 -0.935 . . . . 3.1800000000000002 110.888 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.6 t 59.09 59.15 2.86 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.472 -0.768 . . . . 2.9700000000000002 110.902 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -74.46 153.96 38.93 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.423 -0.798 . . . . 2.4900000000000002 110.962 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -157.36 173.24 17.23 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.749 -0.595 . . . . 3.0499999999999998 110.415 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -65.35 -31.94 73.32 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.137 0.494 . . . . 3.02 110.48 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -154.52 -165.36 2.05 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.565 -0.709 . . . . 2.6099999999999999 109.911 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.594 ' HB3' ' CZ3' ' A' ' 35' ' ' TRP . 21.0 p -145.29 -53.92 0.29 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.223 -0.923 . . . . 3.3799999999999999 110.14 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.772 HG21 HD11 ' A' ' 31' ' ' ILE . 17.2 pt -79.09 -36.32 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.647 -0.658 . . . . 2.1200000000000001 109.937 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.56 HG12 ' N ' ' A' ' 54' ' ' GLY . 0.9 OUTLIER -68.12 -55.08 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.528 -0.733 . . . . 3.0899999999999999 109.453 179.228 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.56 ' N ' HG12 ' A' ' 53' ' ' VAL . . . 85.52 -57.65 4.9 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.339 -1.504 . . . . 2.6099999999999999 109.339 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.525 ' HB3' ' O ' ' A' ' 54' ' ' GLY . 19.1 t70 65.13 162.66 0.14 Allowed 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 122.193 0.997 . . . . 3.1499999999999999 111.557 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 57' ' ' GLU . . . -133.59 45.7 1.1 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 106.557 -2.617 . . . . 3.6299999999999999 106.557 178.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.43 ' HB2' ' O ' ' A' ' 56' ' ' GLY . 10.3 mm-40 63.76 36.54 10.49 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.787 0.803 . . . . 3.8700000000000001 109.875 -177.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.65 47.4 1.18 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.439 -0.788 . . . . 4.6799999999999997 109.857 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.484 ' HG2' ' HD3' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -150.0 -174.6 4.76 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.033 -1.042 . . . . 3.3900000000000001 110.872 -179.436 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.736 ' HB3' HG22 ' A' ' 65' ' ' VAL . 5.4 mt-10 -123.99 74.57 57.41 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.335 -0.853 . . . . 3.3900000000000001 110.563 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.484 ' HD3' ' HG2' ' A' ' 59' ' ' LYS . 43.1 Cg_endo -75.14 -46.44 0.23 Allowed 'Trans proline' 0 N--CA 1.486 1.074 0 O-C-N 123.773 1.407 . . . . 2.6099999999999999 111.941 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -165.51 -67.35 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.864 -1.148 . . . . 3.1699999999999999 111.485 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.5 mt -58.36 -47.18 84.65 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.438 -0.789 . . . . 2.71 110.293 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.452 ' O ' ' HB3' ' A' ' 68' ' ' SER . 0.2 OUTLIER -59.22 -39.24 82.06 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.403 -0.592 . . . . 3.2999999999999998 109.403 178.838 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.736 HG22 ' HB3' ' A' ' 60' ' ' GLU . 5.4 t -67.76 -43.91 86.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 N-CA-C 108.646 -0.872 . . . . 2.3500000000000001 108.646 177.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.501 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 1.7 tt0 -55.9 -44.81 78.57 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.735 -0.603 . . . . 2.4300000000000002 109.534 179.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.473 ' HA ' ' HE3' ' A' ' 70' ' ' LYS . 11.1 m-85 -74.38 -49.41 22.78 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.562 -0.711 . . . . 2.5600000000000001 111.006 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.452 ' HB3' ' O ' ' A' ' 64' ' ' LEU . 0.8 OUTLIER -63.07 -34.19 77.07 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.378 -0.826 . . . . 2.4100000000000001 110.62 -179.923 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -79.59 -43.47 22.88 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.025 -1.047 . . . . 1.8300000000000001 110.078 179.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.501 ' HB3' ' O ' ' A' ' 66' ' ' GLN . 12.7 ptpt -68.82 -31.73 70.92 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.428 -0.795 . . . . 2.0600000000000001 110.801 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.406 ' N ' ' HD2' ' A' ' 72' ' ' PRO . . . -47.6 -63.93 3.17 Favored Glycine 0 N--CA 1.5 2.949 0 N-CA-C 109.228 -1.549 . . . . 1.53 109.228 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.531 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 41.5 Cg_endo -68.44 -41.1 6.96 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.886 1.466 . . . . 2.0800000000000001 109.666 178.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 4.1 t -55.75 -43.81 77.0 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.013 -1.054 . . . . 2.2000000000000002 109.236 178.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 37.9 t -74.5 -45.09 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.504 -0.747 . . . . 1.55 109.351 178.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -53.57 -43.21 68.31 Favored 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.708 0.766 . . . . 2.3799999999999999 109.189 178.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.531 ' HD2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -71.06 -44.75 65.12 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.391 -0.596 . . . . 3.3700000000000001 109.391 178.663 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.84 -40.28 79.69 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 120.223 -0.591 . . . . 2.98 110.231 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.65 -41.24 60.69 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.041 0.448 . . . . 2.21 110.322 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.496 ' HD3' HG23 ' A' ' 88' ' ' VAL . 4.2 mttp -65.52 -43.86 88.7 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 121.504 0.669 . . . . 2.6800000000000002 109.325 179.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.87 -42.31 85.82 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.687 -0.633 . . . . 3.6499999999999999 109.974 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 8.1 ttt -69.5 -44.99 69.96 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.439 0.637 . . . . 4.3399999999999999 110.093 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.62 103.37 40.92 Favored Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.652 -0.655 . . . . 2.98 109.375 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -73.17 15.87 0.47 Allowed 'Trans proline' 0 N--CA 1.492 1.418 0 O-C-N 123.706 1.372 . . . . 3.3399999999999999 112.685 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -73.68 50.16 0.33 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.552 -1.343 . . . . 3.0099999999999998 110.023 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -162.37 160.44 32.65 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.76 -1.336 . . . . 2.96 109.76 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.449 ' O ' ' CB ' ' A' ' 87' ' ' GLU . 49.5 Cg_endo -72.01 -172.29 0.82 Allowed 'Trans proline' 0 C--N 1.31 -1.473 0 O-C-N 123.69 1.363 . . . . 3.3500000000000001 111.165 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.449 ' CB ' ' O ' ' A' ' 86' ' ' PRO . 3.7 tt0 72.78 -58.73 0.59 Allowed 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 108.605 -0.887 . . . . 4.0 108.605 -178.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.503 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 92.4 t -85.51 -35.94 10.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 108.739 -0.838 . . . . 4.1100000000000003 108.739 177.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.503 ' HB2' ' O ' ' A' ' 88' ' ' VAL . 67.6 m80 64.16 -59.75 0.2 Allowed 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.895 -0.503 . . . . 4.46 111.808 178.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 88' ' ' VAL . . . . . . . . 0 N--CA 1.493 2.459 0 CA-C-O 117.895 -1.503 . . . . 4.9400000000000004 109.786 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.705 0 N-CA-C 109.904 -1.278 . . . . 2.8500000000000001 109.904 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 56.26 56.69 5.56 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.589 -0.947 . . . . 3.98 109.936 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.612 ' SD ' ' HB3' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -141.54 170.09 16.37 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.31 -0.869 . . . . 2.5499999999999998 111.137 -179.155 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.2 p -88.31 -28.51 21.0 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.525 -0.734 . . . . 2.5699999999999998 110.617 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -85.19 -144.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.326 -0.859 . . . . 1.8999999999999999 110.96 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.537 ' O ' ' HB3' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -87.77 -73.34 0.49 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.19 -0.944 . . . . 2.4300000000000002 111.101 -179.626 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.612 ' HB3' ' SD ' ' A' ' 3' ' ' MET . 1.2 t70 65.0 -52.88 0.33 Allowed 'General case' 0 N--CA 1.51 2.556 0 O-C-N 121.625 -0.672 . . . . 1.77 110.203 -179.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.468 ' N ' ' O ' ' A' ' 6' ' ' MET . 0.8 OUTLIER -91.09 46.05 1.29 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.191 -0.943 . . . . 1.95 110.039 179.201 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.6 t -159.83 143.89 10.77 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.203 -0.935 . . . . 1.4299999999999999 110.254 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.24 -17.56 50.08 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 O-C-N 124.029 1.541 . . . . 2.1299999999999999 111.502 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.9 t -66.25 -29.94 70.28 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.145 -0.972 . . . . 1.76 109.954 179.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.9 m -51.26 -35.31 36.6 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.586 -0.696 . . . . 1.1200000000000001 110.36 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.448 ' O ' HG22 ' A' ' 17' ' ' VAL . . . -72.34 -53.3 9.02 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 108.952 -1.659 . . . . 1.3700000000000001 108.952 179.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.583 ' O ' HG23 ' A' ' 18' ' ' ILE . 61.5 t -55.81 -39.17 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.868 -0.784 . . . . 2.0899999999999999 109.529 178.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.64 ' HA ' HG12 ' A' ' 18' ' ' ILE . 43.6 t -71.11 -41.39 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.309 -0.869 . . . . 1.3500000000000001 109.707 179.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.419 ' O ' HG12 ' A' ' 20' ' ' ILE . 50.2 m -59.81 -46.63 88.64 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.525 -0.734 . . . . 1.0600000000000001 109.92 179.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.547 ' HA ' HG12 ' A' ' 20' ' ' ILE . 35.7 m -68.9 -42.67 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.436 -0.79 . . . . 1.6000000000000001 111.312 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.64 HG12 ' HA ' ' A' ' 15' ' ' VAL . 15.6 pt -65.42 -31.64 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 120.166 -1.584 . . . . 1.79 109.608 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.459 ' N ' HG13 ' A' ' 18' ' ' ILE . 21.2 t -70.06 -48.88 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.476 -0.765 . . . . 1.1399999999999999 109.342 178.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.547 HG12 ' HA ' ' A' ' 17' ' ' VAL . 2.5 pt -68.22 -31.35 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 120.638 -1.289 . . . . 1.4299999999999999 108.847 178.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.473 ' N ' HG13 ' A' ' 20' ' ' ILE . 10.0 mt -66.66 -52.33 46.08 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.334 -0.854 . . . . 1.78 109.24 177.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.549 HG23 ' O ' ' A' ' 18' ' ' ILE . 30.9 pt -59.53 -42.38 87.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 C-N-CA 118.851 -1.139 . . . . 1.6899999999999999 109.288 178.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.455 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -61.03 -46.8 89.24 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 120.294 -0.562 . . . . 1.1000000000000001 109.707 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.413 HD13 ' HA ' ' A' ' 24' ' ' ILE . 6.1 mm -60.51 -45.53 96.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.256 -0.902 . . . . 1.1799999999999999 108.952 178.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.38 -43.95 97.99 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.563 -0.711 . . . . 1.49 109.666 178.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.81 -44.31 96.51 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.116 -0.698 . . . . 1.49 109.116 178.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.05 -44.53 96.49 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.806 -0.813 . . . . 1.29 108.806 178.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.69 -45.9 94.93 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 108.756 -1.738 . . . . 1.0700000000000001 108.756 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.99 -43.63 95.1 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.502 -0.999 . . . . 1.5700000000000001 109.821 178.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.457 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 7.4 mt -58.27 -41.61 84.7 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.063 -0.717 . . . . 1.99 109.063 178.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 59.9 mt -70.07 -48.26 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.465 -0.772 . . . . 1.0600000000000001 109.411 178.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.12 -48.83 77.69 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.429 -0.795 . . . . 2.1200000000000001 110.255 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.01 -46.8 93.32 Favored Glycine 0 N--CA 1.499 2.836 0 N-CA-C 109.577 -1.409 . . . . 1.47 109.577 179.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.873 ' HB3' HD12 ' A' ' 40' ' ' LEU . 0.8 OUTLIER -63.81 -31.63 72.87 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.329 -1.101 . . . . 2.0600000000000001 110.588 179.564 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.487 ' HZ3' HG23 ' A' ' 53' ' ' VAL . 6.7 m0 -81.58 -59.7 2.52 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.105 -0.997 . . . . 1.1899999999999999 110.059 179.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.46 ' HB3' ' H ' ' A' ' 37' ' ' TYR . 0.1 OUTLIER 36.75 -95.36 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.415 0 N-CA-C 112.212 0.449 . . . . 1.49 112.212 179.833 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.46 ' H ' ' HB3' ' A' ' 36' ' ' CYS . 0.2 OUTLIER -117.54 -1.6 11.65 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.582 -1.324 . . . . 3.3900000000000001 111.102 179.833 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -111.87 -11.8 13.87 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.948 -1.095 . . . . 1.3300000000000001 111.159 179.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.499 ' HD2' ' CE1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER 49.55 44.78 24.36 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.095 -1.003 . . . . 1.1899999999999999 109.981 -179.479 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.873 HD12 ' HB3' ' A' ' 34' ' ' CYS . 0.1 OUTLIER 44.75 39.37 3.41 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.801 -0.562 . . . . 1.75 111.298 -179.619 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.428 ' O ' ' NZ ' ' A' ' 70' ' ' LYS . 9.7 pt20 -81.49 37.51 0.46 Allowed 'General case' 0 N--CA 1.502 2.163 0 O-C-N 120.927 -1.108 . . . . 1.3300000000000001 111.627 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.57 -63.44 1.25 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.693 -1.254 . . . . 2.73 109.138 178.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.476 HG13 ' N ' ' A' ' 44' ' ' SER . 9.3 pt -59.3 -35.33 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-O 121.556 0.693 . . . . 1.6799999999999999 110.286 178.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.476 ' N ' HG13 ' A' ' 43' ' ' ILE . 1.8 t 68.18 64.38 0.36 Allowed 'General case' 0 N--CA 1.504 2.26 0 CA-C-O 121.527 0.68 . . . . 1.25 110.76 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.406 ' HG2' ' N ' ' A' ' 46' ' ' SER . 11.1 pm0 -68.69 -19.93 64.4 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.515 -0.741 . . . . 1.6000000000000001 111.279 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.406 ' N ' ' HG2' ' A' ' 45' ' ' GLN . 0.3 OUTLIER 54.08 52.26 13.09 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.251 -0.906 . . . . 2.1200000000000001 110.928 179.843 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.18 169.63 17.19 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.469 -0.769 . . . . 1.9199999999999999 110.996 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.9 -42.58 3.55 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.215 -0.928 . . . . 2.7200000000000002 110.879 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.01 161.76 29.17 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.008 -1.057 . . . . 4.1600000000000001 111.224 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.406 ' HG2' ' CZ ' ' A' ' 62' ' ' PHE . 1.6 tm-20 -153.8 147.36 25.08 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.539 -0.726 . . . . 2.3700000000000001 109.354 179.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.1 m -162.12 21.36 0.1 Allowed 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.108 -0.995 . . . . 2.7400000000000002 111.302 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.2 mt -121.04 -43.71 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.568 -0.901 . . . . 2.6299999999999999 108.568 179.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.487 HG23 ' HZ3' ' A' ' 35' ' ' TRP . 38.0 t -86.69 -63.45 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-O 121.427 0.632 . . . . 1.9199999999999999 109.389 178.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.65 -52.89 3.37 Favored Glycine 0 N--CA 1.499 2.834 0 N-CA-C 109.713 -1.355 . . . . 1.6599999999999999 109.713 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.0 t70 62.53 -155.59 0.34 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 122.05 -0.677 . . . . 1.6000000000000001 111.016 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.87 -42.52 0.59 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 108.348 -1.901 . . . . 1.55 108.348 -179.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -112.48 -39.46 4.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.58 -0.953 . . . . 2.4399999999999999 111.311 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.556 ' O ' ' HB2' ' A' ' 59' ' ' LYS . 0.2 OUTLIER -57.55 -40.68 79.42 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 120.832 -1.168 . . . . 1.6100000000000001 109.825 179.602 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.556 ' HB2' ' O ' ' A' ' 58' ' ' THR . 2.2 mttt 68.19 120.66 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 CA-C-O 121.602 0.715 . . . . 1.78 111.048 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.546 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 1.1 mp0 46.59 57.8 16.85 Favored Pre-proline 0 N--CA 1.499 1.995 0 O-C-N 121.587 -0.696 . . . . 1.5 111.433 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.54 ' O ' HG12 ' A' ' 65' ' ' VAL . 41.2 Cg_endo -65.85 -29.63 49.93 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 O-C-N 123.524 1.276 . . . . 1.01 111.578 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.499 ' CE1' ' HD2' ' A' ' 39' ' ' ARG . 3.3 m-30 -60.88 -66.41 0.54 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.459 -0.775 . . . . 1.2 110.965 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.591 ' HA ' ' HB2' ' A' ' 66' ' ' GLN . 2.5 pp -65.49 -28.16 69.0 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.493 -0.754 . . . . 1.24 111.0 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.546 ' HB2' ' O ' ' A' ' 60' ' ' GLU . 0.5 OUTLIER -58.08 -57.13 14.2 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.332 -0.855 . . . . 1.5800000000000001 109.692 179.321 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.54 HG12 ' O ' ' A' ' 61' ' ' PRO . 9.0 p -73.51 -29.52 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 C-N-CA 119.387 -0.925 . . . . 0.79000000000000004 109.877 178.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.591 ' HB2' ' HA ' ' A' ' 63' ' ' LEU . 1.8 mm100 -59.36 -49.8 76.41 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.245 -1.02 . . . . 1.04 108.245 177.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -71.37 -47.03 58.82 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.604 -0.685 . . . . 4.3799999999999999 109.841 178.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.528 ' HB2' ' HA ' ' A' ' 65' ' ' VAL . 65.0 m -54.56 -46.8 73.72 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.933 -0.479 . . . . 1.0700000000000001 110.211 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.536 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -72.41 -57.58 4.07 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.202 -0.936 . . . . 0.83999999999999997 111.308 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.539 ' HD2' ' N ' ' A' ' 70' ' ' LYS . 3.8 mptt -52.71 -60.49 3.19 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.432 -0.793 . . . . 0.95999999999999996 112.914 -179.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 70' ' ' LYS . . . -31.74 -67.44 0.15 Allowed Glycine 0 N--CA 1.51 3.597 0 N-CA-C 111.55 -0.62 . . . . 1.1499999999999999 111.55 -178.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.552 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 40.2 Cg_endo -66.28 -40.97 13.52 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.698 1.367 . . . . 1.1699999999999999 110.649 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.536 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -58.9 -42.95 90.79 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.825 -1.172 . . . . 1.5800000000000001 109.277 178.688 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 55.0 t -71.69 -45.04 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 109.327 -0.619 . . . . 1.3700000000000001 109.327 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 1.2 tm-20 -57.08 -42.2 80.22 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 119.855 -0.738 . . . . 1.72 109.427 178.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.552 ' HD2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -66.99 -50.15 63.17 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.5 -0.75 . . . . 1.7 109.703 178.889 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.38 -41.62 85.24 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 120.01 -0.676 . . . . 2.2400000000000002 109.595 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.449 ' O ' ' HD3' ' A' ' 83' ' ' PRO . . . -65.96 -49.03 69.34 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.97 -0.456 . . . . 1.76 109.918 179.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.05 -49.26 76.69 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.206 -0.934 . . . . 1.99 109.807 179.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 24.3 tp -59.27 -41.86 89.88 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.429 -0.795 . . . . 3.1800000000000002 111.393 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 5.4 ttt -81.6 -28.2 33.86 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.137 -0.977 . . . . 3.8300000000000001 110.227 179.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 90.4 m 57.49 79.55 0.32 Allowed Pre-proline 0 N--CA 1.502 2.144 0 O-C-N 121.786 -0.571 . . . . 2.0699999999999998 109.922 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 78' ' ' ALA . 43.4 Cg_endo -68.45 -1.34 7.21 Favored 'Trans proline' 0 N--CA 1.491 1.352 0 O-C-N 123.791 1.416 . . . . 2.5 111.871 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 57.45 23.3 8.91 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.32 -0.863 . . . . 3.6099999999999999 110.985 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.409 ' O ' ' ND1' ' A' ' 89' ' ' HIS . . . -92.59 -91.02 1.5 Allowed Glycine 0 N--CA 1.498 2.793 0 N-CA-C 109.255 -1.538 . . . . 2.3399999999999999 109.255 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.11 -25.52 19.12 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 O-C-N 123.954 1.502 . . . . 2.5499999999999998 110.659 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.0 mp0 -54.87 -38.53 67.61 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.71 -0.619 . . . . 3.0800000000000001 110.293 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.5 p -105.23 -15.98 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.271 -0.893 . . . . 4.0599999999999996 111.083 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.409 ' ND1' ' O ' ' A' ' 85' ' ' GLY . 41.4 m80 -94.2 -35.59 12.42 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.757 -1.214 . . . . 4.4400000000000004 110.931 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.417 0 CA-C-O 118.024 -1.431 . . . . 5.2199999999999998 109.848 -179.97 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.987 0 N-CA-C 110.067 -1.213 . . . . 4.9100000000000001 110.067 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.461 ' O ' HG13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -71.07 -172.73 0.73 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.477 -1.013 . . . . 3.8300000000000001 111.2 -179.752 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.448 ' N ' ' OG ' ' A' ' 2' ' ' SER . 3.7 ptt? -84.63 -27.02 27.46 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 120.963 -1.086 . . . . 3.9399999999999999 110.79 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.459 ' OG ' ' OG1' ' A' ' 11' ' ' THR . 0.3 OUTLIER -107.97 52.58 0.71 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.86 -1.15 . . . . 2.5800000000000001 109.964 178.982 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.527 HD11 ' CE1' ' A' ' 8' ' ' HIS . 1.5 pp -101.19 -164.93 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.619 -0.675 . . . . 3.27 110.388 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.481 ' HG3' ' C ' ' A' ' 5' ' ' ILE . 24.1 mtp -139.51 4.76 2.19 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.102 -0.999 . . . . 4.7400000000000002 111.467 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -65.06 -25.43 67.81 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.825 -1.172 . . . . 3.5699999999999998 110.855 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.527 ' CE1' HD11 ' A' ' 5' ' ' ILE . 27.6 p-80 -146.47 -9.05 0.49 Allowed 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.271 -0.893 . . . . 3.4300000000000002 112.758 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.3 123.25 6.41 Favored Pre-proline 0 N--CA 1.487 1.402 0 O-C-N 120.802 -1.186 . . . . 3.4399999999999999 109.66 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.85 82.0 1.81 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.754 1.397 . . . . 2.3700000000000001 110.295 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.459 ' OG1' ' OG ' ' A' ' 4' ' ' SER . 4.7 t -54.33 -39.12 66.77 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.055 -1.028 . . . . 2.0699999999999998 109.765 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 p -60.61 -40.8 93.21 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.151 -0.968 . . . . 2.5 109.367 177.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.518 ' O ' HG22 ' A' ' 17' ' ' VAL . . . -70.41 -50.82 24.58 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 108.902 -1.679 . . . . 1.6799999999999999 108.902 178.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.597 ' O ' HG12 ' A' ' 18' ' ' ILE . 39.9 t -56.48 -40.21 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.663 -0.904 . . . . 1.6799999999999999 109.109 178.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.628 ' HA ' HG12 ' A' ' 18' ' ' ILE . 34.2 t -70.73 -42.41 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.242 -0.912 . . . . 1.8400000000000001 108.963 178.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 54.2 m -58.16 -46.78 85.1 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.487 -0.758 . . . . 1.97 109.979 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.518 HG22 ' O ' ' A' ' 13' ' ' GLY . 35.8 m -70.16 -41.21 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.271 -0.893 . . . . 1.8400000000000001 111.188 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.628 HG12 ' HA ' ' A' ' 15' ' ' VAL . 4.8 pt -67.89 -33.92 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 120.163 -1.586 . . . . 1.8400000000000001 109.676 178.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.488 ' N ' HG13 ' A' ' 18' ' ' ILE . 20.8 t -67.7 -43.39 86.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 108.41 -0.959 . . . . 1.8799999999999999 108.41 177.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 87.5 mt -67.4 -40.24 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.117 -1.068 . . . . 2.0299999999999998 108.117 177.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.412 ' HB2' ' HA ' ' A' ' 18' ' ' ILE . 10.7 mt -60.8 -52.79 63.58 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.87 -0.519 . . . . 2.1600000000000001 109.817 178.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.545 HG12 ' O ' ' A' ' 18' ' ' ILE . 41.4 pt -59.9 -41.69 86.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 120.943 -1.098 . . . . 1.8799999999999999 109.697 179.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.483 ' N ' HG13 ' A' ' 22' ' ' ILE . . . -61.83 -45.76 92.43 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 120.146 -0.622 . . . . 1.9299999999999999 109.594 178.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.418 ' HA ' HD13 ' A' ' 24' ' ' ILE . 15.8 mm -61.97 -44.5 99.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.313 -0.867 . . . . 2.3199999999999998 108.758 178.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.74 -44.66 96.48 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.544 -0.722 . . . . 2.0299999999999998 109.645 178.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.01 -46.96 88.66 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.972 -0.751 . . . . 2.0299999999999998 108.972 178.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.1 tt -59.78 -45.89 90.88 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.808 -0.812 . . . . 2.5800000000000001 108.808 178.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.07 -45.33 94.01 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 108.937 -1.665 . . . . 2.21 108.937 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.55 -44.03 95.36 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.451 -1.029 . . . . 2.1099999999999999 109.967 179.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.1 mt -59.67 -41.32 90.35 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.089 -0.708 . . . . 2.4300000000000002 109.089 178.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 24.7 mm -68.34 -48.15 74.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.65 -0.656 . . . . 2.6400000000000001 109.374 178.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.17 -48.1 81.35 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.447 -0.783 . . . . 2.5800000000000001 110.052 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.07 -47.5 90.88 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 109.816 -1.314 . . . . 2.23 109.816 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 17.9 t -61.99 -43.38 98.96 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.633 -0.922 . . . . 2.6899999999999999 109.994 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -66.48 -47.0 74.43 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.398 -0.814 . . . . 3.02 109.63 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.5 t -149.01 108.02 3.89 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.418 -0.801 . . . . 2.5499999999999998 108.935 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.524 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -47.2 121.56 3.88 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.448 -0.782 . . . . 3.0600000000000001 110.921 -178.772 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.572 HD21 ' HA ' ' A' ' 44' ' ' SER . 0.3 OUTLIER 42.0 28.41 0.1 Allowed 'General case' 0 N--CA 1.503 2.219 0 CA-C-O 121.245 0.545 . . . . 2.5800000000000001 111.393 -178.794 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.89 28.58 12.73 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.52 -0.738 . . . . 4.2199999999999998 111.44 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.419 ' HG ' ' OG ' ' A' ' 44' ' ' SER . 0.1 OUTLIER 48.15 46.1 19.69 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.366 -0.834 . . . . 2.98 110.564 -179.815 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -104.05 10.78 35.89 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.225 -0.922 . . . . 3.7400000000000002 111.886 -179.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.84 -142.35 0.1 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.635 -1.29 . . . . 4.3300000000000001 109.649 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.417 ' O ' ' HB3' ' A' ' 44' ' ' SER . 0.8 OUTLIER -47.49 -36.62 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 121.089 -1.007 . . . . 3.0099999999999998 110.904 179.399 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.572 ' HA ' HD21 ' A' ' 38' ' ' LEU . 8.6 t 66.31 -57.35 0.37 Allowed 'General case' 0 N--CA 1.504 2.235 0 O-C-N 122.111 -0.368 . . . . 1.95 111.281 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.676 ' HA ' ' CZ ' ' A' ' 67' ' ' TYR . 74.3 mt-30 -70.37 96.84 1.18 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.126 -0.984 . . . . 2.1899999999999999 110.221 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 45.9 t -108.14 -79.6 0.58 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.44 -0.787 . . . . 2.3799999999999999 108.955 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.889 ' HB2' HD13 ' A' ' 63' ' ' LEU . 1.2 mp0 -83.21 162.09 21.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.092 -1.005 . . . . 2.2999999999999998 109.155 178.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.681 ' HB2' ' HB2' ' A' ' 63' ' ' LEU . 5.0 m-20 65.29 130.46 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.324 0 CA-C-O 121.65 0.738 . . . . 1.95 109.909 -179.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -113.75 129.23 56.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.943 -1.098 . . . . 2.52 111.336 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.705 ' HB3' ' HG ' ' A' ' 64' ' ' LEU . 1.0 OUTLIER -133.88 28.21 3.88 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.31 -0.869 . . . . 2.25 111.104 179.357 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.9 p -133.13 -49.12 0.86 Allowed 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.997 -1.064 . . . . 3.1000000000000001 111.518 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.7 mm -83.96 -53.68 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.583 -0.698 . . . . 3.4700000000000002 110.436 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 55' ' ' ASP . 8.6 p -112.69 -35.91 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.294 -0.879 . . . . 2.8399999999999999 111.087 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.694 ' HA2' ' HA ' ' A' ' 50' ' ' GLU . . . 73.09 -71.41 1.18 Allowed Glycine 0 N--CA 1.498 2.827 0 N-CA-C 109.923 -1.271 . . . . 2.3599999999999999 109.923 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.556 ' O ' HG22 ' A' ' 53' ' ' VAL . 3.1 t0 -120.43 -174.22 2.75 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.271 -1.135 . . . . 2.7999999999999998 110.637 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 131.41 -65.72 0.59 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 107.157 -2.377 . . . . 2.6499999999999999 107.157 -179.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.455 ' HA ' ' NZ ' ' A' ' 59' ' ' LYS . 2.9 mm-40 -128.12 -1.36 5.8 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.937 -0.743 . . . . 3.0699999999999998 110.835 177.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.459 ' O ' ' HD3' ' A' ' 61' ' ' PRO . 0.1 OUTLIER -76.43 59.96 1.52 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.909 -1.119 . . . . 2.1200000000000001 109.722 179.204 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.455 ' NZ ' ' HA ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -66.91 135.33 53.68 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.277 -0.889 . . . . 3.1099999999999999 109.81 179.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 45.86 58.64 15.7 Favored Pre-proline 0 N--CA 1.502 2.17 0 O-C-N 121.557 -0.714 . . . . 4.0499999999999998 110.557 -179.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 58' ' ' THR . 43.8 Cg_endo -74.17 159.55 43.9 Favored 'Trans proline' 0 N--CA 1.49 1.268 0 O-C-N 123.765 1.403 . . . . 2.1800000000000002 111.508 -179.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -127.35 -56.27 1.32 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.515 -0.741 . . . . 3.8100000000000001 109.931 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.889 HD13 ' HB2' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -61.49 -31.57 71.56 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.316 -0.865 . . . . 1.6799999999999999 108.882 178.297 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.705 ' HG ' ' HB3' ' A' ' 50' ' ' GLU . 5.6 tt -54.89 -54.72 38.9 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.125 -0.694 . . . . 2.0 109.125 178.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.2 t -65.3 -32.92 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.316 -0.865 . . . . 2.04 108.763 178.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.448 ' HB2' ' HA ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -59.58 -49.4 77.91 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.81 -0.811 . . . . 2.4100000000000001 108.81 178.609 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.676 ' CZ ' ' HA ' ' A' ' 45' ' ' GLN . 10.8 m-85 -62.32 -52.62 62.94 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 108.477 -0.934 . . . . 1.3799999999999999 108.477 177.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.42 ' O ' ' CD ' ' A' ' 72' ' ' PRO . 2.4 m -53.72 -38.41 64.29 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-N 115.808 -0.633 . . . . 1.8500000000000001 111.388 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.36 -41.56 18.05 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.012 -1.055 . . . . 1.8100000000000001 110.969 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.0 mmtp -67.24 -45.78 75.71 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.419 -0.801 . . . . 2.52 111.12 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.409 ' N ' ' HD2' ' A' ' 72' ' ' PRO . . . -43.25 -62.65 2.34 Favored Glycine 0 N--CA 1.506 3.33 0 N-CA-C 110.614 -0.994 . . . . 1.52 110.614 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.556 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 40.8 Cg_endo -66.92 -43.92 6.14 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 O-C-N 123.729 1.384 . . . . 1.8700000000000001 110.03 179.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 31.5 t -54.52 -43.05 71.54 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.935 -1.103 . . . . 2.4700000000000002 109.745 178.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 37.5 t -73.62 -47.0 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.555 -0.716 . . . . 1.9099999999999999 109.552 178.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -54.1 -41.4 68.23 Favored 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 121.58 0.705 . . . . 2.0 109.641 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.556 ' HD2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -69.88 -49.14 55.25 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.832 -0.543 . . . . 2.8999999999999999 110.637 179.496 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.579 ' HG3' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -63.99 -29.3 70.47 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.112 -0.992 . . . . 2.3999999999999999 110.075 179.292 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.579 ' N ' ' HG3' ' A' ' 77' ' ' LYS . . . -75.4 -44.41 44.8 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.283 -0.886 . . . . 2.0800000000000001 109.415 179.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.0 mttt -68.8 -40.59 79.5 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.32 0.581 . . . . 2.25 109.494 178.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.13 -47.6 79.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.587 -0.696 . . . . 2.98 110.021 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 12.5 ttt -69.65 -49.87 49.53 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.444 -0.785 . . . . 4.1100000000000003 110.363 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.6 85.59 38.62 Favored Pre-proline 0 N--CA 1.499 1.981 0 O-C-N 121.485 -0.76 . . . . 2.71 109.334 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.661 ' CB ' HG11 ' A' ' 88' ' ' VAL . 45.3 Cg_endo -69.84 -30.91 21.16 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 O-C-N 123.865 1.455 . . . . 2.52 112.605 -178.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.5 t30 68.44 -51.98 0.55 Allowed 'General case' 0 N--CA 1.507 2.394 0 O-C-N 121.679 -0.638 . . . . 3.0600000000000001 110.813 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 174.09 -113.75 0.48 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.594 -1.402 . . . . 2.5499999999999998 109.594 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.89 -17.33 25.5 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.847 1.446 . . . . 3.3199999999999998 111.638 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -54.05 -32.28 54.06 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.326 -0.859 . . . . 3.21 111.175 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.661 HG11 ' CB ' ' A' ' 83' ' ' PRO . 7.5 p -98.97 -26.93 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.707 -0.621 . . . . 3.1499999999999999 111.427 -179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -94.31 60.28 2.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.308 -0.87 . . . . 4.2300000000000004 110.402 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.502 3.091 0 N-CA-C 109.511 -1.435 . . . . 7.0199999999999996 109.511 -179.871 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.821 0 N-CA-C 109.063 -1.615 . . . . 4.96 109.063 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.5 m 53.62 48.27 21.98 Favored 'General case' 0 N--CA 1.508 2.475 0 O-C-N 121.083 -1.245 . . . . 4.0099999999999998 111.12 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.446 ' O ' ' CB ' ' A' ' 4' ' ' SER . 24.0 mtp -121.11 176.76 5.43 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.06 -1.025 . . . . 3.6600000000000001 110.25 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.446 ' CB ' ' O ' ' A' ' 3' ' ' MET . 0.2 OUTLIER 71.77 -51.02 0.7 Allowed 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 121.181 0.515 . . . . 3.1200000000000001 110.538 -179.504 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -49.14 -43.93 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 CA-C-O 121.516 0.674 . . . . 2.3999999999999999 110.919 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.564 ' HG3' ' HG3' ' A' ' 81' ' ' MET . 0.0 OUTLIER -125.04 35.08 4.84 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.667 0.746 . . . . 2.6400000000000001 110.092 178.845 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -121.07 10.33 10.72 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.434 -0.791 . . . . 1.8300000000000001 110.004 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -103.1 52.77 0.78 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.584 -0.698 . . . . 3.96 110.519 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.42 ' HB3' HG13 ' A' ' 14' ' ' VAL . 0.4 OUTLIER -64.26 133.86 95.78 Favored Pre-proline 0 N--CA 1.5 2.043 0 O-C-N 121.098 -1.001 . . . . 2.1499999999999999 111.019 -179.707 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.96 157.68 57.42 Favored 'Trans proline' 0 C--N 1.316 -1.18 0 O-C-N 123.927 1.488 . . . . 2.5 110.758 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.418 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 11.4 t -53.23 -36.68 61.31 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.451 -0.78 . . . . 2.21 110.309 179.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 p -64.68 -35.16 80.15 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.068 -1.02 . . . . 2.3500000000000001 110.112 178.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.432 ' O ' HG22 ' A' ' 17' ' ' VAL . . . -69.78 -57.2 7.37 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.655 -1.378 . . . . 2.1400000000000001 109.655 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.42 HG13 ' HB3' ' A' ' 9' ' ' SER . 31.1 m -59.95 -34.11 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.501 -1.0 . . . . 2.1200000000000001 110.261 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.6 t -71.59 -42.37 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 120.98 -1.075 . . . . 1.8300000000000001 109.138 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.423 ' O ' HG12 ' A' ' 20' ' ' ILE . 53.2 m -58.97 -51.73 68.78 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.711 -0.618 . . . . 2.3199999999999998 109.771 179.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.643 ' HA ' HG12 ' A' ' 20' ' ' ILE . 35.0 m -64.02 -40.11 87.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.512 -0.743 . . . . 2.2400000000000002 109.91 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.73 HD13 HD23 ' A' ' 21' ' ' LEU . 8.9 mm -63.36 -42.73 97.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.009 -1.057 . . . . 1.77 109.393 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.606 ' O ' HG13 ' A' ' 22' ' ' ILE . 38.4 t -63.93 -43.39 97.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 C-N-CA 119.974 -0.69 . . . . 1.9199999999999999 110.173 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.647 ' O ' HG23 ' A' ' 24' ' ' ILE . 22.2 pt -72.51 -34.77 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 120.52 -1.363 . . . . 2.3999999999999999 109.45 178.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.73 HD23 HD13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -69.36 -45.69 68.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.23 -0.919 . . . . 1.74 109.428 178.55 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.606 HG13 ' O ' ' A' ' 19' ' ' VAL . 1.9 pp -63.73 -39.94 87.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 120.632 -1.293 . . . . 1.6000000000000001 109.146 178.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.26 -50.14 72.89 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.862 -0.523 . . . . 1.9299999999999999 110.768 179.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.647 HG23 ' O ' ' A' ' 20' ' ' ILE . 40.0 pt -63.99 -36.83 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 120.853 -1.155 . . . . 2.2200000000000002 109.155 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.505 ' N ' HG13 ' A' ' 24' ' ' ILE . . . -65.28 -44.64 87.39 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.046 -0.724 . . . . 1.6899999999999999 109.046 178.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.22 -44.6 94.81 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.753 -0.832 . . . . 1.8100000000000001 108.753 178.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.26 -45.12 95.83 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.894 -0.78 . . . . 2.6400000000000001 108.894 178.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.62 -44.7 97.54 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 108.753 -1.739 . . . . 1.9099999999999999 108.753 178.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.99 -41.64 97.45 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.492 -1.005 . . . . 1.8400000000000001 109.848 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.5 mt -60.68 -41.31 94.84 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.051 -0.722 . . . . 2.5099999999999998 109.051 178.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 69.4 mt -69.7 -48.15 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 109.002 -0.74 . . . . 2.5 109.002 178.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.95 -43.45 91.28 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.533 -0.729 . . . . 1.98 110.103 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.42 -50.56 49.12 Favored Glycine 0 N--CA 1.498 2.779 0 N-CA-C 109.342 -1.503 . . . . 2.29 109.342 179.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 18.4 t -60.53 -40.37 91.24 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.545 -0.974 . . . . 3.04 110.145 179.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.42 ' CD1' ' HA ' ' A' ' 39' ' ' ARG . 0.6 OUTLIER -71.89 -42.67 66.51 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.202 -0.936 . . . . 3.6000000000000001 109.548 179.28 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 45.6 t 53.7 -94.55 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.893 -0.505 . . . . 2.4700000000000002 111.209 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -111.54 -24.53 10.07 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.836 -1.165 . . . . 2.5800000000000001 112.235 -179.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.4 pp -73.91 7.43 2.6 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.042 -1.036 . . . . 2.8599999999999999 112.106 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.42 ' HA ' ' CD1' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -56.9 -30.15 63.68 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.119 -0.988 . . . . 2.7799999999999998 112.097 -179.7 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.464 ' O ' ' N ' ' A' ' 42' ' ' ARG . 1.4 mm? 50.79 -100.82 0.09 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.457 -0.777 . . . . 3.1200000000000001 110.433 -179.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.87 -50.33 0.33 Allowed 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.199 -0.938 . . . . 3.6299999999999999 111.09 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.464 ' N ' ' O ' ' A' ' 40' ' ' LEU . 3.1 ttm180 -155.44 -119.59 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.981 -1.075 . . . . 4.9199999999999999 108.691 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -65.42 -37.26 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.702 -1.249 . . . . 3.0 109.775 178.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.41 ' O ' ' NH2' ' A' ' 39' ' ' ARG . 5.5 t 69.79 -65.94 0.29 Allowed 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 109.764 -0.458 . . . . 2.6200000000000001 109.764 -179.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.65 100.33 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.389 -0.819 . . . . 3.0499999999999998 110.055 179.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 47' ' ' GLU . 6.6 p -148.12 -73.13 0.2 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.522 -0.736 . . . . 1.9199999999999999 109.694 -178.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 46' ' ' SER . 2.8 mp0 57.7 -167.98 0.13 Allowed 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.329 0.585 . . . . 2.3100000000000001 111.715 178.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.12 84.64 1.83 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.248 -0.907 . . . . 3.1299999999999999 110.154 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -127.96 173.26 10.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.988 -1.07 . . . . 2.1200000000000001 111.091 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.73 ' HG3' HG23 ' A' ' 58' ' ' THR . 21.9 tt0 -131.01 74.42 1.6 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.406 -0.809 . . . . 2.7000000000000002 110.528 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.414 ' OG ' HG13 ' A' ' 52' ' ' ILE . 4.9 p -169.99 -46.25 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.821 -1.174 . . . . 3.3700000000000001 111.565 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.414 HG13 ' OG ' ' A' ' 51' ' ' SER . 46.0 mt -104.48 -57.96 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.566 -0.708 . . . . 3.1200000000000001 110.418 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.4 p -95.27 -33.5 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.406 -0.808 . . . . 2.5699999999999998 109.89 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.691 ' HA3' HG22 ' A' ' 58' ' ' THR . . . -77.21 63.31 3.29 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.264 -1.534 . . . . 2.52 109.264 179.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -85.81 126.74 34.25 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.426 -1.043 . . . . 4.46 110.806 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.57 36.34 2.65 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 108.386 -1.885 . . . . 3.4300000000000002 108.386 -179.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.431 ' O ' ' NZ ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER 58.16 24.99 11.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.842 -0.799 . . . . 3.6699999999999999 109.877 -178.613 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.73 HG23 ' HG3' ' A' ' 50' ' ' GLU . 15.7 p 40.39 -112.57 0.14 Allowed 'General case' 0 N--CA 1.51 2.559 0 O-C-N 121.678 -0.639 . . . . 2.6299999999999999 111.026 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.474 ' N ' ' OG1' ' A' ' 58' ' ' THR . 0.0 OUTLIER 51.53 -166.24 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.335 -0.853 . . . . 3.4300000000000002 111.452 179.324 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.408 ' HA ' ' HD2' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -105.25 97.95 15.05 Favored Pre-proline 0 N--CA 1.487 1.397 0 O-C-N 121.28 -0.888 . . . . 3.0600000000000001 109.259 179.388 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.761 ' HB2' ' HB2' ' A' ' 64' ' ' LEU . 40.2 Cg_endo -66.68 -26.81 45.61 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 124.102 1.58 . . . . 2.6299999999999999 111.49 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.455 ' O ' ' HB2' ' A' ' 66' ' ' GLN . 58.6 t80 59.29 -73.04 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.64 -0.663 . . . . 3.3599999999999999 111.652 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.485 ' N ' ' O ' ' A' ' 61' ' ' PRO . 2.7 pp -63.13 -32.5 73.9 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.062 -1.024 . . . . 2.5299999999999998 111.26 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.761 ' HB2' ' HB2' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -63.28 -52.17 63.11 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.108 -0.995 . . . . 2.3599999999999999 109.584 179.333 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.7 m -71.44 -36.08 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.392 -0.817 . . . . 1.96 109.383 178.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.455 ' HB2' ' O ' ' A' ' 62' ' ' PHE . 5.2 tt0 -59.37 -48.39 81.83 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.419 -0.801 . . . . 1.96 109.264 178.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.491 ' HA ' ' HG2' ' A' ' 70' ' ' LYS . 2.6 m-85 -69.59 -43.64 72.4 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.579 -0.701 . . . . 2.2000000000000002 109.369 178.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 75.4 m -59.72 -32.43 70.53 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.951 -0.468 . . . . 1.9099999999999999 110.588 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.99 -44.26 11.14 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.144 -0.972 . . . . 1.73 110.4 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.491 ' HG2' ' HA ' ' A' ' 67' ' ' TYR . 10.6 ptpt -65.55 -35.8 81.91 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.466 -0.771 . . . . 1.72 111.02 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.417 ' N ' ' HD2' ' A' ' 72' ' ' PRO . . . -49.78 -62.96 4.51 Favored Glycine 0 N--CA 1.501 2.975 0 N-CA-C 109.723 -1.351 . . . . 1.6899999999999999 109.723 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 71' ' ' GLY . 40.4 Cg_endo -66.49 -33.71 36.19 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 123.79 1.416 . . . . 1.9399999999999999 110.348 178.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.449 ' HB3' ' HA ' ' A' ' 70' ' ' LYS . 15.1 t -67.42 -47.37 70.45 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.253 -0.904 . . . . 1.8500000000000001 109.939 178.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.7 t -66.48 -46.34 86.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.663 -0.648 . . . . 1.6200000000000001 109.301 178.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.473 ' OE2' ' NZ ' ' A' ' 79' ' ' LYS . 5.0 tm-20 -54.95 -42.37 72.25 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 121.367 0.603 . . . . 2.25 109.45 178.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.48 ' O ' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -62.26 -54.91 33.9 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.499 0.666 . . . . 2.6699999999999999 109.835 178.83 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.65 -51.51 69.63 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.2 0.524 . . . . 1.6599999999999999 110.915 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.85 -47.42 80.42 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.882 -0.511 . . . . 1.96 110.68 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -70.27 -38.12 75.02 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.692 -0.803 . . . . 2.5800000000000001 109.904 179.726 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 tp -62.41 -39.65 93.97 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.429 -0.794 . . . . 2.4100000000000001 109.396 178.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.564 ' HG3' ' HG3' ' A' ' 6' ' ' MET . 3.1 ttt -74.17 -36.11 64.06 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.749 -0.834 . . . . 2.5699999999999998 108.749 178.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.441 ' HA ' ' CD ' ' A' ' 87' ' ' GLU . 4.4 m 58.52 71.35 1.02 Allowed Pre-proline 0 N--CA 1.498 1.949 0 O-C-N 121.86 -0.525 . . . . 2.8799999999999999 111.834 179.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.598 ' HG2' ' HD2' ' A' ' 86' ' ' PRO . 49.3 Cg_endo -75.33 12.49 1.29 Allowed 'Trans proline' 0 C--N 1.315 -1.2 0 O-C-N 123.388 1.204 . . . . 2.96 111.13 178.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 60.49 21.53 11.24 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.205 -0.935 . . . . 3.9900000000000002 110.506 -179.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -111.51 -76.8 0.84 Allowed Glycine 0 N--CA 1.497 2.718 0 N-CA-C 110.088 -1.205 . . . . 4.0300000000000002 110.088 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.598 ' HD2' ' HG2' ' A' ' 83' ' ' PRO . 46.9 Cg_endo -80.55 -84.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.223 0 O-C-N 123.842 1.443 . . . . 3.9500000000000002 111.124 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 86' ' ' PRO . 0.4 OUTLIER 64.34 -56.95 0.24 Allowed 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 121.518 0.675 . . . . 3.9399999999999999 109.86 -179.05 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.524 ' N ' ' O ' ' A' ' 86' ' ' PRO . 8.1 p -102.32 -19.6 5.99 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 O-C-N 122.021 -0.424 . . . . 5.0800000000000001 110.009 178.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.535 ' CE1' ' HB2' ' A' ' 86' ' ' PRO . 22.7 m80 54.17 47.92 22.08 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.37 -0.831 . . . . 5.5599999999999996 111.061 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.731 0 CA-C-O 118.018 -1.434 . . . . 6.5700000000000003 109.636 179.699 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.901 0 N-CA-C 109.576 -1.41 . . . . 2.4399999999999999 109.576 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.2 p -51.94 -52.47 49.93 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 121.39 -1.065 . . . . 3.8999999999999999 108.789 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.7 mtt -96.78 127.56 42.88 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.06 -1.089 . . . . 4.2800000000000002 108.06 177.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 64.9 94.8 0.06 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.407 -0.808 . . . . 2.1600000000000001 109.294 -178.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.492 ' C ' HD12 ' A' ' 5' ' ' ILE . 1.3 pp -80.12 -165.45 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.394 -0.816 . . . . 2.0299999999999998 110.275 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 59.4 45.52 13.67 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.284 -0.885 . . . . 2.8799999999999999 110.689 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.444 ' O ' HG23 ' A' ' 12' ' ' THR . 4.6 m-20 -53.66 -24.32 13.96 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.431 -0.793 . . . . 1.6499999999999999 111.245 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -93.74 57.47 2.52 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.16 -0.963 . . . . 3.4399999999999999 109.847 179.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.452 ' H ' ' HD2' ' A' ' 10' ' ' PRO . 2.4 m -160.39 -59.5 0.02 OUTLIER Pre-proline 0 N--CA 1.499 1.976 0 O-C-N 121.066 -1.021 . . . . 1.75 112.075 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.576 ' HG2' HG22 ' A' ' 12' ' ' THR . 47.8 Cg_endo -72.26 -155.06 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.615 0 O-C-N 123.318 1.168 . . . . 1.27 111.7 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.7 p -55.11 -51.53 66.13 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.247 -0.908 . . . . 1.6699999999999999 110.303 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.576 HG22 ' HG2' ' A' ' 10' ' ' PRO . 10.7 t -57.46 -28.46 63.39 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.383 -0.823 . . . . 1.3799999999999999 110.075 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.725 ' O ' HG22 ' A' ' 17' ' ' VAL . . . -75.14 -58.71 3.88 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.501 -1.44 . . . . 0.98999999999999999 109.501 179.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.495 ' HA ' ' CG2' ' A' ' 17' ' ' VAL . 27.7 m -57.79 -33.06 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.612 -0.934 . . . . 1.3799999999999999 109.94 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.607 ' HA ' HG12 ' A' ' 18' ' ' ILE . 37.3 t -72.03 -40.66 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.915 -1.116 . . . . 1.2 109.15 178.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 42.7 m -59.04 -49.78 76.59 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.267 -0.895 . . . . 1.1699999999999999 109.66 178.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.725 HG22 ' O ' ' A' ' 13' ' ' GLY . 2.8 m -64.57 -43.41 96.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.604 -0.685 . . . . 1.53 111.492 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.607 HG12 ' HA ' ' A' ' 15' ' ' VAL . 2.1 pt -66.94 -32.34 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 120.153 -1.592 . . . . 1.24 110.037 179.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.47 ' N ' HG13 ' A' ' 18' ' ' ILE . 40.0 t -69.65 -47.63 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 108.044 -1.095 . . . . 1.05 108.044 177.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 69.6 mt -60.37 -46.2 95.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 N-CA-C 108.609 -0.885 . . . . 1.25 108.609 177.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.574 ' HA ' HG12 ' A' ' 24' ' ' ILE . 4.0 mt -59.36 -51.23 70.79 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.228 -0.656 . . . . 1.53 109.228 178.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.2 mt -56.46 -37.87 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.256 -0.902 . . . . 1.3700000000000001 109.167 178.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.79 -52.0 42.21 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.585 -0.697 . . . . 1.0800000000000001 110.797 179.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.574 HG12 ' HA ' ' A' ' 21' ' ' LEU . 39.4 pt -62.34 -37.27 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.872 -1.142 . . . . 1.4299999999999999 109.201 179.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.496 ' N ' HG13 ' A' ' 24' ' ' ILE . . . -64.8 -45.84 84.58 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.533 -0.729 . . . . 1.1299999999999999 109.118 178.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.03 -43.34 99.05 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.891 -0.781 . . . . 1.1200000000000001 108.891 178.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.4 -47.08 87.42 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.909 -0.775 . . . . 1.45 108.909 178.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.0 -45.97 93.14 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 108.636 -1.786 . . . . 1.02 108.636 178.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.27 -44.83 96.59 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.595 -0.944 . . . . 0.97999999999999998 109.623 178.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.6 mt -58.86 -40.1 83.3 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.787 -0.57 . . . . 1.3 109.503 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.7 mt -68.84 -46.64 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.498 -0.751 . . . . 1.3700000000000001 109.323 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.05 -45.39 94.96 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.442 -0.786 . . . . 1.6599999999999999 109.904 179.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.7 -49.13 75.87 Favored Glycine 0 N--CA 1.499 2.848 0 N-CA-C 109.494 -1.442 . . . . 0.78000000000000003 109.494 179.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.7 t -60.82 -40.45 92.82 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.526 -0.985 . . . . 1.55 109.531 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.497 ' HA ' HD23 ' A' ' 38' ' ' LEU . 61.1 t90 -66.21 -51.34 58.61 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.391 -0.818 . . . . 1.1699999999999999 109.86 179.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 62.57 -67.35 0.08 Allowed 'General case' 0 N--CA 1.506 2.358 0 O-C-N 121.991 -0.443 . . . . 1.26 111.079 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.466 ' N ' ' O ' ' A' ' 35' ' ' TRP . 0.2 OUTLIER 179.66 38.85 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.712 -0.618 . . . . 2.04 110.206 179.577 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.497 HD23 ' HA ' ' A' ' 35' ' ' TRP . 0.9 OUTLIER -85.42 -10.69 55.86 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.996 -1.065 . . . . 1.6100000000000001 111.487 -179.709 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.468 ' HG2' HD12 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -143.43 -104.16 0.12 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.947 -1.095 . . . . 2.8199999999999998 110.51 179.277 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -156.79 22.6 0.33 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.784 -1.197 . . . . 2.0099999999999998 112.032 -179.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -80.02 43.39 0.6 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.854 -1.154 . . . . 1.9399999999999999 111.041 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.481 ' NH2' ' OG ' ' A' ' 68' ' ' SER . 2.2 tpm_? -84.63 -65.92 0.95 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.036 -1.04 . . . . 1.1499999999999999 109.358 179.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.436 HG13 ' H ' ' A' ' 44' ' ' SER . 1.2 pt -65.92 -33.62 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-O 122.115 0.96 . . . . 1.5700000000000001 109.552 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.436 ' H ' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -73.62 72.39 1.44 Allowed 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 115.589 -0.732 . . . . 1.25 110.622 -179.958 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -76.2 -23.43 54.65 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.45 -0.781 . . . . 1.1699999999999999 110.423 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 50.23 39.04 18.89 Favored 'General case' 0 N--CA 1.506 2.361 0 O-C-N 121.365 -0.834 . . . . 1.3700000000000001 111.922 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.431 ' HG2' ' NH2' ' A' ' 76' ' ' ARG . 1.4 pm0 -81.74 -177.66 6.65 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.253 -0.904 . . . . 1.1299999999999999 110.229 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -68.79 -179.88 1.57 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.999 -1.063 . . . . 2.2999999999999998 110.381 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.564 ' HA ' ' HG2' ' A' ' 76' ' ' ARG . 43.6 mm-40 -74.51 100.84 3.98 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.951 -1.093 . . . . 1.46 109.808 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.537 ' CD ' HG22 ' A' ' 53' ' ' VAL . 2.5 tm-20 -116.44 155.01 29.3 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 122.134 0.969 . . . . 1.8899999999999999 111.231 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -174.25 -10.49 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.417 0 N-CA-C 112.842 0.682 . . . . 1.23 112.842 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 39.6 mm -82.62 -42.21 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.566 -1.333 . . . . 1.9399999999999999 110.211 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.537 HG22 ' CD ' ' A' ' 50' ' ' GLU . 12.4 m -95.97 -40.93 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.228 -0.92 . . . . 1.8700000000000001 111.151 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.584 ' HA3' ' SG ' ' A' ' 73' ' ' CYS . . . -50.88 -44.53 49.55 Favored Glycine 0 N--CA 1.5 2.951 0 N-CA-C 110.414 -1.074 . . . . 1.0800000000000001 110.414 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -105.9 27.72 8.27 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.355 -1.085 . . . . 0.93000000000000005 110.159 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -133.43 -34.01 0.33 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.799 -1.72 . . . . 0.91000000000000003 108.799 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.47 -36.25 68.87 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.43 -1.041 . . . . 2.4900000000000002 110.179 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.0 m 52.36 44.48 29.81 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.414 -0.804 . . . . 1.47 110.299 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.53 179.29 4.5 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.543 -0.723 . . . . 1.8500000000000001 110.082 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 53.12 79.25 0.35 Allowed Pre-proline 0 N--CA 1.503 2.19 0 O-C-N 121.589 -0.695 . . . . 1.6599999999999999 111.202 179.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -74.58 11.47 1.32 Allowed 'Trans proline' 0 N--CA 1.493 1.45 0 O-C-N 123.502 1.264 . . . . 1.8100000000000001 112.866 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.486 ' HB2' HG22 ' A' ' 65' ' ' VAL . 45.2 m-85 -88.77 144.2 26.4 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.467 -1.395 . . . . 2.54 110.441 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.1 mt -58.16 -37.62 75.04 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.165 -0.959 . . . . 1.5900000000000001 110.963 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.491 ' O ' ' HB2' ' A' ' 68' ' ' SER . 0.1 OUTLIER -53.97 -59.01 5.2 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.826 -0.546 . . . . 1.6200000000000001 109.977 179.363 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.486 HG22 ' HB2' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -69.12 -36.49 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.549 -0.719 . . . . 1.6200000000000001 110.225 179.606 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.483 ' O ' ' HB3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -56.33 -52.88 62.93 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.463 -0.773 . . . . 2.1200000000000001 109.332 178.793 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.533 ' HA ' ' HG2' ' A' ' 70' ' ' LYS . 9.0 m-85 -69.94 -39.04 76.31 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.556 -0.715 . . . . 1.5700000000000001 109.539 178.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.491 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 8.4 t -57.82 -41.01 81.34 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.814 -0.554 . . . . 0.88 110.403 178.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.68 -47.2 8.85 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.159 -0.963 . . . . 0.72999999999999998 110.964 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.551 ' HA ' ' HB2' ' A' ' 73' ' ' CYS . 6.3 ptpt -66.11 -34.88 79.06 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.396 -0.815 . . . . 1.45 111.306 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.417 ' N ' ' HD2' ' A' ' 72' ' ' PRO . . . -46.69 -63.31 3.19 Favored Glycine 0 N--CA 1.503 3.159 0 N-CA-C 109.543 -1.423 . . . . 0.78000000000000003 109.543 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.545 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 40.5 Cg_endo -67.28 -47.83 2.04 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.929 1.489 . . . . 0.84999999999999998 109.78 178.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.584 ' SG ' ' HA3' ' A' ' 54' ' ' GLY . 4.0 m -53.26 -39.95 64.25 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.15 -0.969 . . . . 0.93999999999999995 110.053 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 1.069 HG11 HG11 ' A' ' 88' ' ' VAL . 24.1 t -74.32 -46.38 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 108.833 -0.803 . . . . 1.02 108.833 178.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.11 -43.23 70.25 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 121.505 0.669 . . . . 1.1699999999999999 109.258 178.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.564 ' HG2' ' HA ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -63.3 -50.44 70.04 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.945 -0.761 . . . . 1.2 108.945 178.52 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.8 mttp -56.11 -44.84 79.48 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 109.167 -0.679 . . . . 1.23 109.167 178.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.486 ' HA ' ' CA ' ' A' ' 82' ' ' THR . . . -55.6 -52.21 64.55 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.415 -0.587 . . . . 1.4099999999999999 109.415 178.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 36.3 mtpt -58.88 -44.32 91.09 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.067 0.461 . . . . 1.5600000000000001 109.837 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.87 -62.88 1.29 Allowed 'General case' 0 N--CA 1.497 1.923 0 CA-C-O 121.573 0.702 . . . . 2.5800000000000001 110.692 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.443 ' O ' ' OG1' ' A' ' 82' ' ' THR . 1.5 ttt -158.63 60.41 0.43 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.527 -0.733 . . . . 3.0099999999999998 109.829 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.486 ' CA ' ' HA ' ' A' ' 78' ' ' ALA . 3.5 p 67.83 147.14 0.11 Allowed Pre-proline 0 N--CA 1.517 2.908 0 O-C-N 121.928 -0.482 . . . . 1.5800000000000001 110.765 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.482 ' CB ' HG13 ' A' ' 74' ' ' VAL . 50.6 Cg_endo -76.2 -22.24 12.96 Favored 'Trans proline' 0 C--N 1.312 -1.348 0 O-C-N 123.742 1.391 . . . . 1.52 111.17 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 53.87 28.67 8.71 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.677 -0.64 . . . . 1.8600000000000001 110.374 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -138.51 99.03 0.26 Allowed Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.048 -1.221 . . . . 1.3500000000000001 110.048 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.05 -18.13 56.25 Favored 'Trans proline' 0 N--CA 1.491 1.366 0 O-C-N 123.754 1.397 . . . . 1.5900000000000001 111.224 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -53.85 -34.8 60.43 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.226 -0.921 . . . . 1.55 109.999 178.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 1.069 HG11 HG11 ' A' ' 74' ' ' VAL . 7.2 p -114.45 -25.53 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.871 -0.518 . . . . 2.2000000000000002 110.64 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -162.94 -72.09 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.966 -1.084 . . . . 3.6499999999999999 110.603 179.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.705 0 CA-C-O 117.865 -1.52 . . . . 1.9399999999999999 109.929 -179.762 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.935 0 N-CA-C 109.311 -1.516 . . . . 7.7800000000000002 109.311 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.3 m -86.78 149.12 25.07 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.881 -1.364 . . . . 5.9100000000000001 110.571 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.501 ' SD ' HD11 ' A' ' 5' ' ' ILE . 1.9 mmt -104.7 118.71 37.26 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.077 -1.014 . . . . 8.5299999999999994 113.401 -177.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.6 m -111.39 6.19 20.18 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.303 -1.369 . . . . 4.1699999999999999 107.303 175.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.501 HD11 ' SD ' ' A' ' 3' ' ' MET . 0.6 OUTLIER -77.63 -153.41 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.578 -0.701 . . . . 3.6699999999999999 109.87 179.843 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 50.12 25.48 1.75 Allowed 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.85 -0.796 . . . . 4.8300000000000001 108.85 -179.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.574 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 0.8 OUTLIER -58.22 -29.23 65.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.72 -0.613 . . . . 2.9199999999999999 110.377 -178.812 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.511 ' CB ' ' O ' ' A' ' 7' ' ' ASP . 6.9 t-80 77.69 4.23 2.99 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 122.076 -0.39 . . . . 2.8300000000000001 110.754 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.546 ' N ' ' HD3' ' A' ' 10' ' ' PRO . 3.3 t 47.99 48.22 5.63 Favored Pre-proline 0 N--CA 1.497 1.921 0 O-C-N 121.52 -0.737 . . . . 2.5699999999999998 112.324 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.574 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 52.0 Cg_endo -81.09 -46.65 0.08 OUTLIER 'Trans proline' 0 C--N 1.32 -0.972 0 O-C-N 123.379 1.2 . . . . 2.8500000000000001 109.756 179.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.477 HG23 ' N ' ' A' ' 12' ' ' THR . 3.9 t -147.69 -44.76 0.17 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.978 -0.451 . . . . 2.79 109.818 179.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.477 ' N ' HG23 ' A' ' 11' ' ' THR . 0.0 OUTLIER -56.68 -45.74 81.56 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.318 -0.864 . . . . 3.3799999999999999 110.349 179.285 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.611 ' O ' HG22 ' A' ' 17' ' ' VAL . . . -62.16 -48.68 81.22 Favored Glycine 0 N--CA 1.499 2.863 0 N-CA-C 109.249 -1.541 . . . . 2.3300000000000001 109.249 179.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 55.1 t -62.33 -37.14 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.513 -0.993 . . . . 1.8100000000000001 109.924 179.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.413 ' O ' HG22 ' A' ' 19' ' ' VAL . 29.7 t -69.87 -51.67 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.102 -0.999 . . . . 2.9300000000000002 110.462 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.6 p -55.67 -49.77 72.03 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.806 -0.559 . . . . 2.98 110.252 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.611 HG22 ' O ' ' A' ' 13' ' ' GLY . 28.8 m -65.2 -35.31 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.136 -0.978 . . . . 1.97 110.081 179.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.428 HD13 ' HA ' ' A' ' 18' ' ' ILE . 5.6 mm -68.18 -48.69 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 120.958 -1.088 . . . . 2.25 110.431 179.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 15' ' ' VAL . 32.6 m -63.52 -36.8 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 C-N-CA 118.973 -1.091 . . . . 2.8700000000000001 108.966 178.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 58.9 mt -66.54 -48.77 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.268 -0.895 . . . . 2.5800000000000001 108.678 177.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 13.1 mt -58.95 -49.31 78.34 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.928 -0.767 . . . . 1.6899999999999999 108.928 178.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 29.7 mt -56.29 -43.61 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 C-N-CA 119.992 -0.683 . . . . 2.6600000000000001 109.457 178.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.34 -45.95 85.59 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.474 -0.766 . . . . 2.4100000000000001 109.731 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 61.4 mt -59.02 -46.5 91.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.394 -0.816 . . . . 1.8400000000000001 109.021 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.54 -45.35 90.96 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.556 -0.715 . . . . 1.8300000000000001 109.841 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.08 -43.94 95.12 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.549 -0.719 . . . . 2.4500000000000002 109.312 178.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.858 ' HA ' HD23 ' A' ' 30' ' ' LEU . 0.4 OUTLIER -63.25 -47.13 83.73 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.876 -0.787 . . . . 2.3599999999999999 108.876 178.333 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.61 -41.6 95.71 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 108.636 -1.786 . . . . 1.6000000000000001 108.636 178.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.05 -47.0 75.8 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.517 -0.99 . . . . 2.1800000000000002 110.306 179.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.858 HD23 ' HA ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -62.27 -37.21 84.61 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.615 -0.678 . . . . 2.6099999999999999 109.722 179.401 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.537 ' N ' ' HG ' ' A' ' 30' ' ' LEU . 9.7 mt -71.02 -46.95 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.304 -0.872 . . . . 1.9099999999999999 109.002 178.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.871 ' CD1' HD11 ' A' ' 52' ' ' ILE . 1.4 tp -58.83 -46.86 86.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.651 -0.655 . . . . 2.27 109.704 178.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' A' ' 37' ' ' TYR . . . -60.49 -57.9 16.66 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 109.345 -1.502 . . . . 2.1899999999999999 109.345 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.515 ' SG ' HD12 ' A' ' 38' ' ' LEU . 0.5 OUTLIER -53.59 -42.33 67.52 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.406 -1.055 . . . . 3.0299999999999998 110.273 179.314 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.535 ' HA ' ' HA ' ' A' ' 39' ' ' ARG . 57.3 t90 -67.27 -56.24 10.65 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.493 -0.755 . . . . 1.75 111.115 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -63.35 -24.09 67.7 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.307 -0.871 . . . . 2.3799999999999999 111.937 -179.388 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.443 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 0.3 OUTLIER -98.47 -48.04 5.17 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.958 -1.089 . . . . 4.4000000000000004 111.374 -179.345 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.515 HD12 ' SG ' ' A' ' 34' ' ' CYS . 2.5 mt -109.67 -37.72 5.6 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.113 -0.992 . . . . 2.8399999999999999 110.715 -179.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.535 ' HA ' ' HA ' ' A' ' 35' ' ' TRP . 0.0 OUTLIER 52.79 47.35 24.87 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.772 -0.58 . . . . 1.9399999999999999 110.622 -179.513 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 42' ' ' ARG . 0.5 OUTLIER -80.24 -63.91 1.3 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.015 -1.053 . . . . 3.1200000000000001 111.887 -179.409 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.415 ' CB ' ' O ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER 68.84 -49.27 0.58 Allowed 'General case' 0 N--CA 1.506 2.368 0 O-C-N 121.342 -0.849 . . . . 2.6899999999999999 109.584 -177.708 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.439 ' N ' ' O ' ' A' ' 40' ' ' LEU . 2.4 ttm105 -149.03 -146.95 0.21 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.436 -0.95 . . . . 3.2400000000000002 108.436 178.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.259 0.3 OUTLIER -62.39 -24.02 33.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 O-C-N 120.77 -1.206 . . . . 3.6299999999999999 110.1 178.805 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.41 ' OG ' ' N ' ' A' ' 45' ' ' GLN . 88.8 p -172.9 -64.86 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.776 -0.577 . . . . 2.6499999999999999 109.621 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.41 ' N ' ' OG ' ' A' ' 44' ' ' SER . 0.0 OUTLIER 46.63 58.57 4.53 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.77 -0.581 . . . . 2.6099999999999999 111.386 179.469 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.02 35.86 0.54 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.83 -1.169 . . . . 2.73 110.976 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -94.9 -177.36 4.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.003 -1.061 . . . . 2.9199999999999999 110.809 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.76 98.79 0.07 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.43 -0.794 . . . . 2.8999999999999999 109.989 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -145.12 146.78 31.94 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.275 -0.891 . . . . 1.97 110.576 -179.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.519 ' HA ' ' CZ2' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -134.79 -175.34 3.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.291 -0.881 . . . . 2.1400000000000001 110.891 -179.57 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.2 t -133.95 -34.3 1.0 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.6 -0.688 . . . . 1.8999999999999999 111.087 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.871 HD11 ' CD1' ' A' ' 32' ' ' LEU . 37.1 mm -88.76 -53.66 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.252 -0.905 . . . . 2.3700000000000001 110.19 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.47 HG12 ' O ' ' A' ' 55' ' ' ASP . 96.0 t -92.31 -66.77 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.507 -0.746 . . . . 2.1200000000000001 109.401 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.31 -62.25 2.65 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 108.589 -1.805 . . . . 1.75 108.589 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.47 ' O ' HG12 ' A' ' 53' ' ' VAL . 1.1 t0 -79.83 -163.72 0.57 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.761 -0.847 . . . . 2.2799999999999998 109.705 178.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 140.89 -58.8 0.57 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 108.874 -1.69 . . . . 1.76 108.874 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -124.81 20.66 8.43 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.68 -0.894 . . . . 2.5299999999999998 110.505 179.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.8 m -70.42 56.02 0.16 Allowed 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.122 -0.986 . . . . 2.0299999999999998 110.288 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.97 -162.15 1.1 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.405 -0.961 . . . . 3.27 108.405 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 60.96 105.76 0.03 OUTLIER Pre-proline 0 N--CA 1.502 2.142 0 O-C-N 121.37 -0.832 . . . . 4.4699999999999998 111.171 178.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -68.23 55.66 0.79 Allowed 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 120.83 1.02 . . . . 3.0699999999999998 110.512 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.465 ' O ' ' HB2' ' A' ' 66' ' ' GLN . 1.1 m-85 -74.24 163.49 27.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.315 -0.865 . . . . 4.8600000000000003 109.553 179.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.2 mt -54.89 -40.45 69.79 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.914 -1.117 . . . . 3.3500000000000001 110.554 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.21 -52.63 64.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.707 -0.621 . . . . 4.71 110.025 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.41 ' HA ' ' HB2' ' A' ' 68' ' ' SER . 14.8 t -68.64 -33.67 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.259 -0.9 . . . . 3.5499999999999998 109.392 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.483 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -59.25 -57.84 11.26 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.764 -0.828 . . . . 2.7200000000000002 108.764 179.107 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -62.55 -40.95 98.47 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.684 -0.635 . . . . 3.6200000000000001 109.608 178.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.413 ' O ' ' CD ' ' A' ' 72' ' ' PRO . 71.2 m -59.93 -41.33 91.55 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.824 -0.547 . . . . 3.8199999999999998 110.209 179.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -81.37 -41.79 21.46 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.206 -0.934 . . . . 2.79 110.488 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 66' ' ' GLN . 1.8 mmtp -61.38 -47.16 87.09 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.467 -0.771 . . . . 2.29 110.687 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 75' ' ' GLU . . . -41.71 -66.45 0.99 Allowed Glycine 0 N--CA 1.503 3.116 0 N-CA-C 110.544 -1.022 . . . . 2.8599999999999999 110.544 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.528 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 41.3 Cg_endo -65.81 -39.84 18.83 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.788 1.415 . . . . 2.8900000000000001 110.56 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 6.5 t -60.63 -43.32 97.64 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.033 -1.042 . . . . 2.1499999999999999 109.325 178.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 69.1 t -70.94 -44.98 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 N-CA-C 109.112 -0.699 . . . . 2.8500000000000001 109.112 178.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 0.6 OUTLIER -56.48 -42.48 78.35 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.614 0.721 . . . . 3.2000000000000002 109.444 178.629 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.528 ' HD2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -66.09 -50.45 64.02 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.624 -0.673 . . . . 3.0299999999999998 109.731 179.05 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -41.21 80.16 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 120.208 -0.597 . . . . 2.9399999999999999 109.655 179.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -66.88 -43.23 84.04 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 122.062 -0.399 . . . . 2.6699999999999999 110.044 179.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.427 ' CE ' ' HA ' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -68.39 -48.54 64.42 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.607 -0.683 . . . . 3.3599999999999999 109.893 179.326 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.1 tp -57.17 -47.1 82.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.486 -0.759 . . . . 2.0600000000000001 109.56 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -68.63 -55.02 12.9 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.591 0.71 . . . . 3.75 109.514 178.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.75 98.54 27.84 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.775 -0.578 . . . . 4.46 109.453 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.404 ' O ' ' CB ' ' A' ' 84' ' ' ASN . 43.7 Cg_endo -67.95 -10.11 27.81 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.465 1.245 . . . . 3.6600000000000001 110.413 178.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.567 ' HB3' ' HB2' ' A' ' 87' ' ' GLU . 2.0 t-20 71.22 -45.83 0.62 Allowed 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.686 -0.634 . . . . 4.9800000000000004 110.656 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.73 -85.42 0.39 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 108.719 -1.753 . . . . 5.0 108.719 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.44 ' HA ' ' H ' ' A' ' 90' ' ' GLY . 51.0 Cg_endo -76.76 -21.05 12.99 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.734 1.386 . . . . 6.0599999999999996 111.39 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.567 ' HB2' ' HB3' ' A' ' 84' ' ' ASN . 1.1 tt0 -58.58 -44.99 89.97 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 120.862 -1.149 . . . . 4.9900000000000002 110.36 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.5 m -92.7 -9.89 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.499 -0.751 . . . . 5.6200000000000001 110.687 178.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -111.23 -61.24 1.72 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.214 -0.929 . . . . 7.6900000000000004 110.706 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.44 ' H ' ' HA ' ' A' ' 86' ' ' PRO . . . . . . . . 0 N--CA 1.493 2.474 0 N-CA-C 109.08 -1.608 . . . . 6.79 109.08 -179.141 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.5 ' N ' ' OG1' ' A' ' 16' ' ' THR . . . . . . . . 0 N--CA 1.494 2.53 0 N-CA-C 110.402 -1.079 . . . . 2.4199999999999999 110.402 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.9 p -104.61 5.44 33.73 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.186 -1.185 . . . . 3.8399999999999999 111.826 -179.431 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.1 mtt -106.46 161.49 14.54 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.947 -1.096 . . . . 3.98 110.09 179.835 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.71 29.16 0.92 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.072 -1.017 . . . . 2.6099999999999999 111.233 -179.877 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -53.1 -43.14 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.509 -0.744 . . . . 2.1499999999999999 111.112 179.367 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.4 mmt 53.2 59.73 4.22 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.379 0.609 . . . . 3.1400000000000001 110.663 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.476 ' HB3' ' CG ' ' A' ' 10' ' ' PRO . 8.1 m-20 -57.22 -33.06 67.14 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.394 -0.817 . . . . 2.8500000000000001 110.18 179.643 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 28.0 t-80 50.31 46.97 24.51 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.745 -0.597 . . . . 2.6200000000000001 111.593 179.391 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.497 ' CB ' ' CD ' ' A' ' 10' ' ' PRO . 0.9 OUTLIER -177.0 -63.03 0.0 OUTLIER Pre-proline 0 N--CA 1.499 2.002 0 O-C-N 121.325 -0.859 . . . . 2.1600000000000001 110.806 179.275 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 9' ' ' SER . 47.7 Cg_endo -73.28 170.44 19.87 Favored 'Trans proline' 0 N--CA 1.487 1.146 0 O-C-N 123.33 1.173 . . . . 1.96 110.899 179.771 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.9 t -59.86 -30.13 68.76 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.247 -0.908 . . . . 2.02 110.867 179.8 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.6 p -60.1 -35.65 75.69 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.93 -1.107 . . . . 2.1200000000000001 109.751 178.705 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.584 ' O ' HG22 ' A' ' 17' ' ' VAL . . . -73.84 -51.91 8.7 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 108.743 -1.743 . . . . 1.51 108.743 178.891 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.503 ' O ' HG23 ' A' ' 18' ' ' ILE . 53.8 t -57.18 -37.99 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.705 -0.88 . . . . 1.28 109.89 178.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.536 ' O ' HG13 ' A' ' 18' ' ' ILE . 43.2 t -72.63 -37.43 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.031 -1.043 . . . . 1.5700000000000001 109.416 178.998 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.5 ' OG1' ' N ' ' A' ' 1' ' ' GLY . 59.5 m -62.17 -50.25 72.59 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.286 -0.884 . . . . 1.4299999999999999 109.712 178.588 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.584 HG22 ' O ' ' A' ' 13' ' ' GLY . 30.9 m -67.24 -41.86 87.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.655 -0.653 . . . . 0.98999999999999999 111.643 -179.502 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.536 HG13 ' O ' ' A' ' 15' ' ' VAL . 2.1 pp -67.69 -30.42 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 120.303 -1.498 . . . . 1.27 109.764 179.138 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.6 t -68.99 -52.2 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.233 -0.917 . . . . 1.25 108.782 178.143 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.577 HG12 ' HA ' ' A' ' 17' ' ' VAL . 44.9 pt -63.96 -37.53 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.162 -0.961 . . . . 1.01 109.083 178.668 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.485 ' N ' HG13 ' A' ' 20' ' ' ILE . 9.9 mt -64.85 -48.34 74.68 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.395 -0.816 . . . . 1.02 109.0 178.028 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.45 HD13 ' HA ' ' A' ' 22' ' ' ILE . 8.0 mm -59.19 -43.57 89.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.317 -0.865 . . . . 1.21 108.873 178.481 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.85 -46.66 88.5 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.387 -0.597 . . . . 0.90000000000000002 109.387 178.711 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.414 HD13 ' HA ' ' A' ' 24' ' ' ILE . 8.4 mm -59.97 -45.44 95.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.306 -0.871 . . . . 1.1399999999999999 108.892 178.386 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.67 -45.4 94.18 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.579 -0.7 . . . . 0.88 109.613 178.751 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.74 -44.94 96.03 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.58 -0.7 . . . . 0.95999999999999996 109.138 178.593 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.4 tt -61.96 -45.92 91.54 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.898 -0.779 . . . . 1.28 108.898 178.192 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.38 -44.09 95.39 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 108.712 -1.755 . . . . 1.1100000000000001 108.712 178.651 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.28 -46.28 84.36 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.428 -1.042 . . . . 1.1299999999999999 109.668 178.912 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.1 mt -56.89 -41.29 77.79 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 109.179 -0.675 . . . . 1.46 109.179 178.719 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.41 ' HA ' HD13 ' A' ' 31' ' ' ILE . 26.6 mm -70.2 -44.9 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.53 -0.731 . . . . 1.46 109.525 178.853 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.496 ' HA ' ' HD1' ' A' ' 35' ' ' TRP . 0.2 OUTLIER -58.17 -48.52 80.05 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.508 -0.745 . . . . 2.2799999999999998 109.891 179.285 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.403 ' HA2' ' CG ' ' A' ' 39' ' ' ARG . . . -68.03 -41.68 86.78 Favored Glycine 0 N--CA 1.499 2.838 0 N-CA-C 110.471 -1.051 . . . . 1.5 110.471 179.773 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 9.8 t -64.38 -41.41 96.7 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.395 -1.062 . . . . 1.95 111.011 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.496 ' HD1' ' HA ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -84.53 -34.43 23.3 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.094 -1.004 . . . . 2.71 110.764 -179.808 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.421 ' HB2' ' CE2' ' A' ' 35' ' ' TRP . 2.5 t -128.27 101.72 6.36 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.006 -1.059 . . . . 2.25 109.995 179.414 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -52.78 -43.15 65.65 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.308 -0.87 . . . . 4.1699999999999999 110.826 -179.784 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.48 -10.69 59.81 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.933 -1.104 . . . . 2.4900000000000002 111.074 179.499 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.403 ' CG ' ' HA2' ' A' ' 33' ' ' GLY . 10.2 mtm105 43.64 41.18 3.36 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.621 -0.674 . . . . 2.0800000000000001 111.254 179.235 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 46.75 46.83 15.17 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.649 -0.657 . . . . 2.73 110.921 -179.673 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -69.33 -1.07 7.28 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.035 -1.041 . . . . 2.7000000000000002 112.118 -179.533 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.725 ' HG3' HG23 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -80.58 -60.03 2.47 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.627 -1.296 . . . . 4.1100000000000003 108.723 178.549 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.725 HG23 ' HG3' ' A' ' 42' ' ' ARG . 13.7 pt -103.32 -38.46 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.534 -0.729 . . . . 3.1000000000000001 110.141 178.782 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.489 ' N ' HG13 ' A' ' 43' ' ' ILE . 5.1 t 61.84 -76.6 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.498 0 O-C-N 122.154 -0.342 . . . . 2.6099999999999999 110.923 -179.474 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -165.72 -176.3 3.83 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.149 -0.97 . . . . 2.4300000000000002 110.241 179.655 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.5 m -155.3 35.5 0.38 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.852 -1.155 . . . . 3.4700000000000002 110.606 179.736 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -98.92 162.38 13.12 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.313 -0.867 . . . . 2.7599999999999998 109.63 179.573 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.454 ' O ' ' N ' ' A' ' 50' ' ' GLU . 21.6 t70 -65.05 -57.29 9.02 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.233 -0.917 . . . . 2.2799999999999998 109.646 179.389 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 62.39 -64.68 0.09 Allowed 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.896 -0.502 . . . . 2.6800000000000002 111.897 179.161 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.454 ' N ' ' O ' ' A' ' 48' ' ' ASP . 3.8 tp10 -136.8 120.79 17.65 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.006 -1.059 . . . . 2.3599999999999999 110.706 179.958 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 96.0 p -155.22 -57.52 0.1 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.351 -0.843 . . . . 2.0600000000000001 111.56 -179.406 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.7 mt -78.09 -59.7 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.655 -0.653 . . . . 2.21 111.081 -178.673 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.1 p -66.91 -46.81 84.2 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.496 -0.752 . . . . 1.8799999999999999 110.985 -179.244 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 63.48 30.12 76.64 Favored Glycine 0 N--CA 1.496 2.664 0 N-CA-C 109.519 -1.433 . . . . 1.3999999999999999 109.519 -179.499 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.408 ' HB3' ' CB ' ' A' ' 62' ' ' PHE . 21.5 m-20 54.42 84.55 0.07 Allowed 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 121.953 0.882 . . . . 2.0600000000000001 110.698 -179.551 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -165.25 -48.33 0.02 OUTLIER Glycine 0 N--CA 1.496 2.653 0 N-CA-C 108.227 -1.949 . . . . 1.23 108.227 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -96.45 -48.8 5.42 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.776 -0.837 . . . . 2.1699999999999999 109.249 178.529 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -119.58 179.12 4.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.627 -0.671 . . . . 1.3300000000000001 109.228 178.699 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.11 -156.57 0.34 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.522 -0.736 . . . . 1.8600000000000001 109.581 -179.356 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.497 ' HG2' ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -63.36 144.35 97.58 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 121.005 -1.059 . . . . 1.6200000000000001 110.398 -179.742 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.497 ' HD2' ' HG2' ' A' ' 60' ' ' GLU . 38.1 Cg_endo -63.62 -33.12 68.24 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 O-C-N 123.424 1.223 . . . . 1.1200000000000001 110.444 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.408 ' CB ' ' HB3' ' A' ' 55' ' ' ASP . 24.6 t80 32.55 -90.85 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.346 0 N-CA-C 112.334 0.494 . . . . 2.5 112.334 178.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.455 ' HA ' ' HB2' ' A' ' 66' ' ' GLN . 1.6 mt -57.36 -33.21 67.55 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.997 -1.065 . . . . 2.02 111.099 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.432 ' HB3' ' HB2' ' A' ' 61' ' ' PRO . 0.2 OUTLIER -60.1 -56.52 20.65 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.445 -0.784 . . . . 1.48 109.844 179.347 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.423 ' HA ' ' HB2' ' A' ' 68' ' ' SER . 33.7 m -71.52 -32.0 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.041 -1.037 . . . . 1.27 110.034 179.137 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.502 ' OE1' ' NZ ' ' A' ' 70' ' ' LYS . 2.6 mt-30 -60.66 -45.48 93.97 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.362 -0.836 . . . . 2.6000000000000001 109.491 178.465 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -74.26 -41.42 61.31 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.654 0.74 . . . . 3.6099999999999999 109.463 178.624 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.423 ' HB2' ' HA ' ' A' ' 65' ' ' VAL . 64.0 m -59.2 -28.54 66.74 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 122.002 -0.436 . . . . 1.1499999999999999 110.938 179.77 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -95.59 -43.99 7.69 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.082 -1.011 . . . . 1.54 111.013 -179.651 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.502 ' NZ ' ' OE1' ' A' ' 66' ' ' GLN . 15.2 mtmt -70.06 -39.83 75.43 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.408 -0.808 . . . . 3.3599999999999999 111.109 -179.394 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.422 ' N ' ' HD2' ' A' ' 72' ' ' PRO . . . -46.0 -61.11 4.11 Favored Glycine 0 N--CA 1.503 3.106 0 N-CA-C 109.603 -1.399 . . . . 1.0700000000000001 109.603 179.821 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.591 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 42.1 Cg_endo -67.74 -43.37 5.45 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 O-C-N 123.801 1.421 . . . . 1.02 109.751 178.462 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 9.1 t -53.75 -44.77 70.23 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.906 -1.121 . . . . 2.1600000000000001 110.202 179.055 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.5 t -72.68 -45.96 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.337 -0.852 . . . . 1.72 109.05 178.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.433 ' HB3' ' HA ' ' A' ' 72' ' ' PRO . 1.3 tm-20 -53.6 -42.59 67.83 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.6 0.714 . . . . 1.28 109.96 178.642 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.62 ' HA ' ' CD ' ' A' ' 79' ' ' LYS . 0.9 OUTLIER -72.74 -45.55 58.14 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.673 -0.642 . . . . 1.79 110.997 179.85 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.485 ' HG3' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -67.27 -28.79 68.32 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.121 -0.987 . . . . 1.8200000000000001 109.984 179.594 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.485 ' N ' ' HG3' ' A' ' 77' ' ' LYS . . . -75.56 -52.36 10.79 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.426 -0.796 . . . . 1.1799999999999999 109.485 179.265 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.62 ' CD ' ' HA ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER -64.84 -28.95 69.9 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.622 -0.674 . . . . 1.6299999999999999 111.332 179.903 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.555 ' N ' ' HG2' ' A' ' 79' ' ' LYS . 2.6 tp -87.93 -36.58 17.04 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.23 -0.919 . . . . 2.1099999999999999 112.166 -178.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -110.88 -38.76 5.02 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.91 -1.119 . . . . 3.5 112.425 -178.659 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 37.0 p -132.27 68.02 79.42 Favored Pre-proline 0 N--CA 1.506 2.352 0 O-C-N 120.533 -1.354 . . . . 1.8899999999999999 111.687 -179.303 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.444 ' O ' ' N ' ' A' ' 85' ' ' GLY . 39.0 Cg_endo -64.48 -23.9 64.28 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 O-C-N 123.505 1.266 . . . . 2.1000000000000001 111.086 179.397 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.5 t30 66.05 -53.52 0.39 Allowed 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.774 -0.579 . . . . 3.2000000000000002 110.46 -179.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 83' ' ' PRO . . . -138.6 86.28 0.22 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.104 -1.598 . . . . 2.79 109.104 179.237 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -61.15 -17.45 52.45 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 O-C-N 123.676 1.356 . . . . 3.3300000000000001 110.575 179.361 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -55.77 -37.52 68.67 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.53 -0.732 . . . . 4.5099999999999998 109.474 178.253 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -98.11 -24.6 4.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.739 -0.601 . . . . 4.5700000000000003 110.107 179.891 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 57.64 -161.39 0.23 Allowed 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.556 -0.715 . . . . 3.3999999999999999 110.14 -179.797 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.413 ' OXT' ' NZ ' ' A' ' 79' ' ' LYS . . . . . . . . 0 N--CA 1.489 2.207 0 N-CA-C 109.471 -1.452 . . . . 2.3799999999999999 109.471 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 3.279 0 N-CA-C 110.464 -1.055 . . . . 4.8099999999999996 110.464 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.492 ' OG ' ' N ' ' A' ' 3' ' ' MET . 15.9 t 50.82 -144.88 0.52 Allowed 'General case' 0 N--CA 1.506 2.332 0 O-C-N 121.442 -1.034 . . . . 5.5499999999999998 109.795 -179.403 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.492 ' N ' ' OG ' ' A' ' 2' ' ' SER . 0.1 OUTLIER -77.71 46.24 0.54 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.824 -1.172 . . . . 5.5 109.581 178.74 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.6 m -155.08 86.18 1.1 Allowed 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.102 -0.703 . . . . 3.25 109.102 -179.759 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.447 ' O ' ' N ' ' A' ' 7' ' ' ASP . 0.6 OUTLIER -77.71 -143.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.767 -0.827 . . . . 3.3399999999999999 108.767 179.761 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.402 ' O ' ' N ' ' A' ' 8' ' ' HIS . 0.1 OUTLIER 64.5 -60.7 0.21 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.372 -0.83 . . . . 3.52 111.95 179.142 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.447 ' N ' ' O ' ' A' ' 5' ' ' ILE . 0.2 OUTLIER 66.26 -45.45 0.42 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.768 -0.583 . . . . 3.4399999999999999 110.376 -178.684 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.402 ' N ' ' O ' ' A' ' 6' ' ' MET . 0.3 OUTLIER -66.64 -28.64 68.64 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.918 -1.114 . . . . 4.6900000000000004 110.408 178.276 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.99 64.78 3.46 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.76 -0.587 . . . . 2.3799999999999999 110.794 -179.655 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -72.18 88.4 0.84 Allowed 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.331 1.174 . . . . 1.8999999999999999 110.428 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.433 HG23 ' N ' ' A' ' 12' ' ' THR . 9.0 t -54.63 -40.69 69.2 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.316 -0.865 . . . . 1.6699999999999999 110.254 179.921 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.433 ' N ' HG23 ' A' ' 11' ' ' THR . 1.7 p -61.61 -38.97 89.55 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.311 -0.868 . . . . 1.46 109.615 178.46 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -70.56 -51.33 21.33 Favored Glycine 0 N--CA 1.495 2.57 0 N-CA-C 108.69 -1.764 . . . . 1.0900000000000001 108.69 178.606 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.7 t -55.4 -40.3 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.838 -0.801 . . . . 1.71 109.3 178.649 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.4 t -69.07 -42.69 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.338 -0.851 . . . . 1.3200000000000001 109.037 178.434 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 53.9 m -57.31 -52.77 64.01 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.131 0.491 . . . . 1.1100000000000001 110.007 179.137 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.3 m -64.29 -37.08 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.519 -0.738 . . . . 1.21 110.043 179.468 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 23.1 mt -66.28 -40.9 88.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.039 -1.038 . . . . 1.49 109.394 178.567 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.3 t -64.52 -45.35 95.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.533 -0.914 . . . . 1.1899999999999999 108.533 178.158 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 86.2 mt -62.15 -46.32 96.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.49 -0.756 . . . . 1.2 109.016 178.312 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 9.8 mt -60.07 -49.59 77.07 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.908 -0.775 . . . . 1.6299999999999999 108.908 178.411 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.9 mt -56.76 -43.13 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.525 -0.735 . . . . 1.3899999999999999 109.394 178.52 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.21 -46.55 83.41 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.669 -0.644 . . . . 1.1399999999999999 109.908 179.032 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.5 mm -59.66 -46.29 93.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.232 -0.918 . . . . 1.3899999999999999 109.02 178.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.96 -45.0 95.57 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.607 -0.683 . . . . 1.3300000000000001 109.664 178.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.35 -43.84 98.19 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.556 -0.715 . . . . 1.29 109.093 178.59 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.74 -48.26 81.53 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.774 -0.824 . . . . 1.3500000000000001 108.774 178.133 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -57.35 -44.65 93.43 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 108.857 -1.697 . . . . 1.25 108.857 178.767 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.32 -43.16 95.54 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.433 -1.04 . . . . 1.4199999999999999 109.866 178.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 6.9 mt -60.27 -41.36 93.12 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.244 -0.651 . . . . 1.72 109.244 178.628 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.942 HG22 ' HB2' ' A' ' 49' ' ' GLU . 97.0 mt -69.11 -52.91 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.558 -0.714 . . . . 1.25 109.29 179.029 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.2 -46.91 72.54 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.491 -0.756 . . . . 2.2200000000000002 109.763 178.867 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.63 -47.53 89.94 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 109.221 -1.552 . . . . 1.54 109.221 178.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -57.86 -41.71 83.0 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.557 -0.967 . . . . 2.0 109.618 178.876 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.483 ' O ' ' N ' ' A' ' 37' ' ' TYR . 1.2 m-90 -68.29 -42.1 79.99 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.289 -0.882 . . . . 1.3799999999999999 109.728 178.868 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.458 ' O ' ' NH1' ' A' ' 39' ' ' ARG . 4.0 t 55.41 -75.58 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.904 -0.498 . . . . 1.99 111.739 179.082 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.483 ' N ' ' O ' ' A' ' 35' ' ' TRP . 0.2 OUTLIER -146.73 14.22 1.2 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.915 -1.116 . . . . 3.1800000000000002 111.946 179.912 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.659 ' O ' HD12 ' A' ' 38' ' ' LEU . 2.6 pp -91.77 22.55 4.1 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.83 -1.169 . . . . 1.6899999999999999 110.886 179.457 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.458 ' NH1' ' O ' ' A' ' 36' ' ' CYS . 68.9 mtt85 -50.3 -48.69 55.01 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.296 -0.878 . . . . 1.4399999999999999 111.206 179.669 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.74 54.19 0.35 Allowed 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.328 -0.857 . . . . 2.7400000000000002 110.92 -179.788 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -90.74 -16.84 27.73 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.173 -0.954 . . . . 2.4399999999999999 110.943 179.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.2 tpp180 -159.04 -134.64 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.16 -0.963 . . . . 2.8500000000000001 109.88 -179.731 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.467 HG13 ' N ' ' A' ' 44' ' ' SER . 5.2 pt -53.34 -33.31 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 O-C-N 121.095 -1.003 . . . . 2.3300000000000001 110.813 179.24 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.467 ' N ' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -53.1 102.1 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 121.259 0.552 . . . . 1.5900000000000001 111.107 -179.943 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -84.51 -25.01 29.13 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.484 -0.76 . . . . 2.9100000000000001 111.142 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 23.1 t -116.06 -68.98 0.88 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.968 -1.083 . . . . 1.7 110.217 179.68 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -115.67 169.26 9.33 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.248 -0.907 . . . . 1.95 110.808 179.545 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.454 ' HB3' ' CD1' ' A' ' 35' ' ' TRP . 24.2 t70 -139.02 -33.64 0.63 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.778 -0.576 . . . . 1.0700000000000001 110.738 -179.916 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.942 ' HB2' HG22 ' A' ' 31' ' ' ILE . 0.9 OUTLIER -73.83 -135.88 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.224 -0.922 . . . . 1.1599999999999999 111.621 -179.852 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.56 80.05 1.97 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.494 -1.379 . . . . 2.6499999999999999 112.285 -178.567 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 42.5 t -161.11 -69.88 0.06 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.391 -0.818 . . . . 1.8500000000000001 109.655 178.343 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.562 ' O ' ' HB2' ' A' ' 55' ' ' ASP . 1.1 pp -68.15 -27.77 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.388 -0.82 . . . . 2.1299999999999999 109.771 178.832 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.441 ' N ' HG13 ' A' ' 52' ' ' ILE . 33.1 m -57.7 -33.41 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.376 -0.828 . . . . 2.3500000000000001 109.033 178.162 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -103.72 42.12 1.97 Allowed Glycine 0 N--CA 1.498 2.805 0 N-CA-C 108.668 -1.773 . . . . 2.1400000000000001 108.668 178.364 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.562 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 2.5 t0 -101.62 95.31 6.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.6 -0.941 . . . . 2.75 110.381 -179.283 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -157.04 -53.98 0.01 OUTLIER Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.828 -1.709 . . . . 2.6499999999999999 108.828 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -95.95 -23.46 16.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.801 -0.823 . . . . 2.8399999999999999 110.343 178.82 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.456 ' O ' ' NZ ' ' A' ' 59' ' ' LYS . 9.4 p -69.44 60.7 0.14 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.517 -0.739 . . . . 2.8300000000000001 110.908 179.908 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.456 ' NZ ' ' O ' ' A' ' 58' ' ' THR . 3.1 mmtt -124.43 -156.28 0.71 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.105 -0.997 . . . . 2.8399999999999999 110.64 -179.581 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.506 ' O ' ' HB2' ' A' ' 64' ' ' LEU . 0.8 OUTLIER -80.05 114.88 50.2 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.641 -0.662 . . . . 3.4199999999999999 109.512 179.264 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.605 ' O ' HG23 ' A' ' 65' ' ' VAL . 39.0 Cg_endo -65.03 -38.13 29.89 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.751 1.395 . . . . 3.0299999999999998 111.758 -178.795 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.502 ' HB3' ' OE1' ' A' ' 60' ' ' GLU . 59.1 t80 -62.84 -55.29 27.59 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.941 -1.099 . . . . 3.7599999999999998 109.776 179.493 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.488 ' HB2' ' HB3' ' A' ' 60' ' ' GLU . 4.3 mt -59.86 -37.78 80.28 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.473 -0.767 . . . . 3.1699999999999999 109.948 178.848 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.506 ' HB2' ' O ' ' A' ' 60' ' ' GLU . 0.3 OUTLIER -58.83 -49.25 78.41 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.713 -0.617 . . . . 2.6400000000000001 109.933 179.356 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 61' ' ' PRO . 17.5 t -73.07 -36.54 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.138 -0.976 . . . . 2.46 109.186 178.821 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.85 -46.73 84.36 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 120.138 -0.625 . . . . 3.9900000000000002 109.404 179.463 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.465 ' HA ' ' CG ' ' A' ' 70' ' ' LYS . 0.4 OUTLIER -70.48 -42.88 70.82 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.604 -0.685 . . . . 3.8999999999999999 109.483 178.457 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.42 ' O ' ' CD ' ' A' ' 72' ' ' PRO . 54.2 m -60.1 -37.39 79.83 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 109.963 -0.384 . . . . 2.0099999999999998 109.963 178.872 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -83.88 -43.57 15.17 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.241 -0.912 . . . . 2.0899999999999999 111.338 -179.711 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.465 ' CG ' ' HA ' ' A' ' 67' ' ' TYR . 0.7 OUTLIER -70.33 -25.65 63.39 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.084 -1.01 . . . . 1.6599999999999999 110.834 -179.795 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' A' ' 75' ' ' GLU . . . -55.11 -64.68 4.15 Favored Glycine 0 N--CA 1.498 2.799 0 N-CA-C 109.063 -1.615 . . . . 1.6200000000000001 109.063 178.918 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.42 ' CD ' ' O ' ' A' ' 68' ' ' SER . 39.6 Cg_endo -65.91 -37.09 28.2 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 124.085 1.571 . . . . 2.2400000000000002 110.055 178.778 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 6.2 t -60.16 -46.21 90.45 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.992 -1.067 . . . . 2.2000000000000002 109.656 178.725 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 39.2 t -72.24 -42.49 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.515 -0.741 . . . . 1.3899999999999999 109.401 178.863 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.518 ' HB2' ' O ' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -57.65 -41.66 81.9 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.717 0.77 . . . . 2.6499999999999999 109.283 178.408 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.4 ttt85 -71.3 -45.32 63.34 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.578 -0.701 . . . . 3.6499999999999999 110.371 179.36 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.25 -44.25 95.42 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.178 -0.951 . . . . 2.3700000000000001 109.262 179.267 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.62 ' HA ' ' CD ' ' A' ' 83' ' ' PRO . . . -64.5 -49.06 72.83 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.526 0.679 . . . . 1.72 110.849 179.329 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.4 mttp -68.24 -46.57 70.12 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.276 -0.89 . . . . 2.98 111.502 -179.655 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.1 tp -70.69 -53.06 17.14 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.226 -0.921 . . . . 2.8500000000000001 112.3 -178.672 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.434 ' CG ' ' HG3' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -100.2 -24.66 14.5 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.214 -0.929 . . . . 3.1899999999999999 112.174 -178.596 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.426 ' HA ' ' O ' ' A' ' 78' ' ' ALA . 86.8 m 53.62 81.47 0.26 Allowed Pre-proline 0 N--CA 1.504 2.255 0 O-C-N 121.223 -0.923 . . . . 2.8999999999999999 111.509 179.567 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.62 ' CD ' ' HA ' ' A' ' 78' ' ' ALA . 50.1 Cg_endo -73.14 17.97 0.39 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.842 1.443 . . . . 2.7200000000000002 112.505 179.428 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -71.54 53.22 0.21 Allowed 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.458 -1.401 . . . . 3.96 108.875 178.487 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 83' ' ' PRO . . . 140.19 -75.16 0.36 Allowed Glycine 0 N--CA 1.494 2.538 0 N-CA-C 108.34 -1.904 . . . . 3.27 108.34 -178.617 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -79.23 -173.53 1.91 Allowed 'Trans proline' 0 C--N 1.315 -1.217 0 O-C-N 123.645 1.34 . . . . 2.4399999999999999 110.321 178.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.434 ' HG3' ' CG ' ' A' ' 81' ' ' MET . 0.1 OUTLIER 67.63 -50.39 0.51 Allowed 'General case' 0 N--CA 1.51 2.532 0 O-C-N 121.375 -0.828 . . . . 3.25 110.229 -178.31 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.0 p -109.97 -6.08 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.706 -0.622 . . . . 4.3200000000000003 110.932 179.057 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 60.75 51.26 4.94 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.158 -0.964 . . . . 4.8399999999999999 110.197 -179.565 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.877 0 CA-C-O 118.105 -1.386 . . . . 5.1100000000000003 110.02 179.85 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.419 ' N ' ' OE2' ' A' ' 57' ' ' GLU . . . . . . . . 0 N--CA 1.496 2.652 0 N-CA-C 109.575 -1.41 . . . . 1.74 109.575 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.431 ' OG ' ' N ' ' A' ' 3' ' ' MET . 90.1 p -161.37 -81.98 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.386 -1.067 . . . . 2.9100000000000001 110.493 179.26 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.431 ' N ' ' OG ' ' A' ' 2' ' ' SER . 22.3 mtt -130.16 73.7 1.55 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.548 -0.72 . . . . 3.3700000000000001 110.534 -179.47 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.4 m -121.05 29.22 7.46 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.351 -0.843 . . . . 2.2000000000000002 110.553 179.852 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.58 -124.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.156 -0.965 . . . . 1.29 110.136 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.414 ' HG3' HG11 ' A' ' 17' ' ' VAL . 5.4 mmt -97.02 39.03 1.19 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.309 -1.494 . . . . 2.71 110.521 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -60.55 -30.26 69.66 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.519 -0.738 . . . . 1.4299999999999999 110.924 179.827 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -102.42 35.08 2.54 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.083 -1.011 . . . . 3.2799999999999998 110.54 179.795 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.6 t -95.05 142.2 24.29 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.151 -0.968 . . . . 1.73 110.37 179.722 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.58 170.94 16.36 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 123.633 1.333 . . . . 2.3700000000000001 110.554 179.729 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.7 t -52.47 -38.77 60.12 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.199 -0.938 . . . . 3.1200000000000001 110.126 179.831 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 p -65.72 -42.03 91.55 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.27 -0.894 . . . . 3.4300000000000002 109.397 178.289 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.42 ' O ' HG22 ' A' ' 17' ' ' VAL . . . -70.31 -51.02 24.1 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.13 -1.588 . . . . 2.3399999999999999 109.13 178.988 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.8 t -53.97 -41.52 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.714 -0.874 . . . . 1.8500000000000001 109.346 178.747 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.6 t -69.99 -41.93 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.278 -0.889 . . . . 2.71 109.261 178.663 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 77.8 m -58.75 -51.57 69.42 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.699 -0.626 . . . . 2.7000000000000002 109.928 179.155 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 13' ' ' GLY . 23.3 m -65.41 -36.43 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.471 -0.768 . . . . 1.76 109.911 179.42 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 21.7 mt -66.58 -40.19 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 121.136 -0.977 . . . . 1.6499999999999999 109.298 178.404 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 36.1 t -64.8 -43.51 96.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.036 -1.04 . . . . 2.4900000000000002 108.474 177.953 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 87.7 mt -63.68 -46.73 93.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 108.919 -0.771 . . . . 2.3799999999999999 108.919 178.139 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.674 HD22 ' O ' ' A' ' 50' ' ' GLU . 44.7 mt -59.56 -49.15 78.87 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.705 -0.85 . . . . 1.3799999999999999 108.705 178.454 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 31.4 mt -56.27 -42.44 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.557 -0.714 . . . . 1.6799999999999999 109.386 178.284 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.44 -45.52 83.5 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.461 -0.774 . . . . 2.0600000000000001 109.663 178.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.0 mt -60.09 -46.11 94.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 108.438 -0.949 . . . . 1.96 108.438 178.367 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.633 ' HB2' ' HB2' ' A' ' 50' ' ' GLU . . . -61.62 -48.12 82.31 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.753 -0.462 . . . . 1.1499999999999999 109.753 178.56 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.48 -44.19 89.27 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.47 -0.769 . . . . 1.4299999999999999 109.078 178.712 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.01 -46.32 89.7 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.844 -0.799 . . . . 2.8500000000000001 108.844 178.116 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.98 -42.5 98.35 Favored Glycine 0 N--CA 1.497 2.717 0 N-CA-C 108.899 -1.68 . . . . 1.6699999999999999 108.899 178.735 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.38 -44.15 95.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.549 -0.971 . . . . 1.1399999999999999 109.315 178.72 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.507 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 6.4 mt -60.79 -40.84 94.11 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.003 -0.74 . . . . 2.02 109.003 178.289 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.1 mt -67.79 -48.54 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.375 -0.828 . . . . 2.9300000000000002 109.208 178.445 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.637 ' HA ' ' HD1' ' A' ' 35' ' ' TRP . 0.2 OUTLIER -56.99 -48.43 78.47 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.391 -0.818 . . . . 2.5600000000000001 109.329 178.848 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.505 ' HA2' ' CZ ' ' A' ' 39' ' ' ARG . . . -64.35 -35.79 92.39 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 110.908 -0.877 . . . . 1.27 110.908 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -79.44 -29.58 41.87 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.983 -1.304 . . . . 2.3999999999999999 111.319 -179.515 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.637 ' HD1' ' HA ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -89.24 -31.09 18.06 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.902 -1.124 . . . . 3.8799999999999999 111.29 -179.694 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.542 ' HB2' ' NE1' ' A' ' 35' ' ' TRP . 6.5 t -127.58 150.37 49.74 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.785 -1.197 . . . . 2.71 110.931 -179.541 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -80.23 -38.19 31.55 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.481 -0.762 . . . . 3.5600000000000001 109.657 179.229 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.474 ' O ' ' C ' ' A' ' 39' ' ' ARG . 6.5 mt -85.03 -61.27 1.81 Allowed 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.309 -0.87 . . . . 3.27 110.688 179.821 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.528 ' O ' ' HD2' ' A' ' 39' ' ' ARG . 0.0 OUTLIER 28.77 71.2 0.06 Allowed 'General case' 0 N--CA 1.511 2.621 0 CA-C-O 122.005 0.907 . . . . 2.1600000000000001 110.878 -179.203 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.9 85.48 6.75 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.412 -0.805 . . . . 3.79 111.136 -178.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -54.17 -19.99 6.01 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.453 -0.78 . . . . 3.0 110.373 178.673 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.506 ' CZ ' ' HA ' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -157.39 -145.4 0.14 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.345 -0.847 . . . . 3.6200000000000001 109.616 179.373 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . 0.258 0.4 OUTLIER -54.88 -26.92 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 O-C-N 120.909 -1.12 . . . . 5.3399999999999999 110.941 179.316 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.6 m -178.86 78.77 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.46 -0.775 . . . . 4.4699999999999998 109.354 179.734 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 43.41 58.71 3.31 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.606 -0.684 . . . . 2.3500000000000001 110.908 -179.602 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 36.6 m -142.22 77.9 1.6 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.066 -1.021 . . . . 3.7799999999999998 111.841 -179.274 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.506 ' HA ' ' CZ ' ' A' ' 42' ' ' ARG . 1.7 pm0 -96.39 154.49 17.24 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.366 -0.834 . . . . 2.02 109.833 178.633 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.21 -54.4 3.08 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.145 -0.972 . . . . 1.9199999999999999 110.613 -179.597 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.81 163.01 40.1 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.175 -0.953 . . . . 1.6399999999999999 110.974 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.674 ' O ' HD22 ' A' ' 21' ' ' LEU . 2.6 tp10 -94.71 91.35 6.47 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.435 -0.79 . . . . 2.0099999999999998 110.304 179.432 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.42 ' OG ' ' N ' ' A' ' 52' ' ' ILE . 96.4 p -145.82 -79.54 0.17 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.048 -1.032 . . . . 1.97 110.498 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.42 ' N ' ' OG ' ' A' ' 51' ' ' SER . 15.2 pt -70.71 -34.5 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.379 -0.826 . . . . 2.4500000000000002 110.472 -179.781 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.2 m -75.87 -33.21 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 O-C-N 121.361 -0.837 . . . . 1.98 110.405 179.544 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -86.32 -24.95 38.13 Favored Glycine 0 N--CA 1.498 2.794 0 N-CA-C 110.031 -1.228 . . . . 1.5700000000000001 110.031 179.855 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.8 t70 62.44 -165.53 0.23 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.66 -0.906 . . . . 2.1600000000000001 111.245 179.891 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.64 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 149.43 -54.53 0.5 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 108.326 -1.91 . . . . 1.1399999999999999 108.326 -179.308 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.419 ' OE2' ' N ' ' A' ' 1' ' ' GLY . 1.0 OUTLIER -117.79 -33.64 4.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.834 -0.804 . . . . 1.5 111.381 179.346 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.498 ' O ' ' NZ ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -52.88 97.61 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.19 -0.944 . . . . 1.71 110.433 179.945 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.498 ' NZ ' ' O ' ' A' ' 58' ' ' THR . 0.0 OUTLIER 68.88 -176.56 0.21 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.24 -0.652 . . . . 1.73 109.24 -178.535 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.472 ' N ' ' CG ' ' A' ' 59' ' ' LYS . 0.4 OUTLIER -99.08 102.49 15.71 Favored Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 120.785 -1.197 . . . . 1.54 110.546 -179.552 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.638 ' HG2' ' HB3' ' A' ' 64' ' ' LEU . 48.4 Cg_endo -73.17 142.9 34.81 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 O-C-N 123.616 1.324 . . . . 1.1100000000000001 111.048 -179.958 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -77.67 -48.1 17.59 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.543 -0.723 . . . . 2.6699999999999999 111.172 -179.751 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 81.3 mt -62.82 -35.25 79.28 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.467 -0.77 . . . . 2.3799999999999999 110.812 -179.657 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.64 HD13 ' HA2' ' A' ' 56' ' ' GLY . 0.5 OUTLIER -60.9 -55.63 30.73 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.19 -0.944 . . . . 2.46 109.975 179.394 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.4 m -68.93 -32.96 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.113 -0.992 . . . . 1.28 110.119 179.813 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.46 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 3.0 mm-40 -61.92 -53.52 54.58 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.239 -0.913 . . . . 1.76 108.881 178.257 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -63.06 -42.06 99.6 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.355 -0.841 . . . . 3.48 109.359 178.277 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 70.4 m -56.26 -35.07 67.02 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.997 -0.44 . . . . 1.6100000000000001 110.678 179.177 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -91.29 -40.94 11.22 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.166 -0.959 . . . . 1.3100000000000001 110.777 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 66' ' ' GLN . 3.4 mmtp -64.59 -44.76 89.63 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.576 -0.702 . . . . 2.8799999999999999 110.746 -179.851 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.41 ' N ' ' HD2' ' A' ' 72' ' ' PRO . . . -46.52 -63.56 3.02 Favored Glycine 0 N--CA 1.502 3.08 0 N-CA-C 110.455 -1.058 . . . . 1.04 110.455 -179.823 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 71' ' ' GLY . 40.2 Cg_endo -65.8 -38.15 24.87 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 O-C-N 123.736 1.387 . . . . 1.3899999999999999 110.644 179.545 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 10.5 t -60.68 -43.38 97.77 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.023 -1.048 . . . . 1.54 109.496 178.841 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 54.1 t -74.26 -42.95 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.487 -0.758 . . . . 1.3999999999999999 109.375 178.76 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -56.03 -44.62 78.92 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.701 -0.851 . . . . 1.5 108.701 178.318 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -66.78 -41.61 87.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.854 -0.529 . . . . 2.23 109.805 178.788 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.6 -50.12 75.13 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.432 -0.792 . . . . 3.3199999999999998 110.095 179.135 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.32 -44.11 92.56 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.61 -0.681 . . . . 1.3700000000000001 110.642 179.849 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.656 ' HD2' ' HB3' ' A' ' 84' ' ' ASN . 3.0 mmmm -66.39 -33.63 76.15 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.522 -0.736 . . . . 1.6599999999999999 110.162 179.488 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.37 -34.24 58.9 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.196 -0.94 . . . . 2.7999999999999998 111.119 -179.844 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.93 -39.62 25.9 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 121.368 -0.832 . . . . 3.1400000000000001 110.372 179.793 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.64 ' HB ' ' HD2' ' A' ' 83' ' ' PRO . 46.1 p -91.09 174.23 4.68 Favored Pre-proline 0 N--CA 1.502 2.174 0 O-C-N 121.339 -0.85 . . . . 1.5800000000000001 109.977 179.571 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.64 ' HD2' ' HB ' ' A' ' 82' ' ' THR . 46.8 Cg_endo -77.43 8.96 3.05 Favored 'Trans proline' 0 C--N 1.316 -1.139 0 O-C-N 123.225 1.118 . . . . 1.5900000000000001 111.651 179.049 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.656 ' HB3' ' HD2' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -76.37 51.03 0.68 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.902 -1.124 . . . . 2.0099999999999998 109.116 179.178 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -80.71 -150.46 6.93 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 110.716 -0.954 . . . . 2.0600000000000001 110.716 -179.083 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.1 -16.53 40.41 Favored 'Trans proline' 0 N--CA 1.49 1.279 0 O-C-N 123.912 1.48 . . . . 2.96 111.225 -179.916 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -63.92 -32.23 73.68 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.229 -0.919 . . . . 4.5599999999999996 108.627 178.512 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 48.8 t -102.92 -32.03 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.612 -0.68 . . . . 2.8199999999999998 109.813 178.284 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -169.87 -58.03 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.096 -1.003 . . . . 3.1099999999999999 111.467 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.793 0 N-CA-C 110.202 -1.159 . . . . 2.3599999999999999 110.202 -179.113 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.815 0 N-CA-C 110.492 -1.043 . . . . 6.75 110.492 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.484 ' OG ' ' N ' ' A' ' 3' ' ' MET . 30.0 t 52.5 -143.0 0.73 Allowed 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.911 -0.758 . . . . 5.9699999999999998 111.023 -179.966 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.484 ' N ' ' OG ' ' A' ' 2' ' ' SER . 0.6 OUTLIER -68.71 66.71 0.13 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.34 -0.85 . . . . 4.4100000000000001 110.446 179.876 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.5 m -79.39 11.56 2.91 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.181 -0.95 . . . . 5.7800000000000002 110.465 179.217 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.589 ' C ' HD12 ' A' ' 5' ' ' ILE . 1.4 pp -82.91 -170.07 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 O-C-N 121.616 -0.677 . . . . 4.9100000000000001 109.41 178.643 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.586 ' O ' ' HB3' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -109.69 -172.38 2.03 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.272 -0.892 . . . . 5.5099999999999998 110.648 179.906 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.586 ' HB3' ' O ' ' A' ' 6' ' ' MET . 1.3 t70 66.58 -43.34 0.41 Allowed 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.899 -0.5 . . . . 3.8300000000000001 111.002 -178.789 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -97.02 -34.19 11.27 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.704 -1.247 . . . . 3.1200000000000001 111.469 -179.754 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.51 ' OG ' ' HD3' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -59.71 -52.86 70.93 Favored Pre-proline 0 N--CA 1.503 2.196 0 O-C-N 121.05 -1.031 . . . . 3.6000000000000001 112.094 -179.609 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.51 ' HD3' ' OG ' ' A' ' 9' ' ' SER . 44.7 Cg_endo -70.4 -38.18 6.73 Favored 'Trans proline' 0 N--CA 1.49 1.292 0 O-C-N 123.039 1.021 . . . . 3.5 111.367 -179.418 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.0 p -69.6 -57.89 4.63 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.372 -0.83 . . . . 2.8300000000000001 110.198 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.3 p -59.52 -37.44 78.35 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.156 -0.965 . . . . 2.25 109.626 179.46 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.412 ' O ' HG22 ' A' ' 17' ' ' VAL . . . -65.44 -57.3 11.72 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.285 -1.526 . . . . 2.23 109.285 179.176 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.5 t -56.3 -39.71 61.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.685 -0.891 . . . . 3.0299999999999998 109.465 179.042 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.3 t -67.45 -42.73 87.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.055 -1.028 . . . . 1.9199999999999999 109.26 178.805 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 66.8 m -60.54 -52.6 64.5 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.685 -0.634 . . . . 1.6299999999999999 109.812 179.08 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.463 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 23.6 m -64.32 -35.46 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 119.829 -0.748 . . . . 2.2200000000000002 109.834 179.397 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.735 ' HA ' HD23 ' A' ' 21' ' ' LEU . 9.8 mt -68.71 -41.78 82.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 120.935 -1.103 . . . . 2.8500000000000001 109.042 178.432 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.8 t -64.04 -42.28 95.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.391 -0.966 . . . . 1.53 108.391 178.063 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 83.3 mt -64.68 -50.09 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.483 -0.761 . . . . 1.5900000000000001 109.153 178.51 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.735 HD23 ' HA ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -61.86 -41.16 97.5 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.878 -0.786 . . . . 2.52 108.878 178.827 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.572 ' N ' ' HG ' ' A' ' 21' ' ' LEU . 7.4 mm -60.97 -44.19 97.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.44 -0.948 . . . . 2.8199999999999998 108.44 177.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.77 -44.86 88.7 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.546 -0.721 . . . . 2.04 109.689 178.817 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.9 mm -59.68 -49.59 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.421 -0.955 . . . . 2.1000000000000001 108.421 178.434 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.1 -44.9 96.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.794 -0.566 . . . . 2.6800000000000002 110.002 178.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.73 -43.44 98.84 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.571 -0.706 . . . . 2.8999999999999999 109.251 178.683 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.1 tt -63.24 -46.97 84.44 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.029 -0.73 . . . . 2.73 109.029 178.24 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.38 -44.61 96.47 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 108.708 -1.757 . . . . 2.8999999999999999 108.708 178.617 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.67 -40.9 96.2 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.609 -0.936 . . . . 3.52 109.573 178.691 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.485 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 6.5 mt -61.33 -43.13 99.4 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.105 -0.702 . . . . 3.8300000000000001 109.105 178.536 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 35.4 mt -67.84 -49.26 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.451 -0.781 . . . . 3.4199999999999999 109.469 179.005 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.72 -39.2 90.69 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.658 -0.652 . . . . 3.7999999999999998 110.391 179.313 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.91 -42.19 31.05 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 110.244 -1.142 . . . . 4.46 110.244 179.86 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 30' ' ' LEU . 1.9 t -70.92 -40.97 71.79 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.054 -1.262 . . . . 4.6399999999999997 110.734 -179.858 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.421 ' CD1' ' HG3' ' A' ' 39' ' ' ARG . 0.3 OUTLIER -94.22 -10.91 31.49 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.285 -0.884 . . . . 3.8799999999999999 111.815 -179.491 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.416 ' O ' ' NH2' ' A' ' 39' ' ' ARG . 0.8 OUTLIER 62.62 172.68 0.14 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 122.192 0.996 . . . . 4.29 111.435 -179.89 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -82.85 -30.03 28.95 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 121.334 -0.854 . . . . 3.8900000000000001 110.888 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.94 11.27 20.65 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.264 -0.898 . . . . 3.1099999999999999 112.005 -179.479 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.421 ' HG3' ' CD1' ' A' ' 35' ' ' TRP . 0.0 OUTLIER 53.08 24.63 3.64 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 121.025 -1.047 . . . . 3.1899999999999999 112.02 179.238 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.15 168.13 20.47 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.232 -0.918 . . . . 3.1299999999999999 110.268 179.613 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 57.32 33.41 23.26 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.506 -0.746 . . . . 2.7000000000000002 109.451 -178.749 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -146.01 -58.21 0.31 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.395 -0.816 . . . . 3.8999999999999999 111.321 -178.801 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.472 HG13 ' OE2' ' A' ' 47' ' ' GLU . 23.2 pt -55.06 -31.45 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 CA-C-O 121.655 0.741 . . . . 3.7999999999999998 110.537 -179.781 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 71.56 49.87 0.28 Allowed 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 121.816 0.817 . . . . 2.98 109.446 -179.179 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -125.65 -63.11 1.15 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.872 -0.518 . . . . 4.0899999999999999 109.723 -179.611 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.7 p -79.59 -23.9 42.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.506 -0.746 . . . . 2.4500000000000002 110.102 179.253 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.472 ' OE2' HG13 ' A' ' 43' ' ' ILE . 0.8 OUTLIER -100.01 172.04 7.46 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-O 121.682 0.753 . . . . 3.1600000000000001 110.618 179.593 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.719 ' HB3' HD23 ' A' ' 64' ' ' LEU . 4.7 m-20 -86.39 -37.74 18.1 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.659 -0.651 . . . . 1.97 111.258 -178.567 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -144.45 174.9 10.53 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.376 -0.828 . . . . 2.0899999999999999 111.363 -178.792 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.78 -67.17 0.8 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.539 -0.725 . . . . 3.3999999999999999 110.556 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.444 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 0.6 OUTLIER -173.39 81.44 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.563 -0.711 . . . . 3.23 110.062 -179.984 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.677 HG23 ' HA ' ' A' ' 60' ' ' GLU . 27.8 mm 65.41 -44.93 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.703 -0.623 . . . . 3.2999999999999998 112.106 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.421 ' N ' ' O ' ' A' ' 51' ' ' SER . 33.7 m -50.37 -33.05 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.304 0 O-C-N 121.324 -0.86 . . . . 3.1699999999999999 111.596 -179.669 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -66.83 61.37 0.2 Allowed Glycine 0 N--CA 1.5 2.918 0 N-CA-C 110.88 -0.888 . . . . 2.0600000000000001 110.88 -179.265 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 53' ' ' VAL . 31.3 m-20 -86.13 146.42 26.6 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.427 -1.043 . . . . 3.4399999999999999 110.226 179.425 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 179.11 -49.74 0.09 OUTLIER Glycine 0 N--CA 1.5 2.954 0 N-CA-C 108.019 -2.033 . . . . 2.4700000000000002 108.019 -179.835 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -103.67 -50.63 3.37 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 122.046 -0.679 . . . . 4.25 109.299 178.554 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.7 m -122.93 124.28 42.85 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.427 -0.796 . . . . 4.0800000000000001 109.477 179.136 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 60' ' ' GLU . 0.0 OUTLIER -69.13 129.17 39.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.263 -0.898 . . . . 4.21 109.005 179.096 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.677 ' HA ' HG23 ' A' ' 52' ' ' ILE . 0.4 OUTLIER 64.04 63.9 1.33 Allowed Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.89 -0.506 . . . . 4.7800000000000002 110.209 -179.068 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.538 ' HB2' ' HB2' ' A' ' 64' ' ' LEU . 43.2 Cg_endo -68.27 55.9 0.82 Allowed 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 121.236 1.29 . . . . 3.1899999999999999 110.878 179.589 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -56.68 -46.01 81.39 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.287 -0.883 . . . . 5.3300000000000001 111.229 -179.544 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.458 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 2.2 mt -62.89 -37.33 86.51 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.588 -0.695 . . . . 4.8899999999999997 110.204 179.836 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.719 HD23 ' HB3' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -58.82 -59.29 5.68 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.31 -0.626 . . . . 2.9300000000000002 109.31 178.871 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.1 m -66.14 -34.65 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.397 -0.814 . . . . 3.0299999999999998 110.154 179.137 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -61.62 -48.11 82.36 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.142 -0.974 . . . . 4.5800000000000001 108.911 178.439 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.458 ' HB2' ' O ' ' A' ' 63' ' ' LEU . 0.1 OUTLIER -66.29 -48.36 70.63 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.967 -0.753 . . . . 5.29 108.967 178.412 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.514 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -55.43 -30.71 60.99 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 116.31 -0.405 . . . . 1.73 111.269 179.746 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.596 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -92.87 -48.18 6.67 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.125 -0.984 . . . . 2.2599999999999998 109.842 179.311 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.9 mmpp? -59.58 -51.41 69.95 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.685 -0.635 . . . . 3.75 111.511 -179.656 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.41 ' N ' ' HD2' ' A' ' 72' ' ' PRO . . . -42.87 -63.05 2.09 Favored Glycine 0 N--CA 1.504 3.231 0 N-CA-C 110.091 -1.203 . . . . 1.75 110.091 -179.631 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.524 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 41.1 Cg_endo -66.18 -40.21 16.03 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 O-C-N 123.721 1.379 . . . . 1.24 110.445 178.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.596 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 0.7 OUTLIER -62.28 -46.31 89.37 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.731 -1.23 . . . . 2.3100000000000001 109.786 179.125 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.472 ' O ' ' HG3' ' A' ' 77' ' ' LYS . 39.0 t -64.85 -49.79 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.694 -0.854 . . . . 2.5699999999999998 108.694 178.819 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.409 ' OE1' ' NZ ' ' A' ' 79' ' ' LYS . 8.6 tp10 -56.58 -40.67 75.63 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.221 0.534 . . . . 3.5299999999999998 110.084 179.025 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.524 ' HB2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -63.7 -52.98 58.17 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.514 -0.741 . . . . 2.5699999999999998 110.227 179.919 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.561 ' HG3' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -66.7 -31.87 72.81 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.334 -0.946 . . . . 3.21 109.778 179.552 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.561 ' N ' ' HG3' ' A' ' 77' ' ' LYS . . . -66.55 -46.69 75.26 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.202 -1.036 . . . . 2.5600000000000001 108.202 177.678 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.564 ' HE2' ' O ' ' A' ' 84' ' ' ASN . 7.8 mmtp -66.43 -40.79 89.72 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.05 -0.722 . . . . 3.4500000000000002 109.05 178.128 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.51 -49.36 78.07 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.301 -0.875 . . . . 2.48 110.504 179.26 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.47 -52.46 10.63 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.45 0.643 . . . . 3.8999999999999999 110.496 -179.725 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.43 122.75 46.95 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.486 -0.759 . . . . 3.9700000000000002 110.081 -179.649 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -71.1 19.97 0.23 Allowed 'Trans proline' 0 N--CA 1.495 1.604 0 O-C-N 123.581 1.306 . . . . 4.5599999999999996 112.046 178.958 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.564 ' O ' ' HE2' ' A' ' 79' ' ' LYS . 0.5 OUTLIER -70.84 45.49 0.09 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 120.973 -1.079 . . . . 5.0999999999999996 110.535 179.201 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 154.64 96.07 0.12 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 108.916 -1.674 . . . . 4.4199999999999999 108.916 -179.361 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.473 ' O ' ' HB3' ' A' ' 87' ' ' GLU . 46.0 Cg_endo -68.18 -166.39 0.14 Allowed 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 124.156 1.608 . . . . 5.3600000000000003 109.873 -179.747 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.473 ' HB3' ' O ' ' A' ' 86' ' ' PRO . 3.4 tt0 69.46 -53.77 0.6 Allowed 'General case' 0 N--CA 1.509 2.522 0 O-C-N 121.143 -0.973 . . . . 5.9500000000000002 109.685 -178.384 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.52 ' CG2' ' HD2' ' A' ' 79' ' ' LYS . 17.4 m -103.83 -1.84 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.689 -0.632 . . . . 3.9399999999999999 110.817 178.919 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 50.3 t60 -84.37 -43.87 14.29 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.844 -1.16 . . . . 3.9100000000000001 108.988 178.757 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.261 0 N-CA-C 108.749 -1.74 . . . . 3.96 108.749 178.828 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.578 0 N-CA-C 110.41 -1.076 . . . . 1.8899999999999999 110.41 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.537 ' HB3' ' O ' ' A' ' 5' ' ' ILE . 41.0 t -98.17 -166.65 1.4 Allowed 'General case' 0 N--CA 1.483 1.216 0 O-C-N 121.034 -1.274 . . . . 2.5899999999999999 109.935 179.435 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.8 mmt -77.91 -38.17 46.23 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.509 -0.744 . . . . 3.8799999999999999 110.429 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 75.4 p -120.62 -76.28 0.58 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.263 -0.898 . . . . 3.25 110.659 -179.739 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.537 ' O ' ' HB3' ' A' ' 2' ' ' SER . 0.2 OUTLIER -95.94 -143.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.814 -0.554 . . . . 3.6000000000000001 110.518 -179.328 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.8 mtt 51.49 65.22 1.55 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.289 -0.882 . . . . 4.1799999999999997 110.988 179.776 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.482 ' HB2' ' HD2' ' A' ' 10' ' ' PRO . 2.7 p30 -55.81 -35.01 65.87 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.229 -0.92 . . . . 1.6399999999999999 109.301 179.201 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 55.72 31.81 18.18 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.125 0.488 . . . . 3.2799999999999998 111.132 179.32 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.594 ' HB3' ' CD ' ' A' ' 10' ' ' PRO . 8.2 t -154.67 -68.22 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.413 -0.804 . . . . 1.8999999999999999 110.227 179.453 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.594 ' CD ' ' HB3' ' A' ' 9' ' ' SER . 39.4 Cg_endo -65.07 -48.64 3.43 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 O-C-N 123.076 1.04 . . . . 1.53 111.599 179.38 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.1 m -64.53 -50.88 65.61 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.013 -1.055 . . . . 1.8899999999999999 110.229 179.792 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -60.32 -37.31 80.2 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.342 -0.849 . . . . 2.1000000000000001 109.84 179.032 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.436 ' O ' HG22 ' A' ' 17' ' ' VAL . . . -69.13 -52.66 22.0 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 108.947 -1.661 . . . . 1.25 108.947 178.849 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.9 t -56.0 -40.25 62.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.785 -0.833 . . . . 1.5 109.477 178.95 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.2 t -68.16 -43.67 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.199 -0.938 . . . . 1.6899999999999999 109.363 178.77 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 53.1 m -58.53 -50.99 71.78 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.628 -0.67 . . . . 1.9099999999999999 110.164 179.436 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 13' ' ' GLY . 31.5 m -66.87 -33.68 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.371 -0.831 . . . . 1.6299999999999999 110.271 179.654 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.2 mm -69.25 -41.4 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 120.892 -1.13 . . . . 1.51 109.29 178.468 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.6 t -64.83 -44.15 96.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 108.413 -0.958 . . . . 1.77 108.413 177.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 21.8 mm -62.97 -46.91 95.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.479 -0.763 . . . . 2.1000000000000001 109.059 178.29 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 14.8 mt -59.98 -48.82 80.13 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.912 -0.773 . . . . 1.75 108.912 178.378 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.5 mm -57.45 -44.03 83.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.533 -0.729 . . . . 1.5800000000000001 109.412 178.503 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.47 -45.04 92.61 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.529 -0.732 . . . . 1.4199999999999999 109.718 179.008 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 37.6 mt -60.55 -45.39 97.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.418 -0.801 . . . . 1.8200000000000001 109.004 178.667 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.57 -45.57 89.87 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.48 -0.763 . . . . 1.1399999999999999 109.753 178.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.68 -43.87 97.17 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.8 -0.815 . . . . 1.1799999999999999 108.8 178.516 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.719 HD13 ' C ' ' A' ' 27' ' ' LEU . 3.0 tm? -60.04 -52.06 66.99 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.834 -0.802 . . . . 1.9199999999999999 108.834 178.076 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -54.91 -44.66 82.21 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 109.033 -1.627 . . . . 1.1899999999999999 109.033 178.68 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.6 -43.57 96.53 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.496 -1.002 . . . . 1.1499999999999999 109.878 179.071 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.8 mt -59.76 -40.78 89.35 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.498 -0.556 . . . . 1.6899999999999999 109.498 178.967 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 8.7 mt -71.54 -44.89 70.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.464 -0.773 . . . . 2.25 109.385 178.977 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.451 ' O ' ' HB2' ' A' ' 36' ' ' CYS . 0.4 OUTLIER -59.37 -48.44 81.64 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.301 -0.875 . . . . 2.0800000000000001 109.667 179.138 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.32 -55.63 28.13 Favored Glycine 0 N--CA 1.499 2.838 0 N-CA-C 109.663 -1.375 . . . . 1.1100000000000001 109.663 179.252 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 44.4 t -51.25 -49.19 61.64 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.493 -1.004 . . . . 1.1499999999999999 109.976 179.195 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 40.4 t90 -63.03 -49.24 75.37 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.294 -0.879 . . . . 3.1800000000000002 110.056 179.224 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -58.33 -33.64 69.75 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.239 -0.913 . . . . 2.04 110.585 179.475 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -79.09 -42.57 26.02 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.36 -0.837 . . . . 2.5800000000000001 110.62 179.864 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.521 HD21 ' HA ' ' A' ' 44' ' ' SER . 6.5 tp -85.25 -44.46 12.87 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.712 -0.617 . . . . 1.22 111.974 -179.261 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.534 ' CZ ' ' HB2' ' A' ' 39' ' ' ARG . 0.0 OUTLIER 66.57 -52.4 0.44 Allowed 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.648 -0.658 . . . . 1.8500000000000001 111.2 -179.244 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 38' ' ' LEU . 1.8 mt -76.56 70.3 3.08 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.282 -0.886 . . . . 2.3999999999999999 111.123 -179.722 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -67.82 -12.24 60.2 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.085 -1.009 . . . . 2.8700000000000001 111.313 179.509 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.467 ' HG3' ' N ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -69.01 -61.61 1.72 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.115 -0.991 . . . . 3.7999999999999998 109.1 179.744 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.467 ' N ' ' HG3' ' A' ' 42' ' ' ARG . 7.6 pt -81.24 -32.18 12.06 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-O 121.842 0.829 . . . . 1.98 108.982 178.277 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.521 ' HA ' HD21 ' A' ' 38' ' ' LEU . 0.1 OUTLIER 61.21 40.87 14.13 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 115.857 -0.61 . . . . 1.8 109.657 -179.462 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.507 ' HG3' ' CD1' ' A' ' 38' ' ' LEU . 3.7 mt-30 59.41 -82.54 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 122.185 -0.322 . . . . 2.27 110.487 -179.425 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.4 m 45.76 34.99 2.0 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.443 -0.786 . . . . 2.4399999999999999 111.679 179.291 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -79.78 165.44 22.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.162 -0.961 . . . . 2.8700000000000001 110.684 -179.658 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.93 86.43 6.53 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.388 -0.82 . . . . 4.4699999999999998 110.482 -179.746 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.75 169.32 10.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.109 -0.994 . . . . 4.7000000000000002 110.208 179.813 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.699 ' HB3' HG22 ' A' ' 53' ' ' VAL . 0.2 OUTLIER -77.81 -64.41 1.16 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.22 -0.925 . . . . 4.6500000000000004 110.181 -179.988 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 m -179.76 -44.74 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.746 -0.596 . . . . 4.8200000000000003 110.491 -179.941 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.554 HD13 ' N ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -125.44 -30.16 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.588 -0.695 . . . . 3.4300000000000002 110.817 -179.589 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.699 HG22 ' HB3' ' A' ' 50' ' ' GLU . 21.7 m -58.75 -34.72 52.75 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.405 0 O-C-N 120.653 -1.279 . . . . 3.5899999999999999 110.889 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -90.75 33.87 4.45 Favored Glycine 0 N--CA 1.499 2.839 0 N-CA-C 110.243 -1.143 . . . . 2.1899999999999999 110.243 179.763 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.425 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 22.7 t70 -76.32 164.96 25.52 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.319 -1.106 . . . . 2.0499999999999998 111.133 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 153.25 -50.9 0.49 Allowed Glycine 0 N--CA 1.495 2.593 0 N-CA-C 108.192 -1.963 . . . . 1.77 108.192 -179.84 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -126.17 31.27 5.46 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.886 -0.773 . . . . 2.4399999999999999 109.76 178.652 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.0 62.38 2.77 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.219 -0.925 . . . . 2.02 110.577 -179.718 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.43 151.22 25.83 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.162 -0.961 . . . . 2.6000000000000001 110.19 179.768 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.537 ' OE1' HG23 ' A' ' 65' ' ' VAL . 1.1 tm-20 -85.76 115.56 62.14 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.23 -0.919 . . . . 2.4900000000000002 110.145 179.87 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -80.69 31.48 0.5 Allowed 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.534 1.281 . . . . 3.6499999999999999 111.581 -179.941 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.7 t80 70.55 -30.17 0.2 Allowed 'General case' 0 N--CA 1.508 2.44 0 O-C-N 121.181 -0.949 . . . . 2.5899999999999999 112.73 -179.851 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.0 mt -56.07 -41.03 74.48 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.959 -1.088 . . . . 2.8399999999999999 111.721 -179.384 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.37 -47.46 84.06 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.686 -0.806 . . . . 3.1099999999999999 110.031 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.537 HG23 ' OE1' ' A' ' 60' ' ' GLU . 21.6 t -70.46 -34.38 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.097 -1.002 . . . . 1.9299999999999999 109.161 178.637 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -58.86 -52.28 66.39 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.783 -0.821 . . . . 2.21 108.783 178.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -66.06 -43.3 87.84 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.597 -0.689 . . . . 4.3099999999999996 109.46 178.28 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.418 ' HB2' ' HA ' ' A' ' 65' ' ' VAL . 69.7 m -58.45 -40.5 82.78 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.9 -0.5 . . . . 2.1699999999999999 110.393 179.342 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.518 ' O ' ' HB2' ' A' ' 73' ' ' CYS . . . -83.71 -44.86 14.03 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.325 -0.86 . . . . 1.47 111.05 -179.948 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.3 mmtp -61.61 -45.7 92.96 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.384 -0.823 . . . . 1.8899999999999999 111.128 -179.613 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -43.02 -64.9 1.56 Allowed Glycine 0 N--CA 1.506 3.319 0 N-CA-C 110.679 -0.968 . . . . 1.3799999999999999 110.679 -179.397 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.418 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 40.6 Cg_endo -65.51 -38.59 24.81 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 O-C-N 123.779 1.41 . . . . 1.4399999999999999 110.45 179.41 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.518 ' HB2' ' O ' ' A' ' 69' ' ' ALA . 0.5 OUTLIER -62.14 -46.36 89.38 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.964 -1.085 . . . . 1.45 109.571 178.8 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.7 t -68.37 -45.4 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 109.004 -0.739 . . . . 1.4099999999999999 109.004 178.672 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.416 ' O ' ' HG3' ' A' ' 79' ' ' LYS . 2.6 tm-20 -56.9 -43.38 81.29 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.502 0.668 . . . . 1.7 109.559 178.549 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.418 ' HD2' ' O ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -64.99 -48.32 74.38 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.728 -0.607 . . . . 2.2599999999999998 109.683 178.925 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.58 -42.67 97.18 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.583 -0.698 . . . . 1.9099999999999999 110.187 179.789 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.03 -41.98 97.25 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.866 -0.521 . . . . 1.1599999999999999 109.657 179.125 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 75' ' ' GLU . 5.0 mttp -68.07 -47.58 67.91 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.29 -0.633 . . . . 1.98 109.29 178.67 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.96 -39.13 71.3 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.425 -0.797 . . . . 1.8400000000000001 109.63 178.904 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.3 ttt -77.13 -59.98 2.55 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.658 -0.651 . . . . 3.1400000000000001 109.981 179.324 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.6 p -129.09 86.39 57.24 Favored Pre-proline 0 N--CA 1.499 2.011 0 O-C-N 121.238 -0.914 . . . . 1.8999999999999999 109.483 179.291 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.412 ' O ' ' CB ' ' A' ' 84' ' ' ASN . 45.1 Cg_endo -68.91 -29.57 27.87 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 O-C-N 123.865 1.455 . . . . 1.6000000000000001 111.822 -179.114 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.412 ' CB ' ' O ' ' A' ' 83' ' ' PRO . 5.0 t30 69.78 -51.14 0.63 Allowed 'General case' 0 N--CA 1.506 2.368 0 O-C-N 121.716 -0.615 . . . . 2.3999999999999999 111.29 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.04 -92.32 0.71 Allowed Glycine 0 N--CA 1.499 2.834 0 N-CA-C 109.48 -1.448 . . . . 2.1000000000000001 109.48 -179.736 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.539 ' O ' ' HB2' ' A' ' 87' ' ' GLU . 50.9 Cg_endo -79.25 -155.85 0.06 OUTLIER 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.838 1.441 . . . . 2.7999999999999998 110.259 179.558 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.539 ' HB2' ' O ' ' A' ' 86' ' ' PRO . 1.2 mp0 65.71 -55.73 0.35 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.582 -0.699 . . . . 3.3599999999999999 109.891 -178.812 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.477 ' N ' ' O ' ' A' ' 86' ' ' PRO . 19.7 t -95.03 -31.14 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.68 -0.638 . . . . 2.3799999999999999 109.544 178.072 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 33.1 m80 49.37 46.64 23.07 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.518 -0.739 . . . . 2.8700000000000001 111.735 179.534 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.843 0 CA-C-O 117.86 -1.522 . . . . 2.54 110.127 179.48 . . . . . . . . 0 0 . 1 stop_ save_